CG	OMIM_ID	REF_SEQ	e_value	gene	description	disease
CG9485-PA	232400	NP_000019	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000019	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000019	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG2316-PA	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG2316-PB	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG2316-PC	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG2316-PD	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG2316-PE	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG2316-PG	300371	NP_000024	0	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG32626-PA	102770	NP_000027	0	AMPD1	AMP DEAMINASE	Myoadenylate deaminase deficiency (3)
CG32626-PB	102770	NP_000027	0	AMPD1	AMP DEAMINASE	Myoadenylate deaminase deficiency (3)
CG32626-PC	102770	NP_000027	0	AMPD1	AMP DEAMINASE	Myoadenylate deaminase deficiency (3)
CG32626-PD	102770	NP_000027	0	AMPD1	AMP DEAMINASE	Myoadenylate deaminase deficiency (3)
CG1651-PA	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PB	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PC	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PD	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PB	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PC	182900	NP_000028	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1886-PA	300011	NP_000043	0	ATP7A;MK;MNK;OHS		Cutis laxa, neonatal (3);Menkes disease, 309400 (3);Occipital horn syndrome, 304150 (3)
CG1886-PA	606882	NP_000044	0	ATP7B;WND		Wilson disease, 277900 (3)
CG1522-PA	601011	NP_000059	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PA	601011	NP_000059	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PB	601011	NP_000059	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PC	601011	NP_000059	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PD	601011	NP_000059	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG1522-PA	114208	NP_000060	0	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG4894-PA	114208	NP_000060	0	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG4894-PB	114208	NP_000060	0	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG4894-PC	114208	NP_000060	0	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG4894-PD	114208	NP_000060	0	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG5284-PA	300008	NP_000075	0	CLCK2;CLCN5;DENTS;NPHL2	CHLORIDE CHANNEL, VOLTAGE-GATED, K2; CLCK2;CLC5	Dent disease, 300009 (3);Hypophosphatemia, type III (3);Nephrolithiasis, type I, 310468 (3);Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis (3)
CG5284-PB	300008	NP_000075	0	CLCK2;CLCN5;DENTS;NPHL2	CHLORIDE CHANNEL, VOLTAGE-GATED, K2; CLCK2;CLC5	Dent disease, 300009 (3);Hypophosphatemia, type III (3);Nephrolithiasis, type I, 310468 (3);Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis (3)
CG7430-PA	238331	NP_000099	0	DLD;LAD;PHE3	BRANCHED CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX, E3 COMPONENT;DIAPHORASE;DIHYDROLIPOYL DEHYDROGENASE;GLYCINE CLEAVAGE SYSTEM L PROTEIN; GCSL;LIPOAMIDE DEHYDROGENASE; LAD;LIPOAMIDE REDUCTASE;LIPOYL DEHYDROGENASE;PYRUVATE DEHYDROGENASE COMPONENT E3; PHE3; E3	Leigh syndrome, 256000 (3);Maple syrup urine disease, type III, 248600 (3)
CG31175-PA	300377	NP_000100	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_000100	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_000100	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG2194-PB	274270	NP_000101	0	DPD;DPYD	DIHYDROPYRIMIDINURIA; DHP;DPD	Thymine-uraciluria (3);{Fluorouracil toxicity, sensitivity to} (3)
CG2194-PC	274270	NP_000101	0	DPD;DPYD	DIHYDROPYRIMIDINURIA; DHP;DPD	Thymine-uraciluria (3);{Fluorouracil toxicity, sensitivity to} (3)
CG8019-PA	133510	NP_000113	0	ERCC3;XPB	XPB GENE; XPB	Trichothiodystrophy, 601675 (3);Xeroderma pigmentosum, group B, 610651 (3)
CG10117-PA	608177	NP_000118	0	EXT1	EXT	Chondrosarcoma, 215300 (3);Exostoses, multiple, type 1, 133700 (3)
CG4094-PA	136850	NP_000134	0	FH	FUMARASE	Fumarase deficiency, 606812 (3);Leiomyomatosis and renal cell cancer, 605839 (3);Multiple cutaneous and uterine leiomyomata, 150800 (3)
CG4094-PB	136850	NP_000134	0	FH	FUMARASE	Fumarase deficiency, 606812 (3);Leiomyomatosis and renal cell cancer, 605839 (3);Multiple cutaneous and uterine leiomyomata, 150800 (3)
CG4095-PA	136850	NP_000134	0	FH	FUMARASE	Fumarase deficiency, 606812 (3);Leiomyomatosis and renal cell cancer, 605839 (3);Multiple cutaneous and uterine leiomyomata, 150800 (3)
CG33138-PA	607839	NP_000149	0	GBE1	1,4-@ALPHA-GLUCAN BRANCHING ENZYME;AMYLO-(1,4 to 1,6) TRANSGLUCOSIDASE;AMYLO-(1,4 to 1,6) TRANSGLYCOSYLASE;GBE	Glycogen storage disease IV, 232500 (3)
CG3999-PA	238300	NP_000161	0	GCE;GCSP;GLDC;HYGN1;NKH	GLYCINE CLEAVAGE SYSTEM P PROTEIN; GCSP;GLYCINE DEHYDROGENASE	Glycine encephalopathy, 605899 (3)
CG8251-PA	172400	NP_000166	0	GPI	AUTOCRINE MOTILITY FACTOR; AMF;GLUCOSEPHOSPHATE ISOMERASE;NEUROLEUKIN; NLK;PHOSPHOGLUCOSE ISOMERASE; PGI;PHOSPHOHEXOSE ISOMERASE; PHI	Hemolytic anemia due to glucosephosphate isomerase deficiency (3);Hydrops fetalis, one form (1)
CG8251-PB	172400	NP_000166	0	GPI	AUTOCRINE MOTILITY FACTOR; AMF;GLUCOSEPHOSPHATE ISOMERASE;NEUROLEUKIN; NLK;PHOSPHOGLUCOSE ISOMERASE; PGI;PHOSPHOHEXOSE ISOMERASE; PHI	Hemolytic anemia due to glucosephosphate isomerase deficiency (3);Hydrops fetalis, one form (1)
CG8251-PC	172400	NP_000166	0	GPI	AUTOCRINE MOTILITY FACTOR; AMF;GLUCOSEPHOSPHATE ISOMERASE;NEUROLEUKIN; NLK;PHOSPHOGLUCOSE ISOMERASE; PGI;PHOSPHOHEXOSE ISOMERASE; PHI	Hemolytic anemia due to glucosephosphate isomerase deficiency (3);Hydrops fetalis, one form (1)
CG7003-PA	600678	NP_000170	0	GTBP;HNPCC5;MSH6	G/T MISMATCH-BINDING PROTEIN; GTBP	Colorectal cancer, hereditary nonpolyposis, type 5 (3);Endometrial carcinoma (3);Ovarian cancer, endometrial type (3);{Cancer susceptibility} (3)
CG4389-PA	600890	NP_000173	0	HADHA;MTPA	ALPHA SUBUNIT; HADHA;ECHA;LONG-CHAIN HYDROXYACYL-CoA DEHYDROGENASE; LCHAD;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT; MTPA;TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT	Fatty liver, acute, of pregnancy (3);HELLP syndrome, maternal, of pregnancy (3);LCHAD deficiency (3);Trifunctional protein deficiency, type 1 (3)
CG4389-PB	600890	NP_000173	0	HADHA;MTPA	ALPHA SUBUNIT; HADHA;ECHA;LONG-CHAIN HYDROXYACYL-CoA DEHYDROGENASE; LCHAD;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT; MTPA;TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT	Fatty liver, acute, of pregnancy (3);HELLP syndrome, maternal, of pregnancy (3);LCHAD deficiency (3);Trifunctional protein deficiency, type 1 (3)
CG4389-PC	600890	NP_000173	0	HADHA;MTPA	ALPHA SUBUNIT; HADHA;ECHA;LONG-CHAIN HYDROXYACYL-CoA DEHYDROGENASE; LCHAD;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT; MTPA;TRIFUNCTIONAL PROTEIN, ALPHA SUBUNIT	Fatty liver, acute, of pregnancy (3);HELLP syndrome, maternal, of pregnancy (3);LCHAD deficiency (3);Trifunctional protein deficiency, type 1 (3)
CG18402-PA	147670	NP_000199	0	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG5602-PA	126391	NP_000225	0	LIG1	DNA LIGASE I	DNA ligase I deficiency (3)
CG3182-PA	152427	NP_000229	0	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3182-PB	152427	NP_000229	0	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG11482-PA	120436	NP_000240	0	COCA2;HNPCC2;MLH1		Cafe-au-lait spots with glioma or leukemia, 114030 (3);Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3);Muir-Torre syndrome, 158320 (3);Turcot syndrome with glioblastoma, 276300 (3)
CG4215-PA	162200	NP_000242	0	NF1;NFNS;VRNF;WSS	NEUROFIBROMATOSIS;VON RECKLINGHAUSEN DISEASE	Leukemia, juvenile myelomonocytic, 607785 (3);Melanoma, desmoplastic neurotropic (2);Neurofibromatosis, familial spinal, 162210 (3);Neurofibromatosis, type 1 (3);Neurofibromatosis-Noonan syndrome, 601321 (3);Pseudarthrosis, tibial, in NF1 (3);Watson syndrome, 193520 (3)
CG4215-PA	609309	NP_000242	0	COCA1;FCC1;HNPCC1;MSH2		Cafe-au-lait spots, multiple, with leukemia, 114030 (3);Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);Glioblastoma, early-onset, 137800 (3);Lymphoma, T-cell (3);Lynch cancer family syndrome II, 114400 (3);Muir-Torre syndrome, 158320 (3);Neurofibromatosis, type I, with leukemia, 162200 (3);Ovarian cancer (3)
CG4215-PB	162200	NP_000242	0	NF1;NFNS;VRNF;WSS	NEUROFIBROMATOSIS;VON RECKLINGHAUSEN DISEASE	Leukemia, juvenile myelomonocytic, 607785 (3);Melanoma, desmoplastic neurotropic (2);Neurofibromatosis, familial spinal, 162210 (3);Neurofibromatosis, type 1 (3);Neurofibromatosis-Noonan syndrome, 601321 (3);Pseudarthrosis, tibial, in NF1 (3);Watson syndrome, 193520 (3)
CG4215-PB	609309	NP_000242	0	COCA1;FCC1;HNPCC1;MSH2		Cafe-au-lait spots, multiple, with leukemia, 114030 (3);Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);Glioblastoma, early-onset, 137800 (3);Lymphoma, T-cell (3);Lynch cancer family syndrome II, 114400 (3);Muir-Torre syndrome, 158320 (3);Neurofibromatosis, type I, with leukemia, 162200 (3);Ovarian cancer (3)
CG9115-PA	300415	NP_000243	0	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG15792-PA	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG15792-PB	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PA	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PB	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PC	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PD	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PE	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PF	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PG	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PH	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PI	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PJ	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PK	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PL	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG17927-PM	160760	NP_000248	0	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG2146-PA	160777	NP_000250	0	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG2146-PB	160777	NP_000250	0	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG2146-PC	160777	NP_000250	0	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG6976-PA	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG6976-PB	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG6976-PC	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG6976-PD	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG7595-PA	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG7595-PB	276903	NP_000251	0	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG12092-PA	607623	NP_000262	0	NPC;NPC1		Niemann-Pick disease, type C1, 257220 (3);Niemann-Pick disease, type D, 257220 (3)
CG5722-PA	607623	NP_000262	0	NPC;NPC1		Niemann-Pick disease, type C1, 257220 (3);Niemann-Pick disease, type D, 257220 (3)
CG4001-PA	610681	NP_000280	0		PFK, MUSCLE TYPE	
CG4001-PB	610681	NP_000280	0		PFK, MUSCLE TYPE	
CG4001-PC	610681	NP_000280	0		PFK, MUSCLE TYPE	
CG7766-PA	306000	NP_000283	0	PHK;PHKA2	GLYCOGENOSIS VIIIA;HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK;LIVER GLYCOGENOSIS, X-LINKED, TYPE I;PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL;X-LINKED LIVER GLYCOGENOSIS; XLG	Glycogenosis, X-linked hepatic, type I (3);Glycogenosis, X-linked hepatic, type II (3)
CG7766-PB	306000	NP_000283	0	PHK;PHKA2	GLYCOGENOSIS VIIIA;HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK;LIVER GLYCOGENOSIS, X-LINKED, TYPE I;PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL;X-LINKED LIVER GLYCOGENOSIS; XLG	Glycogenosis, X-linked hepatic, type I (3);Glycogenosis, X-linked hepatic, type II (3)
CG8475-PA	172490	NP_000284	0	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG6199-PA	153454	NP_000293	0	PLOD;PLOD1	LYSINE HYDROXYLASE;LYSYL HYDROXYLASE 1; LH1;LYSYL HYDROXYLASE; LLH; LH	Ehlers-Danlos syndrome, type VI, 225400 (3);Nevo syndrome, 601451 (3)
CG6199-PB	153454	NP_000293	0	PLOD;PLOD1	LYSINE HYDROXYLASE;LYSYL HYDROXYLASE 1; LH1;LYSYL HYDROXYLASE; LLH; LH	Ehlers-Danlos syndrome, type VI, 225400 (3);Nevo syndrome, 601451 (3)
CG9071-PA	603967	NP_000325	0	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG9071-PB	603967	NP_000325	0	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG9907-PA	603967	NP_000325	0	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG9907-PA	600163	NP_000326	0	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG31547-PA	600839	NP_000329	0	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG31547-PB	600839	NP_000329	0	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG4357-PA	600839	NP_000329	0	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG4357-PA	600968	NP_000330	0	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG12008-PA	182870	NP_000338	0	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG5870-PA	182870	NP_000338	0	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG7642-PA	607633	NP_000370	0	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG10505-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG11897-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG11897-PB	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG14709-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG31792-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG31793-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG4562-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG5789-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG6214-PB	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG7627-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG8799-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG9270-PA	601107	NP_000383	0	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG9433-PA	126340	NP_000391	0	COFS2;EM9;ERCC2;XPD	DNA REPAIR DEFECT EM9 OF CHINESE HAMSTER OVARY CELLS, COMPLEMENTATION;OF; EM9	Cerebrooculofacioskeletal syndrome 2, 610756 (3);Trichothiodystrophy, 601675 (3);Xeroderma pigmentosum, group D, 278730 (3)
CG9433-PB	126340	NP_000391	0	COFS2;EM9;ERCC2;XPD	DNA REPAIR DEFECT EM9 OF CHINESE HAMSTER OVARY CELLS, COMPLEMENTATION;OF; EM9	Cerebrooculofacioskeletal syndrome 2, 610756 (3);Trichothiodystrophy, 601675 (3);Xeroderma pigmentosum, group D, 278730 (3)
CG33038-PA	608210	NP_000392	0	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG33038-PC	608210	NP_000392	0	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG12529-PA	305900	NP_000393	0	G6PD;G6PD1		Favism (3);G6PD deficiency (3);Hemolytic anemia due to G6PD deficiency (3)
CG12529-PB	305900	NP_000393	0	G6PD;G6PD1		Favism (3);G6PD deficiency (3);Hemolytic anemia due to G6PD deficiency (3)
CG8256-PA	138430	NP_000399	0	GPD2	GDH2;GLYCEROPHOSPHATE DEHYDROGENASE-2 Ca(2+)-RESPONSIVE MITOCHONDRIAL FAD-LINKED;GPD, MITOCHONDRIAL; GPDM	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG8256-PB	138430	NP_000399	0	GPD2	GDH2;GLYCEROPHOSPHATE DEHYDROGENASE-2 Ca(2+)-RESPONSIVE MITOCHONDRIAL FAD-LINKED;GPD, MITOCHONDRIAL; GPDM	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG8256-PC	138430	NP_000399	0	GPD2	GDH2;GLYCEROPHOSPHATE DEHYDROGENASE-2 Ca(2+)-RESPONSIVE MITOCHONDRIAL FAD-LINKED;GPD, MITOCHONDRIAL; GPDM	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG15288-PA	156225	NP_000417	0	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG15288-PB	156225	NP_000417	0	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG8440-PA	601545	NP_000421	0	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG8440-PB	601545	NP_000421	0	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG8440-PC	601545	NP_000421	0	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG8440-PD	601545	NP_000421	0	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG8440-PE	601545	NP_000421	0	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG3936-PA	600276	NP_000426	0	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG10181-PA	171060	NP_000434	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10226-PA	171060	NP_000434	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG3879-PA	171060	NP_000434	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG8523-PA	171060	NP_000434	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG32626-PA	102772	NP_000471	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PB	102772	NP_000471	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PC	102772	NP_000471	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PD	102772	NP_000471	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG4861-PA	606945	NP_000518	0	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG5322-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG6206-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG6206-PB	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG9463-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG9465-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG9466-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG9468-PA	609458	NP_000519	0	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG10844-PA	180901	NP_000531	0	CCO;MHS;RYR1	RYANODINE RECEPTOR, SKELETAL MUSCLE; RYDR;SARCOPLASMIC RETICULUM CALCIUM RELEASE CHANNEL;SKELETAL MUSCLE RYANODINE RECEPTOR; SKRR	Central core disease, 117000 (3);{Malignant hyperthermia susceptibility 1}, 145600 (3)
CG10844-PB	180901	NP_000531	0	CCO;MHS;RYR1	RYANODINE RECEPTOR, SKELETAL MUSCLE; RYDR;SARCOPLASMIC RETICULUM CALCIUM RELEASE CHANNEL;SKELETAL MUSCLE RYANODINE RECEPTOR; SKRR	Central core disease, 117000 (3);{Malignant hyperthermia susceptibility 1}, 145600 (3)
CG10844-PC	180901	NP_000531	0	CCO;MHS;RYR1	RYANODINE RECEPTOR, SKELETAL MUSCLE; RYDR;SARCOPLASMIC RETICULUM CALCIUM RELEASE CHANNEL;SKELETAL MUSCLE RYANODINE RECEPTOR; SKRR	Central core disease, 117000 (3);{Malignant hyperthermia susceptibility 1}, 145600 (3)
CG10844-PD	180901	NP_000531	0	CCO;MHS;RYR1	RYANODINE RECEPTOR, SKELETAL MUSCLE; RYDR;SARCOPLASMIC RETICULUM CALCIUM RELEASE CHANNEL;SKELETAL MUSCLE RYANODINE RECEPTOR; SKRR	Central core disease, 117000 (3);{Malignant hyperthermia susceptibility 1}, 145600 (3)
CG6713-PA	163729	NP_000594	0	NOS3	NITRIC OXIDE SYNTHASE, ENDOTHELIAL; ENOS	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);{Coronary spasms, susceptibility to} (3);{Hypertension, pregnancy-induced}, 189800 (3);{Hypertension, susceptibility to}, 145500 (3);{Placental abruption} (3)
CG6713-PA	163731	NP_000611	0	IHPS1;NOS1		{Pyloric stenosis, infantile hypertrophic, 1, susceptibility to}, 179010 (3)
CG6713-PA	163730	NP_000616	0	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG9485-PA	232400	NP_000633	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000633	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000633	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PA	232400	NP_000634	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000634	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000634	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PA	232400	NP_000635	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000635	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000635	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PA	232400	NP_000636	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000636	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000636	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PA	232400	NP_000637	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PB	232400	NP_000637	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG9485-PC	232400	NP_000637	0	AGL;GDE	AGL DEFICIENCY;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;CORI DISEASE;FORBES DISEASE;GDE DEFICIENCY;GLYCOGEN DEBRANCHER DEFICIENCY;GLYCOGEN DEBRANCHING DEFICIENCY;LIMIT DEXTRINOSIS	Glycogen storage disease IIIa (3);Glycogen storage disease IIIb (3)
CG11654-PA	180960	NP_000678	0	AHCY;SAHH	HYPERMETHIONINEMIA WITH DEFICIENCY OF S-ADENOSYLHOMOCYSTEINE HYDROLASE,;SAHH	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase (3)
CG3752-PA	100650	NP_000681	0	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG5670-PA	182340	NP_000693	0	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG5670-PB	182340	NP_000693	0	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG5670-PC	182340	NP_000693	0	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG5670-PD	182340	NP_000693	0	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG1522-PA	114205	NP_000710	0	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG4894-PA	114205	NP_000710	0	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG4894-PB	114205	NP_000710	0	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG4894-PC	114205	NP_000710	0	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG4894-PD	114205	NP_000710	0	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG10367-PA	142910	NP_000850	0	HMGCR	HMG-CoA REDUCTASE	[Statins, attenuated cholesterol lowering by] (3)
CG18402-PA	147370	NP_000866	0	IGF1R		Intrauterine and postnatal growth retardation (3)
CG1799-PA	146690	NP_000874	0	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG1799-PC	146690	NP_000874	0	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG1516-PA	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PB	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PD	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PE	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PG	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PI	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PJ	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PK	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PL	608786	NP_000911	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG10181-PA	171050	NP_000918	0	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG10226-PA	171050	NP_000918	0	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG3879-PA	171050	NP_000918	0	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG8523-PA	171050	NP_000918	0	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG11567-PA	124015	NP_000932	0	POR	CYTOCHROME P450 REDUCTASE	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3);Antley-Bixler syndrome-like with disordered steroidogenesis, 201750 (3);Disordered steroidogenesis, isolated, 201750 (3);POR deficiency, 201750 (3)
CG2165-PA	108733	NP_001001331	0	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG2165-PB	108733	NP_001001331	0	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG32451-PA	604384	NP_001001485	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PC	604384	NP_001001485	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PA	604384	NP_001001486	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PC	604384	NP_001001486	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PA	604384	NP_001001487	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PC	604384	NP_001001487	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG18102-PB	602378	NP_001005360	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PC	602378	NP_001005360	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PD	602378	NP_001005360	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PB	602378	NP_001005361	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PC	602378	NP_001005361	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PD	602378	NP_001005361	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PB	602378	NP_001005362	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PC	602378	NP_001005362	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PD	602378	NP_001005362	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG10693-PA	600150	NP_001014797	0	KCNMA1;SLO	M, ALPHA MEMBER 1; KCNMA1;SLO-ALPHA;SLOWPOKE, DROSOPHILA, HOMOLOG OF; SLO	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
CG10693-PB	600150	NP_001014797	0	KCNMA1;SLO	M, ALPHA MEMBER 1; KCNMA1;SLO-ALPHA;SLOWPOKE, DROSOPHILA, HOMOLOG OF; SLO	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
CG8363-PA	603005	NP_001015880	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PB	603005	NP_001015880	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PC	603005	NP_001015880	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PD	603005	NP_001015880	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PE	603005	NP_001015880	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG7470-PA	138250	NP_001017423	0	PYCS;GSAS	GLUTAMATE GAMMA-SEMIALDEHYDE SYNTHETASE; GSAS;HYPERAMMONEMIA WITH HYPOORNITHINEMIA, HYPOCITRULLINEMIA, HYPOARGININEMIA,;P5CS	Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and hypoprolinemia (3)
CG2093-PA	605978	NP_001018047	0	CHAC;VPS13A	CHAC GENE; CHAC;CHOREIN;KIAA0986	Choreoacanthocytosis, 200150 (3)
CG2093-PA	605978	NP_001018048	0	CHAC;VPS13A	CHAC GENE; CHAC;CHOREIN;KIAA0986	Choreoacanthocytosis, 200150 (3)
CG31092-PA	192977	NP_001018066	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG31092-PB	192977	NP_001018066	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG4861-PA	192977	NP_001018066	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG12008-PA	182870	NP_001020029	0	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG5870-PA	182870	NP_001020029	0	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG32626-PA	102772	NP_001020560	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PB	102772	NP_001020560	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PC	102772	NP_001020560	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PD	102772	NP_001020560	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PA	102772	NP_001020561	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PB	102772	NP_001020561	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PC	102772	NP_001020561	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG32626-PD	102772	NP_001020561	0	AMPD3		[AMP deaminase deficiency, erythrocytic] (3)
CG10844-PA	180902	NP_001026	0	ARVC2;ARVD2;RYR2;VTSIP	RYANODINE RECEPTOR, CARDIAC	Arrhythmogenic right ventricular dysplasia 2, 600996 (3);Ventricular tachycardia, stress-induced polymorphic, 604772 (3)
CG10844-PB	180902	NP_001026	0	ARVC2;ARVD2;RYR2;VTSIP	RYANODINE RECEPTOR, CARDIAC	Arrhythmogenic right ventricular dysplasia 2, 600996 (3);Ventricular tachycardia, stress-induced polymorphic, 604772 (3)
CG10844-PC	180902	NP_001026	0	ARVC2;ARVD2;RYR2;VTSIP	RYANODINE RECEPTOR, CARDIAC	Arrhythmogenic right ventricular dysplasia 2, 600996 (3);Ventricular tachycardia, stress-induced polymorphic, 604772 (3)
CG10844-PD	180902	NP_001026	0	ARVC2;ARVD2;RYR2;VTSIP	RYANODINE RECEPTOR, CARDIAC	Arrhythmogenic right ventricular dysplasia 2, 600996 (3);Ventricular tachycardia, stress-induced polymorphic, 604772 (3)
CG8475-PA	172490	NP_001027005	0	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG12891-PA	600528	NP_001027017	0	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12891-PB	600528	NP_001027017	0	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG8380-PA	163970	NP_001034	0	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15792-PA	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PB	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PA	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PB	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PC	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PD	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PE	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PF	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PG	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PH	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PI	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PJ	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PK	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PL	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PM	160745	NP_001035202	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PA	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PB	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PA	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PB	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PC	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PD	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PE	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PF	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PG	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PH	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PI	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PJ	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PK	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PL	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PM	160745	NP_001035203	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG4545-PA	182138	NP_001036	0	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG10223-PA	126430	NP_001058	0	TOP2A;TOP2	DNA TOPOISOMERASE II; TOP2	DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)
CG32702-PA	602997	NP_001072	0	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG1718-PA	601615	NP_001080	0	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG6052-PA	601615	NP_001080	0	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG10067-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG12051-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG18290-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG18290-PB	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG4027-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG4027-PB	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG5178-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG7478-PA	102610	NP_001091	0	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG10067-PA	102630	NP_001092	0		BETA-ACTIN	
CG12051-PA	102630	NP_001092	0		BETA-ACTIN	
CG18290-PA	102630	NP_001092	0		BETA-ACTIN	
CG18290-PB	102630	NP_001092	0		BETA-ACTIN	
CG4027-PA	102630	NP_001092	0		BETA-ACTIN	
CG4027-PB	102630	NP_001092	0		BETA-ACTIN	
CG5178-PA	102630	NP_001092	0		BETA-ACTIN	
CG7478-PA	102630	NP_001092	0		BETA-ACTIN	
CG4376-PA	102574	NP_001095	0	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG4376-PB	102574	NP_001095	0	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG4376-PC	102574	NP_001095	0	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG1651-PA	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PB	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PC	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PD	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG7462-PB	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG7462-PC	106410	NP_001139	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG6214-PB	603234	NP_001162	0	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG4252-PA	601215	NP_001175	0	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG15804-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG17150-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG17629-PD	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG17866-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG1842-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG3339-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG3723-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG5526-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG7092-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG7507-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG7507-PB	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG9492-PA	603335	NP_001360	0	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG9565-PA	600423	NP_001388	0	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG15319-PB	602700	NP_001420	0	EP300	p300	Colorectal cancer, 114500 (3);Rubinstein-Taybi syndrome, 180849 (3)
CG3937-PA	300017	NP_001447	0	ABPX;FLN1;FLNA;FMD;MNS;NHBP;OPD1;OPD2	ACTIN-BINDING PROTEIN 280; ABP280;FILAMIN 1; FLN1;FILAMIN, ALPHA;FLN	Frontometaphyseal dysplasia, 304120 (3);Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3);Heterotopia, periventricular, 300049 (3);Heterotopia, periventricular, ED variant, 300537 (3);Melnick-Needles syndrome, 309350 (3);Otopalatodigital syndrome, type I, 311300 (3);Otopalatodigital syndrome, type II, 304120 (3)
CG3937-PB	300017	NP_001447	0	ABPX;FLN1;FLNA;FMD;MNS;NHBP;OPD1;OPD2	ACTIN-BINDING PROTEIN 280; ABP280;FILAMIN 1; FLN1;FILAMIN, ALPHA;FLN	Frontometaphyseal dysplasia, 304120 (3);Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3);Heterotopia, periventricular, 300049 (3);Heterotopia, periventricular, ED variant, 300537 (3);Melnick-Needles syndrome, 309350 (3);Otopalatodigital syndrome, type I, 311300 (3);Otopalatodigital syndrome, type II, 304120 (3)
CG3937-PC	300017	NP_001447	0	ABPX;FLN1;FLNA;FMD;MNS;NHBP;OPD1;OPD2	ACTIN-BINDING PROTEIN 280; ABP280;FILAMIN 1; FLN1;FILAMIN, ALPHA;FLN	Frontometaphyseal dysplasia, 304120 (3);Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3);Heterotopia, periventricular, 300049 (3);Heterotopia, periventricular, ED variant, 300537 (3);Melnick-Needles syndrome, 309350 (3);Otopalatodigital syndrome, type I, 311300 (3);Otopalatodigital syndrome, type II, 304120 (3)
CG3937-PA	603381	NP_001448	0	AOI;FLNB;LRS1;SCT	ACTIN-BINDING PROTEIN 276/278; ABP276/278;FILAMIN, BETA	Atelosteogenesis, type III, 108721 (3);Atelostogenesis, type I, 108720 (3);Boomerang dysplasia, 112310 (3);Larson syndrome, 150250 (3);Spondylocarpotarsal synostosis syndrome, 272460 (3)
CG3937-PB	603381	NP_001448	0	AOI;FLNB;LRS1;SCT	ACTIN-BINDING PROTEIN 276/278; ABP276/278;FILAMIN, BETA	Atelosteogenesis, type III, 108721 (3);Atelostogenesis, type I, 108720 (3);Boomerang dysplasia, 112310 (3);Larson syndrome, 150250 (3);Spondylocarpotarsal synostosis syndrome, 272460 (3)
CG3937-PC	603381	NP_001448	0	AOI;FLNB;LRS1;SCT	ACTIN-BINDING PROTEIN 276/278; ABP276/278;FILAMIN, BETA	Atelosteogenesis, type III, 108721 (3);Atelostogenesis, type I, 108720 (3);Boomerang dysplasia, 112310 (3);Larson syndrome, 150250 (3);Spondylocarpotarsal synostosis syndrome, 272460 (3)
CG3937-PA	102565	NP_001449	0		ABPA;ACTIN-BINDING PROTEIN 280, AUTOSOMAL FORM; ABP280A;ACTIN-BINDING PROTEIN-LIKE; ABPL;FILAMIN 2; FLN2;FILAMIN, GAMMA	
CG2259-PA	606857	NP_001489	0	GCLC;GLCLC	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE, CATALYTIC SUBUNIT;GLCLC	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)
CG10067-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG12051-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG18290-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG18290-PB	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG4027-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG4027-PB	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG5178-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG7478-PA	102560	NP_001605	0	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG3725-PA	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PB	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PC	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PD	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PE	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PF	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PG	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PH	108740	NP_001672	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG2165-PA	108733	NP_001674	0	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG2165-PB	108733	NP_001674	0	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG17369-PA	192132	NP_001683	0	ATP6B1;VPP3	1; ATP6V1B1;ATP6B1;VACUOLAR PROTON PUMP, SUBUNIT 3; VPP3	Renal tubular acidosis with deafness, 267300 (3)
CG17369-PB	192132	NP_001683	0	ATP6B1;VPP3	1; ATP6V1B1;ATP6B1;VACUOLAR PROTON PUMP, SUBUNIT 3; VPP3	Renal tubular acidosis with deafness, 267300 (3)
CG6871-PA	115500	NP_001743	0	CAT		Acatalasemia (3)
CG18572-PA	608307	NP_001866	0	CPS1	VENOOCCLUSIVE DISEASE AFTER BONE MARROW TRANSPLANTATION, SUSCEPTIBILITY	Carbamoylphosphate synthetase I deficiency, 237300 (3)
CG12891-PA	600528	NP_001867	0	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12891-PB	600528	NP_001867	0	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG11579-PA	116806	NP_001895	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PB	116806	NP_001895	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PC	116806	NP_001895	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PD	116806	NP_001895	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG6778-PA	600287	NP_002038	0	CMT2D;GARS;SMAD1		Charcot-Marie-Tooth disease, type 2D, 601472 (3);Spinal muscular atrophy, distal, type V, 600794 (3)
CG6778-PB	600287	NP_002038	0	CMT2D;GARS;SMAD1		Charcot-Marie-Tooth disease, type 2D, 601472 (3);Spinal muscular atrophy, distal, type V, 600794 (3)
CG12101-PA	118190	NP_002147	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG12101-PB	118190	NP_002147	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PA	118190	NP_002147	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PB	118190	NP_002147	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PC	118190	NP_002147	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG11579-PA	173325	NP_002221	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PB	173325	NP_002221	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PC	173325	NP_002221	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PD	173325	NP_002221	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG10693-PA	600150	NP_002238	0	KCNMA1;SLO	M, ALPHA MEMBER 1; KCNMA1;SLO-ALPHA;SLOWPOKE, DROSOPHILA, HOMOLOG OF; SLO	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
CG10693-PB	600150	NP_002238	0	KCNMA1;SLO	M, ALPHA MEMBER 1; KCNMA1;SLO-ALPHA;SLOWPOKE, DROSOPHILA, HOMOLOG OF; SLO	Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
CG7123-PA	150325	NP_002283	0	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG7123-PB	150325	NP_002283	0	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG12139-PB	603506	NP_002326	0	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG5912-PA	603506	NP_002326	0	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG8909-PB	603506	NP_002326	0	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG15792-PA	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG15792-PB	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PA	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PB	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PC	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PD	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PE	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PF	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PG	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PH	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PI	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PJ	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PK	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PL	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PM	160720	NP_002461	0	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG15792-PA	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG15792-PB	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PA	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PB	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PC	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PD	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PE	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PF	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PG	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PH	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PI	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PJ	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PK	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PL	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PM	160710	NP_002462	0	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG15792-PA	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG15792-PB	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PA	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PB	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PC	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PD	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PE	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PF	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PG	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PH	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PI	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PJ	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PK	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PL	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG17927-PM	160741	NP_002463	0	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG15792-PA	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG15792-PB	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PA	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PB	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PC	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PD	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PE	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PF	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PG	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PH	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PI	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PJ	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PK	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PL	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PM	160775	NP_002464	0	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG15792-PA	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PB	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PA	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PB	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PC	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PD	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PE	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PF	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PG	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PH	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PI	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PJ	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PK	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PL	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PM	160745	NP_002465	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7766-PA	311870	NP_002628	0	PHKA1		Muscle glycogenosis, 300559 (3)
CG7766-PB	311870	NP_002628	0	PHKA1		Muscle glycogenosis, 300559 (3)
CG8987-PA	174763	NP_002684	0	PEO;POLG;POLG1;POLGA;SANDO;SCAE	POLG, CATALYTIC SUBUNIT;POLG-ALPHA; POLGA;POLYMERASE, DNA, GAMMA-1; POLG1	Alpers syndrome, 203700 (3);Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3);Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, 607459 (3);Spinocerebellar ataxia with epilepsy, 607459 (3)
CG13383-PA	603113	NP_002707	0	PPP2R1B		Lung cancer, 211980 (3)
CG13383-PB	603113	NP_002707	0	PPP2R1B		Lung cancer, 211980 (3)
CG13383-PC	603113	NP_002707	0	PPP2R1B		Lung cancer, 211980 (3)
CG6518-PA	176960	NP_002728	0	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6622-PA	176960	NP_002728	0	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6622-PB	176960	NP_002728	0	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6518-PA	176980	NP_002730	0	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6622-PA	176980	NP_002730	0	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6622-PB	176980	NP_002730	0	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG12703-PA	170995	NP_002849	0	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG7470-PA	138250	NP_002851	0	PYCS;GSAS	GLUTAMATE GAMMA-SEMIALDEHYDE SYNTHETASE; GSAS;HYPERAMMONEMIA WITH HYPOORNITHINEMIA, HYPOCITRULLINEMIA, HYPOARGININEMIA,;P5CS	Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and hypoprolinemia (3)
CG7254-PA	232700	NP_002854	0	PYGL	HERS DISEASE;PHOSPHORYLASE DEFICIENCY GLYCOGEN-STORAGE DISEASE OF LIVER	Glycogen storage disease VI (3)
CG9209-PB	139150	NP_002881	0	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG9209-PC	139150	NP_002881	0	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG9071-PA	603415	NP_002968	0	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG9071-PB	603415	NP_002968	0	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG9907-PA	603415	NP_002968	0	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG17320-PA	184755	NP_002970	0	SCP2	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY, SCPx-DEFICIENT,;STEROL CARRIER PROTEIN X; SCPX	Leukoencephalopathy with dystonia and motor neuropathy (3)
CG2658-PA	602783	NP_003110	0	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG1977-PA	182860	NP_003117	0	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG6146-PA	126420	NP_003277	0	TOP1		DNA topoisomerase I, camptothecin-resistant (3)
CG6146-PB	126420	NP_003277	0	TOP1		DNA topoisomerase I, camptothecin-resistant (3)
CG32019-PA	188840	NP_003310	0	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG31092-PA	192977	NP_003374	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG31092-PB	192977	NP_003374	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG4861-PA	192977	NP_003374	0	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG3736-PA	603615	NP_003570	0	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8711-PA	300304	NP_003579	0	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG10253-PA	603051	NP_003650	0	ADHAPS;AGPS	ALKYL-DHAP SYNTHASE;ALKYLDIHYDROXYACETONEPHOSPHATE SYNTHASE; ADHAPS	Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)
CG11427-PA	603401	NP_003655	0	AP3B1;ADTB3A;HPS2	ADAPTIN, BETA-3A; ADTB3A;HPS2 GENE; HPS2;PEARL, MOUSE, HOMOLOG OF; PE	Hermansky-Pudlak syndrome 2, 608233 (3)
CG2411-PA	603673	NP_003729	0	PTCH2		Basal cell carcinoma, somatic, 605462 (3);Medulloblastoma, 155255 (3)
CG2411-PB	603673	NP_003729	0	PTCH2		Basal cell carcinoma, somatic, 605462 (3);Medulloblastoma, 155255 (3)
CG10181-PA	603201	NP_003733	0	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG10226-PA	603201	NP_003733	0	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG3879-PA	603201	NP_003733	0	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG8523-PA	603201	NP_003733	0	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG7145-PA	606811	NP_003739	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG7145-PB	606811	NP_003739	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG7145-PD	606811	NP_003739	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG4675-PA	603345	NP_003750	0	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG4675-PB	603345	NP_003750	0	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG15804-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG17150-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG17629-PD	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG17866-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG1842-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG3339-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG3723-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG40444-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG5526-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG7092-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG7507-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG9492-PA	603339	NP_003768	0	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG31183-PA	108961	NP_003986	0	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG3216-PB	108961	NP_003986	0	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG31175-PA	300377	NP_003997	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_003997	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_003997	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_003998	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_003998	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_003998	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004000	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004000	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004000	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004001	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004001	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004001	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004002	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004002	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004002	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004003	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004003	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004003	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004004	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004004	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004004	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004005	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004005	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004005	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004011	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004011	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004011	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004012	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004012	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004012	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004013	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004013	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004013	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004014	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004014	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004014	0	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG11089-PA	601731	NP_004035	0	AICAR;ATIC;PURH	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE;AICARFT/IMPCHASE;CYCLOHYDROLASE; ATIC;PURH	AICA-ribosiduria due to ATIC deficiency, 608688 (3)
CG17246-PA	600857	NP_004159	0	SDHA;SDH2;SDHF	SUCCINATE DEHYDROGENASE 2, FLAVOPROTEIN SUBUNIT; SDH2	Leigh syndrome, 256000 (3);Mitochondrial respiratory chain complex II deficiency, 252011 (3)
CG17246-PB	600857	NP_004159	0	SDHA;SDH2;SDHF	SUCCINATE DEHYDROGENASE 2, FLAVOPROTEIN SUBUNIT; SDH2	Leigh syndrome, 256000 (3);Mitochondrial respiratory chain complex II deficiency, 252011 (3)
CG17246-PC	600857	NP_004159	0	SDHA;SDH2;SDHF	SUCCINATE DEHYDROGENASE 2, FLAVOPROTEIN SUBUNIT; SDH2	Leigh syndrome, 256000 (3);Mitochondrial respiratory chain complex II deficiency, 252011 (3)
CG5718-PA	600857	NP_004159	0	SDHA;SDH2;SDHF	SUCCINATE DEHYDROGENASE 2, FLAVOPROTEIN SUBUNIT; SDH2	Leigh syndrome, 256000 (3);Mitochondrial respiratory chain complex II deficiency, 252011 (3)
CG9088-PA	314690	NP_004178	0	DXS1272E;JARID1C;MRXSJ;SMCX;XE169	DXS1272E;JUMONJI, AT-RICH INTERACTIVE DOMAIN 1C; JARID1C;XE169	Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)
CG9088-PB	314690	NP_004178	0	DXS1272E;JARID1C;MRXSJ;SMCX;XE169	DXS1272E;JUMONJI, AT-RICH INTERACTIVE DOMAIN 1C; JARID1C;XE169	Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)
CG7955-PA	300135	NP_004290	0	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG7955-PB	300135	NP_004290	0	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG7955-PC	300135	NP_004290	0	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG3725-PA	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PB	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PC	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PD	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PE	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PF	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PG	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PH	108730	NP_004311	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG31116-PC	600570	NP_004357	0	CLCN2;ECA3;EGI3;EGMA	CLC2	Epilepsy with grand mal seizures on awakening, 607628 (3);Epilepsy, childhood absence, 607682 (3);Epilepsy, juvenile absence, 607631 (3);Epilepsy, juvenile myoclonic, 606904 (3)
CG15319-PB	600140	NP_004371	0	CBP;CREBBP;RSTS	CBP	Rubenstein-Taybi syndrome, 180849 (3)
CG12140-PA	231675	NP_004444	0	ETFDH;MADD	ELECTRON TRANSFER FLAVOPROTEIN:UBIQUINONE OXIDOREDUCTASE; ETFQO	Glutaricaciduria, type IIC, 231680 (3)
CG1970-PA	602985	NP_004541	0	NDUFS2	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 49-KD SUBUNIT	Mitochondrial complex I deficiency, 252010 (3)
CG6235-PA	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_004567	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG17596-PA	300075	NP_004577	0	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17603-PA	313650	NP_004597	0	BA2R;CCG1;DYT3;TAF1;TAF2A	250-KD; TAF1;BA2R;CELL CYCLE BLOCK, G1-TO-S; CCGS;CELL CYCLE GENE 1;CELL CYCLE, G1 PHASE DEFECT; CCG1;TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1;TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 2A; TAF2A;TBP-ASSOCIATED FACTOR, RNA POLYMERASE II, 250-KD; TAFII250	Dystonia-Parkinsonism, X-linked, 314250 (3)
CG1945-PA	400005	NP_004645	0	DFFRY;USP9Y	DROSOPHILA FAT FACETS-RELATED, Y-LINKED; DFFRY	Azoospermia, 415000 (3)
CG1945-PC	400005	NP_004645	0	DFFRY;USP9Y	DROSOPHILA FAT FACETS-RELATED, Y-LINKED; DFFRY	Azoospermia, 415000 (3)
CG8363-PA	603005	NP_004661	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PB	603005	NP_004661	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PC	603005	NP_004661	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PD	603005	NP_004661	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG8363-PE	603005	NP_004661	0	ATPSK2;PAPSS2	ATP SULFURYLASE/ADENOSINE 5-PRIME PHOSPHOSULFATE KINASE 2; ATPSK2;ATP SULFURYLASE/APS KINASE 2;PAPS SYNTHASE 2;PAPS SYNTHETASE 2;PHOSPHOADENOSINE-PHOSPHOSULFATE SYNTHETASE 2;SK2	SEMD, Pakistani type (3)
CG4376-PA	604638	NP_004915	0	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG4376-PB	604638	NP_004915	0	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG4376-PC	604638	NP_004915	0	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG18102-PB	602378	NP_004936	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PC	602378	NP_004936	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG18102-PD	602378	NP_004936	0	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG7765-PA	602821	NP_004975	0	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG5695-PA	600970	NP_004990	0	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG5695-PB	600970	NP_004990	0	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG2286-PA	157655	NP_004997	0	NDUFS1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 75-KD SUBUNIT	Mitochondrial complex I deficiency, 252010 (3)
CG2286-PB	157655	NP_004997	0	NDUFS1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 75-KD SUBUNIT	Mitochondrial complex I deficiency, 252010 (3)
CG5594-PA	604878	NP_005126	0	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG5594-PB	604878	NP_005126	0	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG5594-PC	604878	NP_005126	0	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG5594-PD	604878	NP_005126	0	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG4032-PA	189980	NP_005148	0	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10067-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG12051-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG18290-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG18290-PB	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG4027-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG4027-PB	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5178-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7478-PA	102540	NP_005150	0	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG1522-PA	300110	NP_005174	0	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG4894-PA	300110	NP_005174	0	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG4894-PB	300110	NP_005174	0	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG4894-PC	300110	NP_005174	0	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG4894-PD	300110	NP_005174	0	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG5320-PA	138130	NP_005262	0	GLUD1	GDH;GLUD	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
CG7438-PA	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG7438-PB	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9155-PA	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9155-PB	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9155-PC	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9155-PD	601478	NP_005370	0	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9802-PA	606062	NP_005436	0	BAM;CDLS3;CSPG6;HCAP;SMC3	BAMACAN; BAM;HUMAN CHROMOSOME-ASSOCIATED POLYPEPTIDE; HCAP;STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	Cornelia de Lange syndrome 3, 610759 (3)
CG9802-PB	606062	NP_005436	0	BAM;CDLS3;CSPG6;HCAP;SMC3	BAMACAN; BAM;HUMAN CHROMOSOME-ASSOCIATED POLYPEPTIDE; HCAP;STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	Cornelia de Lange syndrome 3, 610759 (3)
CG7981-PA	142461	NP_005520	0	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG7981-PB	142461	NP_005520	0	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG7981-PC	142461	NP_005520	0	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG7981-PD	142461	NP_005520	0	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG7981-PE	142461	NP_005520	0	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG17896-PA	603178	NP_005580	0	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG17896-PB	603178	NP_005580	0	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG17034-PA	602397	NP_005594	0	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG17034-PB	602397	NP_005594	0	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG17034-PC	602397	NP_005594	0	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG17034-PD	602397	NP_005594	0	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG7254-PA	608455	NP_005600	0	PYGM	MYOPHOSPHORYLASE	McArdle disease, 232600 (3)
CG7793-PA	182530	NP_005624	0	GF1;GINGF;HGF;NS4;SOS1	SOS1 GUANINE NUCLEOTIDE EXCHANGE FACTOR	Fibromatosis, gingival, 135300 (3);Noonan syndrome 4, 610733 (3)
CG6214-PB	601439	NP_005682	0	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7144-PA	605113	NP_005754	0	AASS		Hyperlysinemia, 238700 (3);Saccharopinuria, 268700 (1)
CG4039-PA	601806	NP_005906	0	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG4067-PA	172460	NP_005947	0	MTHFD;MTHFC	C1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC;C1-THF-SYNTHASE;CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE SYNTHETASE, NADP(+)-DEPENDENT;METHYLENETETRAHYDROFOLATE DEHYDROGENASE/METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE;SYNTHETASE, NADP(+)-DEPENDENT	{Abruptio placentae, susceptibility to} (3);{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
CG4067-PB	172460	NP_005947	0	MTHFD;MTHFC	C1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC;C1-THF-SYNTHASE;CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE SYNTHETASE, NADP(+)-DEPENDENT;METHYLENETETRAHYDROFOLATE DEHYDROGENASE/METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE;SYNTHETASE, NADP(+)-DEPENDENT	{Abruptio placentae, susceptibility to} (3);{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
CG4067-PC	172460	NP_005947	0	MTHFD;MTHFC	C1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC;C1-THF-SYNTHASE;CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE SYNTHETASE, NADP(+)-DEPENDENT;METHYLENETETRAHYDROFOLATE DEHYDROGENASE/METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE;SYNTHETASE, NADP(+)-DEPENDENT	{Abruptio placentae, susceptibility to} (3);{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
CG1954-PA	605437	NP_006246	0	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG6057-PA	300040	NP_006297	0	CDLS2;DXS423E;SMC1	DXS423E;KIAA0178;SMC1;SMC1-ALPHA;STRUCTURAL MAINTENANCE OF CHROMOSOMES 1-LIKE 1; SMC1L1	Cornelia de Lange syndrome 2, 300590 (3)
CG1250-PA	610511	NP_006355	0	SEC23A;CLSD		Craniolenticulosutural dysplasia, 607812 (3)
CG1250-PB	610511	NP_006355	0	SEC23A;CLSD		Craniolenticulosutural dysplasia, 607812 (3)
CG7578-PA	605371	NP_006411	0	ARFGEF2;BIG2	BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 2; BIG2	Periventricular heterotopia with microcephaly, 608097 (3)
CG7578-PB	605371	NP_006411	0	ARFGEF2;BIG2	BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 2; BIG2	Periventricular heterotopia with microcephaly, 608097 (3)
CG8877-PA	607300	NP_006436	0	PRPF8;PRPC8;RP13	PRP8;PRPC8;U5 snRNP-SPECIFIC PROTEIN, 220-KD	Retinitis pigmentosa-13, 600059 (3)
CG9907-PA	182389	NP_008851	0	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG12008-PA	604985	NP_008877	0	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG5870-PA	604985	NP_008877	0	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG11423-PA	161015	NP_009034	0	NDUFV1;UQOR1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 51-KD SUBUNIT;UQOR1	Alexander disease, 203450 (3);Leigh syndrome, 256000 (3);Mitochondrial complex I deficiency, 252010 (3)
CG9140-PA	161015	NP_009034	0	NDUFV1;UQOR1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 51-KD SUBUNIT;UQOR1	Alexander disease, 203450 (3);Leigh syndrome, 256000 (3);Mitochondrial complex I deficiency, 252010 (3)
CG2331-PA	601023	NP_009057	0	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG4032-PA	189980	NP_009297	0	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8439-PA	610150	NP_036205	0	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG8439-PB	610150	NP_036205	0	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG12311-PA	607439	NP_037514	0	POMT2		Walker-Warburg syndrome, 236670 (3)
CG5722-PA	608010	NP_037521	0	NPC1L1		[Ezetimibe, nonresponse to] (3)
CG6827-PA	604569	NP_054860	0	CASPR2;CDFE;CNTNAP2;NRXN4	CONTACTIN-ASSOCIATED PROTEIN 2; CASPR2;NEUREXIN IV, DROSOPHILA, HOMOLOG OF; NRXN4	Cortical dysplasia-focal epilepsy syndrome, 610042 (3)
CG6827-PB	604569	NP_054860	0	CASPR2;CDFE;CNTNAP2;NRXN4	CONTACTIN-ASSOCIATED PROTEIN 2; CASPR2;NEUREXIN IV, DROSOPHILA, HOMOLOG OF; NRXN4	Cortical dysplasia-focal epilepsy syndrome, 610042 (3)
CG9907-PA	600702	NP_055006	0		NAV1.6	
CG2139-PA	603859	NP_055066	0	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG2139-PB	603859	NP_055066	0	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG2139-PC	603859	NP_055066	0	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG2139-PD	603859	NP_055066	0	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG32451-PA	604384	NP_055197	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG32451-PC	604384	NP_055197	0	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG12272-PA	610657	NP_055661	0		STRUMPELLIN	
CG3869-PA	608507	NP_055689	0	CMT2A2;KIAA0214;MFN2	KIAA0214	Charcot-Marie-Tooth disease, type 2A2, 609260 (3);Hereditary motor and sensory neuropathy VI, 601152 (3)
CG8566-PD	605995	NP_055889	0	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG2093-PA	605978	NP_056001	0	CHAC;VPS13A	CHAC GENE; CHAC;CHOREIN;KIAA0986	Choreoacanthocytosis, 200150 (3)
CG17704-PE	608667	NP_056199	0	CDLS1;NIPBL	DELANGIN	Cornelia de Lange syndrome 1, 122470 (3)
CG8479-PA	605290	NP_056375	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_056375	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG9115-PA	603557	NP_057240	0	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG2174-PA	602666	NP_057323	0	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG10231-PA	604961	NP_058649	0	PDE11A;PDE11A1;PDE11A2;PDE11A3;PPNAD2	PDE11A1	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)
CG8279-PA	604961	NP_058649	0	PDE11A;PDE11A1;PDE11A2;PDE11A3;PPNAD2	PDE11A1	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)
CG15792-PA	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG15792-PB	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PA	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PB	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PC	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PD	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PE	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PF	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PG	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PH	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PI	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PJ	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PK	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PL	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG17927-PM	160740	NP_060004	0	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG30078-PA	607009	NP_060132	0	TRPM6;CHAK2	CHANNEL KINASE 2; CHAK2;MELASTATIN-RELATED TRP CATION CHANNEL 6;TRPM6	Hypomagnesemia with secondary hypocalcemia, 602014 (3)
CG30078-PB	607009	NP_060132	0	TRPM6;CHAK2	CHANNEL KINASE 2; CHAK2;MELASTATIN-RELATED TRP CATION CHANNEL 6;TRPM6	Hypomagnesemia with secondary hypocalcemia, 602014 (3)
CG30078-PA	605692	NP_060142	0	CHAK;LTRPC7;TRPM7	CHAK;LONG TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; LTRPC7;TRANSIENT RECEPTOR POTENTIAL-PHOSPHOLIPASE C-INTERACTING KINASE; TRP-PLIK;TRPM7	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to}, 105500 (3)
CG30078-PB	605692	NP_060142	0	CHAK;LTRPC7;TRPM7	CHAK;LONG TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; LTRPC7;TRANSIENT RECEPTOR POTENTIAL-PHOSPHOLIPASE C-INTERACTING KINASE; TRP-PLIK;TRPM7	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to}, 105500 (3)
CG3696-PA	608892	NP_060250	0	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG10181-PA	171060	NP_061337	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10226-PA	171060	NP_061337	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG3879-PA	171060	NP_061337	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG8523-PA	171060	NP_061337	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10181-PA	171060	NP_061338	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10226-PA	171060	NP_061338	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG3879-PA	171060	NP_061338	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG8523-PA	171060	NP_061338	0	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG2118-PA	609010	NP_064551	0	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG2118-PB	609010	NP_064551	0	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG6214-PB	601439	NP_064693	0	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6214-PB	601439	NP_064694	0	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1651-PA	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PB	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PC	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PD	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PB	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PC	182900	NP_065208	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PA	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PB	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PC	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PD	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PB	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PC	182900	NP_065209	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PA	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PB	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PC	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1651-PD	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PB	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7462-PC	182900	NP_065210	0	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG12602-PA	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PA	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PB	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PC	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PD	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PE	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PF	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PG	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PH	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PA	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PB	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG7678-PA	605239	NP_065683	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1651-PA	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PB	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PC	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1651-PD	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG7462-PB	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG7462-PC	106410	NP_066187	0	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG6904-PA	138571	NP_068776	0	GYS2	GLYCOGEN SYNTHASE, LIVER;LIVER GLYCOGEN SYNTHASE	Glycogen storage disease, type 0, 240600 (3)
CG6904-PB	138571	NP_068776	0	GYS2	GLYCOGEN SYNTHASE, LIVER;LIVER GLYCOGEN SYNTHASE	Glycogen storage disease, type 0, 240600 (3)
CG6904-PC	138571	NP_068776	0	GYS2	GLYCOGEN SYNTHASE, LIVER;LIVER GLYCOGEN SYNTHASE	Glycogen storage disease, type 0, 240600 (3)
CG11579-PA	173325	NP_068831	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PB	173325	NP_068831	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PC	173325	NP_068831	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG11579-PD	173325	NP_068831	0	DP3;JUP;PDGB	CATENIN, GAMMA;DESMOPLAKIN III; DP III; DP3;PLAKOGLOBIN; PKGB	Naxos disease, 601214 (3)
CG17941-PA	605516	NP_071407	0	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG3352-PA	605516	NP_071407	0	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7749-PA	605516	NP_071407	0	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG3267-PA	609014	NP_071415	0	MCCB;MCCC2	3-@METHYLCROTONYL-CoA CARBOXYLASE, BETA; MCCB;3-@METHYLCROTONYL-CoA CARBOXYLASE, NON-BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)
CG1516-PA	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PB	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PD	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PE	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PG	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PI	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PJ	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PK	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PL	608786	NP_071504	0	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG9209-PB	139150	NP_072179	0	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG9209-PC	139150	NP_072179	0	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG15792-PA	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PB	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PA	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PB	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PC	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PD	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PE	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PF	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PG	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PH	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PI	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PJ	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PK	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PL	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PM	160745	NP_074035	0	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8732-PA	300157	NP_075266	0	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG8732-PB	300157	NP_075266	0	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG8732-PC	300157	NP_075266	0	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG1522-PA	601011	NP_075461	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PA	601011	NP_075461	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PB	601011	NP_075461	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PC	601011	NP_075461	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4894-PD	601011	NP_075461	0	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG3936-PA	600275	NP_077719	0	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG15792-PA	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG15792-PB	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PA	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PB	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PC	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PD	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PE	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PF	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PG	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PH	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PI	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PJ	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PK	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PL	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PM	608568	NP_079005	0	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG4567-PA	606639	NP_079272	0	COXPD1;EFG1;GFM;GFM1	ELONGATION FACTOR G1; EFG; EFG1;GFM	Combined oxidative phosphorylation deficiency 1, 609060 (3)
CG6939-PA	607697	NP_112224	0	CMT4B2;MTMR13;SBF2	KIAA1766;MYOTUBULARIN-RELATED 13; MTMR13	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)
CG6939-PB	607697	NP_112224	0	CMT4B2;MTMR13;SBF2	KIAA1766;MYOTUBULARIN-RELATED 13; MTMR13	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)
CG6214-PB	607040	NP_115972	0	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG18251-PB	608441	NP_149062	0	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG6214-PB	607040	NP_149163	0	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG2093-PA	605978	NP_150648	0	CHAC;VPS13A	CHAC GENE; CHAC;CHOREIN;KIAA0986	Choreoacanthocytosis, 200150 (3)
CG8479-PA	605290	NP_570844	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570844	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570845	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570845	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570846	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570846	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570847	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570847	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570848	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570848	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570849	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570849	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PA	605290	NP_570850	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG8479-PB	605290	NP_570850	0	OPA1;NTG;NPG		Optic atrophy 1, 165500 (3);Optic atrophy and deafness, 125250 (3);{Glaucoma, normal tension, susceptibility to}, 606657 (3)
CG12602-PA	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PA	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PB	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PC	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PD	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PE	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PF	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PG	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PH	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PA	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PB	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG7678-PA	605239	NP_570855	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG12602-PA	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PA	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PB	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PC	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PD	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PE	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PF	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PG	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG1709-PH	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PA	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG18617-PB	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG7678-PA	605239	NP_570856	0	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG32019-PA	188840	NP_596869	0	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG32019-PA	188840	NP_597676	0	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG17704-PE	608667	NP_597677	0	CDLS1;NIPBL	DELANGIN	Cornelia de Lange syndrome 1, 122470 (3)
CG32019-PA	188840	NP_597681	0	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG17603-PA	313650	NP_620278	0	BA2R;CCG1;DYT3;TAF1;TAF2A	250-KD; TAF1;BA2R;CELL CYCLE BLOCK, G1-TO-S; CCGS;CELL CYCLE GENE 1;CELL CYCLE, G1 PHASE DEFECT; CCG1;TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1;TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 2A; TAF2A;TBP-ASSOCIATED FACTOR, RNA POLYMERASE II, 250-KD; TAFII250	Dystonia-Parkinsonism, X-linked, 314250 (3)
CG9799-PA	609669	NP_644810	0	GLC1G;TAWDRP;WDR36	T-CELL ACTIVATION WD REPEAT-CONTAINING PROTEIN; TAWDRP	Glaucoma 1, open angle, G, 609887 (3)
CG5670-PA	182350	NP_689509	0	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG5670-PB	182350	NP_689509	0	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG5670-PC	182350	NP_689509	0	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG5670-PD	182350	NP_689509	0	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG6713-PA	163730	NP_695024	0	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG3725-PA	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PB	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PC	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PD	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PE	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PF	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PG	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3725-PH	108740	NP_733765	0	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG7145-PA	606811	NP_733844	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG7145-PB	606811	NP_733844	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG7145-PD	606811	NP_733844	0	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG3182-PA	152427	NP_742054	0	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3182-PB	152427	NP_742054	0	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3725-PA	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PB	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PC	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PD	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PE	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PF	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PG	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PH	108730	NP_775293	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG9086-PA	605981	NP_777576	0	JBS;UBR1		Johanson-Blizzard syndrome, 243800 (3)
CG6235-PA	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_858060	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PA	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_858061	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PA	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_858062	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PA	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_858063	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PA	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PB	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PC	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PD	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PE	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PF	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PG	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG6235-PH	604325	NP_858064	0	PPP2R2B	B55-BETA;PP2AB-BETA;PP2AB55-BETA;PP2APR55-BETA;PR55-BETA	Spinocerebellar ataxia 12, 604326 (3)
CG13383-PA	603113	NP_859050	0	PPP2R1B		Lung cancer, 211980 (3)
CG13383-PB	603113	NP_859050	0	PPP2R1B		Lung cancer, 211980 (3)
CG13383-PC	603113	NP_859050	0	PPP2R1B		Lung cancer, 211980 (3)
CG18251-PB	608441	NP_892006	0	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG1799-PA	146690	NP_899066	0	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG1799-PC	146690	NP_899066	0	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG8566-PD	605995	NP_904325	0	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG9907-PA	600163	NP_932173	0	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG10236-PA	600805	NP_937762	0	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG12101-PA	118190	NP_955472	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG12101-PB	118190	NP_955472	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PA	118190	NP_955472	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PB	118190	NP_955472	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG7235-PC	118190	NP_955472	0	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG6383-PA	604210	NP_957705	0	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG9115-PA	603557	NP_958435	0	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG9115-PA	603557	NP_958438	0	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG33038-PA	608210	NP_997005	0	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG33038-PC	608210	NP_997005	0	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG6938-PA	608662	NP_998764	0	GDD1;TMEM16E	GDD1 GENE; GDD1	Gnthodiaphyseal dysplasia, 166260 (3)
CG6214-PB	603234	XP_001125860	0	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG3725-PA	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PB	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PC	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PD	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PE	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PF	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PG	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3725-PH	108730	XP_001127578	0	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG4252-PA	601215	XP_001131387	0	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG3936-PA	600275	XP_001133349	0	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG11579-PA	116806	XP_001133660	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PB	116806	XP_001133660	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PC	116806	XP_001133660	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PD	116806	XP_001133660	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PA	116806	XP_001133664	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PB	116806	XP_001133664	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PC	116806	XP_001133664	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PD	116806	XP_001133664	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PA	116806	XP_001133673	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PB	116806	XP_001133673	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PC	116806	XP_001133673	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PD	116806	XP_001133673	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PA	116806	XP_001133675	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PB	116806	XP_001133675	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PC	116806	XP_001133675	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG11579-PD	116806	XP_001133675	0	CTNNB1	CADHERIN-ASSOCIATED PROTEIN, BETA; CTNNB	Colorectal cancer (3);Hepatoblastoma (3);Hepatocellular carcinoma, 114550 (3);Ovarian carcinoma, endometrioid type (3);Pilomatricoma, 132600 (3)
CG8732-PA	300157	NP_004449	1e-180	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG8732-PB	300157	NP_004449	1e-180	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG8732-PC	300157	NP_004449	1e-180	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG7461-PA	609575	NP_000009	2e-180	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG4545-PA	163970	NP_001034	2e-180	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG6214-PB	600509	NP_000343	3e-180	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG4561-PA	603623	NP_003671	3e-180	CMTDIC;TYRRS;YARS;YRS;YTS	TYRRS;YRS;YTS	Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)
CG8169-PA	600259	NP_000526	5e-180	HNPCC4;PMS2;PMSL2	MISMATCH REPAIR GENE PMSL2; PMSL2	Colorectal cancer, hereditary nonpolyposis, type 4 (3);Neuroectodermal tumors, supratentorial primitive, with cafe-au-lait spots, 608623 (3);Turcot syndrome with glioblastoma, 276300 (3)
CG33087-PC	603506	NP_002326	5e-180	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG1516-PH	608786	NP_000911	9e-180	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PH	608786	NP_071504	9e-180	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG7461-PA	609575	NP_001029031	1e-179	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG9071-PA	600163	NP_000326	2e-179	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG9071-PB	600163	NP_000326	2e-179	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG1799-PB	146690	NP_899066	2e-179	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG9071-PA	600163	NP_932173	2e-179	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG9071-PB	600163	NP_932173	2e-179	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4548-PA	300032	NP_000480	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG4548-PB	300032	NP_000480	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG1799-PB	146690	NP_000874	3e-179	IMPDH1;LCA11;RP10	IMPD;INOSINE-5-PRIME-MONOPHOSPHATE DEHYDROGENASE, TYPE I; IMPD1	Leber congenital amaurosis XI (3);Retinitis pigmentosa-10, 180105 (3)
CG4548-PA	300032	NP_612114	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG4548-PB	300032	NP_612114	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG4548-PA	300032	NP_612115	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG4548-PB	300032	NP_612115	3e-179	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG3590-PA	608222	NP_000017	6e-179	ADSL	ADENYLOSUCCINASE	Adenylosuccinase deficiency, 103050 (3)
CG9071-PA	182389	NP_008851	6e-179	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG9071-PB	182389	NP_008851	6e-179	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG18076-PB	601282	NP_000436	8e-179	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_000436	8e-179	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG1516-PF	608786	NP_000911	9e-179	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG1516-PF	608786	NP_071504	9e-179	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG8107-PA	114240	NP_775110	1e-178	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG5320-PB	138130	NP_005262	2e-178	GLUD1	GDH;GLUD	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
CG4141-PA	171834	NP_006209	4e-178	PIK3CA	p110-ALPHA;PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, 110-KD, ALPHA	Breast cancer, 114480 (3);Colorectal cancer, 114500 (3);Ovarian cancer, 604370 (3)
CG4141-PB	171834	NP_006209	4e-178	PIK3CA	p110-ALPHA;PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, 110-KD, ALPHA	Breast cancer, 114480 (3);Colorectal cancer, 114500 (3);Ovarian cancer, 604370 (3)
CG31793-PA	607040	NP_115972	6e-178	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG31793-PA	607040	NP_149163	6e-178	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG9314-PA	115500	NP_001743	9e-178	CAT		Acatalasemia (3)
CG9629-PA	107323	NP_001173	1e-177		ANTIQUITIN; ATQ1	
CG9629-PB	107323	NP_001173	1e-177		ANTIQUITIN; ATQ1	
CG4779-PA	607474	NP_000178	2e-177	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG4779-PA	607474	XP_001123365	2e-177	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG4779-PA	607474	XP_001125869	2e-177	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG4779-PA	607474	XP_001125882	2e-177	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG4006-PA	164731	NP_001617	3e-177	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4006-PB	164731	NP_001617	3e-177	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4006-PC	164731	NP_001617	3e-177	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4562-PA	607040	NP_115972	4e-177	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG4562-PA	607040	NP_149163	4e-177	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11326-PA	600310	NP_000086	5e-177	COMP;EDM1;MED;PSACH		Epiphyseal dysplasia, multiple 1, 132400 (3);Pseudoachondroplasia, 177170 (3)
CG31092-PB	606945	NP_000518	6e-177	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG6140-PA	136850	NP_000134	1e-176	FH	FUMARASE	Fumarase deficiency, 606812 (3);Leiomyomatosis and renal cell cancer, 605839 (3);Multiple cutaneous and uterine leiomyomata, 150800 (3)
CG11144-PA	604096	NP_000834	1e-176	CSNB1B;GRM6;MGLUR6	MGLUR6	Night blindness, congenital stationary, type 1B, 257270 (3)
CG11567-PB	124015	NP_000932	1e-176	POR	CYTOCHROME P450 REDUCTASE	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3);Antley-Bixler syndrome-like with disordered steroidogenesis, 201750 (3);Disordered steroidogenesis, isolated, 201750 (3);POR deficiency, 201750 (3)
CG1915-PC	188840	NP_596869	4e-176	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1140-PB	601424	NP_000427	5e-176	OXCT;OXCT1;SCOT	OXCT;SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE; SCOT	Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)
CG8585-PA	605206	NP_005468	6e-176	HCN4	4; HCN4	Sinus bradycardia syndrome, 163800 (3)
CG9209-PA	139150	NP_072179	7e-176	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG9209-PA	139150	NP_002881	9e-176	CMAVM;GAP;PKWS;RASA1	GTPase-ACTIVATING PROTEIN; GAP;GUANOSINE TRIPHOSPHATASE-ACTIVATING PROTEIN	Basal cell carcinoma, somatic (3);Capillary malformation-arteriovenous malformation, 608354 (3);Parkes Weber syndrome, 608355 (3)
CG1140-PA	601424	NP_000427	1e-175	OXCT;OXCT1;SCOT	OXCT;SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE; SCOT	Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)
CG8380-PA	182138	NP_001036	1e-175	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG5125-PA	606808	NP_059129	1e-175	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17654-PA	131370	NP_001967	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PB	131370	NP_001967	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PC	131370	NP_001967	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PD	131370	NP_001967	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PE	131370	NP_001967	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG8581-PB	120470	NP_005206	3e-175	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG17654-PA	131370	NP_443739	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PB	131370	NP_443739	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PC	131370	NP_443739	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PD	131370	NP_443739	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG17654-PE	131370	NP_443739	3e-175	ENO3	ENOLASE, BETA;ENOLASE, MUSCLE-SPECIFIC; MSE	Enolase-beta deficiency (3)
CG18076-PA	601282	NP_958780	3e-175	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG9907-PA	600163	XP_001131636	3e-175	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG7627-PA	607040	NP_115972	4e-175	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG7627-PA	607040	NP_149163	4e-175	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG18076-PE	601282	NP_958780	5e-175	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5125-PB	606808	NP_059129	7e-175	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG31092-PA	606945	NP_000518	1e-174	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG10697-PA	107930	NP_000781	1e-174	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG10697-PB	107930	NP_000781	1e-174	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG10697-PC	107930	NP_000781	1e-174	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG2830-PA	118190	NP_002147	1e-174	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG1915-PA	188840	NP_596869	1e-174	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG2830-PA	118190	NP_955472	1e-174	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG18076-PA	601282	NP_958781	1e-174	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4581-PA	143450	NP_000174	2e-174	HADHB	BETA SUBUNIT; HADHB;ECHB;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, BETA SUBUNIT;TRIFUNCTIONAL PROTEIN, BETA SUBUNIT	Trifunctional protein deficiency, type II (3)
CG18076-PE	601282	NP_958781	3e-174	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG3333-PA	300126	NP_001354	4e-174	DKC;DKC1		Dyskeratosis congenita-1, 305000 (3);Hoyeraal-Hreidarsson syndrome, 300240 (3)
CG6214-PA	601107	NP_000383	7e-174	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG6199-PA	601865	NP_000926	7e-174	PLOD2	LH2;LYSINE HYDROXYLASE 2;LYSYL HYDROXYLASE 2;TELOPEPTIDE LYSYL HYDROXYLASE; TLH	Bruck syndrome 2, 609220 (3)
CG6199-PB	601865	NP_000926	7e-174	PLOD2	LH2;LYSINE HYDROXYLASE 2;LYSYL HYDROXYLASE 2;TELOPEPTIDE LYSYL HYDROXYLASE; TLH	Bruck syndrome 2, 609220 (3)
CG18076-PA	601282	NP_000436	1e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG7806-PA	601107	NP_000383	2e-173	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG18076-PE	601282	NP_000436	2e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PA	601282	NP_958786	2e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PE	601282	NP_958786	3e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958781	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958781	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958783	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958783	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958786	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958786	4e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PA	601282	NP_958784	5e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958785	5e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958785	5e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958780	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958780	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PA	601282	NP_958783	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958784	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958784	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PA	601282	NP_958785	6e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG9629-PA	107323	XP_001127838	6e-173		ANTIQUITIN; ATQ1	
CG9629-PB	107323	XP_001127838	6e-173		ANTIQUITIN; ATQ1	
CG6190-PA	601623	NP_000453	7e-173	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG6190-PA	601623	NP_570853	7e-173	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG6190-PA	601623	NP_570854	7e-173	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG18076-PA	601282	NP_958782	7e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PB	601282	NP_958782	7e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PG	601282	NP_958782	7e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PE	601282	NP_958784	8e-173	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PE	601282	NP_958782	1e-172	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PE	601282	NP_958783	1e-172	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PE	601282	NP_958785	1e-172	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG8380-PA	126455	NP_001035	2e-172	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG10738-PA	108961	NP_003986	2e-172	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG2174-PA	276903	NP_000251	3e-171	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG9270-PA	607040	NP_115972	7e-171	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG9270-PA	607040	NP_149163	7e-171	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG31116-PC	118425	NP_000074	2e-170	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG3182-PA	152427	NP_742053	3e-170	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3182-PB	152427	NP_742053	3e-170	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG14994-PA	605363	NP_000808	4e-170	GAD1;SCP	GAD;GLUTAMATE DECARBOXYLASE, BRAIN, 67-KD; GAD67	Cerebral palsy, spastic, symmetric, autosomal recessive, 603513 (3)
CG14994-PB	605363	NP_000808	4e-170	GAD1;SCP	GAD;GLUTAMATE DECARBOXYLASE, BRAIN, 67-KD; GAD67	Cerebral palsy, spastic, symmetric, autosomal recessive, 603513 (3)
CG14994-PC	605363	NP_000808	4e-170	GAD1;SCP	GAD;GLUTAMATE DECARBOXYLASE, BRAIN, 67-KD; GAD67	Cerebral palsy, spastic, symmetric, autosomal recessive, 603513 (3)
CG5680-PB	602897	NP_002744	4e-170	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG8107-PA	114240	NP_077320	4e-170	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG14709-PA	607040	NP_115972	4e-170	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG14709-PA	607040	NP_149163	4e-170	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG5680-PB	602897	NP_620446	4e-170	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG6199-PA	601865	NP_891988	4e-170	PLOD2	LH2;LYSINE HYDROXYLASE 2;LYSYL HYDROXYLASE 2;TELOPEPTIDE LYSYL HYDROXYLASE; TLH	Bruck syndrome 2, 609220 (3)
CG6199-PB	601865	NP_891988	4e-170	PLOD2	LH2;LYSINE HYDROXYLASE 2;LYSYL HYDROXYLASE 2;TELOPEPTIDE LYSYL HYDROXYLASE; TLH	Bruck syndrome 2, 609220 (3)
CG5680-PB	602897	NP_620448	5e-170	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG8799-PA	607040	NP_115972	7e-170	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG8799-PA	607040	NP_149163	7e-170	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG8107-PA	114240	NP_000061	2e-169	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG11898-PA	601107	NP_000383	2e-169	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG5889-PA	154270	NP_002387	2e-169	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG10738-PB	108961	NP_003986	2e-169	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG8177-PB	109270	NP_000333	4e-169	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8177-PC	109270	NP_000333	4e-169	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8177-PD	109270	NP_000333	4e-169	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8177-PF	109270	NP_000333	4e-169	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG9071-PA	600702	NP_055006	7e-169		NAV1.6	
CG9071-PB	600702	NP_055006	7e-169		NAV1.6	
CG3131-PA	606759	NP_054799	3e-168	DUOX2;THOX2	THYROID OXIDASE 2; THOX2	Hypothyroidism, congenital, due to DUOX2 deficiency, 607200 (3)
CG12262-PA	607008	NP_000007	4e-168	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG8782-PA	258870	NP_000265	4e-168	OAT	GYRATE ATROPHY;HYPERORNITHINEMIA WITH GYRATE ATROPHY OF CHOROID AND RETINA; HOGA;OAT DEFICIENCY;OKT DEFICIENCY;ORNITHINE KETO ACID AMINOTRANSFERASE DEFICIENCY;ORNITHINE-DELTA-AMINOTRANSFERASE DEFICIENCY	Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive (3)
CG7070-PA	609712	NP_000289	7e-168	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG7070-PB	609712	NP_000289	7e-168	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG7070-PA	609712	NP_870986	7e-168	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG7070-PB	609712	NP_870986	7e-168	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG6127-PA	601920	NP_000205	1e-167	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG30361-PA	604096	NP_000834	1e-167	CSNB1B;GRM6;MGLUR6	MGLUR6	Night blindness, congenital stationary, type 1B, 257270 (3)
CG3937-PB	102565	NP_001449	2e-167		ABPA;ACTIN-BINDING PROTEIN 280, AUTOSOMAL FORM; ABP280A;ACTIN-BINDING PROTEIN-LIKE; ABPL;FILAMIN 2; FLN2;FILAMIN, GAMMA	
CG3937-PC	102565	NP_001449	2e-167		ABPA;ACTIN-BINDING PROTEIN 280, AUTOSOMAL FORM; ABP280A;ACTIN-BINDING PROTEIN-LIKE; ABPL;FILAMIN 2; FLN2;FILAMIN, GAMMA	
CG8583-PA	608648	NP_009145	2e-167	SEC63		Polycystic liver disease, 174050 (3)
CG31116-PD	600570	NP_004357	3e-167	CLCN2;ECA3;EGI3;EGMA	CLC2	Epilepsy with grand mal seizures on awakening, 607628 (3);Epilepsy, childhood absence, 607682 (3);Epilepsy, juvenile absence, 607631 (3);Epilepsy, juvenile myoclonic, 606904 (3)
CG16718-PA	608662	NP_998764	3e-167	GDD1;TMEM16E	GDD1 GENE; GDD1	Gnthodiaphyseal dysplasia, 166260 (3)
CG16718-PB	608662	NP_998764	3e-167	GDD1;TMEM16E	GDD1 GENE; GDD1	Gnthodiaphyseal dysplasia, 166260 (3)
CG33196-PB	134797	NP_000129	1e-166	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG4545-PA	126455	NP_001035	2e-166	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG31116-PA	600570	NP_004357	3e-166	CLCN2;ECA3;EGI3;EGMA	CLC2	Epilepsy with grand mal seizures on awakening, 607628 (3);Epilepsy, childhood absence, 607682 (3);Epilepsy, juvenile absence, 607631 (3);Epilepsy, juvenile myoclonic, 606904 (3)
CG6668-PA	606439	NP_853629	3e-166	SPG3A	ATLASTIN;ATLASTIN 1; ATL1	Spastic paraplegia-3A, 182600 (3)
CG6668-PB	606439	NP_853629	3e-166	SPG3A	ATLASTIN;ATLASTIN 1; ATL1	Spastic paraplegia-3A, 182600 (3)
CG3936-PA	601920	NP_000205	7e-166	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG6668-PA	606439	NP_056999	1e-165	SPG3A	ATLASTIN;ATLASTIN 1; ATL1	Spastic paraplegia-3A, 182600 (3)
CG6668-PB	606439	NP_056999	1e-165	SPG3A	ATLASTIN;ATLASTIN 1; ATL1	Spastic paraplegia-3A, 182600 (3)
CG30361-PB	604096	NP_000834	3e-165	CSNB1B;GRM6;MGLUR6	MGLUR6	Night blindness, congenital stationary, type 1B, 257270 (3)
CG2835-PA	139320	NP_536351	5e-165	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2835-PC	139320	NP_536351	5e-165	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG7595-PA	160777	NP_000250	6e-165	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG7595-PB	160777	NP_000250	6e-165	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG31792-PA	607040	NP_115972	7e-165	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG31792-PA	607040	NP_149163	7e-165	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG6214-PB	607040	NP_660187	9e-165	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG5549-PA	604159	NP_004202	1e-164	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG3127-PA	311800	NP_000282	3e-164	PGK1;PGKA	3-@PHOSPHOGLYCEROKINASE;PGKA	Hemolytic anemia due to PGK deficiency (3);Myoglobinuria/hemolysis due to PGK deficiency (3)
CG5789-PA	607040	NP_115972	6e-164	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG5789-PA	607040	NP_149163	6e-164	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG9547-PA	608801	NP_000150	1e-163	GCDH		Glutaricaciduria, type I, 231670 (3)
CG6706-PA	607340	NP_005449	1e-163	GPR51;GABBR2	G PROTEIN-COUPLED RECEPTOR 51; GPR51;GABA-B RECEPTOR, R2 SUBUNIT; GABABR2	{Nicotine dependence, susceptibility to}, 188890 (3)
CG6706-PB	607340	NP_005449	1e-163	GPR51;GABBR2	G PROTEIN-COUPLED RECEPTOR 51; GPR51;GABA-B RECEPTOR, R2 SUBUNIT; GABABR2	{Nicotine dependence, susceptibility to}, 188890 (3)
CG8594-PA	602727	NP_001278	2e-163	CLC7;CLCN7;OPTA2	CLC7	Osteopetrosis, autosomal dominant, type II, 166600 (3);Osteopetrosis, recessive, 259700 (3)
CG2835-PA	139320	NP_000507	3e-163	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2835-PC	139320	NP_000507	3e-163	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2835-PB	139320	NP_536351	3e-163	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG31116-PA	118425	NP_000074	5e-163	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG31116-PD	118425	NP_000074	5e-163	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG7595-PA	602666	NP_057323	1e-162	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7595-PB	602666	NP_057323	1e-162	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG1725-PA	300189	NP_066943	1e-162	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG1725-PD	300189	NP_066943	1e-162	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG10772-PA	162150	NP_000430	2e-162	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG10772-PC	162150	NP_000430	2e-162	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG10772-PD	162150	NP_000430	2e-162	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG12092-PA	608010	NP_037521	3e-162	NPC1L1		[Ezetimibe, nonresponse to] (3)
CG8183-PA	605995	NP_055889	3e-162	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG8183-PB	605995	NP_055889	3e-162	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG10545-PA	139130	NP_002066	5e-162	GNB3		{Hypertension, essential, susceptibility to}, 145500 (3)
CG10545-PB	139130	NP_002066	5e-162	GNB3		{Hypertension, essential, susceptibility to}, 145500 (3)
CG11913-PA	602985	NP_004541	8e-162	NDUFS2	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 49-KD SUBUNIT	Mitochondrial complex I deficiency, 252010 (3)
CG3322-PA	156225	NP_000417	1e-161	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG2835-PB	139320	NP_000507	2e-161	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG6097-PA	607423	NP_009102	2e-161	POMT1	ROTATED ABDOMEN, DROSOPHILA, HOMOLOG OF; RT	Muscular dystrophy, congenital, plus mental retardation, 236670 (3);Muscular dystrophy, limb-girdle, type 2K, 609308 (3);Walker-Warburg syndrome, 236670 (3)
CG12008-PA	182860	NP_003117	4e-161	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG6767-PA	311850	NP_002755	7e-161	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG2316-PF	300371	NP_000024	9e-161	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG10772-PB	162150	NP_000430	9e-161	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG8107-PA	114240	NP_997630	3e-160	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG31793-PA	607040	NP_660187	9e-160	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG8380-PA	604159	NP_004202	1e-159	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG5905-PA	600423	NP_001388	2e-159	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG5905-PB	600423	NP_001388	2e-159	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG4562-PA	607040	NP_660187	2e-159	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG6976-PA	602666	NP_057323	3e-159	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6976-PB	602666	NP_057323	3e-159	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6976-PC	602666	NP_057323	3e-159	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6976-PD	602666	NP_057323	3e-159	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7002-PA	193400	NP_000543	7e-159	F8VWF;VWF	VON WILLEBRAND FACTOR DEFICIENCY;VWD	von Willebrand disease (3)
CG31075-PA	100650	NP_000681	2e-158	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG1886-PA	606882	NP_001005918	2e-158	ATP7B;WND		Wilson disease, 277900 (3)
CG4311-PA	600234	NP_005509	2e-158	HMGCS2	HMG-CoA SYNTHASE, MITOCHONDRIAL	HMG-CoA synthase-2 deficiency, 605911 (3)
CG4311-PB	600234	NP_005509	2e-158	HMGCS2	HMG-CoA SYNTHASE, MITOCHONDRIAL	HMG-CoA synthase-2 deficiency, 605911 (3)
CG4311-PC	600234	NP_005509	2e-158	HMGCS2	HMG-CoA SYNTHASE, MITOCHONDRIAL	HMG-CoA synthase-2 deficiency, 605911 (3)
CG4311-PD	600234	NP_005509	2e-158	HMGCS2	HMG-CoA SYNTHASE, MITOCHONDRIAL	HMG-CoA synthase-2 deficiency, 605911 (3)
CG4311-PE	600234	NP_005509	2e-158	HMGCS2	HMG-CoA SYNTHASE, MITOCHONDRIAL	HMG-CoA synthase-2 deficiency, 605911 (3)
CG6383-PA	600275	NP_077719	2e-158	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG6383-PA	600275	XP_001133349	2e-158	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8224-PA	190181	NP_004603	3e-158	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG17927-PI	160777	NP_000250	5e-158	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG33196-PB	121050	NP_001990	1e-157	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG7563-PB	114240	NP_000061	2e-157	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG7563-PB	114240	NP_077320	2e-157	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG7779-PA	123825	NP_000078	3e-157	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG17927-PH	160777	NP_000250	3e-157	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG14709-PA	601439	NP_064693	3e-157	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1709-PA	604592	NP_006010	4e-157	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PF	604592	NP_006010	4e-157	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG7627-PA	607040	NP_660187	4e-157	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG3415-PA	601860	NP_000405	5e-157	HSD17B4	17-@BETA-HSD IV;BIFUNCTIONAL PROTEIN;D-3-@HYDROXYACYL-CoA DEHYDRATASE/D-3-HYDROXYACYL-CoA DEHYDROGENASE;D-BIFUNCTIONAL PROTEIN, PEROXISOMAL;DBP, PEROXISOMAL	D-bifunctional protein deficiency, 261515 (3)
CG6767-PB	311850	NP_002755	6e-157	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG1732-PA	300036	NP_005620	9e-157	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG1732-PC	300036	NP_005620	9e-157	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG17927-PD	160777	NP_000250	1e-156	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG31547-PA	600968	NP_000330	1e-156	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG31547-PB	600968	NP_000330	1e-156	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG10060-PA	139360	NP_002061	1e-156	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG4422-PA	300104	NP_001484	2e-156	GDI1;MRX41;MRX48;RABGD1A	OLIGOPHRENIN 2; OPHN2;RAB GDI-ALPHA;RAB GDP-DISSOCIATION INHIBITOR, ALPHA; RABGDIA;RHOGDI	Mental retardation, X-linked nonspecific, 309541 (3)
CG8183-PA	605995	NP_904325	2e-156	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG8183-PB	605995	NP_904325	2e-156	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG18734-PA	162150	NP_000430	3e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG18734-PB	162150	NP_000430	3e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG18734-PC	162150	NP_000430	3e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG14709-PA	601439	NP_064694	3e-156	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG18734-PD	162150	NP_000430	4e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG18734-PE	162150	NP_000430	4e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG18734-PF	162150	NP_000430	4e-156	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG2845-PA	164757	NP_004324	4e-156	BRAF	BRAF1;ONCOGENE BRAF;RAFB1	Adenocarcinoma of lung, somatic, 211980 (3);Cardiofaciocutaneous syndrome, 115150 (3);Colorectal cancer, somatic (3);Melanoma, melignant, somatic (3);Nonsmall cell lung cancer, somatic (3)
CG17927-PF	160777	NP_000250	5e-156	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG17927-PA	160777	NP_000250	6e-156	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG2107-PA	600650	NP_000089	8e-156	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG30446-PA	107930	NP_000781	9e-156	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG7627-PA	601439	NP_064693	9e-156	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG10505-PA	607040	NP_115972	1e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG10505-PA	607040	NP_149163	1e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG2835-PA	139320	NP_536350	1e-155	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2835-PC	139320	NP_536350	1e-155	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17927-PE	160777	NP_000250	2e-155	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG3017-PA	301300	NP_001033056	2e-155	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG3017-PA	301300	NP_001033057	2e-155	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG7873-PA	190090	NP_005408	2e-155	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7873-PB	190090	NP_005408	2e-155	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7873-PA	190090	NP_938033	2e-155	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7873-PB	190090	NP_938033	2e-155	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3017-PA	301300	NP_000023	3e-155	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG31792-PA	601439	NP_064693	4e-155	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11897-PA	607040	NP_115972	4e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11897-PB	607040	NP_115972	4e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11897-PA	607040	NP_149163	4e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11897-PB	607040	NP_149163	4e-155	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG17927-PB	160777	NP_000250	5e-155	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG17927-PM	160777	NP_000250	5e-155	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG3017-PA	301300	NP_001033058	6e-155	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG17927-PC	160777	NP_000250	7e-155	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG2137-PA	138430	NP_000399	1e-154	GPD2	GDH2;GLYCEROPHOSPHATE DEHYDROGENASE-2 Ca(2+)-RESPONSIVE MITOCHONDRIAL FAD-LINKED;GPD, MITOCHONDRIAL; GPDM	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG2048-PA	600864	NP_001884	1e-154			
CG2048-PB	600864	NP_001884	1e-154			
CG2048-PC	600864	NP_001884	1e-154			
CG31175-PA	300377	NP_004008	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004008	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004008	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PA	300377	NP_004009	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004009	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004009	1e-154	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG14709-PA	601439	NP_005682	1e-154	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1709-PC	604592	NP_006010	1e-154	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PE	604592	NP_006010	1e-154	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG2048-PA	600864	NP_620693	1e-154			
CG2048-PB	600864	NP_620693	1e-154			
CG2048-PC	600864	NP_620693	1e-154			
CG18374-PA	300474	NP_000158	2e-154	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG10120-PA	154270	NP_002387	2e-154	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG10120-PB	154270	NP_002387	2e-154	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG1709-PB	604592	NP_006010	2e-154	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PD	604592	NP_006010	2e-154	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG2048-PA	600864	XP_001132734	2e-154			
CG2048-PB	600864	XP_001132734	2e-154			
CG2048-PC	600864	XP_001132734	2e-154			
CG9270-PA	601439	NP_064693	3e-154	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11990-PA	607393	NP_078805	3e-154	C1orf28;HRPT2	C1ORF28;CDC73;PARAFIBROMIN	Hyperparathyroidism, familial primary, 145000 (3);Hyperparathyroidism-jaw tumor syndrome, 145001 (3);Parathyroid adenoma with cystic changes, 145001 (3);Parathyroid carcinoma, 608266 (3)
CG17927-PG	160777	NP_000250	4e-154	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG9313-PA	604366	NP_036276	8e-154	CILD1;DNAI1;ICS;PCD		Ciliary dyskinesia, primary, 1, 242650 (3);Kartagener syndrome, 244400 (3)
CG17927-PL	160777	NP_000250	1e-153	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG7507-PB	603339	NP_003768	1e-153	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG9270-PA	601439	NP_064694	1e-153	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG2835-PB	139320	NP_536350	1e-153	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG7433-PA	137150	NP_000654	2e-153	ABAT;GABAT	GABA TRANSFERASE;GAMMA-AMINOBUTYRATE TRANSAMINASE; GABAT	GABA-transaminase deficiency (3)
CG7433-PB	137150	NP_000654	2e-153	ABAT;GABAT	GABA TRANSFERASE;GAMMA-AMINOBUTYRATE TRANSAMINASE; GABAT	GABA-transaminase deficiency (3)
CG17597-PA	184755	NP_002970	2e-153	SCP2	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY, SCPx-DEFICIENT,;STEROL CARRIER PROTEIN X; SCPX	Leukoencephalopathy with dystonia and motor neuropathy (3)
CG8224-PB	190181	NP_004603	2e-153	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG7433-PA	137150	NP_065737	2e-153	ABAT;GABAT	GABA TRANSFERASE;GAMMA-AMINOBUTYRATE TRANSAMINASE; GABAT	GABA-transaminase deficiency (3)
CG7433-PB	137150	NP_065737	2e-153	ABAT;GABAT	GABA TRANSFERASE;GAMMA-AMINOBUTYRATE TRANSAMINASE; GABAT	GABA-transaminase deficiency (3)
CG7399-PA	261600	NP_000268	3e-153	PAH;PKU1	FOLLING DISEASE;OLIGOPHRENIA PHENYLPYRUVICA;PAH DEFICIENCY;PHENYLALANINE HYDROXYLASE DEFICIENCY;PKU	Phenylketonuria (3);[Hyperphenylalaninemia, mild] (3)
CG18374-PA	300474	NP_976325	3e-153	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG9547-PA	608801	NP_039663	8e-153	GCDH		Glutaricaciduria, type I, 231670 (3)
CG1709-PG	604592	NP_006010	1e-152	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG9270-PA	607040	NP_660187	1e-152	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG31874-PA	136850	NP_000134	2e-152	FH	FUMARASE	Fumarase deficiency, 606812 (3);Leiomyomatosis and renal cell cancer, 605839 (3);Multiple cutaneous and uterine leiomyomata, 150800 (3)
CG7627-PA	600509	NP_000343	3e-152	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG1440-PA	602403	NP_000377	3e-152	BLMH;BMH	BMH	{Alzheimer disease, susceptibility to}, 104300 (3)
CG31175-PA	300377	NP_004006	3e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004006	3e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004006	3e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG17927-PK	160777	NP_000250	4e-152	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG31175-PA	300377	NP_004007	4e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004007	4e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004007	4e-152	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8799-PA	607040	NP_660187	4e-152	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG7627-PA	601439	NP_005682	5e-152	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG9270-PA	601439	NP_005682	8e-152	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG4562-PA	601439	NP_064693	1e-151	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG14709-PA	607040	NP_660187	1e-151	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG8827-PA	106180	NP_690043	1e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG8827-PB	106180	NP_690043	1e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG8827-PA	106180	NP_690044	1e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG8827-PB	106180	NP_690044	1e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG17927-PJ	160777	NP_000250	2e-151	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG3671-PA	600266	NP_000569	2e-151	NRAMP;NRAMP1	MEMBER 1; SLC11A1;NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; NRAMP1; NRAMP	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)
CG3671-PB	600266	NP_000569	2e-151	NRAMP;NRAMP1	MEMBER 1; SLC11A1;NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; NRAMP1; NRAMP	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)
CG8827-PA	106180	NP_000780	2e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG8827-PB	106180	NP_000780	2e-151	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG5009-PA	609751	NP_009223	2e-151	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG5009-PA	609751	NP_004026	3e-151	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG6975-PA	191092	NP_066400	4e-151	LAM;TSC2	TSC4 GENE, FORMERLY; TSC4, FORMERLY;TUBERIN	Lymphangioleiomyomatosis, somatic, 606690 (3);Tuberous sclerosis-2, 191100 (3)
CG33114-PA	108961	NP_003986	7e-151	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG31792-PA	601439	NP_005682	7e-151	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7627-PA	601439	NP_064694	8e-151	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3454-PA	107930	NP_000781	1e-150	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG1743-PB	138290	NP_001028216	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG1743-PC	138290	NP_001028216	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG1743-PB	138290	NP_001028228	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG1743-PC	138290	NP_001028228	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG1743-PB	138290	NP_002056	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG1743-PC	138290	NP_002056	1e-150	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG3263-PA	188830	NP_002725	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PC	188830	NP_002725	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PA	188830	NP_997636	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PC	188830	NP_997636	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PA	188830	NP_997637	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PC	188830	NP_997637	1e-150	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG6638-PA	607036	NP_002216	2e-150	IVD		Isovaleric acidemia, 243500 (3)
CG5300-PA	608283	NP_060111	2e-150	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG7487-PA	603780	NP_004251	3e-150	RECQ4;RECQL4;RTS	DNA HELICASE, RECQ-LIKE, TYPE 4; RECQ4	Baller-Gerold syndrome, 218600 (3);RAPADILINO syndrome, 266280 (3);Rothmund-Thomson syndrome, 268400 (3)
CG7487-PB	603780	NP_004251	3e-150	RECQ4;RECQL4;RTS	DNA HELICASE, RECQ-LIKE, TYPE 4; RECQ4	Baller-Gerold syndrome, 218600 (3);RAPADILINO syndrome, 266280 (3);Rothmund-Thomson syndrome, 268400 (3)
CG6975-PA	191092	NP_066399	3e-150	LAM;TSC2	TSC4 GENE, FORMERLY; TSC4, FORMERLY;TUBERIN	Lymphangioleiomyomatosis, somatic, 606690 (3);Tuberous sclerosis-2, 191100 (3)
CG7563-PB	114240	NP_775110	4e-150	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG15792-PA	160777	NP_000250	5e-150	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG15792-PB	160777	NP_000250	5e-150	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG7563-PB	114240	NP_997630	5e-150	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG31793-PA	601439	NP_064693	9e-150	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3322-PA	150292	NP_005553	1e-149	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG3322-PA	150292	NP_061486	1e-149	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG4703-PA	606885	NP_000008	2e-149	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG18617-PA	604592	NP_006010	2e-149	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG18617-PB	604592	NP_006010	2e-149	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG11898-PA	607040	NP_115972	2e-149	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11898-PA	607040	NP_149163	2e-149	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG32092-PB	602997	NP_001072	3e-149	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG10295-PA	300142	NP_002569	3e-149	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG10295-PB	300142	NP_002569	3e-149	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG10295-PC	300142	NP_002569	3e-149	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG3027-PA	606673	NP_057411	4e-149	BUP1;UPB1	BETA-ALANINE SYNTHASE;BUP1	Beta-ureidopropionase deficiency (3)
CG8742-PA	108961	NP_003986	9e-149	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG9783-PA	600179	NP_000171	1e-148	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG6876-PA	606419	NP_056444	1e-148	PRP31;PRPF31	PRP31	Retinitis pigmentosa-11, 600138 (3)
CG31792-PA	601439	NP_064694	1e-148	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG9071-PA	600163	XP_001131636	2e-148	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG9071-PB	600163	XP_001131636	2e-148	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG7779-PA	600053	NP_001289	3e-148	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG31792-PA	600509	NP_000343	5e-148	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG3671-PA	600523	NP_000608	5e-148	NRAMP2	DIVALENT CATION TRANSPORTER 1; DCT1;DIVALENT METAL TRANSPORTER 1; DMT1;MEMBER 2; SLC11A2;NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 2; NRAMP2	Anemia, hypochromic microcytic, 206100 (3)
CG3671-PB	600523	NP_000608	5e-148	NRAMP2	DIVALENT CATION TRANSPORTER 1; DCT1;DIVALENT METAL TRANSPORTER 1; DMT1;MEMBER 2; SLC11A2;NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 2; NRAMP2	Anemia, hypochromic microcytic, 206100 (3)
CG9122-PA	607478	NP_775489	5e-148	TPH2;NTPH	TRYPTOPHAN HYDROXYLASE, NEURONAL; NTPH	{Unipolar depression, susceptibility to}, 608516 (3)
CG12002-PA	606765	NP_783652	8e-148	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG12002-PA	606765	NP_000538	9e-148	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG12002-PA	606765	NP_783651	9e-148	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3216-PA	108961	NP_003986	2e-147	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG5789-PA	607040	NP_660187	2e-147	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG31793-PA	601439	NP_005682	3e-147	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG4562-PA	601439	NP_005682	3e-147	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG8177-PA	109270	NP_000333	4e-147	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8177-PE	109270	NP_000333	4e-147	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8177-PG	109270	NP_000333	4e-147	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG31792-PA	607040	NP_660187	4e-147	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG12455-PB	608171	NP_758952	4e-147	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG15117-PA	253220	NP_000172	6e-147	GUSB;MPS7	BETA-GLUCURONIDASE DEFICIENCY;GUSB DEFICIENCY;MPS VII; MPS7;SLY SYNDROME	Mucopolysaccharidosis VII (3)
CG15117-PB	253220	NP_000172	6e-147	GUSB;MPS7	BETA-GLUCURONIDASE DEFICIENCY;GUSB DEFICIENCY;MPS VII; MPS7;SLY SYNDROME	Mucopolysaccharidosis VII (3)
CG5320-PC	138130	NP_005262	7e-147	GLUD1	GDH;GLUD	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
CG6920-PA	604610	NP_000048	1e-146	BLM;BS;RECQ2;RECQL3	BLM GENE; BLM;DNA HELICASE, RECQ-LIKE, TYPE 2; RECQ2	Bloom syndrome, 210900 (3)
CG4562-PA	601439	NP_064694	1e-146	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG31793-PA	601439	NP_064694	2e-146	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG12139-PB	192977	NP_003374	3e-146	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG1560-PA	173470	NP_000203	4e-146	GP3A;ITGB3	CD61;GP3A;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;PLATELET GLYCOPROTEIN IIIa; GPIIIa;THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE	Glanzmann thrombasthenia, type B (3)
CG4545-PA	604159	NP_004202	7e-146	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG1753-PA	236200	NP_000062	8e-146	CBS	CBS DEFICIENCY;CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Homocystinuria, B6-responsive and nonresponsive types (3);Thrombosis, hyperhomocysteinemic (3)
CG1753-PB	236200	NP_000062	8e-146	CBS	CBS DEFICIENCY;CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	Homocystinuria, B6-responsive and nonresponsive types (3);Thrombosis, hyperhomocysteinemic (3)
CG6976-PA	160777	NP_000250	8e-146	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG6976-PB	160777	NP_000250	8e-146	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG6976-PC	160777	NP_000250	8e-146	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG6976-PD	160777	NP_000250	8e-146	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG1732-PA	604159	NP_004202	9e-146	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG1732-PC	604159	NP_004202	9e-146	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG12139-PB	192977	NP_001018066	1e-145	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG14991-PA	607900	NP_060141	1e-145	C20orf42;KIND1;URP1	CHROMOSOME 20 OPEN READING FRAME 42; C20ORF42;KIND1;KINDLERIN;UNC112-RELATED PROTEIN 1; URP1	Kindler syndrome, 173650 (3)
CG14991-PB	607900	NP_060141	1e-145	C20orf42;KIND1;URP1	CHROMOSOME 20 OPEN READING FRAME 42; C20ORF42;KIND1;KINDLERIN;UNC112-RELATED PROTEIN 1; URP1	Kindler syndrome, 173650 (3)
CG6975-PA	191092	NP_000539	2e-145	LAM;TSC2	TSC4 GENE, FORMERLY; TSC4, FORMERLY;TUBERIN	Lymphangioleiomyomatosis, somatic, 606690 (3);Tuberous sclerosis-2, 191100 (3)
CG6445-PA	605516	NP_071407	2e-145	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG6445-PB	605516	NP_071407	2e-145	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG1597-PA	601336	NP_006293	6e-145	GCS1		Glucosidase I deficiency, 606056 (3)
CG7563-PA	114240	NP_775110	7e-145	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG7524-PB	190090	NP_005408	1e-144	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7524-PB	190090	NP_938033	1e-144	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG13397-PA	609701	NP_000254	2e-144	NAGLU	N-ACETYL-ALPHA-D-GLUCOSAMINIDASE;N-ACETYL-ALPHA-GLUCOSAMINIDASE	Sanfilippo syndrome, type B, 252920 (3)
CG6383-PA	600276	NP_000426	2e-144	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG12348-PC	176260	NP_000208	3e-144	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG12348-PE	176260	NP_000208	3e-144	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG10524-PA	605437	NP_006246	3e-144	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG14228-PA	607379	NP_000259	4e-144	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG5996-PA	603652	NP_004612	6e-144	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG5996-PB	603652	NP_004612	6e-144	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG5789-PA	601439	NP_064693	6e-144	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG10932-PA	607809	NP_000010	7e-144	ACAT1	ACAT;ACETOACETYL-CoA THIOLASE, MITOCHONDRIAL;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE; MAT;T2	Alpha-methylacetoacetic aciduria, 203750 (3)
CG12455-PB	608171	NP_001005766	7e-144	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG3619-PA	601920	NP_000205	8e-144	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG3619-PB	601920	NP_000205	8e-144	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG31793-PA	603234	NP_001162	8e-144	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG14993-PA	276700	NP_000128	9e-144	FAH	FAH DEFICIENCY;FUMARYLACETOACETASE DEFICIENCY;HEPATORENAL TYROSINEMIA	Tyrosinemia, type I (3)
CG4908-PA	603647	NP_004319	1e-143	BCS1L;FLNMS;GRACILE		GRACILE syndrome, 603358 (3);Leigh syndrome, 256000 (3);Mitochondrial complex III deficiency, 124000 (3)
CG4908-PB	603647	NP_004319	1e-143	BCS1L;FLNMS;GRACILE		GRACILE syndrome, 603358 (3);Leigh syndrome, 256000 (3);Mitochondrial complex III deficiency, 124000 (3)
CG12348-PD	176260	NP_000208	2e-143	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG4562-PA	603234	NP_001162	2e-143	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG4058-PA	600423	NP_001388	2e-143	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG4058-PB	600423	NP_001388	2e-143	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG6535-PA	607585	NP_612149	2e-143	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1977-PA	182870	NP_000338	4e-143	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG4562-PA	600509	NP_000343	4e-143	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG1977-PA	182870	NP_001020029	4e-143	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG11897-PA	601439	NP_064693	4e-143	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11897-PB	601439	NP_064693	4e-143	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6535-PA	607585	NP_000042	5e-143	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10535-PA	603722	NP_003631	7e-143	IKAP;IKBKAP	COMPLEX-ASSOCIATED PROTEIN; IKBKAP;ELP1, YEAST, HOMOLOG OF; ELP1;IKK COMPLEX-ASSOCIATED PROTEIN; IKAP	Dysautonomia, familial, 223900 (3)
CG5226-PA	608893	NP_001003841	1e-142	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG12582-PA	609489	NP_005899	1e-142	MANB1;MANBA	MANB1;MANNANASE;MANNASE	Mannosidosis, beta, 248510 (3)
CG8799-PA	601439	NP_064693	1e-142	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG2204-PB	139360	NP_002061	2e-142	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2204-PD	139360	NP_002061	2e-142	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2204-PE	139360	NP_002061	2e-142	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2204-PF	139360	NP_002061	2e-142	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2204-PG	139360	NP_002061	2e-142	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG9594-PA	608892	NP_060250	2e-142	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG9270-PA	600509	NP_000343	3e-142	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG32300-PB	608124	NP_071449	4e-142	XT1;XYLT1	UDP-D-XYLOSE:PROTEOGLYCAN CORE PROTEIN BETA-D-XYLOSYLTRANSFERASE 1;XT1	{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
CG32300-PB	608124	XP_001125986	4e-142	XT1;XYLT1	UDP-D-XYLOSE:PROTEOGLYCAN CORE PROTEIN BETA-D-XYLOSYLTRANSFERASE 1;XT1	{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
CG8799-PA	600509	NP_000343	1e-141	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG7563-PA	114240	NP_000061	2e-141	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG2204-PA	139360	NP_002061	2e-141	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2204-PC	139360	NP_002061	2e-141	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG11561-PA	601500	NP_005622	2e-141	SMO;SMOH	SMO	Basal cell carcinoma, somatic (3)
CG7563-PA	114240	NP_077320	2e-141	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG5409-PA	102560	NP_001605	3e-141	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG12455-PA	608171	NP_758952	3e-141	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG5409-PA	102630	NP_001092	4e-141		BETA-ACTIN	
CG3902-PA	600301	NP_001600	4e-141	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG5549-PA	300444	NP_009162	5e-141	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG6050-PA	602389	NP_003312	6e-141	COXPD4;EFTU;TUFM	EF-Tu, MITOCHONDRIAL;EF-TuMT;MITOCHONDRIAL TRANSLATION ELONGATION FACTOR Tu	Combined oxidative phosphorylation deficiency 4, 610678 (3)
CG5789-PA	601439	NP_064694	8e-141	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG9155-PA	276903	NP_000251	9e-141	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG9155-PB	276903	NP_000251	9e-141	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG9155-PC	276903	NP_000251	9e-141	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG9155-PD	276903	NP_000251	9e-141	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG5789-PA	601439	NP_005682	1e-140	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7995-PA	300474	NP_000158	2e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PB	300474	NP_000158	2e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PC	300474	NP_000158	2e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PD	300474	NP_000158	2e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PE	300474	NP_000158	2e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG10501-PA	107930	NP_000781	2e-140	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG12455-PA	608171	NP_001005766	2e-140	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG4145-PA	303631	NP_001838	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG4145-PB	303631	NP_001838	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG4145-PC	303631	NP_001838	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG11796-PA	609695	NP_002141	2e-140	HPD	4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE	Hawkinsinuria, 140350 (3);Tyrosinemia, type III, 276710 (3)
CG8103-PA	608892	NP_060250	2e-140	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG10505-PA	601439	NP_064693	2e-140	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG4145-PA	303631	NP_378667	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG4145-PB	303631	NP_378667	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG4145-PC	303631	NP_378667	2e-140	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG2146-PA	276903	NP_000251	3e-140	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG2146-PB	276903	NP_000251	3e-140	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG2146-PC	276903	NP_000251	3e-140	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG11897-PA	603234	NP_001162	3e-140	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG11897-PB	603234	NP_001162	3e-140	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG1411-PA	222748	NP_001376	3e-140	DHP;DPYS		Dihydropyrimidinuria (3)
CG10505-PA	607040	NP_660187	3e-140	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG7995-PA	300474	NP_976325	3e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PB	300474	NP_976325	3e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PC	300474	NP_976325	3e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PD	300474	NP_976325	3e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7995-PE	300474	NP_976325	3e-140	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG10353-PA	608662	NP_998764	5e-140	GDD1;TMEM16E	GDD1 GENE; GDD1	Gnthodiaphyseal dysplasia, 166260 (3)
CG10353-PB	608662	NP_998764	5e-140	GDD1;TMEM16E	GDD1 GENE; GDD1	Gnthodiaphyseal dysplasia, 166260 (3)
CG31731-PA	601615	NP_001080	6e-140	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG13521-PA	608630	NP_071765	8e-140	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG13521-PB	608630	NP_071765	8e-140	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG1732-PA	163970	NP_001034	1e-139	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG1732-PC	163970	NP_001034	1e-139	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG6512-PA	602783	NP_003110	1e-139	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG6512-PB	602783	NP_003110	1e-139	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG7565-PA	609269	NP_055624	1e-139	DLX2;DYLX2;DYX2;KIAA0319		{Dyslexia, susceptibility to, 2}, 600202 (3)
CG10505-PA	600509	NP_000343	2e-139	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG11963-PA	603921	NP_003841	2e-139	SUCLA2	A-BETA;ATP-SPECIFIC SUCCINYL-CoA SYNTHETASE, BETA SUBUNIT	Mitochondrial DNA depletion syndrome, 251880 (3)
CG7075-PA	604159	NP_004202	2e-139	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG1640-PA	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG1640-PB	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG1640-PC	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG1640-PD	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG1640-PE	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG1640-PF	138200	NP_005300	2e-139		ALANINE AMINOTRANSFERASE 1; AAT1; ALT1;ALANINE AMINOTRANSFERASE, SOLUBLE;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE LIVER;GLUTAMATE PYRUVATE TRANSAMINASE, SOLUBLE RED CELL; GPT1	
CG11897-PA	601439	NP_005682	2e-139	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11897-PB	601439	NP_005682	2e-139	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3733-PA	608892	NP_060250	2e-139	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG31793-PA	600509	NP_000343	3e-139	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG1732-PA	126455	NP_001035	3e-139	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG1732-PC	126455	NP_001035	3e-139	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG7595-PA	160775	NP_002464	3e-139	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG7595-PB	160775	NP_002464	3e-139	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG3132-PA	230500	NP_000395	4e-139	GLB1	BETA-GALACTOSIDASE-1 DEFICIENCY;GLB1 DEFICIENCY	GM1-gangliosidosis (3);Mucopolysaccharidosis IVB (3)
CG14291-PA	605270	NP_000190	5e-139	MPS3A;SFMD;SGSH	HEPARAN SULFATE SULFATASE; HSS;SULFAMIDASE	Sanfilippo syndrome, type A, 252900 (3)
CG8224-PA	601300	NP_004293	6e-139	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG9981-PA	602397	NP_005594	6e-139	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG11897-PA	607040	NP_660187	8e-139	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG11897-PB	607040	NP_660187	8e-139	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG12002-PA	131399	NP_000493	9e-139	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG9961-PA	311800	NP_000282	1e-138	PGK1;PGKA	3-@PHOSPHOGLYCEROKINASE;PGKA	Hemolytic anemia due to PGK deficiency (3);Myoglobinuria/hemolysis due to PGK deficiency (3)
CG14228-PA	607379	NP_057502	1e-138	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG14228-PA	607379	NP_861546	1e-138	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG14228-PA	607379	NP_861970	1e-138	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG33085-PA	608310	NP_000039	2e-138	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG33085-PA	608310	NP_001020114	2e-138	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG8799-PA	601439	NP_005682	2e-138	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG12002-PA	606989	NP_000241	3e-138	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG5409-PA	102540	NP_005150	3e-138	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7052-PA	103950	NP_000005	4e-138	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG4675-PA	109270	NP_000333	5e-138	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG4675-PB	109270	NP_000333	5e-138	AE1;EPB3;SLC4A1	ANION EXCHANGE PROTEIN 1; AE1;BAND 3 OF RED CELL MEMBRANE; BND3;ERYTHROCYTE MEMBRANE PROTEIN BAND 3; EMPB3;ERYTHROID PROTEIN BAND 3; EPB3	Hemolytic anemia due to band 3 defect defect (3);Renal tubular acidosis, distal, 179800, 602722 (3);Spherocytosis, hereditary (3);[;[Acanthocytosis, one form] (1);[Blood group, Diego], 110500 (3);[Blood group, Waldner], 112010 (3);[Blood group, Wright], 112050 (3);[Elliptocytosis, Malaysian-Melanesian type] (3)
CG8799-PA	601439	NP_064694	5e-138	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG5409-PA	102610	NP_001091	6e-138	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG7595-PA	160760	NP_000248	8e-138	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG7595-PB	160760	NP_000248	8e-138	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG7595-PA	601478	NP_005370	9e-138	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG7595-PB	601478	NP_005370	9e-138	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG2146-PA	160745	NP_002465	1e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PB	160745	NP_002465	1e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG33092-PA	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PB	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PC	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PD	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PE	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PF	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PG	606811	NP_003739	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG7757-PA	607301	NP_004689	1e-137	HPRP3;RP18	HPRP3;PRP3;PRPF3	Retinitis pigmentosa-18, 601414 (3)
CG2146-PA	160745	NP_074035	1e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PB	160745	NP_074035	1e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG33092-PA	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PB	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PC	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PD	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PE	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PF	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG33092-PG	606811	NP_733844	1e-137	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG11897-PA	601439	NP_064694	2e-137	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11897-PB	601439	NP_064694	2e-137	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG10505-PA	601439	NP_005682	3e-137	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1732-PA	182138	NP_001036	4e-137	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG1732-PC	182138	NP_001036	4e-137	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG2146-PA	160745	NP_001035202	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PB	160745	NP_001035202	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PA	160745	NP_001035203	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PB	160745	NP_001035203	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PC	160745	NP_002465	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PC	160745	NP_074035	7e-137	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG1891-PA	102576	NP_001096	8e-137	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG1891-PB	102576	NP_001096	8e-137	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG30445-PA	107930	NP_000781	9e-137	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG2146-PA	160720	NP_002461	9e-137	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG2146-PB	160720	NP_002461	9e-137	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6355-PA	609414	NP_001002881	1e-136	CFD;PIP5K3	KIAA0981	Corneal fleck dystrophy, 121850 (3)
CG6355-PA	609414	NP_055855	1e-136	CFD;PIP5K3	KIAA0981	Corneal fleck dystrophy, 121850 (3)
CG3936-PA	134797	NP_000129	2e-136	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG18374-PB	300474	NP_000158	2e-136	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG7806-PA	601439	NP_064693	2e-136	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3389-PA	605516	NP_071407	2e-136	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG2146-PC	160745	NP_001035202	3e-136	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PC	160745	NP_001035203	3e-136	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9270-PA	603234	NP_001162	3e-136	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8199-PA	608348	NP_000700	4e-136	BCKDHA;MSUD1	BCKD, E1-ALPHA SUBUNIT; BCKDE1A	Maple syrup urine disease, type Ia, 248600 (3)
CG33087-PC	192977	NP_003374	4e-136	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG6976-PA	160760	NP_000248	6e-136	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG6976-PB	160760	NP_000248	6e-136	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG6976-PC	160760	NP_000248	6e-136	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG6976-PD	160760	NP_000248	6e-136	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG33087-PC	192977	NP_001018066	7e-136	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7757-PB	607301	NP_004689	7e-136	HPRP3;RP18	HPRP3;PRP3;PRPF3	Retinitis pigmentosa-18, 601414 (3)
CG6214-PA	603234	NP_001162	8e-136	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8049-PA	300300	NP_000052	9e-136	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8049-PB	300300	NP_000052	9e-136	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8049-PC	300300	NP_000052	9e-136	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8049-PD	300300	NP_000052	9e-136	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG2146-PA	160760	NP_000248	1e-135	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG2146-PB	160760	NP_000248	1e-135	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG10593-PA	106180	NP_000780	1e-135	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG7595-PA	160710	NP_002462	1e-135	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7595-PB	160710	NP_002462	1e-135	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG2146-PA	160775	NP_002464	1e-135	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG2146-PB	160775	NP_002464	1e-135	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG10505-PA	601439	NP_064694	1e-135	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG10593-PA	106180	NP_690043	1e-135	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG10593-PA	106180	NP_690044	1e-135	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG9761-PA	600423	NP_001388	2e-135	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG2146-PC	160720	NP_002461	2e-135	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7595-PA	160745	NP_002465	2e-135	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PB	160745	NP_002465	2e-135	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PA	160745	NP_074035	2e-135	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PB	160745	NP_074035	2e-135	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG1634-PB	308840	NP_076493	2e-135	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG9155-PA	602666	NP_057323	3e-135	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG9155-PB	602666	NP_057323	3e-135	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG9155-PC	602666	NP_057323	3e-135	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG9155-PD	602666	NP_057323	3e-135	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG2146-PA	160740	NP_060004	3e-135	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG2146-PB	160740	NP_060004	3e-135	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG18374-PB	300474	NP_976325	3e-135	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG8224-PB	601300	NP_004293	4e-135	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1634-PA	308840	NP_076493	4e-135	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG8529-PA	601239	NP_116757	4e-135	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_116757	4e-135	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_116757	4e-135	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG11897-PA	600509	NP_000343	5e-135	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG11897-PB	600509	NP_000343	5e-135	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG1064-PA	601607	NP_001007469	5e-135	INI1;RDT;SMARCB1;SNF5	INTEGRASE INTERACTOR 1; INI1;MALIGNANT RHABDOID TUMOR SUPPRESSOR;SNF5, YEAST, HOMOLOG OF; SNF5;SUBFAMILY B, MEMBER 1; SMARCB1	Rhabdoid predisposition syndrome, familial (3);Rhabdoid tumors (3)
CG2146-PC	160775	NP_002464	6e-135	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG4779-PA	607474	XP_935776	7e-135	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG11876-PA	179060	NP_000916	8e-135	PDHB	E1, BETA POLYPEPTIDE; PHE1B	Pyruvate dehydrogenase E1-beta deficiency (3)
CG11876-PD	179060	NP_000916	8e-135	PDHB	E1, BETA POLYPEPTIDE; PHE1B	Pyruvate dehydrogenase E1-beta deficiency (3)
CG1634-PB	308840	NP_000416	9e-135	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG2146-PC	160760	NP_000248	1e-134	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG9155-PA	160777	NP_000250	1e-134	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG9155-PB	160777	NP_000250	1e-134	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG9155-PC	160777	NP_000250	1e-134	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG9155-PD	160777	NP_000250	1e-134	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG7595-PA	160745	NP_001035202	1e-134	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PB	160745	NP_001035202	1e-134	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PA	160745	NP_001035203	1e-134	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PB	160745	NP_001035203	1e-134	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG11861-PA	300304	NP_003579	1e-134	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG11861-PB	300304	NP_003579	1e-134	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG30171-PB	188840	NP_596869	1e-134	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG2174-PA	160777	NP_000250	2e-134	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG1634-PA	308840	NP_000416	2e-134	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG11861-PC	300304	NP_003579	2e-134	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG2146-PC	160740	NP_060004	2e-134	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG32300-PB	608125	NP_071450	2e-134	XYLT2;XT2	UDP-D-XYLOSE:PROTEOGLYCAN CORE PROTEIN BETA-D-XYLOSYLTRANSFERASE 2;XT2	{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
CG7806-PA	601439	NP_064694	3e-134	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1560-PA	600065	NP_000202	4e-134	CD18;ITGB2;LAD;LCAMB	LEUKOCYTE CELL ADHESION MOLECULE CD18; CD18	Leukocyte adhesion deficiency, 116920 (3)
CG8529-PA	601239	NP_001381	4e-134	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_001381	4e-134	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_001381	4e-134	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG1064-PA	601607	NP_003064	4e-134	INI1;RDT;SMARCB1;SNF5	INTEGRASE INTERACTOR 1; INI1;MALIGNANT RHABDOID TUMOR SUPPRESSOR;SNF5, YEAST, HOMOLOG OF; SNF5;SUBFAMILY B, MEMBER 1; SMARCB1	Rhabdoid predisposition syndrome, familial (3);Rhabdoid tumors (3)
CG33196-PB	600275	NP_077719	4e-134	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG5345-PA	607657	NP_001893	5e-134	CTH	CYSTATHIONASE	Cystathioninuria, 219500 (3);Homocysteine, total plasma, elevated (3)
CG7563-PA	114240	NP_997630	5e-134	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG11898-PA	607040	NP_660187	6e-134	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG10505-PA	603234	NP_001162	7e-134	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG15444-PA	604159	NP_004202	8e-134	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG15444-PB	604159	NP_004202	8e-134	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG15444-PC	604159	NP_004202	8e-134	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG15444-PD	604159	NP_004202	8e-134	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG12139-PB	606945	NP_000518	1e-133	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG14709-PA	603234	NP_001162	1e-133	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG4994-PA	600370	NP_002626	1e-133	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG4994-PB	600370	NP_002626	1e-133	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG4994-PA	600370	NP_998776	1e-133	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG4994-PB	600370	NP_998776	1e-133	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG6320-PA	601949	NP_000717	2e-133	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG6320-PA	601949	NP_001005746	2e-133	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG2718-PB	138290	NP_001028216	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG2718-PC	138290	NP_001028216	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG2718-PB	138290	NP_001028228	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG2718-PC	138290	NP_001028228	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG5789-PA	603234	NP_001162	2e-133	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG14026-PA	603248	NP_001194	2e-133	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG14026-PB	603248	NP_001194	2e-133	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG14026-PC	603248	NP_001194	2e-133	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG2718-PB	138290	NP_002056	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG2718-PC	138290	NP_002056	2e-133	GLUL;GLNS	GLUTAMINE SYNTHETASE; GLNS	Glutamine deficiency, congenital, 610015 (3)
CG10079-PA	131550	NP_005219	2e-133	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8102-PA	161015	NP_009034	2e-133	NDUFV1;UQOR1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 51-KD SUBUNIT;UQOR1	Alexander disease, 203450 (3);Leigh syndrome, 256000 (3);Mitochondrial complex I deficiency, 252010 (3)
CG9138-PA	600275	NP_077719	2e-133	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG2146-PA	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG2146-PB	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG6976-PA	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG6976-PB	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG6976-PC	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG6976-PD	160710	NP_002462	3e-133	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG10079-PB	131550	NP_005219	3e-133	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG4562-PA	603234	XP_001125860	3e-133	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG9270-PA	603234	XP_001125860	3e-133	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG7052-PC	103950	NP_000005	4e-133	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG1451-PA	175100	NP_000029	4e-133	APC;FPC;GS	FAMILIAL ADENOMATOUS POLYPOSIS; FAP;FAMILIAL POLYPOSIS OF THE COLON; FPC;POLYPOSIS, ADENOMATOUS INTESTINAL	Adenoma, periampullary (3);Adenomatous polyposis coli (3);Adenomatous polyposis coli, attenuated (3);Colorectal cancer (3);Desmoid disease, hereditary, 135290 (3);Gardner syndrome (3);Gastric cancer, 137215 (3);Turcot syndrome, 276300 (3)
CG9138-PA	600275	XP_001133349	4e-133	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG2146-PA	602666	NP_057323	6e-133	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG2146-PB	602666	NP_057323	6e-133	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PA	276903	NP_000251	7e-133	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG7438-PB	276903	NP_000251	7e-133	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG3936-PA	121050	NP_001990	7e-133	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG10060-PA	139340	NP_005263	7e-133	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG6320-PA	601949	NP_001005747	8e-133	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG5663-PA	170100	NP_000276	1e-132	PEPD	IMIDODIPEPTIDASE;PROLIDASE	Prolidase deficiency (3)
CG7811-PA	605363	NP_000808	1e-132	GAD1;SCP	GAD;GLUTAMATE DECARBOXYLASE, BRAIN, 67-KD; GAD67	Cerebral palsy, spastic, symmetric, autosomal recessive, 603513 (3)
CG2146-PA	160741	NP_002463	1e-132	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG2146-PB	160741	NP_002463	1e-132	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG7052-PB	103950	NP_000005	2e-132	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG7806-PA	601439	NP_005682	2e-132	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG1417-PA	606810	NP_057419	2e-132	PRODH;PRODH2;SCZD4	PROLINE DEHYDROGENASE 1; PRODH1;PROLINE OXIDASE 1; POX	Hyperprolinemia, type I, 239500 (3);{Schizophrenia, susceptibility to, 4} 600850 (3)
CG6976-PA	606808	NP_059129	2e-132	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG6976-PB	606808	NP_059129	2e-132	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG6976-PC	606808	NP_059129	2e-132	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG6976-PD	606808	NP_059129	2e-132	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG2146-PC	160710	NP_002462	3e-132	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7052-PD	103950	NP_000005	4e-132	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG2146-PC	602666	NP_057323	4e-132	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7052-PE	103950	NP_000005	5e-132	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG10501-PB	107930	NP_000781	5e-132	DDC	AROMATIC L-AMINO ACID DECARBOXYLASE; AADC	Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
CG3263-PD	188830	NP_002725	5e-132	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PD	188830	NP_997636	5e-132	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PD	188830	NP_997637	5e-132	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG14026-PD	603248	NP_001194	6e-132	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG30097-PA	154270	NP_002387	7e-132	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG30097-PD	154270	NP_002387	7e-132	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG11851-PA	606941	NP_079016	9e-132	ALG9;DIBD1	DISRUPTED IN BIPOLAR DISORDER 1; DIBD1	Congenital disorder of glycosylation, type Il, 608776 (3)
CG6058-PB	103850	NP_000025	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PC	103850	NP_000025	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PD	103850	NP_000025	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PF	103850	NP_000025	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG31792-PA	603234	NP_001162	1e-131	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG5977-PA	604277	NP_055761	1e-131	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG5977-PB	604277	NP_055761	1e-131	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG8230-PA	607461	NP_060123	1e-131	DMC;DYM;FLJ90130;SMC	FLJ90130	Dyggve-Melchior-Clausen disease, 223800 (3);Smith-McCort dysplasia, 607326 (3)
CG3835-PA	609186	NP_689996	1e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PB	609186	NP_689996	1e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PC	609186	NP_689996	1e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG6058-PB	103850	NP_908930	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PC	103850	NP_908930	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PD	103850	NP_908930	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PF	103850	NP_908930	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PB	103850	NP_908932	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PC	103850	NP_908932	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PD	103850	NP_908932	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PF	103850	NP_908932	1e-131	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG10701-PD	607379	NP_000259	2e-131	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10236-PA	156225	NP_000417	2e-131	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG6291-PA	300145	NP_003390	2e-131	XPNPEP2	AMINOPEPTIDASE P, 2;X-PROLYL AMINOPEPTIDASE, MEMBRANE-BOUND	{Angioedema induced by ACE inhibitors, susceptibility to} (3)
CG15274-PA	607340	NP_005449	2e-131	GPR51;GABBR2	G PROTEIN-COUPLED RECEPTOR 51; GPR51;GABA-B RECEPTOR, R2 SUBUNIT; GABABR2	{Nicotine dependence, susceptibility to}, 188890 (3)
CG1417-PB	606810	NP_057419	2e-131	PRODH;PRODH2;SCZD4	PROLINE DEHYDROGENASE 1; PRODH1;PROLINE OXIDASE 1; POX	Hyperprolinemia, type I, 239500 (3);{Schizophrenia, susceptibility to, 4} 600850 (3)
CG8224-PA	603248	NP_001194	3e-131	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG31793-PA	603234	XP_001125860	3e-131	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG3835-PA	609186	XP_001130341	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PB	609186	XP_001130341	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PC	609186	XP_001130341	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PA	609186	XP_001130367	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PB	609186	XP_001130367	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG3835-PC	609186	XP_001130367	3e-131	D2HGD	D2HGD	D-2-hydroxyglutaric aciduria, 600721 (3)
CG8224-PB	603248	NP_001194	4e-131	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG7595-PA	160741	NP_002463	4e-131	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG7595-PB	160741	NP_002463	4e-131	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG14026-PA	601299	NP_004320	5e-131	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG14026-PB	601299	NP_004320	5e-131	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG14026-PC	601299	NP_004320	5e-131	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG10079-PA	131550	NP_958441	5e-131	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10079-PA	131550	NP_958439	6e-131	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG3263-PB	188830	NP_002725	7e-131	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15288-PB	600805	NP_937762	7e-131	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG10079-PB	131550	NP_958441	7e-131	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG3263-PB	188830	NP_997636	7e-131	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG3263-PB	188830	NP_997637	7e-131	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG11897-PA	603234	XP_001125860	7e-131	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG11897-PB	603234	XP_001125860	7e-131	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG10079-PB	131550	NP_958439	8e-131	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG1709-PH	604592	NP_006010	9e-131	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG10118-PA	191290	NP_000351	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG10118-PB	191290	NP_000351	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG8799-PA	603234	NP_001162	1e-130	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG40444-PA	603335	NP_001360	1e-130	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG2146-PC	160741	NP_002463	1e-130	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG14026-PD	601299	NP_004320	1e-130	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG1417-PE	606810	NP_057419	1e-130	PRODH;PRODH2;SCZD4	PROLINE DEHYDROGENASE 1; PRODH1;PROLINE OXIDASE 1; POX	Hyperprolinemia, type I, 239500 (3);{Schizophrenia, susceptibility to, 4} 600850 (3)
CG10118-PA	191290	NP_954986	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG10118-PB	191290	NP_954986	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG10118-PA	191290	NP_954987	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG10118-PB	191290	NP_954987	1e-130	TH;TYH		Segawa syndrome, recessive (3)
CG5977-PA	604277	NP_955468	1e-130	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG5977-PB	604277	NP_955468	1e-130	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG9090-PA	600370	NP_002626	2e-130	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG15793-PA	176872	NP_002746	2e-130		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG6977-PA	605516	NP_071407	2e-130	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG9090-PA	600370	NP_998776	2e-130	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG1891-PA	601284	NP_000011	3e-130	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG1891-PB	601284	NP_000011	3e-130	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG10804-PB	608893	NP_001003841	3e-130	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG8909-PB	192977	NP_003374	3e-130	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG12602-PA	604592	NP_006010	3e-130	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG2146-PA	608568	NP_079005	3e-130	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG2146-PB	608568	NP_079005	3e-130	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG30329-PA	605239	NP_065683	4e-130	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG30329-PA	605239	NP_570855	4e-130	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG30329-PA	605239	NP_570856	4e-130	ATP6V0A4;ATP6N1B;VPP2;RTA1C;RTADR	1B; ATP6N1B;ATP6N2;ATPase, H+ TRANSPORTING, LYSOSOMAL, NONCATALYTIC ACCESSORY PROTEIN;VACUOLAR PROTEIN PUMP, SUBUNIT 2; VPP2	Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
CG5658-PA	605995	NP_904325	4e-130	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG2135-PA	253220	NP_000172	5e-130	GUSB;MPS7	BETA-GLUCURONIDASE DEFICIENCY;GUSB DEFICIENCY;MPS VII; MPS7;SLY SYNDROME	Mucopolysaccharidosis VII (3)
CG7806-PA	600509	NP_000343	5e-130	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG31045-PA	160745	NP_002465	5e-130	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PA	160745	NP_074035	5e-130	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG12455-PB	608171	NP_001005737	6e-130	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG5658-PA	605995	NP_055889	6e-130	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1417-PD	606810	NP_057419	6e-130	PRODH;PRODH2;SCZD4	PROLINE DEHYDROGENASE 1; PRODH1;PROLINE OXIDASE 1; POX	Hyperprolinemia, type I, 239500 (3);{Schizophrenia, susceptibility to, 4} 600850 (3)
CG8380-PA	300036	NP_005620	7e-130	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG7595-PA	606808	NP_059129	7e-130	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG7595-PB	606808	NP_059129	7e-130	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5789-PA	603234	XP_001125860	8e-130	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG7280-PA	606887	NP_000447	1e-129	SUOX		Sulfite oxidase deficiency, 272300 (3)
CG7280-PA	606887	NP_001027558	1e-129	SUOX		Sulfite oxidase deficiency, 272300 (3)
CG7280-PA	606887	NP_001027559	1e-129	SUOX		Sulfite oxidase deficiency, 272300 (3)
CG16944-PA	103220	NP_001142	1e-129	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG16944-PB	103220	NP_001142	1e-129	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG16944-PC	103220	NP_001142	1e-129	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG16944-PD	103220	NP_001142	1e-129	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG6976-PA	160741	NP_002463	1e-129	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG6976-PB	160741	NP_002463	1e-129	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG6976-PC	160741	NP_002463	1e-129	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG6976-PD	160741	NP_002463	1e-129	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG6976-PA	160745	NP_002465	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PB	160745	NP_002465	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PC	160745	NP_002465	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PD	160745	NP_002465	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7595-PA	160740	NP_060004	1e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG7595-PB	160740	NP_060004	1e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG11898-PA	601439	NP_064693	1e-129	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6976-PA	160745	NP_074035	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PB	160745	NP_074035	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PC	160745	NP_074035	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PD	160745	NP_074035	1e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2146-PC	608568	NP_079005	1e-129	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG7399-PA	607478	NP_775489	1e-129	TPH2;NTPH	TRYPTOPHAN HYDROXYLASE, NEURONAL; NTPH	{Unipolar depression, susceptibility to}, 608516 (3)
CG32134-PA	176943	NP_000132	2e-129	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG31045-PA	160745	NP_001035202	2e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PA	160745	NP_001035203	2e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG30097-PC	154270	NP_002387	2e-129	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG10701-PD	607379	NP_057502	2e-129	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PD	607379	NP_861546	2e-129	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PD	607379	NP_861970	2e-129	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG8380-PA	300444	NP_009162	3e-129	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG6058-PE	103850	NP_000025	4e-129	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG17927-PI	276903	NP_000251	4e-129	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG2118-PA	232000	NP_000273	4e-129	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG10804-PA	608893	NP_001003841	4e-129	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG7678-PA	604592	NP_006010	4e-129	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG6976-PA	160740	NP_060004	4e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG6976-PB	160740	NP_060004	4e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG6976-PC	160740	NP_060004	4e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG6976-PD	160740	NP_060004	4e-129	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG15793-PA	601263	NP_109587	4e-129		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG6058-PE	103850	NP_908930	4e-129	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PE	103850	NP_908932	4e-129	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG33047-PB	230000	NP_000138	5e-129	FUCA1	ALPHA-L-FUCOSIDASE DEFICIENCY	Fucosidosis (3)
CG33047-PC	230000	NP_000138	5e-129	FUCA1	ALPHA-L-FUCOSIDASE DEFICIENCY	Fucosidosis (3)
CG6976-PA	160720	NP_002461	5e-129	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6976-PB	160720	NP_002461	5e-129	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6976-PC	160720	NP_002461	5e-129	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6976-PD	160720	NP_002461	5e-129	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG17927-PD	276903	NP_000251	6e-129	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG17927-PB	276903	NP_000251	8e-129	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG17927-PM	276903	NP_000251	8e-129	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG6976-PA	601478	NP_005370	8e-129	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG6976-PB	601478	NP_005370	8e-129	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG6976-PC	601478	NP_005370	8e-129	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG6976-PD	601478	NP_005370	8e-129	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG6976-PA	160745	NP_001035202	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PB	160745	NP_001035202	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PC	160745	NP_001035202	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PD	160745	NP_001035202	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PA	160745	NP_001035203	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PB	160745	NP_001035203	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PC	160745	NP_001035203	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PD	160745	NP_001035203	9e-129	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PH	276903	NP_000251	1e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG8909-PB	192977	NP_001018066	1e-128	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG6976-PA	160775	NP_002464	1e-128	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG6976-PB	160775	NP_002464	1e-128	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG6976-PC	160775	NP_002464	1e-128	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG6976-PD	160775	NP_002464	1e-128	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG10505-PA	603234	XP_001125860	1e-128	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG6058-PA	103850	NP_000025	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PG	103850	NP_000025	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG17927-PA	276903	NP_000251	2e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG17927-PF	276903	NP_000251	2e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG12345-PA	118490	NP_065574	2e-128	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG6058-PA	103850	NP_908930	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PG	103850	NP_908930	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PA	103850	NP_908932	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6058-PG	103850	NP_908932	2e-128	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG6438-PA	162150	NP_000430	3e-128	NEC1;PC1;PC3;PCSK1	NEUROENDOCRINE CONVERTASE 1; NEC1;PROHORMONE CONVERTASE 1;PROHORMONE CONVERTASE 3; PC3;PROPROTEIN CONVERTASE 1; PC1	Obestiy with impaired prohormone processing, 600955 (3)
CG7595-PA	608568	NP_079005	3e-128	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG7595-PB	608568	NP_079005	3e-128	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG7766-PA	172490	NP_000284	4e-128	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG7766-PA	172490	NP_001027005	4e-128	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG17927-PK	276903	NP_000251	5e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG14709-PA	603234	XP_001125860	6e-128	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG15792-PA	276903	NP_000251	7e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG15792-PB	276903	NP_000251	7e-128	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG30097-PB	154270	NP_002387	8e-128	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG7595-PA	160720	NP_002461	8e-128	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7595-PB	160720	NP_002461	8e-128	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6045-PA	607633	NP_000370	9e-128	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG1106-PB	137350	NP_000168	1e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PD	137350	NP_000168	1e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PE	137350	NP_000168	1e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PF	137350	NP_000168	1e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG5549-PA	182138	NP_001036	1e-127	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG8475-PA	311870	NP_002628	1e-127	PHKA1		Muscle glycogenosis, 300559 (3)
CG7595-PA	600970	NP_004990	1e-127	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG7595-PB	600970	NP_004990	1e-127	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG9413-PA	604144	NP_055085	1e-127	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG9413-PB	604144	NP_055085	1e-127	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG8529-PA	601239	NP_116760	1e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_116760	1e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_116760	1e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG17927-PC	276903	NP_000251	2e-127	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG1461-PA	276600	NP_000344	2e-127	TAT	KERATOSIS PALMOPLANTARIS WITH CORNEAL DYSTROPHY;OREGON TYPE TYROSINEMIA;RICHNER-HANHART SYNDROME;TYROSINE AMINOTRANSFERASE DEFICIENCY; TAT DEFICIENCY;TYROSINEMIA, TYPE II;TYROSINOSIS, OCULOCUTANEOUS TYPE	Tyrosinemia, type II (3)
CG5905-PA	300550	NP_000435	2e-127	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG5905-PB	300550	NP_000435	2e-127	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG10804-PB	604159	NP_004202	2e-127	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG8224-PA	601299	NP_004320	2e-127	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG1106-PB	137350	NP_937895	2e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PD	137350	NP_937895	2e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PE	137350	NP_937895	2e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PF	137350	NP_937895	2e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1438-PA	608614	NP_997235	2e-127	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG6214-PA	603234	XP_001125860	2e-127	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG17927-PE	276903	NP_000251	3e-127	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG15444-PA	126455	NP_001035	3e-127	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG15444-PB	126455	NP_001035	3e-127	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG15444-PC	126455	NP_001035	3e-127	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG15444-PD	126455	NP_001035	3e-127	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG12345-PA	118490	NP_066264	3e-127	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12345-PA	118490	NP_066265	3e-127	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12345-PA	118490	NP_066266	3e-127	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG1106-PA	137350	NP_000168	4e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PC	137350	NP_000168	4e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG9155-PA	160760	NP_000248	4e-127	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG9155-PB	160760	NP_000248	4e-127	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG9155-PC	160760	NP_000248	4e-127	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG9155-PD	160760	NP_000248	4e-127	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG4434-PA	138130	NP_005262	4e-127	GLUD1	GDH;GLUD	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
CG8529-PA	601239	NP_116761	4e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_116761	4e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_116761	4e-127	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG1106-PA	137350	NP_937895	4e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG1106-PC	137350	NP_937895	4e-127	GSN		Amyloidosis, Finnish type, 105120 (3)
CG7223-PA	134934	NP_000133	6e-127	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7223-PB	134934	NP_000133	6e-127	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7223-PC	134934	NP_000133	6e-127	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17927-PG	276903	NP_000251	6e-127	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG7100-PD	605516	NP_071407	9e-127	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7100-PF	605516	NP_071407	9e-127	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG11898-PA	603234	NP_001162	1e-126	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG5870-PA	604638	NP_004915	1e-126	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG1086-PB	138140	NP_006507	1e-126	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG1086-PC	138140	NP_006507	1e-126	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG9707-PA	609751	NP_009223	1e-126	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG7100-PE	605516	NP_071407	1e-126	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7100-PG	605516	NP_071407	1e-126	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG17691-PA	248611	NP_000047	2e-126	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG11814-PA	606897	NP_000072	2e-126	CHS1;LYST	CHS1 GENE; CHS1	Chediak-Higashi syndrome, 214500 (3)
CG17927-PL	276903	NP_000251	2e-126	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG31319-PA	604258	NP_006085	2e-126	DLC1	RHO GTPase-ACTIVATING PROTEIN 7; ARHGAP7	Colorectal cancer, somatic (3)
CG31319-PA	604258	NP_872584	2e-126	DLC1	RHO GTPase-ACTIVATING PROTEIN 7; ARHGAP7	Colorectal cancer, somatic (3)
CG17691-PA	248611	NP_898871	2e-126	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG32451-PA	108740	NP_001672	3e-126	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG32451-PC	108740	NP_001672	3e-126	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG9155-PA	160745	NP_002465	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PB	160745	NP_002465	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PC	160745	NP_002465	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PD	160745	NP_002465	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9707-PA	609751	NP_004026	3e-126	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG9155-PA	160745	NP_074035	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PB	160745	NP_074035	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PC	160745	NP_074035	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PD	160745	NP_074035	3e-126	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG32451-PA	108740	NP_733765	3e-126	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG32451-PC	108740	NP_733765	3e-126	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG8169-PA	600259	XP_001126008	3e-126	HNPCC4;PMS2;PMSL2	MISMATCH REPAIR GENE PMSL2; PMSL2	Colorectal cancer, hereditary nonpolyposis, type 4 (3);Neuroectodermal tumors, supratentorial primitive, with cafe-au-lait spots, 608623 (3);Turcot syndrome with glioblastoma, 276300 (3)
CG11898-PA	601439	NP_005682	4e-126	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG11898-PA	601439	NP_064694	4e-126	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7627-PA	603234	NP_001162	5e-126	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8529-PA	601239	NP_001382	5e-126	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_001382	5e-126	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_001382	5e-126	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG17927-PJ	276903	NP_000251	6e-126	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG1864-PB	601828	NP_775265	6e-126	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1864-PC	601828	NP_775265	6e-126	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1864-PB	601828	NP_006177	7e-126	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1864-PC	601828	NP_006177	7e-126	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1954-PA	176960	NP_002728	8e-126	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG33085-PA	608310	NP_001020115	9e-126	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG7438-PA	160775	NP_002464	9e-126	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG7438-PB	160775	NP_002464	9e-126	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG2411-PA	601309	NP_000255	1e-125	BCNS;HPE7;NBCCS;PTCH1	PTC;PTCH	Basal cell carcinoma, somatic, 605462 (3);Basal cell nevus syndrome, 109400 (3);Holoprosencephaly-7, 610828 (3);Medulloblastoma, somatic, 155255 (3)
CG6383-PA	601920	NP_000205	2e-125	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG12455-PA	608171	NP_001005737	2e-125	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG10804-PA	604159	NP_004202	2e-125	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG5423-PA	608630	NP_071765	2e-125	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG8799-PA	603234	XP_001125860	2e-125	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG9122-PA	261600	NP_000268	3e-125	PAH;PKU1	FOLLING DISEASE;OLIGOPHRENIA PHENYLPYRUVICA;PAH DEFICIENCY;PHENYLALANINE HYDROXYLASE DEFICIENCY;PKU	Phenylketonuria (3);[Hyperphenylalaninemia, mild] (3)
CG18522-PA	607633	NP_000370	3e-125	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG9783-PA	108961	NP_003986	3e-125	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG31792-PA	603234	XP_001125860	4e-125	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG7356-PA	190195	NP_000350	5e-125	ICR2;LI1;TGM1	TRANSGLUTAMINASE, EPIDERMAL TYPE I;TRANSGLUTAMINASE, KERATINOCYTE; TGK	Ichthyosiform erythroderma, congenital, 242100 (3);Ichthyosis, lamellar, autosomal recessive, 242300 (3);Self-healing collodion baby, 242300 (3)
CG7356-PB	190195	NP_000350	5e-125	ICR2;LI1;TGM1	TRANSGLUTAMINASE, EPIDERMAL TYPE I;TRANSGLUTAMINASE, KERATINOCYTE; TGK	Ichthyosiform erythroderma, congenital, 242100 (3);Ichthyosis, lamellar, autosomal recessive, 242300 (3);Self-healing collodion baby, 242300 (3)
CG3736-PA	604289	NP_036547	5e-125	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG9701-PA	603202	NP_002290	6e-125	LAC;LCT;LPH	LAC;LACTASE-PHLORIZIN HYDROLASE; LPH	Hypolactasia, adult type, 223100 (3)
CG30097-PE	154270	NP_002387	6e-125	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG3376-PA	607608	NP_000534	7e-125	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG3376-PB	607608	NP_000534	7e-125	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG5549-PA	163970	NP_001034	7e-125	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG3252-PA	604159	NP_004202	9e-125	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG10952-PA	152427	NP_000229	1e-124	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG15444-PA	163970	NP_001034	1e-124	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15444-PB	163970	NP_001034	1e-124	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15444-PC	163970	NP_001034	1e-124	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15444-PD	163970	NP_001034	1e-124	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG9155-PA	160745	NP_001035202	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PB	160745	NP_001035202	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PC	160745	NP_001035202	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PD	160745	NP_001035202	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PA	160745	NP_001035203	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PB	160745	NP_001035203	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PC	160745	NP_001035203	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG9155-PD	160745	NP_001035203	1e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG11949-PC	130500	NP_976217	1e-124	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9138-PA	601920	NP_000205	2e-124	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG12030-PA	606953	NP_000394	2e-124	GALE	GALACTOSE EPIMERASE	Galactose epimerase deficiency, 230350 (3)
CG12030-PA	606953	NP_001008217	2e-124	GALE	GALACTOSE EPIMERASE	Galactose epimerase deficiency, 230350 (3)
CG7438-PA	160745	NP_002465	2e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7438-PB	160745	NP_002465	2e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG1718-PA	600046	NP_005493	2e-124	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG15792-PA	602666	NP_057323	2e-124	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG15792-PB	602666	NP_057323	2e-124	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PA	160745	NP_074035	2e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7438-PB	160745	NP_074035	2e-124	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8279-PA	180072	NP_000274	3e-124	CSNB3;PDE6B;PDEB	rd, MOUSE, HOMOLOG OF;rd1;RETINAL ROD PHOTORECEPTOR cGMP PHOSPHODIESTERASE, BETA SUBUNIT; PDEB	Night blindness, congenital stationary, type 3, 163500 (3);Retinitis pigmentosa, autosomal recessive (3)
CG3725-PA	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PB	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PC	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PD	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PE	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PF	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PG	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PH	604384	NP_001001485	3e-124	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG7075-PA	182138	NP_001036	3e-124	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG9155-PA	160775	NP_002464	3e-124	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG9155-PB	160775	NP_002464	3e-124	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG9155-PC	160775	NP_002464	3e-124	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG9155-PD	160775	NP_002464	3e-124	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG8224-PA	601300	NP_064732	3e-124	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG5695-PA	160777	NP_000250	5e-124	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG5695-PB	160777	NP_000250	5e-124	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG33085-PA	608310	NP_001020117	5e-124	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG2174-PA	160775	NP_002464	5e-124	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG9310-PA	600281	NP_001025174	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_001025174	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_001025174	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PA	600281	NP_787110	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_787110	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_787110	6e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PA	600281	NP_000448	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_000448	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_000448	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PA	600281	NP_849180	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_849180	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_849180	7e-124	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG8224-PB	601299	NP_004320	8e-124	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG10952-PA	152427	NP_742054	8e-124	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3536-PA	123825	NP_000078	1e-123	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG7438-PA	160745	NP_001035202	1e-123	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7438-PB	160745	NP_001035202	1e-123	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG33048-PA	603707	NP_005934	1e-123	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG9709-PA	609751	NP_009223	1e-123	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG4096-PA	608990	NP_112219	1e-123	ADAMTS10;WMS	1 MOTIF, 10; ADAMTS10	Weill-Marchesani syndrome, recessive, 277600 (3)
CG5680-PB	602897	NP_620447	1e-123	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG1315-PA	603470	NP_000041	2e-123	ASS		Citrullinemia, 215700 (3)
CG7438-PA	160777	NP_000250	2e-123	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG7438-PB	160777	NP_000250	2e-123	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG3725-PA	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PB	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PC	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PD	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PE	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PF	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PG	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PH	604384	NP_001001486	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PA	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PB	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PC	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PD	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PE	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PF	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PG	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PH	604384	NP_001001487	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG9310-PA	600281	NP_001025175	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_001025175	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_001025175	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG7438-PA	160745	NP_001035203	2e-123	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7438-PB	160745	NP_001035203	2e-123	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15444-PA	182138	NP_001036	2e-123	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG15444-PB	182138	NP_001036	2e-123	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG15444-PC	182138	NP_001036	2e-123	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG15444-PD	182138	NP_001036	2e-123	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG1607-PA	603593	NP_003973	2e-123	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG1607-PB	603593	NP_003973	2e-123	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG3725-PA	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PB	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PC	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PD	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PE	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PF	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PG	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3725-PH	604384	NP_055197	2e-123	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG1315-PA	603470	NP_446464	2e-123	ASS		Citrullinemia, 215700 (3)
CG18255-PA	188840	NP_596869	2e-123	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG9310-PA	600281	NP_849181	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PB	600281	NP_849181	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9310-PC	600281	NP_849181	2e-123	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG3433-PA	121300	NP_000088	3e-123	CPO	COPROPORPHYRINOGEN OXIDASE DEFICIENCY;CPO DEFICIENCY;CPRO DEFICIENCY;CPX DEFICIENCY;HEREDITARY COPROPORPHYRIA; HCP	Coproporphyria (3);Harderoporphyrinuria (3)
CG2174-PA	606808	NP_059129	3e-123	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG32134-PA	134934	NP_000133	4e-123	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG9138-PA	600276	NP_000426	4e-123	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG3210-PA	602378	NP_001005361	4e-123	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG3210-PA	602378	NP_001005362	4e-123	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG7075-PA	163970	NP_001034	4e-123	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG4994-PA	600370	NP_005879	4e-123	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG4994-PB	600370	NP_005879	4e-123	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG7223-PA	136350	NP_075594	4e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PB	136350	NP_075594	4e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PC	136350	NP_075594	4e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG5695-PA	276903	NP_000251	5e-123	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG5695-PB	276903	NP_000251	5e-123	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG11140-PI	609523	NP_000373	5e-123	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PI	609523	NP_001026976	5e-123	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG9709-PA	609751	NP_004026	5e-123	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG7223-PA	136350	NP_056934	5e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PB	136350	NP_056934	5e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PC	136350	NP_056934	5e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18345-PA	603652	NP_004612	6e-123	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG18345-PB	603652	NP_004612	6e-123	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG7223-PA	136350	NP_075593	6e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PB	136350	NP_075593	6e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PC	136350	NP_075593	6e-123	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8544-PA	189967	NP_068780	8e-123	REF1;TCF13;TEAD1	TRANSCRIPTION FACTOR 13; TCF13;TRANSCRIPTIONAL ENHANCER FACTOR 1; TEF1	Sveinsson choreoretinal atrophy, 108985 (3)
CG7766-PB	172490	NP_000284	9e-123	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG7766-PB	172490	NP_001027005	9e-123	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG18516-PA	607633	NP_000370	1e-122	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG2028-PA	600864	XP_001132734	1e-122			
CG2028-PB	600864	XP_001132734	1e-122			
CG2028-PC	600864	XP_001132734	1e-122			
CG10701-PB	607379	NP_000259	2e-122	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG18519-PB	607633	NP_000370	2e-122	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG8956-PA	180960	NP_000678	2e-122	AHCY;SAHH	HYPERMETHIONINEMIA WITH DEFICIENCY OF S-ADENOSYLHOMOCYSTEINE HYDROLASE,;SAHH	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase (3)
CG2028-PA	600864	NP_001884	2e-122			
CG2028-PB	600864	NP_001884	2e-122			
CG2028-PC	600864	NP_001884	2e-122			
CG2174-PA	160745	NP_002465	2e-122	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2174-PA	160745	NP_074035	2e-122	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2028-PA	600864	NP_620693	2e-122			
CG2028-PB	600864	NP_620693	2e-122			
CG2028-PC	600864	NP_620693	2e-122			
CG3210-PA	602378	NP_001005360	3e-122	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG9155-PA	160710	NP_002462	3e-122	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG9155-PB	160710	NP_002462	3e-122	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG9155-PC	160710	NP_002462	3e-122	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG9155-PD	160710	NP_002462	3e-122	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG3210-PA	602378	NP_004936	3e-122	CMTDI1;CMTDIB;DNM2	DYN2	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);Myopathy, centronuclear, 160150 (3)
CG8475-PA	306000	NP_000283	4e-122	PHK;PHKA2	GLYCOGENOSIS VIIIA;HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK;LIVER GLYCOGENOSIS, X-LINKED, TYPE I;PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL;X-LINKED LIVER GLYCOGENOSIS; XLG	Glycogenosis, X-linked hepatic, type I (3);Glycogenosis, X-linked hepatic, type II (3)
CG2174-PA	160745	NP_001035202	5e-122	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2174-PA	160745	NP_001035203	5e-122	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6976-PA	600970	NP_004990	5e-122	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG6976-PB	600970	NP_004990	5e-122	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG6976-PC	600970	NP_004990	5e-122	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG6976-PD	600970	NP_004990	5e-122	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG4545-PA	300036	NP_005620	5e-122	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG33048-PA	603707	NP_005933	5e-122	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG7100-PB	605516	NP_071407	5e-122	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7100-PH	605516	NP_071407	5e-122	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG10060-PA	139330	NP_000163	6e-122	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG9090-PA	600370	NP_005879	6e-122	PHC;SLC25A3	PHOSPHATE CARRIER, MITOCHONDRIAL; PHC	Micochondrial phosphate carrier deficiency, 610773 (3)
CG7100-PA	605516	NP_071407	6e-122	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7100-PC	605516	NP_071407	6e-122	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG10060-PA	139330	NP_653082	6e-122	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG6127-PA	600275	XP_001133349	7e-122	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG7806-PA	603234	NP_001162	8e-122	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG4225-PA	300135	NP_004290	8e-122	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG6127-PA	600275	NP_077719	8e-122	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG9977-PA	180960	NP_000678	1e-121	AHCY;SAHH	HYPERMETHIONINEMIA WITH DEFICIENCY OF S-ADENOSYLHOMOCYSTEINE HYDROLASE,;SAHH	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase (3)
CG4016-PA	605712	NP_006406	1e-121	SPTLC1;LBC1;SPT1;HSN1;HSAN	HSN1;LCB1;SPT1	Neuropathy, hereditary sensory and autonomic, type 1, 162400 (3)
CG4016-PB	605712	NP_006406	1e-121	SPTLC1;LBC1;SPT1;HSN1;HSAN	HSN1;LCB1;SPT1	Neuropathy, hereditary sensory and autonomic, type 1, 162400 (3)
CG4016-PC	605712	NP_006406	1e-121	SPTLC1;LBC1;SPT1;HSN1;HSAN	HSN1;LCB1;SPT1	Neuropathy, hereditary sensory and autonomic, type 1, 162400 (3)
CG8102-PB	161015	NP_009034	1e-121	NDUFV1;UQOR1	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 51-KD SUBUNIT;UQOR1	Alexander disease, 203450 (3);Leigh syndrome, 256000 (3);Mitochondrial complex I deficiency, 252010 (3)
CG8948-PA	605370	NP_055886	1e-121	GRAF	GTPase REGULATOR ASSOCIATED WITH FOCAL ADHESION KINASE; GRAF;KIAA0621	Leukemia, juvenile myelomonocytic, 607785 (3)
CG6976-PA	608568	NP_079005	1e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG6976-PB	608568	NP_079005	1e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG6976-PC	608568	NP_079005	1e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG6976-PD	608568	NP_079005	1e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG33196-PB	600275	XP_001133349	1e-121	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG7223-PA	176943	NP_000132	2e-121	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7223-PB	176943	NP_000132	2e-121	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7223-PC	176943	NP_000132	2e-121	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG30097-PF	154270	NP_002387	2e-121	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG16928-PA	600814	NP_005581	2e-121	ATLD;MRE11;MRE11A	MRE11	Ataxia-telangiectasia-like disorder, 604391 (3)
CG16928-PA	600814	NP_005582	2e-121	ATLD;MRE11;MRE11A	MRE11	Ataxia-telangiectasia-like disorder, 604391 (3)
CG1732-PA	300444	NP_009162	2e-121	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG1732-PC	300444	NP_009162	2e-121	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG10639-PA	609584	NP_079160	2e-121	C14orf160;L2HGDH	C14ORF160;DURANIN	L-2-hydroxyglutaric aciduria, 236792 (3)
CG3701-PA	182340	NP_000693	3e-121	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG4545-PA	300444	NP_009162	3e-121	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG10701-PA	607379	NP_000259	4e-121	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG8475-PB	172490	NP_000284	4e-121	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG33087-PC	606945	NP_000518	4e-121	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG8475-PB	172490	NP_001027005	4e-121	PHKB		Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)
CG9155-PA	608568	NP_079005	5e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG9155-PB	608568	NP_079005	5e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG9155-PC	608568	NP_079005	5e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG9155-PD	608568	NP_079005	5e-121	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG8544-PB	189967	NP_068780	6e-121	REF1;TCF13;TEAD1	TRANSCRIPTION FACTOR 13; TCF13;TRANSCRIPTIONAL ENHANCER FACTOR 1; TEF1	Sveinsson choreoretinal atrophy, 108985 (3)
CG9092-PA	230500	NP_000395	8e-121	GLB1	BETA-GALACTOSIDASE-1 DEFICIENCY;GLB1 DEFICIENCY	GM1-gangliosidosis (3);Mucopolysaccharidosis IVB (3)
CG7595-PA	602129	NP_004136	8e-121	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG7595-PB	602129	NP_004136	8e-121	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG2411-PB	601309	NP_000255	9e-121	BCNS;HPE7;NBCCS;PTCH1	PTC;PTCH	Basal cell carcinoma, somatic, 605462 (3);Basal cell nevus syndrome, 109400 (3);Holoprosencephaly-7, 610828 (3);Medulloblastoma, somatic, 155255 (3)
CG5549-PA	300036	NP_005620	1e-120	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG5603-PB	605018	NP_056062	1e-120	CDMT;CYLD1;EAC		Cylindromatosis, familial, 132700 (3)
CG5603-PC	605018	NP_056062	1e-120	CDMT;CYLD1;EAC		Cylindromatosis, familial, 132700 (3)
CG5603-PD	605018	NP_056062	1e-120	CDMT;CYLD1;EAC		Cylindromatosis, familial, 132700 (3)
CG5603-PE	605018	NP_056062	1e-120	CDMT;CYLD1;EAC		Cylindromatosis, familial, 132700 (3)
CG32134-PA	136350	NP_056934	1e-120	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32134-PA	136350	NP_075593	1e-120	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32134-PA	136350	NP_075594	1e-120	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4542-PA	608103	NP_076984	1e-120	ALG8	ALG8;DOLICHYL-P-GLUCOSE:Glc-1-Man-9-GlcNAc-2-PP-DOLICHYL-ALPHA-3-GLUCOSYLTRANSFERASE	Congenital disorder of glycosylation, type Ih, 608104 (3)
CG3701-PA	182350	NP_689509	1e-120	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG9155-PA	160741	NP_002463	2e-120	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG9155-PB	160741	NP_002463	2e-120	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG9155-PC	160741	NP_002463	2e-120	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG9155-PD	160741	NP_002463	2e-120	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG2146-PA	600970	NP_004990	2e-120	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG2146-PB	600970	NP_004990	2e-120	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG2146-PC	600970	NP_004990	2e-120	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG14938-PA	314995	NP_009061	2e-120	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2146-PC	606808	NP_059129	2e-120	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG8224-PB	601300	NP_064732	2e-120	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG4976-PA	606681	NP_071900	2e-120	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG14938-PA	314995	NP_700359	2e-120	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4976-PA	606681	NP_758859	2e-120	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG6976-PA	602129	NP_004136	3e-120	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6976-PB	602129	NP_004136	3e-120	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6976-PC	602129	NP_004136	3e-120	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6976-PD	602129	NP_004136	3e-120	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG8909-PB	606945	NP_000518	4e-120	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG7075-PA	126455	NP_001035	4e-120	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG10160-PA	150100	NP_002291	4e-120	LDHB	LDH, SUBUNIT H	Lactate dehydrogenase-B deficiency (3)
CG10701-PB	607379	NP_057502	4e-120	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861546	4e-120	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861970	4e-120	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG7399-PA	191290	NP_000351	6e-120	TH;TYH		Segawa syndrome, recessive (3)
CG9155-PA	160720	NP_002461	6e-120	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG9155-PB	160720	NP_002461	6e-120	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG9155-PC	160720	NP_002461	6e-120	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG9155-PD	160720	NP_002461	6e-120	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG4860-PA	606885	NP_000008	7e-120	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG7399-PA	191290	NP_954986	7e-120	TH;TYH		Segawa syndrome, recessive (3)
CG7399-PA	191290	NP_954987	7e-120	TH;TYH		Segawa syndrome, recessive (3)
CG2995-PA	607001	NP_079033	8e-120	EHMT1;EUHMTASE1	EUHMTASE1	Chromosome 9q subtelomeric deletion syndrome, 610253 (3)
CG5549-PA	126455	NP_001035	2e-119	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG4586-PA	609751	NP_004026	2e-119	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG7075-PB	604159	NP_004202	2e-119	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG33141-PA	602716	NP_004637	2e-119	NPHN;NPHS1	NPHN;RENAL GLOMERULUS-SPECIFIC CELL ADHESION RECEPTOR	Nephrosis-1, congenital, Finnish type, 256300 (3)
CG18076-PH	601282	NP_000436	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG7904-PA	602730	NP_001097	3e-119	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG14741-PA	602397	NP_005594	3e-119	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG15444-PA	300036	NP_005620	3e-119	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG15444-PB	300036	NP_005620	3e-119	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG15444-PC	300036	NP_005620	3e-119	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG15444-PD	300036	NP_005620	3e-119	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG9155-PA	160740	NP_060004	3e-119	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG9155-PB	160740	NP_060004	3e-119	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG9155-PC	160740	NP_060004	3e-119	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG9155-PD	160740	NP_060004	3e-119	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG18076-PH	601282	NP_958780	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958781	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958782	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958783	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958784	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958785	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PH	601282	NP_958786	3e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG2174-PA	160760	NP_000248	4e-119	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG18076-PC	601282	NP_000436	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG6598-PA	103720	NP_000659	5e-119	ADH1B;ADH2	ADH, BETA SUBUNIT; ADH1B;ALCOHOL DEHYDROGENASE 2	{Alcoholism, susceptibility to}, 103780 (3)
CG14228-PA	607379	NP_861967	5e-119	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG18076-PC	601282	NP_958780	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958781	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958782	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958783	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958784	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958785	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG18076-PC	601282	NP_958786	5e-119	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG6058-PB	229600	NP_000026	6e-119	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG6058-PC	229600	NP_000026	6e-119	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG6058-PD	229600	NP_000026	6e-119	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG6058-PF	229600	NP_000026	6e-119	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG33196-PB	600276	NP_000426	6e-119	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG7627-PA	603234	XP_001125860	6e-119	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG10701-PA	607379	NP_057502	7e-119	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PA	607379	NP_861546	7e-119	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PA	607379	NP_861970	7e-119	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG4779-PA	607474	XP_001125853	7e-119	HGD;AKU	HGO	Alkaptonuria, 203500 (3)
CG2204-PB	139340	NP_005263	8e-119	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2204-PD	139340	NP_005263	8e-119	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2204-PE	139340	NP_005263	8e-119	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2204-PF	139340	NP_005263	8e-119	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2204-PG	139340	NP_005263	8e-119	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG12703-PA	300371	NP_000024	1e-118	ABCD1;ALD;AMN	ADRENOLEUKODYSTROPHY PROTEIN; ALDP	Adrenoleukodystrophy, 300100 (3);Adrenomyeloneuropathy, 300100 (3)
CG12014-PA	309900	NP_000193	1e-118	IDS;MPS2;SIDS	HUNTER SYNDROME;IDS DEFICIENCY;IDURONATE 2-SULFATASE DEFICIENCY;MPS II; MPS2;SIDS DEFICIENCY;SULFOIDURONATE SULFATASE DEFICIENCY	Mucopolysaccharidosis II (3)
CG3593-PA	258900	NP_000364	2e-118	OPRT;UMPS	OPRT AND OMP DECARBOXYLASE DEFICIENCY;OROTATE PHOSPHORIBOSYLTRANSFERASE AND OMP DECARBOXYLASE DEFICIENCY;OROTIDYLIC PYROPHOSPHORYLASE AND OROTIDYLIC DECARBOXYLASE DEFICIENCY;UMP SYNTHASE DEFICIENCY;UMPS DEFICIENCY;URIDINE MONOPHOSPHATE SYNTHASE DEFICIENCY	Oroticaciduria (3)
CG1683-PA	103220	NP_001142	2e-118	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG1683-PB	103220	NP_001142	2e-118	ANT1;PEO3;SLC25A4;T1	ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANT1;ADP/ATP CARRIER 1; AAC1;ADP/ATP TRANSLOCASE 1;ADP/ATP TRANSLOCATOR OF SKELETAL MUSCLE; ANT;TRANSLOCATOR), MEMBER 4; SLC25A4	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)
CG6174-PA	102560	NP_001605	2e-118	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG3297-PA	603593	NP_003973	2e-118	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG3297-PB	603593	NP_003973	2e-118	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG3297-PC	603593	NP_003973	2e-118	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG17927-PL	602666	NP_057323	2e-118	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6174-PA	102630	NP_001092	3e-118		BETA-ACTIN	
CG2146-PA	606808	NP_059129	3e-118	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG2146-PB	606808	NP_059129	3e-118	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5481-PA	608630	NP_071765	3e-118	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG11949-PB	130500	NP_976217	3e-118	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG7438-PA	160760	NP_000248	4e-118	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG7438-PB	160760	NP_000248	4e-118	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG32094-PA	602997	NP_001072	4e-118	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG17927-PB	602666	NP_057323	4e-118	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG17927-PM	602666	NP_057323	4e-118	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG4012-PA	605377	NP_004400	5e-118	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG2204-PA	139340	NP_005263	5e-118	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2204-PC	139340	NP_005263	5e-118	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG7729-PA	607900	NP_060141	5e-118	C20orf42;KIND1;URP1	CHROMOSOME 20 OPEN READING FRAME 42; C20ORF42;KIND1;KINDLERIN;UNC112-RELATED PROTEIN 1; URP1	Kindler syndrome, 173650 (3)
CG18255-PC	188840	NP_596869	5e-118	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG9155-PA	600970	NP_004990	6e-118	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG9155-PB	600970	NP_004990	6e-118	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG9155-PC	600970	NP_004990	6e-118	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG9155-PD	600970	NP_004990	6e-118	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG7806-PA	607040	NP_115972	6e-118	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG7806-PA	607040	NP_149163	6e-118	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG1718-PA	601691	NP_000341	8e-118	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG7665-PA	152790	NP_000224	9e-118	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG7665-PB	152790	NP_000224	9e-118	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG8279-PA	180071	NP_000431	9e-118	PDE6A;PDEA	RETINAL ROD PHOTORECEPTOR cGMP PHOSPHODIESTERASE, ALPHA SUBUNIT; PDEA	Retinitis pigmentosa, autosomal recessive (3)
CG4587-PA	608171	NP_758952	9e-118	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG7010-PA	300502	NP_000275	1e-117	PDHA1;PHE1A	PDHA;PDHCE1A;PHE1A	Leigh syndrome, X-linked, 308930 (3);Pyruvate dehydrogenase deficiency, 312170 (3)
CG7010-PC	300502	NP_000275	1e-117	PDHA1;PHE1A	PDHA;PDHCE1A;PHE1A	Leigh syndrome, X-linked, 308930 (3);Pyruvate dehydrogenase deficiency, 312170 (3)
CG7010-PD	300502	NP_000275	1e-117	PDHA1;PHE1A	PDHA;PDHCE1A;PHE1A	Leigh syndrome, X-linked, 308930 (3);Pyruvate dehydrogenase deficiency, 312170 (3)
CG8224-PA	102576	NP_001096	1e-117	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG7948-PA	179617	NP_002866	1e-117	RAD51A;RECA	RAD51, S. CEREVISIAE, HOMOLOG OF, A; RAD51A;RECA, E. COLI, HOMOLOG OF;RECOMBINATION PROTEIN A; RECA	{Breast cancer, susceptibility to}, 114480 (3)
CG15279-PA	604159	NP_004202	1e-117	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG15279-PB	604159	NP_004202	1e-117	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG4586-PA	609751	NP_009223	1e-117	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG10231-PA	180072	NP_000274	2e-117	CSNB3;PDE6B;PDEB	rd, MOUSE, HOMOLOG OF;rd1;RETINAL ROD PHOTORECEPTOR cGMP PHOSPHODIESTERASE, BETA SUBUNIT; PDEB	Night blindness, congenital stationary, type 3, 163500 (3);Retinitis pigmentosa, autosomal recessive (3)
CG2827-PA	602063	NP_006746	2e-117	TALDO1		Transaldolase deficiency, 606003 (3)
CG17927-PK	602666	NP_057323	2e-117	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6401-PA	311770	NP_002632	3e-117	PIGA		Paroxysmal nocturnal hemoglobinuria (3)
CG6174-PA	102540	NP_005150	3e-117	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PI	600970	NP_004990	4e-117	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PI	602666	NP_057323	4e-117	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PA	608568	NP_079005	4e-117	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG7438-PB	608568	NP_079005	4e-117	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17927-PD	602666	NP_057323	5e-117	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG2964-PA	609712	NP_000289	6e-117	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG17998-PA	180381	NP_002920	6e-117	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG2964-PA	609712	NP_870986	6e-117	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG1732-PB	300036	NP_005620	7e-117	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG8581-PA	120470	NP_005206	8e-117	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG4058-PA	300550	NP_000435	1e-116	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG4058-PB	300550	NP_000435	1e-116	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG6174-PA	102610	NP_001091	1e-116	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG3536-PA	600053	NP_001289	1e-116	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG2174-PA	160710	NP_002462	1e-116	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5870-PA	182860	NP_003117	1e-116	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG32451-PA	108730	NP_004311	1e-116	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG32451-PC	108730	NP_004311	1e-116	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG15792-PA	600970	NP_004990	1e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG15792-PB	600970	NP_004990	1e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PL	600970	NP_004990	1e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG32451-PA	108730	NP_775293	1e-116	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG32451-PC	108730	NP_775293	1e-116	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG6058-PE	229600	NP_000026	2e-116	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG2146-PA	601478	NP_005370	2e-116	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG2146-PB	601478	NP_005370	2e-116	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG5924-PA	606075	NP_068602	2e-116	C10orf2;PEO1;PEOA3;SANDO;TWINKLE	T7 GENE 4-LIKE PROTEIN WITH INTRAMITOCHONDRIAL NUCLEOID LOCALIZATION;;TWINKLE	Progressive external ophthalmoplegia with mitochondrial DNA deletions, 609286 (3);Sensory ataxia neuropathy, dysarthria, and ophthalmoparesis, 607459 (3)
CG14228-PA	607379	NP_861966	2e-116	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG11949-PA	130500	NP_004428	3e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG11949-PD	130500	NP_004428	3e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1891-PA	190181	NP_004603	3e-116	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG1891-PB	190181	NP_004603	3e-116	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG17927-PC	602666	NP_057323	3e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG17927-PH	602666	NP_057323	3e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG33135-PB	603537	NP_751895	3e-116	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG11949-PA	130500	NP_976217	3e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG11949-PD	130500	NP_976217	3e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG6058-PA	229600	NP_000026	4e-116	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG6058-PG	229600	NP_000026	4e-116	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG13927-PA	137167	NP_000812	4e-116	GGCX		Vitamin K-dependent coagulation defect, 277450 (3)
CG2146-PC	601478	NP_005370	4e-116	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PA	602666	NP_057323	4e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PA	602666	NP_057323	4e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PB	602666	NP_057323	4e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG7438-PA	160710	NP_002462	5e-116	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7438-PB	160710	NP_002462	5e-116	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17927-PF	602666	NP_057323	5e-116	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG1864-PB	601828	NP_775263	5e-116	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1864-PC	601828	NP_775263	5e-116	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1698-PA	604159	NP_004202	6e-116	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG17927-PB	600970	NP_004990	6e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PD	600970	NP_004990	6e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PF	600970	NP_004990	6e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PK	600970	NP_004990	6e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PM	600970	NP_004990	6e-116	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG7806-PA	603234	XP_001125860	6e-116	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG5618-PA	605363	NP_000808	7e-116	GAD1;SCP	GAD;GLUTAMATE DECARBOXYLASE, BRAIN, 67-KD; GAD67	Cerebral palsy, spastic, symmetric, autosomal recessive, 603513 (3)
CG11949-PB	130500	NP_004428	7e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG3001-PA	142600	NP_277031	7e-116	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PA	142600	NP_277032	7e-116	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PA	142600	NP_277033	7e-116	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PA	142600	NP_277035	7e-116	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG11949-PC	130500	NP_004428	9e-116	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG18617-PA	604592	NP_006044	9e-116	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG18617-PB	604592	NP_006044	9e-116	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG3216-PB	600179	NP_000171	1e-115	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG8665-PA	100650	NP_000681	1e-115	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG16954-PA	118190	NP_002147	1e-115	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG16954-PB	118190	NP_002147	1e-115	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG31116-PA	602024	NP_004061	1e-115	CLCNKA	CLCK1	Bartter syndrome, type 4, digenic, 602522 (3)
CG31116-PC	602024	NP_004061	1e-115	CLCNKA	CLCK1	Bartter syndrome, type 4, digenic, 602522 (3)
CG31116-PD	602024	NP_004061	1e-115	CLCNKA	CLCK1	Bartter syndrome, type 4, digenic, 602522 (3)
CG17927-PH	600970	NP_004990	1e-115	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG16954-PA	118190	NP_955472	1e-115	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG16954-PB	118190	NP_955472	1e-115	HSP60;HSPD1;SPG13	CHAPERONIN, 60-KD; CPN60;GroEL, E. COLI, HOMOLOG OF;HSP60	Spastic paraplegia-13, 605280 (3)
CG31175-PA	300377	NP_004010	2e-115	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PB	300377	NP_004010	2e-115	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG31175-PC	300377	NP_004010	2e-115	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG17927-PE	602666	NP_057323	2e-115	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG5725-PA	606157	NP_705902	2e-115	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PB	606157	NP_705902	2e-115	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PC	606157	NP_705902	2e-115	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PD	606157	NP_705902	2e-115	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PE	606157	NP_705902	2e-115	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG32381-PA	608897	NP_954712	2e-115	FHL3;HLH3;HPLH3;MUNC13-4;UNC13D	MUNC13-4	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)
CG2316-PA	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2316-PB	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2316-PC	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2316-PD	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2316-PE	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2316-PG	170995	NP_002849	3e-115	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG2174-PA	602129	NP_004136	3e-115	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG7875-PA	603652	NP_004612	3e-115	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG17927-PG	602666	NP_057323	3e-115	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG3001-PA	142600	NP_000179	4e-115	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG30171-PB	608548	NP_114141	4e-115	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG10738-PA	600179	NP_000171	5e-115	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG10738-PB	600179	NP_000171	5e-115	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG5226-PA	604159	NP_004202	6e-115	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG1709-PA	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PB	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PC	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PD	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PE	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PF	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PG	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG1709-PH	604592	NP_006044	6e-115	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG5939-PA	160741	NP_002463	7e-115	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG5939-PB	160741	NP_002463	7e-115	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG5731-PA	104170	NP_000253	8e-115	NAGA	ALPHA-GALACTOSIDASE B; GALB	Kanzaki disease, 609242 (3);Schindler disease, type I, 609241 (3);Schindler disease, type III, 609241 (3)
CG9565-PA	300550	NP_000435	8e-115	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG5599-PA	248610	NP_001909	8e-115	BCATE2;DBT	BRANCHED-CHAIN ACYLTRANSFERASE, E2 COMPONENT; BCATE2;BRANCHED-CHAIN KETO ACID DEHYDROGENASE COMPLEX, E2 COMPONENT	Maple syrup urine disease, type II, 248600 (3)
CG8850-PA	604159	NP_004202	8e-115	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG8850-PB	604159	NP_004202	8e-115	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG33048-PC	603707	NP_005934	8e-115	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG11898-PA	603234	XP_001125860	9e-115	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG9232-PA	606999	NP_000146	1e-114	GALT		Galactosemia, 230400 (3)
CG31692-PA	229700	NP_000498	1e-114	FBP1	FRUCTOSE-1,6-BISPHOSPHATASE, LIVER;FRUCTOSE-1,6-DIPHOSPHATASE	Fructose-bisphosphatase deficiency (3)
CG31692-PB	229700	NP_000498	1e-114	FBP1	FRUCTOSE-1,6-BISPHOSPHATASE, LIVER;FRUCTOSE-1,6-DIPHOSPHATASE	Fructose-bisphosphatase deficiency (3)
CG17336-PA	137192	NP_000805	1e-114	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG17336-PB	137192	NP_000805	1e-114	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG33048-PC	603707	NP_005933	1e-114	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG3001-PB	142600	NP_277031	1e-114	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PB	142600	NP_277032	1e-114	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PB	142600	NP_277033	1e-114	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3001-PB	142600	NP_277035	1e-114	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG33048-PA	603707	NP_620306	1e-114	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG33048-PC	603707	NP_620306	1e-114	MOCOD;MOCS1		Molybdenum cofactor deficiency, type A, 252150 (3)
CG8224-PA	601284	NP_000011	2e-114	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG8224-PB	601284	NP_000011	2e-114	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG17927-PA	600970	NP_004990	2e-114	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17336-PA	137192	NP_068712	2e-114	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG17336-PB	137192	NP_068712	2e-114	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG12002-PA	606765	NP_783650	2e-114	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG8224-PB	102576	NP_001096	3e-114	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG5695-PA	160775	NP_002464	3e-114	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG5695-PB	160775	NP_002464	3e-114	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG14026-PA	190181	NP_004603	3e-114	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG14026-PB	190181	NP_004603	3e-114	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG14026-PC	190181	NP_004603	3e-114	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG14026-PD	190181	NP_004603	3e-114	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG5870-PA	102574	NP_001095	4e-114	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG2331-PB	601023	NP_009057	4e-114	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG3283-PA	185470	NP_002991	5e-114	PGL4;SDH1;SDHB;SDHIP	SUCCINATE DEHYDROGENASE 1, IRON SULFUR SUBUNIT; SDH1	Paraganglioma, familial chromaffin, 4, 115310 (3);Pheochromocytoma, 171300 (3)
CG8557-PA	608136	NP_055444	5e-114	ARHGEF10;KIAA0294	KIAA0294	Slowed nerve conduction velocity, AD, 608236 (3)
CG8557-PB	608136	NP_055444	5e-114	ARHGEF10;KIAA0294	KIAA0294	Slowed nerve conduction velocity, AD, 608236 (3)
CG3001-PB	142600	NP_000179	8e-114	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG2174-PA	160720	NP_002461	8e-114	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG9554-PA	603550	NP_742101	8e-114	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG9554-PB	603550	NP_742101	8e-114	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG9554-PA	603550	NP_004091	9e-114	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG9554-PB	603550	NP_004091	9e-114	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG2098-PA	177000	NP_001012533	1e-113	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG5939-PA	160720	NP_002461	1e-113	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG5939-PB	160720	NP_002461	1e-113	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG1732-PB	604159	NP_004202	1e-113	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG2174-PA	600970	NP_004990	1e-113	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17988-PA	106180	NP_690043	1e-113	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG17988-PA	106180	NP_690044	1e-113	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG9554-PA	603550	NP_742103	1e-113	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG9554-PB	603550	NP_742103	1e-113	CMD1J;DFNA10;EYA4	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 4	Cardiomyopathy, dilated, 1J, 605362 (3);Deafness, autosomal dominant 10, 601316 (3)
CG17988-PA	106180	NP_000780	2e-113	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG7449-PA	602716	NP_004637	2e-113	NPHN;NPHS1	NPHN;RENAL GLOMERULUS-SPECIFIC CELL ADHESION RECEPTOR	Nephrosis-1, congenital, Finnish type, 256300 (3)
CG7449-PB	602716	NP_004637	2e-113	NPHN;NPHS1	NPHN;RENAL GLOMERULUS-SPECIFIC CELL ADHESION RECEPTOR	Nephrosis-1, congenital, Finnish type, 256300 (3)
CG5939-PA	160740	NP_060004	2e-113	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG5939-PB	160740	NP_060004	2e-113	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG7563-PA	114240	NP_997629	2e-113	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG7563-PB	114240	NP_997629	2e-113	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG2118-PB	232000	NP_000273	3e-113	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG17927-PC	600970	NP_004990	3e-113	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG10079-PA	164870	NP_001005862	4e-113	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10079-PB	164870	NP_001005862	4e-113	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG5695-PA	160745	NP_002465	4e-113	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5695-PB	160745	NP_002465	4e-113	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG4476-PB	604159	NP_004202	4e-113	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG10079-PA	164870	NP_004439	4e-113	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10079-PB	164870	NP_004439	4e-113	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG2174-PA	601478	NP_005370	4e-113	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG5695-PA	160745	NP_074035	4e-113	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5695-PB	160745	NP_074035	4e-113	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8742-PA	600179	NP_000171	5e-113	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG4542-PA	608103	NP_001007028	5e-113	ALG8	ALG8;DOLICHYL-P-GLUCOSE:Glc-1-Man-9-GlcNAc-2-PP-DOLICHYL-ALPHA-3-GLUCOSYLTRANSFERASE	Congenital disorder of glycosylation, type Ih, 608104 (3)
CG17927-PE	600970	NP_004990	6e-113	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PJ	602666	NP_057323	6e-113	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG31116-PA	602023	NP_000076	8e-113	CLCNKB	CLCKB	Bartter syndrome, type 3, 607364 (3);Bartter syndrome, type 4, digenic, 602522 (3)
CG31116-PC	602023	NP_000076	8e-113	CLCNKB	CLCKB	Bartter syndrome, type 3, 607364 (3);Bartter syndrome, type 4, digenic, 602522 (3)
CG31116-PD	602023	NP_000076	8e-113	CLCNKB	CLCKB	Bartter syndrome, type 3, 607364 (3);Bartter syndrome, type 4, digenic, 602522 (3)
CG2204-PA	139330	NP_000163	8e-113	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PC	139330	NP_000163	8e-113	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5610-PA	118507	NP_000739	8e-113	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG2204-PA	139330	NP_653082	8e-113	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PC	139330	NP_653082	8e-113	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2174-PA	608568	NP_079005	9e-113	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG33114-PA	600179	NP_000171	1e-112	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG7665-PA	603372	NP_000360	1e-112	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG7665-PB	603372	NP_000360	1e-112	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG4587-PA	608171	NP_001005766	1e-112	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG6622-PA	605437	NP_006246	1e-112	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG6622-PB	605437	NP_006246	1e-112	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG2174-PA	160740	NP_060004	1e-112	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG33085-PD	608310	NP_000039	2e-112	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG2204-PB	139330	NP_000163	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PD	139330	NP_000163	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PE	139330	NP_000163	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PF	139330	NP_000163	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PG	139330	NP_000163	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG10231-PA	180071	NP_000431	2e-112	PDE6A;PDEA	RETINAL ROD PHOTORECEPTOR cGMP PHOSPHODIESTERASE, ALPHA SUBUNIT; PDEA	Retinitis pigmentosa, autosomal recessive (3)
CG9761-PA	300550	NP_000435	2e-112	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG33085-PD	608310	NP_001020114	2e-112	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG1732-PB	182138	NP_001036	2e-112	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG8177-PA	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PB	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PC	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PD	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PE	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PF	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG8177-PG	603345	NP_003750	2e-112	KNBC;NBC1;SLC4A4;SLC4A5	4; SLC4A4;5, FORMERLY; SLC4A5, FORMERLY;SODIUM BICARBONATE COTRANSPORTER 1; NBC1;SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER	Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)
CG17927-PE	606808	NP_059129	2e-112	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17927-PH	606808	NP_059129	2e-112	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG32000-PA	610513	NP_071372	2e-112	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG32000-PB	610513	NP_071372	2e-112	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG2204-PB	139330	NP_653082	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PD	139330	NP_653082	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PE	139330	NP_653082	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PF	139330	NP_653082	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2204-PG	139330	NP_653082	2e-112	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG10118-PA	261600	NP_000268	3e-112	PAH;PKU1	FOLLING DISEASE;OLIGOPHRENIA PHENYLPYRUVICA;PAH DEFICIENCY;PHENYLALANINE HYDROXYLASE DEFICIENCY;PKU	Phenylketonuria (3);[Hyperphenylalaninemia, mild] (3)
CG10118-PB	261600	NP_000268	3e-112	PAH;PKU1	FOLLING DISEASE;OLIGOPHRENIA PHENYLPYRUVICA;PAH DEFICIENCY;PHENYLALANINE HYDROXYLASE DEFICIENCY;PKU	Phenylketonuria (3);[Hyperphenylalaninemia, mild] (3)
CG5695-PA	160745	NP_001035202	3e-112	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5695-PB	160745	NP_001035202	3e-112	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5695-PA	160745	NP_001035203	3e-112	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5695-PB	160745	NP_001035203	3e-112	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15792-PA	601478	NP_005370	3e-112	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG15792-PB	601478	NP_005370	3e-112	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17923-PA	182340	NP_000693	4e-112	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG17927-PJ	600970	NP_004990	4e-112	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PG	606808	NP_059129	4e-112	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17927-PJ	606808	NP_059129	4e-112	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG6844-PA	118502	NP_000733	5e-112	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG6844-PB	118502	NP_000733	5e-112	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG14938-PB	314995	NP_009061	5e-112	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG17927-PA	606808	NP_059129	5e-112	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG14938-PB	314995	NP_700359	5e-112	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG31651-PA	601756	NP_004473	6e-112	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG7438-PA	160740	NP_060004	6e-112	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG7438-PB	160740	NP_060004	6e-112	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG9554-PA	601653	NP_742057	7e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG9554-PB	601653	NP_742057	7e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG9554-PA	601653	NP_000494	8e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG9554-PB	601653	NP_000494	8e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG17927-PG	600970	NP_004990	8e-112	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG9554-PA	601653	NP_742055	8e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG9554-PB	601653	NP_742055	8e-112	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG5695-PA	601478	NP_005370	9e-112	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG5695-PB	601478	NP_005370	9e-112	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG14001-PA	606897	NP_000072	1e-111	CHS1;LYST	CHS1 GENE; CHS1	Chediak-Higashi syndrome, 214500 (3)
CG2098-PA	177000	NP_000131	1e-111	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG3001-PA	138079	NP_000153	1e-111	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG3216-PA	600179	NP_000171	1e-111	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG1548-PA	116840	NP_001900	1e-111	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG17299-PA	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17299-PB	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17299-PC	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17299-PE	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17299-PF	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17299-PG	602743	NP_057287	1e-111	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG17927-PI	606808	NP_059129	1e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG1830-PB	172471	NP_000285	2e-111	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG10261-PA	605437	NP_006246	2e-111	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG5695-PA	602666	NP_057323	2e-111	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG5695-PB	602666	NP_057323	2e-111	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG17927-PC	606808	NP_059129	2e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17927-PD	606808	NP_059129	2e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5345-PA	607657	NP_714964	2e-111	CTH	CYSTATHIONASE	Cystathioninuria, 219500 (3);Homocysteine, total plasma, elevated (3)
CG3954-PA	176876	NP_002825	3e-111	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG7075-PA	300444	NP_009162	3e-111	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG17927-PK	606808	NP_059129	3e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG3298-PB	605367	NP_060597	3e-111	ELAC2;HPC2		{Prostate cancer, susceptibility to}, 176807 (3)
CG5731-PA	301500	NP_000160	4e-111	GLA	ALPHA-GALACTOSIDASE A DEFICIENCY;ANDERSON-FABRY DISEASE;ANGIOKERATOMA, DIFFUSE;CERAMIDE TRIHEXOSIDASE DEFICIENCY;GLA DEFICIENCY;HEREDITARY DYSTOPIC LIPIDOSIS	Fabry disease (3)
CG17927-PB	606808	NP_059129	4e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17927-PM	606808	NP_059129	4e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG31183-PA	600179	NP_000171	5e-111	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG17927-PF	606808	NP_059129	5e-111	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17923-PA	182350	NP_689509	5e-111	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG1977-PA	604985	NP_008877	6e-111	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG10975-PB	151460	NP_563578	6e-111	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG10975-PB	151460	NP_002829	7e-111	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG4926-PA	602337	NP_004551	7e-111	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG10975-PB	151460	NP_563579	7e-111	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG4376-PB	604985	NP_008877	8e-111	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG16858-PA	303631	NP_001838	9e-111	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG16858-PA	303631	NP_378667	9e-111	COL4A6	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-6	Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)
CG5695-PA	160760	NP_000248	1e-110	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5695-PB	160760	NP_000248	1e-110	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG2174-PA	160741	NP_002463	1e-110	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG7438-PA	160741	NP_002463	1e-110	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG7438-PB	160741	NP_002463	1e-110	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG4376-PA	604985	NP_008877	1e-110	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG17299-PH	602743	NP_057287	1e-110	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG7922-PA	609644	NP_065988	1e-110	FANCM;KIAA1596	FANCONI ANEMIA-ASSOCIATED POLYPEPTIDE, 250-KD; FAAP250;KIAA1596	Fanconi anemia, complementation group M (3)
CG3001-PA	138079	NP_277042	1e-110	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG3001-PB	138079	NP_277042	1e-110	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG3001-PA	138079	NP_277043	1e-110	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG3001-PB	138079	NP_000153	2e-110	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG10804-PB	182138	NP_001036	2e-110	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG18278-PA	607664	NP_002067	2e-110	G6S;GNS	GLUCOSAMINE-6-SULFATASE; G6S	Mucopolysaccharidosis type IIID, 252940 (3)
CG10975-PA	151460	NP_002829	2e-110	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG12317-PA	603593	NP_003973	2e-110	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG30463-PA	601756	NP_004473	2e-110	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG30463-PB	601756	NP_004473	2e-110	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG33135-PB	602232	NP_004510	2e-110	BFNC2;EBN2;KCNQ3	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 3	Epilepsy, benign neonatal, type 2, 121201 (3)
CG3001-PB	138079	NP_277043	2e-110	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG10975-PA	151460	NP_563578	2e-110	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG10975-PA	151460	NP_563579	2e-110	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG15444-PA	300444	NP_009162	3e-110	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG1086-PB	138190	NP_001033	4e-110	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG1086-PC	138190	NP_001033	4e-110	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG14396-PA	164761	NP_066124	4e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PB	164761	NP_066124	4e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PC	164761	NP_066124	4e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PD	164761	NP_066124	4e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PE	164761	NP_066124	4e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7221-PA	605131	NP_057457	5e-110	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG1086-PB	138160	NP_000331	6e-110	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG1086-PC	138160	NP_000331	6e-110	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG9155-PA	606808	NP_059129	6e-110	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG9155-PB	606808	NP_059129	6e-110	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG9155-PC	606808	NP_059129	6e-110	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG9155-PD	606808	NP_059129	6e-110	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG14396-PA	164761	NP_065681	8e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PB	164761	NP_065681	8e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PC	164761	NP_065681	8e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PD	164761	NP_065681	8e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14396-PE	164761	NP_065681	8e-110	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG5695-PA	160720	NP_002461	9e-110	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG5695-PB	160720	NP_002461	9e-110	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG10335-PA	125270	NP_000022	1e-109	ALAD	ALADH	Porphyria, acute hepatic (3);{Lead poisoning, susceptibility to} (3)
CG5432-PA	103850	NP_000025	1e-109	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG15088-PA	604159	NP_004202	1e-109	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG15444-PB	300444	NP_009162	1e-109	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG15444-PC	300444	NP_009162	1e-109	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG15444-PD	300444	NP_009162	1e-109	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG5076-PA	152427	NP_742054	1e-109	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG10118-PB	607478	NP_775489	1e-109	TPH2;NTPH	TRYPTOPHAN HYDROXYLASE, NEURONAL; NTPH	{Unipolar depression, susceptibility to}, 608516 (3)
CG10701-PD	607379	NP_861966	1e-109	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG5432-PA	103850	NP_908930	1e-109	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG5432-PA	103850	NP_908932	1e-109	ALDOA	ALDOLASE 1;ALDOLASE A; ALDA;FRUCTOALDOLASE A;FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE A	Aldolase A deficiency (3)
CG5076-PA	152427	NP_000229	2e-109	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG6798-PA	118507	NP_000739	2e-109	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG30059-PA	607664	NP_002067	2e-109	G6S;GNS	GLUCOSAMINE-6-SULFATASE; G6S	Mucopolysaccharidosis type IIID, 252940 (3)
CG7438-PA	160720	NP_002461	2e-109	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7438-PB	160720	NP_002461	2e-109	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG10118-PA	607478	NP_775489	2e-109	TPH2;NTPH	TRYPTOPHAN HYDROXYLASE, NEURONAL; NTPH	{Unipolar depression, susceptibility to}, 608516 (3)
CG7438-PA	600970	NP_004990	3e-109	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG7438-PB	600970	NP_004990	3e-109	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG17927-PL	606808	NP_059129	3e-109	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG11895-PA	605516	NP_071407	3e-109	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG31729-PA	602397	NP_005594	4e-109	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG31729-PB	602397	NP_005594	4e-109	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG10701-PC	607379	NP_000259	6e-109	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10160-PA	150000	NP_005557	7e-109	LDHA;LDH1	LDH, SUBUNIT M	Exertional myoglobinuria due to deficiency of LDH-A (3)
CG9122-PA	191290	NP_000351	9e-109	TH;TYH		Segawa syndrome, recessive (3)
CG17922-PA	605080	NP_061971	9e-109	CNGB3;ACHM3		Achromatopsia-3, 262300 (3);Macular degeneration, juvenile, 248200 (3)
CG9122-PA	191290	NP_954986	9e-109	TH;TYH		Segawa syndrome, recessive (3)
CG9122-PA	191290	NP_954987	9e-109	TH;TYH		Segawa syndrome, recessive (3)
CG8529-PA	601239	NP_001383	1e-108	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PB	601239	NP_001383	1e-108	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8529-PC	601239	NP_001383	1e-108	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG6214-PA	600509	NP_000343	2e-108	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG1732-PB	126455	NP_001035	2e-108	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG14026-PD	102576	NP_001096	2e-108	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG11796-PB	609695	NP_002141	2e-108	HPD	4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE	Hawkinsinuria, 140350 (3);Tyrosinemia, type III, 276710 (3)
CG5695-PA	160740	NP_060004	2e-108	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG5695-PB	160740	NP_060004	2e-108	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG10701-PA	607379	NP_861966	2e-108	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861966	2e-108	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG14026-PA	102576	NP_001096	3e-108	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG14026-PB	102576	NP_001096	3e-108	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG14026-PC	102576	NP_001096	3e-108	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG8625-PA	608892	NP_060250	3e-108	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG8625-PB	608892	NP_060250	3e-108	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG8625-PC	608892	NP_060250	3e-108	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG7075-PA	300036	NP_005620	4e-108	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG10701-PD	607379	NP_861967	4e-108	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG8107-PA	114240	NP_997629	4e-108	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG33135-PB	602235	NP_742106	5e-108	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG10804-PA	182138	NP_001036	6e-108	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG7075-PB	182138	NP_001036	6e-108	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG7356-PB	134570	NP_000120	7e-108	F13A;F13A1	F13A;FIBRIN STABILIZING FACTOR, A SUBUNIT;FIBRINOLIGASE;FSF, A SUBUNIT;TRANSGLUTAMINASE, PLASMA	Factor XIIIA deficiency (3)
CG6598-PA	103730	NP_000660	7e-108		ADH, GAMMA SUBUNIT; ADH1C;ALCOHOL DEHYDROGENASE 3	
CG7075-PB	163970	NP_001034	7e-108	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG31009-PA	605514	NP_149045	7e-108	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG10523-PA	602544	NP_004553	9e-108	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PB	602544	NP_004553	9e-108	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PC	602544	NP_004553	9e-108	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG6214-PA	601439	NP_064693	9e-108	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7356-PA	134570	NP_000120	1e-107	F13A;F13A1	F13A;FIBRIN STABILIZING FACTOR, A SUBUNIT;FIBRINOLIGASE;FSF, A SUBUNIT;TRANSGLUTAMINASE, PLASMA	Factor XIIIA deficiency (3)
CG5695-PA	160710	NP_002462	1e-107	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5695-PB	160710	NP_002462	1e-107	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG1819-PA	607800	NP_056472	1e-107	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG7997-PA	301500	NP_000160	2e-107	GLA	ALPHA-GALACTOSIDASE A DEFICIENCY;ANDERSON-FABRY DISEASE;ANGIOKERATOMA, DIFFUSE;CERAMIDE TRIHEXOSIDASE DEFICIENCY;GLA DEFICIENCY;HEREDITARY DYSTOPIC LIPIDOSIS	Fabry disease (3)
CG7997-PB	301500	NP_000160	2e-107	GLA	ALPHA-GALACTOSIDASE A DEFICIENCY;ANDERSON-FABRY DISEASE;ANGIOKERATOMA, DIFFUSE;CERAMIDE TRIHEXOSIDASE DEFICIENCY;GLA DEFICIENCY;HEREDITARY DYSTOPIC LIPIDOSIS	Fabry disease (3)
CG5939-PA	160710	NP_002462	2e-107	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5939-PB	160710	NP_002462	2e-107	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG4376-PC	604985	NP_008877	2e-107	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG7438-PA	606808	NP_059129	2e-107	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG7438-PB	606808	NP_059129	2e-107	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG1819-PA	607800	NP_775099	2e-107	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG6465-PA	104620	NP_000657	3e-107	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG1891-PA	603248	NP_001194	3e-107	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG1891-PB	603248	NP_001194	3e-107	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG12736-PA	602389	NP_003312	3e-107	COXPD4;EFTU;TUFM	EF-Tu, MITOCHONDRIAL;EF-TuMT;MITOCHONDRIAL TRANSLATION ELONGATION FACTOR Tu	Combined oxidative phosphorylation deficiency 4, 610678 (3)
CG5695-PA	608568	NP_079005	3e-107	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG5695-PB	608568	NP_079005	3e-107	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG1516-PA	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PB	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PD	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PE	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PG	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PI	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PJ	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PK	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG1516-PL	609010	NP_064551	4e-107	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG9206-PA	601143	NP_075408	4e-107	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG7223-PA	136350	NP_075599	4e-107	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PB	136350	NP_075599	4e-107	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7223-PC	136350	NP_075599	4e-107	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG9206-PA	601143	NP_004073	5e-107	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG33135-PB	602235	NP_004509	5e-107	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG14869-PA	608990	NP_112219	5e-107	ADAMTS10;WMS	1 MOTIF, 10; ADAMTS10	Weill-Marchesani syndrome, recessive, 277600 (3)
CG7010-PB	300502	NP_000275	6e-107	PDHA1;PHE1A	PDHA;PDHCE1A;PHE1A	Leigh syndrome, X-linked, 308930 (3);Pyruvate dehydrogenase deficiency, 312170 (3)
CG10718-PA	605995	NP_055889	7e-107	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG10952-PA	152427	NP_742053	7e-107	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG3936-PA	604210	NP_957705	7e-107	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG10701-PC	607379	NP_861966	9e-107	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG1762-PA	173470	NP_000203	1e-106	GP3A;ITGB3	CD61;GP3A;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;PLATELET GLYCOPROTEIN IIIa; GPIIIa;THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE	Glanzmann thrombasthenia, type B (3)
CG5287-PA	191350	NP_001373	1e-106	DPAGT2;DGPT	DPAGT2;GlcNAc-1-P TRANSFERASE;UDP-GlcNAc:DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE	Congenital disorder of glycosylation, type Ij, 608093 (3)
CG1954-PA	176980	NP_002730	1e-106	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10166-PA	603503	NP_003850	1e-106	DPM1;MPDS;CDGIE	DOLICHOL-PHOSPHATE MANNOSYLTRANSFERASE 1;DOLICHOL-PHOSPHATE-MANNOSE SYNTHASE 1;MPD SYNTHASE; MPDS	Congenital disorder of glycosylation, type Ie, 608799 (3)
CG9936-PB	608771	NP_056150	1e-106	KIAA1025;PROSIT240;THRAP2;TRAP240L	KIAA1025;PROTEIN SIMILAR TO TRAP240; PROSIT240;TRAP240-LIKE PROTEIN; TRAP240L	Transposition of the great arteries, dextro-looped, 608808 (3)
CG9936-PC	608771	NP_056150	1e-106	KIAA1025;PROSIT240;THRAP2;TRAP240L	KIAA1025;PROTEIN SIMILAR TO TRAP240; PROSIT240;TRAP240-LIKE PROTEIN; TRAP240L	Transposition of the great arteries, dextro-looped, 608808 (3)
CG9936-PD	608771	NP_056150	1e-106	KIAA1025;PROSIT240;THRAP2;TRAP240L	KIAA1025;PROTEIN SIMILAR TO TRAP240; PROSIT240;TRAP240-LIKE PROTEIN; TRAP240L	Transposition of the great arteries, dextro-looped, 608808 (3)
CG9936-PE	608771	NP_056150	1e-106	KIAA1025;PROSIT240;THRAP2;TRAP240L	KIAA1025;PROTEIN SIMILAR TO TRAP240; PROSIT240;TRAP240-LIKE PROTEIN; TRAP240L	Transposition of the great arteries, dextro-looped, 608808 (3)
CG10701-PC	607379	NP_057502	1e-106	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG18255-PA	608548	NP_114141	1e-106	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG18255-PC	608548	NP_114141	1e-106	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG10701-PC	607379	NP_861546	1e-106	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PC	607379	NP_861970	1e-106	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10718-PA	605995	NP_904325	1e-106	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG8996-PA	608053	NP_000117	2e-106	ETFA;GA2;MADD		Glutaricaciduria, type IIA, 231680 (3)
CG8996-PB	608053	NP_000117	2e-106	ETFA;GA2;MADD		Glutaricaciduria, type IIA, 231680 (3)
CG1516-PA	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PB	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PD	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PE	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PG	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PI	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PJ	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PK	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG1516-PL	232000	NP_000273	2e-106	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG10117-PA	608210	NP_000392	2e-106	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG1543-PA	609312	NP_000778	2e-106	DBH	DOPAMINE BETA-MONOOXYGENASE	Dopamine beta-hydroxylase deficiency, 223360 (3);Parkinson disease, resistance to, 168600 (3);[Dopamine-beta-hydroxylase activity levels, plasma] (3)
CG1543-PB	609312	NP_000778	2e-106	DBH	DOPAMINE BETA-MONOOXYGENASE	Dopamine beta-hydroxylase deficiency, 223360 (3);Parkinson disease, resistance to, 168600 (3);[Dopamine-beta-hydroxylase activity levels, plasma] (3)
CG1732-PB	163970	NP_001034	2e-106	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG17922-PA	600724	NP_001288	2e-106	CNCG2;CNCG3L;CNGB1	CNCG3L;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 2; CNCG2;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 3-LIKE;;GLUTAMIC ACID-RICH PROTEIN 1; GAR1; GARP;RETINAL ROD cGMP-GATED CHANNEL, BETA SUBUNIT;RETINAL ROD cGMP-GATED CHANNEL, GAMMA SUBUNIT	Retinitis pigmentosa, autosomal recessive, 268000 (3)
CG3803-PA	603646	NP_510870	2e-106	COX15	COX15, S. CEREVISIAE, HOMOLOG OF	Cardiomyopathy, hypertrophic, early-onset fatal (3);Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)
CG33135-PB	602235	NP_742104	2e-106	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG10117-PA	608210	NP_997005	2e-106	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG5695-PA	160741	NP_002463	3e-106	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG5695-PB	160741	NP_002463	3e-106	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG1891-PA	601299	NP_004320	3e-106	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG1891-PB	601299	NP_004320	3e-106	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG32134-PA	176943	NP_075259	3e-106	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG6264-PA	607854	NP_004174	4e-106	BEST1;VMD2	TU15B;VMD2 GENE	Macular dystrophy, vitelliform type, 153700 (3);Maculopathy, bull's-eye, 153870 (3);Vitelliform macular dystrophy, adult-onset, 608161 (3)
CG6822-PA	601567	NP_005561	4e-106	ERGIC53;F5F8D;LMAN1;MCFD1	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT 53; ERGIC53;INTRACELLULAR MANNOSE SPECIFIC LECTIN; MR60	Combined factor V and VIII deficiency, 227300 (3)
CG6822-PB	601567	NP_005561	4e-106	ERGIC53;F5F8D;LMAN1;MCFD1	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT 53; ERGIC53;INTRACELLULAR MANNOSE SPECIFIC LECTIN; MR60	Combined factor V and VIII deficiency, 227300 (3)
CG15792-PA	606808	NP_059129	4e-106	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG15792-PB	606808	NP_059129	4e-106	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG32849-PA	142600	NP_277031	4e-106	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG32849-PA	142600	NP_277032	4e-106	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG32849-PA	142600	NP_277033	4e-106	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG32849-PA	142600	NP_277035	4e-106	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG12348-PB	176260	NP_000208	5e-106	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG17927-PA	601478	NP_005370	5e-106	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG12008-PA	604638	NP_004915	6e-106	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG5656-PA	171760	NP_000469	7e-106	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG17927-PH	601478	NP_005370	7e-106	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG4587-PA	608171	NP_001005737	8e-106	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG12176-PA	601837	NP_002303	8e-106	LIG4	DNA LIGASE IV	LIG4 syndrome, 606593 (3);{Multiple myeloma, resistance to}, 254500 (3)
CG6385-PA	605849	NP_037523	8e-106	DMGDH;DMGDHD		Dimethylglycine dehydrogenase deficiency, 605850 (3)
CG12176-PA	601837	NP_996820	8e-106	LIG4	DNA LIGASE IV	LIG4 syndrome, 606593 (3);{Multiple myeloma, resistance to}, 254500 (3)
CG10691-PA	176705	NP_002625	9e-106	PHB	PHB1	Breast cancer, sporadic (3)
CG10691-PB	176705	NP_002625	9e-106	PHB	PHB1	Breast cancer, sporadic (3)
CG7948-PB	179617	NP_002866	1e-105	RAD51A;RECA	RAD51, S. CEREVISIAE, HOMOLOG OF, A; RAD51A;RECA, E. COLI, HOMOLOG OF;RECOMBINATION PROTEIN A; RECA	{Breast cancer, susceptibility to}, 114480 (3)
CG14938-PD	314995	NP_009061	1e-105	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2304-PA	603046	NP_009149	1e-105	HRCA1;RCA1;TRC8	TRC8	Renal cell carcinoma, 144700 (3)
CG2304-PB	603046	NP_009149	1e-105	HRCA1;RCA1;TRC8	TRC8	Renal cell carcinoma, 144700 (3)
CG14938-PD	314995	NP_700359	1e-105	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG32849-PA	142600	NP_000179	2e-105	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG4376-PB	182870	NP_000338	2e-105	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG1818-PA	176100	NP_000365	2e-105	UROD	PCT;PCT, 'FAMILIAL' TYPE;PCT, TYPE II;PORPHYRIA CUTANEA TARDA, TYPE II;PORPHYRIA, HEPATOCUTANEOUS TYPE;UROD DEFICIENCY;UROPORPHYRINOGEN DECARBOXYLASE DEFICIENCY	Porphyria cutanea tarda (3);Porphyria, hepatoerythropoietic (3)
CG4376-PB	182870	NP_001020029	2e-105	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG3252-PA	163970	NP_001034	2e-105	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG17927-PD	601478	NP_005370	2e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG1718-PA	607800	NP_056472	2e-105	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG1718-PA	607800	NP_775099	2e-105	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG4376-PA	182870	NP_000338	3e-105	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG5610-PA	118502	NP_000733	3e-105	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG10804-PB	126455	NP_001035	3e-105	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG31045-PA	160775	NP_002464	3e-105	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG17927-PI	601478	NP_005370	3e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG11186-PA	607108	NP_000271	4e-105	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG9374-PA	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PB	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PC	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PD	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PE	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PF	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PH	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG9374-PI	602216	NP_000446	4e-105	LKB1;PJS;STK11	LKB1	Melanoma, malignant sporadic (3);Pancreatic cancer, sporadic (3);Peutz-Jeghers syndrome, 175200 (3)
CG4376-PA	182870	NP_001020029	4e-105	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG31045-PB	160745	NP_002465	4e-105	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PE	160745	NP_002465	4e-105	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PB	160745	NP_074035	4e-105	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PE	160745	NP_074035	4e-105	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG11949-PA	130500	NP_976218	4e-105	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG11949-PD	130500	NP_976218	4e-105	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG30092-PD	603381	NP_001448	5e-105	AOI;FLNB;LRS1;SCT	ACTIN-BINDING PROTEIN 276/278; ABP276/278;FILAMIN, BETA	Atelosteogenesis, type III, 108721 (3);Atelostogenesis, type I, 108720 (3);Boomerang dysplasia, 112310 (3);Larson syndrome, 150250 (3);Spondylocarpotarsal synostosis syndrome, 272460 (3)
CG17927-PB	601478	NP_005370	5e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PG	601478	NP_005370	5e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PK	601478	NP_005370	5e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PM	601478	NP_005370	5e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG10443-PA	151460	NP_563578	5e-105	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG10443-PA	151460	NP_002829	6e-105	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG17927-PE	601478	NP_005370	6e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PL	601478	NP_005370	6e-105	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG8224-PA	601300	NP_064733	6e-105	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG10443-PA	151460	NP_563579	6e-105	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG3573-PA	300535	NP_001578	7e-105	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG10236-PA	608400	NP_009054	7e-105	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG1516-PH	609010	NP_064551	7e-105	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG31349-PB	607709	NP_963923	8e-105	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG31349-PF	607709	NP_963923	8e-105	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG9176-PB	123825	NP_000078	1e-104	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG9176-PC	123825	NP_000078	1e-104	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG7997-PA	104170	NP_000253	1e-104	NAGA	ALPHA-GALACTOSIDASE B; GALB	Kanzaki disease, 609242 (3);Schindler disease, type I, 609241 (3);Schindler disease, type III, 609241 (3)
CG7997-PB	104170	NP_000253	1e-104	NAGA	ALPHA-GALACTOSIDASE B; GALB	Kanzaki disease, 609242 (3);Schindler disease, type I, 609241 (3);Schindler disease, type III, 609241 (3)
CG11140-PA	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PB	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PC	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PD	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PF	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PG	609523	NP_000373	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PA	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PB	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PC	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PD	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PF	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG11140-PG	609523	NP_001026976	1e-104	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG5261-PB	608770	NP_001922	1e-104		M2 ANTIGEN COMPLEX, 70-KD SUBUNIT;PYRUVATE DEHYDROGENASE COMPLEX, E2 SUBUNIT; PDCE2	
CG10763-PA	139130	NP_002066	1e-104	GNB3		{Hypertension, essential, susceptibility to}, 145500 (3)
CG3022-PA	607340	NP_005449	1e-104	GPR51;GABBR2	G PROTEIN-COUPLED RECEPTOR 51; GPR51;GABA-B RECEPTOR, R2 SUBUNIT; GABABR2	{Nicotine dependence, susceptibility to}, 188890 (3)
CG7678-PA	604592	NP_006044	1e-104	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG11949-PB	130500	NP_976218	1e-104	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG11949-PC	130500	NP_976218	1e-104	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG10827-PA	171760	NP_000469	2e-104	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG8147-PA	171760	NP_000469	2e-104	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG10804-PB	163970	NP_001034	2e-104	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG7075-PB	126455	NP_001035	2e-104	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG31045-PB	160745	NP_001035202	2e-104	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PE	160745	NP_001035202	2e-104	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PB	160745	NP_001035203	2e-104	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PE	160745	NP_001035203	2e-104	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17927-PC	601478	NP_005370	2e-104	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG17927-PF	601478	NP_005370	2e-104	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG6052-PA	600046	NP_005493	2e-104	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG5245-PA	314995	NP_009061	2e-104	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1516-PF	609010	NP_064551	2e-104	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG5245-PA	314995	NP_700359	2e-104	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10236-PA	608400	NP_996816	2e-104	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG17907-PA	177400	NP_000046	3e-104	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG1516-PH	232000	NP_000273	3e-104	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG6844-PA	118507	NP_000739	3e-104	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG6844-PB	118507	NP_000739	3e-104	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG1869-PA	600031	NP_003456	3e-104	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG7806-PA	607040	NP_660187	3e-104	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG3573-PA	300535	NP_000267	4e-104	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG15088-PB	604159	NP_004202	4e-104	GLYT2;SLC6A5	5; SLC6A5;GLYCINE TRANSPORTER, TYPE 2; GLYT2	Hyperekplexia, 149400 (3)
CG1291-PA	607905	NP_149078	4e-104	ALG2;CDGII	ALG2	Congenital disorder of glycosylation, type Ii, 607906 (3)
CG5942-PA	608892	NP_060250	5e-104	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG5942-PB	608892	NP_060250	5e-104	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG5942-PC	608892	NP_060250	5e-104	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG5942-PD	608892	NP_060250	5e-104	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG7069-PA	609712	NP_870986	5e-104	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG7069-PA	609712	NP_000289	6e-104	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG8850-PA	182138	NP_001036	6e-104	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG8850-PB	182138	NP_001036	6e-104	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG12602-PA	604592	NP_006044	6e-104	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG5939-PA	160760	NP_000248	8e-104	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5939-PB	160760	NP_000248	8e-104	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG6726-PA	104620	NP_000657	9e-104	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG6726-PB	104620	NP_000657	9e-104	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG1732-PB	300444	NP_009162	9e-104	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG6214-PA	601439	NP_005682	1e-103	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6214-PA	601439	NP_064694	1e-103	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG32134-PA	136350	NP_075599	1e-103	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG15288-PA	600805	NP_937762	1e-103	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG17320-PA	184755	NP_001007099	2e-103	SCP2	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY, SCPx-DEFICIENT,;STEROL CARRIER PROTEIN X; SCPX	Leukoencephalopathy with dystonia and motor neuropathy (3)
CG17597-PA	184755	NP_001007099	2e-103	SCP2	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY, SCPx-DEFICIENT,;STEROL CARRIER PROTEIN X; SCPX	Leukoencephalopathy with dystonia and motor neuropathy (3)
CG10524-PA	176960	NP_002728	2e-103	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6661-PA	606811	NP_003739	2e-103	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG31349-PB	607709	NP_004808	2e-103	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG31349-PF	607709	NP_004808	2e-103	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG17927-PJ	601478	NP_005370	2e-103	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG9613-PA	609825	NP_056512	2e-103	COQ2	PARAHYDROXYBENZOATE-POLYPRENYLTRANSFERASE, MITOCHONDRIAL	Coenzyme Q10 deficiency, 607426 (3)
CG6661-PA	606811	NP_733844	2e-103	ALDH4;ALDH4A1;P5CDH	ALDEHYDE DEHYDROGENASE 4; ALDH4;P5CD;PYRROLINE-5-CARBOXYLATE DEHYDROGENASE; P5CDH	Hyperprolinemia, type II, 239510 (3)
CG14228-PA	607379	NP_861968	2e-103	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG14228-PA	607379	NP_861969	2e-103	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG8298-PA	300474	NP_000158	3e-103	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG1698-PA	182138	NP_001036	3e-103	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG2316-PF	170995	NP_002849	3e-103	ABCD3;PMP70;PXMP1	PEROXISOMAL MEMBRANE PROTEIN 1; PXMP1;PEROXISOMAL MEMBRANE PROTEIN, 70-KD; PMP70	Zellweger syndrome-2 (3)
CG1915-PC	188840	NP_003310	3e-103	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1915-PC	188840	NP_597676	3e-103	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1915-PC	188840	NP_597681	3e-103	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7665-PA	136435	NP_000136	5e-103	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG7665-PB	136435	NP_000136	5e-103	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG10804-PA	126455	NP_001035	5e-103	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG10622-PA	603921	NP_003841	6e-103	SUCLA2	A-BETA;ATP-SPECIFIC SUCCINYL-CoA SYNTHETASE, BETA SUBUNIT	Mitochondrial DNA depletion syndrome, 251880 (3)
CG4032-PA	190090	NP_005408	6e-103	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4032-PA	190090	NP_938033	6e-103	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG5610-PA	118504	NP_000735	9e-103	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG14026-PA	601284	NP_000011	1e-102	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG14026-PB	601284	NP_000011	1e-102	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG14026-PC	601284	NP_000011	1e-102	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG14026-PD	601284	NP_000011	1e-102	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG1516-PF	232000	NP_000273	1e-102	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG30359-PA	104614	NP_000332	1e-102	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG7311-PA	138430	NP_000399	1e-102	GPD2	GDH2;GLYCEROPHOSPHATE DEHYDROGENASE-2 Ca(2+)-RESPONSIVE MITOCHONDRIAL FAD-LINKED;GPD, MITOCHONDRIAL; GPDM	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG6070-PA	603593	NP_003973	1e-102	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG8948-PA	300127	NP_002538	2e-102	MRX60;OPHN1	OPN1	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)
CG6193-PA	175100	NP_000029	3e-102	APC;FPC;GS	FAMILIAL ADENOMATOUS POLYPOSIS; FAP;FAMILIAL POLYPOSIS OF THE COLON; FPC;POLYPOSIS, ADENOMATOUS INTESTINAL	Adenoma, periampullary (3);Adenomatous polyposis coli (3);Adenomatous polyposis coli, attenuated (3);Colorectal cancer (3);Desmoid disease, hereditary, 135290 (3);Gardner syndrome (3);Gastric cancer, 137215 (3);Turcot syndrome, 276300 (3)
CG11186-PA	607108	NP_001595	3e-102	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG6844-PA	118504	NP_000735	4e-102	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG6844-PB	118504	NP_000735	4e-102	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG10335-PA	125270	NP_001003945	4e-102	ALAD	ALADH	Porphyria, acute hepatic (3);{Lead poisoning, susceptibility to} (3)
CG32134-PA	134934	NP_075254	4e-102	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6214-PA	607040	NP_115972	4e-102	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG6214-PA	607040	NP_149163	4e-102	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG1372-PA	606945	NP_000518	5e-102	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG10804-PA	163970	NP_001034	5e-102	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG12008-PA	102574	NP_001095	5e-102	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG32849-PA	138079	NP_277043	5e-102	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG4376-PC	182870	NP_000338	6e-102	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG7140-PA	305900	NP_000393	6e-102	G6PD;G6PD1		Favism (3);G6PD deficiency (3);Hemolytic anemia due to G6PD deficiency (3)
CG4376-PC	182870	NP_001020029	7e-102	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG5656-PA	171800	NP_001623	7e-102		PLAP;REGAN ISOZYME	
CG7873-PA	189980	NP_005148	9e-102	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7873-PB	189980	NP_005148	9e-102	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7873-PA	189980	NP_009297	9e-102	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7873-PB	189980	NP_009297	9e-102	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG2577-PA	600864	NP_001884	1e-101			
CG7094-PA	600864	NP_001884	1e-101			
CG17697-PA	604579	NP_036325	1e-101	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG2577-PA	600864	NP_620693	1e-101			
CG7094-PA	600864	NP_620693	1e-101			
CG8298-PA	300474	NP_976325	1e-101	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG2577-PA	600864	XP_001132734	1e-101			
CG7094-PA	600864	XP_001132734	1e-101			
CG6718-PA	603604	NP_001004426	2e-101	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PB	603604	NP_001004426	2e-101	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PC	603604	NP_001004426	2e-101	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PD	603604	NP_001004426	2e-101	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG31349-PA	607709	NP_963923	3e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG31349-PC	607709	NP_963923	3e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG32849-PA	138079	NP_000153	4e-101	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG30092-PD	300017	NP_001447	4e-101	ABPX;FLN1;FLNA;FMD;MNS;NHBP;OPD1;OPD2	ACTIN-BINDING PROTEIN 280; ABP280;FILAMIN 1; FLN1;FILAMIN, ALPHA;FLN	Frontometaphyseal dysplasia, 304120 (3);Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3);Heterotopia, periventricular, 300049 (3);Heterotopia, periventricular, ED variant, 300537 (3);Melnick-Needles syndrome, 309350 (3);Otopalatodigital syndrome, type I, 311300 (3);Otopalatodigital syndrome, type II, 304120 (3)
CG31349-PA	607709	NP_004808	4e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG31349-PC	607709	NP_004808	4e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG8224-PB	601300	NP_064733	4e-101	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG32849-PA	138079	NP_277042	4e-101	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG31349-PE	607709	NP_963923	4e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG10592-PA	171760	NP_000469	5e-101	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG3725-PB	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PC	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PD	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PE	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PF	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PG	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG3725-PH	182340	NP_000693	5e-101	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG15279-PA	182138	NP_001036	5e-101	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG15279-PB	182138	NP_001036	5e-101	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG31349-PE	607709	NP_004808	5e-101	TJP2;ZO2	ZONA OCCLUDENS 2; ZO2	Hypercholanemia, familial, 607748 (3)
CG10261-PA	176960	NP_002728	7e-101	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG4562-PA	602421	NP_000483	8e-101	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG7349-PA	185470	NP_002991	9e-101	PGL4;SDH1;SDHB;SDHIP	SUCCINATE DEHYDROGENASE 1, IRON SULFUR SUBUNIT; SDH1	Paraganglioma, familial chromaffin, 4, 115310 (3);Pheochromocytoma, 171300 (3)
CG9325-PA	102680	NP_054909	9e-101	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PB	102680	NP_054909	9e-101	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PD	102680	NP_054909	9e-101	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PE	102680	NP_054909	9e-101	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PF	102680	NP_054909	9e-101	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG10399-PA	246450	NP_000182	1e-100	HMGCL	HL DEFICIENCY;HMG-CoA LYASE DEFICIENCY;HYDROXYMETHYLGLUTARIC ACIDURIA;LEUCINE METABOLISM, DEFECT IN	HMG-CoA lyase deficiency (3)
CG5150-PA	171760	NP_000469	1e-100	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG6415-PA	238310	NP_000472	1e-100	AMT;GCE;NKH	GLYCINE CLEAVAGE SYSTEM T PROTEIN; GCST	Glycine encephalopathy, 605899 (3)
CG17110-PA	104620	NP_000657	1e-100	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG3725-PA	182340	NP_000693	1e-100	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG5226-PA	182138	NP_001036	1e-100	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG9325-PA	102680	NP_001110	1e-100	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PB	102680	NP_001110	1e-100	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PD	102680	NP_001110	1e-100	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PE	102680	NP_001110	1e-100	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PF	102680	NP_001110	1e-100	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG3068-PA	603072	NP_003591	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3252-PA	300444	NP_009162	1e-100	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG8743-PA	605248	NP_065394	1e-100	MCOLN1;ML4	ML4 GENE;MUCOLIPIDIN	Mucolipidosis IV, 252650 (3)
CG8094-PA	142600	NP_277032	1e-100	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG8094-PA	142600	NP_277033	1e-100	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG3068-PA	603072	NP_940835	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3068-PA	603072	NP_940836	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3068-PA	603072	NP_940837	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3068-PA	603072	NP_940838	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3068-PA	603072	NP_940839	1e-100	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17907-PA	100740	NP_000656	2e-100	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG14895-PA	300142	NP_002569	2e-100	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG7356-PA	603805	NP_963925	2e-100	TGM6;TGX	TRANSGLUTAMINASE X; TGX	Peeling skin syndrome, acral type, 609796 (3)
CG7356-PB	603805	NP_963925	2e-100	TGM6;TGX	TRANSGLUTAMINASE X; TGX	Peeling skin syndrome, acral type, 609796 (3)
CG7123-PA	150310	NP_000219	3e-100	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7123-PB	150310	NP_000219	3e-100	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7123-PA	150310	NP_001017402	3e-100	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7123-PB	150310	NP_001017402	3e-100	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG2146-PA	602129	NP_004136	3e-100	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG2146-PB	602129	NP_004136	3e-100	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG2146-PC	602129	NP_004136	3e-100	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG9901-PA	102540	NP_005150	3e-100	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5776-PA	601023	NP_009057	3e-100	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG8412-PA	607144	NP_077010	3e-100	ALG12	ALG12	Congenital disorder of glycosylation, type Ig, 607143 (3)
CG4288-PA	604322	NP_036566	4e-100	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG4288-PB	604322	NP_036566	4e-100	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG18012-PA	605907	NP_061982	4e-100	ALG1;HMAT1;HMT1	ASPARAGINE-LINKED GLYCOSYLATION 1 HOMOLOG;BETA-1,4 MANNOSYLTRANSFERASE;HMAT1;HMT1	Congenital disorder of glycosylation, type Ik, 608540 (3)
CG13778-PA	131100	NP_570711	4e-100	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570711	4e-100	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG6127-PA	600276	NP_000426	5e-100	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG3264-PA	171760	NP_000469	6e-100	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG15279-PA	163970	NP_001034	7e-100	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15279-PB	163970	NP_001034	7e-100	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG31096-PA	606655	NP_570718	7e-100	GREAT;LGR8	GPR106;GREAT	Cryptorchidism, bilateral, 219050 (3)
CG14935-PA	104614	NP_000332	8e-100	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG14935-PB	104614	NP_000332	8e-100	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG33085-PD	608310	NP_001020115	8e-100	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG8094-PA	142600	NP_000179	9e-100	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG2248-PA	602049	NP_002863	9e-100	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG9000-PA	606480	NP_005848	9e-100	FACE1;MADB;STE24;ZMPSTE24	FACE1;STE24, S. CEREVISIAE, HOMOLOG OF	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);Restrictive dermopathy, lethal, 275210 (3)
CG17907-PA	100740	NP_056646	9e-100	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8094-PA	142600	NP_277031	9e-100	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG8094-PA	142600	NP_277035	9e-100	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG9901-PA	102630	NP_001092	1e-99		BETA-ACTIN	
CG9901-PA	102560	NP_001605	1e-99	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG8094-PA	138079	NP_277043	1e-99	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG3290-PA	171760	NP_000469	2e-99	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG9901-PA	102610	NP_001091	2e-99	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG9319-PA	604489	NP_055139	2e-99	AMACR		Alpha-methylacyl-CoA racemase deficiency (3)
CG7223-PA	134934	NP_075254	2e-99	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7223-PB	134934	NP_075254	2e-99	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7223-PC	134934	NP_075254	2e-99	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8094-PA	138079	NP_000153	3e-99	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG7526-PA	121050	NP_001990	3e-99	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG33167-PB	609526	NP_056247	4e-99	PLEKHG4	PLEKHG4;PURATROPHIN 1;PURKINJE CELL ATROPHY-ASSOCIATED PROTEIN 1	Spinocerebellar ataxia 4, pure Japanese type, 117210 (3)
CG8094-PA	138079	NP_277042	4e-99	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG18076-PE	182870	NP_000338	5e-99	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG18076-PE	182870	NP_001020029	5e-99	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG3530-PA	603557	NP_057240	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3530-PB	603557	NP_057240	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3530-PA	603557	NP_958435	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3530-PB	603557	NP_958435	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3530-PA	603557	NP_958438	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3530-PB	603557	NP_958438	6e-99	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG1721-PA	261670	NP_000281	7e-99	PGAM2;PGAMM	MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY; PGAMM DEFICIENCY	Myopathy due to phosphoglycerate mutase deficiency (3)
CG8693-PA	104614	NP_000332	7e-99	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG3752-PA	602733	NP_000687	8e-99		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG4078-PA	605882	NP_114432	8e-99	BACH1;BRIP1;FANCJ	BRCA1-ASSOCIATED C-TERMINAL HELICASE 1; BACH1;DELETIONS OF GUANINE-RICH DNA, C. ELEGANS, HOMOLOG OF;DOG1, HOMOLOG OF;FANCJ GENE; FANCJ	Breast cancer, early-onset, 114480 (3);Fanconi anemia, complementation group J, 609054 (3)
CG18096-PA	103950	NP_000005	9e-99	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG4476-PB	182138	NP_001036	1e-98	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG5261-PA	608770	NP_001922	1e-98		M2 ANTIGEN COMPLEX, 70-KD SUBUNIT;PYRUVATE DEHYDROGENASE COMPLEX, E2 SUBUNIT; PDCE2	
CG14895-PB	300142	NP_002569	1e-98	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG10804-PB	300444	NP_009162	1e-98	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG3753-PA	606622	NP_054859	1e-98	HARP;SIOD;SMARCAL1	HepA-RELATED PROTEIN; HARP;SMARCA-LIKE PROTEIN 1;SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1	Schimke immunoosseous dysplasia, 242900 (3)
CG33135-PA	607542	NP_000209	2e-98	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG33135-PB	607542	NP_000209	2e-98	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG15148-PA	603335	NP_001360	2e-98	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG1891-PA	601300	NP_004293	2e-98	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1891-PB	601300	NP_004293	2e-98	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1511-PA	600997	NP_004433	2e-98	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PB	600997	NP_004433	2e-98	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PE	600997	NP_004433	2e-98	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8709-PA	605519	NP_055461	2e-98			
CG13778-PA	131100	NP_000235	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_000235	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG5226-PA	163970	NP_001034	3e-98	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG8556-PA	602049	NP_002863	3e-98	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG13778-PA	131100	NP_570712	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570712	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PA	131100	NP_570713	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570713	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PA	131100	NP_570714	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570714	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PA	131100	NP_570715	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570715	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PA	131100	NP_570716	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG13778-PB	131100	NP_570716	3e-98	MEN1	ENDOCRINE ADENOMATOSIS, MULTIPLE;MEA I;MEN I;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IA; MEN1A;WERMER SYNDROME	Adrenal adenoma, somatic (3);Angiofibroma, somatic (3);Carcinoid tumor of lung (3);Hyperparathyroidism, AD, 145000 (3);Lipoma, somatic (3);Multiple endocrine neoplasia I (3);Parathyroid adenoma, somatic (3);Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)
CG11140-PH	609523	NP_000373	4e-98	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG33085-PD	608310	NP_001020117	4e-98	ASL	ARGININOSUCCINASE	Argininosuccinic aciduria, 207900 (3)
CG11140-PH	609523	NP_001026976	4e-98	ALDH10;ALDH3A2;FALDH;SLS	ALDEHYDE DEHYDROGENASE 10; ALDH10;FATTY ALDEHYDE DEHYDROGENASE; FALDH	Sjogren-Larsson syndrome, 270200 (3)
CG3376-PA	607608	NP_001007594	5e-98	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG3376-PB	607608	NP_001007594	5e-98	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG2302-PA	118504	NP_000735	7e-98	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG6718-PA	603604	NP_003551	7e-98	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PB	603604	NP_003551	7e-98	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PC	603604	NP_003551	7e-98	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG6718-PD	603604	NP_003551	7e-98	INAD1;IPLA2;PLA2G6	PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT; IPLA2	Infantile neuroaxonal dystrophy 1, 256600 (3);Karak syndrome, 608395 (3);Neurodegeneration with brain iron accumulation, 610217 (3)
CG1775-PA	600993	NP_005350	8e-98	DPC4;JIP;MADH4;SMAD4	DELETED IN PANCREATIC CARCINOMA 4; DPC4;MADH4;SMA- AND MAD-RELATED PROTEIN 4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3);Pancreatic cancer (3);Polyposis, juvenile intestinal, 174900 (3)
CG1775-PB	600993	NP_005350	8e-98	DPC4;JIP;MADH4;SMAD4	DELETED IN PANCREATIC CARCINOMA 4; DPC4;MADH4;SMA- AND MAD-RELATED PROTEIN 4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3);Pancreatic cancer (3);Polyposis, juvenile intestinal, 174900 (3)
CG1775-PC	600993	NP_005350	8e-98	DPC4;JIP;MADH4;SMAD4	DELETED IN PANCREATIC CARCINOMA 4; DPC4;MADH4;SMA- AND MAD-RELATED PROTEIN 4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3);Pancreatic cancer (3);Polyposis, juvenile intestinal, 174900 (3)
CG1775-PD	600993	NP_005350	8e-98	DPC4;JIP;MADH4;SMAD4	DELETED IN PANCREATIC CARCINOMA 4; DPC4;MADH4;SMA- AND MAD-RELATED PROTEIN 4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3);Pancreatic cancer (3);Polyposis, juvenile intestinal, 174900 (3)
CG14934-PA	104614	NP_000332	1e-97	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG4330-PA	604322	NP_036566	1e-97	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG5076-PA	152427	NP_742053	1e-97	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG1560-PA	147557	NP_000204	2e-97	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG11669-PA	104614	NP_000332	2e-97	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG1560-PA	147557	NP_001005619	2e-97	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG1560-PA	147557	NP_001005731	2e-97	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG1698-PA	163970	NP_001034	3e-97	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG15148-PA	603339	NP_003768	3e-97	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG5695-PA	602129	NP_004136	3e-97	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG5695-PB	602129	NP_004136	3e-97	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6297-PA	300075	NP_004577	3e-97	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG6297-PB	300075	NP_004577	3e-97	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4476-PB	163970	NP_001034	4e-97	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG3252-PA	126455	NP_001035	4e-97	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG15088-PA	182138	NP_001036	4e-97	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG3264-PA	171800	NP_001623	4e-97		PLAP;REGAN ISOZYME	
CG1511-PA	600997	NP_059145	4e-97	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PB	600997	NP_059145	4e-97	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PE	600997	NP_059145	4e-97	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7223-PA	176943	NP_075259	4e-97	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7223-PB	176943	NP_075259	4e-97	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7223-PC	176943	NP_075259	4e-97	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG1809-PA	171760	NP_000469	5e-97	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG6518-PA	605437	NP_006246	5e-97	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10523-PA	602544	NP_054642	5e-97	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PB	602544	NP_054642	5e-97	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PC	602544	NP_054642	5e-97	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG8475-PB	306000	NP_000283	6e-97	PHK;PHKA2	GLYCOGENOSIS VIIIA;HEPATIC PHOSPHORYLASE KINASE DEFICIENCY; PHK;LIVER GLYCOGENOSIS, X-LINKED, TYPE I;PHOSPHORYLASE KINASE DEFICIENCY OF LIVER; PYK; PYKL;X-LINKED LIVER GLYCOGENOSIS; XLG	Glycogenosis, X-linked hepatic, type I (3);Glycogenosis, X-linked hepatic, type II (3)
CG6747-PA	600681	NP_000882	6e-97	HHIRK1;IRK1;KCNJ2;KIR2.1;LQT7;SQT3	HHIRK1;IRK1;KIR2.1	Long QT syndrome-7, 170390 (3);Short QT syndrome-3, 609622 (3)
CG10804-PB	300036	NP_005620	6e-97	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG8475-PB	311870	NP_002628	7e-97	PHKA1		Muscle glycogenosis, 300559 (3)
CG6733-PA	104620	NP_000657	8e-97	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG10592-PA	171800	NP_001623	8e-97		PLAP;REGAN ISOZYME	
CG5670-PA	108740	NP_001672	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG5670-PB	108740	NP_001672	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG5670-PC	108740	NP_001672	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG5670-PA	108740	NP_733765	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG5670-PB	108740	NP_733765	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG5670-PC	108740	NP_733765	8e-97	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG14709-PA	602421	NP_000483	1e-96	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG11348-PA	118507	NP_000739	1e-96	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG1411-PB	222748	NP_001376	1e-96	DHP;DPYS		Dihydropyrimidinuria (3)
CG5226-PA	300444	NP_009162	1e-96	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG10804-PA	300444	NP_009162	2e-96	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG18803-PB	104311	NP_000012	3e-96	AD3;PSEN1	PS1;S182	Alzheimer disease, type 3, 607822 (3);Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3);Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3);Cardiomyopathy, dilated, 1U (3);Dementia, frontotemporal, 600274 (3);Pick disease, 172700 (3)
CG17109-PA	104620	NP_000657	3e-96	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG6798-PA	118502	NP_000733	3e-96	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG8147-PA	171800	NP_001623	3e-96		PLAP;REGAN ISOZYME	
CG14026-PA	601300	NP_004293	3e-96	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PB	601300	NP_004293	3e-96	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PC	601300	NP_004293	3e-96	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PD	601300	NP_004293	3e-96	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1511-PC	600997	NP_004433	3e-96	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PD	600997	NP_004433	3e-96	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7024-PA	300502	NP_000275	4e-96	PDHA1;PHE1A	PDHA;PDHCE1A;PHE1A	Leigh syndrome, X-linked, 308930 (3);Pyruvate dehydrogenase deficiency, 312170 (3)
CG9413-PA	603593	NP_003973	4e-96	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG9413-PB	603593	NP_003973	4e-96	LPI;SLC7A7	y(+)L-TYPE AMINO ACID TRANSPORTER 1;y(+)LAT1	Lysinuric protein intolerance, 222700 (3)
CG9712-PA	601387	NP_006283	4e-96	TSG101	VACUOLAR PROTEIN SORTING 23, YEAST, HOMOLOG OF; VPS23	Breast cancer (3)
CG4713-PA	610055	NP_060191	4e-96	CC2D1A;MRT3		Mental retardation, autosomal recessive 3, 608443 (3)
CG5807-PA	605522	NP_071903	4e-96	ACHP;C7orf2;LMBR1;PPD2	CHROMOSOME 7 OPEN READING FRAME 2; C7ORF2	Acheiropody, 200500 (3);Polydactyly, preaxial type II, 174500 (3);Triphalangeal thumb, type I, 174500 (3)
CG3725-PA	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PB	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PC	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PD	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PE	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PF	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PG	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG3725-PH	182350	NP_689509	4e-96	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG9325-PA	102680	NP_789771	4e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PB	102680	NP_789771	4e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PD	102680	NP_789771	4e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PE	102680	NP_789771	4e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PF	102680	NP_789771	4e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG12348-PA	176260	NP_000208	5e-96	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG18076-PB	182870	NP_000338	5e-96	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG18076-PG	182870	NP_000338	5e-96	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG18076-PB	182870	NP_001020029	5e-96	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG18076-PG	182870	NP_001020029	5e-96	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG15279-PA	126455	NP_001035	5e-96	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG15279-PB	126455	NP_001035	5e-96	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG9325-PA	102680	NP_054908	5e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PB	102680	NP_054908	5e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PD	102680	NP_054908	5e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PE	102680	NP_054908	5e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG9325-PF	102680	NP_054908	5e-96	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG3252-PA	182138	NP_001036	6e-96	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG6963-PA	600864	NP_001884	7e-96			
CG6963-PB	600864	NP_001884	7e-96			
CG6963-PE	600864	NP_001884	7e-96			
CG6963-PA	600864	NP_620693	7e-96			
CG6963-PB	600864	NP_620693	7e-96			
CG6963-PE	600864	NP_620693	7e-96			
CG6963-PA	600864	XP_001132734	7e-96			
CG6963-PB	600864	XP_001132734	7e-96			
CG6963-PE	600864	XP_001132734	7e-96			
CG17645-PA	261670	NP_000281	8e-96	PGAM2;PGAMM	MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY; PGAMM DEFICIENCY	Myopathy due to phosphoglycerate mutase deficiency (3)
CG14815-PA	600414	NP_000310	8e-96	PEX5;PTS1R;PXR1	PEROXIN 5; PEX5;PTS1 RECEPTOR; PTS1R	Adrenoleukodystrophy, neonatal, 202370 (3);Zellweger syndrome, 214100 (3)
CG14815-PB	600414	NP_000310	8e-96	PEX5;PTS1R;PXR1	PEROXIN 5; PEX5;PTS1 RECEPTOR; PTS1R	Adrenoleukodystrophy, neonatal, 202370 (3);Zellweger syndrome, 214100 (3)
CG7873-PA	300300	NP_000052	9e-96	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG7873-PB	300300	NP_000052	9e-96	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8696-PA	104614	NP_000332	9e-96	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG18519-PA	607633	NP_000370	1e-95	XDH	XANTHINE OXIDASE; XO;XANTHINE OXIDOREDUCTASE; XOR	Xanthinuria, type I, 278300 (3)
CG10827-PA	171800	NP_001623	1e-95		PLAP;REGAN ISOZYME	
CG9554-PA	601653	NP_742056	1e-95	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG9554-PB	601653	NP_742056	1e-95	BOR;EYA1	EYES ABSENT, DROSOPHILA, HOMOLOG OF, 1	Anterior segment anomalies and cataract (3);Branchiootic syndrome (3);Branchiootorenal syndrome with cataract, 113650 (3);Branchiootorenal syndrome, 113650 (3);Otofaciocervical syndrome, 166780 (3)
CG8690-PA	104614	NP_000332	2e-95	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG18076-PA	182870	NP_000338	2e-95	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG1698-PA	126455	NP_001035	2e-95	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG9176-PB	600053	NP_001289	2e-95	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG9176-PC	600053	NP_001289	2e-95	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG9155-PA	602129	NP_004136	2e-95	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG9155-PB	602129	NP_004136	2e-95	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG9155-PC	602129	NP_004136	2e-95	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG9155-PD	602129	NP_004136	2e-95	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG1086-PA	138140	NP_006507	2e-95	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG12147-PA	600864	XP_001132734	2e-95			
CG7068-PA	103950	NP_000005	3e-95	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG18076-PA	182870	NP_001020029	3e-95	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG15088-PA	163970	NP_001034	3e-95	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG2302-PA	118502	NP_000733	4e-95	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG3578-PA	601621	NP_005987	4e-95	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG1511-PC	600997	NP_059145	4e-95	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1511-PD	600997	NP_059145	4e-95	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG6798-PA	118504	NP_000735	5e-95	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG7719-PA	608221	NP_116233	6e-95	FLJ14813;THC2	FLJ14813	Thrombocytopenia-2, 188000 (3)
CG6963-PC	600864	NP_001884	7e-95			
CG6963-PD	600864	NP_001884	7e-95			
CG6963-PC	600864	NP_620693	7e-95			
CG6963-PD	600864	NP_620693	7e-95			
CG6963-PC	600864	XP_001132734	8e-95			
CG6963-PD	600864	XP_001132734	8e-95			
CG15088-PB	182138	NP_001036	9e-95	HTT;OCD1;SLC6A4	5-@HYDROXYTRYPTAMINE TRANSPORTER; 5-HTT;HTT;MEMBER 4; SLC6A4;SEROTONIN TRANSPORTER; SERT	Anxiety-related personality traits, 607834 (3);{Obsessive-compulsive disorder 1}, 164230 (3)
CG18803-PA	104311	NP_000012	1e-94	AD3;PSEN1	PS1;S182	Alzheimer disease, type 3, 607822 (3);Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3);Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3);Cardiomyopathy, dilated, 1U (3);Dementia, frontotemporal, 600274 (3);Pick disease, 172700 (3)
CG5432-PA	229600	NP_000026	1e-94	ALDOB	ALDOLASE B DEFICIENCY; ALDOB DEFICIENCY;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;FRUCTOSEMIA	Fructose intolerance (3)
CG1830-PA	172471	NP_000285	1e-94	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1830-PC	172471	NP_000285	1e-94	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG12147-PA	600864	NP_001884	1e-94			
CG8153-PA	278720	NP_004619	1e-94	XPC;XPCC	XERODERMA PIGMENTOSUM III; XP3;XP, GROUP C;XPC GENE;XPCC	Xeroderma pigmentosum, group C (3)
CG8153-PB	278720	NP_004619	1e-94	XPC;XPCC	XERODERMA PIGMENTOSUM III; XP3;XP, GROUP C;XPC GENE;XPCC	Xeroderma pigmentosum, group C (3)
CG8153-PC	278720	NP_004619	1e-94	XPC;XPCC	XERODERMA PIGMENTOSUM III; XP3;XP, GROUP C;XPC GENE;XPCC	Xeroderma pigmentosum, group C (3)
CG8049-PA	190090	NP_005408	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PB	190090	NP_005408	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PC	190090	NP_005408	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PD	190090	NP_005408	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10804-PA	300036	NP_005620	1e-94	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG31935-PA	602536	NP_036365	1e-94	P130;RAB3GAP1;WARBM1	KIAA0066;p130;RAB3GAP;RAB3GAP, 130-KD SUBUNIT;RAB3GAP, CATALYTIC SUBUNIT;WARBM1 GENE	Warburg micro syndrome 1, 600118 (3)
CG4096-PA	604539	NP_055059	1e-94	ADAMTS2;NPI	1 MOTIF, 2; ADAMTS2;PROCOLLAGEN I N-PROTEINASE; NPI	Ehlers-Danlos syndrome, type VIIC, 225410 (3)
CG12147-PA	600864	NP_620693	1e-94			
CG8049-PA	190090	NP_938033	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PB	190090	NP_938033	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PC	190090	NP_938033	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8049-PD	190090	NP_938033	1e-94	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG11348-PA	118504	NP_000735	2e-94	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG30092-PD	102565	NP_001449	2e-94		ABPA;ACTIN-BINDING PROTEIN 280, AUTOSOMAL FORM; ABP280A;ACTIN-BINDING PROTEIN-LIKE; ABPL;FILAMIN 2; FLN2;FILAMIN, GAMMA	
CG3290-PA	171800	NP_001623	2e-94		PLAP;REGAN ISOZYME	
CG6225-PA	300145	NP_003390	2e-94	XPNPEP2	AMINOPEPTIDASE P, 2;X-PROLYL AMINOPEPTIDASE, MEMBRANE-BOUND	{Angioedema induced by ACE inhibitors, susceptibility to} (3)
CG33038-PA	608177	NP_000118	3e-94	EXT1	EXT	Chondrosarcoma, 215300 (3);Exostoses, multiple, type 1, 133700 (3)
CG33038-PC	608177	NP_000118	3e-94	EXT1	EXT	Chondrosarcoma, 215300 (3);Exostoses, multiple, type 1, 133700 (3)
CG12327-PA	607854	NP_004174	3e-94	BEST1;VMD2	TU15B;VMD2 GENE	Macular dystrophy, vitelliform type, 153700 (3);Maculopathy, bull's-eye, 153870 (3);Vitelliform macular dystrophy, adult-onset, 608161 (3)
CG10701-PD	607379	NP_861968	3e-94	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PD	607379	NP_861969	3e-94	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG17759-PA	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PB	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PC	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PE	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PG	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PH	139360	NP_002061	4e-94	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG1771-PB	147556	NP_000201	5e-94	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG6738-PA	104620	NP_000657	5e-94	ACY1;ACY1D	ACYLASE;N-ACYL-L-AMINO ACID AMIDOHYDROLASE	Aminoacylase 1 deficiency, 609924 (3)
CG15088-PA	126455	NP_001035	5e-94	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG11121-PA	601205	NP_005973	5e-94	BOS3;DFNA23;SIX1		Brachiootic syndrome 3, 608389 (3);Deafness, autosomal dominant 23, 605192 (3)
CG1762-PA	600065	NP_000202	6e-94	CD18;ITGB2;LAD;LCAMB	LEUKOCYTE CELL ADHESION MOLECULE CD18; CD18	Leukocyte adhesion deficiency, 116920 (3)
CG15279-PA	300444	NP_009162	6e-94	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG15279-PB	300444	NP_009162	6e-94	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG5122-PA	118490	NP_065574	6e-94	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG4568-PA	608507	NP_055689	8e-94	CMT2A2;KIAA0214;MFN2	KIAA0214	Charcot-Marie-Tooth disease, type 2A2, 609260 (3);Hereditary motor and sensory neuropathy VI, 601152 (3)
CG7627-PA	602421	NP_000483	9e-94	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG5150-PA	171800	NP_001623	9e-94		PLAP;REGAN ISOZYME	
CG31793-PA	602421	NP_000483	1e-93	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG1768-PA	602121	NP_005210	1e-93	DFNA1;DIAPH1;LFHL1	DIA1	Deafness, autosomal dominant 1, 124900 (3)
CG1768-PB	602121	NP_005210	1e-93	DFNA1;DIAPH1;LFHL1	DIA1	Deafness, autosomal dominant 1, 124900 (3)
CG5122-PA	118490	NP_066264	1e-93	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG5122-PA	118490	NP_066265	1e-93	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG5122-PA	118490	NP_066266	1e-93	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG15102-PA	132810	NP_000111	2e-93	EPHX1	EPOXIDE HYDROLASE, MICROSOMAL XENOBIOTIC; EPOX;EPOXIDE HYDROLASE; EPHX	Diphenylhydantoin toxicity (1);Fetal hydantoin syndrome (1) (?);Hypercholanemia, familial, 607748 (3);{Preeclampsia, susceptibility to}, 189800 (3)
CG3530-PA	300415	NP_000243	2e-93	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG3530-PB	300415	NP_000243	2e-93	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG1462-PA	171760	NP_000469	2e-93	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG3292-PA	171760	NP_000469	2e-93	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG32451-PA	182340	NP_000693	2e-93	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG32451-PC	182340	NP_000693	2e-93	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG11348-PA	118502	NP_000733	2e-93	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG1809-PA	171800	NP_001623	2e-93		PLAP;REGAN ISOZYME	
CG5747-PA	603009	NP_003485	2e-93	DYSF;LGMD2B		Miyoshi myopathy, 254130 (3);Muscular dystrophy, limb-girdle, type 2B, 253601 (3);Myopathy, distal, with anterior tibial onset, 606768 (3)
CG10699-PA	600577	NP_055379	2e-93	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG10699-PB	600577	NP_055379	2e-93	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG3578-PA	601621	NP_057653	2e-93	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG10699-PA	600577	NP_835258	2e-93	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG10699-PB	600577	NP_835258	2e-93	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG8695-PA	104614	NP_000332	3e-93	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG1698-PA	300444	NP_009162	3e-93	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG8850-PA	163970	NP_001034	5e-93	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG8850-PB	163970	NP_001034	5e-93	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG4476-PB	126455	NP_001035	5e-93	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG8098-PA	604322	NP_036566	5e-93	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG8098-PB	604322	NP_036566	5e-93	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG11186-PB	607108	NP_000271	7e-93	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG5695-PA	606808	NP_059129	7e-93	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5695-PB	606808	NP_059129	7e-93	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5670-PA	604384	NP_001001485	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PB	604384	NP_001001485	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PC	604384	NP_001001485	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PA	604384	NP_001001486	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PB	604384	NP_001001486	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PC	604384	NP_001001486	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PA	604384	NP_001001487	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PB	604384	NP_001001487	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PC	604384	NP_001001487	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PA	604384	NP_055197	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PB	604384	NP_055197	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PC	604384	NP_055197	8e-93	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG8298-PB	300474	NP_000158	9e-93	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG8850-PA	300444	NP_009162	9e-93	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG8850-PB	300444	NP_009162	9e-93	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG6052-PA	607800	NP_056472	9e-93	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG11144-PA	601199	NP_000379	1e-92	CASR;FIH;HHC1;PCAR1	PARATHYROID CA(2+)-SENSING RECEPTOR 1; PCAR1	Hyperparathyroidism, neonatal, 239200 (3);Hypocalcemia, autosomal dominant, 146200 (3);Hypocalcemia, autosomal dominant, with Bartter syndrome (3);Hypocalciuric hypercalcemia, type I, 145980 (3)
CG10315-PA	606687	NP_001029288	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PB	606687	NP_001029288	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PC	606687	NP_001029288	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG18495-PA	602855	NP_002782	1e-92	P27K;PROS27;PSMA6	p27K;PROS27;PROTEASOME SUBUNIT IOTA	{Myocardial infarcation, susceptibility to} (3)
CG18495-PB	602855	NP_002782	1e-92	P27K;PROS27;PSMA6	p27K;PROS27;PROTEASOME SUBUNIT IOTA	{Myocardial infarcation, susceptibility to} (3)
CG30382-PA	602855	NP_002782	1e-92	P27K;PROS27;PSMA6	p27K;PROS27;PROTEASOME SUBUNIT IOTA	{Myocardial infarcation, susceptibility to} (3)
CG17927-PB	602129	NP_004136	1e-92	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PM	602129	NP_004136	1e-92	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG10539-PA	300075	NP_004577	1e-92	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG9739-PA	604579	NP_036325	1e-92	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG9739-PB	604579	NP_036325	1e-92	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG32858-PA	607643	NP_036550	1e-92	FSCN2;RFSN	FASCIN, RETINAL; RFSN	Retinitis pigmentosa-30, 607921 (3)
CG32858-PB	607643	NP_036550	1e-92	FSCN2;RFSN	FASCIN, RETINAL; RFSN	Retinitis pigmentosa-30, 607921 (3)
CG32858-PC	607643	NP_036550	1e-92	FSCN2;RFSN	FASCIN, RETINAL; RFSN	Retinitis pigmentosa-30, 607921 (3)
CG10315-PA	606687	NP_056451	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PB	606687	NP_056451	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PC	606687	NP_056451	1e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG6052-PA	607800	NP_775099	1e-92	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG10701-PA	607379	NP_861968	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861968	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PC	607379	NP_861968	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PA	607379	NP_861969	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861969	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PC	607379	NP_861969	1e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG5946-PA	250800	NP_000389	2e-92	DIA1	DIAPHORASE DEFICIENCY;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY	Methemoglobinemia, type I (3);Methemoglobinemia, type II (3)
CG5946-PB	250800	NP_000389	2e-92	DIA1	DIAPHORASE DEFICIENCY;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY	Methemoglobinemia, type I (3);Methemoglobinemia, type II (3)
CG3159-PA	600111	NP_004163	2e-92	EA6;EAAT1;SLC1A3	EXCITATORY AMINO ACID TRANSPORTER 1; EAAT1;GLAST;GLAST1;GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER;GLUTAMATE/ASPARTATE TRANSPORTER, HIGH AFFINITY, SODIUM-DEPENDENT;;MEMBER 3; SLC1A3	Episodic ataxia, type 6 (3)
CG3697-PA	133520	NP_005227	2e-92	ERCC4;XPF		Xeroderma pigmentosum, group F, 278760 (3)
CG3985-PB	313440	NP_008881	2e-92	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG3985-PF	313440	NP_008881	2e-92	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG7075-PB	300444	NP_009162	2e-92	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG5946-PA	250800	NP_015565	2e-92	DIA1	DIAPHORASE DEFICIENCY;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY	Methemoglobinemia, type I (3);Methemoglobinemia, type II (3)
CG5946-PB	250800	NP_015565	2e-92	DIA1	DIAPHORASE DEFICIENCY;NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY	Methemoglobinemia, type I (3);Methemoglobinemia, type II (3)
CG3985-PB	313440	NP_598006	2e-92	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG3985-PF	313440	NP_598006	2e-92	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG10315-PA	606687	NP_751945	2e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PB	606687	NP_751945	2e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG10315-PC	606687	NP_751945	2e-92	EIF2B4	EIF2B-DELTA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, DELTA	Leukoencephaly with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG3656-PA	608614	NP_997235	2e-92	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG1817-PB	600925	NP_002834	3e-92	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG1817-PC	600925	NP_002834	3e-92	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG18347-PA	609302	NP_078974	3e-92	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG10699-PA	602146	NP_203129	3e-92	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG32186-PA	601615	NP_001080	4e-92	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG5915-PA	602298	NP_004628	4e-92	CMT2B;PSN;RAB7		Charcot-Marie-Tooth disease, type 2B, 600882 (3)
CG4006-PA	605437	NP_006246	4e-92	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG4006-PB	605437	NP_006246	4e-92	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG4006-PC	605437	NP_006246	4e-92	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10701-PA	607379	NP_861967	4e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PB	607379	NP_861967	4e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG10701-PC	607379	NP_861967	4e-92	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG8694-PA	104614	NP_000332	5e-92	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG2118-PA	608786	NP_000911	5e-92	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG7524-PB	189980	NP_005148	5e-92	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7524-PB	189980	NP_009297	5e-92	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG2118-PA	608786	NP_071504	5e-92	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG6052-PA	601691	NP_000341	6e-92	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG4445-PA	601756	NP_004473	6e-92	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG33135-PA	602232	NP_004510	6e-92	BFNC2;EBN2;KCNQ3	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 3	Epilepsy, benign neonatal, type 2, 121201 (3)
CG10211-PA	606989	NP_000241	7e-92	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG31045-PA	160720	NP_002461	7e-92	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7075-PB	300036	NP_005620	7e-92	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG3803-PA	603646	NP_004367	9e-92	COX15	COX15, S. CEREVISIAE, HOMOLOG OF	Cardiomyopathy, hypertrophic, early-onset fatal (3);Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)
CG7538-PA	601806	NP_005906	1e-91	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG5091-PA	604566	NP_037471	1e-91	ALG6	ALG6	Congenital disorder of glycosylation, type Ic, 603147 (3)
CG3297-PA	604144	NP_055085	1e-91	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG3297-PB	604144	NP_055085	1e-91	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG3297-PC	604144	NP_055085	1e-91	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG6188-PA	606628	NP_061833	1e-91	GNMT		Glycine N-methyltransferase deficiency, 606664 (3)
CG2125-PA	165240	NP_000159	2e-91	ACLS;GLI3;PAPA;PAPB	ONCOGENE GLI3	Acrocallosal syndrome, 200990 (3);Greig cephalopolysyndactyly syndrome, 175700 (3);Pallister-Hall syndrome, 146510 (3);Polydactyly, postaxial, types A1 and B, 174200 (3);Polydactyly, preaxial, type IV, 174700 (3)
CG18582-PA	300142	NP_002569	2e-91	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG17927-PK	602129	NP_004136	2e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PL	602129	NP_004136	2e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG1698-PA	300036	NP_005620	2e-91	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG10699-PB	602146	NP_203129	2e-91	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG9138-PA	604210	NP_957705	2e-91	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG17927-PA	602129	NP_004136	3e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PD	602129	NP_004136	3e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PF	602129	NP_004136	3e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG1916-PA	601570	NP_004616	3e-91	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG32495-PB	601002	NP_000169	4e-91	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG3292-PA	171800	NP_001623	4e-91		PLAP;REGAN ISOZYME	
CG3254-PA	601756	NP_004473	4e-91	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG8298-PB	300474	NP_976325	4e-91	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG5670-PA	108730	NP_004311	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PB	108730	NP_004311	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PC	108730	NP_004311	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PA	108730	NP_775293	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PB	108730	NP_775293	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PC	108730	NP_775293	5e-91	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG17927-PH	602129	NP_004136	6e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PI	602129	NP_004136	6e-91	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG7113-PA	300256	NP_004484	8e-91	ERAB;HADH2	2-@METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE; MHBD;3-@HYDROXYACYL-CoA DEHYDROGENASE II;3-@HYDROXYACYL-CoA DEHYDROGENASE, SHORT CHAIN; SCHAD;AMYLOID BETA-BINDING ALCOHOL DEHYDROGENASE; ABAD;AMYLOID BETA-BINDING POLYPEPTIDE ERAB; ERAB;HYDROXYACYL-CoA DEHYDROGENASE II; HADH2	2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, 300438 (3)
CG4476-PB	300444	NP_009162	8e-91	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG32451-PA	182350	NP_689509	8e-91	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG32451-PC	182350	NP_689509	8e-91	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG15101-PA	132810	NP_000111	1e-90	EPHX1	EPOXIDE HYDROLASE, MICROSOMAL XENOBIOTIC; EPOX;EPOXIDE HYDROLASE; EPHX	Diphenylhydantoin toxicity (1);Fetal hydantoin syndrome (1) (?);Hypercholanemia, familial, 607748 (3);{Preeclampsia, susceptibility to}, 189800 (3)
CG7223-PA	134935	NP_002002	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PB	134935	NP_002002	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PC	134935	NP_002002	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PA	134935	NP_075252	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PB	134935	NP_075252	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PC	134935	NP_075252	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PA	134935	NP_998812	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PB	134935	NP_998812	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PC	134935	NP_998812	1e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG32669-PA	601843	NP_000444	2e-90	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG12295-PB	608171	NP_001005737	2e-90	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG32134-PA	134935	NP_002002	2e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3499-PB	602783	NP_003110	2e-90	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG9398-PA	602280	NP_003313	2e-90	RP14;TULP1		Retinitis pigmentosa-14, 600132 (3)
CG7438-PA	602129	NP_004136	2e-90	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG7438-PB	602129	NP_004136	2e-90	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG3626-PA	605849	NP_037523	2e-90	DMGDH;DMGDHD		Dimethylglycine dehydrogenase deficiency, 605850 (3)
CG3021-PA	610230	NP_060476	2e-90	TRMU;MTO2;TRNT1	MTO2, S. CEREVISIAE, HOMOLOG OF; MTO2;TRNT1	Deafness, mitochondrial, modifier of, 580000 (3)
CG5703-PA	600532	NP_066552	2e-90	NDUFV2	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 24-KD SUBUNIT	{Parkinson disease, susceptibility to}, 168600 (3)
CG32134-PA	134935	NP_075252	2e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG32134-PA	134935	NP_998812	2e-90	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4032-PA	300300	NP_000052	3e-90	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG6798-PA	100690	NP_000070	3e-90	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG12295-PB	608171	NP_001005766	3e-90	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG1372-PA	192977	NP_001018066	3e-90	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG1372-PA	192977	NP_003374	3e-90	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG10043-PA	300267	NP_004831	3e-90	ARHGEF6;COOL2;MRX46	ALPHA-PIX;COOL2;PAK-INTERACTING EXCHANGE FACTOR, ALPHA; PIXA	Mental retardation, X-linked nonspecific, type 46, 300436 (3)
CG10043-PB	300267	NP_004831	3e-90	ARHGEF6;COOL2;MRX46	ALPHA-PIX;COOL2;PAK-INTERACTING EXCHANGE FACTOR, ALPHA; PIXA	Mental retardation, X-linked nonspecific, type 46, 300436 (3)
CG12295-PB	608171	NP_758952	3e-90	CACNA2D4;RCD4		Retinal cone dystrophy 4, 610478 (3)
CG5670-PD	108740	NP_001672	4e-90	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG17759-PD	139360	NP_002061	4e-90	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17759-PF	139360	NP_002061	4e-90	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG7848-PA	154270	NP_002387	4e-90	ME2	MALIC ENZYME, NAD(+)-DEPENDENT, MITOCHONDRIAL	{Epilepsy, idopathic generalized, susceptibility to}, 600669 (3)
CG15279-PA	300036	NP_005620	4e-90	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG15279-PB	300036	NP_005620	4e-90	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG12317-PA	604144	NP_055085	4e-90	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG4405-PA	605268	NP_065706	4e-90	JPH3;JP3;HDL2	JP3	Huntington disease-like 2, 606438 (3)
CG4405-PB	605268	NP_065706	4e-90	JPH3;JP3;HDL2	JP3	Huntington disease-like 2, 606438 (3)
CG5670-PD	108740	NP_733765	4e-90	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG15792-PA	602129	NP_004136	5e-90	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG15792-PB	602129	NP_004136	5e-90	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17922-PA	123825	NP_000078	6e-90	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG4122-PA	603103	NP_001299	6e-90	CPN;CPN1;SCPN	ANAPHYLATOXIN INACTIVATOR;CARBOXYPEPTIDASE B, SERUM;CARBOXYPEPTIDASE N, CATALYTIC SUBUNIT;CARBOXYPEPTIDASE N, SERUM; CPN;KININASE I;SERUM CARBOXYPEPTIDASE N; SCPN	Carboxypeptidase N deficiency, 212070 (3)
CG4122-PB	603103	NP_001299	6e-90	CPN;CPN1;SCPN	ANAPHYLATOXIN INACTIVATOR;CARBOXYPEPTIDASE B, SERUM;CARBOXYPEPTIDASE N, CATALYTIC SUBUNIT;CARBOXYPEPTIDASE N, SERUM; CPN;KININASE I;SERUM CARBOXYPEPTIDASE N; SCPN	Carboxypeptidase N deficiency, 212070 (3)
CG4122-PC	603103	NP_001299	6e-90	CPN;CPN1;SCPN	ANAPHYLATOXIN INACTIVATOR;CARBOXYPEPTIDASE B, SERUM;CARBOXYPEPTIDASE N, CATALYTIC SUBUNIT;CARBOXYPEPTIDASE N, SERUM; CPN;KININASE I;SERUM CARBOXYPEPTIDASE N; SCPN	Carboxypeptidase N deficiency, 212070 (3)
CG11186-PB	607108	NP_001595	6e-90	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG1462-PA	171800	NP_001623	6e-90		PLAP;REGAN ISOZYME	
CG4535-PA	602623	NP_004108	6e-90	FKBP5;FKBP51	FK506-BINDING PROTEIN, 51-KD; FKBP51;FKBP54	{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)
CG2302-PA	118507	NP_000739	7e-90	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG8182-PA	601756	NP_004473	7e-90	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG8182-PB	601756	NP_004473	7e-90	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG17759-PA	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PB	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PC	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PE	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PG	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PH	139340	NP_005263	8e-90	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG5287-PA	191350	NP_976061	8e-90	DPAGT2;DGPT	DPAGT2;GlcNAc-1-P TRANSFERASE;UDP-GlcNAc:DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINEPHOSPHOTRANSFERASE	Congenital disorder of glycosylation, type Ij, 608093 (3)
CG16771-PA	171760	NP_000469	1e-89	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG10211-PA	131399	NP_000493	1e-89	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG15088-PB	163970	NP_001034	1e-89	NAT1;NET1;SLC6A2	MEMBER 2; SLC6A2;NEUROTRANSMITTER TRANSPORTER, NORADRENALINE; NAT1;NOREPINEPHRINE TRANSPORTER PROTEIN 1; NET; NET1	Orthostatic intolerance, 604715 (3)
CG10524-PA	176980	NP_002730	1e-89	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG31134-PA	601478	NP_005370	1e-89	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG11020-PA	106410	NP_066187	1e-89	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG15444-PA	608893	NP_001003841	2e-89	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG15444-PB	608893	NP_001003841	2e-89	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG15444-PC	608893	NP_001003841	2e-89	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG15444-PD	608893	NP_001003841	2e-89	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG11020-PA	106410	NP_001139	2e-89	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG6331-PA	604190	NP_003050	2e-89	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG12079-PA	603846	NP_004542	2e-89	NDUFS3	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 30-KD SUBUNIT	Leigh syndrome, 256000 (3)
CG18455-PA	603714	NP_005404	2e-89	HPE2;SIX3		Holoprosencephaly-2, 157170 (3)
CG3252-PA	300036	NP_005620	2e-89	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG33135-PA	607542	NP_861462	2e-89	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG33135-PB	607542	NP_861462	2e-89	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG33135-PA	607542	NP_861463	2e-89	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG33135-PB	607542	NP_861463	2e-89	ATFB1;KCNA9;KCNQ1;KVLQT1;LQT1;SQT2	9; KCNA9;KCNA8;KVLQT1;POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER	Atrial fibrillation, familial, 607554 (3);Jervell and Lange-Nielsen syndrome, 220400 (3);Long QT syndrome-1, 192500 (3);Short QT syndrome-2, 609621 (3);Torsades de pointes, drug-associated (3)
CG7524-PB	300300	NP_000052	3e-89	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8930-PA	152790	NP_000224	3e-89	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG8930-PB	152790	NP_000224	3e-89	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG8930-PC	152790	NP_000224	3e-89	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG8930-PD	152790	NP_000224	3e-89	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG8930-PE	152790	NP_000224	3e-89	LHCGR	GONADOTROPIN RECEPTOR;LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; LCGR	Hypogonadotropic hypogonadism (3);Leydig cell adenoma, with precocious puberty (3);Micropenis (3);Precocious puberty, male, 176410 (3);Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)
CG17927-PC	602129	NP_004136	3e-89	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG17927-PG	602129	NP_004136	3e-89	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG5485-PA	604943	NP_945350	3e-89	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG10363-PA	103950	NP_000005	4e-89	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG15088-PB	126455	NP_001035	4e-89	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG31045-PA	608568	NP_079005	4e-89	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG31045-PA	160760	NP_000248	5e-89	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG9623-PB	607759	NP_000410	5e-89	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG2989-PA	600031	NP_003456	5e-89	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG1954-PA	164731	NP_001617	6e-89	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG17927-PE	602129	NP_004136	6e-89	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6394-PA	601756	NP_004473	6e-89	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG6394-PB	601756	NP_004473	6e-89	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG5603-PA	605018	NP_056062	6e-89	CDMT;CYLD1;EAC		Cylindromatosis, familial, 132700 (3)
CG6944-PA	150341	NP_116126	6e-89	LMNB2;LMN2		Lipodystrophy, partial, acquired, 608709 (3)
CG6084-PB	604741	NP_005980	7e-89		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG18455-PA	606326	NP_031400	7e-89	SIX6;MCOPCT2		Microphthalmia, isolated, with cataract 2, 212550 (3)
CG6070-PA	604144	NP_055085	7e-89	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG31045-PB	160775	NP_002464	9e-89	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG31045-PE	160775	NP_002464	9e-89	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG3926-PA	604285	NP_000021	1e-88	AGXT;SPAT	AGT;SERINE-PYRUVATE AMINOTRANSFERASE; SPT; SPAT	Hyperoxaluria, primary, type 1, 259900 (3)
CG10261-PA	176980	NP_002730	1e-88	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG17927-PJ	602129	NP_004136	1e-88	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG10079-PA	131550	NP_958440	1e-88	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG3656-PB	608614	NP_997235	1e-88	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG32538-PB	118502	NP_000733	2e-88	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG8850-PA	126455	NP_001035	2e-88	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG8850-PB	126455	NP_001035	2e-88	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG1126-PA	603650	NP_689597	2e-88	BBS5		Bardet-Biedl syndrome 5, 209900 (3)
CG10079-PB	131550	NP_958440	2e-88	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG5485-PA	604943	NP_996766	2e-88	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG1126-PA	603650	XP_001131846	2e-88	BBS5		Bardet-Biedl syndrome 5, 209900 (3)
CG5549-PA	608893	NP_001003841	3e-88	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG9325-PC	102680	NP_001110	3e-88	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG6331-PA	603377	NP_003051	3e-88	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG8049-PA	189980	NP_005148	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PB	189980	NP_005148	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PC	189980	NP_005148	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PD	189980	NP_005148	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14938-PC	314995	NP_009061	3e-88	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8049-PA	189980	NP_009297	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PB	189980	NP_009297	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PC	189980	NP_009297	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8049-PD	189980	NP_009297	3e-88	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG9325-PC	102680	NP_054909	3e-88	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG14938-PC	314995	NP_700359	3e-88	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG9325-PC	102680	NP_789771	3e-88	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG2171-PA	190450	NP_000356	4e-88	TPI1	TPI	Hemolytic anemia due to triosephosphate isomerase deficiency (3)
CG2171-PB	190450	NP_000356	4e-88	TPI1	TPI	Hemolytic anemia due to triosephosphate isomerase deficiency (3)
CG2171-PC	190450	NP_000356	4e-88	TPI1	TPI	Hemolytic anemia due to triosephosphate isomerase deficiency (3)
CG3156-PA	171050	NP_000918	4e-88	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG7143-PA	603968	NP_006493	4e-88	POLH;XPV	RAD30, S. CEREVISIAE, HOMOLOG OF, A; RAD30A	Xeroderma pigmentosum, variant type, 278750 (3)
CG9325-PC	102680	NP_054908	4e-88	ADD1	ADDUCIN, ALPHA	{Hypertension, essential, salt-sensitive}, 145500 (3)
CG1607-PA	604144	NP_055085	4e-88	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG1607-PB	604144	NP_055085	4e-88	CSNU3;SLC7A9		Cystinuria, type II (3);Cystinuria, type III (3)
CG2125-PA	165230	NP_005261	5e-88	GLI2;HPE9	ONCOGENE GLI2	Holoprosencephaly-9, 610829 (3);Pituitary anomalies with holoprosencephaly-like features (3)
CG5226-PA	300036	NP_005620	5e-88	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG1891-PA	601300	NP_064732	5e-88	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1891-PB	601300	NP_064732	5e-88	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG6716-PA	606597	NP_852122	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_852122	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PA	606597	NP_852123	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_852123	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PA	606597	NP_852124	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_852124	5e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1771-PB	600536	NP_002197	6e-88	ITGA7		Myopathy, congenital (3)
CG7526-PA	134797	NP_000129	7e-88	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG7535-PB	138491	NP_000162	7e-88	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG4370-PB	600681	NP_000882	7e-88	HHIRK1;IRK1;KCNJ2;KIR2.1;LQT7;SQT3	HHIRK1;IRK1;KIR2.1	Long QT syndrome-7, 170390 (3);Short QT syndrome-3, 609622 (3)
CG4978-PA	601806	NP_005906	7e-88	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG14938-PA	300573	NP_001034980	8e-88	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG11348-PA	100720	NP_000742	9e-88	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG5475-PA	602897	NP_002744	9e-88	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG5475-PB	602897	NP_002744	9e-88	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG15088-PA	300444	NP_009162	9e-88	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG5525-PA	610150	NP_036205	9e-88	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG7177-PA	605232	NP_061852	9e-88	WNK1;PRKWNK1;KDP;PHA2C	KDP;PRKWNK1	Pseudohypoaldosteronism, type IIC, 145260 (3)
CG5475-PA	602897	NP_620446	9e-88	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG5475-PB	602897	NP_620446	9e-88	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG33135-PA	603537	NP_751895	9e-88	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG3388-PA	606597	NP_852124	9e-88	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG7499-PA	180297	NP_000315	1e-87	RH50A;RHAG	RH2;RHESUS ASSOCIATED POLYPEPTIDE, 50-KD; RH50A	Anemia, hemolytic, Rh-null, regulator type, 268150 (3);Rh-mod syndrome (3)
CG10444-PA	601843	NP_000444	1e-87	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG4370-PA	600681	NP_000882	1e-87	HHIRK1;IRK1;KCNJ2;KIR2.1;LQT7;SQT3	HHIRK1;IRK1;KIR2.1	Long QT syndrome-7, 170390 (3);Short QT syndrome-3, 609622 (3)
CG5670-PD	604384	NP_001001485	1e-87	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PD	604384	NP_001001486	1e-87	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5670-PD	604384	NP_001001487	1e-87	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG1877-PA	300304	NP_003579	1e-87	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG1877-PB	300304	NP_003579	1e-87	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG1877-PC	300304	NP_003579	1e-87	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG1877-PD	300304	NP_003579	1e-87	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG33135-PA	603537	NP_004691	1e-87	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG33135-PB	603537	NP_004691	1e-87	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG5044-PA	610690	NP_055177	1e-87	HIBCH	BETA-HYDROXYISOBUTYRUL-COENZYME A HYDROLASE;HIBYL-CoA-H	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
CG5044-PB	610690	NP_055177	1e-87	HIBCH	BETA-HYDROXYISOBUTYRUL-COENZYME A HYDROLASE;HIBYL-CoA-H	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
CG5670-PD	604384	NP_055197	1e-87	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5475-PA	602897	NP_620448	1e-87	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG5475-PB	602897	NP_620448	1e-87	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7049-PA	607939	NP_877437	1e-87	SUMF1;FGE	C-ALPHA-FORMYLGLYCINE-GENERATING ENZYME; FGE;FGLY-GENERATING ENZYME	Multiple sulfatase deficiency, 272200 (3)
CG9081-PA	608614	NP_997235	1e-87	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG9874-PA	600075	NP_003185	2e-87	SCA17;TBP	SCA17 GENE	Huntington disease-like-4, 607136 (3);Parkinson disease, 168600 (3);Spinocerebellar ataxia 17, 607136 (3)
CG3747-PA	600111	NP_004163	2e-87	EA6;EAAT1;SLC1A3	EXCITATORY AMINO ACID TRANSPORTER 1; EAAT1;GLAST;GLAST1;GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER;GLUTAMATE/ASPARTATE TRANSPORTER, HIGH AFFINITY, SODIUM-DEPENDENT;;MEMBER 3; SLC1A3	Episodic ataxia, type 6 (3)
CG3747-PB	600111	NP_004163	2e-87	EA6;EAAT1;SLC1A3	EXCITATORY AMINO ACID TRANSPORTER 1; EAAT1;GLAST;GLAST1;GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER;GLUTAMATE/ASPARTATE TRANSPORTER, HIGH AFFINITY, SODIUM-DEPENDENT;;MEMBER 3; SLC1A3	Episodic ataxia, type 6 (3)
CG3747-PC	600111	NP_004163	2e-87	EA6;EAAT1;SLC1A3	EXCITATORY AMINO ACID TRANSPORTER 1; EAAT1;GLAST;GLAST1;GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER;GLUTAMATE/ASPARTATE TRANSPORTER, HIGH AFFINITY, SODIUM-DEPENDENT;;MEMBER 3; SLC1A3	Episodic ataxia, type 6 (3)
CG2049-PB	605437	NP_006246	2e-87	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG2049-PC	605437	NP_006246	2e-87	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG2049-PE	605437	NP_006246	2e-87	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG2049-PF	605437	NP_006246	2e-87	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG3388-PA	606597	NP_852122	2e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG3388-PA	606597	NP_852123	2e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG30483-PA	606230	XP_037493	2e-87	KIAA1650;PROSAP2;PSAP2;SHANK3	KIAA1650;PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN 2; PSAP2;PROSAP2	Autism, chromosome 22q13.3 deletion syndrome-related (3);Chromosome 22q13.3 deletion syndrome, 606232 (3)
CG1771-PA	147556	NP_000201	3e-87	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG14938-PB	300573	NP_001034980	3e-87	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG8721-PA	165640	NP_002530	3e-87	ODC1		{Colonic adenoma recurrence, reduced risk of}, 114500 (3)
CG9774-PA	605377	NP_004400	3e-87	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG3961-PA	300157	NP_004449	3e-87	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG3961-PC	300157	NP_004449	3e-87	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG6084-PA	604741	NP_005980	4e-87		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG3961-PA	300157	NP_075266	4e-87	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG3961-PC	300157	NP_075266	4e-87	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG1768-PA	300108	NP_006720	5e-87	DIA;DIAPH2;POF2	DIA;DIA2	Premature ovarian failure, 300511 (3)
CG1768-PB	300108	NP_006720	5e-87	DIA;DIAPH2;POF2	DIA;DIA2	Premature ovarian failure, 300511 (3)
CG30360-PA	104614	NP_000332	6e-87	ATR1;D2H;NBAT;SLC3A1	AMINO ACID TRANSPORTER 1; ATR1;D2H;RBAT;TRANSPORTER), MEMBER 1; SLC3A1	Cystinuria, 220100 (3);Homozygous 2p16 deletion syndrome, 606407 (3)
CG8770-PA	139130	NP_002066	6e-87	GNB3		{Hypertension, essential, susceptibility to}, 145500 (3)
CG3388-PA	606597	NP_852125	6e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG33135-PA	602235	NP_742107	7e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG33135-PB	602235	NP_742107	7e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG12151-PA	605993	NP_060914	8e-87	PDP1;PDPC;PPM2C	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 2, CATALYTIC SUBUNIT;PYRUVATE DEHYDROGENASE PHOSPHATASE, CATALYTIC SUBUNIT; PDPC;PYRUVATE DEHYDROGENASE PHOSPHATASE; PDP1	Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)
CG33135-PA	602235	NP_742104	8e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG33135-PA	602235	NP_742105	8e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG33135-PB	602235	NP_742105	8e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG33135-PA	602235	NP_742106	8e-87	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG3466-PA	608614	NP_997235	8e-87	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG6716-PA	606597	NP_852125	9e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_852125	9e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PA	606597	NP_852126	9e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_852126	9e-87	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG4006-PA	176960	NP_002728	1e-86	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG4006-PB	176960	NP_002728	1e-86	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG4006-PC	176960	NP_002728	1e-86	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6287-PA	606879	NP_006614	1e-86	PHGDH	3-@PHOSPHOGYLCERATE DEHYDROGENASE; 3PGDH	Phosphoglycerate dehydrogenase deficiency, 601815 (3)
CG33103-PA	608990	NP_112219	1e-86	ADAMTS10;WMS	1 MOTIF, 10; ADAMTS10	Weill-Marchesani syndrome, recessive, 277600 (3)
CG33103-PB	608990	NP_112219	1e-86	ADAMTS10;WMS	1 MOTIF, 10; ADAMTS10	Weill-Marchesani syndrome, recessive, 277600 (3)
CG17759-PA	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PB	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PC	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PE	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PG	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PH	139330	NP_000163	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG1462-PB	171760	NP_000469	2e-86	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG31792-PA	602421	NP_000483	2e-86	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG2049-PB	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG2049-PC	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG2049-PE	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG2049-PF	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6622-PA	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6622-PB	164731	NP_001617	2e-86	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10104-PA	116840	NP_001900	2e-86	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG7260-PA	601397	NP_003172	2e-86	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG33135-PA	602235	NP_004509	2e-86	EBN1;KCNQ2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 2	Epilepsy, benign, neonatal, type 1, 121200 (3);Myokymia with neonatal epilepsy, 606437 (3)
CG1236-PA	604296	NP_036335	2e-86	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG5725-PA	606157	NP_079236	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PB	606157	NP_079236	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PC	606157	NP_079236	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PD	606157	NP_079236	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PE	606157	NP_079236	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG17759-PA	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PB	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PC	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PE	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PG	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PH	139330	NP_653082	2e-86	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5725-PA	606157	NP_705904	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PB	606157	NP_705904	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PC	606157	NP_705904	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PD	606157	NP_705904	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG5725-PE	606157	NP_705904	2e-86	HARP;NBIA1;PANK2;PKAN		HARP syndrome, 607236 (3);Neurodegeneration, pantothenate kinase-associated, 234200 (3)
CG3388-PA	606597	NP_852126	2e-86	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG31075-PA	602733	NP_000687	3e-86		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG4476-PB	300036	NP_005620	3e-86	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG14869-PA	604539	NP_055059	3e-86	ADAMTS2;NPI	1 MOTIF, 2; ADAMTS2;PROCOLLAGEN I N-PROTEINASE; NPI	Ehlers-Danlos syndrome, type VIIC, 225410 (3)
CG1066-PA	607604	NP_598004	3e-86		KV11.1	
CG1066-PB	607604	NP_598004	3e-86		KV11.1	
CG4096-PA	604134	NP_620594	3e-86	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG4096-PA	604134	NP_620596	3e-86	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG6798-PA	100690	NP_001034612	4e-86	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG15088-PA	300036	NP_005620	4e-86	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG12108-PA	600722	NP_000301	5e-86	PPT1;CLN1	PALMITOYL-PROTEIN THIOESTERASE; PPT	Ceroid lipofuscinosis, neuronal, variant juvenile type, with granular osmiophilic deposits (3);Ceroid lipofuscinosis, neuronal-1, infantile, 256730 (3)
CG6214-PA	607040	NP_660187	5e-86	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG4257-PB	604260	NP_036580	6e-86	STAT5B		Growth hormone insensitivity with immunodeficiency, 245590 (3);Leukemia, acute promyelocytic, STAT5B/RARA type (3)
CG4257-PC	604260	NP_036580	6e-86	STAT5B		Growth hormone insensitivity with immunodeficiency, 245590 (3);Leukemia, acute promyelocytic, STAT5B/RARA type (3)
CG4257-PD	604260	NP_036580	6e-86	STAT5B		Growth hormone insensitivity with immunodeficiency, 245590 (3);Leukemia, acute promyelocytic, STAT5B/RARA type (3)
CG8959-PA	608815	NP_060570	8e-86	EFHC1;EJM1;FLJ10466	EF-HAND DOMAIN-CONTAINING 1;FLJ10466	Myoclonic epilepsy, juvenile, 1, 254770 (3)
CG3692-PA	114240	NP_775110	9e-86	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG31536-PC	300628	NP_919253	9e-86	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG30361-PA	601199	NP_000379	1e-85	CASR;FIH;HHC1;PCAR1	PARATHYROID CA(2+)-SENSING RECEPTOR 1; PCAR1	Hyperparathyroidism, neonatal, 239200 (3);Hypocalcemia, autosomal dominant, 146200 (3);Hypocalcemia, autosomal dominant, with Bartter syndrome (3);Hypocalciuric hypercalcemia, type I, 145980 (3)
CG4545-PA	608893	NP_001003841	1e-85	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG7356-PA	603805	NP_004236	1e-85	TGM6;TGX	TRANSGLUTAMINASE X; TGX	Peeling skin syndrome, acral type, 609796 (3)
CG7356-PB	603805	NP_004236	1e-85	TGM6;TGX	TRANSGLUTAMINASE X; TGX	Peeling skin syndrome, acral type, 609796 (3)
CG4301-PA	602397	NP_005594	1e-85	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG15106-PA	132810	NP_000111	2e-85	EPHX1	EPOXIDE HYDROLASE, MICROSOMAL XENOBIOTIC; EPOX;EPOXIDE HYDROLASE; EPHX	Diphenylhydantoin toxicity (1);Fetal hydantoin syndrome (1) (?);Hypercholanemia, familial, 607748 (3);{Preeclampsia, susceptibility to}, 189800 (3)
CG5304-PA	604322	NP_036566	2e-85	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG5265-PA	118490	NP_065574	2e-85	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG5265-PA	118490	NP_066264	2e-85	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG5265-PA	118490	NP_066265	2e-85	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG5265-PA	118490	NP_066266	2e-85	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG2087-PA	604032	NP_004827	3e-85	EIF2AK3;PEK;PERK;WRS	HRI;PANCREATIC EIF2-ALPHA KINASE; PEK;PERK	Wolcott-Rallison syndrome, 226980 (3)
CG15088-PB	300036	NP_005620	3e-85	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG10776-PA	600799	NP_001195	4e-85	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG18419-PA	602397	NP_005594	4e-85	ATP8B1;BRIC;FIC1;PFIC1	FIC GENE 1; FIC1	Cholestasis, benign recurrent intrahepatic, 243300 (3);Cholestasis, progressive familial intrahepatic 1, 211600 (3)
CG14026-PA	601300	NP_064732	4e-85	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PB	601300	NP_064732	4e-85	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PC	601300	NP_064732	4e-85	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PD	601300	NP_064732	4e-85	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG6760-PA	602136	NP_000457	5e-85	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG31045-PA	160740	NP_060004	5e-85	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG2049-PB	176960	NP_002728	6e-85	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG2049-PC	176960	NP_002728	6e-85	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG2049-PE	176960	NP_002728	6e-85	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG2049-PF	176960	NP_002728	6e-85	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG1915-PA	188840	NP_596870	6e-85	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1915-PC	188840	NP_596870	6e-85	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4637-PA	600726	NP_002172	7e-85	BDA1;IHH		Acrocapitofemoral dysplasia, 607778 (3);Brachydactyly, type A1, 112500 (3)
CG18076-PB	604985	NP_008877	7e-85	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG18076-PG	604985	NP_008877	7e-85	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG1768-PA	300108	NP_009293	7e-85	DIA;DIAPH2;POF2	DIA;DIA2	Premature ovarian failure, 300511 (3)
CG1768-PB	300108	NP_009293	7e-85	DIA;DIAPH2;POF2	DIA;DIA2	Premature ovarian failure, 300511 (3)
CG30361-PB	601199	NP_000379	9e-85	CASR;FIH;HHC1;PCAR1	PARATHYROID CA(2+)-SENSING RECEPTOR 1; PCAR1	Hyperparathyroidism, neonatal, 239200 (3);Hypocalcemia, autosomal dominant, 146200 (3);Hypocalcemia, autosomal dominant, with Bartter syndrome (3);Hypocalciuric hypercalcemia, type I, 145980 (3)
CG7480-PA	601756	NP_004473	9e-85	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG8850-PA	300036	NP_005620	9e-85	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG8850-PB	300036	NP_005620	9e-85	CRTR;SLC6A8	CREATINE TRANSPORTER; CT1; CRTR;MEMBER 8; SLC6A8	Creatine deficiency syndrome, X-linked, 300352 (3)
CG7665-PA	136435	NP_852111	9e-85	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG7665-PB	136435	NP_852111	9e-85	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG30329-PA	604592	NP_006010	1e-84	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG6747-PA	600937	NP_000516	2e-84	BIR;HHF2;KCNJ11;PHHI;TNDM3	BETA-CELL INWARD RECTIFIER SUBUNIT; BIR;INWARDLY RECTIFYING POTASSIUM CHANNEL Kir6.2;POTASSIUM CHANNEL, INWARDLY RECTIFYING, BIR SUBUNIT	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3), {Diabetes mellitus, type 2, susceptibility to}, 125853 (3);Diabetes mellitus, transient neonatal, 3, 610582 (3);Diabetes, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)
CG7113-PA	300256	NP_001032900	2e-84	ERAB;HADH2	2-@METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE; MHBD;3-@HYDROXYACYL-CoA DEHYDROGENASE II;3-@HYDROXYACYL-CoA DEHYDROGENASE, SHORT CHAIN; SCHAD;AMYLOID BETA-BINDING ALCOHOL DEHYDROGENASE; ABAD;AMYLOID BETA-BINDING POLYPEPTIDE ERAB; ERAB;HYDROXYACYL-CoA DEHYDROGENASE II; HADH2	2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, 300438 (3)
CG13610-PA	604190	NP_003050	2e-84	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1915-PA	188840	NP_003310	3e-84	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5670-PD	108730	NP_004311	3e-84	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG18076-PE	604985	NP_008877	3e-84	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG9254-PA	604322	NP_036566	3e-84	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG1915-PA	188840	NP_597676	3e-84	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1915-PA	188840	NP_597681	3e-84	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5670-PD	108730	NP_775293	3e-84	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG1372-PA	603506	NP_002326	4e-84	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG7393-PA	602897	NP_002744	4e-84	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG17759-PD	139340	NP_005263	4e-84	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17759-PF	139340	NP_005263	4e-84	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG15088-PB	300444	NP_009162	4e-84	SLC6A14;OBX	AMINO ACID TRANSPORTER B(0+);ATB(0+);SLC6A14	{Obesity, susceptibility to}, 300306 (3)
CG7393-PA	602897	NP_620446	4e-84	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7393-PA	602897	NP_620448	4e-84	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7535-PA	138491	NP_000162	5e-84	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG1462-PB	171800	NP_001623	5e-84		PLAP;REGAN ISOZYME	
CG6509-PA	604090	NP_004738	5e-84	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG6509-PB	604090	NP_004738	5e-84	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG2677-PA	606454	NP_055054	5e-84	EIF2B2	EIF2B-BETA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, BETA	Leukoencephalopathy with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG1041-PA	118490	NP_065574	5e-84	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG11621-PA	171834	NP_006209	6e-84	PIK3CA	p110-ALPHA;PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, 110-KD, ALPHA	Breast cancer, 114480 (3);Colorectal cancer, 114500 (3);Ovarian cancer, 604370 (3)
CG11621-PC	171834	NP_006209	6e-84	PIK3CA	p110-ALPHA;PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, 110-KD, ALPHA	Breast cancer, 114480 (3);Colorectal cancer, 114500 (3);Ovarian cancer, 604370 (3)
CG18076-PA	604985	NP_008877	6e-84	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG11898-PA	602421	NP_000483	7e-84	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG11020-PA	182900	NP_000028	1e-83	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG5610-PA	100690	NP_000070	1e-83	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG3057-PA	212138	NP_000378	1e-83	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG2187-PA	601843	NP_000444	1e-83	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG1548-PA	179820	NP_000528	1e-83	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG31045-PA	160741	NP_002463	1e-83	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG6978-PA	604322	NP_036566	1e-83	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15288-PA	150292	NP_061486	1e-83	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG15288-PB	150292	NP_061486	1e-83	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG11020-PA	182900	NP_065208	1e-83	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG11020-PA	182900	NP_065209	1e-83	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG11020-PA	182900	NP_065210	1e-83	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG1041-PA	118490	NP_066264	1e-83	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG1041-PA	118490	NP_066265	1e-83	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG1041-PA	118490	NP_066266	1e-83	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG3156-PA	171060	NP_000434	2e-83	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG4370-PA	600937	NP_000516	2e-83	BIR;HHF2;KCNJ11;PHHI;TNDM3	BETA-CELL INWARD RECTIFIER SUBUNIT; BIR;INWARDLY RECTIFYING POTASSIUM CHANNEL Kir6.2;POTASSIUM CHANNEL, INWARDLY RECTIFYING, BIR SUBUNIT	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3), {Diabetes mellitus, type 2, susceptibility to}, 125853 (3);Diabetes mellitus, transient neonatal, 3, 610582 (3);Diabetes, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)
CG4370-PB	600937	NP_000516	2e-83	BIR;HHF2;KCNJ11;PHHI;TNDM3	BETA-CELL INWARD RECTIFIER SUBUNIT; BIR;INWARDLY RECTIFYING POTASSIUM CHANNEL Kir6.2;POTASSIUM CHANNEL, INWARDLY RECTIFYING, BIR SUBUNIT	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3), {Diabetes mellitus, type 2, susceptibility to}, 125853 (3);Diabetes mellitus, transient neonatal, 3, 610582 (3);Diabetes, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)
CG6899-PA	600925	NP_002834	2e-83	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG6899-PB	600925	NP_002834	2e-83	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG9357-PA	600031	NP_003456	2e-83	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG15288-PA	150292	NP_005553	2e-83	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG15288-PB	150292	NP_005553	2e-83	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG16973-PA	606808	NP_059129	2e-83	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG3156-PA	171060	NP_061337	2e-83	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG3156-PA	171060	NP_061338	2e-83	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG1915-PA	608548	NP_114141	2e-83	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1915-PC	608548	NP_114141	2e-83	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG10302-PA	607544	NP_573566	2e-83	LRP130;LRPPRC;LSFC	LEUCINE-RICH PROTEIN, 130-KD; LRP130	Leigh syndrome, French-Canadian type, 220111 (3)
CG1332-PA	606897	NP_000072	3e-83	CHS1;LYST	CHS1 GENE; CHS1	Chediak-Higashi syndrome, 214500 (3)
CG4637-PA	600725	NP_000184	3e-83	HLP3;HPE3;SHH;SMMCI		Coloboma, ocular, 120200 (3);Holoprosencephaly-3, 142945 (3);Solitary median maxillary central incisor, 147250 (3)
CG6944-PA	150340	NP_005564	3e-83	LMNB1	LMNB	Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)
CG12014-PA	309900	NP_006114	3e-83	IDS;MPS2;SIDS	HUNTER SYNDROME;IDS DEFICIENCY;IDURONATE 2-SULFATASE DEFICIENCY;MPS II; MPS2;SIDS DEFICIENCY;SULFOIDURONATE SULFATASE DEFICIENCY	Mucopolysaccharidosis II (3)
CG10037-PA	300039	NP_000298	4e-83	DFN3;POU3F4	BRAIN-4	Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)
CG5245-PA	300573	NP_001034980	4e-83	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG10524-PA	164731	NP_001617	4e-83	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG8665-PA	602733	NP_000687	5e-83		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG1824-PA	171050	NP_000918	5e-83	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG11897-PA	602421	NP_000483	6e-83	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG11897-PB	602421	NP_000483	6e-83	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG8799-PA	602421	NP_000483	6e-83	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG4637-PA	605423	NP_066382	6e-83	DHH		Gonadal dysgenesis, 46XY, partial, with minifascicular neuropathy, 607080 (3)
CG2692-PA	606597	NP_852125	6e-83	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG2692-PA	606597	NP_852126	6e-83	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1133-PA	603073	NP_009060	7e-83	HPE5;ZIC2	ZIC FAMILY MEMBER 2	Holoprosencephaly-5, 609637 (3)
CG2692-PA	606597	NP_852122	8e-83	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG2692-PA	606597	NP_852123	8e-83	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG2692-PA	606597	NP_852124	8e-83	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1732-PA	608893	NP_001003841	1e-82	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG1732-PC	608893	NP_001003841	1e-82	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG4082-PA	601806	NP_005906	1e-82	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG17299-PD	602743	NP_057287	1e-82	CMH6;PRKAG2;WPWS	AMP-ACTIVATED PROTEIN KINASE, NONCATALYTIC, GAMMA-2;AMPK-GAMMA-2	Cardiomyopathy, hypertrophic 6, with WPW, 600858 (3);Wolff-Parkinson-White syndrome, 194200 (3)
CG8930-PA	603372	NP_000360	2e-82	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG8930-PB	603372	NP_000360	2e-82	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG8930-PC	603372	NP_000360	2e-82	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG8930-PD	603372	NP_000360	2e-82	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG8930-PE	603372	NP_000360	2e-82	TSHR	LGR3;THYROTROPIN RECEPTOR	Hyperthyroidism, familial gestational, 603373 (3);Hyperthyroidism, nonautoimmune, 609152 (3);Hypothyroidism, congenital, nongoitrous, 1 275200 (3);Thyroid adenoma, hyperfunctioning, somatic (3);Thyroid carcinoma with thyrotoxicosis (3)
CG4159-PA	608109	NP_001002019	2e-82	MLASA;PUS1		Mitochondrial myopathy and sideroblastic anemia, 600462 (3)
CG4159-PA	608109	NP_001002020	2e-82	MLASA;PUS1		Mitochondrial myopathy and sideroblastic anemia, 600462 (3)
CG10539-PA	164731	NP_001617	2e-82	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG1771-PA	600536	NP_002197	2e-82	ITGA7		Myopathy, congenital (3)
CG15288-PA	142461	NP_005520	2e-82	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG15288-PB	142461	NP_005520	2e-82	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG11397-PA	300040	NP_006297	2e-82	CDLS2;DXS423E;SMC1	DXS423E;KIAA0178;SMC1;SMC1-ALPHA;STRUCTURAL MAINTENANCE OF CHROMOSOMES 1-LIKE 1; SMC1L1	Cornelia de Lange syndrome 2, 300590 (3)
CG4159-PA	608109	NP_079491	2e-82	MLASA;PUS1		Mitochondrial myopathy and sideroblastic anemia, 600462 (3)
CG1916-PA	165330	NP_110380	2e-82	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG1827-PA	208400	NP_000018	3e-82	AGA	AGA DEFICIENCY;AGU;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;ASPARTYLGLYCOSAMINURIA;GLYCOASPARAGINASE;GLYCOSYLASPARAGINASE DEFICIENCY	Aspartylglucosaminuria (3)
CG30019-PA	601498	NP_000278	3e-82	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG8908-PB	601615	NP_001080	3e-82	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG17922-PA	600053	NP_001289	3e-82	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG10261-PA	164731	NP_001617	3e-82	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4726-PA	604322	NP_036566	3e-82	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG11048-PA	608815	NP_060570	3e-82	EFHC1;EJM1;FLJ10466	EF-HAND DOMAIN-CONTAINING 1;FLJ10466	Myoclonic epilepsy, juvenile, 1, 254770 (3)
CG10505-PA	602421	NP_000483	4e-82	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG32538-PB	118504	NP_000735	4e-82	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG18803-PA	600759	NP_000438	5e-82	AD4;PSEN2;STM2	PS2;STM2	Alzheimer disease-4, 606889 (3);Cardiomyopathy, dilated, 1V (3)
CG18803-PB	600759	NP_000438	5e-82	AD4;PSEN2;STM2	PS2;STM2	Alzheimer disease-4, 606889 (3);Cardiomyopathy, dilated, 1V (3)
CG14938-PD	300573	NP_001034980	5e-82	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG6620-PA	603072	NP_003591	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1824-PA	603201	NP_003733	5e-82	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG18803-PA	600759	NP_036618	5e-82	AD4;PSEN2;STM2	PS2;STM2	Alzheimer disease-4, 606889 (3);Cardiomyopathy, dilated, 1V (3)
CG18803-PB	600759	NP_036618	5e-82	AD4;PSEN2;STM2	PS2;STM2	Alzheimer disease-4, 606889 (3);Cardiomyopathy, dilated, 1V (3)
CG10523-PA	602544	NP_054643	5e-82	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PB	602544	NP_054643	5e-82	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG10523-PC	602544	NP_054643	5e-82	LPRS2;PARK2;PDJ;PRKN	PRKN	Adenocarcinoma of lung, somatic, 211980 (3);Adenocarcinoma, ovarian, somatic, 604370 (3);Parkinson disease, juvenile, type 2, 600116 (3);{Leprosy, susceptibility to}, 607572 (3)
CG6620-PA	603072	NP_940835	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6620-PA	603072	NP_940836	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6620-PA	603072	NP_940837	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6620-PA	603072	NP_940838	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6620-PA	603072	NP_940839	5e-82	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3619-PA	600275	NP_077719	6e-82	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG3619-PB	600275	NP_077719	6e-82	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG3619-PA	600275	XP_001133349	6e-82	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG3619-PB	600275	XP_001133349	6e-82	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG2098-PC	177000	NP_001012533	7e-82	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG6265-PB	600423	NP_001388	7e-82	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG17134-PA	116840	NP_001900	7e-82	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG30329-PA	604592	NP_006044	7e-82	TCIRG1;TIRC7;OC116;OPTB1	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 3;VACUOLAR PROTON PUMP, ALPHA SUBUNIT 3	Osteopetrosis, recessive, 259700 (3)
CG4626-PA	604579	NP_036325	8e-82	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG31649-PA	608441	NP_056108	8e-82	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG5747-PA	603681	NP_004793	9e-82	DFNB9;NSRD9;OTOF		Deafness, autosomal recessive 9, 601071 (3)
CG5747-PA	603681	NP_919303	9e-82	DFNB9;NSRD9;OTOF		Deafness, autosomal recessive 9, 601071 (3)
CG6775-PA	606897	NP_000072	1e-81	CHS1;LYST	CHS1 GENE; CHS1	Chediak-Higashi syndrome, 214500 (3)
CG6775-PB	606897	NP_000072	1e-81	CHS1;LYST	CHS1 GENE; CHS1	Chediak-Higashi syndrome, 214500 (3)
CG32538-PB	118507	NP_000739	1e-81	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG31146-PD	300427	NP_065793	1e-81	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG31146-PD	300427	NP_851849	1e-81	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG5747-PA	603681	NP_919224	1e-81	DFNB9;NSRD9;OTOF		Deafness, autosomal recessive 9, 601071 (3)
CG9149-PA	607809	NP_000010	2e-81	ACAT1	ACAT;ACETOACETYL-CoA THIOLASE, MITOCHONDRIAL;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE; MAT;T2	Alpha-methylacetoacetic aciduria, 203750 (3)
CG6844-PA	100690	NP_000070	2e-81	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PB	100690	NP_000070	2e-81	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG1086-PA	138160	NP_000331	2e-81	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG5905-PA	110900	NP_000411	2e-81	KEL		[Blood group, Kell] (3)
CG5905-PB	110900	NP_000411	2e-81	KEL		[Blood group, Kell] (3)
CG6723-PA	601843	NP_000444	2e-81	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG10104-PA	179820	NP_000528	2e-81	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG10236-PA	142461	NP_005520	2e-81	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG5899-PA	608892	NP_060250	2e-81	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG18255-PD	188840	NP_596869	2e-81	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG31649-PA	608441	NP_892006	2e-81	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG8909-PA	603506	NP_002326	3e-81	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG31045-PA	160710	NP_002462	3e-81	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG3540-PA	608614	NP_997235	3e-81	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG5037-PA	602125	NP_001294	4e-81	COX10	COX10, S. CEREVISIAE, HOMOLOG OF;HEME A:FARNESYLTRANSFERASE	Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency (3)
CG9620-PA	605881	NP_060859	4e-81	SLC35C1;FUCT1	GDP-FUCOSE TRANSPORTER 1; FUCT1	Congenital disorder of glycosylation, type IIc, 266265 (3)
CG17759-PD	139330	NP_000163	5e-81	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PF	139330	NP_000163	5e-81	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG16758-PB	164050	NP_000261	5e-81	NP	PURINE-NUCLEOSIDE:ORTHOPHOSPHATE RIBOSYLTRANSFERASE; PNP	Nucleoside phosphorylase deficiency, immunodeficiency due to (3)
CG6453-PA	177060	NP_001001329	5e-81	G19P1;PCLD;PRKCSH	G19P1;GLUCOSIDASE II, BETA SUBUNIT	Polycystic liver disease, 174050 (3)
CG17759-PD	139330	NP_653082	5e-81	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG17759-PF	139330	NP_653082	5e-81	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG1827-PB	208400	NP_000018	6e-81	AGA	AGA DEFICIENCY;AGU;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;ASPARTYLGLYCOSAMINURIA;GLYCOASPARAGINASE;GLYCOSYLASPARAGINASE DEFICIENCY	Aspartylglucosaminuria (3)
CG1616-PA	601806	NP_005906	6e-81	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG1882-PA	604780	NP_057090	6e-81	ABHD5;CGI58;IECN2;NCIE2	COMPARATIVE GENE IDENTIFICATION 58; CGI58;NCIE2 GENE; NCIE2	Chanarin-Dorfman syndrome, 275630 (3)
CG7260-PA	604614	NP_005140	7e-81	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG7402-PA	253200	NP_000037	8e-81	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG5687-PA	601843	NP_000444	8e-81	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG4678-PA	603103	NP_001299	9e-81	CPN;CPN1;SCPN	ANAPHYLATOXIN INACTIVATOR;CARBOXYPEPTIDASE B, SERUM;CARBOXYPEPTIDASE N, CATALYTIC SUBUNIT;CARBOXYPEPTIDASE N, SERUM; CPN;KININASE I;SERUM CARBOXYPEPTIDASE N; SCPN	Carboxypeptidase N deficiency, 212070 (3)
CG4678-PB	603103	NP_001299	9e-81	CPN;CPN1;SCPN	ANAPHYLATOXIN INACTIVATOR;CARBOXYPEPTIDASE B, SERUM;CARBOXYPEPTIDASE N, CATALYTIC SUBUNIT;CARBOXYPEPTIDASE N, SERUM; CPN;KININASE I;SERUM CARBOXYPEPTIDASE N; SCPN	Carboxypeptidase N deficiency, 212070 (3)
CG16758-PC	164050	NP_000261	1e-80	NP	PURINE-NUCLEOSIDE:ORTHOPHOSPHATE RIBOSYLTRANSFERASE; PNP	Nucleoside phosphorylase deficiency, immunodeficiency due to (3)
CG16758-PD	164050	NP_000261	1e-80	NP	PURINE-NUCLEOSIDE:ORTHOPHOSPHATE RIBOSYLTRANSFERASE; PNP	Nucleoside phosphorylase deficiency, immunodeficiency due to (3)
CG31649-PA	608441	NP_149062	1e-80	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG11715-PA	608614	NP_997235	1e-80	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG33135-PA	603537	XP_001132376	1e-80	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG33135-PB	603537	XP_001132376	1e-80	DFNA2;KCNQ4	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY Q, MEMBER 4	Deafness, autosomal dominant 2, 600101 (3)
CG3036-PA	604322	NP_036566	2e-80	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG9864-PA	604322	NP_036566	2e-80	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG6097-PA	607439	NP_037514	2e-80	POMT2		Walker-Warburg syndrome, 236670 (3)
CG8590-PA	608283	NP_060111	2e-80	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1403-PA	604061	NP_006631	3e-80	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG12201-PB	609302	NP_078974	3e-80	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG2302-PA	100690	NP_000070	4e-80	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG3961-PB	300157	NP_004449	4e-80	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG32186-PA	607800	NP_056472	4e-80	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG3961-PB	300157	NP_075266	4e-80	ACS4;FACL4;MRX63	ACYL-CoA SYNTHETASE 4; ACS4	Mental retardation, X-linked nonspecific, 63, 300387 (3)
CG18255-PA	606566	NP_149109	4e-80	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18255-PB	606566	NP_149109	4e-80	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18255-PC	606566	NP_149109	4e-80	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18255-PF	606566	NP_149109	4e-80	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18255-PG	606566	NP_149109	4e-80	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG10211-PA	606765	NP_783652	4e-80	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG5747-PA	603681	NP_919304	4e-80	DFNB9;NSRD9;OTOF		Deafness, autosomal recessive 9, 601071 (3)
CG10211-PA	606765	NP_000538	5e-80	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG4860-PA	600301	NP_001600	5e-80	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG10236-PA	150325	NP_002283	5e-80	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG32186-PA	607800	NP_775099	5e-80	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG10211-PA	606765	NP_783651	5e-80	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG6692-PA	601105	NP_000387	6e-80	CTSK		Pycnodysostosis, 265800 (3)
CG6692-PB	601105	NP_000387	6e-80	CTSK		Pycnodysostosis, 265800 (3)
CG6692-PC	601105	NP_000387	6e-80	CTSK		Pycnodysostosis, 265800 (3)
CG6879-PA	131399	NP_000493	6e-80	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG1133-PA	300265	NP_003404	6e-80	HTX;HTX1;ZIC3	HTX1;ZIC FAMILY MEMBER 3	Heterotaxy, X-linked visceral, 306955 (3)
CG6203-PA	309550	NP_002015	7e-80	FMR1;FRAXA	FRAGILE X MENTAL RETARDATION PROTEIN; FMRP	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3)
CG6203-PC	309550	NP_002015	7e-80	FMR1;FRAXA	FRAGILE X MENTAL RETARDATION PROTEIN; FMRP	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3)
CG6203-PD	309550	NP_002015	7e-80	FMR1;FRAXA	FRAGILE X MENTAL RETARDATION PROTEIN; FMRP	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3)
CG9270-PA	602421	NP_000483	8e-80	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG2098-PC	177000	NP_000131	9e-80	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG7073-PA	607690	NP_001028675	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG7073-PC	607690	NP_001028675	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG7073-PD	607690	NP_001028675	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG13610-PA	603377	NP_003051	1e-79	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG7073-PA	607690	NP_057187	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG7073-PC	607690	NP_057187	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG7073-PD	607690	NP_057187	1e-79	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG6903-PA	610453	XP_372038	1e-79	HGSNAT;TMEM76;MPS3C	TRANSMEMBRANE PROTEIN 76; TMEM76	Sanfilippo syndrome, type C, 252930 (3)
CG6903-PA	610453	XP_945851	1e-79	HGSNAT;TMEM76;MPS3C	TRANSMEMBRANE PROTEIN 76; TMEM76	Sanfilippo syndrome, type C, 252930 (3)
CG5873-PA	606989	NP_000241	2e-79	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG31045-PB	160760	NP_000248	2e-79	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG31045-PE	160760	NP_000248	2e-79	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5610-PA	100690	NP_001034612	2e-79	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG7834-PA	130410	NP_001976	2e-79	ETFB;MADD		Glutaricaciduria, type IIB, 231680 (3)
CG7834-PB	130410	NP_001976	2e-79	ETFB;MADD		Glutaricaciduria, type IIB, 231680 (3)
CG4261-PA	609413	NP_000115	3e-79	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG9657-PA	601843	NP_000444	3e-79	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG31146-PD	300336	NP_061850	3e-79	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG3692-PA	114240	NP_077320	3e-79	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG4145-PA	120070	NP_000082	4e-79	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PB	120070	NP_000082	4e-79	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PC	120070	NP_000082	4e-79	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG8105-PA	171760	NP_000469	4e-79	ALPL;HOPS;TNSALP	ALKALINE PHOSPHATASE, LIVER/BONE/KIDNEY TYPE;ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC; TNSALP; TNAP	Hypophosphatasia, childhood, 241510 (3);Hypophosphatasia, infantile, 241500 (3);Odontohypophosphatasia, 146300 (3)
CG8705-PA	604061	NP_006631	4e-79	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG8705-PB	604061	NP_006631	4e-79	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG8930-PA	136435	NP_000136	5e-79	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PB	136435	NP_000136	5e-79	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PC	136435	NP_000136	5e-79	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PD	136435	NP_000136	5e-79	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PE	136435	NP_000136	5e-79	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8825-PA	607198	NP_001008744	5e-79	TDP1		Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)
CG8719-PA	165640	NP_002530	5e-79	ODC1		{Colonic adenoma recurrence, reduced risk of}, 114500 (3)
CG8825-PA	607198	NP_060789	5e-79	TDP1		Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)
CG3837-PA	147370	NP_000866	8e-79	IGF1R		Intrauterine and postnatal growth retardation (3)
CG9181-PA	176885	NP_002818	8e-79	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG9181-PB	176885	NP_002818	8e-79	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG5796-PA	600923	NP_000300	9e-79	PPOX		Porphyria variegata, 176200 (3)
CG31213-PA	601615	NP_001080	1e-78	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG7177-PA	601844	NP_115763	1e-78	PHA2B;PRKWNK4;WNK4	PRKWNK4	Pseudohypoaldosteronism type II, 145260 (3)
CG5485-PA	604943	NP_996767	1e-78	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG3692-PA	114240	NP_000061	2e-78	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG6879-PA	606989	NP_000241	2e-78	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG14709-PA	600509	NP_000343	2e-78	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG6265-PB	300550	NP_000435	2e-78	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG1086-PA	138190	NP_001033	2e-78	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG6203-PB	309550	NP_002015	2e-78	FMR1;FRAXA	FRAGILE X MENTAL RETARDATION PROTEIN; FMRP	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3)
CG6725-PA	607664	NP_002067	2e-78	G6S;GNS	GLUCOSAMINE-6-SULFATASE; G6S	Mucopolysaccharidosis type IIID, 252940 (3)
CG7807-PA	601601	NP_003212	2e-78	CHAR;TFAP2B		Char syndrome, 169100 (3)
CG7807-PB	601601	NP_003212	2e-78	CHAR;TFAP2B		Char syndrome, 169100 (3)
CG13772-PA	300427	NP_065793	2e-78	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG18255-PE	188840	NP_596869	2e-78	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG13772-PA	300427	NP_851849	2e-78	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG1126-PA	603650	XP_001131828	2e-78	BBS5		Bardet-Biedl syndrome 5, 209900 (3)
CG1824-PA	171060	NP_000434	3e-78	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG16771-PA	171800	NP_001623	3e-78		PLAP;REGAN ISOZYME	
CG1824-PA	171060	NP_061337	3e-78	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG1824-PA	171060	NP_061338	3e-78	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10244-PA	136350	NP_075593	3e-78	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10244-PA	136350	NP_075594	3e-78	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4096-PA	604134	NP_620595	3e-78	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG8222-PA	173490	NP_006197	4e-78	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8222-PB	173490	NP_006197	4e-78	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8222-PC	173490	NP_006197	4e-78	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8464-PA	606441	NP_037379	4e-78	HTRA2;OMI;PARK13;PRSS25	HTRA, E. COLI, HOMOLOG OF, 2;OMI;PROTEASE, SERINE, 25; PRSS25	Parkinson disease 13, 610297 (3)
CG10244-PA	136350	NP_056934	4e-78	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG31956-PA	601756	NP_004473	5e-78	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG15523-PA	607817	NP_060360	5e-78	COH1	KIAA0532;VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	Cohen syndrome, 216550 (3)
CG15523-PA	607817	NP_689777	5e-78	COH1	KIAA0532;VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	Cohen syndrome, 216550 (3)
CG5873-PA	606765	NP_783652	5e-78	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG5873-PA	606765	NP_000538	6e-78	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG5873-PA	606765	NP_783651	6e-78	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG9165-PA	609806	NP_000181	7e-78	HMBS;PBGD;UPS	PORPHOBILINOGEN DEAMINASE; PBGD;PRE-UROPORPHYRINOGEN SYNTHASE;UROPORPHYRINOGEN I SYNTHASE;UROPORPHYRINOGEN I SYNTHETASE	Porphyria, acute intermittent, 176000 (3);Porphyria, acute intermittent, nonerythroid variant, 176000 (3)
CG17941-PA	605514	NP_149045	7e-78	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG4145-PA	120130	NP_001836	8e-78	COL4A1	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-1 CHAIN	Brain small vessel disease with hemorrhage, 607595 (3);Porencephaly, 175780 (3)
CG4145-PB	120130	NP_001836	8e-78	COL4A1	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-1 CHAIN	Brain small vessel disease with hemorrhage, 607595 (3);Porencephaly, 175780 (3)
CG4145-PC	120130	NP_001836	8e-78	COL4A1	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-1 CHAIN	Brain small vessel disease with hemorrhage, 607595 (3);Porencephaly, 175780 (3)
CG4626-PB	604579	NP_036325	9e-78	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG1882-PB	604780	NP_057090	9e-78	ABHD5;CGI58;IECN2;NCIE2	COMPARATIVE GENE IDENTIFICATION 58; CGI58;NCIE2 GENE; NCIE2	Chanarin-Dorfman syndrome, 275630 (3)
CG1882-PC	604780	NP_057090	9e-78	ABHD5;CGI58;IECN2;NCIE2	COMPARATIVE GENE IDENTIFICATION 58; CGI58;NCIE2 GENE; NCIE2	Chanarin-Dorfman syndrome, 275630 (3)
CG1882-PD	604780	NP_057090	9e-78	ABHD5;CGI58;IECN2;NCIE2	COMPARATIVE GENE IDENTIFICATION 58; CGI58;NCIE2 GENE; NCIE2	Chanarin-Dorfman syndrome, 275630 (3)
CG4145-PA	303630	NP_000486	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PB	303630	NP_000486	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PC	303630	NP_000486	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG9165-PA	609806	NP_001019553	1e-77	HMBS;PBGD;UPS	PORPHOBILINOGEN DEAMINASE; PBGD;PRE-UROPORPHYRINOGEN SYNTHASE;UROPORPHYRINOGEN I SYNTHASE;UROPORPHYRINOGEN I SYNTHETASE	Porphyria, acute intermittent, 176000 (3);Porphyria, acute intermittent, nonerythroid variant, 176000 (3)
CG6383-PA	121050	NP_001990	1e-77	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG9181-PC	176885	NP_002818	1e-77	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG5588-PA	602049	NP_002863	1e-77	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG5588-PB	602049	NP_002863	1e-77	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG5588-PC	602049	NP_002863	1e-77	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG7259-PA	607854	NP_004174	1e-77	BEST1;VMD2	TU15B;VMD2 GENE	Macular dystrophy, vitelliform type, 153700 (3);Maculopathy, bull's-eye, 153870 (3);Vitelliform macular dystrophy, adult-onset, 608161 (3)
CG1417-PC	606810	NP_057419	1e-77	PRODH;PRODH2;SCZD4	PROLINE DEHYDROGENASE 1; PRODH1;PROLINE OXIDASE 1; POX	Hyperprolinemia, type I, 239500 (3);{Schizophrenia, susceptibility to, 4} 600850 (3)
CG4145-PA	303630	NP_203699	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PB	303630	NP_203699	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PC	303630	NP_203699	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PA	303630	NP_203700	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PB	303630	NP_203700	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG4145-PC	303630	NP_203700	1e-77	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG32538-PB	100690	NP_000070	2e-77	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG5789-PA	600509	NP_000343	2e-77	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG6969-PA	131399	NP_000493	2e-77	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG3944-PA	602141	NP_002487	2e-77	NDUFS8	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 23-KD SUBUNIT;TYKY	Leigh syndrome, 256000 (3)
CG6054-PA	607035	NP_057253	2e-77	SUFU;SUFUXL;SUFUH	SUFUH	Medulloblastoma, desmoplastic, 155255 (3)
CG4719-PA	182900	NP_065210	2e-77	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG4719-PA	182900	NP_000028	3e-77	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG11348-PA	100710	NP_000738	3e-77	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6798-PA	100720	NP_000742	3e-77	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PA	100690	NP_001034612	3e-77	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PB	100690	NP_001034612	3e-77	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG33128-PA	116840	NP_001900	3e-77	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG9699-PA	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG9699-PB	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG9699-PC	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG9699-PD	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG9699-PE	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG9699-PF	604061	NP_006631	3e-77	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG1347-PA	606837	NP_055596	3e-77	CC1;KIAA0203;RB1CC1	CC1;KIAA0203	Breast cancer, somatic, 114480 (3)
CG4719-PA	182900	NP_065208	3e-77	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG4719-PA	182900	NP_065209	3e-77	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG2118-PB	608786	NP_000911	5e-77	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG6518-PA	164731	NP_001617	5e-77	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG2005-PA	151460	NP_002829	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2005-PB	151460	NP_002829	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2118-PB	608786	NP_071504	5e-77	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG2005-PA	151460	NP_563578	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2005-PB	151460	NP_563578	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2005-PA	151460	NP_563579	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2005-PB	151460	NP_563579	5e-77	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG7123-PA	156225	NP_000417	6e-77	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7123-PB	156225	NP_000417	6e-77	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG3985-PD	313440	NP_008881	6e-77	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG10244-PA	176943	NP_075259	6e-77	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3985-PD	313440	NP_598006	6e-77	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG10244-PA	176943	NP_000132	7e-77	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG32186-PA	600046	NP_005493	7e-77	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG4630-PA	604190	NP_003050	8e-77	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1977-PA	604638	NP_004915	8e-77	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG6944-PA	150330	NP_005563	8e-77	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG2196-PA	601843	NP_000444	9e-77	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG6944-PA	150330	NP_733821	9e-77	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG7402-PA	253200	NP_942002	9e-77	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG31148-PA	606463	NP_000148	1e-76	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG6747-PA	600359	NP_000211	1e-76	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG6969-PA	606989	NP_000241	1e-76	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG31148-PA	606463	NP_001005741	1e-76	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31148-PA	606463	NP_001005742	1e-76	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31148-PA	606463	NP_001005749	1e-76	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31148-PA	606463	NP_001005750	1e-76	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG4821-PA	606709	NP_003610	1e-76	PRSS12;BSSP3;MRT1	BRAIN-SPECIFIC SERINE PROTEASE 3; BSSP3;MOTOPSIN;NEUROTRYPSIN	Mental retardation, autosomal recessive 1, 249500 (3)
CG4821-PB	606709	NP_003610	1e-76	PRSS12;BSSP3;MRT1	BRAIN-SPECIFIC SERINE PROTEASE 3; BSSP3;MOTOPSIN;NEUROTRYPSIN	Mental retardation, autosomal recessive 1, 249500 (3)
CG4821-PD	606709	NP_003610	1e-76	PRSS12;BSSP3;MRT1	BRAIN-SPECIFIC SERINE PROTEASE 3; BSSP3;MOTOPSIN;NEUROTRYPSIN	Mental retardation, autosomal recessive 1, 249500 (3)
CG10895-PB	604373	NP_009125	1e-76	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10895-PC	604373	NP_009125	1e-76	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1916-PA	603490	NP_110388	1e-76	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG30410-PA	180430	NP_653164	1e-76	RPI;RPIA	RPI	Ribose 5-phosphate isomerase deficiency, 608611 (3)
CG6747-PA	600359	NP_722448	1e-76	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG6747-PA	600359	NP_722449	1e-76	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG6747-PA	600359	NP_722450	1e-76	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG6747-PA	600359	NP_722451	1e-76	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG3837-PA	147670	NP_000199	2e-76	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG9565-PA	110900	NP_000411	2e-76	KEL		[Blood group, Kell] (3)
CG5873-PA	131399	NP_000493	2e-76	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG1411-PC	222748	NP_001376	2e-76	DHP;DPYS		Dihydropyrimidinuria (3)
CG2013-PA	312180	NP_003327	2e-76		HHR6A;RAD6, YEAST, HOMOLOG OF, TYPE A; RAD6A	
CG3536-PA	605080	NP_061971	2e-76	CNGB3;ACHM3		Achromatopsia-3, 262300 (3);Macular degeneration, juvenile, 248200 (3)
CG2070-PA	608830	NP_689656	2e-76	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG9701-PA	604824	NP_710150	2e-76	KL		{Coronary artery disease, susceptibility to} (3)
CG12008-PA	601282	NP_958781	2e-76	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG2165-PA	108740	NP_001672	3e-76	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG2165-PB	108740	NP_001672	3e-76	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG9962-PA	600864	NP_001884	3e-76			
CG2103-PA	601756	NP_004473	3e-76	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG2103-PB	601756	NP_004473	3e-76	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG12286-PA	300095	NP_006508	3e-76	DXS128;SLC16A2;XPCT	2; SLC16A2;DXS128E;MONOCARBOXYLATE TRANSPORTER 8; MCT8;X-LINKED PEST-CONTAINING TRANSPORTER; XPCT	Allan-Herndon-Dudley syndrome, 300523 (3)
CG31782-PA	314995	NP_009061	3e-76	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11780-PA	604327	NP_009186	3e-76	B4GALT7;XGALT1;XGPT1	GALACTOSYLTRANSFERASE I;XGPT1; XGALT1	Ehlers-Danlos syndrome, progeroid form, 130070 (3)
CG9962-PA	600864	NP_620693	3e-76			
CG31782-PA	314995	NP_700359	3e-76	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2165-PA	108740	NP_733765	3e-76	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG2165-PB	108740	NP_733765	3e-76	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG9962-PA	600864	XP_001132734	3e-76			
CG4703-PA	600301	NP_001600	4e-76	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG12530-PA	602049	NP_002863	4e-76	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG12530-PB	602049	NP_002863	4e-76	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG9701-PA	604824	NP_004786	4e-76	KL		{Coronary artery disease, susceptibility to} (3)
CG3985-PC	313440	NP_008881	4e-76	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG3985-PC	313440	NP_598006	4e-76	SYN1	BRAIN PROTEIN 4.1	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)
CG9153-PA	601623	NP_000453	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG9153-PB	601623	NP_000453	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG31632-PA	600871	NP_005254	6e-76	GFI1;ZNF163	ZNF163	Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3);Neutropenia, severe congenital, 202700 (3)
CG8714-PA	138140	NP_006507	6e-76	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG8474-PA	314995	NP_009061	6e-76	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG15095-PA	604322	NP_036566	6e-76	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15095-PB	604322	NP_036566	6e-76	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG9153-PA	601623	NP_570853	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG9153-PB	601623	NP_570853	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG9153-PA	601623	NP_570854	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG9153-PB	601623	NP_570854	6e-76	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8474-PA	314995	NP_700359	6e-76	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6944-PA	150330	NP_733822	6e-76	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG2302-PA	100690	NP_001034612	7e-76	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG3536-PA	600724	NP_001288	7e-76	CNCG2;CNCG3L;CNGB1	CNCG3L;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 2; CNCG2;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 3-LIKE;;GLUTAMIC ACID-RICH PROTEIN 1; GAR1; GARP;RETINAL ROD cGMP-GATED CHANNEL, BETA SUBUNIT;RETINAL ROD cGMP-GATED CHANNEL, GAMMA SUBUNIT	Retinitis pigmentosa, autosomal recessive, 268000 (3)
CG12008-PA	601282	NP_958780	7e-76	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG8778-PA	600529	NP_001689	8e-76	AUH	3-@METHYLGLUTACONYL-CoA HYDRATASE	3-methylglutaconic aciduria, type I, 250950 (3)
CG11348-PA	100690	NP_000070	9e-76	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG14938-PC	300573	NP_001034980	1e-75	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG30491-PA	608830	NP_689656	1e-75	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG12008-PA	601282	NP_958783	1e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG12008-PA	601282	NP_958784	1e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG9441-PA	600225	NP_000152	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PB	600225	NP_000152	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PC	600225	NP_000152	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PA	600225	NP_001019195	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PB	600225	NP_001019195	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PC	600225	NP_001019195	2e-75	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG11033-PA	300560	NP_055922	2e-75	KIAA1111;MRXSSD;PHF8;ZNF422	KIAA1111;ZINC FINGER PROTEIN 422; ZNF422	Mental retardation syndrome, X-linked, Siderius type, 300263 (3)
CG8549-PA	607444	NP_057122	2e-75	SBDS;SDS		Shwachman-Diamond syndrome, 260400 (3)
CG2658-PA	602783	NP_955399	2e-75	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG8464-PA	602194	NP_002766	3e-75		HTRA, E. COLI, HOMOLOG OF; HTRA;PROTEASE, SERINE, 11; PRSS11	
CG3986-PA	600031	NP_003456	3e-75	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG9307-PA	600031	NP_003456	3e-75	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG31045-PB	160740	NP_060004	3e-75	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG31045-PE	160740	NP_060004	3e-75	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG31040-PA	606978	NP_705831	3e-75	CDG2E;COG7		Congenital disorder of glycosylation, type IIe, 608779 (3)
CG5870-PA	601282	NP_958781	3e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG12008-PA	601282	NP_000436	4e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG3322-PA	150325	NP_002283	4e-75	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG18076-PA	604638	NP_004915	4e-75	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG18076-PB	604638	NP_004915	4e-75	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG18076-PE	604638	NP_004915	4e-75	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG18076-PG	604638	NP_004915	4e-75	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG12008-PA	601282	NP_958786	4e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5870-PA	601282	NP_000436	5e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG12008-PA	601282	NP_958782	5e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG12008-PA	601282	NP_958785	5e-75	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG1487-PA	181031	NP_000532	6e-75	SAG	ARRESTIN;S-ARRESTIN	Oguchi disease-1, 258100 (3)
CG17336-PA	137163	NP_000806	6e-75		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG17336-PB	137163	NP_000806	6e-75		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG10895-PB	604373	NP_001005735	6e-75	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10895-PC	604373	NP_001005735	6e-75	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG32843-PA	114131	NP_001733	6e-75	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG3156-PA	603201	NP_003733	6e-75	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG8625-PA	609413	NP_000115	7e-75	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG8625-PB	609413	NP_000115	7e-75	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG8625-PC	609413	NP_000115	7e-75	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG13690-PA	606034	NP_006388	7e-75		RIBONUCLEASE HI, LARGE SUBUNIT;RNase HI, LARGE SUBUNIT	
CG14476-PA	606800	NP_000143	8e-75	GAA	ACID ALPHA-GLUCOSIDASE;ACID MALTASE;ALPHA-1,4-GLUCOSIDASE;ALPHA-GLUCOSIDASE, ACID	Glycogen storage disease II, 232300 (3)
CG14476-PB	606800	NP_000143	8e-75	GAA	ACID ALPHA-GLUCOSIDASE;ACID MALTASE;ALPHA-1,4-GLUCOSIDASE;ALPHA-GLUCOSIDASE, ACID	Glycogen storage disease II, 232300 (3)
CG14476-PC	606800	NP_000143	8e-75	GAA	ACID ALPHA-GLUCOSIDASE;ACID MALTASE;ALPHA-1,4-GLUCOSIDASE;ALPHA-GLUCOSIDASE, ACID	Glycogen storage disease II, 232300 (3)
CG14476-PD	606800	NP_000143	8e-75	GAA	ACID ALPHA-GLUCOSIDASE;ACID MALTASE;ALPHA-1,4-GLUCOSIDASE;ALPHA-GLUCOSIDASE, ACID	Glycogen storage disease II, 232300 (3)
CG14476-PE	606800	NP_000143	8e-75	GAA	ACID ALPHA-GLUCOSIDASE;ACID MALTASE;ALPHA-1,4-GLUCOSIDASE;ALPHA-GLUCOSIDASE, ACID	Glycogen storage disease II, 232300 (3)
CG10537-PB	137192	NP_000805	8e-75	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG10537-PC	137192	NP_000805	8e-75	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG10537-PB	137192	NP_068712	8e-75	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG10537-PC	137192	NP_068712	8e-75	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG8646-PA	253200	NP_942002	8e-75	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG10537-PA	138491	NP_000162	9e-75	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG18076-PA	102574	NP_001095	9e-75	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG18076-PB	102574	NP_001095	9e-75	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG18076-PE	102574	NP_001095	9e-75	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG18076-PG	102574	NP_001095	9e-75	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG10895-PA	604373	NP_009125	9e-75	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG8646-PA	253200	NP_000037	1e-74	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG8905-PA	147460	NP_000627	1e-74		INDOPHENOLOXIDASE B; IPO-B;MANGANESE SUPEROXIDE DISMUTASE; MNSOD;SUPEROXIDE DISMUTASE, MITOCHONDRIAL	
CG10895-PA	604373	NP_001005735	1e-74	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG8905-PA	147460	NP_001019636	1e-74		INDOPHENOLOXIDASE B; IPO-B;MANGANESE SUPEROXIDE DISMUTASE; MNSOD;SUPEROXIDE DISMUTASE, MITOCHONDRIAL	
CG4006-PA	176980	NP_002730	1e-74	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG4006-PB	176980	NP_002730	1e-74	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG4006-PC	176980	NP_002730	1e-74	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG18140-PA	600031	NP_003456	1e-74	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG9887-PA	604322	NP_036566	1e-74	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG17759-PD	139320	NP_536351	1e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PF	139320	NP_536351	1e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG5870-PA	601282	NP_958783	1e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5870-PA	601282	NP_958785	1e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5789-PA	602421	NP_000483	2e-74	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG6844-PA	100720	NP_000742	2e-74	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PB	100720	NP_000742	2e-74	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG8105-PA	171800	NP_001623	2e-74		PLAP;REGAN ISOZYME	
CG5863-PA	116840	NP_001900	2e-74	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG2246-PB	311850	NP_002755	2e-74	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG2246-PD	311850	NP_002755	2e-74	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG2246-PF	311850	NP_002755	2e-74	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG15288-PA	608400	NP_009054	2e-74	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG15288-PB	608400	NP_009054	2e-74	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG4625-PA	602744	NP_055051	2e-74	GNPAT;DHAPAT	ACYL-CoA:DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE;DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; DHAPAT; DAPAT	Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)
CG17759-PA	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PB	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PC	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PE	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PG	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PH	139320	NP_536351	2e-74	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG7293-PA	605995	NP_904325	2e-74	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG4321-PA	608614	NP_997235	2e-74	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG9907-PA	601011	NP_000059	3e-74	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG1762-PA	147557	NP_000204	3e-74	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG1762-PA	147557	NP_001005619	3e-74	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG1762-PA	147557	NP_001005731	3e-74	ITGB4		Epidermolysis bullosa of hands and feet, 131800 (3);Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)
CG7293-PA	605995	NP_055889	3e-74	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG9907-PA	601011	NP_075461	3e-74	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG4049-PA	300032	NP_612115	3e-74	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG4049-PA	300032	NP_000480	4e-74	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG16858-PA	303630	NP_000486	4e-74	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG18255-PA	188840	NP_003310	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PB	188840	NP_003310	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PC	188840	NP_003310	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PF	188840	NP_003310	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG17309-PA	189980	NP_005148	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PB	189980	NP_005148	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PC	189980	NP_005148	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PD	189980	NP_005148	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PE	189980	NP_005148	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PA	189980	NP_009297	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PB	189980	NP_009297	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PC	189980	NP_009297	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PD	189980	NP_009297	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG17309-PE	189980	NP_009297	4e-74	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG16858-PA	303630	NP_203699	4e-74	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG16858-PA	303630	NP_203700	4e-74	ASLN;ATS;COL4A5	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-5 CHAIN	Alport syndrome, 301050 (3)
CG18255-PB	188840	NP_596869	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PF	188840	NP_596869	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PA	188840	NP_597676	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PB	188840	NP_597676	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PC	188840	NP_597676	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PF	188840	NP_597676	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PA	188840	NP_597681	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PB	188840	NP_597681	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PC	188840	NP_597681	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PF	188840	NP_597681	4e-74	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4049-PA	300032	NP_612114	4e-74	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG5044-PA	610690	NP_932164	4e-74	HIBCH	BETA-HYDROXYISOBUTYRUL-COENZYME A HYDROLASE;HIBYL-CoA-H	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
CG5044-PB	610690	NP_932164	4e-74	HIBCH	BETA-HYDROXYISOBUTYRUL-COENZYME A HYDROLASE;HIBYL-CoA-H	3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
CG5870-PA	601282	NP_958780	4e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5870-PA	601282	NP_958782	4e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5870-PA	601282	NP_958784	4e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5870-PA	601282	NP_958786	4e-74	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG10244-PA	134934	NP_000133	5e-74	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10688-PA	601785	NP_000294	5e-74	PMM2;CDG1		Carbohydrate-deficient glycoprotein syndrome, type I, 212065 (3)
CG10244-PA	134934	NP_075254	5e-74	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6969-PA	606765	NP_000538	6e-74	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG6798-PB	118502	NP_000733	6e-74	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG4006-PA	300075	NP_004577	6e-74	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4006-PB	300075	NP_004577	6e-74	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4006-PC	300075	NP_004577	6e-74	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17119-PA	606272	NP_004928	6e-74	CTNS		Cystinosis, atypical nephropathic (3);Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3);Cystinosis, nephropathic, 219800 (3);Cystinosis, ocular nonnephropathic, 219750 (3)
CG17119-PB	606272	NP_004928	6e-74	CTNS		Cystinosis, atypical nephropathic (3);Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3);Cystinosis, nephropathic, 219800 (3);Cystinosis, ocular nonnephropathic, 219750 (3)
CG13772-PA	300336	NP_061850	6e-74	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG6969-PA	606765	NP_783651	6e-74	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG6969-PA	606765	NP_783652	6e-74	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3326-PA	604277	NP_955468	6e-74	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG15288-PA	608400	NP_996816	6e-74	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG15288-PB	608400	NP_996816	6e-74	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG15288-PB	600805	NP_000218	7e-74	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG17119-PA	606272	NP_001026851	7e-74	CTNS		Cystinosis, atypical nephropathic (3);Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3);Cystinosis, nephropathic, 219800 (3);Cystinosis, ocular nonnephropathic, 219750 (3)
CG17119-PB	606272	NP_001026851	7e-74	CTNS		Cystinosis, atypical nephropathic (3);Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3);Cystinosis, nephropathic, 219800 (3);Cystinosis, ocular nonnephropathic, 219750 (3)
CG17596-PA	164731	NP_001617	7e-74	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG3326-PA	604277	NP_055761	7e-74	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG15899-PB	603967	NP_000325	8e-74	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG31045-PB	160741	NP_002463	8e-74	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG31045-PE	160741	NP_002463	8e-74	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG11502-PB	604485	NP_055064	9e-74	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG10537-PB	138491	NP_000162	1e-73	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG10537-PC	138491	NP_000162	1e-73	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG15534-PA	607608	NP_000534	1e-73	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG10537-PA	137192	NP_000805	1e-73	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG6022-PA	300056	NP_005324	1e-73	HCCS;MCOPS7		Microphthalmia, syndromic 7, 309801 (3)
CG9375-PA	190020	NP_005334	1e-73	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG10537-PA	137192	NP_068712	1e-73	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG10244-PA	134935	NP_075252	1e-73	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG31159-PA	606639	NP_079272	1e-73	COXPD1;EFG1;GFM;GFM1	ELONGATION FACTOR G1; EFG; EFG1;GFM	Combined oxidative phosphorylation deficiency 1, 609060 (3)
CG18255-PD	608548	NP_114141	1e-73	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1776-PA	606566	NP_149109	1e-73	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG10595-PA	160777	NP_000250	2e-73	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG1084-PA	308840	NP_000416	2e-73	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG9081-PA	601310	NP_000769	2e-73		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG15666-PA	607968	NP_001028777	2e-73	BBS9;PTHB1	BBS9 GENE; BBS9;PTH-RESPONSIVE B1 GENE; B1; PTHB1	Bardet-Biedl syndrome 9, 209900 (3)
CG10244-PA	134935	NP_002002	2e-73	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG9151-PB	602460	NP_002691	2e-73	BRN3C;POU4F3	BRN3.1, MOUSE, HOMOLOG OF;POU-DOMAIN TRANSCRIPTION FACTOR BRN3C; BRN3C	Deafness, autosomal dominant 15, 602459 (3)
CG12252-PA	604927	NP_004706	2e-73	CCFDN;CTDP1;FCP1	CTD OF POLR2A, PHOSPHATASE OF, SUBUNIT 1;SUBUNIT 1; CTDP1;TFIIF-ASSOCIATING CTD PHOSPHATASE 1;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1, ISOFORM A,;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1, ISOFORM B,;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1; FCP1	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)
CG11121-PA	606326	NP_031400	2e-73	SIX6;MCOPCT2		Microphthalmia, isolated, with cataract 2, 212550 (3)
CG10244-PA	164761	NP_065681	2e-73	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10244-PA	164761	NP_066124	2e-73	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG1084-PA	308840	NP_076493	2e-73	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG3352-PA	605514	NP_149045	2e-73	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG12252-PA	604927	NP_430255	2e-73	CCFDN;CTDP1;FCP1	CTD OF POLR2A, PHOSPHATASE OF, SUBUNIT 1;SUBUNIT 1; CTDP1;TFIIF-ASSOCIATING CTD PHOSPHATASE 1;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1, ISOFORM A,;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1, ISOFORM B,;TRANSCRIPTION FACTOR IIF-ASSOCIATING CTD PHOSPHATASE 1; FCP1	Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)
CG14032-PA	608614	NP_997235	2e-73	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG10244-PA	134935	NP_998812	2e-73	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3057-PA	212138	XP_001133926	2e-73	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG6798-PA	100710	NP_000738	3e-73	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4926-PA	191315	NP_001007793	3e-73	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4926-PA	191315	NP_001012331	3e-73	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4926-PA	600456	NP_001018074	3e-73	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG32538-PB	100690	NP_001034612	3e-73	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6117-PA	164731	NP_001617	3e-73	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6117-PB	164731	NP_001617	3e-73	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6203-PE	309550	NP_002015	3e-73	FMR1;FRAXA	FRAGILE X MENTAL RETARDATION PROTEIN; FMRP	Fragile X syndrome, 300624 (3);Fragile X tremor/ataxia syndrome, 300623 (3)
CG4926-PA	191315	NP_002520	3e-73	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG9151-PA	602460	NP_002691	3e-73	BRN3C;POU4F3	BRN3.1, MOUSE, HOMOLOG OF;POU-DOMAIN TRANSCRIPTION FACTOR BRN3C; BRN3C	Deafness, autosomal dominant 15, 602459 (3)
CG9279-PA	601143	NP_004073	3e-73	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG9279-PB	601143	NP_004073	3e-73	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG4926-PA	600456	NP_006171	3e-73	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14026-PA	601300	NP_064733	3e-73	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PB	601300	NP_064733	3e-73	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PC	601300	NP_064733	3e-73	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG14026-PD	601300	NP_064733	3e-73	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG9279-PA	601143	NP_075408	3e-73	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG9279-PB	601143	NP_075408	3e-73	DCTN1	p150(GLUED), DROSOPHILA, HOMOLOG OF	Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3);{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CG17759-PD	139320	NP_000507	4e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PF	139320	NP_000507	4e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG4206-PA	601806	NP_005906	4e-73	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG6230-PA	610513	NP_071372	4e-73	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG5610-PA	100720	NP_000742	5e-73	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG2835-PB	139340	NP_005263	5e-73	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG3322-PA	600805	NP_937762	5e-73	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG17759-PA	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PB	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PC	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PE	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PG	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PH	139320	NP_000507	6e-73	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2049-PD	164731	NP_001617	6e-73	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG2835-PA	139340	NP_005263	6e-73	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG2835-PC	139340	NP_005263	6e-73	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG17336-PA	138491	NP_000162	7e-73	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG17336-PB	138491	NP_000162	7e-73	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG1721-PA	222800	NP_001715	7e-73	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG1721-PA	222800	NP_954655	7e-73	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG4145-PA	120131	NP_000083	8e-73	COL4A4	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-4 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, familial benign (3)
CG4145-PB	120131	NP_000083	8e-73	COL4A4	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-4 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, familial benign (3)
CG4145-PC	120131	NP_000083	8e-73	COL4A4	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-4 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, familial benign (3)
CG31999-PA	134797	NP_000129	1e-72	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG11898-PA	600509	NP_000343	1e-72	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG3619-PA	600276	NP_000426	1e-72	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG3619-PB	600276	NP_000426	1e-72	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG2191-PA	601843	NP_000444	1e-72	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG5610-PA	100710	NP_000738	1e-72	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG9375-PA	190070	NP_004976	1e-72	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG10236-PA	150310	NP_000219	2e-72	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG10236-PA	150310	NP_001017402	2e-72	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG4007-PA	600456	NP_001018074	2e-72	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG10539-PA	176960	NP_002728	2e-72	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10173-PA	607854	NP_004174	2e-72	BEST1;VMD2	TU15B;VMD2 GENE	Macular dystrophy, vitelliform type, 153700 (3);Maculopathy, bull's-eye, 153870 (3);Vitelliform macular dystrophy, adult-onset, 608161 (3)
CG4007-PA	600456	NP_006171	2e-72	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG2049-PD	605437	NP_006246	2e-72	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG16761-PA	608614	NP_997235	2e-72	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG10474-PA	208400	NP_000018	3e-72	AGA	AGA DEFICIENCY;AGU;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;ASPARTYLGLYCOSAMINURIA;GLYCOASPARAGINASE;GLYCOSYLASPARAGINASE DEFICIENCY	Aspartylglucosaminuria (3)
CG3156-PA	170261	NP_000535	3e-72	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG4859-PA	120353	NP_002412	3e-72	CLG;MMP1	COLLAGENASE, FIBROBLAST; CLG; CLGN;COLLAGENASE, INTERSTITIAL	COPD, rate of decline of lung function in, 606963 (3)
CG4859-PB	120353	NP_002412	3e-72	CLG;MMP1	COLLAGENASE, FIBROBLAST; CLG; CLGN;COLLAGENASE, INTERSTITIAL	COPD, rate of decline of lung function in, 606963 (3)
CG2049-PB	176980	NP_002730	3e-72	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG2049-PC	176980	NP_002730	3e-72	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG2049-PE	176980	NP_002730	3e-72	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG2049-PF	176980	NP_002730	3e-72	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG11121-PA	603714	NP_005404	3e-72	HPE2;SIX3		Holoprosencephaly-2, 157170 (3)
CG30022-PA	608451	NP_055112	3e-72	ETHE1;HSCO;D83198	D83198;HEPATOMA SUBTRACTED CLONE ONE; HSCO	Ethylmalonic encephalopathy, 602473 (3)
CG2060-PA	608614	NP_997235	3e-72	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG5671-PA	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG5671-PB	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG5671-PC	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG5671-PD	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG5671-PE	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG5671-PF	601728	NP_000305	4e-72	MMAC1;PTEN	MUTATED IN MULTIPLE ADVANCED CANCERS 1; MMAC1;PHOSPHATASE AND TENSIN HOMOLOG DELETED ON CHROMOSOME 10;PTEN1	Bannayan-Riley-Ruvalcaba;Bannayan-Zonana syndrome, 153480 (3);Cowden disease, 158350 (3);Endometrial carcinoma (3);Lhermitte-Duclos syndrome (3);Thyroid carcinoma, follicular, 188470 (3);{Prostate cancer}, 176807 (3)
CG4630-PA	603377	NP_003051	4e-72	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG4719-PA	106410	NP_066187	4e-72	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG18255-PE	608548	NP_114141	4e-72	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG32019-PA	606566	NP_149109	4e-72	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG4677-PA	610192	NP_689842	4e-72	GLIS3;ZNF515	GLI-SIMILAR PROTEIN 3;ZINC FINGER PROTEIN 515; ZNF515	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
CG4677-PB	610192	NP_689842	4e-72	GLIS3;ZNF515	GLI-SIMILAR PROTEIN 3;ZINC FINGER PROTEIN 515; ZNF515	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
CG7834-PA	130410	NP_001014763	5e-72	ETFB;MADD		Glutaricaciduria, type IIB, 231680 (3)
CG7834-PB	130410	NP_001014763	5e-72	ETFB;MADD		Glutaricaciduria, type IIB, 231680 (3)
CG4703-PA	607036	NP_002216	5e-72	IVD		Isovaleric acidemia, 243500 (3)
CG9375-PA	164790	NP_002515	5e-72	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG12532-PA	603401	NP_003655	5e-72	AP3B1;ADTB3A;HPS2	ADAPTIN, BETA-3A; ADTB3A;HPS2 GENE; HPS2;PEARL, MOUSE, HOMOLOG OF; PE	Hermansky-Pudlak syndrome 2, 608233 (3)
CG8637-PA	605377	NP_004400	5e-72	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG31045-PB	160710	NP_002462	6e-72	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG31045-PE	160710	NP_002462	6e-72	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG14396-PA	176943	NP_075259	7e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PB	176943	NP_075259	7e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PC	176943	NP_075259	7e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PD	176943	NP_075259	7e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PE	176943	NP_075259	7e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG2204-PB	139320	NP_536351	8e-72	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PD	139320	NP_536351	8e-72	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PE	139320	NP_536351	8e-72	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PF	139320	NP_536351	8e-72	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PG	139320	NP_536351	8e-72	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG14396-PA	176943	NP_000132	9e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PB	176943	NP_000132	9e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PC	176943	NP_000132	9e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PD	176943	NP_000132	9e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG14396-PE	176943	NP_000132	9e-72	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4719-PA	106410	NP_001139	9e-72	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG18076-PC	608441	NP_892006	9e-72	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PE	608441	NP_892006	9e-72	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG6816-PA	124030	NP_000097	1e-71	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG6816-PB	124030	NP_000097	1e-71	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG15533-PA	607608	NP_000534	1e-71	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG11348-PA	100690	NP_001034612	1e-71	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG32451-PA	108733	NP_001674	1e-71	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG32451-PC	108733	NP_001674	1e-71	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG15096-PA	604322	NP_036566	1e-71	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15096-PB	604322	NP_036566	1e-71	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15666-PA	607968	NP_940820	1e-71	BBS9;PTHB1	BBS9 GENE; BBS9;PTH-RESPONSIVE B1 GENE; B1; PTHB1	Bardet-Biedl syndrome 9, 209900 (3)
CG5072-PA	123829	NP_000066	2e-71	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG5072-PB	123829	NP_000066	2e-71	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG5072-PC	123829	NP_000066	2e-71	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG32495-PD	601002	NP_000169	2e-71	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG4685-PA	602733	NP_000687	2e-71		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG10539-PA	605437	NP_006246	2e-71	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG7223-PA	164761	NP_065681	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7223-PB	164761	NP_065681	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7223-PC	164761	NP_065681	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7223-PA	164761	NP_066124	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7223-PB	164761	NP_066124	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7223-PC	164761	NP_066124	2e-71	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG9375-PA	190070	NP_203524	2e-71	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG2065-PA	608830	NP_689656	2e-71	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG2062-PA	608614	NP_997235	2e-71	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG31090-PA	601843	NP_000444	3e-71	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG6863-PA	602997	NP_001072	3e-71	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG6863-PB	602997	NP_001072	3e-71	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG8417-PA	154550	NP_002426	3e-71	MPI;PMI1	PHOSPHOMANNOSE ISOMERASE 1; PMI1; PMI	Carbohydrate-deficient glycoprotein syndrome, type Ib, 602579 (3)
CG5719-PA	108961	NP_003986	3e-71	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG11202-PA	602054	NP_005983	3e-71	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG33103-PA	604539	NP_055059	3e-71	ADAMTS2;NPI	1 MOTIF, 2; ADAMTS2;PROCOLLAGEN I N-PROTEINASE; NPI	Ehlers-Danlos syndrome, type VIIC, 225410 (3)
CG33103-PB	604539	NP_055059	3e-71	ADAMTS2;NPI	1 MOTIF, 2; ADAMTS2;PROCOLLAGEN I N-PROTEINASE; NPI	Ehlers-Danlos syndrome, type VIIC, 225410 (3)
CG31009-PA	605516	NP_071407	3e-71	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG11202-PA	602054	NP_542377	3e-71	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG2064-PA	608830	NP_689656	3e-71	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG6879-PA	606765	NP_000538	4e-71	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG17645-PA	222800	NP_001715	4e-71	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG11202-PA	602054	NP_542378	4e-71	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6879-PA	606765	NP_783651	4e-71	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG6879-PA	606765	NP_783652	4e-71	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG17645-PA	222800	NP_954655	4e-71	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG6127-PA	604210	NP_957705	4e-71	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG8791-PA	604322	NP_036566	5e-71	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG14396-PA	136350	NP_075593	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PB	136350	NP_075593	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PC	136350	NP_075593	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PD	136350	NP_075593	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PE	136350	NP_075593	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PA	136350	NP_075594	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PB	136350	NP_075594	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PC	136350	NP_075594	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PD	136350	NP_075594	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PE	136350	NP_075594	5e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18734-PA	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG18734-PB	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG18734-PC	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG18734-PD	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG18734-PE	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG18734-PF	607830	NP_079350	5e-71	FRAS1	FRAS1;KIAA1500	Fraser syndrome, 219000 (3)
CG10119-PA	150341	NP_116126	5e-71	LMNB2;LMN2		Lipodystrophy, partial, acquired, 608709 (3)
CG12002-PA	606765	NP_783653	5e-71	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3632-PA	603557	NP_958435	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PC	603557	NP_958435	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PD	603557	NP_958435	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PA	603557	NP_958438	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PC	603557	NP_958438	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PD	603557	NP_958438	5e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG6214-PB	602421	NP_000483	6e-71	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG13095-PA	116840	NP_001900	6e-71	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG14396-PA	136350	NP_056934	6e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PB	136350	NP_056934	6e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PC	136350	NP_056934	6e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PD	136350	NP_056934	6e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PE	136350	NP_056934	6e-71	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG3632-PA	603557	NP_057240	6e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PC	603557	NP_057240	6e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG3632-PD	603557	NP_057240	6e-71	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG32465-PB	300427	NP_065793	6e-71	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG18076-PC	608441	NP_149062	6e-71	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PE	608441	NP_149062	6e-71	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG32465-PB	300427	NP_851849	6e-71	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG1891-PA	601300	NP_064733	7e-71	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG1891-PB	601300	NP_064733	7e-71	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG2204-PA	139320	NP_536351	7e-71	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PC	139320	NP_536351	7e-71	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG5610-PA	100725	NP_000071	9e-71	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6486-PA	601757	NP_000279	9e-71	PEX7;RCDP1	PEROXIN 7;PEROXISOMAL PTS2 RECEPTOR	Refsum disease, 266500 (3);Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)
CG16858-PA	120130	NP_001836	9e-71	COL4A1	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-1 CHAIN	Brain small vessel disease with hemorrhage, 607595 (3);Porencephaly, 175780 (3)
CG1494-PA	601615	NP_001080	1e-70	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG9317-PA	603377	NP_003051	1e-70	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG10522-PA	605377	NP_004400	1e-70	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG1628-PB	603861	NP_055067	1e-70	HHH;ORNT1;SLC25A15	MEMBER 15; SLC25A15;ORNITHINE TRANSPORTER, MITOCHONDRIAL, 1; ORNT1	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)
CG32134-PA	164761	NP_065681	1e-70	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG32134-PA	164761	NP_066124	1e-70	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10642-PA	605995	NP_904325	1e-70	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG10755-PA	608614	NP_997235	1e-70	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG16858-PA	120070	NP_000082	2e-70	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG1819-PA	601691	NP_000341	2e-70	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG6214-PA	602421	NP_000483	2e-70	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG1824-PA	170261	NP_000535	2e-70	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG4685-PA	100650	NP_000681	2e-70	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG6798-PB	118504	NP_000735	2e-70	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG6508-PA	116840	NP_001900	2e-70	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG32134-PA	191306	NP_002244	2e-70	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG9317-PA	604190	NP_003050	2e-70	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG7061-PA	609275	NP_036546	2e-70	KIAA0839;p150;RAB3GAP150;RAB3GAP2	KIAA0839;p150;RAB3GAP, 150-KD SUBUNIT; RAB3GAP150	Martsolf syndrome, 212720 (3)
CG10642-PA	605995	NP_055889	2e-70	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG8302-PA	608614	NP_997235	2e-70	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG33196-PB	601920	NP_000205	3e-70	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG2204-PB	139320	NP_000507	3e-70	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PD	139320	NP_000507	3e-70	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PE	139320	NP_000507	3e-70	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PF	139320	NP_000507	3e-70	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PG	139320	NP_000507	3e-70	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG1824-PA	170260	NP_000584	3e-70	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG18076-PA	608441	NP_892006	3e-70	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PB	608441	NP_892006	3e-70	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PG	608441	NP_892006	3e-70	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG4879-PA	604610	NP_000048	4e-70	BLM;BS;RECQ2;RECQL3	BLM GENE; BLM;DNA HELICASE, RECQ-LIKE, TYPE 2; RECQ2	Bloom syndrome, 210900 (3)
CG4879-PB	604610	NP_000048	4e-70	BLM;BS;RECQ2;RECQL3	BLM GENE; BLM;DNA HELICASE, RECQ-LIKE, TYPE 2; RECQ2	Bloom syndrome, 210900 (3)
CG9071-PA	114208	NP_000060	4e-70	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG9071-PB	114208	NP_000060	4e-70	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG3656-PA	601310	NP_000769	4e-70		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG3954-PB	176876	NP_002825	4e-70	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG3954-PC	176876	NP_002825	4e-70	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG3790-PA	604190	NP_003050	4e-70	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG8367-PA	314995	NP_009061	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PB	314995	NP_009061	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PC	314995	NP_009061	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PD	314995	NP_009061	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PA	314995	NP_700359	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PB	314995	NP_700359	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PC	314995	NP_700359	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8367-PD	314995	NP_700359	4e-70	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4105-PA	608614	NP_997235	4e-70	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG1438-PA	601310	NP_000769	5e-70		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG15666-PA	607968	NP_001028776	5e-70	BBS9;PTHB1	BBS9 GENE; BBS9;PTH-RESPONSIVE B1 GENE; B1; PTHB1	Bardet-Biedl syndrome 9, 209900 (3)
CG8190-PA	606273	NP_065098	5e-70	EIF2B3	EIF2B-GAMMA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, GAMMA	Leukoencephalopathy with vanishing white matter, 603896 (3)
CG2165-PA	108730	NP_004311	6e-70	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG2165-PB	108730	NP_004311	6e-70	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG2165-PA	108730	NP_775293	6e-70	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG2165-PB	108730	NP_775293	6e-70	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG3692-PA	114240	NP_997630	6e-70	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG3733-PA	609413	NP_000115	7e-70	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG5942-PA	609413	NP_000115	7e-70	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG5942-PB	609413	NP_000115	7e-70	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG5942-PC	609413	NP_000115	7e-70	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG5942-PD	609413	NP_000115	7e-70	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG14396-PA	134934	NP_075254	7e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PB	134934	NP_075254	7e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PC	134934	NP_075254	7e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PD	134934	NP_075254	7e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PE	134934	NP_075254	7e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PA	134934	NP_000133	8e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PB	134934	NP_000133	8e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PC	134934	NP_000133	8e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PD	134934	NP_000133	8e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14396-PE	134934	NP_000133	8e-70	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14043-PA	609367	NP_056449	8e-70	KIAA1279		Goldberg-Shprintzen megacolon syndrome, 609460 (3)
CG9176-PB	605080	NP_061971	8e-70	CNGB3;ACHM3		Achromatopsia-3, 262300 (3);Macular degeneration, juvenile, 248200 (3)
CG9176-PC	605080	NP_061971	8e-70	CNGB3;ACHM3		Achromatopsia-3, 262300 (3);Macular degeneration, juvenile, 248200 (3)
CG5220-PA	300499	NP_803183	8e-70	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG5220-PA	300499	NP_803188	8e-70	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG4665-PA	261630	NP_000311	9e-70	DHPR;QDPR	DIHYDROPTERIDINE REDUCTASE DEFICIENCY; DHPR DEFICIENCY;PKU, ATYPICAL;PKU2;QDPR DEFICIENCY;QUINOID DIHYDROPTERIDINE REDUCTASE DEFICIENCY	Phenylketonuria due to dihydropteridine reductase deficiency (3)
CG14670-PA	609018	NP_000402	9e-70	HCS;HLCS	HCS	Holocarboxylase synthetase deficiency, 253270 (3)
CG18255-PG	188840	NP_003310	9e-70	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PG	188840	NP_597676	9e-70	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PG	188840	NP_597681	9e-70	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5485-PA	606718	NP_000103	1e-69	D5S1708;DTD;DTDST;EDM4;SLC26A2	DTD SULFATE TRANSPORTER; DTDST	Achondrogenesis Ib, 600972 (3);Atelosteogenesis II, 256050 (3);Diastrophic dysplasia, 222600 (3);Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3);Epiphyseal dysplasia, multiple, 4, 226900 (3)
CG11198-PA	232000	NP_000273	1e-69	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG11198-PB	232000	NP_000273	1e-69	PCCA	pccA COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG8451-PA	601843	NP_000444	1e-69	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG4379-PA	164731	NP_001617	1e-69	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4379-PB	164731	NP_001617	1e-69	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG14396-PA	134935	NP_002002	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PB	134935	NP_002002	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PC	134935	NP_002002	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PD	134935	NP_002002	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PE	134935	NP_002002	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7293-PA	602821	NP_004975	1e-69	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG17036-PA	603941	NP_008927	1e-69	SLC19A2;THTR1	THIAMINE TRANSPORTER PROTEIN 1; THTR1	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)
CG7123-PA	608400	NP_009054	1e-69	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG7123-PB	608400	NP_009054	1e-69	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG14396-PA	134935	NP_075252	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PB	134935	NP_075252	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PC	134935	NP_075252	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PD	134935	NP_075252	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PE	134935	NP_075252	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8891-PA	147520	NP_258412	1e-69	ITPA	INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE	[Inosine triphosphatase deficiency] (3)
CG18255-PG	188840	NP_596869	1e-69	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG14396-PA	134935	NP_998812	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PB	134935	NP_998812	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PC	134935	NP_998812	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PD	134935	NP_998812	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PE	134935	NP_998812	1e-69	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG9907-PA	114208	NP_000060	2e-69	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG11348-PA	100725	NP_000071	2e-69	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4370-PA	600359	NP_000211	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PB	600359	NP_000211	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG2204-PA	139320	NP_000507	2e-69	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PC	139320	NP_000507	2e-69	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG8908-PA	601615	NP_001080	2e-69	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG4881-PA	602218	NP_002959	2e-69	HSAL1;SALL1;TBS	HSAL1	Townes-Brocks branchiootorenal-like syndrome, 107480 (3);Townes-Brocks syndrome, 107480 (3)
CG4881-PB	602218	NP_002959	2e-69	HSAL1;SALL1;TBS	HSAL1	Townes-Brocks branchiootorenal-like syndrome, 107480 (3);Townes-Brocks syndrome, 107480 (3)
CG6574-PA	603941	NP_008927	2e-69	SLC19A2;THTR1	THIAMINE TRANSPORTER PROTEIN 1; THTR1	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)
CG18076-PA	608441	NP_149062	2e-69	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PB	608441	NP_149062	2e-69	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PG	608441	NP_149062	2e-69	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG4370-PA	600359	NP_722448	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PB	600359	NP_722448	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PA	600359	NP_722449	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PB	600359	NP_722449	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PA	600359	NP_722450	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PB	600359	NP_722450	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PA	600359	NP_722451	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG4370-PB	600359	NP_722451	2e-69	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG1977-PA	102574	NP_001095	3e-69	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG17309-PA	190090	NP_005408	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PB	190090	NP_005408	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PC	190090	NP_005408	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PD	190090	NP_005408	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PE	190090	NP_005408	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG15899-PB	182389	NP_008851	3e-69	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG11895-PA	605514	NP_149045	3e-69	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG17309-PA	190090	NP_938033	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PB	190090	NP_938033	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PC	190090	NP_938033	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PD	190090	NP_938033	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG17309-PE	190090	NP_938033	3e-69	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG2835-PB	139330	NP_000163	4e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5594-PA	600839	NP_000329	4e-69	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG5594-PB	600839	NP_000329	4e-69	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG5594-PC	600839	NP_000329	4e-69	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG5594-PD	600839	NP_000329	4e-69	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG2049-PD	176960	NP_002728	4e-69	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG1512-PA	300304	NP_003579	4e-69	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG1512-PB	300304	NP_003579	4e-69	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG1707-PA	138750	NP_006699	4e-69	GLO1		{Autism, susceptibility to}, 209850 (3)
CG8571-PA	601023	NP_009057	4e-69	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10236-PA	150292	NP_061486	4e-69	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG2835-PB	139330	NP_653082	4e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG8930-PA	136435	NP_852111	4e-69	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PB	136435	NP_852111	4e-69	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PC	136435	NP_852111	4e-69	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PD	136435	NP_852111	4e-69	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG8930-PE	136435	NP_852111	4e-69	FSHR;ODG1	FSH RECEPTOR	Ovarian dysgenesis 1, 233300 (3);Ovarian hyperstimulation syndrome, 608115 (3);Ovarian response to FSH stimulation, 276400 (3);Ovarian sex cord tumors (3)
CG17461-PA	605995	NP_904325	4e-69	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG7123-PA	608400	NP_996816	4e-69	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG7123-PB	608400	NP_996816	4e-69	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG15088-PA	608893	NP_001003841	5e-69	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG8222-PA	164770	NP_005202	5e-69	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG8222-PB	164770	NP_005202	5e-69	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG8222-PC	164770	NP_005202	5e-69	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG10236-PA	150292	NP_005553	5e-69	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG5220-PA	300499	NP_036412	5e-69	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG2835-PA	139330	NP_000163	6e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2835-PC	139330	NP_000163	6e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG7660-PB	606989	NP_000241	6e-69	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG17461-PA	605995	NP_055889	6e-69	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG2835-PA	139330	NP_653082	6e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2835-PC	139330	NP_653082	6e-69	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG6868-PA	602997	NP_001072	7e-69	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG17336-PA	137140	NP_000798	8e-69	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG17336-PB	137140	NP_000798	8e-69	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG3322-PA	142461	NP_005520	8e-69	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG12232-PA	139320	NP_536351	8e-69	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG6798-PB	118507	NP_000739	9e-69	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG1698-PA	608893	NP_001003841	9e-69	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG10843-PA	608614	NP_997235	9e-69	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG5582-PA	607042	NP_000077	1e-68	CLN3;BTS	BATTENIN	Ceroid-lipofuscinosis, neuronal-3, juvenile, 204200 (3)
CG2302-PA	100720	NP_000742	1e-68	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6816-PA	124040	NP_000764	1e-68		CYP2E1;ETHANOL-INDUCIBLE P450;P450C2E	
CG6816-PB	124040	NP_000764	1e-68		CYP2E1;ETHANOL-INDUCIBLE P450;P450C2E	
CG7904-PA	190182	NP_001020018	1e-68	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14526-PA	600423	NP_001388	1e-68	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG7558-PA	102560	NP_001605	1e-68	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG7180-PA	151460	NP_002829	1e-68	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG3790-PA	603377	NP_003051	1e-68	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG7904-PA	190182	NP_003233	1e-68	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG4859-PA	604629	NP_004762	1e-68	MMP20	ENAMELYSIN	Amelogenesis imperfecta, pigmented hypomaturation type, 204700 (3)
CG4859-PB	604629	NP_004762	1e-68	MMP20	ENAMELYSIN	Amelogenesis imperfecta, pigmented hypomaturation type, 204700 (3)
CG8977-PA	610150	NP_036205	1e-68	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG8977-PB	610150	NP_036205	1e-68	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG15666-PA	607968	NP_055266	1e-68	BBS9;PTHB1	BBS9 GENE; BBS9;PTH-RESPONSIVE B1 GENE; B1; PTHB1	Bardet-Biedl syndrome 9, 209900 (3)
CG11466-PA	124010	NP_059488	1e-68		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7180-PA	151460	NP_563578	1e-68	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG7180-PA	151460	NP_563579	1e-68	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG9071-PA	601011	NP_000059	2e-68	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG9071-PB	601011	NP_000059	2e-68	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG3736-PA	609413	NP_000115	2e-68	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG4894-PA	603967	NP_000325	2e-68	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG4894-PB	603967	NP_000325	2e-68	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG4894-PD	603967	NP_000325	2e-68	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG10580-PA	602576	NP_001035257	2e-68	LFNG;SCDO3	FRINGE, DROSOPHILA, HOMOLOG OF, LUNATIC	Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)
CG7558-PA	102630	NP_001092	2e-68		BETA-ACTIN	
CG15899-PB	603415	NP_002968	2e-68	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG9071-PA	601011	NP_075461	2e-68	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG9071-PB	601011	NP_075461	2e-68	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG32191-PA	253200	NP_942002	2e-68	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG32191-PA	253200	NP_000037	3e-68	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG10595-PA	276903	NP_000251	3e-68	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG17336-PA	137160	NP_000797	3e-68	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG17336-PB	137160	NP_000797	3e-68	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG2014-PA	601825	NP_077718	3e-68	NDUFS7;PSST	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 20-KD SUBUNIT;NADH-COENZYME Q REDUCTASE, 20-KD;PSST	Leigh syndrome, 256000 (3)
CG9172-PA	601825	NP_077718	3e-68	NDUFS7;PSST	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 20-KD SUBUNIT;NADH-COENZYME Q REDUCTASE, 20-KD;PSST	Leigh syndrome, 256000 (3)
CG9172-PB	601825	NP_077718	3e-68	NDUFS7;PSST	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 20-KD SUBUNIT;NADH-COENZYME Q REDUCTASE, 20-KD;PSST	Leigh syndrome, 256000 (3)
CG1864-PB	601828	NP_775264	3e-68	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG1864-PC	601828	NP_775264	3e-68	NOT;NR4A2;NURR1;TINUR	NUCLEAR RECEPTOR OF T CELLS; NOT;NUCLEAR RECEPTOR-RELATED 1; NURR1;TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR; TINUR	{Parkinson disease}, 168600 (3)
CG7586-PA	103950	NP_000005	4e-68	A2M	MACROGLOBULIN, ALPHA-2	Emphysema due to alpha-2-macroglobulin deficiency (1);{Alzheimer disease, susceptibility to}, 104300 (3)
CG15110-PA	608210	NP_000392	4e-68	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG1732-PB	608893	NP_001003841	4e-68	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG11377-PA	607170	NP_001026887	4e-68	AVSD2;CRELD1	CIRRIN	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3);{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)
CG11377-PA	607170	NP_056328	4e-68	AVSD2;CRELD1	CIRRIN	Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3);{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)
CG33102-PA	142600	NP_277031	4e-68	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG33102-PA	142600	NP_277032	4e-68	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG33102-PA	142600	NP_277033	4e-68	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG33102-PA	142600	NP_277035	4e-68	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG15110-PA	608210	NP_997005	4e-68	EXT2		Exostoses, multiple, type 2, 133701 (3)
CG6297-PA	164731	NP_001617	5e-68	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6297-PB	164731	NP_001617	5e-68	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG17678-PA	139360	NP_002061	5e-68	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG10119-PA	150330	NP_005563	5e-68	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG17697-PB	604579	NP_036325	5e-68	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG10119-PA	150330	NP_733821	6e-68	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG18076-PH	608441	NP_892006	6e-68	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG6844-PA	100725	NP_000071	7e-68	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PB	100725	NP_000071	7e-68	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG3696-PA	609413	NP_000115	7e-68	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG7883-PA	606686	NP_001405	7e-68	EIF2B1;EIF2BA	EIF2B-ALPHA;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, ALPHA	Leukoencephalopathy with vanishing white matter, 603896 (3)
CG17759-PD	139320	NP_536350	7e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PF	139320	NP_536350	7e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG9623-PA	607759	NP_000410	8e-68	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG15088-PB	608893	NP_001003841	8e-68	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG13334-PA	150100	NP_002291	8e-68	LDHB	LDH, SUBUNIT H	Lactate dehydrogenase-B deficiency (3)
CG31536-PC	130500	NP_004428	9e-68	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9907-PA	300110	NP_005174	9e-68	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG7749-PA	605514	NP_149045	9e-68	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG17759-PA	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PB	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PC	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PE	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PG	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17759-PH	139320	NP_536350	9e-68	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG8823-PA	278000	NP_000226	1e-67	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG17134-PA	179820	NP_000528	1e-67	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG15279-PA	608893	NP_001003841	1e-67	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG15279-PB	608893	NP_001003841	1e-67	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG7904-PA	600799	NP_001195	1e-67	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG4007-PA	191315	NP_002520	1e-67	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG9764-PA	130500	NP_004428	1e-67	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG15899-PB	300110	NP_005174	1e-67	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG6422-PA	610640	NP_057342	1e-67	YTHDF2		{Longevity, susceptibility to}, 152430 (3)
CG6422-PB	610640	NP_057342	1e-67	YTHDF2		{Longevity, susceptibility to}, 152430 (3)
CG3842-PA	608830	NP_689656	1e-67	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG31536-PC	130500	NP_976217	1e-67	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9764-PA	130500	NP_976217	1e-67	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG3902-PA	606885	NP_000008	2e-67	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG33102-PA	142600	NP_000179	2e-67	HK1		Hemolytic anemia due to hexokinase deficiency (3)
CG1464-PA	607108	NP_000271	2e-67	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG2331-PA	601498	NP_000278	2e-67	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG7660-PB	606765	NP_000538	2e-67	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3156-PA	170260	NP_000584	2e-67	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG7535-PB	137140	NP_000798	2e-67	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG4007-PA	191315	NP_001007793	2e-67	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4007-PA	191315	NP_001012331	2e-67	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7558-PA	102610	NP_001091	2e-67	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG10642-PA	602821	NP_004975	2e-67	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG31213-PA	600046	NP_005493	2e-67	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG9527-PA	609751	NP_009223	2e-67	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG1167-PA	600098	NP_036382	2e-67	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG3903-PA	300427	NP_065793	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PC	300427	NP_065793	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PD	300427	NP_065793	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PE	300427	NP_065793	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG7660-PB	606765	NP_783651	2e-67	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7660-PB	606765	NP_783652	2e-67	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3903-PA	300427	NP_851849	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PC	300427	NP_851849	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PD	300427	NP_851849	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PE	300427	NP_851849	2e-67	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG6730-PA	608614	NP_997235	2e-67	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG4860-PA	607008	NP_000007	3e-67	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG8103-PA	609413	NP_000115	3e-67	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG8850-PA	608893	NP_001003841	3e-67	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG8850-PB	608893	NP_001003841	3e-67	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG3725-PA	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PB	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PC	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PD	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PE	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PF	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PG	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PH	108733	NP_001674	3e-67	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG11339-PA	130500	NP_004428	3e-67	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG7558-PA	102540	NP_005150	3e-67	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG9071-PA	300110	NP_005174	3e-67	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG9071-PB	300110	NP_005174	3e-67	CACNA1F;CORDX3;CSNB2;CSNB2A		Cone-rod dystrophy, X-linked, 3, 300476 (3);Night blindness, congenital stationary, X-linked, type 2, 300071 (3)
CG11348-PA	100730	NP_005190	3e-67	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG15094-PA	604322	NP_036566	3e-67	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15094-PB	604322	NP_036566	3e-67	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG8453-PA	124010	NP_059488	3e-67		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG31045-PB	608568	NP_079005	3e-67	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG31045-PE	608568	NP_079005	3e-67	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG17800-PC	608548	NP_114141	3e-67	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7981-PA	600805	NP_937762	3e-67	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG7981-PB	600805	NP_937762	3e-67	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG7981-PC	600805	NP_937762	3e-67	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG7981-PD	600805	NP_937762	3e-67	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG7981-PE	600805	NP_937762	3e-67	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG11339-PA	130500	NP_976217	3e-67	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG2331-PA	602136	NP_000457	4e-67	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG12232-PA	139320	NP_000507	4e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG17678-PA	139340	NP_005263	4e-67	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG3903-PA	300336	NP_061850	4e-67	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG3903-PC	300336	NP_061850	4e-67	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG3903-PD	300336	NP_061850	4e-67	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG3903-PE	300336	NP_061850	4e-67	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG18076-PH	608441	NP_149062	4e-67	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG2204-PA	139320	NP_536350	4e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PC	139320	NP_536350	4e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG9623-PB	147556	NP_000201	5e-67	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG10119-PA	150330	NP_733822	5e-67	CMD1A;EMD2;FPLD;HGPS;LGMD1B;LMN1;LMNA	LAMIN A;LAMIN C; LMNC	Cardiomyopathy, dilated, 1A, 115200 (3);Charcot-Marie-Tooth disease,;Emery-Dreifuss muscular dystrophy, AD, 181350 (3);Emery-Dreifuss muscular dystrophy, AR, 604929 (3);Lipodystrophy, familial partial, 151660 (3)
CG9594-PA	609413	NP_000115	6e-67	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG6113-PA	278000	NP_000226	6e-67	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG8523-PA	601107	NP_000383	6e-67	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG12598-PA	601059	NP_056655	6e-67	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG12598-PB	601059	NP_056655	6e-67	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG5058-PB	608576	NP_079191	6e-67	DFNA28;TFCP2L3	BROTHER OF GRAINYHEAD; BOM;GRAINYHEAD, DROSOPHILA, HOMOLOG OF, 2;TRANSCRIPTION FACTOR CP2-LIKE 3; TFCP2L3	Deafness, autosomal dominant 28, 608641 (3)
CG5058-PC	608576	NP_079191	6e-67	DFNA28;TFCP2L3	BROTHER OF GRAINYHEAD; BOM;GRAINYHEAD, DROSOPHILA, HOMOLOG OF, 2;TRANSCRIPTION FACTOR CP2-LIKE 3; TFCP2L3	Deafness, autosomal dominant 28, 608641 (3)
CG2204-PB	139320	NP_536350	6e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PD	139320	NP_536350	6e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PE	139320	NP_536350	6e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PF	139320	NP_536350	6e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2204-PG	139320	NP_536350	6e-67	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG4173-PA	604061	NP_006631	7e-67	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG3022-PB	607340	NP_005449	8e-67	GPR51;GABBR2	G PROTEIN-COUPLED RECEPTOR 51; GPR51;GABA-B RECEPTOR, R2 SUBUNIT; GABABR2	{Nicotine dependence, susceptibility to}, 188890 (3)
CG17800-PD	608548	NP_114141	8e-67	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG4703-PA	607008	NP_000007	9e-67	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG10011-PA	106410	NP_066187	9e-67	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG6798-PA	100725	NP_000071	1e-66	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG15899-PB	600163	NP_000326	1e-66	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG8714-PA	138190	NP_001033	1e-66	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG2835-PA	139360	NP_002061	1e-66	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG2835-PC	139360	NP_002061	1e-66	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17544-PA	609751	NP_004026	1e-66	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG17544-PB	609751	NP_004026	1e-66	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG17544-PC	609751	NP_004026	1e-66	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG14791-PC	603868	NP_004571	1e-66	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG10595-PA	600970	NP_004990	1e-66	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG5133-PA	601621	NP_005987	1e-66	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG32245-PC	604766	NP_055440	1e-66	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG11228-PA	606808	NP_059129	1e-66	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG3903-PB	300336	NP_061850	1e-66	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG14791-PC	603868	NP_899057	1e-66	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG14791-PC	603868	NP_899058	1e-66	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG14791-PC	603868	NP_899059	1e-66	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG15899-PB	600163	NP_932173	1e-66	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG3656-PB	601310	NP_000769	2e-66		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG10011-PA	106410	NP_001139	2e-66	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG7052-PA	120900	NP_001726	2e-66	C5		C5 deficiency (1)
CG3902-PA	607036	NP_002216	2e-66	IVD		Isovaleric acidemia, 243500 (3)
CG17596-PA	176960	NP_002728	2e-66	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG7061-PB	609275	NP_036546	2e-66	KIAA0839;p150;RAB3GAP150;RAB3GAP2	KIAA0839;p150;RAB3GAP, 150-KD SUBUNIT; RAB3GAP150	Martsolf syndrome, 212720 (3)
CG10207-PA	604322	NP_036566	2e-66	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG32245-PB	604766	NP_055440	2e-66	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG31543-PA	606425	NP_071334	2e-66	C1orf12;ECYT3;EGLN1;HIFPH2;PHD2;SM20;ZMYND6	CHROMOSOME 1 OPEN READING FRAME 12; C1ORF12;HIF-PROLYL HYDROXYLASE 2; HIFPH2; HPH2;PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2; PHD2;SM20, RAT, HOMOLOG OF; SM20;ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 6; ZMYND6	Erythrocytosis, familial, 3, 609820 (3)
CG31543-PC	606425	NP_071334	2e-66	C1orf12;ECYT3;EGLN1;HIFPH2;PHD2;SM20;ZMYND6	CHROMOSOME 1 OPEN READING FRAME 12; C1ORF12;HIF-PROLYL HYDROXYLASE 2; HIFPH2; HPH2;PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2; PHD2;SM20, RAT, HOMOLOG OF; SM20;ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 6; ZMYND6	Erythrocytosis, familial, 3, 609820 (3)
CG12232-PA	139320	NP_536350	2e-66	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG2835-PB	139360	NP_002061	3e-66	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG4860-PA	607036	NP_002216	3e-66	IVD		Isovaleric acidemia, 243500 (3)
CG7003-PA	600887	NP_002430	3e-66	MSH3		Endometrial carcinoma (3)
CG1228-PA	130500	NP_004428	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PC	130500	NP_004428	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PD	130500	NP_004428	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9331-PA	604296	NP_036335	3e-66	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG9331-PB	604296	NP_036335	3e-66	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG9331-PC	604296	NP_036335	3e-66	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG9331-PD	604296	NP_036335	3e-66	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG32245-PA	604766	NP_055440	3e-66	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG31543-PB	606425	NP_071334	3e-66	C1orf12;ECYT3;EGLN1;HIFPH2;PHD2;SM20;ZMYND6	CHROMOSOME 1 OPEN READING FRAME 12; C1ORF12;HIF-PROLYL HYDROXYLASE 2; HIFPH2; HPH2;PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2; PHD2;SM20, RAT, HOMOLOG OF; SM20;ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 6; ZMYND6	Erythrocytosis, familial, 3, 609820 (3)
CG30495-PA	608830	NP_689656	3e-66	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG1228-PA	130500	NP_976217	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PC	130500	NP_976217	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PD	130500	NP_976217	3e-66	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG7660-PA	606989	NP_000241	4e-66	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG5670-PA	108733	NP_001674	4e-66	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PB	108733	NP_001674	4e-66	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PC	108733	NP_001674	4e-66	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PD	108733	NP_001674	4e-66	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG8885-PA	603644	NP_004580	4e-66	SCO1;SCOD1	CYTOCHROME OXIDASE-DEFICIENT 1, S. CEREVISIAE, HOMOLOG OF; SCOD1	Hepatic failure, early onset, and neurologic disorder (3)
CG18455-PA	601205	NP_005973	4e-66	BOS3;DFNA23;SIX1		Brachiootic syndrome 3, 608389 (3);Deafness, autosomal dominant 23, 605192 (3)
CG18405-PA	608166	NP_036563	4e-66	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG17150-PC	603335	NP_001360	5e-66	CILD3;DNAH5;HL1;PCD	HL1	Ciliary dyskinesia, primary, 3 608644 (3);Kartagener syndrome, 244400 (3)
CG7779-PA	605080	NP_061971	5e-66	CNGB3;ACHM3		Achromatopsia-3, 262300 (3);Macular degeneration, juvenile, 248200 (3)
CG17596-PA	605437	NP_006246	6e-66	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG11641-PA	609062	NP_009183	6e-66	POU6F2;WT5;WTSL	RETINA-DERIVED POU-DOMAIN FACTOR 1; RPF1	{Wilms tumor susceptibility-5}, 601583 (3)
CG3466-PA	601310	NP_000769	7e-66		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG3903-PB	300427	NP_065793	7e-66	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3903-PB	300427	NP_851849	7e-66	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG8474-PA	300573	NP_001034980	8e-66	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG7033-PA	610150	NP_036205	8e-66	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG7033-PB	610150	NP_036205	8e-66	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG7033-PC	610150	NP_036205	8e-66	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG17800-PA	608548	NP_114141	8e-66	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG17800-PB	608548	NP_114141	8e-66	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG3632-PA	300415	NP_000243	9e-66	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG3632-PC	300415	NP_000243	9e-66	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG3632-PD	300415	NP_000243	9e-66	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG18802-PA	609458	NP_000519	9e-66	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG6816-PA	601129	NP_000761	9e-66	CYP2C8		Rhabdomyolysis, cerivastatin-induced (3)
CG6816-PB	601129	NP_000761	9e-66	CYP2C8		Rhabdomyolysis, cerivastatin-induced (3)
CG7882-PA	138140	NP_006507	9e-66	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG7882-PB	138140	NP_006507	9e-66	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG12010-PB	601023	NP_009057	9e-66	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG17678-PA	139330	NP_000163	1e-65	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG10702-PA	147670	NP_000199	1e-65	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG10702-PB	147670	NP_000199	1e-65	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG10702-PC	147670	NP_000199	1e-65	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG6504-PA	173910	NP_000288	1e-65	PKD2;PKD4	POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE II; APKD2	Polycystic kidney disease, adult, type II (3)
CG1522-PA	603967	NP_000325	1e-65	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG13423-PA	602403	NP_000377	1e-65	BLMH;BMH	BMH	{Alzheimer disease, susceptibility to}, 104300 (3)
CG3476-PA	212138	NP_000378	1e-65	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG31146-PD	100740	NP_000656	1e-65	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG17760-PA	139360	NP_002061	1e-65	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG9623-PB	600536	NP_002197	1e-65	ITGA7		Myopathy, congenital (3)
CG7223-PA	191306	NP_002244	1e-65	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG7223-PB	191306	NP_002244	1e-65	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG7223-PC	191306	NP_002244	1e-65	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG3758-PA	602150	NP_003059	1e-65	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG9610-PA	167416	NP_006185	1e-65	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG31146-PD	100740	NP_056646	1e-65	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG17678-PA	139330	NP_653082	1e-65	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG12262-PA	606885	NP_000008	2e-65	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG10236-PA	600805	NP_000218	2e-65	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG32538-PB	100720	NP_000742	2e-65	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG18085-PA	147370	NP_000866	2e-65	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10531-PA	600031	NP_003456	2e-65	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG1847-PA	605555	NP_003968	2e-65		ARA9;HEPATITIS B VIRUS X-ASSOCIATED PROTEIN 2; XAP2	
CG9527-PA	609751	NP_004026	2e-65	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG32134-PA	136351	NP_004110	2e-65	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG16785-PA	604579	NP_036325	2e-65	EVR1;FZD4		Exudative vitreoretinopathy, 133780 (3);Retinopathy of prematurity, 133780 (3)
CG12598-PA	601059	NP_056656	2e-65	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG12598-PB	601059	NP_056656	2e-65	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG10142-PA	106180	NP_690043	2e-65	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG10142-PA	106180	NP_690044	2e-65	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG32134-PA	136352	NP_891555	2e-65	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14031-PA	608614	NP_997235	2e-65	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG8714-PA	138160	NP_000331	3e-65	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG11567-PA	163731	NP_000611	3e-65	IHPS1;NOS1		{Pyloric stenosis, infantile hypertrophic, 1, susceptibility to}, 179010 (3)
CG32134-PA	136352	NP_002011	3e-65	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG4861-PA	603506	NP_002326	3e-65	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG15862-PA	188830	NP_002725	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PB	188830	NP_002725	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PC	188830	NP_002725	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG2262-PA	600993	NP_005350	3e-65	DPC4;JIP;MADH4;SMAD4	DELETED IN PANCREATIC CARCINOMA 4; DPC4;MADH4;SMA- AND MAD-RELATED PROTEIN 4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3);Pancreatic cancer (3);Polyposis, juvenile intestinal, 174900 (3)
CG10638-PA	604741	NP_005980	3e-65		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG5093-PA	601621	NP_005987	3e-65	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG14694-PA	603941	NP_008927	3e-65	SLC19A2;THTR1	THIAMINE TRANSPORTER PROTEIN 1; THTR1	Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)
CG4523-PA	608309	NP_115785	3e-65	PINK1;PARK6		Parkinson disease 6, early onset, 605909 (3)
CG4523-PB	608309	NP_115785	3e-65	PINK1;PARK6		Parkinson disease 6, early onset, 605909 (3)
CG15862-PA	188830	NP_997636	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PB	188830	NP_997636	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PC	188830	NP_997636	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PA	188830	NP_997637	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PB	188830	NP_997637	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG15862-PC	188830	NP_997637	3e-65	CAR;CNC1;PPNAD1;PRKAR1A;TSE1	TISSUE-SPECIFIC EXTINGUISHER 1; TSE1	Adrenocortical tumor, somatic (3);Carney complex, type 1, 160980 (3);Myxoma, intracardiac, 255960 (3);Pigmented adrenocortical disease, primary, 1, 610489 (3);Thyroid carcinoma, papillary, 188550 (3)
CG12292-PA	609383	XP_371777	3e-65	ICHYN		Ichthyosis, congenital, autosomal recessive (3)
CG15899-PB	601011	NP_000059	4e-65	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG11567-PA	163730	NP_000616	4e-65	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG10142-PA	106180	NP_000780	4e-65	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG18296-PA	604569	NP_054860	4e-65	CASPR2;CDFE;CNTNAP2;NRXN4	CONTACTIN-ASSOCIATED PROTEIN 2; CASPR2;NEUREXIN IV, DROSOPHILA, HOMOLOG OF; NRXN4	Cortical dysplasia-focal epilepsy syndrome, 610042 (3)
CG15899-PB	601011	NP_075461	4e-65	CACNA1A;CACNL1A4;SCA6	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 4; CACNL1A4	Cerebellar ataxia, pure (3);Episodic ataxia, type 2, 108500 (3);Hemiplegic migraine, familial, 141500 (3);Spinocerebellar ataxia-6, 183086 (3)
CG11567-PA	163730	NP_695024	4e-65	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG8766-PA	300394	NP_851828	4e-65	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PB	300394	NP_851828	4e-65	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PC	300394	NP_851828	4e-65	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG7408-PB	253200	NP_000037	5e-65	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG2210-PA	156490	NP_000260	5e-65	NM23;NME1	AWD, DROSOPHILA, HOMOLOG OF; AWD;GZMA-ACTIVATED DNase; GAAD;METASTASIS INHIBITION FACTOR NM23;NONMETASTATIC PROTEIN 23, HOMOLOG 1; NM23H1;NONMETASTATIC PROTEIN 23; NM23;NUCLEOSIDE DIPHOSPHATE KINASE-A; NDPKA	Neuroblastoma, 256700 (3)
CG7720-PA	601843	NP_000444	5e-65	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG7720-PB	601843	NP_000444	5e-65	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG7236-PA	300203	NP_001032420	5e-65	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4894-PA	603415	NP_002968	5e-65	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG4894-PB	603415	NP_002968	5e-65	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG4894-PD	603415	NP_002968	5e-65	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG7236-PA	300203	NP_003150	5e-65	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG12072-PA	605377	NP_004400	5e-65	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG1819-PA	600046	NP_005493	5e-65	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG31536-PA	300628	NP_919253	5e-65	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG3972-PA	608614	NP_997235	5e-65	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG6844-PA	100730	NP_005190	6e-65	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG6844-PB	100730	NP_005190	6e-65	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG10242-PA	124010	NP_059488	6e-65		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG6875-PA	605481	NP_060606	6e-65	ASPM;MCPH5	ASP, DROSOPHILA, HOMOLOG OF;MCPH5 GENE	Microcephaly, primary autosomal recessive, 5, 608716 (3)
CG2210-PA	156490	NP_937818	6e-65	NM23;NME1	AWD, DROSOPHILA, HOMOLOG OF; AWD;GZMA-ACTIVATED DNase; GAAD;METASTASIS INHIBITION FACTOR NM23;NONMETASTATIC PROTEIN 23, HOMOLOG 1; NM23H1;NONMETASTATIC PROTEIN 23; NM23;NUCLEOSIDE DIPHOSPHATE KINASE-A; NDPKA	Neuroblastoma, 256700 (3)
CG14527-PA	600423	NP_001388	7e-65	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG4007-PA	602337	NP_004551	7e-65	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG10119-PA	150340	NP_005564	7e-65	LMNB1	LMNB	Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)
CG3578-PA	601719	NP_060958	7e-65	TBX4		Small patella syndrome, 147891 (3)
CG6816-PA	601130	NP_000762	8e-65	CYP2C9		Tolbutamide poor metabolizer (3);Warfarin sensitivity, 122700 (3)
CG6816-PB	601130	NP_000762	8e-65	CYP2C9		Tolbutamide poor metabolizer (3);Warfarin sensitivity, 122700 (3)
CG11466-PA	605325	NP_000768	8e-65	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG30019-PA	601023	NP_009057	8e-65	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10595-PA	602666	NP_057323	8e-65	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG5125-PA	602666	NP_057323	8e-65	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG5125-PB	602666	NP_057323	8e-65	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG9375-PA	190020	NP_789765	8e-65	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG12598-PA	601059	NP_001020278	9e-65	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG12598-PB	601059	NP_001020278	9e-65	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG10060-PA	139320	NP_536351	9e-65	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG4600-PA	607809	NP_000010	1e-64	ACAT1	ACAT;ACETOACETYL-CoA THIOLASE, MITOCHONDRIAL;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE; MAT;T2	Alpha-methylacetoacetic aciduria, 203750 (3)
CG6201-PA	252800	NP_000194	1e-64	IDA;IDUA	IDURONIDASE, ALPHA-L	Mucopolysaccharidosis Ih, 607014 (3);Mucopolysaccharidosis Ih/s, 607015 (3);Mucopolysaccharidosis Is, 607016 (3)
CG4894-PA	600163	NP_000326	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PB	600163	NP_000326	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PD	600163	NP_000326	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG10181-PA	170260	NP_000584	1e-64	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG11567-PB	163731	NP_000611	1e-64	IHPS1;NOS1		{Pyloric stenosis, infantile hypertrophic, 1, susceptibility to}, 179010 (3)
CG12598-PA	601059	NP_001102	1e-64	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG12598-PB	601059	NP_001102	1e-64	ADAR;DRADA;DSH;DSRAD	ADENOSINE DEAMINASE, RNA-SPECIFIC, 1; ADAR1;DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE; DSRAD;DRADA	Dyschromatosis symmetrica hereditaria, 127400 (3)
CG32134-PA	164770	NP_005202	1e-64	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG6083-PA	604741	NP_005980	1e-64		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG5374-PA	610150	NP_036205	1e-64	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG5374-PB	610150	NP_036205	1e-64	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG8345-PA	124010	NP_059488	1e-64		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG4894-PA	600163	NP_932173	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PB	600163	NP_932173	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PD	600163	NP_932173	1e-64	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG14723-PA	138491	NP_000162	2e-64	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG18301-PA	278000	NP_000226	2e-64	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG5226-PA	126455	NP_001035	2e-64	DAT1;SLC6A3	DOPAMINE TRANSPORTER; DAT; DAT1;MEMBER 3; SLC6A3	{Attention-deficit hyperactivity disorder, susceptibility to}, 143465 (2);{Nicotine dependence, protection against} (3)
CG1464-PA	607108	NP_001595	2e-64	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG12262-PA	600301	NP_001600	2e-64	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG5965-PA	602221	NP_003444	2e-64	FIM;RAMP;SCLL;ZNF198	FUSED IN MYELOPROLIFERATIVE DISORDERS; FIM;REARRANGED IN ATYPICAL MYELOPROLIFERATIVE DISORDER; RAMP	Stem-cell leukemia/lymphoma syndrome (3)
CG1954-PA	300075	NP_004577	2e-64	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG12766-PA	604741	NP_005980	2e-64		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG11202-PA	601621	NP_005987	2e-64	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG31674-PA	604296	NP_036335	2e-64	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG5965-PA	602221	NP_932072	2e-64	FIM;RAMP;SCLL;ZNF198	FUSED IN MYELOPROLIFERATIVE DISORDERS; FIM;REARRANGED IN ATYPICAL MYELOPROLIFERATIVE DISORDER; RAMP	Stem-cell leukemia/lymphoma syndrome (3)
CG32186-PA	601691	NP_000341	3e-64	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG10060-PA	139320	NP_000507	3e-64	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG6816-PA	124020	NP_000760	3e-64	CYP2C;CYP2C19	CYP2C;MEPHENYTOIN 4-PRIME-HYDROXYLASE;P450C2C	Mephenytoin poor metabolizer (3);Opremazole poor metabolizer (3);Proguanil poor metabolizer (3)
CG6816-PB	124020	NP_000760	3e-64	CYP2C;CYP2C19	CYP2C;MEPHENYTOIN 4-PRIME-HYDROXYLASE;P450C2C	Mephenytoin poor metabolizer (3);Opremazole poor metabolizer (3);Proguanil poor metabolizer (3)
CG30054-PB	139360	NP_002061	3e-64	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG5610-PA	100730	NP_005190	3e-64	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG10244-PA	136350	NP_075599	3e-64	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32134-PA	164920	NP_000213	4e-64	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG31731-PA	601691	NP_000341	4e-64	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG11567-PB	163730	NP_000616	4e-64	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG9907-PA	114205	NP_000710	4e-64	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG17336-PA	138492	NP_000815	4e-64	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG17336-PB	138492	NP_000815	4e-64	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG32387-PA	608548	NP_114141	4e-64	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG32387-PB	608548	NP_114141	4e-64	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG11567-PB	163730	NP_695024	4e-64	NOS2;NOS2A	NITRIC OXIDE SYNTHASE, INDUCIBLE; INOS;NITRIC OXIDE SYNTHASE, MACROPHAGE;NOS2;NOS2A, INDUCIBLE, HEPATOCYTE	{Hypertension, susceptibility to}, 145500 (2);{Malaria, resistance to}, 248310 (3)
CG7297-PA	601756	NP_004473	5e-64	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG2302-PA	100730	NP_005190	5e-64	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG10863-PA	604741	NP_005980	5e-64		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG17544-PA	609751	NP_009223	5e-64	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG17544-PB	609751	NP_009223	5e-64	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG17544-PC	609751	NP_009223	5e-64	ACOX;ACOX1;SCOX	ACYL-CoA OXIDASE, PALMITOYL, PEROXISOMAL;ACYL-CoA OXIDASE, STRAIGHT-CHAIN; SCOX;ACYL-CoA OXIDASE; ACOX;PALMITOYL-CoA OXIDASE	Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
CG17678-PA	139320	NP_536351	5e-64	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG31194-PA	227646	NP_001018125	6e-64	FACD;FAD;FANCD;FANCD2	FAD2;FANCD2 GENE;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;FANCONI PANCYTOPENIA, TYPE 4; FA4	Fanconi anemia, complementation group D2 (3)
CG6126-PA	604190	NP_003050	6e-64	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG5187-PA	601621	NP_005987	6e-64	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG7462-PB	608774	NP_848605	6e-64	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG7462-PC	608774	NP_848605	6e-64	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG8250-PA	147670	NP_000199	7e-64	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG7535-PA	137140	NP_000798	7e-64	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG10539-PA	176980	NP_002730	7e-64	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6798-PA	100730	NP_005190	7e-64	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG10642-PA	608283	NP_060111	7e-64	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG5658-PA	608283	NP_060111	7e-64	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG3156-PA	170261	NP_061313	7e-64	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG6835-PC	601002	NP_000169	8e-64	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG6835-PD	601002	NP_000169	8e-64	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG7779-PA	600724	NP_001288	8e-64	CNCG2;CNCG3L;CNGB1	CNCG3L;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 2; CNCG2;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 3-LIKE;;GLUTAMIC ACID-RICH PROTEIN 1; GAR1; GARP;RETINAL ROD cGMP-GATED CHANNEL, BETA SUBUNIT;RETINAL ROD cGMP-GATED CHANNEL, GAMMA SUBUNIT	Retinitis pigmentosa, autosomal recessive, 268000 (3)
CG9176-PB	600724	NP_001288	8e-64	CNCG2;CNCG3L;CNGB1	CNCG3L;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 2; CNCG2;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 3-LIKE;;GLUTAMIC ACID-RICH PROTEIN 1; GAR1; GARP;RETINAL ROD cGMP-GATED CHANNEL, BETA SUBUNIT;RETINAL ROD cGMP-GATED CHANNEL, GAMMA SUBUNIT	Retinitis pigmentosa, autosomal recessive, 268000 (3)
CG9176-PC	600724	NP_001288	8e-64	CNCG2;CNCG3L;CNGB1	CNCG3L;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 2; CNCG2;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 3-LIKE;;GLUTAMIC ACID-RICH PROTEIN 1; GAR1; GARP;RETINAL ROD cGMP-GATED CHANNEL, BETA SUBUNIT;RETINAL ROD cGMP-GATED CHANNEL, GAMMA SUBUNIT	Retinitis pigmentosa, autosomal recessive, 268000 (3)
CG4894-PA	182389	NP_008851	8e-64	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG4894-PB	182389	NP_008851	8e-64	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG4894-PD	182389	NP_008851	8e-64	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG1500-PA	173610	NP_002996	9e-64	GRMP;SELP	CD62;GMP140;GRANULOCYTE MEMBRANE PROTEIN; GRMP;P-SELECTIN;PLATELET ALPHA-GRANULE MEMBRANE PROTEIN	Platelet alpha/delta storage pool deficiency (1);{Atopy, susceptibility to}, 147050 (3)
CG5125-PB	276903	NP_000251	1e-63	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG4894-PC	603967	NP_000325	1e-63	HYPP;NAC1A;SCN4A	NAV1.4	Cramps, familial, potassium-aggravated (3);Hyperkalemic periodic paralysis, 170500 (3);Hypokalemic periodic paralysis, 170400 (3);Myasthenic syndrome (3);Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3);Paramyotonia congenita, 168300 (3)
CG7660-PA	606765	NP_000538	1e-63	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7535-PB	137160	NP_000797	1e-63	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG15485-PA	600423	NP_001388	1e-63	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG4215-PA	600887	NP_002430	1e-63	MSH3		Endometrial carcinoma (3)
CG4215-PB	600887	NP_002430	1e-63	MSH3		Endometrial carcinoma (3)
CG4158-PA	602150	NP_003059	1e-63	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG17150-PC	603339	NP_003768	1e-63	DNAH11;DNAHC11	DNAHC11;DPL11	Kartagener syndrome, 244400 (3);Situs inversus viscerum, 270100 (3)
CG6622-PA	300075	NP_004577	1e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG6622-PB	300075	NP_004577	1e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4300-PA	300105	NP_004586	1e-63	MRSR;SMS;SRS		Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)
CG12010-PA	601023	NP_009057	1e-63	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10229-PA	604277	NP_055761	1e-63	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG10241-PA	124010	NP_059488	1e-63		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG31522-PB	605512	NP_073563	1e-63	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31522-PD	605512	NP_073563	1e-63	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG14825-PA	209901	NP_078925	1e-63	BBS1		Bardet-Biedl syndrome 1, 209900 (3)
CG7660-PA	606765	NP_783651	1e-63	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7660-PA	606765	NP_783652	1e-63	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7223-PA	136352	NP_891555	1e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG7223-PB	136352	NP_891555	1e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG7223-PC	136352	NP_891555	1e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG10229-PA	604277	NP_955468	1e-63	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG5125-PA	276903	NP_000251	2e-63	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG4058-PA	110900	NP_000411	2e-63	KEL		[Blood group, Kell] (3)
CG4058-PB	110900	NP_000411	2e-63	KEL		[Blood group, Kell] (3)
CG9071-PA	114205	NP_000710	2e-63	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG9071-PB	114205	NP_000710	2e-63	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG4476-PB	608893	NP_001003841	2e-63	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG7223-PA	136352	NP_002011	2e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG7223-PB	136352	NP_002011	2e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG7223-PC	136352	NP_002011	2e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG31092-PA	603506	NP_002326	2e-63	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG31092-PB	603506	NP_002326	2e-63	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG7458-PA	603377	NP_003051	2e-63	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG9317-PB	603377	NP_003051	2e-63	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG7223-PA	164770	NP_005202	2e-63	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG7223-PB	164770	NP_005202	2e-63	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG7223-PC	164770	NP_005202	2e-63	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG4379-PA	605437	NP_006246	2e-63	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG4379-PB	605437	NP_006246	2e-63	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG31522-PA	605512	NP_073563	2e-63	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG9109-PA	610308	NP_919299	2e-63		BETA-3-GLYCOSYLTRANSFERASE-LIKE; B3GTL	
CG7052-PB	120700	NP_000055	3e-63	C3		C3 deficiency (3)
CG18858-PA	606967	NP_000220	3e-63	LCAT		Fish-eye disease, 136120 (3);Norum disease, 245900 (3)
CG9347-PA	180069	NP_000320	3e-63	RP20;RPE65		Leber congenital amaurosis-2, 204100 (3);Retinitis pigmentosa-20 (3)
CG4527-PA	606808	NP_059129	3e-63	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG4527-PB	606808	NP_059129	3e-63	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG17461-PA	608283	NP_060111	3e-63	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG31194-PA	227646	NP_149075	3e-63	FACD;FAD;FANCD;FANCD2	FAD2;FANCD2 GENE;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;FANCONI PANCYTOPENIA, TYPE 4; FA4	Fanconi anemia, complementation group D2 (3)
CG3578-PA	601620	NP_542449	3e-63	TBX5		Holt-Oram syndrome, 142900 (3)
CG10842-PA	608614	NP_997235	3e-63	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG15899-PB	114208	NP_000060	4e-63	CACNA1S;CACNL1A3;CCHL1A3	CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 3, SKELETAL;CALCIUM CHANNEL, SKELETAL MUSCLE DIHYDROPYRIDINE-SENSITIVE, ALPHA-1;CCHL1A3;MUSCLE; CACNL1A3;SUBUNIT	Hypokalemic periodic paralysis, 170400 (3);{Malignant hyperthermia susceptibility 5}, 601887 (3);{Thyrotoxic periodic paralysis, susceptibility to}, 188580 (3)
CG6798-PB	100690	NP_000070	4e-63	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG32956-PB	133530	NP_000114	4e-63	COFS3;ERCC5;XPG	ERCM2;RAD2, YEAST, HOMOLOG OF;ULTRAVIOLET SENSITIVITY, MOUSE, COMPLEMENTATION OF;UV DAMAGE, EXCISION REPAIR OF, UV-135; UVDR;XERODERMA PIGMENTOSUM, GROUP G CORRECTING PROTEIN; XPGC;XPG	Cerebrooculofacioskeletal syndrome 3 (3);Xeroderma pigmentosum, group G, 278780 (3)
CG32956-PC	133530	NP_000114	4e-63	COFS3;ERCC5;XPG	ERCM2;RAD2, YEAST, HOMOLOG OF;ULTRAVIOLET SENSITIVITY, MOUSE, COMPLEMENTATION OF;UV DAMAGE, EXCISION REPAIR OF, UV-135; UVDR;XERODERMA PIGMENTOSUM, GROUP G CORRECTING PROTEIN; XPGC;XPG	Cerebrooculofacioskeletal syndrome 3 (3);Xeroderma pigmentosum, group G, 278780 (3)
CG32956-PD	133530	NP_000114	4e-63	COFS3;ERCC5;XPG	ERCM2;RAD2, YEAST, HOMOLOG OF;ULTRAVIOLET SENSITIVITY, MOUSE, COMPLEMENTATION OF;UV DAMAGE, EXCISION REPAIR OF, UV-135; UVDR;XERODERMA PIGMENTOSUM, GROUP G CORRECTING PROTEIN; XPGC;XPG	Cerebrooculofacioskeletal syndrome 3 (3);Xeroderma pigmentosum, group G, 278780 (3)
CG1484-PA	137350	NP_000168	4e-63	GSN		Amyloidosis, Finnish type, 105120 (3)
CG3578-PA	601620	NP_000183	4e-63	TBX5		Holt-Oram syndrome, 142900 (3)
CG31683-PA	606967	NP_000220	4e-63	LCAT		Fish-eye disease, 136120 (3);Norum disease, 245900 (3)
CG15288-PA	150325	NP_002283	4e-63	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG15288-PB	150325	NP_002283	4e-63	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG9317-PB	604190	NP_003050	4e-63	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1847-PB	605555	NP_003968	4e-63		ARA9;HEPATITIS B VIRUS X-ASSOCIATED PROTEIN 2; XAP2	
CG5133-PA	601621	NP_057653	4e-63	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG1824-PA	170261	NP_061313	4e-63	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG3578-PA	601620	NP_542448	4e-63	TBX5		Holt-Oram syndrome, 142900 (3)
CG3578-PA	601620	NP_852259	4e-63	TBX5		Holt-Oram syndrome, 142900 (3)
CG18085-PA	147670	NP_000199	5e-63	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG6446-PA	608166	NP_036563	5e-63	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG11198-PA	609010	NP_064551	5e-63	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG11198-PB	609010	NP_064551	5e-63	MCCA;MCCC1	3-@METHYLCROTONYL-CoA CARBOXYLASE, ALPHA; MCCA;3-@METHYLCROTONYL-CoA CARBOXYLASE, BIOTIN-CONTAINING SUBUNIT	3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
CG2759-PA	605460	NP_071882	5e-63	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG11949-PB	300628	NP_919253	5e-63	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG1484-PA	137350	NP_937895	5e-63	GSN		Amyloidosis, Finnish type, 105120 (3)
CG13095-PA	179820	NP_000528	6e-63	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG10537-PB	137163	NP_000806	6e-63		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG31999-PA	121050	NP_001990	8e-63	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG5939-PC	160720	NP_002461	8e-63	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG5939-PD	160720	NP_002461	8e-63	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7458-PA	604190	NP_003050	8e-63	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG14396-PA	136352	NP_002011	9e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PB	136352	NP_002011	9e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PC	136352	NP_002011	9e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PD	136352	NP_002011	9e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PE	136352	NP_002011	9e-63	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG2049-PB	300075	NP_004577	9e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG2049-PC	300075	NP_004577	9e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG2049-PE	300075	NP_004577	9e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG2049-PF	300075	NP_004577	9e-63	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG31045-PA	160777	NP_000250	1e-62	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG10537-PC	137163	NP_000806	1e-62		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG7073-PB	607690	NP_001028675	1e-62	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG14396-PA	191306	NP_002244	1e-62	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG14396-PB	191306	NP_002244	1e-62	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG14396-PC	191306	NP_002244	1e-62	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG14396-PD	191306	NP_002244	1e-62	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG14396-PE	191306	NP_002244	1e-62	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG5169-PA	300142	NP_002569	1e-62	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG4379-PA	176960	NP_002728	1e-62	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG4379-PB	176960	NP_002728	1e-62	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG7223-PA	136351	NP_004110	1e-62	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG7223-PB	136351	NP_004110	1e-62	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG7223-PC	136351	NP_004110	1e-62	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG1594-PA	147796	NP_004963	1e-62	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG7073-PB	607690	NP_057187	1e-62	CMRD;SAR1B;SARA2	SAR1B	Anderson disease, 607689 (3);Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3);Chylomicron retention disease, 246700 (3)
CG5030-PA	300427	NP_065793	1e-62	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG10060-PA	139320	NP_536350	1e-62	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG32311-PB	188840	NP_596869	1e-62	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG30171-PB	188840	NP_597676	1e-62	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5030-PA	300427	NP_851849	1e-62	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG14396-PA	136352	NP_891555	1e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PB	136352	NP_891555	1e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PC	136352	NP_891555	1e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PD	136352	NP_891555	1e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG14396-PE	136352	NP_891555	1e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG7765-PA	605995	NP_904325	1e-62	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG11949-PA	300628	NP_919253	1e-62	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG11949-PC	300628	NP_919253	1e-62	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG11949-PD	300628	NP_919253	1e-62	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG7123-PA	600805	NP_937762	1e-62	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG7123-PB	600805	NP_937762	1e-62	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG6383-PA	134797	NP_000129	2e-62	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG32495-PA	601002	NP_000169	2e-62	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG8571-PA	602136	NP_000457	2e-62	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG1787-PA	606869	NP_000511	2e-62	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG1787-PA	606873	NP_000512	2e-62	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG8250-PA	147370	NP_000866	2e-62	IGF1R		Intrauterine and postnatal growth retardation (3)
CG6816-PA	124030	NP_001020332	2e-62	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG6816-PB	124030	NP_001020332	2e-62	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG10580-PA	602576	NP_001035258	2e-62	LFNG;SCDO3	FRINGE, DROSOPHILA, HOMOLOG OF, LUNATIC	Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)
CG4859-PA	600108	NP_002418	2e-62	CLG3;MMP13	COLLAGENASE 3; CLG3	Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)
CG4859-PB	600108	NP_002418	2e-62	CLG3;MMP13	COLLAGENASE 3; CLG3	Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)
CG7861-PA	604934	NP_003184	2e-62	HRD;KCS;KCS1;TBCE	COFACTOR E	Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3);Kenny-Caffey syndrome-1, 244460 (3)
CG14791-PB	603868	NP_004571	2e-62	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG1429-PA	600660	NP_005578	2e-62	ADCAD1;MEF2A		Coronary artery disease, autosomal dominant, 1, 608320 (3)
CG1429-PB	600660	NP_005578	2e-62	ADCAD1;MEF2A		Coronary artery disease, autosomal dominant, 1, 608320 (3)
CG1429-PC	600660	NP_005578	2e-62	ADCAD1;MEF2A		Coronary artery disease, autosomal dominant, 1, 608320 (3)
CG1429-PD	600660	NP_005578	2e-62	ADCAD1;MEF2A		Coronary artery disease, autosomal dominant, 1, 608320 (3)
CG12299-PA	314995	NP_009061	2e-62	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7765-PA	605995	NP_055889	2e-62	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG17036-PA	606152	NP_079519	2e-62	SLC19A3		Basal ganglia disease, biotin-responsive, 607483 (3)
CG6574-PA	606152	NP_079519	2e-62	SLC19A3		Basal ganglia disease, biotin-responsive, 607483 (3)
CG12299-PA	314995	NP_700359	2e-62	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8891-PA	147520	NP_852470	2e-62	ITPA	INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE	[Inosine triphosphatase deficiency] (3)
CG14791-PB	603868	NP_899057	2e-62	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG14791-PB	603868	NP_899058	2e-62	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG14791-PB	603868	NP_899059	2e-62	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG31871-PA	278000	NP_000226	3e-62	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG2054-PA	600031	NP_003456	3e-62	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG8590-PA	602821	NP_004975	3e-62	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG2916-PA	604061	NP_006631	3e-62	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG2916-PB	604061	NP_006631	3e-62	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG7009-PA	300499	NP_036412	3e-62	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG5169-PA	606808	NP_059129	3e-62	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG18405-PA	607292	NP_071762	3e-62	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG7009-PA	300499	NP_803183	3e-62	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG7009-PA	300499	NP_803188	3e-62	FTSJ1;JM23;MRX44;MRX9;SPB1	JM23;SPB1, S. CEREVISIAE, HOMOLOG OF	Mental retardation, X-linked-9, 309549 (3)
CG10011-PA	182900	NP_000028	4e-62	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7223-PA	600221	NP_000450	4e-62	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG7223-PB	600221	NP_000450	4e-62	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG7223-PC	600221	NP_000450	4e-62	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG5776-PA	602136	NP_000457	4e-62	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG1318-PA	606873	NP_000512	4e-62	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG1318-PB	606873	NP_000512	4e-62	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG1318-PD	606873	NP_000512	4e-62	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG15899-PB	114205	NP_000710	4e-62	CACNA1C;CACNL1A1;CCHL1A1;TS	CACH2;CACNL1A1;CALCIUM CHANNEL, CARDIAC DIHYDROPYRIDINE-SENSITIVE, ALPHA-1 SUBUNIT;CALCIUM CHANNEL, L TYPE, ALPHA-1 POLYPEPTIDE, ISOFORM 1, CARDIAC MUSCLE;;CaV1.2;CCHL1A1;DHPR, ALPHA-1 SUBUNIT	Timothy syndrome, 601005 (3)
CG10537-PA	137163	NP_000806	4e-62		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG10413-PA	604878	NP_005126	4e-62	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG15899-PB	600702	NP_055006	4e-62		NAV1.6	
CG10011-PA	182900	NP_065208	4e-62	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG10011-PA	182900	NP_065209	4e-62	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG10011-PA	182900	NP_065210	4e-62	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG31665-PA	600275	NP_077719	4e-62	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG31665-PA	600275	XP_001133349	4e-62	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG7052-PC	120700	NP_000055	5e-62	C3		C3 deficiency (3)
CG7660-PB	131399	NP_000493	5e-62	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG6844-PA	100710	NP_000738	5e-62	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG6844-PB	100710	NP_000738	5e-62	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG10537-PC	138492	NP_000815	5e-62	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG30054-PA	139360	NP_002061	5e-62	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG17461-PA	602821	NP_004975	5e-62	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG8625-PA	604289	NP_036547	5e-62	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8625-PB	604289	NP_036547	5e-62	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8625-PC	604289	NP_036547	5e-62	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG6414-PA	100740	NP_056646	5e-62	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10244-PA	136352	NP_891555	5e-62	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG2302-PA	100725	NP_000071	6e-62	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG8093-PA	278000	NP_000226	6e-62	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG6414-PA	100740	NP_000656	6e-62	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10537-PB	138492	NP_000815	6e-62	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG3871-PA	601205	NP_005973	6e-62	BOS3;DFNA23;SIX1		Brachiootic syndrome 3, 608389 (3);Deafness, autosomal dominant 23, 605192 (3)
CG3871-PB	601205	NP_005973	6e-62	BOS3;DFNA23;SIX1		Brachiootic syndrome 3, 608389 (3);Deafness, autosomal dominant 23, 605192 (3)
CG15669-PA	605262	NP_006087	8e-62	CMT4D;HMSNL;NDRG1	PROTEIN REGULATED BY OXYGEN 1; PROXY1	Charcot-Marie-Tooth disease, type 4D, 601455 (3)
CG15669-PD	605262	NP_006087	8e-62	CMT4D;HMSNL;NDRG1	PROTEIN REGULATED BY OXYGEN 1; PROXY1	Charcot-Marie-Tooth disease, type 4D, 601455 (3)
CG12230-PA	608552	NP_061138	8e-62	VPS33B		ARC syndrome, 208085 (3)
CG12230-PB	608552	NP_061138	8e-62	VPS33B		ARC syndrome, 208085 (3)
CG10537-PA	137140	NP_000798	9e-62	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG2165-PA	604384	NP_001001485	9e-62	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PB	604384	NP_001001485	9e-62	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PA	604384	NP_055197	9e-62	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PB	604384	NP_055197	9e-62	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG33102-PA	138079	NP_277043	9e-62	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG6331-PA	607096	NP_653186	9e-62	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG33102-PA	138079	NP_000153	1e-61	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG11049-PA	167409	NP_000269	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PB	167409	NP_000269	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	607108	NP_000271	1e-61	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG10226-PA	601107	NP_000383	1e-61	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG13374-PA	179820	NP_000528	1e-61	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG7535-PB	137192	NP_000805	1e-61	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG17336-PA	137164	NP_000807	1e-61	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG17336-PB	137164	NP_000807	1e-61	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG10537-PA	138492	NP_000815	1e-61	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG2165-PA	604384	NP_001001486	1e-61	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PB	604384	NP_001001486	1e-61	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PA	604384	NP_001001487	1e-61	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG2165-PB	604384	NP_001001487	1e-61	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG13374-PA	116840	NP_001900	1e-61	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG10244-PA	136352	NP_002011	1e-61	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG11049-PA	167409	NP_003978	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PB	167409	NP_003978	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PA	167409	NP_003979	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PB	167409	NP_003979	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PA	167409	NP_003980	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PB	167409	NP_003980	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PA	167409	NP_003981	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PB	167409	NP_003981	1e-61	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG4700-PA	608166	NP_036563	1e-61	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG4700-PB	608166	NP_036563	1e-61	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG4700-PC	608166	NP_036563	1e-61	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG11049-PA	167415	NP_054698	1e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PB	167415	NP_054698	1e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG31213-PA	607800	NP_056472	1e-61	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG5093-PA	601621	NP_057653	1e-61	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG8654-PA	607096	NP_653186	1e-61	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG31213-PA	607800	NP_775099	1e-61	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG17336-PA	137164	NP_944494	1e-61	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG17336-PB	137164	NP_944494	1e-61	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG18096-PA	120700	NP_000055	2e-61	C3		C3 deficiency (3)
CG7052-PE	120700	NP_000055	2e-61	C3		C3 deficiency (3)
CG8947-PA	601105	NP_000387	2e-61	CTSK		Pycnodysostosis, 265800 (3)
CG7981-PA	156225	NP_000417	2e-61	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7981-PB	156225	NP_000417	2e-61	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7981-PC	156225	NP_000417	2e-61	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7981-PD	156225	NP_000417	2e-61	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7981-PE	156225	NP_000417	2e-61	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG17678-PA	139320	NP_000507	2e-61	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG32451-PA	108733	NP_001001331	2e-61	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG32451-PC	108733	NP_001001331	2e-61	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG10524-PA	300075	NP_004577	2e-61	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG13334-PA	150000	NP_005557	2e-61	LDHA;LDH1	LDH, SUBUNIT M	Exertional myoglobinuria due to deficiency of LDH-A (3)
CG5942-PA	604289	NP_036547	2e-61	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PB	604289	NP_036547	2e-61	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PC	604289	NP_036547	2e-61	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PD	604289	NP_036547	2e-61	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG9826-PA	604322	NP_036566	2e-61	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG11049-PA	167415	NP_039245	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PB	167415	NP_039245	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PA	167415	NP_039246	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PB	167415	NP_039246	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PA	167415	NP_039247	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PB	167415	NP_039247	2e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG33102-PA	138079	NP_277042	2e-61	GCK;HHF3	GK; GLK;HEXOKINASE 4; HK4	Diabetes mellitus, gestational, 125851 (3);Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3);MODY, type II, 125851 (3)
CG5137-PA	608614	NP_997235	2e-61	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG15899-PB	600163	XP_001131636	2e-61	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG6638-PA	606885	NP_000008	3e-61	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG6716-PA	607108	NP_000271	3e-61	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG3267-PA	232050	NP_000523	3e-61	PCCB	pccBC COMPLEMENTATION GROUP	Propionicacidemia, 606054 (3)
CG10241-PA	605325	NP_000768	3e-61	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10537-PB	137140	NP_000798	3e-61	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG10537-PC	137140	NP_000798	3e-61	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG11049-PA	167415	NP_003457	3e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11049-PB	167415	NP_003457	3e-61	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4300-PB	300105	NP_004586	3e-61	MRSR;SMS;SRS		Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)
CG9453-PC	602445	NP_005016	3e-61	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG6860-PA	610368	NP_055931	3e-61		KIAA1016	
CG6860-PB	610368	NP_055931	3e-61		KIAA1016	
CG9191-PA	608283	NP_060111	3e-61	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG7052-PA	120700	NP_000055	4e-61	C3		C3 deficiency (3)
CG10537-PA	137160	NP_000797	4e-61	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG1522-PA	603415	NP_002968	4e-61	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG7635-PA	604766	NP_055440	4e-61	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG9438-PA	124010	NP_059488	4e-61		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG11202-PA	601719	NP_060958	4e-61	TBX4		Small patella syndrome, 147891 (3)
CG7535-PB	137192	NP_068712	4e-61	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG6816-PA	608713	NP_078790	4e-61	CYP2R1		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
CG6816-PB	608713	NP_078790	4e-61	CYP2R1		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
CG11339-PA	130500	NP_976218	4e-61	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG32495-PC	601002	NP_000169	5e-61	GSHS;GSS	GSHS	Glutathione synthetase deficiency, 266130 (3);Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)
CG15669-PB	605262	NP_006087	5e-61	CMT4D;HMSNL;NDRG1	PROTEIN REGULATED BY OXYGEN 1; PROXY1	Charcot-Marie-Tooth disease, type 4D, 601455 (3)
CG15669-PC	605262	NP_006087	5e-61	CMT4D;HMSNL;NDRG1	PROTEIN REGULATED BY OXYGEN 1; PROXY1	Charcot-Marie-Tooth disease, type 4D, 601455 (3)
CG11352-PB	314995	NP_009061	5e-61	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11352-PC	314995	NP_009061	5e-61	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7097-PA	606808	NP_059129	5e-61	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG7097-PB	606808	NP_059129	5e-61	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG5475-PA	602897	NP_620447	5e-61	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG5475-PB	602897	NP_620447	5e-61	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG11352-PB	314995	NP_700359	5e-61	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11352-PC	314995	NP_700359	5e-61	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11202-PA	601621	NP_057653	6e-61	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG11202-PA	601620	NP_542449	6e-61	TBX5		Holt-Oram syndrome, 142900 (3)
CG5030-PA	300336	NP_061850	7e-61	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG6126-PA	603377	NP_003051	8e-61	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG4894-PA	600702	NP_055006	8e-61		NAV1.6	
CG4894-PB	600702	NP_055006	8e-61		NAV1.6	
CG4894-PD	600702	NP_055006	8e-61		NAV1.6	
CG2781-PA	605512	NP_073563	8e-61	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG11202-PA	601620	NP_542448	8e-61	TBX5		Holt-Oram syndrome, 142900 (3)
CG11202-PA	601620	NP_000183	9e-61	TBX5		Holt-Oram syndrome, 142900 (3)
CG4898-PB	191010	NP_001018005	9e-61	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018005	9e-61	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018005	9e-61	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018005	9e-61	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG9453-PA	602445	NP_005016	9e-61	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG9453-PB	602445	NP_005016	9e-61	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG10585-PA	610564	NP_065114	9e-61	PDSS2;DLP1;C6orf210	CHROMOSOME 6 OPEN READING FRAME 210; C6ORF210;D-LESS POLYPRENYL PYROPHOSPHATE SYNTHASE 1; DLP1;DECAPRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2	Coenzyme Q10 deficiency, 607426 (3)
CG14869-PA	604134	NP_620596	9e-61	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG11202-PA	601620	NP_852259	9e-61	TBX5		Holt-Oram syndrome, 142900 (3)
CG5719-PA	600179	NP_000171	1e-60	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG10244-PA	600221	NP_000450	1e-60	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8453-PA	605325	NP_000768	1e-60	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8536-PA	137060	NP_001488	1e-60	B4GALT1;GGTB2;GT1;GTB	B4GALT1;BETA-1,4-GALACTOSYLTRANSFERASE 1;GALACTOSYLTRANSFERASE 1; GT1;GLYCOPROTEIN 4-BETA-GALACTOSYLTRANSFERASE 2; GGTB2;GTB	Congenital disorder of glycosylation, type IId, 607091 (3)
CG4859-PA	185250	NP_002413	1e-60	MMP3;STMY1	STROMELYSIN I; STMY1; STR1;TRANSIN	{Coronary heart disease, susceptibility to} (3)
CG4859-PB	185250	NP_002413	1e-60	MMP3;STMY1	STROMELYSIN I; STMY1; STR1;TRANSIN	{Coronary heart disease, susceptibility to} (3)
CG12232-PA	139340	NP_005263	1e-60	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG1193-PA	604277	NP_055761	1e-60	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG1193-PB	604277	NP_055761	1e-60	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG11502-PB	604485	NP_057430	1e-60	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG10595-PA	606808	NP_059129	1e-60	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG2397-PA	124010	NP_059488	1e-60		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG5295-PA	609059	NP_065109	1e-60	ATGL;PNPLA2;TTS2	ADIPOSE TRIGLYCERIDE LIPASE; ATGL;DESNUTRIN;IPLA2-ZETA;PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT, ZETA;TRANSPORT-SECRETION PROTEIN 2; TTS2;TTS2.2	Neutral lipid storage disease with myopathy, 610717 (3)
CG14869-PA	604134	NP_620594	1e-60	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG8590-PA	605995	NP_904325	1e-60	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1193-PA	604277	NP_955468	1e-60	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG1193-PB	604277	NP_955468	1e-60	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG7052-PD	120700	NP_000055	2e-60	C3		C3 deficiency (3)
CG8766-PA	300394	NP_000107	2e-60	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PB	300394	NP_000107	2e-60	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PC	300394	NP_000107	2e-60	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG31213-PA	601691	NP_000341	2e-60	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG8224-PA	190182	NP_001020018	2e-60	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG8293-PA	300079	NP_001158	2e-60	API3;BIRC4;XIAP;XLP2	APOPTOSIS INHIBITOR 3; API3;IAP-LIKE PROTEIN; ILP;INHIBITOR OF APOPTOSIS, X-LINKED; XIAP;MAMMALIAN IAP HOMOLOG A; MIHA	Lymphoproliferative syndrome, X-linked, 2, 300635 (3)
CG8293-PB	300079	NP_001158	2e-60	API3;BIRC4;XIAP;XLP2	APOPTOSIS INHIBITOR 3; API3;IAP-LIKE PROTEIN; ILP;INHIBITOR OF APOPTOSIS, X-LINKED; XIAP;MAMMALIAN IAP HOMOLOG A; MIHA	Lymphoproliferative syndrome, X-linked, 2, 300635 (3)
CG2005-PA	600925	NP_002834	2e-60	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG2005-PB	600925	NP_002834	2e-60	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG7562-PA	600075	NP_003185	2e-60	SCA17;TBP	SCA17 GENE	Huntington disease-like-4, 607136 (3);Parkinson disease, 168600 (3);Spinocerebellar ataxia 17, 607136 (3)
CG8224-PA	190182	NP_003233	2e-60	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG32134-PA	173490	NP_006197	2e-60	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG6297-PA	605437	NP_006246	2e-60	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG6297-PB	605437	NP_006246	2e-60	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG8590-PA	605995	NP_055889	2e-60	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG5187-PA	601621	NP_057653	2e-60	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG13977-PA	124010	NP_059488	2e-60		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG3616-PA	124010	NP_059488	2e-60		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7765-PA	608283	NP_060111	2e-60	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG11430-PA	610277	NP_116179	2e-60		CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; CRACM1;ORAI1;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, WITH CRAC CHANNEL	
CG11430-PB	610277	NP_116179	2e-60		CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; CRACM1;ORAI1;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, WITH CRAC CHANNEL	
CG8196-PA	106180	NP_690043	2e-60	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG8196-PA	106180	NP_690044	2e-60	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG6919-PA	109690	NP_000015	3e-60	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG4847-PA	601105	NP_000387	3e-60	CTSK		Pycnodysostosis, 265800 (3)
CG4847-PB	601105	NP_000387	3e-60	CTSK		Pycnodysostosis, 265800 (3)
CG4847-PC	601105	NP_000387	3e-60	CTSK		Pycnodysostosis, 265800 (3)
CG4847-PD	601105	NP_000387	3e-60	CTSK		Pycnodysostosis, 265800 (3)
CG8196-PA	106180	NP_000780	3e-60	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG4007-PA	147370	NP_000866	3e-60	IGF1R		Intrauterine and postnatal growth retardation (3)
CG4894-PC	603415	NP_002968	3e-60	NENA;PN1;SCN9A	NAV1.7;NEUROENDOCRINE SODIUM CHANNEL; NENA;PERIPHERAL SODIUM CHANNEL 1; PN1	Erythermalgia, primary, 133020 (3);Insensitivity to pain, channelopathy-associated, 243000 (3)
CG8231-PA	610150	NP_036205	3e-60	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG3619-PA	602768	NP_058637	3e-60	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG3619-PB	602768	NP_058637	3e-60	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG8859-PA	124010	NP_059488	3e-60		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG8183-PA	608283	NP_060111	3e-60	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG8183-PB	608283	NP_060111	3e-60	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG7408-PB	253200	NP_942002	3e-60	ARSB;MPS6	ARYLSULFATASE B DEFICIENCY; ARSB DEFICIENCY;MAROTEAUX-LAMY SYNDROME;MPS VI; MPS6;N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	Maroteaux-Lamy syndrome, several forms (3)
CG3619-PA	602768	NP_982353	3e-60	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG3619-PB	602768	NP_982353	3e-60	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG18104-PA	608313	NP_000036	4e-60	ARG1		Argininemia, 207800 (3)
CG12891-PA	600650	NP_000089	4e-60	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG12891-PB	600650	NP_000089	4e-60	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG30054-PB	139330	NP_000163	4e-60	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG10226-PA	170260	NP_000584	4e-60	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG6546-PA	102630	NP_001092	4e-60		BETA-ACTIN	
CG6546-PA	102560	NP_001605	4e-60	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG17596-PA	176980	NP_002730	4e-60	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG7442-PA	604190	NP_003050	4e-60	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG2822-PA	176264	NP_004968	4e-60	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG2822-PB	176264	NP_004968	4e-60	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG8250-PA	136350	NP_075593	4e-60	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8250-PA	136350	NP_075594	4e-60	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG30054-PB	139330	NP_653082	4e-60	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG4894-PC	600163	NP_000326	5e-60	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG10181-PA	170261	NP_000535	5e-60	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG6920-PA	604611	NP_000544	5e-60	RECQ3;RECQL2;WRN	DNA HELICASE, RECQ-LIKE, TYPE 3; RECQ3;WRN GENE; WRN	Werner syndrome, 277700 (3)
CG6638-PA	600301	NP_001600	5e-60	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG17907-PA	114840	NP_001798	5e-60	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG8250-PA	136350	NP_056934	5e-60	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4261-PA	608892	NP_060250	5e-60	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG5133-PA	601620	NP_542449	5e-60	TBX5		Holt-Oram syndrome, 142900 (3)
CG4894-PC	600163	NP_932173	5e-60	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG3619-PA	604210	NP_957705	5e-60	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG3619-PB	604210	NP_957705	5e-60	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG8432-PA	300390	NP_000381	6e-60	CHM;TCD	GGTA;RAB ESCORT PROTEIN 1; REP1;RAB GERANYLGERANYLTRANSFERASE, COMPONENT A;RAB GG TRANSFERASE	Choroideremia, 303100 (3)
CG10242-PA	605325	NP_000768	6e-60	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10702-PA	147370	NP_000866	6e-60	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10702-PB	147370	NP_000866	6e-60	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10702-PC	147370	NP_000866	6e-60	IGF1R		Intrauterine and postnatal growth retardation (3)
CG32451-PA	108730	XP_001127578	6e-60	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG32451-PC	108730	XP_001127578	6e-60	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG7411-PA	138491	NP_000162	7e-60	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG5235-PA	609312	NP_000778	7e-60	DBH	DOPAMINE BETA-MONOOXYGENASE	Dopamine beta-hydroxylase deficiency, 223360 (3);Parkinson disease, resistance to, 168600 (3);[Dopamine-beta-hydroxylase activity levels, plasma] (3)
CG6518-PA	300075	NP_004577	7e-60	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG7904-PA	190181	NP_004603	7e-60	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG5278-PA	605512	NP_073563	7e-60	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG5133-PA	601620	NP_542448	7e-60	TBX5		Holt-Oram syndrome, 142900 (3)
CG5133-PA	601620	NP_000183	8e-60	TBX5		Holt-Oram syndrome, 142900 (3)
CG4926-PA	147670	NP_000199	8e-60	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8674-PA	608918	NP_663729	8e-60	ATPAF2;ATP12	ATP12, S. CEREVISIAE, HOMOLOG OF; ATP12	Complex V, mitochondrial respiratory chain, deficiency of, 604273 (3)
CG10895-PB	604373	NP_665861	8e-60	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10895-PC	604373	NP_665861	8e-60	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG5133-PA	601620	NP_852259	8e-60	TBX5		Holt-Oram syndrome, 142900 (3)
CG9652-PA	126453	NP_000789	9e-60	DRD1B;DRD1L2;DRD5	DOPAMINE RECEPTOR D1B; DRD1B	Dystonia, primary cervical (3);{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3);{Blepharospasm, primary benign}, 606798 (3)
CG10537-PB	137160	NP_000797	9e-60	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG10537-PC	137160	NP_000797	9e-60	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG10537-PA	137164	NP_000807	9e-60	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG3806-PA	603945	NP_003898	9e-60	CACH;CLE;EIF2B5;LVWM	EIF2B-EPSILON;EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, EPSILON	Leukoencephalopathy with vanishing white matter, 603896 (3);Ovarioleukodystrophy, 603896 (3)
CG12311-PA	607423	NP_009102	9e-60	POMT1	ROTATED ABDOMEN, DROSOPHILA, HOMOLOG OF; RT	Muscular dystrophy, congenital, plus mental retardation, 236670 (3);Muscular dystrophy, limb-girdle, type 2K, 609308 (3);Walker-Warburg syndrome, 236670 (3)
CG10537-PA	137164	NP_944494	9e-60	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG32538-PB	100725	NP_000071	1e-59	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG18076-PC	182870	NP_000338	1e-59	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG8523-PA	170260	NP_000584	1e-59	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG7535-PA	137192	NP_000805	1e-59	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG7921-PA	602616	NP_001015883	1e-59	CDGS2;MGAT2	GlcNAc-T II;GnT II;GnT2;II;MGAT2;UDP-N-ACETYLGLUCOSAMINE:ALPHA-6-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE	Carbohydrate-deficient glycoprotein syndrome, type II, 212066 (3)
CG18076-PC	182870	NP_001020029	1e-59	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG12066-PB	164731	NP_001617	1e-59	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10215-PA	126380	NP_001974	1e-59	COFS4;ERCC1;UV20	DNA REPAIR DEFECT UV-20 OF CHINESE HAMSTER OVARY CELLS, COMPLEMENTATION;OF; UV20	Cerebrooculofacioskeletal syndrome 4, 610758 (3)
CG7921-PA	602616	NP_002399	1e-59	CDGS2;MGAT2	GlcNAc-T II;GnT II;GnT2;II;MGAT2;UDP-N-ACETYLGLUCOSAMINE:ALPHA-6-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE	Carbohydrate-deficient glycoprotein syndrome, type II, 212066 (3)
CG5939-PC	160741	NP_002463	1e-59	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG5939-PD	160741	NP_002463	1e-59	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG14396-PA	164770	NP_005202	1e-59	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG14396-PB	164770	NP_005202	1e-59	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG14396-PC	164770	NP_005202	1e-59	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG14396-PD	164770	NP_005202	1e-59	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG14396-PE	164770	NP_005202	1e-59	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG4486-PA	124010	NP_059488	1e-59		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG15097-PB	605379	NP_071324	1e-59	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG3280-PA	606706	NP_619636	1e-59	DFNA36;DFNB11;DFNB7;TMC1		Deafness, autosomal dominant 36, 606705 (3);Deafness, autosomal recessive 7, 600974 (3)
CG4007-PA	147670	NP_000199	2e-59	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG6475-PA	191740	NP_000454	2e-59	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG8345-PA	605325	NP_000768	2e-59	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG4321-PA	601310	NP_000769	2e-59		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG10537-PB	137164	NP_000807	2e-59	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG10537-PC	137164	NP_000807	2e-59	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG7535-PB	138492	NP_000815	2e-59	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG13667-PA	124015	NP_000932	2e-59	POR	CYTOCHROME P450 REDUCTASE	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3);Antley-Bixler syndrome-like with disordered steroidogenesis, 201750 (3);Disordered steroidogenesis, isolated, 201750 (3);POR deficiency, 201750 (3)
CG13667-PB	124015	NP_000932	2e-59	POR	CYTOCHROME P450 REDUCTASE	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3);Antley-Bixler syndrome-like with disordered steroidogenesis, 201750 (3);Disordered steroidogenesis, isolated, 201750 (3);POR deficiency, 201750 (3)
CG18402-PA	600456	NP_001018074	2e-59	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6498-PA	164731	NP_001617	2e-59	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG12232-PA	139360	NP_002061	2e-59	GIP;GNAI2;GNAI2B	2; GNAI2;G PROTEIN, ALPHA-INHIBITING 2B; GNAI2B	Pituitary ACTH-secreting adenoma (3);Ventricular tachycardia, idiopathic, 192605 (3)
CG40129-PA	180381	NP_002920	2e-59	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG8566-PD	602821	NP_004975	2e-59	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG32538-PB	100730	NP_005190	2e-59	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG18402-PA	600456	NP_006171	2e-59	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG5133-PA	601719	NP_060958	2e-59	TBX4		Small patella syndrome, 147891 (3)
CG12891-PA	118490	NP_065574	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PB	118490	NP_065574	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG2945-PA	603930	NP_065857	2e-59	GEPH;GPH;KIAA1385	GPH; GEPH;KIAA1385	Hyperekplexia, 149400 (3);Molybdenum cofactor deficiency, type C, 252150 (3)
CG2945-PB	603930	NP_065857	2e-59	GEPH;GPH;KIAA1385	GPH; GEPH;KIAA1385	Hyperekplexia, 149400 (3);Molybdenum cofactor deficiency, type C, 252150 (3)
CG33106-PA	106410	NP_066187	2e-59	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG33106-PB	106410	NP_066187	2e-59	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG12891-PA	118490	NP_066264	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PB	118490	NP_066264	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PA	118490	NP_066265	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PB	118490	NP_066265	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PA	118490	NP_066266	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12891-PB	118490	NP_066266	2e-59	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG10537-PB	137164	NP_944494	2e-59	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG10537-PC	137164	NP_944494	2e-59	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG3903-PA	177400	NP_000046	3e-59	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG3903-PC	177400	NP_000046	3e-59	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG3903-PD	177400	NP_000046	3e-59	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG3903-PE	177400	NP_000046	3e-59	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG7820-PA	259730	NP_000058	3e-59	CA2	CARBONIC ANHYDRASE II DEFICIENCY;GUIBAUD-VAINSEL SYNDROME;MARBLE BRAIN DISEASE	Renal tubular acidosis-osteopetrosis syndrome (3)
CG10244-PA	147670	NP_000199	3e-59	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG3322-PA	150310	NP_000219	3e-59	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7660-PA	131399	NP_000493	3e-59	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG8523-PA	170261	NP_000535	3e-59	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG3879-PA	170260	NP_000584	3e-59	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG7955-PA	171050	NP_000918	3e-59	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG7955-PB	171050	NP_000918	3e-59	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG7955-PC	171050	NP_000918	3e-59	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG3322-PA	150310	NP_001017402	3e-59	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG3879-PA	300135	NP_004290	3e-59	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG10261-PA	300075	NP_004577	3e-59	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG12600-PA	610533	NP_056053	3e-59		KIAA0869;KIDNEY AND BRAIN EXPRESSED PROTEIN; KIBRA	
CG7535-PA	137192	NP_068712	3e-59	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG13610-PA	607096	NP_653186	3e-59	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG2945-PA	603930	NP_001019389	4e-59	GEPH;GPH;KIAA1385	GPH; GEPH;KIAA1385	Hyperekplexia, 149400 (3);Molybdenum cofactor deficiency, type C, 252150 (3)
CG2945-PB	603930	NP_001019389	4e-59	GEPH;GPH;KIAA1385	GPH; GEPH;KIAA1385	Hyperekplexia, 149400 (3);Molybdenum cofactor deficiency, type C, 252150 (3)
CG10776-PA	602730	NP_001097	4e-59	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG9943-PA	185620	NP_003163	4e-59	SURF1		Leigh syndrome, due to COX deficiency, 256000 (3)
CG17760-PA	139340	NP_005263	4e-59	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG4894-PC	182389	NP_008851	4e-59	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG8351-PA	610150	NP_036205	4e-59	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG10246-PA	124010	NP_059488	4e-59		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG8566-PD	608283	NP_060111	4e-59	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1817-PB	151460	NP_563578	4e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG1817-PC	151460	NP_563578	4e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG8874-PB	300300	NP_000052	5e-59	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8874-PC	300300	NP_000052	5e-59	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG33106-PA	106410	NP_001139	5e-59	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG33106-PB	106410	NP_001139	5e-59	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG1817-PB	151460	NP_002829	5e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG1817-PC	151460	NP_002829	5e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG30054-PB	139340	NP_005263	5e-59	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG7293-PA	608283	NP_060111	5e-59	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG8250-PA	134934	NP_075254	5e-59	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG1817-PB	151460	NP_563579	5e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG1817-PC	151460	NP_563579	5e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG7948-PA	179617	NP_597994	5e-59	RAD51A;RECA	RAD51, S. CEREVISIAE, HOMOLOG OF, A; RAD51A;RECA, E. COLI, HOMOLOG OF;RECOMBINATION PROTEIN A; RECA	{Breast cancer, susceptibility to}, 114480 (3)
CG7948-PB	179617	NP_597994	5e-59	RAD51A;RECA	RAD51, S. CEREVISIAE, HOMOLOG OF, A; RAD51A;RECA, E. COLI, HOMOLOG OF;RECOMBINATION PROTEIN A; RECA	{Breast cancer, susceptibility to}, 114480 (3)
CG10211-PA	606765	NP_783650	5e-59	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG8250-PA	134934	NP_000133	6e-59	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6798-PB	100690	NP_001034612	6e-59	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG8224-PA	602730	NP_001097	6e-59	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG8224-PB	602730	NP_001097	6e-59	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG10595-PA	160775	NP_002464	6e-59	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG8874-PA	600997	NP_004433	6e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PB	600997	NP_004433	6e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PC	600997	NP_004433	6e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PD	600997	NP_004433	6e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG5300-PA	602821	NP_004975	6e-59	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG10212-PA	300040	NP_006297	6e-59	CDLS2;DXS423E;SMC1	DXS423E;KIAA0178;SMC1;SMC1-ALPHA;STRUCTURAL MAINTENANCE OF CHROMOSOMES 1-LIKE 1; SMC1L1	Cornelia de Lange syndrome 2, 300590 (3)
CG17975-PA	138140	NP_006507	6e-59	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG5939-PC	160740	NP_060004	6e-59	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG5939-PD	160740	NP_060004	6e-59	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG9342-PA	157147	NP_000244	7e-59	MTP	MTP, LARGE SUBUNIT	Abetalipoproteinemia, 200100 (3);{Metabolic syndrome, protection against}, 605552 (3)
CG8824-PB	606873	NP_000512	7e-59	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG8824-PC	606873	NP_000512	7e-59	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG4128-PC	118502	NP_000733	7e-59	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG6638-PA	609576	NP_001599	7e-59	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG8874-PA	600997	NP_059145	7e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PB	600997	NP_059145	7e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PC	600997	NP_059145	7e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8874-PD	600997	NP_059145	7e-59	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG5483-PA	609007	NP_940980	7e-59	LRRK2;PARK8	DARDARIN	Parkinson disease-8, 607060 (3)
CG10212-PA	606062	NP_005436	8e-59	BAM;CDLS3;CSPG6;HCAP;SMC3	BAMACAN; BAM;HUMAN CHROMOSOME-ASSOCIATED POLYPEPTIDE; HCAP;STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	Cornelia de Lange syndrome 3, 610759 (3)
CG3936-PA	600985	NP_061978	8e-59	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG30171-PB	188840	NP_596870	8e-59	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG3388-PA	607108	NP_000271	9e-59	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG10244-PA	147370	NP_000866	9e-59	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8908-PB	600046	NP_005493	9e-59	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG6899-PA	151460	NP_563578	9e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG6899-PB	151460	NP_563578	9e-59	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG17970-PA	608614	NP_997235	9e-59	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG3902-PA	607008	NP_000007	1e-58	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG6638-PA	607008	NP_000007	1e-58	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG6816-PA	601771	NP_000095	1e-58	CYP1B1;GLC3A	P4501B1	Glaucoma 3A, primary congenital, 231300 (3);Glaucoma, early-onset, digenic (3);Glaucoma, primary open angle, adult-onset, 137760 (3);Glaucoma, primary open angle, juvenile-onset, 137750 (3);Peters anomaly, 604229 (3)
CG6816-PB	601771	NP_000095	1e-58	CYP1B1;GLC3A	P4501B1	Glaucoma 3A, primary congenital, 231300 (3);Glaucoma, early-onset, digenic (3);Glaucoma, primary open angle, adult-onset, 137760 (3);Glaucoma, primary open angle, juvenile-onset, 137750 (3);Peters anomaly, 604229 (3)
CG30054-PA	139330	NP_000163	1e-58	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG10226-PA	170261	NP_000535	1e-58	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG16761-PA	601310	NP_000769	1e-58		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG4926-PA	147370	NP_000866	1e-58	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10361-PA	301300	NP_001033058	1e-58	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG6546-PA	102610	NP_001091	1e-58	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG6716-PB	607108	NP_001595	1e-58	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG12262-PA	607036	NP_002216	1e-58	IVD		Isovaleric acidemia, 243500 (3)
CG31045-PB	160720	NP_002461	1e-58	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG31045-PE	160720	NP_002461	1e-58	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG6899-PA	151460	NP_002829	1e-58	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG6899-PB	151460	NP_002829	1e-58	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG10443-PA	600925	NP_002834	1e-58	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG6977-PA	605514	NP_149045	1e-58	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG7100-PD	605514	NP_149045	1e-58	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG7100-PF	605514	NP_149045	1e-58	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG6899-PA	151460	NP_563579	1e-58	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG6899-PB	151460	NP_563579	1e-58	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG30054-PA	139330	NP_653082	1e-58	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG9191-PA	605995	NP_904325	1e-58	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG10361-PA	301300	NP_000023	2e-58	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG3903-PB	177400	NP_000046	2e-58	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG8874-PA	300300	NP_000052	2e-58	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8874-PD	300300	NP_000052	2e-58	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG7223-PA	164920	NP_000213	2e-58	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG7223-PB	164920	NP_000213	2e-58	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG7223-PC	164920	NP_000213	2e-58	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG7955-PA	171060	NP_000434	2e-58	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PB	171060	NP_000434	2e-58	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PC	171060	NP_000434	2e-58	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG4128-PC	118507	NP_000739	2e-58	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG10246-PA	605325	NP_000768	2e-58	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10361-PA	301300	NP_001033056	2e-58	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG10361-PA	301300	NP_001033057	2e-58	ALAS2;ANH1;ASB	ANEMIA, HEREDITARY SIDEROBLASTIC;ANEMIA, HYPOCHROMIC;ANH1;HEREDITARY IRON-LOADING ANEMIA;XLSA; ASB	Anemia, sideroblastic/hypochromic (3)
CG12299-PA	300573	NP_001034980	2e-58	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG5939-PA	160775	NP_002464	2e-58	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG5939-PB	160775	NP_002464	2e-58	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG6006-PA	603377	NP_003051	2e-58	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG5125-PA	602129	NP_004136	2e-58	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG5125-PB	602129	NP_004136	2e-58	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG6546-PA	102540	NP_005150	2e-58	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG6842-PA	604277	NP_055761	2e-58	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG9191-PA	605995	NP_055889	2e-58	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG32000-PC	610513	NP_071372	2e-58	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG32000-PD	610513	NP_071372	2e-58	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG32000-PE	610513	NP_071372	2e-58	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG32000-PF	610513	NP_071372	2e-58	ATP13A2;PARK9;KRPPD		Kufor-Rakeb syndrome, 606693 (3)
CG5018-PA	607456	NP_116219	2e-58	CIRH1A;KIAA1988;NAIC;TEX292	KIAA1988;TESTIS-EXPRESSED GENE 292; TEX292	Cirrhosis, North American Indian childhood type, 604901 (3)
CG6842-PA	604277	NP_955468	2e-58	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG1228-PA	130500	NP_976218	2e-58	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PC	130500	NP_976218	2e-58	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG1228-PD	130500	NP_976218	2e-58	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9764-PA	130500	NP_976218	2e-58	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG3902-PA	609575	NP_000009	3e-58	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG12345-PA	600650	NP_000089	3e-58	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG10413-PA	600968	NP_000330	3e-58	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG6713-PA	124015	NP_000932	3e-58	POR	CYTOCHROME P450 REDUCTASE	Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency, 201750 (3);Antley-Bixler syndrome-like with disordered steroidogenesis, 201750 (3);Disordered steroidogenesis, isolated, 201750 (3);POR deficiency, 201750 (3)
CG3902-PA	609575	NP_001029031	3e-58	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG6716-PA	607108	NP_001595	3e-58	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG12069-PA	605437	NP_006246	3e-58	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG3871-PA	606326	NP_031400	3e-58	SIX6;MCOPCT2		Microphthalmia, isolated, with cataract 2, 212550 (3)
CG3871-PB	606326	NP_031400	3e-58	SIX6;MCOPCT2		Microphthalmia, isolated, with cataract 2, 212550 (3)
CG5187-PA	601719	NP_060958	3e-58	TBX4		Small patella syndrome, 147891 (3)
CG14694-PA	606152	NP_079519	3e-58	SLC19A3		Basal ganglia disease, biotin-responsive, 607483 (3)
CG4898-PB	191010	NP_000357	4e-58	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_000357	4e-58	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_000357	4e-58	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_000357	4e-58	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG7806-PA	602421	NP_000483	4e-58	ABCC7;CF;CFTR;MRP7	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 7; ABCC7	Congenital bilateral absence of vas deferens, 277180 (3);Cystic fibrosis, 219700 (3);Sweat chloride elevation without CF (3);{Hypertrypsinemia, neonatal} (3);{Pancreatitis, idiopathic} (3)
CG30171-PB	188840	NP_003310	4e-58	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG30054-PA	139340	NP_005263	4e-58	ACHM4;GNAT2	2; GNAT2;G PROTEIN, ALPHA-TRANSDUCING 2;TRANSDUCIN, CONE-SPECIFIC, ALPHA POLYPEPTIDE	Achromatopsia-4 (3)
CG30171-PB	188840	NP_597681	4e-58	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5899-PA	609413	NP_000115	5e-58	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG7535-PA	138492	NP_000815	5e-58	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG18402-PA	134935	NP_002002	5e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG2105-PA	606635	NP_002763	5e-58	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG4032-PA	600997	NP_004433	5e-58	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG9436-PA	604741	NP_005980	5e-58		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG11247-PA	314995	NP_009061	5e-58	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11247-PB	314995	NP_009061	5e-58	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG18402-PA	134935	NP_075252	5e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG11247-PA	314995	NP_700359	5e-58	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11247-PB	314995	NP_700359	5e-58	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG18402-PA	134935	NP_998812	5e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG32134-PA	600221	NP_000450	6e-58	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG32975-PA	118502	NP_000733	6e-58	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG32387-PA	120470	NP_005206	6e-58	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG32387-PB	120470	NP_005206	6e-58	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG4032-PA	600997	NP_059145	6e-58	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10895-PA	604373	NP_665861	6e-58	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG4032-PA	134935	NP_002002	7e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4032-PA	134935	NP_075252	7e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4032-PA	134935	NP_998812	7e-58	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8224-PB	190182	NP_003233	8e-58	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG2822-PA	607604	NP_598004	8e-58		KV11.1	
CG2822-PB	607604	NP_598004	8e-58		KV11.1	
CG2397-PA	605325	NP_000768	9e-58	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8224-PB	190182	NP_001020018	9e-58	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG18402-PA	134934	NP_000133	1e-57	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG14526-PA	300550	NP_000435	1e-57	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG6649-PA	191740	NP_000454	1e-57	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG33128-PA	179820	NP_000528	1e-57	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG1500-PA	120620	NP_000564	1e-57	C3BR;CR1	C3-BINDING PROTEIN; CD35;COMPLEMENT COMPONENT 3b/4b RECEPTOR	CR1 deficiency (1);[Blood group, Knops system], 607486 (3);{?SLE susceptibility} (1)
CG1500-PA	120620	NP_000642	1e-57	C3BR;CR1	C3-BINDING PROTEIN; CD35;COMPLEMENT COMPONENT 3b/4b RECEPTOR	CR1 deficiency (1);[Blood group, Knops system], 607486 (3);{?SLE susceptibility} (1)
CG31782-PA	300573	NP_001034980	1e-57	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG11228-PA	300142	NP_002569	1e-57	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG6297-PA	176960	NP_002728	1e-57	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6297-PB	176960	NP_002728	1e-57	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG15523-PA	607817	NP_056058	1e-57	COH1	KIAA0532;VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	Cohen syndrome, 216550 (3)
CG5326-PA	605512	NP_073563	1e-57	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG18402-PA	134934	NP_075254	1e-57	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8355-PA	600275	NP_077719	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8355-PB	600275	NP_077719	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8355-PC	600275	NP_077719	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG31999-PA	608548	NP_114141	1e-57	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7526-PA	608548	NP_114141	1e-57	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG5187-PA	601620	NP_542448	1e-57	TBX5		Holt-Oram syndrome, 142900 (3)
CG5187-PA	601620	NP_542449	1e-57	TBX5		Holt-Oram syndrome, 142900 (3)
CG12292-PA	608145	NP_653200	1e-57	NIPA1;SPG6	REGION 1; NIPA1	Spastic paraplegia-6, 600363 (3)
CG1651-PA	608774	NP_848605	1e-57	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG1651-PB	608774	NP_848605	1e-57	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG1651-PC	608774	NP_848605	1e-57	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG1651-PD	608774	NP_848605	1e-57	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG8355-PA	600275	XP_001133349	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8355-PB	600275	XP_001133349	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8355-PC	600275	XP_001133349	1e-57	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG8250-PA	176943	NP_000132	2e-57	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG31414-PA	606463	NP_000148	2e-57	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG17760-PA	139330	NP_000163	2e-57	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5187-PA	601620	NP_000183	2e-57	TBX5		Holt-Oram syndrome, 142900 (3)
CG31045-PB	160777	NP_000250	2e-57	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG31045-PE	160777	NP_000250	2e-57	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG17975-PA	138160	NP_000331	2e-57	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG17800-PA	308840	NP_000416	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PB	308840	NP_000416	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PC	308840	NP_000416	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PD	308840	NP_000416	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG31665-PA	600276	NP_000426	2e-57	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG11715-PA	601310	NP_000769	2e-57		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG17484-PA	602861	NP_001005242	2e-57	PKP2;ARVD9		Arrhythmogenic right ventricular dysplasia, familial, 9, 609040 (3)
CG31414-PA	606463	NP_001005741	2e-57	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31414-PA	606463	NP_001005742	2e-57	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31414-PA	606463	NP_001005749	2e-57	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG31414-PA	606463	NP_001005750	2e-57	GBA	ACID BETA-GLUCOSIDASE;BETA-GLUCOSIDASE, ACID;GLUCOCEREBROSIDASE;GLUCOSYLCERAMIDASE	Gaucher disease, perinatal lethal, 608013 (3);Gaucher disease, type I, 230800(3);Gaucher disease, type II, 230900 (3);Gaucher disease, type III, 231000 (3);Gaucher disease, type IIIC, 231005 (3)
CG4898-PB	191010	NP_001018004	2e-57	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018004	2e-57	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018004	2e-57	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018004	2e-57	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG10595-PA	602129	NP_004136	2e-57	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG10595-PA	601478	NP_005370	2e-57	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG4084-PA	608750	NP_005778	2e-57	ALG3;CDGS4;NOT56L	NOT56-LIKE PROTEIN; NOT56L	Congenital disorder of glycosylation, type Id, 601110 (3)
CG30265-PA	604322	NP_036566	2e-57	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG15844-PA	608283	NP_060111	2e-57	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG8250-PA	176943	NP_075259	2e-57	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17800-PA	308840	NP_076493	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PB	308840	NP_076493	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PC	308840	NP_076493	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17800-PD	308840	NP_076493	2e-57	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17760-PA	139330	NP_653082	2e-57	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5187-PA	601620	NP_852259	2e-57	TBX5		Holt-Oram syndrome, 142900 (3)
CG6816-PA	122720	NP_000753	3e-57	CYP2A;CYP2A3;CYP2A6;P450C2A	COUMARIN 7-HYDROXYLASE;CYP2A3, FORMERLY;CYTOCHROME P450, PHENOBARBITAL-INDUCIBLE; P450PB	Coumarin resistance, 122700 (3);{Lung cancer, resistance to}, 211980 (3);{Nicotine addiction, protection from} (3)
CG6816-PB	122720	NP_000753	3e-57	CYP2A;CYP2A3;CYP2A6;P450C2A	COUMARIN 7-HYDROXYLASE;CYP2A3, FORMERLY;CYTOCHROME P450, PHENOBARBITAL-INDUCIBLE; P450PB	Coumarin resistance, 122700 (3);{Lung cancer, resistance to}, 211980 (3);{Nicotine addiction, protection from} (3)
CG12800-PA	605325	NP_000768	3e-57	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8380-PA	608893	NP_001003841	3e-57	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG4032-PA	176947	NP_001070	3e-57	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG12069-PA	164731	NP_001617	3e-57	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG12345-PA	600528	NP_001867	3e-57	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG8416-PA	602049	NP_002863	3e-57	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG8416-PB	602049	NP_002863	3e-57	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG8416-PC	602049	NP_002863	3e-57	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG8416-PD	602049	NP_002863	3e-57	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG7442-PA	603377	NP_003051	3e-57	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG3903-PA	100740	NP_056646	3e-57	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PB	100740	NP_056646	3e-57	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PC	100740	NP_056646	3e-57	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PD	100740	NP_056646	3e-57	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PE	100740	NP_056646	3e-57	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG12800-PA	124010	NP_059488	3e-57		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG10718-PA	608283	NP_060111	3e-57	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG17678-PA	139320	NP_536350	3e-57	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG5300-PA	605995	NP_904325	3e-57	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG3725-PA	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PB	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PC	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PD	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PE	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PF	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PG	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3725-PH	108733	NP_001001331	4e-57	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG3956-PA	602150	NP_003059	4e-57	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG4261-PA	604289	NP_036547	4e-57	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5093-PA	601719	NP_060958	4e-57	TBX4		Small patella syndrome, 147891 (3)
CG8250-PA	134935	NP_075252	4e-57	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7981-PA	608548	NP_114141	4e-57	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7981-PC	608548	NP_114141	4e-57	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7981-PD	608548	NP_114141	4e-57	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1944-PA	608614	NP_997235	4e-57	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG7356-PA	177070	NP_000110	5e-57	EPB42		Spherocytosis, hereditary, Japanese type (3)
CG7356-PB	177070	NP_000110	5e-57	EPB42		Spherocytosis, hereditary, Japanese type (3)
CG12232-PA	139330	NP_000163	5e-57	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG5594-PA	600968	NP_000330	5e-57	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG5594-PB	600968	NP_000330	5e-57	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG8250-PA	134935	NP_002002	5e-57	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8250-PA	191315	NP_002520	5e-57	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7097-PA	300142	NP_002569	5e-57	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG7097-PB	300142	NP_002569	5e-57	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG5300-PA	605995	NP_055889	5e-57	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG31731-PA	607800	NP_056472	5e-57	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG3736-PA	608892	NP_060250	5e-57	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG9664-PA	605460	NP_071882	5e-57	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG9664-PB	605460	NP_071882	5e-57	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG12232-PA	139330	NP_653082	5e-57	GNAT1	1; GNAT1;G PROTEIN, ALPHA-TRANSDUCING 1;TRANSDUCIN, ROD-SPECIFIC, ALPHA POLYPEPTIDE	Night blindness, congenital stationary (3)
CG2110-PA	608614	NP_997235	5e-57	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG8250-PA	134935	NP_998812	5e-57	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG15831-PA	276903	NP_000251	6e-57	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG3616-PA	605325	NP_000768	6e-57	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8250-PA	191315	NP_001007793	6e-57	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8250-PA	191315	NP_001012331	6e-57	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7904-PA	603248	NP_001194	6e-57	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG12066-PB	176960	NP_002728	6e-57	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6760-PA	601023	NP_009057	6e-57	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG16801-PA	604485	NP_055064	6e-57	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG8687-PB	124010	NP_059488	6e-57		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG31731-PA	607800	NP_775099	6e-57	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG31536-PC	130500	NP_976218	6e-57	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG4677-PA	165240	NP_000159	7e-57	ACLS;GLI3;PAPA;PAPB	ONCOGENE GLI3	Acrocallosal syndrome, 200990 (3);Greig cephalopolysyndactyly syndrome, 175700 (3);Pallister-Hall syndrome, 146510 (3);Polydactyly, postaxial, types A1 and B, 174200 (3);Polydactyly, preaxial, type IV, 174700 (3)
CG4677-PB	165240	NP_000159	7e-57	ACLS;GLI3;PAPA;PAPB	ONCOGENE GLI3	Acrocallosal syndrome, 200990 (3);Greig cephalopolysyndactyly syndrome, 175700 (3);Pallister-Hall syndrome, 146510 (3);Polydactyly, postaxial, types A1 and B, 174200 (3);Polydactyly, preaxial, type IV, 174700 (3)
CG9594-PA	604289	NP_036547	7e-57	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG1847-PA	604392	NP_055151	7e-57	AIPL1;LCA4		Cone-rod dystrophy (3);Leber congenital amaurosis, 604393 (3);Retinitis pigmentosa, juvenile (3)
CG2086-PB	600985	NP_061978	7e-57	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG4703-PA	609575	NP_000009	8e-57	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG8799-PA	171060	NP_000434	8e-57	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG4703-PA	609575	NP_001029031	8e-57	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG16801-PB	604485	NP_055064	8e-57	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG3879-PA	601107	NP_000383	9e-57	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG4879-PA	604611	NP_000544	9e-57	RECQ3;RECQL2;WRN	DNA HELICASE, RECQ-LIKE, TYPE 3; RECQ3;WRN GENE; WRN	Werner syndrome, 277700 (3)
CG4879-PB	604611	NP_000544	9e-57	RECQ3;RECQL2;WRN	DNA HELICASE, RECQ-LIKE, TYPE 3; RECQ3;WRN GENE; WRN	Werner syndrome, 277700 (3)
CG11502-PB	600281	NP_001025174	9e-57	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG10175-PA	114840	NP_001798	9e-57	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG10175-PC	114840	NP_001798	9e-57	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG1776-PA	188840	NP_003310	9e-57	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4261-PA	603615	NP_003570	9e-57	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG1522-PA	182389	NP_008851	9e-57	FEB3;GEFSP2;SCN1A;SMEI	NAV1.1;SODIUM CHANNEL, BRAIN TYPE I, ALPHA SUBUNIT; NAC1	Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3);Epilepsy, intractable childhood, with generalized tonic-clonic seizures, 607208 (3);Epilepsy, severe myoclonic, of infancy, 607208 (3);Febrile convulsions, familial, 3, 604403 (3);Migraine, familial hemiplegic, 3, 609634 (3)
CG1776-PA	188840	NP_597676	9e-57	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG1776-PA	188840	NP_597681	9e-57	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG11502-PB	600281	NP_787110	9e-57	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG11186-PA	167409	NP_000269	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PB	167409	NP_000269	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG3903-PA	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PB	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PC	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PD	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3903-PE	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4757-PA	100740	NP_000656	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG11502-PB	600281	NP_001025175	1e-56	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG5125-PA	160745	NP_002465	1e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5125-PB	160745	NP_002465	1e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG11186-PA	167409	NP_003979	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PB	167409	NP_003979	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PA	167409	NP_003980	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PB	167409	NP_003980	1e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG4154-PA	108961	NP_003986	1e-56	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG4154-PC	108961	NP_003986	1e-56	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG10244-PA	136351	NP_004110	1e-56	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG7873-PA	600997	NP_004433	1e-56	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7873-PB	600997	NP_004433	1e-56	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG12245-PA	603716	NP_004743	1e-56	GCMB	GCMB	Hypoparathyroidism, familial isolated, 146200 (3)
CG9191-PA	602821	NP_004975	1e-56	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG3871-PA	603714	NP_005404	1e-56	HPE2;SIX3		Holoprosencephaly-2, 157170 (3)
CG3871-PB	603714	NP_005404	1e-56	HPE2;SIX3		Holoprosencephaly-2, 157170 (3)
CG30084-PB	605906	NP_009009	1e-56	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG4360-PA	314995	NP_009061	1e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1522-PA	600702	NP_055006	1e-56		NAV1.6	
CG4757-PA	100740	NP_056646	1e-56	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG18402-PA	136350	NP_056934	1e-56	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PA	600997	NP_059145	1e-56	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7873-PB	600997	NP_059145	1e-56	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG5125-PA	160745	NP_074035	1e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5125-PB	160745	NP_074035	1e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG18402-PA	136350	NP_075593	1e-56	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18402-PA	136350	NP_075594	1e-56	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG6445-PA	605516	NP_443068	1e-56	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG6445-PB	605516	NP_443068	1e-56	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG5093-PA	601620	NP_542449	1e-56	TBX5		Holt-Oram syndrome, 142900 (3)
CG1776-PA	188840	NP_596869	1e-56	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4360-PA	314995	NP_700359	1e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4894-PA	600163	XP_001131636	1e-56	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PB	600163	XP_001131636	1e-56	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4894-PD	600163	XP_001131636	1e-56	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG10498-PA	123829	NP_000066	2e-56	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10498-PB	123829	NP_000066	2e-56	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG5093-PA	601620	NP_000183	2e-56	TBX5		Holt-Oram syndrome, 142900 (3)
CG31665-PA	601920	NP_000205	2e-56	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG14527-PA	300550	NP_000435	2e-56	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG4302-PA	191740	NP_000454	2e-56	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG2302-PA	100710	NP_000738	2e-56	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG1829-PA	605325	NP_000768	2e-56	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG14723-PA	138492	NP_000815	2e-56	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG8250-PA	600456	NP_001018074	2e-56	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG2107-PA	600528	NP_001867	2e-56	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG3156-PA	300135	NP_004290	2e-56	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG7904-PA	601299	NP_004320	2e-56	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG10033-PA	300075	NP_004577	2e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10033-PB	300075	NP_004577	2e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10033-PC	300075	NP_004577	2e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10033-PD	300075	NP_004577	2e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10033-PE	300075	NP_004577	2e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG3858-PA	603716	NP_004743	2e-56	GCMB	GCMB	Hypoparathyroidism, familial isolated, 146200 (3)
CG31731-PA	600046	NP_005493	2e-56	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG8250-PA	600456	NP_006171	2e-56	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG31224-PA	314995	NP_009061	2e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG3696-PA	604289	NP_036547	2e-56	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8103-PA	604289	NP_036547	2e-56	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5093-PA	601620	NP_542448	2e-56	TBX5		Holt-Oram syndrome, 142900 (3)
CG7393-PA	602897	NP_620447	2e-56	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG14869-PA	604134	NP_620595	2e-56	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG31224-PA	314995	NP_700359	2e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG5093-PA	601620	NP_852259	2e-56	TBX5		Holt-Oram syndrome, 142900 (3)
CG10181-PA	601107	NP_000383	3e-56	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG3540-PA	601310	NP_000769	3e-56		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG1379-PA	151385	NP_001001890	3e-56	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG11352-PB	300573	NP_001034980	3e-56	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG11352-PC	300573	NP_001034980	3e-56	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG3978-PA	600576	NP_002043	3e-56	GATA4		Atrial septal defect-2, 607941 (3)
CG3978-PB	600576	NP_002043	3e-56	GATA4		Atrial septal defect-2, 607941 (3)
CG6117-PA	300075	NP_004577	3e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG6117-PB	300075	NP_004577	3e-56	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG7955-PA	171060	NP_061337	3e-56	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PB	171060	NP_061337	3e-56	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PC	171060	NP_061337	3e-56	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG18402-PA	176943	NP_075259	3e-56	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG12201-PA	609302	NP_078974	3e-56	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG17800-PD	188840	NP_596869	3e-56	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG17309-PA	300300	NP_000052	4e-56	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG17309-PB	300300	NP_000052	4e-56	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG17309-PC	300300	NP_000052	4e-56	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG17309-PD	300300	NP_000052	4e-56	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG17309-PE	300300	NP_000052	4e-56	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG18402-PA	176943	NP_000132	4e-56	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG1522-PA	600163	NP_000326	4e-56	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4128-PC	118504	NP_000735	4e-56	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG7535-PA	137160	NP_000797	4e-56	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG1379-PA	151385	NP_001745	4e-56	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1041-PA	600528	NP_001867	4e-56	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG14026-PA	190182	NP_003233	4e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PB	190182	NP_003233	4e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PC	190182	NP_003233	4e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PD	190182	NP_003233	4e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG11186-PA	167409	NP_003978	4e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PB	167409	NP_003978	4e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PA	167409	NP_003981	4e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11186-PB	167409	NP_003981	4e-56	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG3705-PA	172480	NP_004568	4e-56	PSP	PSP	Phosphoserine phosphatase deficiency (3)
CG8874-PA	189980	NP_005148	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PB	189980	NP_005148	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PC	189980	NP_005148	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PD	189980	NP_005148	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PA	189980	NP_009297	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PB	189980	NP_009297	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PC	189980	NP_009297	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8874-PD	189980	NP_009297	4e-56	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8766-PA	300394	NP_851830	4e-56	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PB	300394	NP_851830	4e-56	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PC	300394	NP_851830	4e-56	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG1522-PA	600163	NP_932173	4e-56	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG5485-PA	126650	NP_000102	5e-56	CLD;DRA;SLC26A3	DOWNREGULATED IN ADENOMA; DRA	Chloride diarrhea, congenital, Finnish type, 214700 (3);Colon cancer (1) (?)
CG11502-PB	600281	NP_000448	5e-56	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG14026-PA	190182	NP_001020018	5e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PB	190182	NP_001020018	5e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PC	190182	NP_001020018	5e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG14026-PD	190182	NP_001020018	5e-56	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG5527-PA	600423	NP_001388	5e-56	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG10595-PA	160745	NP_002465	5e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31776-PA	601756	NP_004473	5e-56	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG8183-PA	602821	NP_004975	5e-56	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG8183-PB	602821	NP_004975	5e-56	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG11186-PA	167415	NP_054698	5e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PB	167415	NP_054698	5e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4894-PC	600702	NP_055006	5e-56		NAV1.6	
CG10595-PA	160745	NP_074035	5e-56	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG2125-PA	610192	NP_689842	5e-56	GLIS3;ZNF515	GLI-SIMILAR PROTEIN 3;ZINC FINGER PROTEIN 515; ZNF515	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
CG11502-PB	600281	NP_849180	5e-56	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG11502-PB	600281	NP_849181	5e-56	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG31089-PA	278000	NP_000226	6e-56	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG5772-PA	600509	NP_000343	6e-56	ABCC8;HHF1;PHHI;SUR;SUR1;TNDM2	SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY;SULFONYLUREA RECEPTOR; SUR;SUR1	Diabetes mellitus, noninsulin-dependent, 125853 (3);Diabetes mellitus, permanent neonatal, 606176 (3);Diabetes mellitus, transient neonatal 2, 610374 (3);Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);Hypoglycemia of infancy, leucine-sensitive, 240800 (3)
CG5485-PA	605646	NP_000432	6e-56	DFNB4;PDS;SLC26A4	PDS GENE;PENDRIN	Deafness, autosomal recessive 4, 600791 (3);Enlarged vestibular aqueduct, 603545 (3);Pendred syndrome, 274600 (3)
CG7627-PA	171060	NP_000434	6e-56	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG2049-PD	176980	NP_002730	6e-56	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG9825-PA	604322	NP_036566	6e-56	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG11186-PA	167415	NP_039247	6e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PB	167415	NP_039247	6e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG14900-PA	605516	NP_071407	6e-56	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7100-PE	605514	NP_149045	6e-56	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG7100-PG	605514	NP_149045	6e-56	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG5873-PA	606765	NP_783650	6e-56	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG18076-PH	182870	NP_000338	7e-56	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG9656-PA	131320	NP_001002295	7e-56	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG7981-PA	192977	NP_001018066	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PB	192977	NP_001018066	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PC	192977	NP_001018066	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PD	192977	NP_001018066	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PE	192977	NP_001018066	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG18076-PH	182870	NP_001020029	7e-56	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG3388-PA	607108	NP_001595	7e-56	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG7981-PA	192977	NP_003374	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PB	192977	NP_003374	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PC	192977	NP_003374	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PD	192977	NP_003374	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG7981-PE	192977	NP_003374	7e-56	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG6392-PA	602821	NP_004975	7e-56	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG18402-PA	191315	NP_001007793	8e-56	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG15269-PA	314995	NP_009061	8e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG11186-PA	167415	NP_039245	8e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PB	167415	NP_039245	8e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PA	167415	NP_039246	8e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PB	167415	NP_039246	8e-56	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4700-PA	607292	NP_071762	8e-56	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG4700-PB	607292	NP_071762	8e-56	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG4700-PC	607292	NP_071762	8e-56	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG16869-PA	106180	NP_690043	8e-56	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG16869-PA	106180	NP_690044	8e-56	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG15269-PA	314995	NP_700359	8e-56	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10215-PA	126380	NP_973730	8e-56	COFS4;ERCC1;UV20	DNA REPAIR DEFECT UV-20 OF CHINESE HAMSTER OVARY CELLS, COMPLEMENTATION;OF; UV20	Cerebrooculofacioskeletal syndrome 4, 610758 (3)
CG18247-PA	176947	NP_997402	8e-56	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG18402-PA	191315	NP_001012331	9e-56	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG18402-PA	191315	NP_002520	9e-56	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17800-PC	188840	NP_596869	9e-56	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG31665-PA	604210	NP_957705	9e-56	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG6716-PA	167409	NP_000269	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	167409	NP_000269	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6633-PA	191740	NP_000454	1e-55	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG4382-PA	100740	NP_000656	1e-55	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8859-PA	605325	NP_000768	1e-55	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG9438-PA	605325	NP_000768	1e-55	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG16869-PA	106180	NP_000780	1e-55	ACE;ACE1;DCP1	ACE1;DIPEPTIDYL CARBOXYPEPTIDASE 1; DCP1;IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO,;KININASE II	Renal tubular dysgenesis, 267430 (3);[Angiotensin I-converting enzyme, benign serum increase] (3);{Alzheimer disease, susceptibility to}, 104300 (3);{Diabetic nephropathy, susceptibility to}, 603933 (3);{Myocardial infarction, susceptibility to} (3);{SARS, progression of} (3)
CG5125-PA	160745	NP_001035202	1e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5125-PB	160745	NP_001035202	1e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5125-PA	160745	NP_001035203	1e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5125-PB	160745	NP_001035203	1e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8665-PA	107323	NP_001173	1e-55		ANTIQUITIN; ATQ1	
CG5122-PA	600528	NP_001867	1e-55	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG8654-PA	603377	NP_003051	1e-55	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG11186-PA	167415	NP_003457	1e-55	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11186-PB	167415	NP_003457	1e-55	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PA	167409	NP_003979	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	167409	NP_003979	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PA	167409	NP_003980	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	167409	NP_003980	1e-55	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8885-PA	604272	NP_005129	1e-55	SCO2		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, 604377 (3)
CG31190-PA	120470	NP_005206	1e-55	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG4685-PA	603178	NP_005580	1e-55	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG30084-PC	605906	NP_009009	1e-55	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG12490-PA	604322	NP_036566	1e-55	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG4382-PA	100740	NP_056646	1e-55	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG1829-PA	124010	NP_059488	1e-55		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG31523-PA	605512	NP_073563	1e-55	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31523-PB	605512	NP_073563	1e-55	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31523-PC	605512	NP_073563	1e-55	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31523-PD	605512	NP_073563	1e-55	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG6392-PA	605995	NP_904325	1e-55	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG4376-PA	601282	NP_958780	1e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958780	1e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958784	1e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG3476-PA	212138	XP_001133926	1e-55	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG18076-PA	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_000100	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG4376-PA	601282	NP_000436	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_000436	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG30019-PA	602136	NP_000457	2e-55	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG32975-PA	118504	NP_000735	2e-55	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG2107-PA	600528	NP_001027017	2e-55	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG14476-PA	609845	NP_001032	2e-55	SI		Sucrase-isomaltase deficiency, congenital, 222900 (3)
CG14476-PB	609845	NP_001032	2e-55	SI		Sucrase-isomaltase deficiency, congenital, 222900 (3)
CG14476-PC	609845	NP_001032	2e-55	SI		Sucrase-isomaltase deficiency, congenital, 222900 (3)
CG14476-PD	609845	NP_001032	2e-55	SI		Sucrase-isomaltase deficiency, congenital, 222900 (3)
CG14476-PE	609845	NP_001032	2e-55	SI		Sucrase-isomaltase deficiency, congenital, 222900 (3)
CG10595-PA	160745	NP_001035202	2e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG10595-PA	160745	NP_001035203	2e-55	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG18247-PA	176947	NP_001070	2e-55	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7820-PA	114800	NP_001729	2e-55		CA I;CARBONIC ANHYDRASE A;CARBONIC ANHYDRASE I, ERYTHROCYTE, ELECTROPHORETIC VARIANTS OF	
CG13758-PA	114131	NP_001733	2e-55	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG9656-PA	131320	NP_002042	2e-55	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG4328-PA	602575	NP_002307	2e-55	LMX1B;NPS1	LMX1.2	Nail-patella syndrome with open-angle glaucoma, 137750 (3);Nail-patella syndrome, 161200 (3)
CG7892-PA	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PB	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PC	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PE	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PF	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PG	602897	NP_002744	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG6006-PA	604190	NP_003050	2e-55	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG3696-PA	603615	NP_003570	2e-55	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG9594-PA	603615	NP_003570	2e-55	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG18076-PA	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_003997	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PA	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_003998	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PA	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_004000	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PA	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_004001	2e-55	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18345-PC	603652	NP_004612	2e-55	FSGS2;TRP6;TRPC6	TRANSIENT RECEPTOR POTENTIAL, DROSOPHILA, HOMOLOG OF, 6; TRP6;TRPC6	Glomerulosclerosis, focal segmental, 2, 603965 (3)
CG13521-PA	120470	NP_005206	2e-55	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG13521-PB	120470	NP_005206	2e-55	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG6117-PA	605437	NP_006246	2e-55	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG6117-PB	605437	NP_006246	2e-55	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG17976-PA	138140	NP_006507	2e-55	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG3322-PA	608400	NP_009054	2e-55	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG6392-PA	605995	NP_055889	2e-55	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG2107-PA	118490	NP_065574	2e-55	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG2107-PA	118490	NP_066264	2e-55	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG2107-PA	118490	NP_066265	2e-55	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG2107-PA	118490	NP_066266	2e-55	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG6485-PA	600532	NP_066552	2e-55	NDUFV2	COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 24-KD SUBUNIT	{Parkinson disease, susceptibility to}, 168600 (3)
CG11069-PA	605459	NP_071881	2e-55	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG17800-PA	188840	NP_596869	2e-55	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG17800-PB	188840	NP_596869	2e-55	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7892-PA	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PB	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PC	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PE	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PF	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PG	602897	NP_620446	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PA	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PB	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PC	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PE	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PF	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PG	602897	NP_620448	2e-55	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG6126-PA	607096	NP_653186	2e-55	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG6879-PA	606765	NP_783650	2e-55	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG15523-PA	607817	NP_858047	2e-55	COH1	KIAA0532;VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	Cohen syndrome, 216550 (3)
CG4376-PA	601282	NP_958781	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958781	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	601282	NP_958782	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958782	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	601282	NP_958783	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958783	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	601282	NP_958784	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	601282	NP_958785	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958785	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	601282	NP_958786	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PB	601282	NP_958786	2e-55	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG1066-PA	176260	NP_000208	3e-55	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG1066-PB	176260	NP_000208	3e-55	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG7882-PA	138160	NP_000331	3e-55	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG7882-PB	138160	NP_000331	3e-55	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG6347-PA	601105	NP_000387	3e-55	CTSK		Pycnodysostosis, 265800 (3)
CG5711-PA	181031	NP_000532	3e-55	SAG	ARRESTIN;S-ARRESTIN	Oguchi disease-1, 258100 (3)
CG32134-PA	147370	NP_000866	3e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG5670-PA	108733	NP_001001331	3e-55	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PB	108733	NP_001001331	3e-55	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PC	108733	NP_001001331	3e-55	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG5670-PD	108733	NP_001001331	3e-55	ATP2B2;PMCA2	PLASMA MEMBRANE Ca(2+)-ATPase, TYPE 2; PMCA2	Deafness, autosomal recessive 12, modifier of, 601386 (3)
CG1379-PA	600211	NP_001015051	3e-55	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG1379-PA	600211	NP_001019801	3e-55	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG12262-PA	609576	NP_001599	3e-55	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG10175-PB	114840	NP_001798	3e-55	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG1379-PA	600211	NP_004339	3e-55	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG31673-PA	604296	NP_036335	3e-55	GRHPR;GLXR	GLXR	Hyperoxaluria, primary, type II, 260000 (3)
CG8799-PA	171060	NP_061337	3e-55	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10226-PA	601439	NP_064693	3e-55	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG17907-PA	300427	NP_065793	3e-55	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG17907-PA	300427	NP_851849	3e-55	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3879-PA	170261	NP_000535	4e-55	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG15534-PA	607608	NP_001007594	4e-55	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG12345-PA	600528	NP_001027017	4e-55	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG5261-PA	608769	NP_003468	4e-55	PDX1	PDX1;PYRUVATE DEHYDROGENASE COMPLEX, E3-BINDING PROTEIN SUBUNIT; E3BP;PYRUVATE DEHYDROGENASE COMPLEX, LIPOYL-CONTAINING COMPONENT X	Lacticacidemia due to PDX1 deficiency, 245349 (3)
CG5261-PB	608769	NP_003468	4e-55	PDX1	PDX1;PYRUVATE DEHYDROGENASE COMPLEX, E3-BINDING PROTEIN SUBUNIT; E3BP;PYRUVATE DEHYDROGENASE COMPLEX, LIPOYL-CONTAINING COMPONENT X	Lacticacidemia due to PDX1 deficiency, 245349 (3)
CG31782-PB	314995	NP_009061	4e-55	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG31782-PB	314995	NP_700359	4e-55	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7223-PA	147670	NP_000199	5e-55	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG7223-PB	147670	NP_000199	5e-55	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG7223-PC	147670	NP_000199	5e-55	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG32019-PA	600958	NP_000247	5e-55	CMH4;MYBPC3	CARDIAC MYOSIN-BINDING PROTEIN C; MYBPC	Cardiomyopathy, dilated, 115200 (3) (?);Cardiomyopathy, familial hypertrophic, 4, 115197 (3)
CG7411-PA	138492	NP_000815	5e-55	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG14396-PA	147370	NP_000866	5e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG14396-PB	147370	NP_000866	5e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG14396-PC	147370	NP_000866	5e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG14396-PD	147370	NP_000866	5e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG14396-PE	147370	NP_000866	5e-55	IGF1R		Intrauterine and postnatal growth retardation (3)
CG4225-PA	171050	NP_000918	5e-55	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG5939-PC	160710	NP_002462	5e-55	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5939-PD	160710	NP_002462	5e-55	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG12069-PA	176960	NP_002728	5e-55	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6634-PA	601621	NP_005987	5e-55	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG8908-PB	607800	NP_056472	5e-55	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG7955-PA	171060	NP_061338	5e-55	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PB	171060	NP_061338	5e-55	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7955-PC	171060	NP_061338	5e-55	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG8908-PB	607800	NP_775099	5e-55	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG13977-PA	605325	NP_000768	6e-55	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG3362-PA	606224	NP_001002010	6e-55	NT5C3;UMPH1;PSN1	NUCLEOTIDASE, 5-PRIME, CYTOSOLIC III;PYRIMIDINE 5-PRIME-NUCLEOTIDASE 1; P5N1;URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE 1; UMPH1	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)
CG4032-PA	600456	NP_001018074	6e-55	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG4032-PA	600456	NP_006171	6e-55	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6716-PA	606597	NP_039230	6e-55	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_039230	6e-55	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG18402-PA	164761	NP_065681	6e-55	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG18402-PA	164761	NP_066124	6e-55	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG4007-PA	134934	NP_075254	6e-55	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG13232-PA	600374	NP_149017	6e-55	BBS4		Bardet-Biedl syndrome 4, 209900 (3)
CG3322-PA	608400	NP_996816	6e-55	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG4007-PA	134934	NP_000133	7e-55	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG2822-PA	176260	NP_000208	7e-55	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG2822-PB	176260	NP_000208	7e-55	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG5367-PA	601105	NP_000387	7e-55	CTSK		Pycnodysostosis, 265800 (3)
CG6716-PA	606597	NP_000429	7e-55	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6716-PB	606597	NP_000429	7e-55	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG5860-PA	179820	NP_000528	7e-55	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG1847-PB	604392	NP_055151	7e-55	AIPL1;LCA4		Cone-rod dystrophy (3);Leber congenital amaurosis, 604393 (3);Retinitis pigmentosa, juvenile (3)
CG15831-PA	602666	NP_057323	7e-55	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG14396-PA	136350	NP_075599	7e-55	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PB	136350	NP_075599	7e-55	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PC	136350	NP_075599	7e-55	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PD	136350	NP_075599	7e-55	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14396-PE	136350	NP_075599	7e-55	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7100-PB	605514	NP_149045	7e-55	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG7100-PH	605514	NP_149045	7e-55	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG6246-PA	300039	NP_000298	8e-55	DFN3;POU3F4	BRAIN-4	Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)
CG3362-PA	606224	NP_001002009	8e-55	NT5C3;UMPH1;PSN1	NUCLEOTIDASE, 5-PRIME, CYTOSOLIC III;PYRIMIDINE 5-PRIME-NUCLEOTIDASE 1; P5N1;URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE 1; UMPH1	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)
CG4898-PB	191010	NP_001018006	8e-55	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018006	8e-55	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018006	8e-55	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018006	8e-55	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG3362-PA	606224	NP_057573	8e-55	NT5C3;UMPH1;PSN1	NUCLEOTIDASE, 5-PRIME, CYTOSOLIC III;PYRIMIDINE 5-PRIME-NUCLEOTIDASE 1; P5N1;URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE 1; UMPH1	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)
CG5932-PA	278000	NP_000226	9e-55	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG11198-PA	608786	NP_000911	9e-55	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG11198-PB	608786	NP_000911	9e-55	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG15831-PA	600970	NP_004990	9e-55	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG10240-PA	124010	NP_059488	9e-55		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG11198-PA	608786	NP_071504	9e-55	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG11198-PB	608786	NP_071504	9e-55	PC		Pyruvate carboxylase deficiency, 266150 (3)
CG6446-PA	607292	NP_071762	9e-55	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG5939-PC	160760	NP_000248	1e-54	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5939-PD	160760	NP_000248	1e-54	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5772-PA	601107	NP_000383	1e-54	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG18085-PA	600456	NP_001018074	1e-54	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG15831-PA	160745	NP_001035202	1e-54	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15831-PA	160745	NP_001035203	1e-54	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG15831-PA	160775	NP_002464	1e-54	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG15831-PA	160745	NP_002465	1e-54	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8103-PA	603615	NP_003570	1e-54	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG18085-PA	600456	NP_006171	1e-54	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG12066-PB	605437	NP_006246	1e-54	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10245-PA	124010	NP_059488	1e-54		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG4373-PA	124010	NP_059488	1e-54		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG6634-PA	601719	NP_060958	1e-54	TBX4		Small patella syndrome, 147891 (3)
CG5772-PA	601439	NP_064693	1e-54	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG15831-PA	160745	NP_074035	1e-54	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG13691-PA	608132	NP_653197	1e-54	BBS8;TTC8	BBS8 GENE	Bardet-Biedl syndrome 8, 209900 (3)
CG10023-PA	176947	NP_997402	1e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10023-PB	176947	NP_997402	1e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10023-PC	176947	NP_997402	1e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG4372-PA	208400	NP_000018	2e-54	AGA	AGA DEFICIENCY;AGU;ASPARTYLGLUCOSAMINIDASE DEFICIENCY;ASPARTYLGLYCOSAMINURIA;GLYCOASPARAGINASE;GLYCOSYLASPARAGINASE DEFICIENCY	Aspartylglucosaminuria (3)
CG1464-PA	167409	NP_000269	2e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG7362-PA	609712	NP_000289	2e-54	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG5594-PC	600968	NP_000330	2e-54	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG5594-PD	600968	NP_000330	2e-54	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG33124-PA	601843	NP_000444	2e-54	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG5962-PA	181031	NP_000532	2e-54	SAG	ARRESTIN;S-ARRESTIN	Oguchi disease-1, 258100 (3)
CG4486-PA	605325	NP_000768	2e-54	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG2062-PA	601310	NP_000769	2e-54		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG8799-PA	171050	NP_000918	2e-54	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG7075-PA	608893	NP_001003841	2e-54	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG8905-PA	147460	NP_001019637	2e-54		INDOPHENOLOXIDASE B; IPO-B;MANGANESE SUPEROXIDE DISMUTASE; MNSOD;SUPEROXIDE DISMUTASE, MITOCHONDRIAL	
CG17975-PA	138190	NP_001033	2e-54	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG4685-PA	107323	NP_001173	2e-54		ANTIQUITIN; ATQ1	
CG1464-PA	167409	NP_003978	2e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG1464-PA	167409	NP_003979	2e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG1464-PA	167409	NP_003980	2e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG1464-PA	167409	NP_003981	2e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG12529-PA	138090	NP_004276	2e-54	H6PD;GDH;G6PDH	G6PD, H FORM; G6PDH;GDH/6PGL ENDOPLASMIC BIFUNCTIONAL PROTEIN;GLUCOSE 1-DEHYDROGENASE;GLUCOSE DEHYDROGENASE; GDH;GLUCOSE-6-PHOSPHATE DEHYDROGENASE, SALIVARY;HEXOSE-6-PHOSPHATE DEHYDROGENASE PRECURSOR	Cortisone reductase deficiency, 604931 (3)
CG12529-PB	138090	NP_004276	2e-54	H6PD;GDH;G6PDH	G6PD, H FORM; G6PDH;GDH/6PGL ENDOPLASMIC BIFUNCTIONAL PROTEIN;GLUCOSE 1-DEHYDROGENASE;GLUCOSE DEHYDROGENASE; GDH;GLUCOSE-6-PHOSPHATE DEHYDROGENASE, SALIVARY;HEXOSE-6-PHOSPHATE DEHYDROGENASE PRECURSOR	Cortisone reductase deficiency, 604931 (3)
CG1824-PA	300135	NP_004290	2e-54	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG5069-PA	602402	NP_005242	2e-54	FKHL14;FOXC2;MFH1	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 14; FKHL14;LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS,;MESENCHYME FORKHEAD 1; MFH1	Lymphedema and ptosis, 153000 (3);Lymphedema, hereditary II, 153200 (3);Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus (3);Lymphedema-distichiasis syndrome, 153400 (3);Yellow nail syndrome, 153300 (3)
CG1429-PE	600660	NP_005578	2e-54	ADCAD1;MEF2A		Coronary artery disease, autosomal dominant, 1, 608320 (3)
CG5289-PA	601023	NP_009057	2e-54	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG2202-PA	314995	NP_009061	2e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6654-PA	314995	NP_009061	2e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10243-PA	124010	NP_059488	2e-54		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG10175-PA	300427	NP_065793	2e-54	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG10175-PC	300427	NP_065793	2e-54	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG32697-PA	151460	NP_563578	2e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PB	151460	NP_563578	2e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PC	151460	NP_563578	2e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PD	151460	NP_563578	2e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG2202-PA	314995	NP_700359	2e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6654-PA	314995	NP_700359	2e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10175-PA	300427	NP_851849	2e-54	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG10175-PC	300427	NP_851849	2e-54	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG7362-PA	609712	NP_870986	2e-54	PK1;PKLR	PKRL;PYRUVATE KINASE 1; PK1;PYRUVATE KINASE, LIVER TYPE; PKL;PYRUVATE KINASE, RED CELL TYPE; PKR	Pyruvate kinase deficiency, 266200 (3)
CG13691-PA	608132	NP_938051	2e-54	BBS8;TTC8	BBS8 GENE	Bardet-Biedl syndrome 8, 209900 (3)
CG4685-PA	107323	XP_001127838	2e-54		ANTIQUITIN; ATQ1	
CG7223-PA	147370	NP_000866	3e-54	IGF1R		Intrauterine and postnatal growth retardation (3)
CG7223-PB	147370	NP_000866	3e-54	IGF1R		Intrauterine and postnatal growth retardation (3)
CG7223-PC	147370	NP_000866	3e-54	IGF1R		Intrauterine and postnatal growth retardation (3)
CG1041-PA	600528	NP_001027017	3e-54	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG32697-PA	151460	NP_002829	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PB	151460	NP_002829	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PC	151460	NP_002829	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PD	151460	NP_002829	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG10226-PA	601439	NP_005682	3e-54	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6604-PA	601621	NP_005987	3e-54	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG7881-PA	604322	NP_036566	3e-54	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG18347-PA	603859	NP_055066	3e-54	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG31472-PA	603287	NP_060599	3e-54	PNPO	PYRIDOXAMINE-PHOSPHATE OXIDASE	Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)
CG31472-PB	603287	NP_060599	3e-54	PNPO	PYRIDOXAMINE-PHOSPHATE OXIDASE	Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)
CG7627-PA	171060	NP_061337	3e-54	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG10226-PA	601439	NP_064694	3e-54	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7210-PA	605379	NP_071324	3e-54	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG7210-PB	605379	NP_071324	3e-54	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG4007-PA	134935	NP_075252	3e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PA	134935	NP_075252	3e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PB	134935	NP_075252	3e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG32697-PA	151460	NP_563579	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PB	151460	NP_563579	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PC	151460	NP_563579	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG32697-PD	151460	NP_563579	3e-54	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG14396-PA	147670	NP_000199	4e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG14396-PB	147670	NP_000199	4e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG14396-PC	147670	NP_000199	4e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG14396-PD	147670	NP_000199	4e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG14396-PE	147670	NP_000199	4e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG9262-PA	176260	NP_000208	4e-54	AEMK;EA1;KCNA1	1; KCNA1;KV1.1;MK1, MOUSE, HOMOLOG OF	Episodic ataxia/myokymia syndrome, 160120 (3)
CG6508-PA	179820	NP_000528	4e-54	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG14723-PA	137192	NP_000805	4e-54	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG8049-PA	191315	NP_001007793	4e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PB	191315	NP_001007793	4e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PC	191315	NP_001007793	4e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PD	191315	NP_001007793	4e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PA	176947	NP_001070	4e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10023-PB	176947	NP_001070	4e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10023-PC	176947	NP_001070	4e-54	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG5092-PA	601215	NP_001175	4e-54	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG4007-PA	134935	NP_002002	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PA	134935	NP_002002	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PB	134935	NP_002002	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10181-PA	300135	NP_004290	4e-54	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG4926-PA	600997	NP_004433	4e-54	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4677-PA	165230	NP_005261	4e-54	GLI2;HPE9	ONCOGENE GLI2	Holoprosencephaly-9, 610829 (3);Pituitary anomalies with holoprosencephaly-like features (3)
CG4677-PB	165230	NP_005261	4e-54	GLI2;HPE9	ONCOGENE GLI2	Holoprosencephaly-9, 610829 (3);Pituitary anomalies with holoprosencephaly-like features (3)
CG2767-PA	604741	NP_005980	4e-54		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG4926-PA	600997	NP_059145	4e-54	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14723-PA	137192	NP_068712	4e-54	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG4007-PA	134935	NP_998812	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PA	134935	NP_998812	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7873-PB	134935	NP_998812	4e-54	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8665-PA	107323	XP_001127838	4e-54		ANTIQUITIN; ATQ1	
CG7329-PA	278000	NP_000226	5e-54	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG1771-PB	607759	NP_000410	5e-54	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG10178-PA	191740	NP_000454	5e-54	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG10248-PA	605325	NP_000768	5e-54	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8049-PA	191315	NP_001012331	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PB	191315	NP_001012331	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PC	191315	NP_001012331	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PD	191315	NP_001012331	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PA	191315	NP_002520	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PB	191315	NP_002520	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PC	191315	NP_002520	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8049-PD	191315	NP_002520	5e-54	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10000-PA	601756	NP_004473	5e-54	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG2711-PA	314995	NP_009061	5e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG9262-PA	607604	NP_598004	5e-54		KV11.1	
CG2711-PA	314995	NP_700359	5e-54	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4562-PA	171060	NP_000434	6e-54	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG2692-PA	167409	NP_003979	6e-54	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG17309-PA	136350	NP_056934	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PB	136350	NP_056934	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PC	136350	NP_056934	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PD	136350	NP_056934	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PE	136350	NP_056934	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17577-PA	124010	NP_059488	6e-54		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG6608-PA	606521	NP_068380	6e-54	DNC;MCPHA;MUP1;SLC25A19	MEMBER 19; SLC25A19;MITOCHONDRIAL DEOXYNUCLEOTIDE CARRIER; DNC;MITOCHONDRIAL UNCOUPLING PROTEIN 1; MUP1	Microcephaly, Amish type, 607196 (3)
CG6608-PB	606521	NP_068380	6e-54	DNC;MCPHA;MUP1;SLC25A19	MEMBER 19; SLC25A19;MITOCHONDRIAL DEOXYNUCLEOTIDE CARRIER; DNC;MITOCHONDRIAL UNCOUPLING PROTEIN 1; MUP1	Microcephaly, Amish type, 607196 (3)
CG17309-PA	136350	NP_075593	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PB	136350	NP_075593	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PC	136350	NP_075593	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PD	136350	NP_075593	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PE	136350	NP_075593	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PA	136350	NP_075594	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PB	136350	NP_075594	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PC	136350	NP_075594	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PD	136350	NP_075594	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PE	136350	NP_075594	6e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32134-PA	147670	NP_000199	7e-54	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17200-PA	191740	NP_000454	7e-54	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG6117-PA	176960	NP_002728	7e-54	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG6117-PB	176960	NP_002728	7e-54	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG32697-PA	176885	NP_002818	7e-54	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG32697-PB	176885	NP_002818	7e-54	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG32697-PC	176885	NP_002818	7e-54	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG32697-PD	176885	NP_002818	7e-54	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG5592-PA	603377	NP_003051	7e-54	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG31075-PA	603178	NP_005580	7e-54	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG4032-PA	176943	NP_075259	7e-54	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4032-PA	136350	NP_075593	7e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4032-PA	136350	NP_075594	7e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8355-PA	604210	NP_957705	7e-54	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG8355-PB	604210	NP_957705	7e-54	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG8355-PC	604210	NP_957705	7e-54	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG4032-PA	176943	NP_000132	8e-54	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG2692-PA	607108	NP_000271	8e-54	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG7882-PA	138190	NP_001033	8e-54	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG7882-PB	138190	NP_001033	8e-54	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG15081-PA	176705	NP_002625	8e-54	PHB	PHB1	Breast cancer, sporadic (3)
CG15081-PB	176705	NP_002625	8e-54	PHB	PHB1	Breast cancer, sporadic (3)
CG15081-PC	176705	NP_002625	8e-54	PHB	PHB1	Breast cancer, sporadic (3)
CG4032-PA	136350	NP_056934	8e-54	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8203-PA	123829	NP_000066	9e-54	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG15288-PA	150310	NP_000219	9e-54	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG15288-PB	150310	NP_000219	9e-54	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG14396-PA	600221	NP_000450	9e-54	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG14396-PB	600221	NP_000450	9e-54	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG14396-PC	600221	NP_000450	9e-54	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG14396-PD	600221	NP_000450	9e-54	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG14396-PE	600221	NP_000450	9e-54	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG15288-PA	150310	NP_001017402	9e-54	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG15288-PB	150310	NP_001017402	9e-54	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG5125-PA	160741	NP_002463	9e-54	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG5125-PB	160741	NP_002463	9e-54	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG1401-PA	300304	NP_003579	9e-54	CUL4B;MRXHF2;MRXSC;SFM2		Mental retardation syndrome, X-linked, Cabezas type, 300354 (3);Mental retardation-hypotonic facies syndrome, X-linked, 2, 300639 (3)
CG2727-PA	173510	NP_000063	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PB	173510	NP_000063	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PC	173510	NP_000063	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG6816-PA	609300	NP_000093	1e-53	CYP17;CYP17A1;P450C17	CYP17;CYTOCHROME P450, SUBFAMILY XVII;P450C17;S17AH;STEROID 17-ALPHA-MONOOXYGENASE;STEROID 17-HYDROXYLASE/17,20-LYASE	17,20-lyase deficiency, isolated, 202110 (3);17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)
CG6816-PB	609300	NP_000093	1e-53	CYP17;CYP17A1;P450C17	CYP17;CYTOCHROME P450, SUBFAMILY XVII;P450C17;S17AH;STEROID 17-ALPHA-MONOOXYGENASE;STEROID 17-HYDROXYLASE/17,20-LYASE	17,20-lyase deficiency, isolated, 202110 (3);17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)
CG2692-PA	167409	NP_000269	1e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG4225-PA	171060	NP_000434	1e-53	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG5863-PA	179820	NP_000528	1e-53	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG10843-PA	601310	NP_000769	1e-53		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG2727-PA	173510	NP_001001547	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PB	173510	NP_001001547	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PC	173510	NP_001001547	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PA	173510	NP_001001548	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PB	173510	NP_001001548	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG2727-PC	173510	NP_001001548	1e-53	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG8049-PA	600456	NP_001018074	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PB	600456	NP_001018074	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PC	600456	NP_001018074	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PD	600456	NP_001018074	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG9181-PD	176885	NP_002818	1e-53	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG3388-PA	167409	NP_003979	1e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG2692-PA	167409	NP_003980	1e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8049-PA	600456	NP_006171	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PB	600456	NP_006171	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PC	600456	NP_006171	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8049-PD	600456	NP_006171	1e-53	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG4225-PA	171060	NP_061338	1e-53	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG2759-PA	605459	NP_071881	1e-53	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG32072-PA	605512	NP_073563	1e-53	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG4889-PA	603490	NP_110388	1e-53	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG4889-PB	603490	NP_110388	1e-53	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG4252-PA	607585	NP_612149	1e-53	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG33106-PA	182900	NP_000028	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PB	182900	NP_000028	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG4252-PA	607585	NP_000042	2e-53	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG5125-PA	160760	NP_000248	2e-53	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG5125-PB	160760	NP_000248	2e-53	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG11459-PA	601105	NP_000387	2e-53	CTSK		Pycnodysostosis, 265800 (3)
CG4032-PA	600221	NP_000450	2e-53	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG9441-PA	600225	NP_001019241	2e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PB	600225	NP_001019241	2e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PC	600225	NP_001019241	2e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG31926-PA	116840	NP_001900	2e-53	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG3992-PB	600576	NP_002043	2e-53	GATA4		Atrial septal defect-2, 607941 (3)
CG3992-PC	600576	NP_002043	2e-53	GATA4		Atrial septal defect-2, 607941 (3)
CG6600-PA	604190	NP_003050	2e-53	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6600-PA	603377	NP_003051	2e-53	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG5794-PA	400005	NP_004645	2e-53	DFFRY;USP9Y	DROSOPHILA FAT FACETS-RELATED, Y-LINKED; DFFRY	Azoospermia, 415000 (3)
CG5794-PB	400005	NP_004645	2e-53	DFFRY;USP9Y	DROSOPHILA FAT FACETS-RELATED, Y-LINKED; DFFRY	Azoospermia, 415000 (3)
CG5658-PA	602821	NP_004975	2e-53	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG5125-PA	600970	NP_004990	2e-53	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG5125-PB	600970	NP_004990	2e-53	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG10247-PA	124010	NP_059488	2e-53		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG10248-PA	124010	NP_059488	2e-53		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG33106-PA	182900	NP_065208	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PB	182900	NP_065208	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PA	182900	NP_065209	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PB	182900	NP_065209	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PA	182900	NP_065210	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG33106-PB	182900	NP_065210	2e-53	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG2013-PA	312180	NP_861427	2e-53		HHR6A;RAD6, YEAST, HOMOLOG OF, TYPE A; RAD6A	
CG4376-PC	601282	NP_958780	2e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4032-PA	134934	NP_000133	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8250-PA	164860	NP_000236	3e-53	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG6562-PA	300535	NP_000267	3e-53	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG6562-PB	300535	NP_000267	3e-53	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG3388-PA	167409	NP_000269	3e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG11049-PA	607108	NP_000271	3e-53	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG11049-PB	607108	NP_000271	3e-53	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG1318-PA	606869	NP_000511	3e-53	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG1318-PB	606869	NP_000511	3e-53	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG1318-PD	606869	NP_000511	3e-53	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG32538-PB	100710	NP_000738	3e-53	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG8687-PB	605325	NP_000768	3e-53	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG4105-PA	601310	NP_000769	3e-53		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG9441-PA	600225	NP_001019242	3e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PB	600225	NP_001019242	3e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG9441-PC	600225	NP_001019242	3e-53	DYT5;GCH1		Dystonia, DOPA-responsive, 128230 (3);Phenylketonuria, atypical, due to GCH1 deficiency, 233910 (1)
CG8049-PA	176947	NP_001070	3e-53	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PB	176947	NP_001070	3e-53	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PC	176947	NP_001070	3e-53	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PD	176947	NP_001070	3e-53	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG6562-PA	300535	NP_001578	3e-53	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG6562-PB	300535	NP_001578	3e-53	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG4703-PA	609576	NP_001599	3e-53	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG3388-PA	167409	NP_003980	3e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG1909-PA	601592	NP_005046	3e-53	CMS1D;CMS1E;RAPSN	RAPSYN	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3)
CG1909-PB	601592	NP_005046	3e-53	CMS1D;CMS1E;RAPSN	RAPSYN	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency, 608931 (3)
CG17800-PA	120470	NP_005206	3e-53	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG17800-PB	120470	NP_005206	3e-53	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG17800-PC	120470	NP_005206	3e-53	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG17800-PD	120470	NP_005206	3e-53	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG3578-PA	602054	NP_005983	3e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6634-PA	602054	NP_005983	3e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG7987-PA	314995	NP_009061	3e-53	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7987-PB	314995	NP_009061	3e-53	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8258-PA	610150	NP_036205	3e-53	CCT5;CCTE;KIAA0098	CCT-EPSILON; CCTE;CHAPERONIN CONTAINING TCP1, SUBUNIT 5;KIAA0098	Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CG3050-PA	124010	NP_059488	3e-53		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7158-PA	606352	NP_065970	3e-53	ALS2;ALSJ;PLSJ;IAHSP	ALS2 GENE;KIAA1563	Amyotrophic lateral sclerosis, juvenile, 205100 (3);Primary lateral sclerosis, juvenile, 606353 (3);Spastic paralysis, infantile onset ascending, 607225 (3)
CG33110-PA	605512	NP_073563	3e-53	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG17309-PA	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PB	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PC	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PD	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PE	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG4032-PA	134934	NP_075254	3e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG3578-PA	602054	NP_542377	3e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6634-PA	602054	NP_542377	3e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG7987-PA	314995	NP_700359	3e-53	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7987-PB	314995	NP_700359	3e-53	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4376-PC	601282	NP_958784	3e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG17309-PA	134934	NP_000133	4e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PB	134934	NP_000133	4e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PC	134934	NP_000133	4e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PD	134934	NP_000133	4e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17309-PE	134934	NP_000133	4e-53	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG4376-PC	601282	NP_000436	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG8367-PB	300573	NP_001034980	4e-53	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG4225-PA	603201	NP_003733	4e-53	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG8127-PB	601487	NP_005028	4e-53	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG8874-PB	190090	NP_005408	4e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8874-PC	190090	NP_005408	4e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8127-PB	601487	NP_056953	4e-53	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG5560-PA	609059	NP_065109	4e-53	ATGL;PNPLA2;TTS2	ADIPOSE TRIGLYCERIDE LIPASE; ATGL;DESNUTRIN;IPLA2-ZETA;PHOSPHOLIPASE A2, CALCIUM-INDEPENDENT, ZETA;TRANSPORT-SECRETION PROTEIN 2; TTS2;TTS2.2	Neutral lipid storage disease with myopathy, 610717 (3)
CG3578-PA	602054	NP_542378	4e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6634-PA	602054	NP_542378	4e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6634-PA	601620	NP_542449	4e-53	TBX5		Holt-Oram syndrome, 142900 (3)
CG8127-PB	601487	NP_619725	4e-53	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG8127-PB	601487	NP_619726	4e-53	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG8874-PB	190090	NP_938033	4e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8874-PC	190090	NP_938033	4e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4376-PC	601282	NP_958781	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PC	601282	NP_958782	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PC	601282	NP_958783	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PC	601282	NP_958785	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PC	601282	NP_958786	4e-53	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG17577-PA	605325	NP_000768	5e-53	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG8367-PA	300573	NP_001034980	5e-53	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG8367-PC	300573	NP_001034980	5e-53	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG8367-PD	300573	NP_001034980	5e-53	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG14528-PA	600423	NP_001388	5e-53	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG3733-PA	604289	NP_036547	5e-53	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG17964-PA	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PB	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PC	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PD	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PE	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PF	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG17964-PG	153245	NP_057353	5e-53	LEF1	TCF1-ALPHA;TRANSCRIPTION FACTOR, T CELL-SPECIFIC, 1-ALPHA	Sebaceous tumors, somatic (3)
CG10181-PA	170261	NP_061313	5e-53	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG4225-PA	171060	NP_061337	5e-53	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG9865-PA	610273	NP_660150	5e-53	PIGM	PIGM MANNOSYLTRANSFERASE	Glycosylphosphatidylinositol deficiency, 610293 (3)
CG9865-PB	610273	NP_660150	5e-53	PIGM	PIGM MANNOSYLTRANSFERASE	Glycosylphosphatidylinositol deficiency, 610293 (3)
CG5363-PA	123829	NP_000066	6e-53	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG3388-PA	606597	NP_000429	6e-53	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG17484-PA	601975	NP_001005337	6e-53	PKP1		Ectodermal dysplasia/skin fragility syndrome, 604536 (3)
CG4032-PA	191315	NP_001007793	6e-53	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG6535-PA	601215	NP_001175	6e-53	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG7461-PA	600301	NP_001600	6e-53	ACADSB;SBCAD	2-@METHYLBUTYRYL-CoA DEHYDROGENASE;SBCAD	2-methylbutyrylglycinuria, 610006 (3)
CG5912-PA	192977	NP_003374	6e-53	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG31536-PA	130500	NP_004428	6e-53	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG8874-PA	190090	NP_005408	6e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8874-PD	190090	NP_005408	6e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3388-PA	606597	NP_039230	6e-53	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG5125-PA	160740	NP_060004	6e-53	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG5125-PB	160740	NP_060004	6e-53	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG6634-PA	601620	NP_542448	6e-53	TBX5		Holt-Oram syndrome, 142900 (3)
CG8874-PA	190090	NP_938033	6e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8874-PD	190090	NP_938033	6e-53	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG6634-PA	601620	NP_000183	7e-53	TBX5		Holt-Oram syndrome, 142900 (3)
CG10243-PA	605325	NP_000768	7e-53	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG2060-PA	601310	NP_000769	7e-53		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG4032-PA	191315	NP_001012331	7e-53	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4032-PA	191315	NP_002520	7e-53	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4383-PA	608166	NP_036563	7e-53	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG4032-PA	164761	NP_065681	7e-53	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG6634-PA	601620	NP_852259	7e-53	TBX5		Holt-Oram syndrome, 142900 (3)
CG31536-PA	130500	NP_976217	7e-53	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG4009-PA	131399	NP_000493	8e-53	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG7411-PA	137192	NP_000805	8e-53	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG8523-PA	300135	NP_004290	8e-53	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG8250-PA	189980	NP_005148	8e-53	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG6604-PA	602054	NP_005983	8e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG8250-PA	189980	NP_009297	8e-53	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG4032-PA	164761	NP_066124	8e-53	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7411-PA	137192	NP_068712	8e-53	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG15097-PA	605379	NP_071324	8e-53	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG7873-PA	136350	NP_075593	8e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PB	136350	NP_075593	8e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PA	136350	NP_075594	8e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PB	136350	NP_075594	8e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4145-PA	120120	NP_000085	9e-53	COL7A1	LC COLLAGEN;LONG-CHAIN COLLAGEN	EBD, Bart type, 132000 (3);EBD, localisata variant (3);Epidermolysis bullosa dystrophica, AD, 131750 (3);Epidermolysis bullosa dystrophica, AR, 226600 (3);Epidermolysis bullosa pruriginosa, 604129 (3);Epidermolysis bullosa, pretibial, 131850 (3);Toenail dystrophy, isolated, 607523 (3);Transient bullous of the newborn, 131705 (3)
CG4145-PB	120120	NP_000085	9e-53	COL7A1	LC COLLAGEN;LONG-CHAIN COLLAGEN	EBD, Bart type, 132000 (3);EBD, localisata variant (3);Epidermolysis bullosa dystrophica, AD, 131750 (3);Epidermolysis bullosa dystrophica, AR, 226600 (3);Epidermolysis bullosa pruriginosa, 604129 (3);Epidermolysis bullosa, pretibial, 131850 (3);Toenail dystrophy, isolated, 607523 (3);Transient bullous of the newborn, 131705 (3)
CG4145-PC	120120	NP_000085	9e-53	COL7A1	LC COLLAGEN;LONG-CHAIN COLLAGEN	EBD, Bart type, 132000 (3);EBD, localisata variant (3);Epidermolysis bullosa dystrophica, AD, 131750 (3);Epidermolysis bullosa dystrophica, AR, 226600 (3);Epidermolysis bullosa pruriginosa, 604129 (3);Epidermolysis bullosa, pretibial, 131850 (3);Toenail dystrophy, isolated, 607523 (3);Transient bullous of the newborn, 131705 (3)
CG12773-PA	600968	NP_000330	9e-53	NCCT;SLC12A3;TSC	SLC12A3;SODIUM-CHLORIDE COTRANSPORTER, THIAZIDE-SENSITIVE; NCCT;THIAZIDE-SENSITIVE NA-CL COTRANSPORTER; TSC	Gitelman syndrome, 263800 (3)
CG4606-PA	609458	NP_000519	9e-53	MAN2B1;MANB	LAMAN;MANNOSIDASE, ALPHA B, LYSOSOMAL; MANB	Mannosidosis, alpha-, types I and II, 248500 (3)
CG10247-PA	605325	NP_000768	9e-53	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG5265-PA	600528	NP_001867	9e-53	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG17283-PA	116840	NP_001900	9e-53	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG6716-PA	167409	NP_003978	9e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	167409	NP_003978	9e-53	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG7873-PA	136350	NP_056934	9e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PB	136350	NP_056934	9e-53	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG2064-PA	605131	NP_057457	9e-53	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG4926-PA	164761	NP_065681	9e-53	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG6604-PA	602054	NP_542377	9e-53	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG18402-PA	164860	NP_000236	1e-52	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7059-PA	261670	NP_000281	1e-52	PGAM2;PGAMM	MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY; PGAMM DEFICIENCY	Myopathy due to phosphoglycerate mutase deficiency (3)
CG7059-PC	261670	NP_000281	1e-52	PGAM2;PGAMM	MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY; PGAMM DEFICIENCY	Myopathy due to phosphoglycerate mutase deficiency (3)
CG7059-PD	261670	NP_000281	1e-52	PGAM2;PGAMM	MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY; PGAMM DEFICIENCY	Myopathy due to phosphoglycerate mutase deficiency (3)
CG7847-PA	129010	NP_000390	1e-52	EGR2;KROX20	KROX20	Charcot-Marie-Tooth disease, type 1D, 607678 (3);Dejerine-Sottas neuropathy, 145900 (3);Neuropathy, congenital hypomyelinating, 1, 605253 (3)
CG7847-PB	129010	NP_000390	1e-52	EGR2;KROX20	KROX20	Charcot-Marie-Tooth disease, type 1D, 607678 (3);Dejerine-Sottas neuropathy, 145900 (3);Neuropathy, congenital hypomyelinating, 1, 605253 (3)
CG15661-PA	191740	NP_000454	1e-52	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG6653-PA	191740	NP_000454	1e-52	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG15455-PA	151385	NP_001001890	1e-52	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG2202-PA	300573	NP_001034980	1e-52	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG40129-PA	164731	NP_001617	1e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG15455-PA	151385	NP_001745	1e-52	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG9656-PA	600576	NP_002043	1e-52	GATA4		Atrial septal defect-2, 607941 (3)
CG4006-PA	180381	NP_002920	1e-52	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG4006-PB	180381	NP_002920	1e-52	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG4006-PC	180381	NP_002920	1e-52	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG6716-PA	167409	NP_003981	1e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG6716-PB	167409	NP_003981	1e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG10913-PA	602445	NP_005016	1e-52	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG30084-PA	605906	NP_009009	1e-52	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG30084-PD	605906	NP_009009	1e-52	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG11902-PA	314995	NP_009061	1e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6716-PA	167415	NP_039247	1e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PB	167415	NP_039247	1e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PA	167415	NP_054698	1e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PB	167415	NP_054698	1e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1651-PA	243305	NP_055240	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PB	243305	NP_055240	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PC	243305	NP_055240	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PD	243305	NP_055240	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG5723-PB	600985	NP_061978	1e-52	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG4926-PA	164761	NP_066124	1e-52	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PA	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PB	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PC	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PD	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PE	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4007-PA	176943	NP_075259	1e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG6604-PA	602054	NP_542378	1e-52	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG11902-PA	314995	NP_700359	1e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1651-PA	243305	NP_899068	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PB	243305	NP_899068	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PC	243305	NP_899068	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1651-PD	243305	NP_899068	1e-52	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG18657-PA	600805	NP_937762	1e-52	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG17309-PA	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PB	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PC	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PD	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG17309-PE	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4007-PA	176943	NP_000132	2e-52	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4926-PA	164860	NP_000236	2e-52	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG4739-PA	191740	NP_000454	2e-52	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG10240-PA	605325	NP_000768	2e-52	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10245-PA	605325	NP_000768	2e-52	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG14032-PA	601310	NP_000769	2e-52		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG8127-PB	170998	NP_001001928	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PC	170998	NP_001001928	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PB	170998	NP_001001929	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PC	170998	NP_001001929	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PB	170998	NP_001001930	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PC	170998	NP_001001930	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG5122-PA	600528	NP_001027017	2e-52	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG10033-PA	164731	NP_001617	2e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10033-PB	164731	NP_001617	2e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10033-PC	164731	NP_001617	2e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10033-PD	164731	NP_001617	2e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10033-PE	164731	NP_001617	2e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG32105-PB	602575	NP_002307	2e-52	LMX1B;NPS1	LMX1.2	Nail-patella syndrome with open-angle glaucoma, 137750 (3);Nail-patella syndrome, 161200 (3)
CG8654-PA	604190	NP_003050	2e-52	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6716-PA	167415	NP_003457	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PB	167415	NP_003457	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8625-PA	603615	NP_003570	2e-52	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8625-PB	603615	NP_003570	2e-52	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8625-PC	603615	NP_003570	2e-52	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG8127-PB	170998	NP_005027	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PC	170998	NP_005027	2e-52	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG9610-PB	167416	NP_006185	2e-52	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG3277-PA	173490	NP_006197	2e-52	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG3277-PB	173490	NP_006197	2e-52	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8637-PA	605437	NP_006246	2e-52	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG3578-PA	604895	NP_037483	2e-52	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG6716-PA	167415	NP_039245	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PB	167415	NP_039245	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PA	167415	NP_039246	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6716-PB	167415	NP_039246	2e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG30491-PA	605131	NP_057457	2e-52	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG6634-PA	601621	NP_057653	2e-52	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG4562-PA	171060	NP_061337	2e-52	ABCB4;MDR3;PGY3	MULTIDRUG RESISTANCE 3; MDR3;P-GLYCOPROTEIN 3; PGY3	Cholestasis, familial intrahepatic, of pregnancy, 147480 (3);Cholestasis, progressive familial intrahepatic 3, 602347 (3);Gallbladder disease 1, 600803 (3)
CG7735-PA	608845	NP_115522	2e-52	ARL6;BBS3	ARF-LIKE 6;BBS3 GENE	Bardet-Biedl syndrome 1, modifier of, 209900 (3);Bardet-Biedl syndrome 3, 209900 (3)
CG7735-PA	608845	NP_816931	2e-52	ARL6;BBS3	ARF-LIKE 6;BBS3 GENE	Bardet-Biedl syndrome 1, modifier of, 209900 (3);Bardet-Biedl syndrome 3, 209900 (3)
CG3024-PA	605204	NP_000104	3e-52	DYT1;TOR1A	DYT1 GENE;TOR1A	Dystonia, early-onset atypical, with myoclonic features (3);Dystonia-1, torsion, 128100 (3)
CG9610-PA	167409	NP_000269	3e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG5912-PA	606945	NP_000518	3e-52	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG10175-PA	100740	NP_000656	3e-52	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10175-PC	100740	NP_000656	3e-52	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG2165-PA	182340	NP_000693	3e-52	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG2165-PB	182340	NP_000693	3e-52	ATP1A2;FHM2;MHP2	Na,K-ATPase, ALPHA-A(+) CATALYTIC POLYPEPTIDE;Na,K-ATPase, ALPHA-B POLYPEPTIDE;SODIUM-POTASSIUM-ATPase, ALPHA-2 POLYPEPTIDE	Alternating hemiplegia of childhood, 104290 (3);Migraine, familial basilar, 602481 (3);Migraine, familial hemiplegic, 2, 602481 (3)
CG31075-PA	107323	NP_001173	3e-52		ANTIQUITIN; ATQ1	
CG8425-PA	114840	NP_001798	3e-52	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG10595-PA	160720	NP_002461	3e-52	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG7955-PA	603201	NP_003733	3e-52	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG7955-PB	603201	NP_003733	3e-52	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG7955-PC	603201	NP_003733	3e-52	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG9610-PA	167409	NP_003978	3e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG9610-PA	167409	NP_003979	3e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG9610-PA	167409	NP_003980	3e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG7002-PA	602574	NP_005413	3e-52	DFNA12;DFNA8;DFNB21;TECTA		Deafness, autosomal dominant 12, 601842 (3);Deafness, autosomal dominant 8, 601543 (3);Deafness, autosomal recessive 21, 603629 (3)
CG10175-PA	100740	NP_056646	3e-52	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10175-PC	100740	NP_056646	3e-52	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG5026-PA	603557	NP_057240	3e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG5026-PB	603557	NP_057240	3e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG31146-PD	177400	NP_000046	4e-52	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG15455-PA	600211	NP_001015051	4e-52	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG1891-PA	602730	NP_001097	4e-52	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG1891-PB	602730	NP_001097	4e-52	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG4379-PA	176980	NP_002730	4e-52	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG4379-PB	176980	NP_002730	4e-52	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG9366-PA	602049	NP_002863	4e-52	RAC2	RHO FAMILY, SMALL GTP-BINDING PROTEIN RAC2	Neutrophil immunodeficiency syndrome, 608203 (3)
CG9610-PA	167409	NP_003981	4e-52	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG15455-PA	600211	NP_004339	4e-52	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG10923-PA	608283	NP_060111	4e-52	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG17754-PC	605379	NP_071324	4e-52	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG17754-PD	605379	NP_071324	4e-52	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG2086-PB	600275	NP_077719	4e-52	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG13521-PA	608548	NP_114141	4e-52	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG13521-PB	608548	NP_114141	4e-52	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7100-PA	605514	NP_149045	4e-52	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG7100-PC	605514	NP_149045	4e-52	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG5026-PA	603557	NP_958435	4e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG5026-PB	603557	NP_958435	4e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG5026-PA	603557	NP_958438	4e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG5026-PB	603557	NP_958438	4e-52	CMT4B1;MTMR2	KIAA1073	Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
CG4894-PC	600163	XP_001131636	4e-52	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG5912-PA	192977	NP_001018066	5e-52	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG15455-PA	600211	NP_001019801	5e-52	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG7987-PA	300573	NP_001034980	5e-52	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG7987-PB	300573	NP_001034980	5e-52	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG3324-PA	164731	NP_001617	5e-52	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG5481-PA	608548	NP_114141	5e-52	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG33103-PA	604134	NP_620594	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG33103-PB	604134	NP_620594	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG33103-PA	604134	NP_620595	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG33103-PB	604134	NP_620595	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG33103-PA	604134	NP_620596	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG33103-PB	604134	NP_620596	5e-52	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG10923-PA	605995	NP_904325	5e-52	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG32975-PA	118507	NP_000739	6e-52	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG12244-PA	176872	NP_002746	6e-52		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG3455-PA	601023	NP_009057	6e-52	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG6634-PA	300307	NP_058650	6e-52	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG3466-PA	124010	NP_059488	6e-52		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG8250-PA	164761	NP_065681	6e-52	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8250-PA	164761	NP_066124	6e-52	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG5125-PA	160720	NP_002461	7e-52	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG5125-PB	160720	NP_002461	7e-52	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG5125-PA	160710	NP_002462	7e-52	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG5125-PB	160710	NP_002462	7e-52	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG18783-PA	314995	NP_009061	7e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG18783-PB	314995	NP_009061	7e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1464-PA	167415	NP_039247	7e-52	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG18085-PA	136350	NP_075593	7e-52	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18085-PA	136350	NP_075594	7e-52	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG6445-PA	605514	NP_149045	7e-52	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG6445-PB	605514	NP_149045	7e-52	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG18783-PA	314995	NP_700359	7e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG18783-PB	314995	NP_700359	7e-52	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1041-PA	600650	NP_000089	8e-52	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG31045-PA	276903	NP_000251	8e-52	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG12287-PA	300039	NP_000298	8e-52	DFN3;POU3F4	BRAIN-4	Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)
CG12287-PB	300039	NP_000298	8e-52	DFN3;POU3F4	BRAIN-4	Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)
CG10413-PA	600839	NP_000329	8e-52	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG10975-PB	600925	NP_002834	8e-52	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG32697-PA	600925	NP_002834	8e-52	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG32697-PB	600925	NP_002834	8e-52	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG32697-PC	600925	NP_002834	8e-52	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG32697-PD	600925	NP_002834	8e-52	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG16916-PA	601023	NP_009057	8e-52	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10923-PA	605995	NP_055889	8e-52	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG18085-PA	136350	NP_056934	8e-52	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG6604-PA	601719	NP_060958	8e-52	TBX4		Small patella syndrome, 147891 (3)
CG6604-PA	601620	NP_542449	8e-52	TBX5		Holt-Oram syndrome, 142900 (3)
CG6654-PA	300573	NP_001034980	9e-52	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG4379-PA	300075	NP_004577	9e-52	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4379-PB	300075	NP_004577	9e-52	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG5772-PA	601439	NP_005682	9e-52	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG5772-PA	601439	NP_064694	9e-52	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3962-PA	605379	NP_071324	9e-52	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG3962-PB	605379	NP_071324	9e-52	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG3962-PC	605379	NP_071324	9e-52	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG7524-PB	176943	NP_000132	1e-51	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG6604-PA	601620	NP_000183	1e-51	TBX5		Holt-Oram syndrome, 142900 (3)
CG1594-PA	600173	NP_000206	1e-51	JAK3;JAKL	JANUS KINASE, LEUKOCYTE; JAKL;LJAK	SCID, autosomal recessive, T-negative/B-positive type (3)
CG6658-PA	191740	NP_000454	1e-51	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG14723-PA	137140	NP_000798	1e-51	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG7223-PA	600456	NP_001018074	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7223-PB	600456	NP_001018074	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7223-PC	600456	NP_001018074	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG31999-PA	601548	NP_001034437	1e-51	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG31999-PA	601548	NP_001034438	1e-51	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG18783-PA	300573	NP_001034980	1e-51	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG18783-PB	300573	NP_001034980	1e-51	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG12066-PA	164731	NP_001617	1e-51	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG5860-PA	116840	NP_001900	1e-51	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG17998-PA	176960	NP_002728	1e-51	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG3324-PA	176960	NP_002728	1e-51	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10975-PA	600925	NP_002834	1e-51	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG1891-PA	190182	NP_003233	1e-51	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG1891-PB	190182	NP_003233	1e-51	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG31999-PA	601548	NP_004096	1e-51	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG15831-PA	602129	NP_004136	1e-51	CELIAC4;MYO9B;MYR5	MYOSIN, RAT, HOMOLOG OF; MYR5	{Celiac disease, susceptibility to, 4}, 609753 (3)
CG40129-PA	300075	NP_004577	1e-51	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG8127-PC	601487	NP_005028	1e-51	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG10244-PA	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PA	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PB	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PC	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PD	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PE	189980	NP_005148	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7223-PA	600456	NP_006171	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7223-PB	600456	NP_006171	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7223-PC	600456	NP_006171	1e-51	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6484-PA	138140	NP_006507	1e-51	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG1341-PA	601023	NP_009057	1e-51	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG7372-PA	314995	NP_009061	1e-51	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8301-PA	314995	NP_009061	1e-51	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10244-PA	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PA	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PB	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PC	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PD	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PE	189980	NP_009297	1e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG30272-PA	604322	NP_036566	1e-51	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG1464-PA	167415	NP_054698	1e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4007-PA	136350	NP_056934	1e-51	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8127-PC	601487	NP_056953	1e-51	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG4485-PA	124010	NP_059488	1e-51		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7524-PB	176943	NP_075259	1e-51	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4007-PA	136350	NP_075593	1e-51	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4007-PA	136350	NP_075594	1e-51	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG5661-PA	608548	NP_114141	1e-51	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG30054-PB	139320	NP_536351	1e-51	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG6604-PA	601620	NP_542448	1e-51	TBX5		Holt-Oram syndrome, 142900 (3)
CG8127-PC	601487	NP_619725	1e-51	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG8127-PC	601487	NP_619726	1e-51	PPARG;PPARG1;PPARG2		Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367 (3);Insulin resistance, severe, digenic, 604367 (3);Lipodystrophy, familial partial, 151660 (3);Obesity, severe, 601665 (3);[Obesity, resistance to] (3);{Abdominal body fat distribution, modifier of}, 609830 (3);{Glioblastoma, susceptibility to}, 137800 (3)
CG2165-PA	182350	NP_689509	1e-51	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG2165-PB	182350	NP_689509	1e-51	ATP1A3;DYT12;RDP	SODIUM-POTASSIUM-ATPase, ALPHA-3 POLYPEPTIDE	Dystonia-12, 128235 (3)
CG7372-PA	314995	NP_700359	1e-51	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8301-PA	314995	NP_700359	1e-51	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6604-PA	601620	NP_852259	1e-51	TBX5		Holt-Oram syndrome, 142900 (3)
CG15844-PA	605995	NP_904325	1e-51	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG31075-PA	107323	XP_001127838	1e-51		ANTIQUITIN; ATQ1	
CG18069-PA	172471	NP_000285	2e-51	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG18069-PB	172471	NP_000285	2e-51	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG18069-PC	172471	NP_000285	2e-51	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG2086-PB	600276	NP_000426	2e-51	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG1031-PA	100740	NP_000656	2e-51	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG5137-PA	601310	NP_000769	2e-51		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG4032-PA	147370	NP_000866	2e-51	IGF1R		Intrauterine and postnatal growth retardation (3)
CG14709-PA	171050	NP_000918	2e-51	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG4843-PA	191010	NP_001018005	2e-51	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_001018005	2e-51	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG1891-PA	190182	NP_001020018	2e-51	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG1891-PB	190182	NP_001020018	2e-51	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG5265-PA	600528	NP_001027017	2e-51	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG7904-PA	102576	NP_001096	2e-51	ACVR1;ACVRLK2;ALK2;FOP	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 2; ACVRLK2;ACTIVIN RECEPTOR-LIKE KINASE 2; ALK2	Fibrodysplasia ossificans progressiva, 135100 (3)
CG14026-PA	602730	NP_001097	2e-51	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG14026-PB	602730	NP_001097	2e-51	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG14026-PC	602730	NP_001097	2e-51	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG14026-PD	602730	NP_001097	2e-51	ACVR2B	ACTRIIB	Left-right axis malformations (3)
CG7052-PB	120900	NP_001726	2e-51	C5		C5 deficiency (1)
CG4926-PA	134935	NP_002002	2e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PB	136352	NP_002011	2e-51	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG12559-PB	602897	NP_002744	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PC	602897	NP_002744	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PD	602897	NP_002744	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG2005-PA	176876	NP_002825	2e-51	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG2005-PB	176876	NP_002825	2e-51	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG1464-PA	167415	NP_003457	2e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG3733-PA	603615	NP_003570	2e-51	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG3324-PA	300075	NP_004577	2e-51	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG40263-PA	604322	NP_036566	2e-51	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG1464-PA	167415	NP_039245	2e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1464-PA	167415	NP_039246	2e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG15844-PA	605995	NP_055889	2e-51	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1031-PA	100740	NP_056646	2e-51	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG31045-PA	602666	NP_057323	2e-51	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG6604-PA	601621	NP_057653	2e-51	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG8523-PA	170261	NP_061313	2e-51	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG10175-PB	300427	NP_065793	2e-51	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4314-PA	605460	NP_071882	2e-51	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG4926-PA	134935	NP_075252	2e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10595-PA	608568	NP_079005	2e-51	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG4698-PA	603490	NP_110388	2e-51	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG12559-PB	602897	NP_620446	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PC	602897	NP_620446	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PD	602897	NP_620446	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PB	602897	NP_620448	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PC	602897	NP_620448	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG12559-PD	602897	NP_620448	2e-51	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG8766-PA	300394	NP_851829	2e-51	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PB	300394	NP_851829	2e-51	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG8766-PC	300394	NP_851829	2e-51	BTHS;CMD3A;EFE2;LVNCX;TAZ	G4.5	Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3);Endocardial fibroelastosis-2 (2);Noncompaction of left ventricular myocardium, isolated, 300183 (3)
CG10175-PB	300427	NP_851849	2e-51	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG8222-PB	136352	NP_891555	2e-51	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG4926-PA	134935	NP_998812	2e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG5092-PA	601215	XP_001131387	2e-51	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG2086-PB	600275	XP_001133349	2e-51	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG18657-PA	156225	NP_000417	3e-51	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG7535-PB	137164	NP_000807	3e-51	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG32134-PA	191315	NP_001007793	3e-51	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG32134-PA	191315	NP_001012331	3e-51	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG15436-PA	300573	NP_001034980	3e-51	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG32134-PA	191315	NP_002520	3e-51	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4007-PA	189980	NP_005148	3e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG18466-PA	172460	NP_005947	3e-51	MTHFD;MTHFC	C1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC;C1-THF-SYNTHASE;CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE SYNTHETASE, NADP(+)-DEPENDENT;METHYLENETETRAHYDROFOLATE DEHYDROGENASE/METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE;SYNTHETASE, NADP(+)-DEPENDENT	{Abruptio placentae, susceptibility to} (3);{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
CG18466-PB	172460	NP_005947	3e-51	MTHFD;MTHFC	C1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC;C1-THF-SYNTHASE;CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE SYNTHETASE, NADP(+)-DEPENDENT;METHYLENETETRAHYDROFOLATE DEHYDROGENASE/METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE/FORMYLTETRAHYDROFOLATE;SYNTHETASE, NADP(+)-DEPENDENT	{Abruptio placentae, susceptibility to} (3);{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)
CG8250-PA	604705	NP_006334	3e-51	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG4007-PA	189980	NP_009297	3e-51	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG2070-PA	605131	NP_057457	3e-51	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG11202-PA	300307	NP_058650	3e-51	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG4926-PA	134934	NP_075254	3e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7873-PA	134934	NP_075254	3e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7873-PB	134934	NP_075254	3e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7675-PB	608830	NP_689656	3e-51	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG4926-PA	134934	NP_000133	4e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7873-PA	134934	NP_000133	4e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7873-PB	134934	NP_000133	4e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10595-PA	160760	NP_000248	4e-51	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG8908-PB	601691	NP_000341	4e-51	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG4373-PA	605325	NP_000768	4e-51	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10755-PA	601310	NP_000769	4e-51		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG3752-PA	107323	NP_001173	4e-51		ANTIQUITIN; ATQ1	
CG6859-PA	603164	NP_003621	4e-51	PEX3	PEROXIN 3	Zellweger syndrome, complementation group G, 214100 (3)
CG9610-PA	167415	NP_039246	4e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11502-PA	604485	NP_057430	4e-51	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG18085-PA	176943	NP_075259	4e-51	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3752-PA	107323	XP_001127838	4e-51		ANTIQUITIN; ATQ1	
CG16858-PA	120131	NP_000083	5e-51	COL4A4	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-4 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, familial benign (3)
CG18085-PA	176943	NP_000132	5e-51	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4032-PA	147670	NP_000199	5e-51	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG1915-PC	600958	NP_000247	5e-51	CMH4;MYBPC3	CARDIAC MYOSIN-BINDING PROTEIN C; MYBPC	Cardiomyopathy, dilated, 115200 (3) (?);Cardiomyopathy, familial hypertrophic, 4, 115197 (3)
CG12010-PA	602136	NP_000457	5e-51	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG3972-PA	601310	NP_000769	5e-51		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG8222-PB	191306	NP_002244	5e-51	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG3277-PA	136351	NP_004110	5e-51	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG3277-PB	136351	NP_004110	5e-51	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG17484-PA	602861	NP_004563	5e-51	PKP2;ARVD9		Arrhythmogenic right ventricular dysplasia, familial, 9, 609040 (3)
CG9610-PA	167415	NP_039245	5e-51	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG11502-PA	604485	NP_055064	5e-51	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG10226-PA	170261	NP_061313	5e-51	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG17907-PA	300336	NP_061850	5e-51	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG8222-PA	134934	NP_075254	5e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8222-PB	134934	NP_075254	5e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8222-PC	134934	NP_075254	5e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG5772-PA	607040	NP_115972	5e-51	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG5772-PA	607040	NP_149163	5e-51	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG8222-PA	134934	NP_000133	6e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8222-PB	134934	NP_000133	6e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8222-PC	134934	NP_000133	6e-51	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG32387-PA	308840	NP_000416	6e-51	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG32387-PB	308840	NP_000416	6e-51	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG7535-PB	137163	NP_000806	6e-51		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG5022-PA	130500	NP_004428	6e-51	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG10923-PA	602821	NP_004975	6e-51	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG10370-PA	601023	NP_009057	6e-51	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG2241-PA	601023	NP_009057	6e-51	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG32387-PA	308840	NP_076493	6e-51	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG32387-PB	308840	NP_076493	6e-51	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG5022-PA	130500	NP_976217	6e-51	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG13270-PA	191740	NP_000454	7e-51	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG2692-PA	607108	NP_001595	7e-51	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG3902-PA	609576	NP_001599	7e-51	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG6356-PA	604190	NP_003050	7e-51	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG18076-PA	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_004002	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PA	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PB	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PC	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PE	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PG	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PH	300377	NP_004003	7e-51	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG6498-PA	605437	NP_006246	7e-51	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG9774-PA	605437	NP_006246	7e-51	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG12201-PB	603859	NP_055066	7e-51	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG6407-PA	603490	NP_110388	7e-51	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG9652-PA	109690	NP_000015	8e-51	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG1567-PA	601920	NP_000205	8e-51	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG10244-PA	164920	NP_000213	8e-51	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG4009-PA	606989	NP_000241	8e-51	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG9858-PA	100740	NP_000656	8e-51	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG15533-PA	607608	NP_001007594	8e-51	NPD;SMPD1	SPHINGOMYELINASE, ACID; ASM	Niemann-Pick disease, type A, 257200 (3);Niemann-Pick disease, type B, 607616 (3)
CG7052-PC	120900	NP_001726	8e-51	C5		C5 deficiency (1)
CG18085-PA	134935	NP_002002	8e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PA	136352	NP_002011	8e-51	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG10226-PA	300135	NP_004290	8e-51	ABC7;ABCB7;ASAT	ABC TRANSPORTER 7;ATP-BINDING CASSETTE 7; ABC7;ATP-BINDING CASSETTE TRANSPORTER 7	Anemia, sideroblastic, with ataxia, 301310 (3)
CG1954-PA	605377	NP_004400	8e-51	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG9858-PA	100740	NP_056646	8e-51	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG18085-PA	134935	NP_075252	8e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG5058-PA	608576	NP_079191	8e-51	DFNA28;TFCP2L3	BROTHER OF GRAINYHEAD; BOM;GRAINYHEAD, DROSOPHILA, HOMOLOG OF, 2;TRANSCRIPTION FACTOR CP2-LIKE 3; TFCP2L3	Deafness, autosomal dominant 28, 608641 (3)
CG5058-PD	608576	NP_079191	8e-51	DFNA28;TFCP2L3	BROTHER OF GRAINYHEAD; BOM;GRAINYHEAD, DROSOPHILA, HOMOLOG OF, 2;TRANSCRIPTION FACTOR CP2-LIKE 3; TFCP2L3	Deafness, autosomal dominant 28, 608641 (3)
CG5058-PG	608576	NP_079191	8e-51	DFNA28;TFCP2L3	BROTHER OF GRAINYHEAD; BOM;GRAINYHEAD, DROSOPHILA, HOMOLOG OF, 2;TRANSCRIPTION FACTOR CP2-LIKE 3; TFCP2L3	Deafness, autosomal dominant 28, 608641 (3)
CG18085-PA	134935	NP_998812	8e-51	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8824-PB	606869	NP_000511	9e-51	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG8824-PC	606869	NP_000511	9e-51	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG8908-PA	600046	NP_005493	9e-51	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG8222-PA	136352	NP_891555	9e-51	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG18085-PA	134934	NP_000133	1e-50	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG17976-PA	138160	NP_000331	1e-50	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG18578-PA	191740	NP_000454	1e-50	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG12010-PB	602136	NP_000457	1e-50	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG2331-PB	602136	NP_000457	1e-50	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG1689-PA	151385	NP_001001890	1e-50	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1689-PA	151385	NP_001745	1e-50	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG3388-PA	167409	NP_003978	1e-50	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG3388-PA	167409	NP_003981	1e-50	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG1489-PA	601023	NP_009057	1e-50	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10175-PA	300336	NP_061850	1e-50	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG10175-PC	300336	NP_061850	1e-50	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG18085-PA	134934	NP_075254	1e-50	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG1500-PA	120620	XP_001126036	1e-50	C3BR;CR1	C3-BINDING PROTEIN; CD35;COMPLEMENT COMPONENT 3b/4b RECEPTOR	CR1 deficiency (1);[Blood group, Knops system], 607486 (3);{?SLE susceptibility} (1)
CG5870-PA	300377	NP_000100	2e-50	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG7873-PA	176943	NP_000132	2e-50	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7873-PB	176943	NP_000132	2e-50	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG9623-PA	147556	NP_000201	2e-50	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG6753-PA	278000	NP_000226	2e-50	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG15831-PA	160777	NP_000250	2e-50	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG8422-PA	168468	NP_000307	2e-50	PTHR;PTHR1	PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PROTEIN RECEPTOR;PTH RECEPTOR; PTHR;PTH/PTHRP RECEPTOR	Enchondromatosis, Ollier type, 166000 (3);Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)
CG6919-PA	109630	NP_000675	2e-50	ADRB1;ADRB1R;RHR	ADRB1R;B1AR	[Resting heart rate], 607276 (3);{congestive heart failure, susceptibility to} (3)
CG17896-PA	602733	NP_000687	2e-50		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG17896-PB	602733	NP_000687	2e-50		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG6730-PA	601310	NP_000769	2e-50		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG14723-PA	137164	NP_000807	2e-50	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG11247-PA	300573	NP_001034980	2e-50	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG11247-PB	300573	NP_001034980	2e-50	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG5939-PA	160745	NP_001035203	2e-50	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5939-PB	160745	NP_001035203	2e-50	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17998-PA	164731	NP_001617	2e-50	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG8222-PC	136352	NP_002011	2e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG18657-PA	150325	NP_002283	2e-50	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG5939-PA	160745	NP_002465	2e-50	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5939-PB	160745	NP_002465	2e-50	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG6622-PA	180381	NP_002920	2e-50	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG6622-PB	180381	NP_002920	2e-50	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG5870-PA	300377	NP_004000	2e-50	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG6498-PA	605377	NP_004400	2e-50	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG12072-PA	300075	NP_004577	2e-50	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG2049-PD	300075	NP_004577	2e-50	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG9456-PA	602445	NP_005016	2e-50	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG18402-PA	604705	NP_006334	2e-50	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG18076-PC	604985	NP_008877	2e-50	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG15436-PA	314995	NP_009061	2e-50	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4926-PA	136350	NP_056934	2e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG6224-PA	605379	NP_071324	2e-50	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG11801-PA	605512	NP_073563	2e-50	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG7873-PA	176943	NP_075259	2e-50	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7873-PB	176943	NP_075259	2e-50	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4926-PA	136350	NP_075593	2e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4926-PA	136350	NP_075594	2e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG15436-PA	314995	NP_700359	2e-50	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8222-PC	136352	NP_891555	2e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG1488-PB	608614	NP_997235	2e-50	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG6535-PA	601215	XP_001131387	2e-50	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG7461-PA	607008	NP_000007	3e-50	ACADM;MCAD	MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE; MCAD; MCADH	Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
CG1362-PA	123829	NP_000066	3e-50	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG18302-PA	278000	NP_000226	3e-50	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG1771-PA	607759	NP_000410	3e-50	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG11793-PA	147450	NP_000445	3e-50	ALS1;SOD1	INDOPHENOLOXIDASE A; IPOA;SOD, SOLUBLE;SUPEROXIDE DISMUTASE, COPPER-ZINC;SUPEROXIDE DISMUTASE, CYSTOLIC;SUPEROXIDE DISMUTASE, SOLUBLE	Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)
CG14723-PA	137160	NP_000797	3e-50	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG7446-PA	137160	NP_000797	3e-50	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG32134-PA	600456	NP_001018074	3e-50	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG11049-PA	607108	NP_001595	3e-50	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG11049-PB	607108	NP_001595	3e-50	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG3277-PB	136352	NP_002011	3e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG16973-PA	300142	NP_002569	3e-50	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG14964-PA	188840	NP_003310	3e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7524-PB	600997	NP_004433	3e-50	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG5452-PA	188250	NP_004605	3e-50	TK2		Mitochondrial DNA depletion myopathy, 251880 (3)
CG4357-PA	604878	NP_005126	3e-50	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG32134-PA	600456	NP_006171	3e-50	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG4032-PA	604705	NP_006334	3e-50	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG2065-PA	605131	NP_057457	3e-50	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG3936-PA	602768	NP_058637	3e-50	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG7524-PB	600997	NP_059145	3e-50	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4969-PA	603490	NP_110388	3e-50	WNT4		Rokitansky-Kuster-Hauser syndrome, 277000 (3)
CG31190-PA	608548	NP_114141	3e-50	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7981-PB	608548	NP_114141	3e-50	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7981-PE	608548	NP_114141	3e-50	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG14964-PA	188840	NP_596869	3e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG14964-PA	188840	NP_597676	3e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG14964-PA	188840	NP_597681	3e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG3277-PB	136352	NP_891555	3e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG3936-PA	602768	NP_982353	3e-50	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG7904-PA	601284	NP_000011	4e-50	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG30054-PB	139320	NP_000507	4e-50	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG12370-PA	114131	NP_001733	4e-50	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG5125-PA	160775	NP_002464	4e-50	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG5125-PB	160775	NP_002464	4e-50	DFNA17;FTNS;MHA;MYH9	CELLULAR MYOSIN HEAVY CHAIN, TYPE A;MYOSIN, HEAVY CHAIN, NONMUSCLE, TYPE A; NMMHCA	Deafness, autosomal dominant 17, 603622 (3);Epstein syndrome, 153650 (3);Fechtner syndrome, 153640 (3);Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3);May-Hegglin anomaly, 155100 (3);Sebastian syndrome, 605249 (3)
CG9738-PA	176872	NP_002746	4e-50		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG9460-PA	602445	NP_005016	4e-50	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG5125-PA	601478	NP_005370	4e-50	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG5125-PB	601478	NP_005370	4e-50	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG31999-PA	604580	NP_006320	4e-50	FBLN5;ARMD3	DEVELOPMENTAL ARTERIES AND NEURAL CREST EGF-LIKE; DANCE	Cutis laxa, autosomal dominant, 123700 (3);Cutis laxa, autosomal recessive, 219100 (3);Macular degeneration, age-related, 3, 608895 (3)
CG9475-PB	601023	NP_009057	4e-50	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG2692-PA	606597	NP_039230	4e-50	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG32048-PA	605551	NP_055512	4e-50	CAPON;KIAA0464;NOS1AP	C-TERMINAL PDZ DOMAIN LIGAND OF NEURONAL NITRIC OXIDE SYNTHASE;CAPON	QT interval, modifier of, 610141 (3)
CG7524-PB	136350	NP_056934	4e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7524-PB	136350	NP_075593	4e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7524-PB	136350	NP_075594	4e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG30054-PA	139320	NP_536351	4e-50	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG3277-PA	136352	NP_891555	4e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG2772-PA	278000	NP_000226	5e-50	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG2692-PA	606597	NP_000429	5e-50	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1849-PA	151385	NP_001001890	5e-50	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1689-PA	600211	NP_001015051	5e-50	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG6638-PA	609575	NP_001029031	5e-50	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG1849-PA	151385	NP_001745	5e-50	AML1;CBFA2;RUNX1	ACUTE MYELOID LEUKEMIA 1 GENE; AML1;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2; CBFA2;PEBP2-ALPHA-B; PEBP2AB	Leukemia, acute myeloid, 601626 (3);Platelet disorder, familial, with associated myeloid malignancy, 601399 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG3277-PA	136352	NP_002011	5e-50	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG3578-PA	601397	NP_003172	5e-50	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG7186-PA	603072	NP_003591	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG5870-PA	300377	NP_003997	5e-50	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG1689-PA	600211	NP_004339	5e-50	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG18076-PH	604985	NP_008877	5e-50	SCA5;SPTBN2	SPECTRIN, BETA-III	Spinocerebellar ataxia-5, 600224 (3)
CG1389-PA	136350	NP_075593	5e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG1389-PA	136350	NP_075594	5e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8027-PA	607840	NP_077288	5e-50	GNPTA;GNPTAB	GNPTA;MGC4170	Mucolipidosis II, 252500 (3);Mucolipidosis IIIA, 252600 (3)
CG17760-PA	139320	NP_536351	5e-50	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG9023-PA	107776	NP_932766	5e-50	AQP1;CHIP28;CO	AQP-CHIP;AQUAPORIN-CHIP;CHANNEL-LIKE INTEGRAL MEMBRANE PROTEIN, 28-KD; CHIP28	[Aquaporin-1 deficiency] (3);[Blood group, Colton], 110450 (3)
CG9023-PB	107776	NP_932766	5e-50	AQP1;CHIP28;CO	AQP-CHIP;AQUAPORIN-CHIP;CHANNEL-LIKE INTEGRAL MEMBRANE PROTEIN, 28-KD; CHIP28	[Aquaporin-1 deficiency] (3);[Blood group, Colton], 110450 (3)
CG13691-PA	608132	NP_938052	5e-50	BBS8;TTC8	BBS8 GENE	Bardet-Biedl syndrome 8, 209900 (3)
CG7186-PA	603072	NP_940835	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7186-PA	603072	NP_940836	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7186-PA	603072	NP_940837	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7186-PA	603072	NP_940838	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7186-PA	603072	NP_940839	5e-50	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6638-PA	609575	NP_000009	6e-50	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG7535-PA	137163	NP_000806	6e-50		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG4898-PA	191010	NP_001018005	6e-50	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG1689-PA	600211	NP_001019801	6e-50	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG31782-PB	300573	NP_001034980	6e-50	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG4839-PA	605437	NP_006246	6e-50	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG4839-PB	605437	NP_006246	6e-50	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG1389-PA	136350	NP_056934	6e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG30495-PA	605131	NP_057457	6e-50	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG32311-PB	608548	NP_114141	6e-50	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG3790-PA	607096	NP_653186	6e-50	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG12673-PA	609312	NP_000778	7e-50	DBH	DOPAMINE BETA-MONOOXYGENASE	Dopamine beta-hydroxylase deficiency, 223360 (3);Parkinson disease, resistance to, 168600 (3);[Dopamine-beta-hydroxylase activity levels, plasma] (3)
CG10270-PA	314995	NP_009061	7e-50	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6604-PA	300307	NP_058650	7e-50	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG4145-PA	120070	NP_112730	7e-50	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PB	120070	NP_112730	7e-50	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PC	120070	NP_112730	7e-50	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG3389-PA	605516	NP_443068	7e-50	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG10270-PA	314995	NP_700359	7e-50	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG31002-PA	191740	NP_000454	8e-50	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG15831-PA	160710	NP_002462	8e-50	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG7524-PB	134934	NP_075254	8e-50	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8222-PA	136350	NP_075593	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PB	136350	NP_075593	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PC	136350	NP_075593	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PA	136350	NP_075594	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PB	136350	NP_075594	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PC	136350	NP_075594	8e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32387-PA	188840	NP_596869	8e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG32387-PB	188840	NP_596869	8e-50	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG6111-PA	608595	NP_997055	8e-50	ASRT2;GPR154;GPRA;PGR14;VRR1	G PROTEIN-COUPLED RECEPTOR FOR ASTHMA SUSCEPTIBILITY; GPRA;NEUROPEPTIDE S RECEPTOR; NPSR;PGR14;VASOPRESSIN RECEPTOR-RELATED RECEPTOR 1; VRR1	{Asthma, susceptibility to, 2}, 608584 (3)
CG6111-PA	608595	NP_997056	8e-50	ASRT2;GPR154;GPRA;PGR14;VRR1	G PROTEIN-COUPLED RECEPTOR FOR ASTHMA SUSCEPTIBILITY; GPRA;NEUROPEPTIDE S RECEPTOR; NPSR;PGR14;VASOPRESSIN RECEPTOR-RELATED RECEPTOR 1; VRR1	{Asthma, susceptibility to, 2}, 608584 (3)
CG7524-PB	134934	NP_000133	9e-50	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6433-PA	137350	NP_000168	9e-50	GSN		Amyloidosis, Finnish type, 105120 (3)
CG6433-PB	137350	NP_000168	9e-50	GSN		Amyloidosis, Finnish type, 105120 (3)
CG12163-PA	601105	NP_000387	9e-50	CTSK		Pycnodysostosis, 265800 (3)
CG12163-PB	601105	NP_000387	9e-50	CTSK		Pycnodysostosis, 265800 (3)
CG3050-PA	605325	NP_000768	9e-50	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG6919-PA	126453	NP_000789	9e-50	DRD1B;DRD1L2;DRD5	DOPAMINE RECEPTOR D1B; DRD1B	Dystonia, primary cervical (3);{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3);{Blepharospasm, primary benign}, 606798 (3)
CG4386-PA	606635	NP_002763	9e-50	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG2692-PA	167409	NP_003978	9e-50	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8222-PA	136350	NP_056934	9e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PB	136350	NP_056934	9e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8222-PC	136350	NP_056934	9e-50	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4383-PA	607292	NP_071762	9e-50	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG12262-PA	609575	NP_000009	1e-49	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG18657-PA	150310	NP_000219	1e-49	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG6358-PA	278700	NP_000371	1e-49	XPA	XERODERMA PIGMENTOSUM I; XP1;XP, GROUP A;XPA COMPLEMENTING; XPAC;XPA CORRECTING	Xeroderma pigmentosum, group A (3)
CG2110-PA	601310	NP_000769	1e-49		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG7411-PA	137160	NP_000797	1e-49	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG18085-PA	191315	NP_001007793	1e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG18657-PA	150310	NP_001017402	1e-49	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG12262-PA	609575	NP_001029031	1e-49	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG2711-PA	300573	NP_001034980	1e-49	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG31224-PA	300573	NP_001034980	1e-49	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG5069-PA	601090	NP_001444	1e-49	FKHL7;FOXC1;FREAC3	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 7; FKHL7;FORKHEAD-RELATED ACTIVATOR 3; FREAC3	Anterior segment mesenchymal dysgenesis (3);Axenfeld anomaly (3);Iridogoniodysgenesis, 601631 (3);Iris hypoplasia and glaucoma (3);Rieger anomaly (3)
CG30092-PB	603381	NP_001448	1e-49	AOI;FLNB;LRS1;SCT	ACTIN-BINDING PROTEIN 276/278; ABP276/278;FILAMIN, BETA	Atelosteogenesis, type III, 108721 (3);Atelostogenesis, type I, 108720 (3);Boomerang dysplasia, 112310 (3);Larson syndrome, 150250 (3);Spondylocarpotarsal synostosis syndrome, 272460 (3)
CG5748-PA	602438	NP_001529	1e-49	CTM;HSF4		Cataract, lamellar, 116800 (3);Cataract, Marner type, 116800 (3)
CG7052-PD	120900	NP_001726	1e-49	C5		C5 deficiency (1)
CG8422-PA	114131	NP_001733	1e-49	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG6414-PA	114840	NP_001798	1e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG4527-PA	300142	NP_002569	1e-49	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG4527-PB	300142	NP_002569	1e-49	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG2692-PA	167409	NP_003981	1e-49	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG7904-PA	601300	NP_004293	1e-49	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG8049-PA	600997	NP_004433	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PB	600997	NP_004433	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PC	600997	NP_004433	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PD	600997	NP_004433	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3752-PA	603178	NP_005580	1e-49	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG11049-PA	167416	NP_006185	1e-49	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG11049-PB	167416	NP_006185	1e-49	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG1449-PA	104155	NP_008816	1e-49	ATBF1	ALPHA-FETOPROTEIN ENHANCER-BINDING PROTEIN;AT-BINDING TRANSCRIPTION FACTOR 1	{Prostate cancer, susceptibility to}, 176807 (3)
CG1915-PA	608092	NP_057165	1e-49	KIAA0992;PALLD;PNCA1	KIAA0992	{Pancreatic cancer, susceptibility to, 1}, 606856 (3)
CG1915-PC	608092	NP_057165	1e-49	KIAA0992;PALLD;PNCA1	KIAA0992	{Pancreatic cancer, susceptibility to, 1}, 606856 (3)
CG8049-PA	600997	NP_059145	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PB	600997	NP_059145	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PC	600997	NP_059145	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8049-PD	600997	NP_059145	1e-49	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PA	134935	NP_075252	1e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PB	134935	NP_075252	1e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PC	134935	NP_075252	1e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PD	134935	NP_075252	1e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PE	134935	NP_075252	1e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG5423-PA	608548	NP_114141	1e-49	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7660-PB	606765	NP_783650	1e-49	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG4926-PA	176943	NP_000132	2e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG32843-PA	168468	NP_000307	2e-49	PTHR;PTHR1	PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PROTEIN RECEPTOR;PTH RECEPTOR; PTHR;PTH/PTHRP RECEPTOR	Enchondromatosis, Ollier type, 166000 (3);Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)
CG2505-PA	100740	NP_000656	2e-49	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG6798-PB	100720	NP_000742	2e-49	ACHRD;CHRND;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, DELTA SUBUNIT; ACHRD	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG18085-PA	191315	NP_001012331	2e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG5939-PA	160745	NP_001035202	2e-49	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5939-PB	160745	NP_001035202	2e-49	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG17309-PA	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PB	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PC	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PD	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PE	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7524-PB	134935	NP_002002	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10595-PA	160710	NP_002462	2e-49	ASD3;MYH6;MYHCA	MYH, CARDIAC; MYHC;MYOSIN, CARDIAC, HEAVY CHAIN, ALPHA; MYHCA	Atrial septal defect 3 (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG18085-PA	191315	NP_002520	2e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG2246-PA	311850	NP_002755	2e-49	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG2246-PC	311850	NP_002755	2e-49	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG2246-PE	311850	NP_002755	2e-49	PRPS1		Phosphoribosyl pyrophosphate synthetase-related gout (3)
CG6492-PA	602044	NP_003347	2e-49	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG9610-PA	167415	NP_003457	2e-49	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8250-PA	190090	NP_005408	2e-49	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG2505-PA	100740	NP_056646	2e-49	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG31999-PA	604633	NP_058634	2e-49	EFEMP2;FBLN4;UPH1	FIBULIN 4; FBLN4	Cutis laxa, autosomal recessive, type I, 219100 (3)
CG7873-PA	164761	NP_065681	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7873-PB	164761	NP_065681	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7873-PA	164761	NP_066124	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7873-PB	164761	NP_066124	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8222-PA	164761	NP_066124	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8222-PB	164761	NP_066124	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8222-PC	164761	NP_066124	2e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG11824-PA	606797	NP_068813	2e-49	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG6921-PA	605512	NP_073563	2e-49	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG6921-PB	605512	NP_073563	2e-49	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG6921-PC	605512	NP_073563	2e-49	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG5939-PA	160745	NP_074035	2e-49	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG5939-PB	160745	NP_074035	2e-49	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7524-PB	134935	NP_075252	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4926-PA	176943	NP_075259	2e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG15831-PA	608568	NP_079005	2e-49	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG30054-PB	139320	NP_536350	2e-49	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG7675-PA	608830	NP_689656	2e-49	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG9764-PA	300628	NP_919253	2e-49	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG6433-PA	137350	NP_937895	2e-49	GSN		Amyloidosis, Finnish type, 105120 (3)
CG6433-PB	137350	NP_937895	2e-49	GSN		Amyloidosis, Finnish type, 105120 (3)
CG8250-PA	190090	NP_938033	2e-49	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG6512-PA	602783	NP_955399	2e-49	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG6512-PB	602783	NP_955399	2e-49	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG7873-PA	176947	NP_997402	2e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7873-PB	176947	NP_997402	2e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PA	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PB	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PC	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PD	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG17309-PE	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7524-PB	134935	NP_998812	2e-49	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG5125-PB	160777	NP_000250	3e-49	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG17484-PA	601975	NP_000290	3e-49	PKP1		Ectodermal dysplasia/skin fragility syndrome, 604536 (3)
CG1500-PA	131210	NP_000441	3e-49	ELAM1;SELE	E-SELECTIN;ELAM;ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ELAM1	[Blood pressure regulation QTL], 145500 (2);{Atherosclerosis, susceptibility to} (2);{IgA nephropathy, susceptiblity to}, 161950 (3)
CG10175-PB	100740	NP_000656	3e-49	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4485-PA	605325	NP_000768	3e-49	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG1488-PB	601310	NP_000769	3e-49		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG30092-PB	102565	NP_001449	3e-49		ABPA;ACTIN-BINDING PROTEIN 280, AUTOSOMAL FORM; ABP280A;ACTIN-BINDING PROTEIN-LIKE; ABPL;FILAMIN 2; FLN2;FILAMIN, GAMMA	
CG7052-PE	120900	NP_001726	3e-49	C5		C5 deficiency (1)
CG7461-PA	607036	NP_002216	3e-49	IVD		Isovaleric acidemia, 243500 (3)
CG6899-PA	176885	NP_002818	3e-49	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG6899-PB	176885	NP_002818	3e-49	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG8925-PA	603377	NP_003051	3e-49	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG6492-PA	601693	NP_003346	3e-49	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG9802-PA	300040	NP_006297	3e-49	CDLS2;DXS423E;SMC1	DXS423E;KIAA0178;SMC1;SMC1-ALPHA;STRUCTURAL MAINTENANCE OF CHROMOSOMES 1-LIKE 1; SMC1L1	Cornelia de Lange syndrome 2, 300590 (3)
CG18085-PA	604705	NP_006334	3e-49	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10175-PB	100740	NP_056646	3e-49	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG30171-PA	606566	NP_149109	3e-49	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG30171-PB	606566	NP_149109	3e-49	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG4860-PA	609575	NP_000009	4e-49	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG13772-PA	177400	NP_000046	4e-49	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG4032-PA	164860	NP_000236	4e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG10842-PA	601310	NP_000769	4e-49		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG4316-PA	229000	NP_000883	4e-49	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG10023-PA	164870	NP_001005862	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10023-PB	164870	NP_001005862	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10023-PC	164870	NP_001005862	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4860-PA	609575	NP_001029031	4e-49	ACADVL;VLCAD	VLCAD	VLCAD deficiency, 201475 (3)
CG7372-PA	300573	NP_001034980	4e-49	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG31928-PA	116840	NP_001900	4e-49	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG10033-PA	176960	NP_002728	4e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10033-PB	176960	NP_002728	4e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10033-PC	176960	NP_002728	4e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10033-PD	176960	NP_002728	4e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG10033-PE	176960	NP_002728	4e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG1817-PB	176885	NP_002818	4e-49	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG1817-PC	176885	NP_002818	4e-49	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG10023-PA	164870	NP_004439	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10023-PB	164870	NP_004439	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10023-PC	164870	NP_004439	4e-49	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG18247-PA	131550	NP_005219	4e-49	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8591-PA	314995	NP_009061	4e-49	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1389-PA	164761	NP_065681	4e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG1389-PA	164761	NP_066124	4e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG1634-PA	608548	NP_114141	4e-49	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1634-PB	608548	NP_114141	4e-49	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG18243-PA	151460	NP_563578	4e-49	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG18243-PA	151460	NP_563579	4e-49	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG8591-PA	314995	NP_700359	4e-49	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG15923-PA	609884	NP_714915	4e-49	JBTS6;MKS3;TMEM67	MECKELIN;MKS3 GENE; MKS3	Joubert syndrome 6, 610688 (3);Meckel syndrome, type 3, 607361 (3)
CG10363-PA	120700	NP_000055	5e-49	C3		C3 deficiency (3)
CG14396-PA	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG14396-PB	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG14396-PC	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG14396-PD	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG14396-PE	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7223-PA	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7223-PB	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7223-PC	164860	NP_000236	5e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG5125-PA	160777	NP_000250	5e-49	GS1;MYH12;MYO5A	DILUTE, MOUSE, HOMOLOG OF;MYO5;MYOSIN, HEAVY CHAIN 12; MYH12;MYOXIN	Griscelli syndrome, type 1, 214450 (3)
CG4843-PA	191010	NP_000357	5e-49	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_000357	5e-49	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG1488-PA	601310	NP_000769	5e-49		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG14723-PA	137163	NP_000806	5e-49		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG4898-PA	191010	NP_001018004	5e-49	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG1832-PA	300573	NP_001034980	5e-49	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG18243-PA	151460	NP_002829	5e-49	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG7052-PB	120810	NP_009224	5e-49	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG9610-PA	167415	NP_054698	5e-49	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8222-PA	176943	NP_075259	5e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8222-PB	176943	NP_075259	5e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8222-PC	176943	NP_075259	5e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4969-PA	165330	NP_110380	5e-49	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG1112-PA	177400	NP_000046	6e-49	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG8222-PA	176943	NP_000132	6e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8222-PB	176943	NP_000132	6e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8222-PC	176943	NP_000132	6e-49	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG31091-PA	278000	NP_000226	6e-49	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG8355-PA	600276	NP_000426	6e-49	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG8355-PB	600276	NP_000426	6e-49	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG8355-PC	600276	NP_000426	6e-49	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG8966-PA	601843	NP_000444	6e-49	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG7223-PA	191315	NP_001007793	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PB	191315	NP_001007793	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PC	191315	NP_001007793	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PA	191315	NP_001012331	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PB	191315	NP_001012331	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PC	191315	NP_001012331	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4843-PA	191010	NP_001018004	6e-49	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_001018004	6e-49	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG7873-PA	176947	NP_001070	6e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7873-PB	176947	NP_001070	6e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PA	191315	NP_002520	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PB	191315	NP_002520	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7223-PC	191315	NP_002520	6e-49	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG6498-PA	176960	NP_002728	6e-49	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG3850-PA	165230	NP_005261	6e-49	GLI2;HPE9	ONCOGENE GLI2	Holoprosencephaly-9, 610829 (3);Pituitary anomalies with holoprosencephaly-like features (3)
CG9610-PA	167415	NP_039247	6e-49	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG16761-PA	124010	NP_059488	6e-49		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG8222-PA	164761	NP_065681	6e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8222-PB	164761	NP_065681	6e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8222-PC	164761	NP_065681	6e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG4314-PA	605459	NP_071881	6e-49	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG14723-PA	137164	NP_944494	6e-49	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG11819-PA	608897	NP_954712	6e-49	FHL3;HLH3;HPLH3;MUNC13-4;UNC13D	MUNC13-4	Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)
CG4839-PA	164731	NP_001617	7e-49	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG4839-PB	164731	NP_001617	7e-49	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG3903-PA	114840	NP_001798	7e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG3903-PB	114840	NP_001798	7e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG3903-PC	114840	NP_001798	7e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG3903-PD	114840	NP_001798	7e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG3903-PE	114840	NP_001798	7e-49	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG4353-PA	176872	NP_002746	7e-49		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG4353-PC	176872	NP_002746	7e-49		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG5592-PA	604190	NP_003050	7e-49	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG3969-PA	176947	NP_997402	7e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG3969-PB	176947	NP_997402	7e-49	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG4926-PA	300300	NP_000052	8e-49	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG32134-PA	164860	NP_000236	8e-49	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7873-PA	600456	NP_001018074	8e-49	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7873-PB	600456	NP_001018074	8e-49	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG31711-PA	300203	NP_001032420	8e-49	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5363-PA	300203	NP_001032420	8e-49	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG31711-PA	300203	NP_003150	8e-49	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5363-PA	300203	NP_003150	8e-49	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG7579-PA	601756	NP_004473	8e-49	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG7873-PA	600456	NP_006171	8e-49	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7873-PB	600456	NP_006171	8e-49	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6392-PA	608283	NP_060111	8e-49	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG4007-PA	164761	NP_065681	8e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG6414-PA	300427	NP_065793	8e-49	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG6414-PA	300427	NP_851849	8e-49	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG1444-PA	605573	NP_000188	9e-49	EDH17B3;HSD17B3	17-@BETA-HSD III;ESTRADIOL 17-BETA-DEHYDROGENASE; EDH17B3;TESTICULAR 17-@BETA-HYDROXYSTEROID DEHYDROGENASE III	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
CG8250-PA	602337	NP_004551	9e-49	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG18069-PA	300075	NP_004577	9e-49	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG18069-PB	300075	NP_004577	9e-49	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG18069-PC	300075	NP_004577	9e-49	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4007-PA	164761	NP_066124	9e-49	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG1389-PA	134934	NP_075254	9e-49	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8250-PA	300300	NP_000052	1e-48	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG6124-PA	134797	NP_000129	1e-48	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG1389-PA	134934	NP_000133	1e-48	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6644-PA	191740	NP_000454	1e-48	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17760-PA	139320	NP_000507	1e-48	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG30054-PA	139320	NP_000507	1e-48	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG10369-PA	600937	NP_000516	1e-48	BIR;HHF2;KCNJ11;PHHI;TNDM3	BETA-CELL INWARD RECTIFIER SUBUNIT; BIR;INWARDLY RECTIFYING POTASSIUM CHANNEL Kir6.2;POTASSIUM CHANNEL, INWARDLY RECTIFYING, BIR SUBUNIT	Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3), {Diabetes mellitus, type 2, susceptibility to}, 125853 (3);Diabetes mellitus, transient neonatal, 3, 610582 (3);Diabetes, permanent neonatal, 606176 (3);Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)
CG6018-PA	100740	NP_000656	1e-48	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4128-PA	118504	NP_000735	1e-48	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG3466-PA	605325	NP_000768	1e-48	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG18247-PA	164870	NP_001005862	1e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4898-PB	191010	NP_001018007	1e-48	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018007	1e-48	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018007	1e-48	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018007	1e-48	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG8909-PA	192977	NP_001018066	1e-48	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG9138-PA	121050	NP_001990	1e-48	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG9623-PA	600536	NP_002197	1e-48	ITGA7		Myopathy, congenital (3)
CG9564-PA	601564	NP_002761	1e-48	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG7084-PA	604190	NP_003050	1e-48	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG7084-PB	604190	NP_003050	1e-48	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG8909-PA	192977	NP_003374	1e-48	VLDLR;VLDLRCH		Cerebellar hypoplasia, VLDLR-associated, 224050 (3)
CG18247-PA	164870	NP_004439	1e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4059-PA	184757	NP_004950	1e-48	FTZ1;FTZF1;SF1	ADRENAL 4 BINDING PROTEIN; AD4BP;FUSHI TARAZU FACTOR, DROSOPHILA, HOMOLOG 1; FTZF1; FTZ1;STEROIDOGENIC FACTOR 1; SF1	Adrenocortical insufficiency without ovarian defect (3);Sex reversal, XY, with adrenal failure (3)
CG4059-PB	184757	NP_004950	1e-48	FTZ1;FTZF1;SF1	ADRENAL 4 BINDING PROTEIN; AD4BP;FUSHI TARAZU FACTOR, DROSOPHILA, HOMOLOG 1; FTZF1; FTZ1;STEROIDOGENIC FACTOR 1; SF1	Adrenocortical insufficiency without ovarian defect (3);Sex reversal, XY, with adrenal failure (3)
CG10244-PA	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG14396-PA	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG14396-PB	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG14396-PC	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG14396-PD	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG14396-PE	604705	NP_006334	1e-48	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG18476-PA	314995	NP_009061	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8573-PA	314995	NP_009061	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8573-PB	314995	NP_009061	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7052-PC	120810	NP_009224	1e-48	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG7462-PB	243305	NP_055240	1e-48	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG7462-PC	243305	NP_055240	1e-48	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG1494-PA	607800	NP_056472	1e-48	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG6018-PA	100740	NP_056646	1e-48	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4484-PA	606202	NP_057264	1e-48	AIM1;MATP;SLC45A2	MELANOMA ANTIGEN AIM1; AIM1;MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN; MATP	Oculocutaneous albinism, type IV, 606574 (3);[Pigmentation of hair, skin, and eyes, variation in] (3)
CG5187-PA	300307	NP_058650	1e-48	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG10595-PA	160740	NP_060004	1e-48	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG31212-PA	608892	NP_060250	1e-48	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG3879-PA	170261	NP_061313	1e-48	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG8177-PA	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PB	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PC	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PD	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PE	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PF	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG8177-PG	610206	NP_114423	1e-48	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG18476-PA	314995	NP_700359	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8573-PA	314995	NP_700359	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8573-PB	314995	NP_700359	1e-48	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1494-PA	607800	NP_775099	1e-48	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG7462-PB	243305	NP_899068	1e-48	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG7462-PC	243305	NP_899068	1e-48	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG33196-PB	604210	NP_957705	1e-48	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG7526-PA	600275	XP_001133349	1e-48	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG32975-PA	100690	NP_000070	2e-48	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4215-PA	600678	NP_000170	2e-48	GTBP;HNPCC5;MSH6	G/T MISMATCH-BINDING PROTEIN; GTBP	Colorectal cancer, hereditary nonpolyposis, type 5 (3);Endometrial carcinoma (3);Ovarian cancer, endometrial type (3);{Cancer susceptibility} (3)
CG4215-PB	600678	NP_000170	2e-48	GTBP;HNPCC5;MSH6	G/T MISMATCH-BINDING PROTEIN; GTBP	Colorectal cancer, hereditary nonpolyposis, type 5 (3);Endometrial carcinoma (3);Ovarian cancer, endometrial type (3);{Cancer susceptibility} (3)
CG8874-PA	147670	NP_000199	2e-48	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8874-PB	147670	NP_000199	2e-48	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8874-PC	147670	NP_000199	2e-48	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8874-PD	147670	NP_000199	2e-48	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG18085-PA	164860	NP_000236	2e-48	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7526-PA	600276	NP_000426	2e-48	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG6857-PA	118444	NP_000721	2e-48			
CG7411-PA	137140	NP_000798	2e-48	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG7873-PA	164870	NP_001005862	2e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7873-PB	164870	NP_001005862	2e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG13702-PB	182455	NP_001044	2e-48	SSTR5		Acromegaly, 102200 (3)
CG3969-PA	176947	NP_001070	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG3969-PB	176947	NP_001070	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG4860-PA	609576	NP_001599	2e-48	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG10023-PA	134935	NP_002002	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PB	134935	NP_002002	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PC	134935	NP_002002	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG1389-PA	134935	NP_002002	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG15831-PA	160720	NP_002461	2e-48	MYH3	MYHC-EMB;MYOSIN, SKELETAL, HEAVY CHAIN, EMBRYONIC 1; MYHSE1	Arthrogryposis, distal, type 2A, 193700 (3);Arthrogryposis, distal, type 2B, 601680 (3)
CG4376-PA	182860	NP_003117	2e-48	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG4376-PB	182860	NP_003117	2e-48	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG4376-PC	182860	NP_003117	2e-48	SPTA1		Elliptocytosis-2, 130600 (3);Pyropoikilocytosis, 266140 (3);Spherocytosis, recessive, 270970 (3)
CG6622-PA	605377	NP_004400	2e-48	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG6622-PB	605377	NP_004400	2e-48	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG7873-PA	164870	NP_004439	2e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7873-PB	164870	NP_004439	2e-48	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG6498-PA	300075	NP_004577	2e-48	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG6798-PB	100730	NP_005190	2e-48	ACHRG;CHRNG	ACETYLCHOLINE RECEPTOR, MUSCLE, GAMMA SUBUNIT; ACHRG	Escobar syndrome, 265000 (3);Multiple pterygium syndrome, lethal type, 253290 (3);Myasthenia gravis, neonatal transient (2)
CG10244-PA	164770	NP_005202	2e-48	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG10023-PA	131550	NP_005219	2e-48	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10023-PB	131550	NP_005219	2e-48	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10023-PC	131550	NP_005219	2e-48	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10033-PA	605437	NP_006246	2e-48	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10033-PB	605437	NP_006246	2e-48	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10033-PC	605437	NP_006246	2e-48	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10033-PD	605437	NP_006246	2e-48	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10033-PE	605437	NP_006246	2e-48	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG7257-PA	601023	NP_009057	2e-48	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG2003-PA	604322	NP_036566	2e-48	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG2003-PB	604322	NP_036566	2e-48	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG7260-PA	604895	NP_037483	2e-48	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG10023-PA	134935	NP_075252	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PB	134935	NP_075252	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PC	134935	NP_075252	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG1389-PA	134935	NP_075252	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG5125-PA	608568	NP_079005	2e-48	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG5125-PB	608568	NP_079005	2e-48	DFNA4;KIAA2034;MYH14	KIAA2034;NMHC IIC;NONMUSCLE MYOSIN HEAVY CHAIN IIC	Deafness, autosomal dominant 4, 600652 (3)
CG9738-PA	601263	NP_109587	2e-48		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG4244-PA	601623	NP_570853	2e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PB	601623	NP_570853	2e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PC	601623	NP_570853	2e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PD	601623	NP_570853	2e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8049-PA	176947	NP_997402	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PB	176947	NP_997402	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PC	176947	NP_997402	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8049-PD	176947	NP_997402	2e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10023-PA	134935	NP_998812	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PB	134935	NP_998812	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10023-PC	134935	NP_998812	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG1389-PA	134935	NP_998812	2e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG13521-PA	308840	NP_000416	3e-48	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG13521-PB	308840	NP_000416	3e-48	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG4244-PA	601623	NP_000453	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PB	601623	NP_000453	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PC	601623	NP_000453	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PD	601623	NP_000453	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8652-PA	191740	NP_000454	3e-48	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG3131-PA	606765	NP_000538	3e-48	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG4128-PA	118502	NP_000733	3e-48	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG8591-PA	300573	NP_001034980	3e-48	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG31792-PA	603201	NP_003733	3e-48	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG3792-PA	604041	NP_004861	3e-48	CDGIF;MPDU1;SL15	LEC35;SUPPRESSOR OF LEC15; SL15	Congenital disorder of glycosylation, type If, 609180 (3)
CG10023-PA	189980	NP_005148	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10023-PB	189980	NP_005148	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10023-PC	189980	NP_005148	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG4926-PA	189980	NP_005148	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG14396-PA	190090	NP_005408	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PB	190090	NP_005408	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PC	190090	NP_005408	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PD	190090	NP_005408	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PE	190090	NP_005408	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10023-PA	189980	NP_009297	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10023-PB	189980	NP_009297	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10023-PC	189980	NP_009297	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG4926-PA	189980	NP_009297	3e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG5899-PA	604289	NP_036547	3e-48	RAD54B	RAD54B	Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG3656-PB	124010	NP_059488	3e-48		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG4316-PA	606797	NP_068813	3e-48	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG13521-PA	308840	NP_076493	3e-48	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG13521-PB	308840	NP_076493	3e-48	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG17760-PA	139320	NP_536350	3e-48	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG4244-PA	601623	NP_570854	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PB	601623	NP_570854	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PC	601623	NP_570854	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4244-PD	601623	NP_570854	3e-48	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG3131-PA	606765	NP_783651	3e-48	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG3131-PA	606765	NP_783652	3e-48	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG14396-PA	190090	NP_938033	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PB	190090	NP_938033	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PC	190090	NP_938033	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PD	190090	NP_938033	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG14396-PE	190090	NP_938033	3e-48	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG12073-PA	109690	NP_000015	4e-48	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG18085-PA	300300	NP_000052	4e-48	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG1944-PA	601310	NP_000769	4e-48		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG7446-PA	137140	NP_000798	4e-48	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG7524-PB	176947	NP_001070	4e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG3936-PA	602997	NP_001072	4e-48	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG6018-PA	114840	NP_001798	4e-48	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG6297-PA	176980	NP_002730	4e-48	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6297-PB	176980	NP_002730	4e-48	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG5776-PA	602783	NP_003110	4e-48	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG1912-PA	108961	NP_003986	4e-48	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG10175-PB	300336	NP_061850	4e-48	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG6383-PA	600985	NP_061978	4e-48	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG7524-PB	164761	NP_065681	4e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7524-PB	164761	NP_066124	4e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG5284-PB	118425	NP_000074	5e-48	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG15831-PA	160760	NP_000248	5e-48	CMD1S;CMH1;MPD1;MYH7	MYOSIN, CARDIAC, HEAVY CHAIN, BETA; MYHCB	Cardiomyopathy, dilated, 1S (3);Cardiomyopathy, familial hypertrophic, 1, 192600 (3);Myopathy, Laing distal, 160500 (3);Myopathy, myosin storage, 608358 (3)
CG14808-PA	601411	NP_000328	5e-48	CMD1L;LGMD2F;SGCD;SGD		Cardiomyopathy, dilated, 1L, 606685 (3);Muscular dystrophy, limb-girdle, type 2F, 601287 (3)
CG4464-PA	603474	NP_001013	5e-48	DBA;RPS19		Anemia, Diamond-Blackfan, 105650 (3)
CG4464-PB	603474	NP_001013	5e-48	DBA;RPS19		Anemia, Diamond-Blackfan, 105650 (3)
CG4464-PC	603474	NP_001013	5e-48	DBA;RPS19		Anemia, Diamond-Blackfan, 105650 (3)
CG32120-PA	600871	NP_005254	5e-48	GFI1;ZNF163	ZNF163	Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3);Neutropenia, severe congenital, 202700 (3)
CG7052-PA	120810	NP_009224	5e-48	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG9610-PA	606597	NP_039230	5e-48	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG3388-PA	167415	NP_039245	5e-48	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8457-PA	124010	NP_059488	5e-48		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7260-PA	601620	NP_542449	5e-48	TBX5		Holt-Oram syndrome, 142900 (3)
CG4154-PA	600179	NP_000171	6e-48	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG4154-PC	600179	NP_000171	6e-48	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG9610-PA	606597	NP_000429	6e-48	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG10595-PA	160741	NP_002463	6e-48	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG4032-PA	131550	NP_005219	6e-48	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG16892-PA	605378	NP_056480	6e-48	AAAS;AAA	ADRACALIN;ALADIN	Achalasia-addisonianism-alacrimia syndrome, 231550 (3)
CG8222-PA	134935	NP_075252	6e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PB	134935	NP_075252	6e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PC	134935	NP_075252	6e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7449-PA	608548	NP_114141	6e-48	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG7449-PB	608548	NP_114141	6e-48	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG30054-PA	139320	NP_536350	6e-48	AHO;GNAS;GNAS1;GPSA;PHP1A;PHP1B;POH	1; GNAS1;ADENYLATE CYCLASE STIMULATORY PROTEIN, ALPHA SUBUNIT;Gs, ALPHA SUBUNIT;GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-STIMULATING ACTIVITY POLYPEPTIDE;SECRETOGRANIN VI;STIMULATORY G PROTEIN	Acromegaly, 102200 (3);McCune-Albright syndrome, 174800 (3);Osseous heteroplasia, progressive, 166350 (3);Pituitary ACTH secreting adenoma (3);Prolonged bleeding time, brachydac;Pseudohypoparathyroidism, type Ia, 103580 (3);Pseudohypoparathyroidism, type Ib, 603233 (3);Somatotrophinoma (3)
CG7535-PB	137164	NP_944494	6e-48	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG4032-PA	176947	NP_997402	6e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG9138-PA	134797	NP_000129	7e-48	FBN1;MFS1;WMS	FIBRILLIN; FBN	Aortic aneurysm, ascending, and dissection (3);Ectopia lentis, familial, 129600 (3);Marfan syndrome, 154700 (3);MASS syndrome, 604308 (3);Shprintzen-Goldberg syndrome, 182212 (3);Weill-Marchesani syndrome, dominant, 608328 (3)
CG10079-PA	164860	NP_000236	7e-48	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG10079-PB	164860	NP_000236	7e-48	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8222-PA	134935	NP_002002	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PB	134935	NP_002002	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PC	134935	NP_002002	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG7223-PA	189980	NP_005148	7e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7223-PB	189980	NP_005148	7e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7223-PC	189980	NP_005148	7e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3164-PA	605460	NP_071882	7e-48	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG3164-PB	605460	NP_071882	7e-48	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG8222-PA	134935	NP_998812	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PB	134935	NP_998812	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8222-PC	134935	NP_998812	7e-48	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3850-PA	165240	NP_000159	8e-48	ACLS;GLI3;PAPA;PAPB	ONCOGENE GLI3	Acrocallosal syndrome, 200990 (3);Greig cephalopolysyndactyly syndrome, 175700 (3);Pallister-Hall syndrome, 146510 (3);Polydactyly, postaxial, types A1 and B, 174200 (3);Polydactyly, preaxial, type IV, 174700 (3)
CG14529-PA	600423	NP_001388	8e-48	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG3701-PA	108740	NP_001672	8e-48	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG3277-PA	164770	NP_005202	8e-48	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG3277-PB	164770	NP_005202	8e-48	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG1380-PA	138140	NP_006507	8e-48	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG1380-PB	138140	NP_006507	8e-48	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG7223-PA	189980	NP_009297	8e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7223-PB	189980	NP_009297	8e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG7223-PC	189980	NP_009297	8e-48	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG31045-PB	602666	NP_057323	8e-48	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG31045-PE	602666	NP_057323	8e-48	MYO15A;DFNB3	MYOSIN XV; MYO15	Deafness, autosomal recessive 3, 600316 (3)
CG3722-PA	605516	NP_071407	8e-48	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG1956-PA	190070	NP_203524	8e-48	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG7260-PA	601620	NP_542448	8e-48	TBX5		Holt-Oram syndrome, 142900 (3)
CG10079-PA	176947	NP_997402	8e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10079-PB	176947	NP_997402	8e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14992-PA	176947	NP_997402	8e-48	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7260-PA	601620	NP_000183	9e-48	TBX5		Holt-Oram syndrome, 142900 (3)
CG4898-PA	191010	NP_000357	9e-48	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG8222-PA	191306	NP_002244	9e-48	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG8874-PA	164761	NP_065681	9e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PB	164761	NP_065681	9e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PC	164761	NP_065681	9e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PD	164761	NP_065681	9e-48	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG30193-PA	609139	NP_075063	9e-48	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG30193-PB	609139	NP_075063	9e-48	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG30193-PC	609139	NP_075063	9e-48	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG30193-PE	609139	NP_075063	9e-48	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG30193-PF	609139	NP_075063	9e-48	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG3701-PA	108740	NP_733765	9e-48	ATP2A2;ATP2B;DAR	ATP2B;SARCOPLASMIC RETICULUM Ca(2+)-ATPase 2; SERCA2	Acrokeratosis verruciformis, 101900 (3);Darier disease, 124200 (3)
CG7260-PA	601620	NP_852259	9e-48	TBX5		Holt-Oram syndrome, 142900 (3)
CG15388-PA	600275	XP_001133349	9e-48	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG7461-PA	606885	NP_000008	1e-47	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG8585-PA	123825	NP_000078	1e-47	CNCG1;CNGA1	CNCG;CYCLIC NUCLEOTIDE-GATED CHANNEL, PHOTORECEPTOR, cGMP-GATED, 1; CNCG1;RETINAL ROD cGMP-GATED CHANNEL, ALPHA SUBUNIT	Retinitis pigmentosa, autosomal recessive (3)
CG7873-PA	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG7873-PB	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8049-PA	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8049-PB	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8049-PC	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8049-PD	147670	NP_000199	1e-47	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG8909-PA	606945	NP_000518	1e-47	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG1112-PA	100740	NP_000656	1e-47	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4032-PA	164870	NP_001005862	1e-47	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG1849-PA	600211	NP_001015051	1e-47	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG4012-PA	164731	NP_001617	1e-47	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG7059-PA	222800	NP_001715	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG7059-PC	222800	NP_001715	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG7059-PD	222800	NP_001715	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG32703-PA	602897	NP_002744	1e-47	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG17594-PA	600635	NP_003308	1e-47	NKX2A;TITF1;TTF1	NK2, DROSOPHILA, HOMOLOG OF, A; NKX2A;NK2.1, MOUSE, HOMOLOG OF;THYROID NUCLEAR FACTOR;THYROID-SPECIFIC ENHANCER-BINDING PROTEIN; TEBP;TTF1	Chorea, hereditary benign, 118700 (3);Choreoathetosis, hypothyroidism, and respiratory distress (3);Goiter, familial, due to TTF-1 defect (1)
CG5942-PA	603615	NP_003570	1e-47	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PB	603615	NP_003570	1e-47	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PC	603615	NP_003570	1e-47	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG5942-PD	603615	NP_003570	1e-47	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG10244-PA	600997	NP_004433	1e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4032-PA	164870	NP_004439	1e-47	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG2163-PA	602279	NP_004634	1e-47	PAB2;PABP2;PABPN1	POLY(A)-BINDING PROTEIN 2;POLYADENYLATE-BINDING PROTEIN 2; PABP2; PAB2	Oculopharyngeal muscular dystrophy, 164300 (3)
CG2163-PB	602279	NP_004634	1e-47	PAB2;PABP2;PABPN1	POLY(A)-BINDING PROTEIN 2;POLYADENYLATE-BINDING PROTEIN 2; PABP2; PAB2	Oculopharyngeal muscular dystrophy, 164300 (3)
CG32134-PA	189980	NP_005148	1e-47	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG32134-PA	189980	NP_009297	1e-47	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG1112-PA	100740	NP_056646	1e-47	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3842-PA	605131	NP_057457	1e-47	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG10295-PA	606808	NP_059129	1e-47	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG10295-PB	606808	NP_059129	1e-47	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG10295-PC	606808	NP_059129	1e-47	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG15831-PA	606808	NP_059129	1e-47	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG8874-PA	164761	NP_066124	1e-47	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PB	164761	NP_066124	1e-47	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PC	164761	NP_066124	1e-47	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8874-PD	164761	NP_066124	1e-47	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG15388-PA	600275	NP_077719	1e-47	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG32703-PA	602897	NP_620446	1e-47	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG32703-PA	602897	NP_620448	1e-47	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG9610-PA	606597	NP_852125	1e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG9610-PA	606597	NP_852126	1e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG7059-PA	222800	NP_954655	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG7059-PC	222800	NP_954655	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG7059-PD	222800	NP_954655	1e-47	BPGM	2,3-@DPG MUTASE DEFICIENCY;BISPHOSPHOGLYCEROMUTASE DEFICIENCY; BPGM DEFICIENCY;DPGAM DEFICIENCY;DPGM DEFICIENCY	Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3)
CG31711-PA	123829	NP_000066	2e-47	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG11049-PA	606597	NP_000429	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_000429	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG3978-PA	131320	NP_001002295	2e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG3978-PB	131320	NP_001002295	2e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG10079-PA	176947	NP_001070	2e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10079-PB	176947	NP_001070	2e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14992-PA	176947	NP_001070	2e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG30092-PB	300017	NP_001447	2e-47	ABPX;FLN1;FLNA;FMD;MNS;NHBP;OPD1;OPD2	ACTIN-BINDING PROTEIN 280; ABP280;FILAMIN 1; FLN1;FILAMIN, ALPHA;FLN	Frontometaphyseal dysplasia, 304120 (3);Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3);Heterotopia, periventricular, 300049 (3);Heterotopia, periventricular, ED variant, 300537 (3);Melnick-Needles syndrome, 309350 (3);Otopalatodigital syndrome, type I, 311300 (3);Otopalatodigital syndrome, type II, 304120 (3)
CG8222-PC	191306	NP_002244	2e-47	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG2005-PA	176885	NP_002818	2e-47	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG2005-PB	176885	NP_002818	2e-47	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG18243-PA	600925	NP_002834	2e-47	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG5133-PA	601397	NP_003172	2e-47	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG10023-PA	600997	NP_004433	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10023-PB	600997	NP_004433	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10023-PC	600997	NP_004433	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1832-PA	314995	NP_009061	2e-47	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7052-PE	120810	NP_009224	2e-47	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG5187-PA	604895	NP_037483	2e-47	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG11049-PA	606597	NP_039230	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_039230	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG10023-PA	600997	NP_059145	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10023-PB	600997	NP_059145	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10023-PC	600997	NP_059145	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10244-PA	600997	NP_059145	2e-47	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7260-PA	601719	NP_060958	2e-47	TBX4		Small patella syndrome, 147891 (3)
CG3571-PA	605379	NP_071324	2e-47	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG1634-PA	608630	NP_071765	2e-47	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG1634-PB	608630	NP_071765	2e-47	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG4353-PA	601263	NP_109587	2e-47		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG4353-PC	601263	NP_109587	2e-47		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG11593-PA	608179	NP_149053	2e-47	ATCAY;CLAC;KIAA1872	ATCAY;KIAA1872	Ataxia, cerebellar, Cayman type, 601238 (3)
CG5092-PA	607585	NP_612149	2e-47	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1832-PA	314995	NP_700359	2e-47	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG9610-PA	606597	NP_852122	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG9610-PA	606597	NP_852123	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG9610-PA	606597	NP_852124	2e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG4136-PA	142993	NP_878314	2e-47	CHX10;HOX10;MCOP2;MCOPCB3	HOMEOBOX 10; HOX10	Microphthalmia, isolated 2, 610093 (3);Microphthalmia, isolated, with coloboma 3, 610092 (3)
CG11895-PA	604210	NP_957705	2e-47	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG5092-PA	607585	NP_000042	3e-47	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG16858-PA	120120	NP_000085	3e-47	COL7A1	LC COLLAGEN;LONG-CHAIN COLLAGEN	EBD, Bart type, 132000 (3);EBD, localisata variant (3);Epidermolysis bullosa dystrophica, AD, 131750 (3);Epidermolysis bullosa dystrophica, AR, 226600 (3);Epidermolysis bullosa pruriginosa, 604129 (3);Epidermolysis bullosa, pretibial, 131850 (3);Toenail dystrophy, isolated, 607523 (3);Transient bullous of the newborn, 131705 (3)
CG17097-PA	278000	NP_000226	3e-47	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG17097-PB	278000	NP_000226	3e-47	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG13772-PA	100740	NP_000656	3e-47	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3252-PA	608893	NP_001003841	3e-47	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG10776-PA	190182	NP_001020018	3e-47	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG10498-PA	300203	NP_001032420	3e-47	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10498-PB	300203	NP_001032420	3e-47	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10620-PA	190000	NP_001054	3e-47	TF		Atransferrinemia, 209300 (3);{Iron deficiency anemia, susceptibility to} (3)
CG8358-PA	600423	NP_001388	3e-47	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG4402-PA	153455	NP_002308	3e-47	LOX		Cutis laxa, recessive, type I, 219100 (1)
CG15831-PA	160741	NP_002463	3e-47	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG4839-PA	176960	NP_002728	3e-47	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG4839-PB	176960	NP_002728	3e-47	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG3355-PA	606635	NP_002763	3e-47	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG17181-PA	602150	NP_003059	3e-47	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG1489-PA	602783	NP_003110	3e-47	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG10498-PA	300203	NP_003150	3e-47	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10498-PB	300203	NP_003150	3e-47	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5187-PA	601397	NP_003172	3e-47	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG10776-PA	190182	NP_003233	3e-47	AAT3;HNPCC6;MFS2;TGFBR2		Aortic aneurysm, familial thoracic 3, 608967 (3);Colon cancer (3);Colorectal cancer, hereditary nonpolyposis, type 6 (3);Esophageal cancer, 133239 (3);Loeys-Dietz syndrome, 609192 (3);Marfan syndrome, type II, 154705 (3)
CG8637-PA	300075	NP_004577	3e-47	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG12172-PA	602445	NP_005016	3e-47	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG5093-PA	604895	NP_037483	3e-47	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG13772-PA	100740	NP_056646	3e-47	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3841-PA	300427	NP_065793	3e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG30021-PA	300189	NP_066943	3e-47	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG17528-PC	300121	NP_835364	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PD	300121	NP_835364	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PC	300121	NP_835365	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PD	300121	NP_835365	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PC	300121	NP_835366	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PD	300121	NP_835366	3e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG3841-PA	300427	NP_851849	3e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG8874-PA	176947	NP_997402	3e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PB	176947	NP_997402	3e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PC	176947	NP_997402	3e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PD	176947	NP_997402	3e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG1389-PA	176943	NP_000132	4e-47	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7328-PA	229800	NP_000212	4e-47	KHK	HEPATIC FRUCTOKINASE DEFICIENCY;KETOHEXOKINASE DEFICIENCY	[Fructosuria] (3)
CG3277-PB	164920	NP_000213	4e-47	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG11598-PA	278000	NP_000226	4e-47	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG1380-PA	138160	NP_000331	4e-47	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG1380-PB	138160	NP_000331	4e-47	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG8874-PA	600221	NP_000450	4e-47	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8874-PB	600221	NP_000450	4e-47	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8874-PC	600221	NP_000450	4e-47	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8874-PD	600221	NP_000450	4e-47	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17528-PC	300121	NP_000546	4e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG17528-PD	300121	NP_000546	4e-47	DBCN;DCX;LISX	DBCN	Lissencephaly, X-linked, 300067 (3);Subcortical laminal heteropia, X-linked, 300067 (3)
CG11567-PA	163729	NP_000594	4e-47	NOS3	NITRIC OXIDE SYNTHASE, ENDOTHELIAL; ENOS	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);{Coronary spasms, susceptibility to} (3);{Hypertension, pregnancy-induced}, 189800 (3);{Hypertension, susceptibility to}, 145500 (3);{Placental abruption} (3)
CG12066-PB	176980	NP_002730	4e-47	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG2331-PA	602783	NP_003110	4e-47	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG5093-PA	601397	NP_003172	4e-47	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG30171-PB	142461	NP_005520	4e-47	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG5189-PA	610389	NP_054736	4e-47	MAPBPIP;p14	MAPBPIP;p14	Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)
CG5093-PA	300307	NP_058650	4e-47	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG1389-PA	176943	NP_075259	4e-47	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8250-PA	136350	NP_075599	4e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG11049-PA	606597	NP_852125	4e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_852125	4e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PA	606597	NP_852126	4e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_852126	4e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8250-PA	176947	NP_997402	4e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG1128-PB	177400	NP_000046	5e-47	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG3131-PA	131399	NP_000493	5e-47	EPX		Eosinophil peroxidase deficiency, 261500 (3)
CG8049-PA	147370	NP_000866	5e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8049-PB	147370	NP_000866	5e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8049-PC	147370	NP_000866	5e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8049-PD	147370	NP_000866	5e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG3992-PB	131320	NP_001002295	5e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG3992-PC	131320	NP_001002295	5e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG7084-PA	603377	NP_003051	5e-47	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG7084-PB	603377	NP_003051	5e-47	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG4839-PA	300075	NP_004577	5e-47	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4839-PB	300075	NP_004577	5e-47	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG5661-PA	608166	NP_036563	5e-47	KIAA0331;SEMA3E;SEMAH	KIAA0331;SEMAPHORIN H, MOUSE, HOMOLOG OF; SEMAH	CHARGE syndrome, 214800 (3)
CG18402-PA	136350	NP_075599	5e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG11049-PA	606597	NP_852122	5e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_852122	5e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PA	606597	NP_852123	5e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_852123	5e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6989-PA	109690	NP_000015	6e-47	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG9610-PA	607108	NP_000271	6e-47	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG30438-PA	191740	NP_000454	6e-47	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG30438-PB	191740	NP_000454	6e-47	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG30438-PC	191740	NP_000454	6e-47	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG30438-PD	191740	NP_000454	6e-47	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG10023-PA	147370	NP_000866	6e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10023-PB	147370	NP_000866	6e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG10023-PC	147370	NP_000866	6e-47	IGF1R		Intrauterine and postnatal growth retardation (3)
CG6124-PA	121050	NP_001990	6e-47	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG3978-PA	131320	NP_002042	6e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG3978-PB	131320	NP_002042	6e-47	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG1954-PA	180381	NP_002920	6e-47	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG9475-PA	601023	NP_009057	6e-47	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG9375-PA	600098	NP_036382	6e-47	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG10339-PA	300427	NP_065793	6e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4382-PA	300427	NP_065793	6e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG8733-PA	608713	NP_078790	6e-47	CYP2R1		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
CG10339-PA	300427	NP_851849	6e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4382-PA	300427	NP_851849	6e-47	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG11049-PA	606597	NP_852124	6e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11049-PB	606597	NP_852124	6e-47	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG12008-PA	300377	NP_000100	7e-47	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8874-PA	176947	NP_001070	7e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PB	176947	NP_001070	7e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PC	176947	NP_001070	7e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8874-PD	176947	NP_001070	7e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG4365-PA	609023	NP_056303	7e-47	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG1725-PF	300189	NP_066943	7e-47	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG5265-PA	600650	NP_000089	8e-47	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG9774-PA	176960	NP_002728	8e-47	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG7095-PA	604067	NP_003826	8e-47	RGS9;PERRS		Bradyopsia, 608415 (3)
CG17998-PA	605437	NP_006246	8e-47	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10061-PA	609279	NP_060921	8e-47	CEMPJ;CPAP;MCPH6	CENTROSOMAL P4.1-ASSOCIATED PROTEIN; CPAP	Microcephaly, primary autosomal recessive, 6, 608393 (3)
CG10023-PA	176943	NP_075259	8e-47	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10023-PB	176943	NP_075259	8e-47	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10023-PC	176943	NP_075259	8e-47	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG7526-PA	600275	NP_077719	8e-47	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG3131-PA	606989	NP_000241	9e-47	MPO		Myeloperoxidase deficiency, 254600 (3);{Alzheimer disease, susceptibility to}, 104300 (3)
CG31926-PA	179820	NP_000528	9e-47	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG7535-PA	137164	NP_000807	9e-47	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG4380-PA	600281	NP_001025175	9e-47	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG8250-PA	176947	NP_001070	9e-47	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG12428-PA	600528	NP_001867	9e-47	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PB	600528	NP_001867	9e-47	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PC	600528	NP_001867	9e-47	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PD	600528	NP_001867	9e-47	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PE	600528	NP_001867	9e-47	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG5395-PA	604277	NP_055761	9e-47	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG32659-PA	600985	NP_061978	9e-47	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG10023-PA	136350	NP_075593	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PB	136350	NP_075593	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PC	136350	NP_075593	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PA	136350	NP_075594	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PB	136350	NP_075594	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PC	136350	NP_075594	9e-47	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG5133-PA	602054	NP_542378	9e-47	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG5395-PA	604277	NP_955468	9e-47	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG1522-PA	600163	XP_001131636	9e-47	CDCD2;CMD1E;HB1;IVF;LQT3;SCN5A;SSS1	NAV1.5	Brugada syndrome, 601144 (3);Cardiomyopathy, dilated, 1E, 601154 (3);Heart block, nonprogressive, 113900 (3);Heart block, progressive, type I, 113900 (3);Long QT syndrome-3, 603830 (3);Sick sinus syndrome, 608567 (3);Ventricular fibrillation, idiopathic, 603829 (3)
CG4382-PA	177400	NP_000046	1e-46	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG5179-PA	123829	NP_000066	1e-46	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10023-PA	176943	NP_000132	1e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10023-PB	176943	NP_000132	1e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10023-PC	176943	NP_000132	1e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG12344-PA	138491	NP_000162	1e-46	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG17309-PA	147670	NP_000199	1e-46	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17309-PB	147670	NP_000199	1e-46	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17309-PC	147670	NP_000199	1e-46	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17309-PD	147670	NP_000199	1e-46	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17309-PE	147670	NP_000199	1e-46	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG32702-PA	601920	NP_000205	1e-46	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG15288-PA	600805	NP_000218	1e-46	LAMA3;LOCS	LAM5, ALPHA-3 SUBUNIT;LAMININ 5, ALPHA-3 SUBUNIT;LAMININ A3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);Laryngoonychocutaneous syndrome, 245660 (3)
CG10244-PA	164860	NP_000236	1e-46	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG1495-PA	172471	NP_000285	1e-46	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1495-PB	172471	NP_000285	1e-46	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1495-PC	172471	NP_000285	1e-46	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1495-PE	172471	NP_000285	1e-46	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1495-PG	172471	NP_000285	1e-46	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG10037-PA	173110	NP_000297	1e-46	POU1F1;PIT1	GROWTH HORMONE FACTOR 1; GHF1;PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1	Pituitary hormone deficiency, combined (3)
CG12773-PA	600839	NP_000329	1e-46	NKCC2;SLC12A1	MEMBER 1; SLC12A1;SODIUM-POTASSIUM-CHLORIDE TRANSPORTER 2; NKCC2	Bartter syndrome, type 1, 601678 (3)
CG8049-PA	600221	NP_000450	1e-46	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8049-PB	600221	NP_000450	1e-46	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8049-PC	600221	NP_000450	1e-46	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8049-PD	600221	NP_000450	1e-46	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG7555-PA	601623	NP_000453	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PB	601623	NP_000453	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PC	601623	NP_000453	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG1318-PC	606873	NP_000512	1e-46	HEXB		Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3);Spinal muscular atrophy, juvenile (3)
CG3355-PA	229000	NP_000883	1e-46	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG3701-PA	604384	NP_001001485	1e-46	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3701-PA	604384	NP_001001486	1e-46	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG3701-PA	604384	NP_001001487	1e-46	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5161-PA	300202	NP_001011658	1e-46	SEDL;SEDT		Spondyloepiphyseal dysplasia tarda, 313400 (3)
CG4843-PA	191010	NP_001018006	1e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_001018006	1e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG10244-PA	600456	NP_001018074	1e-46	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG4380-PA	600281	NP_001025174	1e-46	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9774-PA	164731	NP_001617	1e-46	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG6917-PA	114840	NP_001798	1e-46	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG11202-PA	601397	NP_003172	1e-46	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG1467-PA	603666	NP_003754	1e-46		SYN16	
CG4007-PA	600997	NP_004433	1e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7873-PA	602337	NP_004551	1e-46	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7873-PB	602337	NP_004551	1e-46	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG9455-PA	602445	NP_005016	1e-46	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG10079-PA	189980	NP_005148	1e-46	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10079-PB	189980	NP_005148	1e-46	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG5133-PA	602054	NP_005983	1e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG10244-PA	600456	NP_006171	1e-46	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG3388-PA	167416	NP_006185	1e-46	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG1389-PA	173490	NP_006197	1e-46	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG7052-PD	120810	NP_009224	1e-46	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG10079-PA	189980	NP_009297	1e-46	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10079-PB	189980	NP_009297	1e-46	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3701-PA	604384	NP_055197	1e-46	ATP2C1;BCPM;HHD	ATPase, Ca(2+)-SEQUESTERING	Hailey-Hailey disease, 169600 (3)
CG5161-PA	300202	NP_055378	1e-46	SEDL;SEDT		Spondyloepiphyseal dysplasia tarda, 313400 (3)
CG10023-PA	136350	NP_056934	1e-46	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PB	136350	NP_056934	1e-46	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10023-PC	136350	NP_056934	1e-46	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG9138-PA	602768	NP_058637	1e-46	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG3578-PA	300307	NP_058650	1e-46	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG4007-PA	600997	NP_059145	1e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3540-PA	124010	NP_059488	1e-46		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG15831-PA	160740	NP_060004	1e-46	MYH2	MHC IIa;MYHC IIa;MYOSIN, HEAVY CHAIN, IIa; MYHC2A; MYH2A;MYOSIN, SKELETAL, HEAVY CHAIN, ADULT 2; MYHSA2	Inclusion body myopathy-3, 605637 (3)
CG18085-PA	164761	NP_065681	1e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG18085-PA	164761	NP_066124	1e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG2857-PA	606521	NP_068380	1e-46	DNC;MCPHA;MUP1;SLC25A19	MEMBER 19; SLC25A19;MITOCHONDRIAL DEOXYNUCLEOTIDE CARRIER; DNC;MITOCHONDRIAL UNCOUPLING PROTEIN 1; MUP1	Microcephaly, Amish type, 607196 (3)
CG32387-PA	608630	NP_071765	1e-46	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG32387-PB	608630	NP_071765	1e-46	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG32702-PA	600275	NP_077719	1e-46	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG1167-PA	190070	NP_203524	1e-46	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG7555-PA	601623	NP_570853	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PB	601623	NP_570853	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PC	601623	NP_570853	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PA	601623	NP_570854	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PB	601623	NP_570854	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7555-PC	601623	NP_570854	1e-46	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7981-PE	188840	NP_596869	1e-46	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4630-PA	607096	NP_653186	1e-46	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG4380-PA	600281	NP_787110	1e-46	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9138-PA	602768	NP_982353	1e-46	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG1488-PA	608614	NP_997235	1e-46	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG32702-PA	600275	XP_001133349	1e-46	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG6798-PB	100725	NP_000071	2e-46	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG12428-PA	600650	NP_000089	2e-46	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG12428-PB	600650	NP_000089	2e-46	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG12428-PC	600650	NP_000089	2e-46	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG12428-PD	600650	NP_000089	2e-46	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG12428-PE	600650	NP_000089	2e-46	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG8733-PA	124030	NP_000097	2e-46	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG8049-PA	176943	NP_000132	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PB	176943	NP_000132	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PC	176943	NP_000132	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PD	176943	NP_000132	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3277-PA	164920	NP_000213	2e-46	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG8246-PA	167409	NP_000269	2e-46	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG7981-PA	606945	NP_000518	2e-46	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG7981-PB	606945	NP_000518	2e-46	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG7981-PC	606945	NP_000518	2e-46	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG7981-PD	606945	NP_000518	2e-46	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG7981-PE	606945	NP_000518	2e-46	FH;FHC;LDLR		Hypercholesterolemia, familial, 143890 (3)
CG8733-PA	124040	NP_000764	2e-46		CYP2E1;ETHANOL-INDUCIBLE P450;P450C2E	
CG31072-PA	147280	NP_000867	2e-46	IGF2R;MPRI	CIMPR;MANNOSE 6-PHOSPHATE RECEPTOR, CATION-INDEPENDENT; MPRI	Hepatocellular carcinoma (3)
CG31072-PB	147280	NP_000867	2e-46	IGF2R;MPRI	CIMPR;MANNOSE 6-PHOSPHATE RECEPTOR, CATION-INDEPENDENT; MPRI	Hepatocellular carcinoma (3)
CG31072-PC	147280	NP_000867	2e-46	IGF2R;MPRI	CIMPR;MANNOSE 6-PHOSPHATE RECEPTOR, CATION-INDEPENDENT; MPRI	Hepatocellular carcinoma (3)
CG8250-PA	164870	NP_001005862	2e-46	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4898-PA	191010	NP_001018006	2e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG7524-PB	600456	NP_001018074	2e-46	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG1849-PA	600211	NP_001019801	2e-46	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG12428-PA	600528	NP_001027017	2e-46	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PB	600528	NP_001027017	2e-46	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PC	600528	NP_001027017	2e-46	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PD	600528	NP_001027017	2e-46	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG12428-PE	600528	NP_001027017	2e-46	CPT1A	CPT I, LIVER;CPT IA;CPT1	CPT deficiency, hepatic, type IA, 255120 (3)
CG1891-PA	600799	NP_001195	2e-46	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG1891-PB	600799	NP_001195	2e-46	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG1131-PA	114840	NP_001798	2e-46	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG13772-PA	114840	NP_001798	2e-46	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG6127-PA	121050	NP_001990	2e-46	CCA;FBN2	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9;BEALS SYNDROME;CCA	Contractural arachnodactyly, congenital (3)
CG14217-PD	300142	NP_002569	2e-46	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG14217-PE	300142	NP_002569	2e-46	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG8246-PA	167409	NP_003978	2e-46	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8246-PA	167409	NP_003979	2e-46	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8246-PA	167409	NP_003980	2e-46	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG8246-PA	167409	NP_003981	2e-46	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG12008-PA	300377	NP_004000	2e-46	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG1849-PA	600211	NP_004339	2e-46	AML3;CBFA1;PEBP2A1;RUNX2	AML3 GENE; AML3;CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 1; CBFA1;OSF2;PEBP2-ALPHA-A	Cleidocranial dysplasia, 119600 (3);Dental anomalies, isolated (3)
CG8250-PA	164870	NP_004439	2e-46	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14992-PA	131550	NP_005219	2e-46	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG1167-PA	190020	NP_005334	2e-46	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG1494-PA	600046	NP_005493	2e-46	ABC1;ABCA1;HDLDT1;TGD	ABC TRANSPORTER 1;ATP-BINDING CASSETTE 1; ABC1;ATP-BINDING CASSETTE TRANSPORTER 1;CHOLESTEROL EFFLUX REGULATORY PROTEIN; CERP;CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION	HDL deficiency, familial, 604091 (3);Tangier disease, 205400 (3);{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)
CG7524-PB	600456	NP_006171	2e-46	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6716-PA	167416	NP_006185	2e-46	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG6716-PB	167416	NP_006185	2e-46	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG5073-PA	609118	NP_009148	2e-46	CCM3;PDCD10;TFAR15	TFAR15	Cerebral cavernous malformations 3, 603285 (3)
CG6492-PA	113730	NP_068605	2e-46	UCP1	BROWN ADIPOSE TISSUE UNCOUPLING PROTEIN;THERMOGENIN;UCP	{Obesity, susceptibility to}, 601665 (3)
CG9664-PA	605459	NP_071881	2e-46	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG9664-PB	605459	NP_071881	2e-46	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG8049-PA	176943	NP_075259	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PB	176943	NP_075259	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PC	176943	NP_075259	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8049-PD	176943	NP_075259	2e-46	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG2139-PA	609302	NP_078974	2e-46	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG2139-PB	609302	NP_078974	2e-46	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG2139-PC	609302	NP_078974	2e-46	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG2139-PD	609302	NP_078974	2e-46	GC1;SLC25A22	22; SLC25A22;GLUTAMATE CARRIER 1; GC1	Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)
CG16858-PA	120070	NP_112730	2e-46	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG5133-PA	602054	NP_542377	2e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG5073-PA	609118	NP_665858	2e-46	CCM3;PDCD10;TFAR15	TFAR15	Cerebral cavernous malformations 3, 603285 (3)
CG5073-PA	609118	NP_665859	2e-46	CCM3;PDCD10;TFAR15	TFAR15	Cerebral cavernous malformations 3, 603285 (3)
CG4380-PA	600281	NP_849181	2e-46	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG15782-PA	142993	NP_878314	2e-46	CHX10;HOX10;MCOP2;MCOPCB3	HOMEOBOX 10; HOX10	Microphthalmia, isolated 2, 610093 (3);Microphthalmia, isolated, with coloboma 3, 610092 (3)
CG17336-PA	137164	NP_944493	2e-46	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG17336-PB	137164	NP_944493	2e-46	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG15388-PA	604210	NP_957705	2e-46	CRB1;LCA8;RP12		Leber congenital amaurosis VIII (3);Pigmented paravenous chorioretinal atrophy, 172870 (3);Retinitis pigmentosa-12, autosomal recessive, 600105 (3)
CG3879-PA	603234	XP_001125860	2e-46	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG7279-PA	278000	NP_000226	3e-46	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG9761-PA	110900	NP_000411	3e-46	KEL		[Blood group, Kell] (3)
CG4380-PA	600281	NP_000448	3e-46	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG1131-PA	100740	NP_000656	3e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG7873-PA	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG7873-PB	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8874-PA	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8874-PB	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8874-PC	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8874-PD	147370	NP_000866	3e-46	IGF1R		Intrauterine and postnatal growth retardation (3)
CG8203-PA	300203	NP_001032420	3e-46	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG15269-PA	300573	NP_001034980	3e-46	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG3879-PA	603234	NP_001162	3e-46	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8224-PA	600799	NP_001195	3e-46	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG8224-PB	600799	NP_001195	3e-46	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG2241-PA	602783	NP_003110	3e-46	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG8203-PA	300203	NP_003150	3e-46	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG1956-PA	190070	NP_004976	3e-46	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG7873-PA	131550	NP_005219	3e-46	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG7873-PB	131550	NP_005219	3e-46	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG1956-PA	190020	NP_005334	3e-46	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG10522-PA	605437	NP_006246	3e-46	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG6646-PA	602533	NP_009193	3e-46	DJ1;PARK7	DJ1;PARK7 GENE; PARK7	Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3);Parkinson disease 7, autosomal recessive early-onset, 606324 (3)
CG3388-PA	167415	NP_039247	3e-46	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG3388-PA	167415	NP_054698	3e-46	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1131-PA	100740	NP_056646	3e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10776-PA	600956	NP_065434	3e-46	AMHR;AMHR2	ANTI-MULLERIAN HORMONE RECEPTOR; AMHR	Persistent Mullerian duct syndrome, type II, 261550 (3)
CG32094-PA	600275	NP_077719	3e-46	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG31175-PA	601239	NP_116757	3e-46	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PB	601239	NP_116757	3e-46	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PC	601239	NP_116757	3e-46	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG8107-PA	114240	NP_775111	3e-46	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG4380-PA	600281	NP_849180	3e-46	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG1765-PA	190120	NP_955366	3e-46	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PB	190120	NP_955366	3e-46	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PC	190120	NP_955366	3e-46	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PD	190120	NP_955366	3e-46	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PE	190120	NP_955366	3e-46	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG32094-PA	600275	XP_001133349	3e-46	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG18284-PA	278000	NP_000226	4e-46	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG8874-PA	164860	NP_000236	4e-46	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8874-PB	164860	NP_000236	4e-46	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8874-PC	164860	NP_000236	4e-46	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8874-PD	164860	NP_000236	4e-46	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7411-PA	137164	NP_000807	4e-46	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG11902-PA	300573	NP_001034980	4e-46	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG17148-PA	114840	NP_001798	4e-46	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG7693-PA	300142	NP_002569	4e-46	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG7693-PB	300142	NP_002569	4e-46	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG12008-PA	300377	NP_003997	4e-46	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG7576-PA	603868	NP_004571	4e-46	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG8137-PA	602445	NP_005016	4e-46	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG10244-PA	190090	NP_005408	4e-46	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4012-PA	605437	NP_006246	4e-46	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG3388-PA	167415	NP_039246	4e-46	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG5133-PA	300307	NP_058650	4e-46	CPX;TBX22		Cleft palate with ankyloglossia, 303400 (3)
CG8049-PA	134935	NP_075252	4e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PB	134935	NP_075252	4e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PC	134935	NP_075252	4e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PD	134935	NP_075252	4e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG12073-PA	126451	NP_387512	4e-46	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG5187-PA	602054	NP_542377	4e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG7576-PA	603868	NP_899057	4e-46	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG7576-PA	603868	NP_899058	4e-46	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG7576-PA	603868	NP_899059	4e-46	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG10244-PA	190090	NP_938033	4e-46	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7535-PA	137164	NP_944494	4e-46	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG1228-PB	130500	NP_976218	4e-46	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG31872-PA	278000	NP_000226	5e-46	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG18741-PA	126451	NP_000787	5e-46	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG18741-PB	126451	NP_000787	5e-46	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG1467-PA	603666	NP_001001433	5e-46		SYN16	
CG4898-PB	191010	NP_001018020	5e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018020	5e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018020	5e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018020	5e-46	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG8049-PA	134935	NP_002002	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PB	134935	NP_002002	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PC	134935	NP_002002	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PD	134935	NP_002002	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3388-PA	167415	NP_003457	5e-46	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG15844-PA	602821	NP_004975	5e-46	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG4926-PA	604705	NP_006334	5e-46	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10339-PA	300336	NP_061850	5e-46	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG10023-PA	164761	NP_065681	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PB	164761	NP_065681	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PC	164761	NP_065681	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PA	164761	NP_066124	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PB	164761	NP_066124	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PC	164761	NP_066124	5e-46	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG9326-PA	300189	NP_066943	5e-46	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG9326-PB	300189	NP_066943	5e-46	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG9326-PC	300189	NP_066943	5e-46	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG4365-PA	609023	NP_072094	5e-46	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG4365-PB	609023	NP_072094	5e-46	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG4365-PC	609023	NP_072094	5e-46	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG8049-PA	134934	NP_075254	5e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PB	134934	NP_075254	5e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PC	134934	NP_075254	5e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PD	134934	NP_075254	5e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG5187-PA	602054	NP_542378	5e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG6847-PA	607365	NP_640341	5e-46	LIPH	LPD LIPASE-RELATED PROTEIN; LPDLR;MEMBRANE-ASSOCIATED PHOSPHATIDIC ACID-SELECTIVE PHOSPHOLIPASE A1;;MPAPLA1;PHOSPHOLIPASE A1, PHOSPHATIDIC ACID-SELECTIVE, MEMBRANE-ASSOCIATED	Hypotrichosis, total, Mari type, 604379 (3)
CG3850-PA	610192	NP_689842	5e-46	GLIS3;ZNF515	GLI-SIMILAR PROTEIN 3;ZINC FINGER PROTEIN 515; ZNF515	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
CG8049-PA	134935	NP_998812	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PB	134935	NP_998812	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PC	134935	NP_998812	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PD	134935	NP_998812	5e-46	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8049-PA	134934	NP_000133	6e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PB	134934	NP_000133	6e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PC	134934	NP_000133	6e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8049-PD	134934	NP_000133	6e-46	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6484-PA	138160	NP_000331	6e-46	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG1108-PA	100740	NP_000656	6e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8424-PA	100740	NP_000656	6e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG31661-PA	116840	NP_001900	6e-46	CLN10;CPSD;CTSD		Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
CG3969-PA	600997	NP_004433	6e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3969-PB	600997	NP_004433	6e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4365-PB	609023	NP_056303	6e-46	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG4365-PC	609023	NP_056303	6e-46	BRP17;DYT8;FPD1;KIPP1184;MR1;PDC;PNKD;TAHCCP2	BRAIN PROTEIN 17, MOUSE, HOMOLOG OF; BRP17;KIAA1184;MR1;TRANSACTIVATED BY HEPATITIS C VIRUS CORE PROTEIN 2; TAHCCP2	Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
CG1108-PA	100740	NP_056646	6e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8424-PA	100740	NP_056646	6e-46	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3969-PA	600997	NP_059145	6e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3969-PB	600997	NP_059145	6e-46	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG12244-PA	601263	NP_109587	6e-46		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG4268-PA	123829	NP_000066	7e-46	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG4268-PC	123829	NP_000066	7e-46	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG13702-PB	600018	NP_000905	7e-46	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG13702-PB	600018	NP_001008504	7e-46	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG3992-PB	131320	NP_002042	7e-46	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG3992-PC	131320	NP_002042	7e-46	GATA3;HDR	ENHANCER-BINDING PROTEIN GATA3	Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)
CG1956-PA	164790	NP_002515	7e-46	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG40129-PA	176960	NP_002728	7e-46	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG7314-PA	601693	NP_003346	7e-46	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG7314-PB	601693	NP_003346	7e-46	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG5093-PA	602054	NP_005983	7e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG9696-PA	608892	NP_060250	7e-46	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG9696-PD	608892	NP_060250	7e-46	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG9696-PE	608892	NP_060250	7e-46	CHD7	KIAA1416	CHARGE syndrome, 214800 (3)
CG7981-PC	188840	NP_596869	7e-46	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7981-PD	188840	NP_596869	7e-46	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7660-PA	606765	NP_783650	7e-46	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG17896-PA	100650	NP_000681	8e-46	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG17896-PB	100650	NP_000681	8e-46	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG13702-PB	600018	NP_001008503	8e-46	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG13702-PB	600018	NP_001008505	8e-46	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG2899-PA	164757	NP_004324	8e-46	BRAF	BRAF1;ONCOGENE BRAF;RAFB1	Adenocarcinoma of lung, somatic, 211980 (3);Cardiofaciocutaneous syndrome, 115150 (3);Colorectal cancer, somatic (3);Melanoma, melignant, somatic (3);Nonsmall cell lung cancer, somatic (3)
CG11502-PC	604485	NP_055064	8e-46	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG9019-PA	604485	NP_055064	8e-46	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG5093-PA	602054	NP_542377	8e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG18085-PA	600221	NP_000450	9e-46	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG7411-PA	137163	NP_000806	9e-46		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG1795-PA	601982	NP_002533	9e-46	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG12066-PA	176960	NP_002728	9e-46	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG5133-PA	604614	NP_005140	9e-46	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG5187-PA	602054	NP_005983	9e-46	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG8246-PA	167415	NP_054698	9e-46	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG6414-PA	177400	NP_000046	1e-45	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG10079-PA	300300	NP_000052	1e-45	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG10079-PB	300300	NP_000052	1e-45	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8908-PA	601691	NP_000341	1e-45	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG14529-PA	300550	NP_000435	1e-45	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG4926-PA	600221	NP_000450	1e-45	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17146-PA	103000	NP_000467	1e-45	AK1	ADENYLATE KINASE, SOLUBLE	Hemolytic anemia due to adenylate kinase deficiency (3)
CG17146-PB	103000	NP_000467	1e-45	AK1	ADENYLATE KINASE, SOLUBLE	Hemolytic anemia due to adenylate kinase deficiency (3)
CG9652-PA	109630	NP_000675	1e-45	ADRB1;ADRB1R;RHR	ADRB1R;B1AR	[Resting heart rate], 607276 (3);{congestive heart failure, susceptibility to} (3)
CG7446-PA	137164	NP_000807	1e-45	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG17976-PA	138190	NP_001033	1e-45	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG8424-PA	114840	NP_001798	1e-45	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG9858-PA	114840	NP_001798	1e-45	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG4012-PA	176960	NP_002728	1e-45	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG32697-PA	176876	NP_002825	1e-45	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG32697-PB	176876	NP_002825	1e-45	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG32697-PC	176876	NP_002825	1e-45	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG32697-PD	176876	NP_002825	1e-45	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG1130-PA	602150	NP_003059	1e-45	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG18085-PA	602337	NP_004551	1e-45	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG1167-PA	190070	NP_004976	1e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG9739-PA	601500	NP_005622	1e-45	SMO;SMOH	SMO	Basal cell carcinoma, somatic (3)
CG9739-PB	601500	NP_005622	1e-45	SMO;SMOH	SMO	Basal cell carcinoma, somatic (3)
CG7013-PA	601916	NP_006001	1e-45	ARMET;ARP	ARGININE-RICH PROTEIN; ARP	Pancreatic cancer, 260350 (3)
CG7526-PA	604580	NP_006320	1e-45	FBLN5;ARMD3	DEVELOPMENTAL ARTERIES AND NEURAL CREST EGF-LIKE; DANCE	Cutis laxa, autosomal dominant, 123700 (3);Cutis laxa, autosomal recessive, 219100 (3);Macular degeneration, age-related, 3, 608895 (3)
CG6512-PA	601023	NP_009057	1e-45	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG6512-PB	601023	NP_009057	1e-45	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG8246-PA	167415	NP_039245	1e-45	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8246-PA	167415	NP_039246	1e-45	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8246-PA	167415	NP_039247	1e-45	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1225-PA	300429	NP_056000	1e-45	ARHGEF9;KIAA0424;PEM2	COLLYBISTIN;KIAA0424;PEM2	Hyperekplexia and epilepsy, 300607 (3)
CG1225-PB	300429	NP_056000	1e-45	ARHGEF9;KIAA0424;PEM2	COLLYBISTIN;KIAA0424;PEM2	Hyperekplexia and epilepsy, 300607 (3)
CG1225-PC	300429	NP_056000	1e-45	ARHGEF9;KIAA0424;PEM2	COLLYBISTIN;KIAA0424;PEM2	Hyperekplexia and epilepsy, 300607 (3)
CG1225-PE	300429	NP_056000	1e-45	ARHGEF9;KIAA0424;PEM2	COLLYBISTIN;KIAA0424;PEM2	Hyperekplexia and epilepsy, 300607 (3)
CG8908-PA	607800	NP_056472	1e-45	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG17309-PA	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PB	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PC	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PD	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PE	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PA	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PB	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PC	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PD	164761	NP_065681	1e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10023-PA	134934	NP_075254	1e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10023-PB	134934	NP_075254	1e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10023-PC	134934	NP_075254	1e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG5093-PA	602054	NP_542378	1e-45	CAFS;CTHM;DGCR;DGS;DORV;TBX1;TGA;VCFS		Conotruncal anomaly face syndrome, 217095 (3);DiGeorge syndrome, 188400 (3);Velocardiofacial syndrome, 192430 (3)
CG7221-PA	605131	NP_570607	1e-45	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG7777-PB	107776	NP_932766	1e-45	AQP1;CHIP28;CO	AQP-CHIP;AQUAPORIN-CHIP;CHANNEL-LIKE INTEGRAL MEMBRANE PROTEIN, 28-KD; CHIP28	[Aquaporin-1 deficiency] (3);[Blood group, Colton], 110450 (3)
CG7411-PA	137164	NP_944494	1e-45	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG7446-PA	137164	NP_944494	1e-45	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG10579-PA	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10579-PB	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10579-PC	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10579-PD	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10579-PE	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7597-PA	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7597-PB	123829	NP_000066	2e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG10023-PA	134934	NP_000133	2e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10023-PB	134934	NP_000133	2e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10023-PC	134934	NP_000133	2e-45	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10023-PA	147670	NP_000199	2e-45	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG10023-PB	147670	NP_000199	2e-45	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG10023-PC	147670	NP_000199	2e-45	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG31045-PB	276903	NP_000251	2e-45	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG31045-PE	276903	NP_000251	2e-45	DFNA11;DFNB2;MYO7A;USH1B	MYOSIN, UNCONVENTIONAL, FAMILY VII, MEMBER A; MYU7A	Deafness, autosomal dominant 11, neurosensory, 601317 (3);Deafness, autosomal recessive 2, neurosensory, 600060 (3);Usher syndrome, type 1B, 276900 (3)
CG18128-PA	164050	NP_000261	2e-45	NP	PURINE-NUCLEOSIDE:ORTHOPHOSPHATE RIBOSYLTRANSFERASE; PNP	Nucleoside phosphorylase deficiency, immunodeficiency due to (3)
CG1489-PA	602136	NP_000457	2e-45	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG2241-PA	602136	NP_000457	2e-45	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG3455-PA	602136	NP_000457	2e-45	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG7257-PA	602136	NP_000457	2e-45	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG17691-PA	179060	NP_000916	2e-45	PDHB	E1, BETA POLYPEPTIDE; PHE1B	Pyruvate dehydrogenase E1-beta deficiency (3)
CG14992-PA	164870	NP_001005862	2e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8573-PA	300573	NP_001034980	2e-45	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG8573-PB	300573	NP_001034980	2e-45	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG14517-PA	137060	NP_001488	2e-45	B4GALT1;GGTB2;GT1;GTB	B4GALT1;BETA-1,4-GALACTOSYLTRANSFERASE 1;GALACTOSYLTRANSFERASE 1; GT1;GLYCOPROTEIN 4-BETA-GALACTOSYLTRANSFERASE 2; GGTB2;GTB	Congenital disorder of glycosylation, type IId, 607091 (3)
CG6117-PA	176980	NP_002730	2e-45	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6117-PB	176980	NP_002730	2e-45	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG9564-PA	276000	NP_002760	2e-45	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG31954-PA	601564	NP_002761	2e-45	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG10443-PA	176876	NP_002825	2e-45	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG2005-PA	600079	NP_002826	2e-45	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG2005-PB	600079	NP_002826	2e-45	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG8246-PA	167415	NP_003457	2e-45	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1228-PB	130500	NP_004428	2e-45	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG14992-PA	164870	NP_004439	2e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG18402-PA	602337	NP_004551	2e-45	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG12066-PB	300075	NP_004577	2e-45	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG12069-PA	300075	NP_004577	2e-45	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG18085-PA	131550	NP_005219	2e-45	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG4926-PA	190090	NP_005408	2e-45	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG1200-PA	604641	NP_005447	2e-45	MAPK8IP1;IB1	ISLET-BRAIN 1; IB1;JNK-INTERACTING PROTEIN 1; JIP1	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG1200-PB	604641	NP_005447	2e-45	MAPK8IP1;IB1	ISLET-BRAIN 1; IB1;JNK-INTERACTING PROTEIN 1; JIP1	{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG8403-PA	142461	NP_005520	2e-45	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG11186-PA	167416	NP_006185	2e-45	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG11186-PB	167416	NP_006185	2e-45	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG3499-PB	601023	NP_009057	2e-45	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG7526-PA	604633	NP_058634	2e-45	EFEMP2;FBLN4;UPH1	FIBULIN 4; FBLN4	Cutis laxa, autosomal recessive, type I, 219100 (3)
CG6414-PA	300336	NP_061850	2e-45	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG17309-PA	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PB	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PC	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PD	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG17309-PE	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PA	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PB	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PC	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8049-PD	164761	NP_066124	2e-45	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3571-PB	605379	NP_071324	2e-45	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG8418-PA	190070	NP_203524	2e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG7749-PA	605516	NP_443068	2e-45	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG1133-PA	610192	NP_689842	2e-45	GLIS3;ZNF515	GLI-SIMILAR PROTEIN 3;ZINC FINGER PROTEIN 515; ZNF515	Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)
CG8908-PA	607800	NP_775099	2e-45	ABCA12;ICR2B;LI2		Ichthyosis, harlequin, 242500 (3);Ichthyosis, lamellar 2, 601277 (3)
CG4926-PA	190090	NP_938033	2e-45	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG1228-PB	130500	NP_976217	2e-45	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG9716-PA	608614	NP_997235	2e-45	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG15110-PA	608177	NP_000118	3e-45	EXT1	EXT	Chondrosarcoma, 215300 (3);Exostoses, multiple, type 1, 133700 (3)
CG17528-PA	172471	NP_000285	3e-45	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG17528-PB	172471	NP_000285	3e-45	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG17528-PC	172471	NP_000285	3e-45	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG17528-PD	172471	NP_000285	3e-45	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG16827-PA	607759	NP_000410	3e-45	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG9652-PA	182135	NP_000612	3e-45	HTR2A	SEROTONIN 5-HT-2 RECEPTOR, FORMERLY; HTR2, FORMERLY;SEROTONIN 5-HT-2A RECEPTOR	{Alcohol dependence, susceptibility to}, 103780 (3);{Anorexia nervosa, susceptibility to}, 606788 (3);{Major depressive disorder, response to citalopram therapy in}, 608516 (3);{Obsessive-compulsive disorder, susceptibility to}, 164230 (3);{Schizophrenia, susceptibility to}, 181500 (3);{Seasonal affective disorder, susceptibility to}, 608516 (3)
CG1128-PB	100740	NP_000656	3e-45	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG12072-PA	164731	NP_001617	3e-45	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG17998-PA	176980	NP_002730	3e-45	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG4386-PA	601564	NP_002761	3e-45	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG17752-PA	604190	NP_003050	3e-45	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG4265-PA	191342	NP_004172	3e-45	PARK5;UCHL1	PGP9.5;UBIQUITIN C-TERMINAL HYDROLASE, NEURON-SPECIFIC	Parkinson disease, familial, 168600 (3)
CG4969-PA	601570	NP_004616	3e-45	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG5187-PA	604614	NP_005140	3e-45	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG15831-PA	601478	NP_005370	3e-45	DFNA48;MYO1A		Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)
CG18657-PA	608400	NP_009054	3e-45	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG4677-PA	603073	NP_009060	3e-45	HPE5;ZIC2	ZIC FAMILY MEMBER 2	Holoprosencephaly-5, 609637 (3)
CG4677-PB	603073	NP_009060	3e-45	HPE5;ZIC2	ZIC FAMILY MEMBER 2	Holoprosencephaly-5, 609637 (3)
CG1128-PB	100740	NP_056646	3e-45	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG1644-PA	124010	NP_059488	3e-45		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG7527-PA	605516	NP_071407	3e-45	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG7563-PA	605286	NP_075571	3e-45	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG4009-PA	606765	NP_783652	3e-45	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7777-PA	107776	NP_932766	3e-45	AQP1;CHIP28;CO	AQP-CHIP;AQUAPORIN-CHIP;CHANNEL-LIKE INTEGRAL MEMBRANE PROTEIN, 28-KD; CHIP28	[Aquaporin-1 deficiency] (3);[Blood group, Colton], 110450 (3)
CG18247-PA	300300	NP_000052	4e-45	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG18247-PA	147670	NP_000199	4e-45	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG17437-PA	601545	NP_000421	4e-45	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG8137-PA	107300	NP_000479	4e-45	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG4009-PA	606765	NP_000538	4e-45	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG4128-PA	118507	NP_000739	4e-45	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG7241-PA	124040	NP_000764	4e-45		CYP2E1;ETHANOL-INDUCIBLE P450;P450C2E	
CG2872-PB	600018	NP_000905	4e-45	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG7873-PA	191315	NP_001007793	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7873-PB	191315	NP_001007793	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG2872-PB	600018	NP_001008503	4e-45	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG2872-PB	600018	NP_001008504	4e-45	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG2872-PB	600018	NP_001008505	4e-45	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG7873-PA	191315	NP_001012331	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7873-PB	191315	NP_001012331	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7873-PA	191315	NP_002520	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7873-PB	191315	NP_002520	4e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7314-PA	602044	NP_003347	4e-45	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG7314-PB	602044	NP_003347	4e-45	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG17596-PA	605377	NP_004400	4e-45	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG8418-PA	190070	NP_004976	4e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG1349-PA	602533	NP_009193	4e-45	DJ1;PARK7	DJ1;PARK7 GENE; PARK7	Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3);Parkinson disease 7, autosomal recessive early-onset, 606324 (3)
CG4701-PA	604277	NP_055761	4e-45	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG7563-PB	605286	NP_075571	4e-45	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG4009-PA	606765	NP_783651	4e-45	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG4701-PA	604277	NP_955468	4e-45	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG1090-PA	609802	NP_995322	4e-45	SLC24A5;NCKX5	5; SLC24A5;JSX;SODIUM/CALCIUM/POTASSIUM EXCHANGER 5; NCKX5	[Pigmentation of skin, variation in] (3)
CG1090-PB	609802	NP_995322	4e-45	SLC24A5;NCKX5	5; SLC24A5;JSX;SODIUM/CALCIUM/POTASSIUM EXCHANGER 5; NCKX5	[Pigmentation of skin, variation in] (3)
CG4007-PA	300300	NP_000052	5e-45	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG18530-PA	278000	NP_000226	5e-45	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG9453-PC	107300	NP_000479	5e-45	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG12414-PA	118504	NP_000735	5e-45	CHRNA4;ENFL1	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-4 SUBUNIT	Epilepsy, nocturnal frontal lobe, 1, 600513 (3);{Nicotine addiction, susceptibility to}, 188890 (3)
CG14031-PA	601310	NP_000769	5e-45		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG2849-PA	190070	NP_004976	5e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG2849-PC	190070	NP_004976	5e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG2849-PA	190020	NP_005334	5e-45	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG2849-PC	190020	NP_005334	5e-45	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG9904-PA	606158	NP_116056	5e-45	BSCL2;SPG17	GNG3LG, MOUSE, HOMOLOG OF;SEIPIN	Lipodystrophy, congenital generalized, type 2, 269700 (3);Silver spastic paraplegia syndrome, 270685 (3);Spinal muscular atrophy, distal, type V, 600794 (3)
CG10537-PA	137164	NP_944493	5e-45	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG12061-PA	609802	NP_995322	5e-45	SLC24A5;NCKX5	5; SLC24A5;JSX;SODIUM/CALCIUM/POTASSIUM EXCHANGER 5; NCKX5	[Pigmentation of skin, variation in] (3)
CG4757-PA	177400	NP_000046	6e-45	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG8095-PA	147556	NP_000201	6e-45	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG7551-PB	229800	NP_000212	6e-45	KHK	HEPATIC FRUCTOKINASE DEFICIENCY;KETOHEXOKINASE DEFICIENCY	[Fructosuria] (3)
CG10023-PA	164860	NP_000236	6e-45	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG10023-PB	164860	NP_000236	6e-45	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG10023-PC	164860	NP_000236	6e-45	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG12370-PA	168468	NP_000307	6e-45	PTHR;PTHR1	PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PROTEIN RECEPTOR;PTH RECEPTOR; PTHR;PTH/PTHRP RECEPTOR	Enchondromatosis, Ollier type, 166000 (3);Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)
CG8246-PA	606597	NP_000429	6e-45	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG4007-PA	600221	NP_000450	6e-45	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8169-PA	600258	NP_000525	6e-45	HNPCC3;PMS1;PMSL1	MISMATCH REPAIR GENE PMSL1; PMSL1	Colorectal cancer, hereditary nonpolyposis, type 3 (3)
CG7487-PA	604611	NP_000544	6e-45	RECQ3;RECQL2;WRN	DNA HELICASE, RECQ-LIKE, TYPE 3; RECQ3;WRN GENE; WRN	Werner syndrome, 277700 (3)
CG7487-PB	604611	NP_000544	6e-45	RECQ3;RECQL2;WRN	DNA HELICASE, RECQ-LIKE, TYPE 3; RECQ3;WRN GENE; WRN	Werner syndrome, 277700 (3)
CG14396-PA	191315	NP_001007793	6e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PB	191315	NP_001007793	6e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PC	191315	NP_001007793	6e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PD	191315	NP_001007793	6e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PE	191315	NP_001007793	6e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG4484-PA	606202	NP_001012527	6e-45	AIM1;MATP;SLC45A2	MELANOMA ANTIGEN AIM1; AIM1;MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN; MATP	Oculocutaneous albinism, type IV, 606574 (3);[Pigmentation of hair, skin, and eyes, variation in] (3)
CG8637-PA	164731	NP_001617	6e-45	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG8418-PA	164790	NP_002515	6e-45	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG8235-PA	603623	NP_003671	6e-45	CMTDIC;TYRRS;YARS;YRS;YTS	TYRRS;YRS;YTS	Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)
CG8246-PA	606597	NP_039230	6e-45	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG17800-PA	608630	NP_071765	6e-45	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG17800-PB	608630	NP_071765	6e-45	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG17800-PC	608630	NP_071765	6e-45	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG17800-PD	608630	NP_071765	6e-45	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG8874-PA	134935	NP_075252	6e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PB	134935	NP_075252	6e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PC	134935	NP_075252	6e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PD	134935	NP_075252	6e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4675-PA	610206	NP_114423	6e-45	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG4675-PB	610206	NP_114423	6e-45	SLC4A11;BTR1;NABC1;CHED2	BICARBONATE TRANSPORTER-RELATED PROTEIN 1; BTR1;SLC4A11;SODIUM-COUPLED BORATE COTRANSPORTER 1; NABC1	Congenital hereditary endothelial dystrophy 2, 217700 (3)
CG2849-PA	190070	NP_203524	6e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG2849-PC	190070	NP_203524	6e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG5772-PA	603234	XP_001125860	6e-45	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8571-PA	601498	NP_000278	7e-45	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG9629-PA	602733	NP_000687	7e-45		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG9629-PB	602733	NP_000687	7e-45		ALDEHYDE DEHYDROGENASE 9; ALDH9;E3	
CG14396-PA	191315	NP_001012331	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PB	191315	NP_001012331	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PC	191315	NP_001012331	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PD	191315	NP_001012331	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PE	191315	NP_001012331	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PA	134935	NP_002002	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PB	134935	NP_002002	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PC	134935	NP_002002	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PD	134935	NP_002002	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG14396-PA	191315	NP_002520	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PB	191315	NP_002520	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PC	191315	NP_002520	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PD	191315	NP_002520	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14396-PE	191315	NP_002520	7e-45	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG12605-PB	602150	NP_003059	7e-45	SLUG;SNAI2;WS2D	NEURAL CREST TRANSCRIPTION FACTOR SLUG;SLUG, CHICKEN, HOMOLOG OF; SLUG	Melanoma metastasis, modification of (1);Piebaldism, 172800 (3);Waardenburg syndrome, type IID, 608890 (3)
CG10244-PA	173490	NP_006197	7e-45	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG9310-PA	604485	NP_055064	7e-45	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG9310-PB	604485	NP_055064	7e-45	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG9310-PC	604485	NP_055064	7e-45	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG8874-PA	134935	NP_998812	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PB	134935	NP_998812	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PC	134935	NP_998812	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PD	134935	NP_998812	7e-45	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG1362-PB	123829	NP_000066	8e-45	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG2086-PB	601920	NP_000205	8e-45	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG8049-PA	164870	NP_001005862	8e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PB	164870	NP_001005862	8e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PC	164870	NP_001005862	8e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PD	164870	NP_001005862	8e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4360-PA	300573	NP_001034980	8e-45	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG5772-PA	603234	NP_001162	8e-45	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG8585-PA	600053	NP_001289	8e-45	ACHM2;CNG3;CNGA3	CONE PHOTORECEPTOR cGMP-GATED CHANNEL;CYCLIC NUCLEOTIDE-GATED CHANNEL, OLFACTORY, 3; CNG3	Achromatopsia-2, 216900 (3)
CG1121-PA	114840	NP_001798	8e-45	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG2505-PA	114840	NP_001798	8e-45	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG11567-PA	602568	NP_002445	8e-45	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG11567-PB	602568	NP_002445	8e-45	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG1167-PA	164790	NP_002515	8e-45	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG10261-PA	180381	NP_002920	8e-45	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG10524-PA	180381	NP_002920	8e-45	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG2849-PB	190070	NP_004976	8e-45	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG3578-PA	604614	NP_005140	8e-45	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG2849-PB	190020	NP_005334	8e-45	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG9426-PA	605379	NP_071324	8e-45	GAN;GAN1	GAN1;GIGAXONIN	Giant axonal neuropathy-1, 256850 (3)
CG11567-PA	602568	NP_076915	8e-45	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG11567-PB	602568	NP_076915	8e-45	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG33196-PB	608548	NP_114141	8e-45	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1228-PA	300628	NP_919253	8e-45	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG1228-PC	300628	NP_919253	8e-45	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG1228-PD	300628	NP_919253	8e-45	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG1121-PA	100740	NP_000656	9e-45	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG12344-PA	138492	NP_000815	9e-45	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG1341-PA	602783	NP_003110	9e-45	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG1019-PA	600824	NP_003467	9e-45	CLP;CMD1M;CRP3;CSRP3	CLP LIM DOMAIN PROTEIN, MUSCLE; MLP;CYSTEINE-RICH PROTEIN 3; CRP3;LIM DOMAIN PROTEIN, CARDIAC	Cardiomyopathy, dilated, 1M, 607482 (3)
CG1019-PB	600824	NP_003467	9e-45	CLP;CMD1M;CRP3;CSRP3	CLP LIM DOMAIN PROTEIN, MUSCLE; MLP;CYSTEINE-RICH PROTEIN 3; CRP3;LIM DOMAIN PROTEIN, CARDIAC	Cardiomyopathy, dilated, 1M, 607482 (3)
CG1389-PA	136351	NP_004110	9e-45	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG8049-PA	164870	NP_004439	9e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PB	164870	NP_004439	9e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PC	164870	NP_004439	9e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8049-PD	164870	NP_004439	9e-45	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4380-PA	604485	NP_055064	9e-45	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG1121-PA	100740	NP_056646	9e-45	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG1131-PA	177400	NP_000046	1e-44	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG8967-PA	134934	NP_000133	1e-44	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG9149-PA	143450	NP_000174	1e-44	HADHB	BETA SUBUNIT; HADHB;ECHB;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, BETA SUBUNIT;TRIFUNCTIONAL PROTEIN, BETA SUBUNIT	Trifunctional protein deficiency, type II (3)
CG8095-PB	147556	NP_000201	1e-44	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG6760-PA	601498	NP_000278	1e-44	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG15388-PA	600276	NP_000426	1e-44	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG7873-PA	600221	NP_000450	1e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG7873-PB	600221	NP_000450	1e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8250-PA	600221	NP_000450	1e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG3356-PA	601623	NP_000453	1e-44	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7955-PA	170260	NP_000584	1e-44	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG7955-PB	170260	NP_000584	1e-44	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG7955-PC	170260	NP_000584	1e-44	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG1089-PA	100740	NP_000656	1e-44	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG31146-PD	114840	NP_001798	1e-44	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG30132-PC	603072	NP_003591	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_003591	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_003591	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_003591	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10524-PA	605377	NP_004400	1e-44	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG6117-PA	605377	NP_004400	1e-44	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG6117-PB	605377	NP_004400	1e-44	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG4971-PA	601570	NP_004616	1e-44	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG11202-PA	604614	NP_005140	1e-44	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG5133-PA	604895	NP_037483	1e-44	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG1089-PA	100740	NP_056646	1e-44	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG32465-PB	100740	NP_056646	1e-44	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8049-PA	136350	NP_056934	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PB	136350	NP_056934	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PC	136350	NP_056934	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PD	136350	NP_056934	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PA	136350	NP_075593	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PB	136350	NP_075593	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PC	136350	NP_075593	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PD	136350	NP_075593	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PA	136350	NP_075594	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PB	136350	NP_075594	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PC	136350	NP_075594	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8049-PD	136350	NP_075594	1e-44	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG32019-PA	608548	NP_114141	1e-44	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG4821-PA	605511	NP_115777	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PB	605511	NP_115777	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PD	605511	NP_115777	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PA	605511	NP_115780	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PB	605511	NP_115780	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PD	605511	NP_115780	1e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG3751-PA	602412	NP_148982	1e-44	DBA3;RPS24		Diamond-blackfan anemia, 610629 (3)
CG2849-PB	190070	NP_203524	1e-44	KRAS2;NS3;RASK2	C-KRAS;KIRSTEN MURINE SARCOMA VIRUS 2; RASK2;ONCOGENE KRAS2; KRAS2	Bladder cancer, 109800 (3);Breast cancer, somatic, 114480 (3);Leukemia, acute myelogenous (3);Lung cancer, 211980 (3);Noonan syndrome 3, 609942 (3);Pancreatic carcinoma, somatic, 260350 (3);Stomach cancer, 137215 (3)
CG3356-PA	601623	NP_570853	1e-44	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG3356-PA	601623	NP_570854	1e-44	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG30132-PC	603072	NP_940835	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_940835	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_940835	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_940835	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PC	603072	NP_940836	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_940836	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_940836	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_940836	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PC	603072	NP_940837	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_940837	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_940837	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_940837	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PC	603072	NP_940838	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_940838	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_940838	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_940838	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PC	603072	NP_940839	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PD	603072	NP_940839	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PE	603072	NP_940839	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PG	603072	NP_940839	1e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10537-PB	137164	NP_944493	1e-44	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG10537-PC	137164	NP_944493	1e-44	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG6847-PA	609252	NP_945347	1e-44	LIPI;LPDL;PRED5	LPD LIPASE; LPDL;PRED5	{Hypertriglyceridemia, susceptibility to}, 145750 (3)
CG18657-PA	608400	NP_996816	1e-44	USH2A	USH2; US2;USHERIN	Retinitis pigmentosa, AR, without hearing loss, 268000 (3);Usher syndrome, type 2A, 276901 (3)
CG1128-PA	177400	NP_000046	2e-44	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG12789-PA	173510	NP_000063	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG12789-PB	173510	NP_000063	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG17348-PA	164860	NP_000236	2e-44	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG1520-PA	300392	NP_000368	2e-44	IMD2;THC;WAS	WAS PROTEIN; WASP	Neutropenia, severe congenital, X-linked, 300299 (3);Thrombocytopenia, X-linked, 313900 (3);Thrombocytopenia, X-linked, intermittent, 313900 (3);Wiskott-Aldrich syndrome, 301000 (3)
CG1520-PB	300392	NP_000368	2e-44	IMD2;THC;WAS	WAS PROTEIN; WASP	Neutropenia, severe congenital, X-linked, 300299 (3);Thrombocytopenia, X-linked, 313900 (3);Thrombocytopenia, X-linked, intermittent, 313900 (3);Wiskott-Aldrich syndrome, 301000 (3)
CG32702-PA	600276	NP_000426	2e-44	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG5527-PA	300550	NP_000435	2e-44	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG17324-PA	191740	NP_000454	2e-44	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG12414-PA	118507	NP_000739	2e-44	CHRNB2;EFNL3	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, BETA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CG12789-PA	173510	NP_001001547	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG12789-PB	173510	NP_001001547	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG12789-PA	173510	NP_001001548	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG12789-PB	173510	NP_001001548	2e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG10244-PA	191315	NP_001007793	2e-44	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10244-PA	191315	NP_001012331	2e-44	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG3751-PA	602412	NP_001017	2e-44	DBA3;RPS24		Diamond-blackfan anemia, 610629 (3)
CG32975-PA	100690	NP_001034612	2e-44	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG7285-PA	182455	NP_001044	2e-44	SSTR5		Acromegaly, 102200 (3)
CG8137-PA	107280	NP_001076	2e-44	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG31175-PA	601239	NP_001381	2e-44	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PB	601239	NP_001381	2e-44	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PC	601239	NP_001381	2e-44	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG1112-PA	114840	NP_001798	2e-44	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG10244-PA	191315	NP_002520	2e-44	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG18340-PA	602044	NP_003347	2e-44	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG14396-PA	600997	NP_004433	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PB	600997	NP_004433	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PC	600997	NP_004433	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PD	600997	NP_004433	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PE	600997	NP_004433	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7304-PA	601756	NP_004473	2e-44	GALNT3;HFTC;HHS	3; GALNT3;GalNAc TRANSFERASE 3; GalNAcT3;POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3	Hyperostosis-hyperphosphatemia syndrome, 610233 (3);Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
CG5093-PA	604614	NP_005140	2e-44	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG8049-PA	131550	NP_005219	2e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8049-PB	131550	NP_005219	2e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8049-PC	131550	NP_005219	2e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8049-PD	131550	NP_005219	2e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG14992-PA	190090	NP_005408	2e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG18247-PA	190090	NP_005408	2e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4917-PA	606201	NP_005996	2e-44	DFNA6;WFRS;WFS;WFS1	WOLFRAMIN	Hearing loss, low-frequency sensorineural, 600965 (3);Wolfram syndrome, 222300 (3);Wolfram-like syndrome, autosomal dominant, 222300 (3)
CG4917-PB	606201	NP_005996	2e-44	DFNA6;WFRS;WFS;WFS1	WOLFRAMIN	Hearing loss, low-frequency sensorineural, 600965 (3);Wolfram syndrome, 222300 (3);Wolfram-like syndrome, autosomal dominant, 222300 (3)
CG10229-PA	601023	NP_009057	2e-44	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG14396-PA	600997	NP_059145	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PB	600997	NP_059145	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PC	600997	NP_059145	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PD	600997	NP_059145	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14396-PE	600997	NP_059145	2e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4821-PA	605511	NP_076927	2e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PB	605511	NP_076927	2e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4821-PD	605511	NP_076927	2e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG32311-PB	188840	NP_597676	2e-44	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5873-PA	606765	NP_783653	2e-44	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG8246-PA	606597	NP_852122	2e-44	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8246-PA	606597	NP_852123	2e-44	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8246-PA	606597	NP_852124	2e-44	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8246-PA	606597	NP_852125	2e-44	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8246-PA	606597	NP_852126	2e-44	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG14992-PA	190090	NP_938033	2e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG18247-PA	190090	NP_938033	2e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG11715-PB	608614	NP_997235	2e-44	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG3969-PA	300300	NP_000052	3e-44	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG3969-PB	300300	NP_000052	3e-44	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG4280-PA	173510	NP_000063	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG4280-PB	173510	NP_000063	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG9696-PA	609413	NP_000115	3e-44	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG9696-PD	609413	NP_000115	3e-44	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG9696-PE	609413	NP_000115	3e-44	ARMD5;CKN2;COFS1;CSB;ERCC6	CSB GENE;RAD26, S. CEREVISIAE, HOMOLOG OF	Cerebrooculofacioskeletal syndrome 1, 214150 (3);Cockayne syndrome, type B, 133540 (3);De Sanctis-Cacchione syndrome, 278800 (3);{Macular degeneration, age-related, susceptibility to 5} (3)
CG8095-PA	607759	NP_000410	3e-44	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG32465-PB	100740	NP_000656	3e-44	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG18247-PA	147370	NP_000866	3e-44	IGF1R		Intrauterine and postnatal growth retardation (3)
CG11824-PA	229000	NP_000883	3e-44	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG4280-PA	173510	NP_001001547	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG4280-PB	173510	NP_001001547	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG4280-PA	173510	NP_001001548	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG4280-PB	173510	NP_001001548	3e-44	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG3319-PA	300203	NP_001032420	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG7597-PA	300203	NP_001032420	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG7597-PB	300203	NP_001032420	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG1380-PA	138190	NP_001033	3e-44	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG1380-PB	138190	NP_001033	3e-44	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG14026-PA	600799	NP_001195	3e-44	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG14026-PB	600799	NP_001195	3e-44	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG14026-PC	600799	NP_001195	3e-44	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG14026-PD	600799	NP_001195	3e-44	BMPR2;PPH1		Pulmonary hypertension, familial primary, 178600 (3)
CG5284-PB	602727	NP_001278	3e-44	CLC7;CLCN7;OPTA2	CLC7	Osteopetrosis, autosomal dominant, type II, 166600 (3);Osteopetrosis, recessive, 259700 (3)
CG7432-PA	606635	NP_002763	3e-44	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG16727-PA	604190	NP_003050	3e-44	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG16916-PA	602783	NP_003110	3e-44	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG3319-PA	300203	NP_003150	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG7597-PA	300203	NP_003150	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG7597-PB	300203	NP_003150	3e-44	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG6715-PA	603072	NP_003591	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7627-PA	603201	NP_003733	3e-44	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG9270-PA	603201	NP_003733	3e-44	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG4012-PA	300075	NP_004577	3e-44	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG8418-PA	190020	NP_005334	3e-44	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG3324-PA	605437	NP_006246	3e-44	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG33101-PA	601023	NP_009057	3e-44	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG6018-PA	300427	NP_065793	3e-44	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG30193-PD	609139	NP_075063	3e-44	C2ORF23;REEP1;SPG31	CHROMOSOME 2 OPEN READING FRAME 23; C2ORF23	Spastic paraplegia 31, 610250 (3)
CG6018-PA	300427	NP_851849	3e-44	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG6715-PA	603072	NP_940835	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6715-PA	603072	NP_940836	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6715-PA	603072	NP_940837	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6715-PA	603072	NP_940838	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6715-PA	603072	NP_940839	3e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4128-PA	100690	NP_000070	4e-44	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4128-PC	100690	NP_000070	4e-44	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4225-PA	170261	NP_000535	4e-44	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG18735-PA	601564	NP_002761	4e-44	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG4290-PA	603072	NP_003591	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PA	605377	NP_004400	4e-44	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG4379-PB	605377	NP_004400	4e-44	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG14396-PA	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG14396-PB	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG14396-PC	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG14396-PD	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG14396-PE	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8874-PA	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8874-PB	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8874-PC	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8874-PD	131550	NP_005219	4e-44	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG18085-PA	190090	NP_005408	4e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG33142-PB	606480	NP_005848	4e-44	FACE1;MADB;STE24;ZMPSTE24	FACE1;STE24, S. CEREVISIAE, HOMOLOG OF	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);Restrictive dermopathy, lethal, 275210 (3)
CG33142-PC	606480	NP_005848	4e-44	FACE1;MADB;STE24;ZMPSTE24	FACE1;STE24, S. CEREVISIAE, HOMOLOG OF	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);Restrictive dermopathy, lethal, 275210 (3)
CG14396-PA	173490	NP_006197	4e-44	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG14396-PB	173490	NP_006197	4e-44	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG14396-PC	173490	NP_006197	4e-44	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG14396-PD	173490	NP_006197	4e-44	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG14396-PE	173490	NP_006197	4e-44	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG1956-PA	600098	NP_036382	4e-44	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG3355-PA	605511	NP_115777	4e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG3355-PA	605511	NP_115780	4e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG18085-PA	190090	NP_938033	4e-44	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4290-PA	603072	NP_940835	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4290-PA	603072	NP_940836	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4290-PA	603072	NP_940837	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4290-PA	603072	NP_940838	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4290-PA	603072	NP_940839	4e-44	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15485-PA	300550	NP_000435	5e-44	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG17309-PA	600221	NP_000450	5e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17309-PB	600221	NP_000450	5e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17309-PC	600221	NP_000450	5e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17309-PD	600221	NP_000450	5e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17309-PE	600221	NP_000450	5e-44	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG1495-PA	604373	NP_001005735	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PB	604373	NP_001005735	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PC	604373	NP_001005735	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PE	604373	NP_001005735	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PG	604373	NP_001005735	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1819-PA	601615	NP_001080	5e-44	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG9610-PA	607108	NP_001595	5e-44	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG2049-PB	180381	NP_002920	5e-44	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG2049-PC	180381	NP_002920	5e-44	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG2049-PE	180381	NP_002920	5e-44	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG2049-PF	180381	NP_002920	5e-44	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG7342-PA	604190	NP_003050	5e-44	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1495-PA	604373	NP_009125	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PB	604373	NP_009125	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PC	604373	NP_009125	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PE	604373	NP_009125	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1495-PG	604373	NP_009125	5e-44	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG12348-PD	607604	NP_598004	5e-44		KV11.1	
CG14992-PA	300300	NP_000052	6e-44	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG31928-PA	179820	NP_000528	6e-44	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG9629-PA	100650	NP_000681	6e-44	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG9629-PB	100650	NP_000681	6e-44	ALDH2	ACETALDEHYDE DEHYDROGENASE 2;ALDEHYDE DEHYDROGENASE 2;ALDH, LIVER MITOCHONDRIAL	Alcohol intolerance, acute (3);{?Fetal alcohol syndrome} (1)
CG12073-PA	126451	NP_000787	6e-44	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG12069-PA	176980	NP_002730	6e-44	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG17697-PA	601500	NP_005622	6e-44	SMO;SMOH	SMO	Basal cell carcinoma, somatic (3)
CG2005-PA	600716	NP_057051	6e-44	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG2005-PB	600716	NP_057051	6e-44	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG31045-PA	606808	NP_059129	6e-44	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG18735-PA	606797	NP_068813	6e-44	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG8355-PA	601920	NP_000205	7e-44	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG8355-PB	601920	NP_000205	7e-44	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG8355-PC	601920	NP_000205	7e-44	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG5026-PA	300415	NP_000243	7e-44	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG5026-PB	300415	NP_000243	7e-44	MTM1;MTMX		Myotubular myopathy, X-linked, 310400 (3)
CG18085-PA	164870	NP_001005862	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3969-PA	164870	NP_001005862	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3969-PB	164870	NP_001005862	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG4395-PA	114131	NP_001733	7e-44	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG17752-PA	603377	NP_003051	7e-44	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG10079-PA	600997	NP_004433	7e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10079-PB	600997	NP_004433	7e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG18085-PA	164870	NP_004439	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3969-PA	164870	NP_004439	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3969-PB	164870	NP_004439	7e-44	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3941-PA	314995	NP_009061	7e-44	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG3941-PB	314995	NP_009061	7e-44	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7904-PA	601300	NP_064732	7e-44	ACVR1B;ACVRLK4;ALK4	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 4; ACVRLK4;ACTIVIN RECEPTOR-LIKE KINASE 4; ALK4	Pancreatic cancer, somatic (3)
CG3355-PA	605511	NP_076927	7e-44	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG32105-PB	602146	NP_203129	7e-44	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG3941-PA	314995	NP_700359	7e-44	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG3941-PB	314995	NP_700359	7e-44	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG7524-PB	176947	NP_997402	7e-44	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7524-PB	164860	NP_000236	8e-44	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG18735-PA	229000	NP_000883	8e-44	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG9334-PA	602445	NP_005016	8e-44	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG18402-PA	189980	NP_005148	8e-44	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG12066-PA	605437	NP_006246	8e-44	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10079-PA	600997	NP_059145	8e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10079-PB	600997	NP_059145	8e-44	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG9858-PA	300427	NP_065793	8e-44	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG9858-PA	300427	NP_851849	8e-44	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG2827-PA	602063	XP_001129887	8e-44	TALDO1		Transaldolase deficiency, 606003 (3)
CG32094-PA	601920	NP_000205	9e-44	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG18402-PA	189980	NP_009297	9e-44	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3389-PA	605514	NP_149045	9e-44	DFNB23;PCDH15		Deafness, autosomal recessive 23, 609533 (3);Usher syndrome, type 1F, 602083 (3)
CG10011-PA	608774	NP_848605	9e-44	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG7068-PA	120700	NP_000055	1e-43	C3		C3 deficiency (3)
CG7524-PB	147670	NP_000199	1e-43	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG14808-PA	608896	NP_000222	1e-43	DMDA1;LGMD2C;SCG3;SGCG	DYSTROPHIN-ASSOCIATED GLYCOPROTEIN, 35-KD	Muscular dystrophy, limb-girdle, type 2C, 253700 (3)
CG8095-PB	607759	NP_000410	1e-43	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG4943-PA	601623	NP_000453	1e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG10913-PA	107300	NP_000479	1e-43	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG8457-PA	605325	NP_000768	1e-43	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG10369-PA	600681	NP_000882	1e-43	HHIRK1;IRK1;KCNJ2;KIR2.1;LQT7;SQT3	HHIRK1;IRK1;KIR2.1	Long QT syndrome-7, 170390 (3);Short QT syndrome-3, 609622 (3)
CG32134-PA	164870	NP_001005862	1e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG5338-PB	603474	NP_001013	1e-43	DBA;RPS19		Anemia, Diamond-Blackfan, 105650 (3)
CG4898-PB	191010	NP_001018008	1e-43	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PD	191010	NP_001018008	1e-43	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PG	191010	NP_001018008	1e-43	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4898-PJ	191010	NP_001018008	1e-43	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG6127-PA	602997	NP_001072	1e-43	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG1128-PB	114840	NP_001798	1e-43	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG9656-PA	305371	NP_002040	1e-43	ERYF1;GATA1;GF1;NFE1	ERYTHROID TRANSCRIPTION FACTOR 1; ERYF1;GLOBIN TRANSCRIPTION FACTOR 1; GF1;TRANSCRIPTION FACTOR GATA1	Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Leukemia, megakaryoblastic, of Down syndrome, 190685 (3);Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3);Macrothrombocytopenia, 300367 (3)
CG8637-PA	176960	NP_002728	1e-43	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG1817-PB	600079	NP_002826	1e-43	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG1817-PC	600079	NP_002826	1e-43	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG3455-PA	602783	NP_003110	1e-43	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG1765-PA	190120	NP_003241	1e-43	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PB	190120	NP_003241	1e-43	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PC	190120	NP_003241	1e-43	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PD	190120	NP_003241	1e-43	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1765-PE	190120	NP_003241	1e-43	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG1470-PA	108961	NP_003986	1e-43	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG8250-PA	600997	NP_004433	1e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG32134-PA	164870	NP_004439	1e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14992-PA	189980	NP_005148	1e-43	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8246-PA	167416	NP_006185	1e-43	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG14992-PA	189980	NP_009297	1e-43	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG11020-PA	243305	NP_055240	1e-43	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG8250-PA	600997	NP_059145	1e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3656-PA	124010	NP_059488	1e-43		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG4316-PA	264900	NP_062505	1e-43	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG11069-PA	605460	NP_071882	1e-43	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG33087-PC	600275	NP_077719	1e-43	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG4943-PA	601623	NP_570853	1e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4943-PA	601623	NP_570854	1e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG11020-PA	243305	NP_899068	1e-43	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG33087-PC	600275	XP_001133349	1e-43	AGS2;NOTCH2		Alagille syndrome 2, 610205 (3)
CG7487-PA	604610	NP_000048	2e-43	BLM;BS;RECQ2;RECQL3	BLM GENE; BLM;DNA HELICASE, RECQ-LIKE, TYPE 2; RECQ2	Bloom syndrome, 210900 (3)
CG7487-PB	604610	NP_000048	2e-43	BLM;BS;RECQ2;RECQL3	BLM GENE; BLM;DNA HELICASE, RECQ-LIKE, TYPE 2; RECQ2	Bloom syndrome, 210900 (3)
CG4316-PA	264900	NP_000119	2e-43	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG17309-PA	164860	NP_000236	2e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG17309-PB	164860	NP_000236	2e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG17309-PC	164860	NP_000236	2e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG17309-PD	164860	NP_000236	2e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG17309-PE	164860	NP_000236	2e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG32094-PA	600276	NP_000426	2e-43	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG7524-PB	147370	NP_000866	2e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG31954-PA	229000	NP_000883	2e-43	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG6147-PA	605284	NP_001008567	2e-43	TSC1;LAM	HAMARTIN	Focal cortical dysplasia, Taylor balloon cell type, 607341 (3);Lymphangioleiomyomatosis, 606690 (3);Tuberous sclerosis-1, 191100 (3)
CG14396-PA	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PB	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PC	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PD	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PE	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PA	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PB	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PC	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PD	600456	NP_001018074	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8925-PA	604190	NP_003050	2e-43	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6231-PA	603377	NP_003051	2e-43	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG6231-PB	603377	NP_003051	2e-43	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG6231-PC	603377	NP_003051	2e-43	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG6231-PD	603377	NP_003051	2e-43	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG30171-PA	188840	NP_003310	2e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG4677-PA	300265	NP_003404	2e-43	HTX;HTX1;ZIC3	HTX1;ZIC FAMILY MEMBER 3	Heterotaxy, X-linked visceral, 306955 (3)
CG4677-PB	300265	NP_003404	2e-43	HTX;HTX1;ZIC3	HTX1;ZIC FAMILY MEMBER 3	Heterotaxy, X-linked visceral, 306955 (3)
CG30132-PB	603072	NP_003591	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_003591	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17309-PA	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PB	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PC	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PD	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PE	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG18402-PA	600997	NP_004433	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10244-PA	602337	NP_004551	2e-43	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG32955-PE	602821	NP_004975	2e-43	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG32387-PA	142461	NP_005520	2e-43	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG32387-PB	142461	NP_005520	2e-43	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG14396-PA	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PB	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PC	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PD	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG14396-PE	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PA	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PB	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PC	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8874-PD	600456	NP_006171	2e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG12072-PA	605437	NP_006246	2e-43	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG7328-PA	229800	NP_006479	2e-43	KHK	HEPATIC FRUCTOKINASE DEFICIENCY;KETOHEXOKINASE DEFICIENCY	[Fructosuria] (3)
CG1618-PA	601023	NP_009057	2e-43	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG32772-PA	314995	NP_009061	2e-43	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2005-PA	600716	NP_036543	2e-43	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG2005-PB	600716	NP_036543	2e-43	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG17309-PA	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PB	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PC	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PD	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PE	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG18402-PA	600997	NP_059145	2e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG8107-PA	605286	NP_075571	2e-43	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG6407-PA	165330	NP_110380	2e-43	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG9433-PA	605882	NP_114432	2e-43	BACH1;BRIP1;FANCJ	BRCA1-ASSOCIATED C-TERMINAL HELICASE 1; BACH1;DELETIONS OF GUANINE-RICH DNA, C. ELEGANS, HOMOLOG OF;DOG1, HOMOLOG OF;FANCJ GENE; FANCJ	Breast cancer, early-onset, 114480 (3);Fanconi anemia, complementation group J, 609054 (3)
CG9433-PB	605882	NP_114432	2e-43	BACH1;BRIP1;FANCJ	BRCA1-ASSOCIATED C-TERMINAL HELICASE 1; BACH1;DELETIONS OF GUANINE-RICH DNA, C. ELEGANS, HOMOLOG OF;DOG1, HOMOLOG OF;FANCJ GENE; FANCJ	Breast cancer, early-onset, 114480 (3);Fanconi anemia, complementation group J, 609054 (3)
CG12348-PC	607604	NP_598004	2e-43		KV11.1	
CG12348-PE	607604	NP_598004	2e-43		KV11.1	
CG32772-PA	314995	NP_700359	2e-43	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG30132-PB	603072	NP_940835	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_940835	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PB	603072	NP_940836	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_940836	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PB	603072	NP_940837	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_940837	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PB	603072	NP_940838	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_940838	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PB	603072	NP_940839	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG30132-PF	603072	NP_940839	2e-43	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG5966-PA	609252	NP_945347	2e-43	LIPI;LPDL;PRED5	LPD LIPASE; LPDL;PRED5	{Hypertriglyceridemia, susceptibility to}, 145750 (3)
CG5670-PA	108730	XP_001127578	2e-43	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PB	108730	XP_001127578	2e-43	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PC	108730	XP_001127578	2e-43	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG5670-PD	108730	XP_001127578	2e-43	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG10175-PA	177400	NP_000046	3e-43	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG10175-PC	177400	NP_000046	3e-43	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG5122-PA	600650	NP_000089	3e-43	CPT2	CPT II	CPT deficiency, hepatic, type II, 600649 (3);CPT II deficiency, lethal neonatal, 608836 (3);Myopathy due to CPT II deficiency, 255110 (3)
CG3156-PA	601107	NP_000383	3e-43	ABCC2;CMOAT	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2;MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT	Dubin-Johnson syndrome, 237500 (3)
CG7524-PB	600221	NP_000450	3e-43	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG17932-PA	191740	NP_000454	3e-43	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17932-PB	191740	NP_000454	3e-43	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG9455-PA	107300	NP_000479	3e-43	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG11567-PB	163729	NP_000594	3e-43	NOS3	NITRIC OXIDE SYNTHASE, ENDOTHELIAL; ENOS	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);{Coronary spasms, susceptibility to} (3);{Hypertension, pregnancy-induced}, 189800 (3);{Hypertension, susceptibility to}, 145500 (3);{Placental abruption} (3)
CG4163-PA	601130	NP_000762	3e-43	CYP2C9		Tolbutamide poor metabolizer (3);Warfarin sensitivity, 122700 (3)
CG10833-PA	605325	NP_000768	3e-43	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG13702-PA	182455	NP_001044	3e-43	SSTR5		Acromegaly, 102200 (3)
CG18402-PA	136352	NP_002011	3e-43	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG5166-PB	601517	NP_002964	3e-43	ATX2;ATXN2;SCA2		Spinocerebellar ataxia-2, 183090 (3)
CG4029-PA	600838	NP_003584	3e-43	WHN	FORKHEAD BOX N1; FOXN1	T-cell immunodeficiency, congenital alopecia, and nail dystrophy (3)
CG5284-PB	600570	NP_004357	3e-43	CLCN2;ECA3;EGI3;EGMA	CLC2	Epilepsy with grand mal seizures on awakening, 607628 (3);Epilepsy, childhood absence, 607682 (3);Epilepsy, juvenile absence, 607631 (3);Epilepsy, juvenile myoclonic, 606904 (3)
CG4032-PA	602337	NP_004551	3e-43	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG6407-PA	601570	NP_004616	3e-43	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG10443-PA	120470	NP_005206	3e-43	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG10023-PA	190090	NP_005408	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10023-PB	190090	NP_005408	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10023-PC	190090	NP_005408	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7204-PA	314995	NP_009061	3e-43	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2692-PA	167415	NP_054698	3e-43	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8874-PA	136350	NP_075593	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PB	136350	NP_075593	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PC	136350	NP_075593	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PD	136350	NP_075593	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PA	136350	NP_075594	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PB	136350	NP_075594	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PC	136350	NP_075594	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PD	136350	NP_075594	3e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4698-PA	165330	NP_110380	3e-43	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG30171-PA	188840	NP_596869	3e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG30171-PA	188840	NP_597676	3e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG30171-PA	188840	NP_597681	3e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG5772-PA	607040	NP_660187	3e-43	ABCC11;MRP8;EWWD;WW	MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 8; MRP8	[Earwax, wet/dry], 117800 (3)
CG7204-PA	314995	NP_700359	3e-43	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10211-PA	606765	NP_783653	3e-43	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG10023-PA	190090	NP_938033	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10023-PB	190090	NP_938033	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10023-PC	190090	NP_938033	3e-43	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG30387-PA	182900	NP_000028	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PB	182900	NP_000028	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PC	182900	NP_000028	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG6927-PA	138491	NP_000162	4e-43	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG3915-PA	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG3915-PB	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8049-PA	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8049-PB	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8049-PC	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8049-PD	164860	NP_000236	4e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8302-PA	601310	NP_000769	4e-43		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG4914-PA	229000	NP_000883	4e-43	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG10023-PA	600456	NP_001018074	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG10023-PB	600456	NP_001018074	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG10023-PC	600456	NP_001018074	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG7342-PA	603377	NP_003051	4e-43	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG18247-PA	600997	NP_004433	4e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10023-PA	600456	NP_006171	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG10023-PB	600456	NP_006171	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG10023-PC	600456	NP_006171	4e-43	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG1464-PA	167416	NP_006185	4e-43	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG10023-PA	604705	NP_006334	4e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10023-PB	604705	NP_006334	4e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10023-PC	604705	NP_006334	4e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8418-PA	600098	NP_036382	4e-43	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG2692-PA	167415	NP_039247	4e-43	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG8874-PA	136350	NP_056934	4e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PB	136350	NP_056934	4e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PC	136350	NP_056934	4e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG8874-PD	136350	NP_056934	4e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18247-PA	600997	NP_059145	4e-43	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1453-PA	608283	NP_060111	4e-43	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1453-PB	608283	NP_060111	4e-43	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1453-PC	608283	NP_060111	4e-43	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1453-PD	608283	NP_060111	4e-43	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG1453-PE	608283	NP_060111	4e-43	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG31954-PA	264900	NP_062505	4e-43	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG30387-PA	182900	NP_065208	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PB	182900	NP_065208	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PC	182900	NP_065208	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PA	182900	NP_065209	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PB	182900	NP_065209	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PC	182900	NP_065209	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PA	182900	NP_065210	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PB	182900	NP_065210	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PC	182900	NP_065210	4e-43	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG6331-PA	607096	NP_700357	4e-43	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG31665-PA	602768	NP_982353	4e-43	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG3692-PA	114240	NP_997629	4e-43	CANP3;CAPN3	CALCIUM-ACTIVATED NEUTRAL PROTEASE 3, MUSCLE-SPECIFIC, LARGE SUBUNIT;;CALPAIN III, LARGE SUBUNIT; CANPL3;CALPAIN, LARGE POLYPEPTIDE L3;CANP3;p94	Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
CG31954-PA	264900	NP_000119	5e-43	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG6847-PA	151670	NP_000227	5e-43	LIPC	HEPATIC TRIGLYCERIDE LIPASE; HTGL; HL;LIPH	Hepatic lipase deficiency (3)
CG1494-PA	601691	NP_000341	5e-43	ABCA4;ABCR;ARMD2;CORD3;FFM;RP19;STGD1	ABC TRANSPORTER, RETINA-SPECIFIC;ATP-BINDING CASSETTE TRANSPORTER, RETINA-SPECIFIC; ABCR;PHOTORECEPTOR RIM PROTEIN; RMP	Cone-rod dystrophy 3, 604116 (3);Fundus flavimaculatus, 248200 (3);Macular degeneration, age-related, 2, 153800 (3);Retinitis pigmentosa-19, 601718 (3);Stargardt disease-1, 248200 (3)
CG11403-PA	126340	NP_000391	5e-43	COFS2;EM9;ERCC2;XPD	DNA REPAIR DEFECT EM9 OF CHINESE HAMSTER OVARY CELLS, COMPLEMENTATION;OF; EM9	Cerebrooculofacioskeletal syndrome 2, 610756 (3);Trichothiodystrophy, 601675 (3);Xeroderma pigmentosum, group D, 278730 (3)
CG9481-PA	191740	NP_000454	5e-43	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17283-PA	179820	NP_000528	5e-43	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG4163-PA	601129	NP_000761	5e-43	CYP2C8		Rhabdomyolysis, cerivastatin-induced (3)
CG17309-PA	147370	NP_000866	5e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG17309-PB	147370	NP_000866	5e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG17309-PC	147370	NP_000866	5e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG17309-PD	147370	NP_000866	5e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG17309-PE	147370	NP_000866	5e-43	IGF1R		Intrauterine and postnatal growth retardation (3)
CG7806-PA	171050	NP_000918	5e-43	ABCB1;MDR1;PGY1	DOXORUBICIN RESISTANCE;GP170;MULTIDRUG RESISTANCE 1; MDR1;P-GLYCOPROTEIN 1; PGY1	Colchicine resistance (3)
CG14396-PA	164870	NP_001005862	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PB	164870	NP_001005862	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PC	164870	NP_001005862	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PD	164870	NP_001005862	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PE	164870	NP_001005862	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG10244-PA	191306	NP_002244	5e-43	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG2849-PA	164790	NP_002515	5e-43	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG2849-PC	164790	NP_002515	5e-43	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG5125-PA	300142	NP_002569	5e-43	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG5125-PB	300142	NP_002569	5e-43	MRX30;MRX47;PAK3	OLIGOPHRENIN 3; OPHN3	Mental retardation, X-linked 30, 300558 (3)
CG9181-PA	176876	NP_002825	5e-43	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG9181-PB	176876	NP_002825	5e-43	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG9475-PB	602783	NP_003110	5e-43	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG14396-PA	136351	NP_004110	5e-43	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG14396-PB	136351	NP_004110	5e-43	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG14396-PC	136351	NP_004110	5e-43	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG14396-PD	136351	NP_004110	5e-43	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG14396-PE	136351	NP_004110	5e-43	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG14396-PA	164870	NP_004439	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PB	164870	NP_004439	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PC	164870	NP_004439	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PD	164870	NP_004439	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14396-PE	164870	NP_004439	5e-43	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG12348-PD	176264	NP_004968	5e-43	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG10718-PA	602821	NP_004975	5e-43	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG7831-PA	602821	NP_004975	5e-43	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG7873-PA	604705	NP_006334	5e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7873-PB	604705	NP_006334	5e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7068-PA	120810	NP_009224	5e-43	C4A;C4S	ACIDIC C4;COMPLEMENT COMPONENT 4S; C4S;RODGERS FORM OF C4	C4 deficiency (3);[Blood group, Rodgers] (2)
CG2692-PA	167415	NP_039245	5e-43	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG2692-PA	167415	NP_039246	5e-43	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG10339-PA	100740	NP_056646	5e-43	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG31665-PA	602768	NP_058637	5e-43	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG14895-PA	606808	NP_059129	5e-43	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG14895-PB	606808	NP_059129	5e-43	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG3327-PA	605460	NP_071882	5e-43	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG6492-PA	602044	NP_073714	5e-43	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG4889-PA	165330	NP_110380	5e-43	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG7981-PA	188840	NP_596869	5e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG11608-PA	278000	NP_000226	6e-43	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG18247-PA	191315	NP_001007793	6e-43	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG18247-PA	191315	NP_001012331	6e-43	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG31632-PA	300573	NP_001034980	6e-43	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG14882-PA	602568	NP_002445	6e-43	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG2849-PB	164790	NP_002515	6e-43	NRAS	ONCOGENE NRAS; NRAS1	Colorectal cancer, 114500 (3);Thyroid carcinoma, follicular, 188470 (3)
CG18247-PA	191315	NP_002520	6e-43	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG9181-PC	176876	NP_002825	6e-43	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG2692-PA	167415	NP_003457	6e-43	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG12348-PC	176264	NP_004968	6e-43	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG12348-PE	176264	NP_004968	6e-43	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG1133-PA	165230	NP_005261	6e-43	GLI2;HPE9	ONCOGENE GLI2	Holoprosencephaly-9, 610829 (3);Pituitary anomalies with holoprosencephaly-like features (3)
CG4007-PA	604705	NP_006334	6e-43	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG17309-PA	136350	NP_075599	6e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PB	136350	NP_075599	6e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PC	136350	NP_075599	6e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PD	136350	NP_075599	6e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG17309-PE	136350	NP_075599	6e-43	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14882-PA	602568	NP_076915	6e-43	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG4328-PA	602146	NP_203129	6e-43	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG7223-PA	300300	NP_000052	7e-43	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG7223-PB	300300	NP_000052	7e-43	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG7223-PC	300300	NP_000052	7e-43	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG11186-PA	606597	NP_000429	7e-43	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_000429	7e-43	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG8184-PA	601623	NP_000453	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8184-PB	601623	NP_000453	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4898-PA	191010	NP_001018008	7e-43	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG18444-PA	601564	NP_002761	7e-43	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG8299-PA	601564	NP_002761	7e-43	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG4898-PB	190990	NP_003280	7e-43	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PD	190990	NP_003280	7e-43	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PG	190990	NP_003280	7e-43	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PJ	190990	NP_003280	7e-43	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG11186-PA	606597	NP_039230	7e-43	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_039230	7e-43	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG7981-PA	150292	NP_061486	7e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PB	150292	NP_061486	7e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PC	150292	NP_061486	7e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PD	150292	NP_061486	7e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PE	150292	NP_061486	7e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG11895-PA	605516	NP_443068	7e-43	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG6977-PA	605516	NP_443068	7e-43	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG8184-PA	601623	NP_570853	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8184-PB	601623	NP_570853	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8184-PA	601623	NP_570854	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8184-PB	601623	NP_570854	7e-43	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG4898-PB	191030	NP_689476	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PD	191030	NP_689476	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PG	191030	NP_689476	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PJ	191030	NP_689476	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PB	191030	NP_705935	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PD	191030	NP_705935	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PG	191030	NP_705935	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG4898-PJ	191030	NP_705935	7e-43	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG1121-PA	177400	NP_000046	8e-43	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG5776-PA	601498	NP_000278	8e-43	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG6798-PB	100710	NP_000738	8e-43	ACHRB;CHRNB1;CMS1D;CMS2A;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, BETA SUBUNIT; ACHRB;CHRNB	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG7524-PB	602337	NP_004551	8e-43	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7981-PA	150292	NP_005553	8e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PB	150292	NP_005553	8e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PC	150292	NP_005553	8e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PD	150292	NP_005553	8e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7981-PE	150292	NP_005553	8e-43	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG2658-PA	601023	NP_009057	8e-43	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG5661-PA	607292	NP_071762	8e-43	CORD10;RP35;SEMA4A;SEMB	SEMAPHORIN B; SEMAB; SEMB	Cone-rod dystrophy 10, 610283 (3);Retinitis pigmentosa 35, 610282 (3)
CG17559-PA	164860	NP_000236	9e-43	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG31668-PA	601843	NP_000444	9e-43	SLC5A5;NIS	SODIUM-IODIDE SYMPORTER; NIS	Hypothyroidism, congenital, 274400 (3)
CG9334-PA	107280	NP_001076	9e-43	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG7223-PA	173490	NP_006197	9e-43	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG7223-PB	173490	NP_006197	9e-43	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG7223-PC	173490	NP_006197	9e-43	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8425-PA	300427	NP_065793	9e-43	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4889-PB	165330	NP_110380	9e-43	INT4;WNT3	ONCOGENE INT4; INT4	Tetra-amelia, autosomal recessive, 273395 (3)
CG13521-PA	188840	NP_596869	9e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG13521-PB	188840	NP_596869	9e-43	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG8425-PA	300427	NP_851849	9e-43	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG18402-PA	136352	NP_891555	9e-43	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG5870-PA	608441	NP_892006	9e-43	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG10244-PA	300300	NP_000052	1e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG1133-PA	165240	NP_000159	1e-42	ACLS;GLI3;PAPA;PAPB	ONCOGENE GLI3	Acrocallosal syndrome, 200990 (3);Greig cephalopolysyndactyly syndrome, 175700 (3);Pallister-Hall syndrome, 146510 (3);Polydactyly, postaxial, types A1 and B, 174200 (3);Polydactyly, preaxial, type IV, 174700 (3)
CG14396-PA	164920	NP_000213	1e-42	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG14396-PB	164920	NP_000213	1e-42	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG14396-PC	164920	NP_000213	1e-42	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG14396-PD	164920	NP_000213	1e-42	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG14396-PE	164920	NP_000213	1e-42	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG7873-PA	164860	NP_000236	1e-42	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG7873-PB	164860	NP_000236	1e-42	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG9455-PA	107400	NP_000286	1e-42	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG6147-PA	605284	NP_000359	1e-42	TSC1;LAM	HAMARTIN	Focal cortical dysplasia, Taylor balloon cell type, 607341 (3);Lymphangioleiomyomatosis, 606690 (3);Tuberous sclerosis-1, 191100 (3)
CG10443-PA	308840	NP_000416	1e-42	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG13271-PA	191740	NP_000454	1e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG9334-PA	107300	NP_000479	1e-42	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG9453-PA	107300	NP_000479	1e-42	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG9453-PB	107300	NP_000479	1e-42	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG9460-PA	107300	NP_000479	1e-42	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG4613-PA	229000	NP_000883	1e-42	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG4998-PA	229000	NP_000883	1e-42	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG9455-PA	107400	NP_001002235	1e-42	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG9455-PA	107400	NP_001002236	1e-42	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG7524-PB	164870	NP_001005862	1e-42	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG18247-PA	600456	NP_001018074	1e-42	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG11228-PA	176872	NP_002746	1e-42		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG4386-PA	276000	NP_002760	1e-42	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG18735-PA	606635	NP_002763	1e-42	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG6518-PA	180381	NP_002920	1e-42	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG10261-PA	605377	NP_004400	1e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG10539-PA	605377	NP_004400	1e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG6297-PA	605377	NP_004400	1e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG6297-PB	605377	NP_004400	1e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG7524-PB	164870	NP_004439	1e-42	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG9454-PA	602445	NP_005016	1e-42	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG18085-PA	189980	NP_005148	1e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3969-PA	131550	NP_005219	1e-42	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG3969-PB	131550	NP_005219	1e-42	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8250-PA	131550	NP_005219	1e-42	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG3182-PA	605206	NP_005468	1e-42	HCN4	4; HCN4	Sinus bradycardia syndrome, 163800 (3)
CG3182-PB	605206	NP_005468	1e-42	HCN4	4; HCN4	Sinus bradycardia syndrome, 163800 (3)
CG7223-PA	604705	NP_006334	1e-42	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7223-PB	604705	NP_006334	1e-42	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7223-PC	604705	NP_006334	1e-42	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7551-PB	229800	NP_006479	1e-42	KHK	HEPATIC FRUCTOKINASE DEFICIENCY;KETOHEXOKINASE DEFICIENCY	[Fructosuria] (3)
CG18085-PA	189980	NP_009297	1e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG8760-PA	607928	NP_056219	1e-42	WHRN;CIP98;KIAA1526;DFNB31	CASK-INTERACTING PROTEIN, 98-KD;CIP98;KIAA1526	Deafness, autosomal recessive 31, 607084 (3)
CG1817-PB	600716	NP_057051	1e-42	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG1817-PC	600716	NP_057051	1e-42	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG8425-PA	300336	NP_061850	1e-42	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG7499-PA	111700	NP_065231	1e-42	RHCE	BLOOD GROUP--RHESUS SYSTEM Cc/Ee POLYPEPTIDE;RHC;RHE	Rh-null disease, amorph type (3);[Blood group, Rhesus] (3)
CG4386-PA	606797	NP_068813	1e-42	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG10443-PA	308840	NP_076493	1e-42	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG2105-PA	605511	NP_076927	1e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG11824-PA	605511	NP_115777	1e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG11824-PA	605511	NP_115780	1e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG3219-PA	605995	NP_904325	1e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG7404-PA	133430	NP_000116	2e-42	ESR;ESR1	ESTROGEN RECEPTOR, ALPHA; ESRA;ESTROGEN RECEPTOR; ESR; ER	Breast cancer (1);Estrogen resistance (3);{Atherosclerosis, susceptibility to} (3);{HDL response to hormone replacement, augmented} (3);{Migraine, susceptibility to}, 157300 (3);{Myocardial infarction, susceptibility to}, 608446 (3)
CG7404-PB	133430	NP_000116	2e-42	ESR;ESR1	ESTROGEN RECEPTOR, ALPHA; ESRA;ESTROGEN RECEPTOR; ESR; ER	Breast cancer (1);Estrogen resistance (3);{Atherosclerosis, susceptibility to} (3);{HDL response to hormone replacement, augmented} (3);{Migraine, susceptibility to}, 157300 (3);{Myocardial infarction, susceptibility to}, 608446 (3)
CG11824-PA	264900	NP_000119	2e-42	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG1464-PA	606597	NP_000429	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG6816-PA	201910	NP_000491	2e-42	CA21H;CYP21;CYP21A2	21-@HYDROXYLASE DEFICIENCY;ADRENAL HYPERPLASIA III;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1;CYP21 DEFICIENCY;HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY,	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency (3);Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency (3)
CG6816-PB	201910	NP_000491	2e-42	CA21H;CYP21;CYP21A2	21-@HYDROXYLASE DEFICIENCY;ADRENAL HYPERPLASIA III;CONGENITAL ADRENAL HYPERPLASIA 1; CAH1;CYP21 DEFICIENCY;HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY,	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency (3);Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency (3)
CG1128-PA	100740	NP_000656	2e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG6917-PA	100740	NP_000656	2e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4163-PA	124020	NP_000760	2e-42	CYP2C;CYP2C19	CYP2C;MEPHENYTOIN 4-PRIME-HYDROXYLASE;P450C2C	Mephenytoin poor metabolizer (3);Opremazole poor metabolizer (3);Proguanil poor metabolizer (3)
CG3656-PA	605325	NP_000768	2e-42	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG4268-PA	300203	NP_001032420	2e-42	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4268-PC	300203	NP_001032420	2e-42	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG1031-PA	114840	NP_001798	2e-42	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG3324-PA	176980	NP_002730	2e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10443-PA	600079	NP_002826	2e-42	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG18024-PA	184429	NP_003097	2e-42	MCOPS3;SOX2	SRY-RELATED HMG-BOX GENE 2	Microphthalmia, syndromic 3, 206900 (3);Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)
CG5289-PA	602783	NP_003110	2e-42	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG4268-PA	300203	NP_003150	2e-42	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4268-PC	300203	NP_003150	2e-42	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4548-PA	603615	NP_003570	2e-42	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG4548-PB	603615	NP_003570	2e-42	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG10505-PA	603201	NP_003733	2e-42	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG32134-PA	600997	NP_004433	2e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7873-PA	147796	NP_004963	2e-42	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG7873-PB	147796	NP_004963	2e-42	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG18247-PA	189980	NP_005148	2e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG18247-PA	600456	NP_006171	2e-42	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG18247-PA	189980	NP_009297	2e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG11202-PA	604895	NP_037483	2e-42	TBX21;TBET	T-BOX EXPRESSED IN T CELLS; TBET	Asthma and nasal polyps, 208550 (3);{Asthma, aspirin-induced, susceptibility to}, 208550 (3)
CG1464-PA	606597	NP_039230	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG14644-PA	604766	NP_055440	2e-42	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG8311-PA	610746	NP_055723	2e-42	TMEM15;DK1;SEC59;KIAA1094	DOLICHOL KINASE 1; DK1;KIAA1094;SEC59, YEAST, HOMOLOG OF; SEC59	Congenital disorder of glycosylation, type Im, 610768 (3)
CG7504-PA	608465	NP_055861	2e-42	ALS4;AOA2;SCAR1;SETX	SETX	Amyotrophic lateral sclerosis 4, juvenile, 602433 (3);Ataxia-ocular apraxia-2, 606002 (3)
CG3219-PA	605995	NP_055889	2e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1128-PA	100740	NP_056646	2e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG6917-PA	100740	NP_056646	2e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG32134-PA	600997	NP_059145	2e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7831-PA	608283	NP_060111	2e-42	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG11824-PA	264900	NP_062505	2e-42	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG7314-PA	113730	NP_068605	2e-42	UCP1	BROWN ADIPOSE TISSUE UNCOUPLING PROTEIN;THERMOGENIN;UCP	{Obesity, susceptibility to}, 601665 (3)
CG7314-PB	113730	NP_068605	2e-42	UCP1	BROWN ADIPOSE TISSUE UNCOUPLING PROTEIN;THERMOGENIN;UCP	{Obesity, susceptibility to}, 601665 (3)
CG7959-PA	121360	NP_074036	2e-42	CBFB	POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2-BETA; PEBP2B	Myeloid leukemia, acute, M4Eo subtype (3)
CG11824-PA	605511	NP_076927	2e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG31175-PA	601239	NP_116761	2e-42	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PB	601239	NP_116761	2e-42	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PC	601239	NP_116761	2e-42	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG18069-PA	606566	NP_149109	2e-42	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18069-PB	606566	NP_149109	2e-42	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG18069-PC	606566	NP_149109	2e-42	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1167-PA	190020	NP_789765	2e-42	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG11186-PA	606597	NP_852122	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_852122	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PA	606597	NP_852123	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_852123	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PA	606597	NP_852124	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_852124	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PA	606597	NP_852125	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_852125	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PA	606597	NP_852126	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG11186-PB	606597	NP_852126	2e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG4926-PA	176947	NP_997402	2e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PA	300300	NP_000052	3e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG14396-PB	300300	NP_000052	3e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG14396-PC	300300	NP_000052	3e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG14396-PD	300300	NP_000052	3e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG14396-PE	300300	NP_000052	3e-42	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG8874-PA	134934	NP_000133	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PB	134934	NP_000133	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PC	134934	NP_000133	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PD	134934	NP_000133	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG4860-PA	608801	NP_000150	3e-42	GCDH		Glutaricaciduria, type I, 231670 (3)
CG10339-PA	100740	NP_000656	3e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3656-PB	605325	NP_000768	3e-42	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG4386-PA	229000	NP_000883	3e-42	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG11876-PB	179060	NP_000916	3e-42	PDHB	E1, BETA POLYPEPTIDE; PHE1B	Pyruvate dehydrogenase E1-beta deficiency (3)
CG11876-PC	179060	NP_000916	3e-42	PDHB	E1, BETA POLYPEPTIDE; PHE1B	Pyruvate dehydrogenase E1-beta deficiency (3)
CG1830-PB	604373	NP_001005735	3e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10522-PA	164731	NP_001617	3e-42	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG18096-PA	120900	NP_001726	3e-42	C5		C5 deficiency (1)
CG14992-PA	134935	NP_002002	3e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG9181-PA	600925	NP_002834	3e-42	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG9181-PB	600925	NP_002834	3e-42	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG9181-PC	600925	NP_002834	3e-42	DEP1;PTPRJ	DEP1;PROTEIN-TYROSINE PHOSPHATASE, ETA;SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF; SCC1	Colon cancer, somatic, 114500 (3)
CG6356-PA	603377	NP_003051	3e-42	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG6214-PB	603201	NP_003733	3e-42	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG4006-PA	605377	NP_004400	3e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG4006-PB	605377	NP_004400	3e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG4006-PC	605377	NP_004400	3e-42	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG18085-PA	600997	NP_004433	3e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG10776-PA	190181	NP_004603	3e-42	AAT5;ALK5;TGFBR1	ACTIVIN RECEPTOR-LIKE KINASE 5; ALK5	Aortic aneurysm, familial thoracic 5, 610380 (3);Furlong syndrome, 610168 (3);Loeys-Dietz syndrome, 609192 (3)
CG4698-PA	601570	NP_004616	3e-42	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG7260-PA	601621	NP_005987	3e-42	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG8487-PA	605371	NP_006411	3e-42	ARFGEF2;BIG2	BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 2; BIG2	Periventricular heterotopia with microcephaly, 608097 (3)
CG8487-PB	605371	NP_006411	3e-42	ARFGEF2;BIG2	BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 2; BIG2	Periventricular heterotopia with microcephaly, 608097 (3)
CG7386-PA	314995	NP_009061	3e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1830-PB	604373	NP_009125	3e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG7091-PA	604322	NP_036566	3e-42	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG18085-PA	600997	NP_059145	3e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG1438-PA	124010	NP_059488	3e-42		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG14992-PA	134935	NP_075252	3e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG8874-PA	134934	NP_075254	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PB	134934	NP_075254	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PC	134934	NP_075254	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PD	134934	NP_075254	3e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG7386-PA	314995	NP_700359	3e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6969-PA	606765	NP_783650	3e-42	TPO;TPX	THYROPEROXIDASE	Goiter, congenital (3);Hyperthyroidism, congenital (3);Thyroid hormone organification defect IIA, 274500 (3);Total iodide organification defect, 274500 (3)
CG7223-PA	176947	NP_997402	3e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PB	176947	NP_997402	3e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PC	176947	NP_997402	3e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14992-PA	134935	NP_998812	3e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3319-PA	123829	NP_000066	4e-42	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG4163-PA	124030	NP_000097	4e-42	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG3969-PA	164860	NP_000236	4e-42	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG15902-PA	191740	NP_000454	4e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG1594-PA	600997	NP_004433	4e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG3969-PA	189980	NP_005148	4e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3969-PB	189980	NP_005148	4e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG13521-PA	142461	NP_005520	4e-42	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG13521-PB	142461	NP_005520	4e-42	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG3969-PA	189980	NP_009297	4e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG3969-PB	189980	NP_009297	4e-42	ABL1	ABELSON STRAIN OF MURINE LEUKEMIA VIRUS; ABL;TRANSFORMATION GENE: ONCOGENE ABL	Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
CG10011-PA	243305	NP_055240	4e-42	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG14736-PA	604766	NP_055440	4e-42	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG14736-PB	604766	NP_055440	4e-42	NPHS2;PDCN;SRN1	PDCN	Nephrotic syndrome, steroid-resistant, autosomal recessive, 600995 (3)
CG1594-PA	600997	NP_059145	4e-42	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7458-PA	607096	NP_653186	4e-42	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG10011-PA	243305	NP_899068	4e-42	INV;INVS;NPH2;NPHP2	INVERSION OF EMBRYONIC TURNING; INV;NEPHROCYSTIN 2; NPHP2	Nephronophthisis 2, infantile, 602088 (3)
CG11339-PA	300628	NP_919253	4e-42	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG31536-PA	130500	NP_976218	4e-42	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG7003-PA	162200	NP_000242	5e-42	NF1;NFNS;VRNF;WSS	NEUROFIBROMATOSIS;VON RECKLINGHAUSEN DISEASE	Leukemia, juvenile myelomonocytic, 607785 (3);Melanoma, desmoplastic neurotropic (2);Neurofibromatosis, familial spinal, 162210 (3);Neurofibromatosis, type 1 (3);Neurofibromatosis-Noonan syndrome, 601321 (3);Pseudarthrosis, tibial, in NF1 (3);Watson syndrome, 193520 (3)
CG7003-PA	609309	NP_000242	5e-42	COCA1;FCC1;HNPCC1;MSH2		Cafe-au-lait spots, multiple, with leukemia, 114030 (3);Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);Glioblastoma, early-onset, 137800 (3);Lymphoma, T-cell (3);Lynch cancer family syndrome II, 114400 (3);Muir-Torre syndrome, 158320 (3);Neurofibromatosis, type I, with leukemia, 162200 (3);Ovarian cancer (3)
CG4225-PA	170260	NP_000584	5e-42	ABCB2;PSF1;RING4;TAP1	1;1; TAP1;ABC TRANSPORTER, MHC, 1;ANTIGEN PEPTIDE TRANSPORTER 1; APT1;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 2; ABCB2;PEPTIDE SUPPLY FACTOR 1; PSF1;PEPTIDE TRANSPORTER PSF1;RING4;TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;TRANSPORTER, ABC, MHC, 1	Bare lymphocyte syndrome, type I, 604571 (3)
CG8425-PA	100740	NP_000656	5e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4926-PA	176947	NP_001070	5e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PA	176947	NP_001070	5e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PB	176947	NP_001070	5e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG7223-PC	176947	NP_001070	5e-42	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17596-PA	180381	NP_002920	5e-42	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG17528-PA	300075	NP_004577	5e-42	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17528-PB	300075	NP_004577	5e-42	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17528-PC	300075	NP_004577	5e-42	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17528-PD	300075	NP_004577	5e-42	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG6717-PA	602445	NP_005016	5e-42	PI12;SERPINI1	NEUROSERPIN;SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)
CG4257-PB	600555	NP_009330	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG4257-PC	600555	NP_009330	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG4257-PD	600555	NP_009330	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG8425-PA	100740	NP_056646	5e-42	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG4257-PB	600555	NP_644671	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG4257-PC	600555	NP_644671	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG4257-PD	600555	NP_644671	5e-42	STAT1		Mycobacterial infection, atypical, familial disseminated, 209950 (3);STAT1 deficiency, complete (3)
CG1464-PA	606597	NP_852125	5e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1464-PA	606597	NP_852126	5e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1453-PA	605995	NP_904325	5e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PB	605995	NP_904325	5e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PC	605995	NP_904325	5e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PD	605995	NP_904325	5e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PE	605995	NP_904325	5e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG7589-PA	138491	NP_000162	6e-42	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG18377-PA	606530	NP_000775	6e-42	CTX;CYP27;CYP27A1	CYP27;STEROL 27-HYDROXYLASE	Cerebrotendinous xanthomatosis, 213700 (3)
CG18069-PA	604373	NP_001005735	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG18069-PB	604373	NP_001005735	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG18069-PC	604373	NP_001005735	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1830-PA	604373	NP_001005735	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1830-PC	604373	NP_001005735	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG10033-PA	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10033-PB	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10033-PC	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10033-PD	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG10033-PE	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6498-PA	176980	NP_002730	6e-42	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG5789-PA	603201	NP_003733	6e-42	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG18069-PA	604373	NP_009125	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG18069-PB	604373	NP_009125	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG18069-PC	604373	NP_009125	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1830-PA	604373	NP_009125	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1830-PC	604373	NP_009125	6e-42	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG7675-PB	605131	NP_057457	6e-42	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG10443-PA	608630	NP_071765	6e-42	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG10079-PA	136350	NP_075593	6e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10079-PB	136350	NP_075593	6e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10079-PA	136350	NP_075594	6e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10079-PB	136350	NP_075594	6e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG2505-PA	177400	NP_000046	7e-42	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG1208-PA	138160	NP_000331	7e-42	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG6919-PA	182135	NP_000612	7e-42	HTR2A	SEROTONIN 5-HT-2 RECEPTOR, FORMERLY; HTR2, FORMERLY;SEROTONIN 5-HT-2A RECEPTOR	{Alcohol dependence, susceptibility to}, 103780 (3);{Anorexia nervosa, susceptibility to}, 606788 (3);{Major depressive disorder, response to citalopram therapy in}, 608516 (3);{Obsessive-compulsive disorder, susceptibility to}, 164230 (3);{Schizophrenia, susceptibility to}, 181500 (3);{Seasonal affective disorder, susceptibility to}, 608516 (3)
CG12414-PA	118502	NP_000733	7e-42	CHRNA2	ACETYLCHOLINE RECEPTOR, NEURONAL NICOTINIC, ALPHA-2 SUBUNIT	Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
CG6081-PA	605325	NP_000768	7e-42	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG31728-PA	229000	NP_000883	7e-42	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG18247-PA	134935	NP_002002	7e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG6464-PA	602218	NP_002959	7e-42	HSAL1;SALL1;TBS	HSAL1	Townes-Brocks branchiootorenal-like syndrome, 107480 (3);Townes-Brocks syndrome, 107480 (3)
CG4007-PA	164770	NP_005202	7e-42	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG5373-PA	171834	NP_006209	7e-42	PIK3CA	p110-ALPHA;PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, 110-KD, ALPHA	Breast cancer, 114480 (3);Colorectal cancer, 114500 (3);Ovarian cancer, 604370 (3)
CG31670-PA	314995	NP_009061	7e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1453-PA	605995	NP_055889	7e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PB	605995	NP_055889	7e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PC	605995	NP_055889	7e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PD	605995	NP_055889	7e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG1453-PE	605995	NP_055889	7e-42	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG10079-PA	136350	NP_056934	7e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10079-PB	136350	NP_056934	7e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG10443-PA	600716	NP_057051	7e-42	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG4382-PA	300336	NP_061850	7e-42	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG18247-PA	134935	NP_075252	7e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG31954-PA	605511	NP_115777	7e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG31954-PA	605511	NP_115780	7e-42	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG31670-PA	314995	NP_700359	7e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1464-PA	606597	NP_852122	7e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1464-PA	606597	NP_852123	7e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG1464-PA	606597	NP_852124	7e-42	CDHS;HUP2;PAX3;WS1	PAIRED DOMAIN GENE HuP2; HUP2	Craniofacial-deafness-hand syndrome, 122880 (3);Rhabdomyosarcoma, alveolar, 268220 (3);Waardenburg syndrome, type I, 193500 (3);Waardenburg syndrome, type III, 148820 (3)
CG18247-PA	134935	NP_998812	7e-42	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG13284-PA	605573	NP_000188	8e-42	EDH17B3;HSD17B3	17-@BETA-HSD III;ESTRADIOL 17-BETA-DEHYDROGENASE; EDH17B3;TESTICULAR 17-@BETA-HYDROXYSTEROID DEHYDROGENASE III	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
CG13284-PB	605573	NP_000188	8e-42	EDH17B3;HSD17B3	17-@BETA-HSD III;ESTRADIOL 17-BETA-DEHYDROGENASE; EDH17B3;TESTICULAR 17-@BETA-HYDROXYSTEROID DEHYDROGENASE III	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
CG2086-PB	156225	NP_000417	8e-42	LAMA2;LAMM	LAMININ 2, HEAVY CHAIN	Muscular dystrophy, congenital merosin-deficient, 607855 (3);Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)
CG17322-PA	191740	NP_000454	8e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17322-PB	191740	NP_000454	8e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17322-PC	191740	NP_000454	8e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG17322-PD	191740	NP_000454	8e-42	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG7960-PA	121360	NP_001746	8e-42	CBFB	POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2-BETA; PEBP2B	Myeloid leukemia, acute, M4Eo subtype (3)
CG31954-PA	276000	NP_002760	8e-42	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG6231-PA	604190	NP_003050	8e-42	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6231-PB	604190	NP_003050	8e-42	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6231-PC	604190	NP_003050	8e-42	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG6231-PD	604190	NP_003050	8e-42	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG2125-PA	603073	NP_009060	8e-42	HPE5;ZIC2	ZIC FAMILY MEMBER 2	Holoprosencephaly-5, 609637 (3)
CG7904-PA	600956	NP_065434	8e-42	AMHR;AMHR2	ANTI-MULLERIAN HORMONE RECEPTOR; AMHR	Persistent Mullerian duct syndrome, type II, 261550 (3)
CG7960-PA	121360	NP_074036	8e-42	CBFB	POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2-BETA; PEBP2B	Myeloid leukemia, acute, M4Eo subtype (3)
CG10079-PA	134934	NP_075254	8e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10079-PB	134934	NP_075254	8e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG6127-PA	602768	NP_982353	8e-42	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG10079-PA	134934	NP_000133	9e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10079-PB	134934	NP_000133	9e-42	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG10932-PA	143450	NP_000174	9e-42	HADHB	BETA SUBUNIT; HADHB;ECHB;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, BETA SUBUNIT;TRIFUNCTIONAL PROTEIN, BETA SUBUNIT	Trifunctional protein deficiency, type II (3)
CG18262-PA	314995	NP_009061	9e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG6127-PA	602768	NP_058637	9e-42	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG18582-PA	606808	NP_059129	9e-42	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG4007-PA	136350	NP_075599	9e-42	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18262-PA	314995	NP_700359	9e-42	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1956-PA	190020	NP_789765	9e-42	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG32105-PB	600577	NP_835258	9e-42	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG32465-PB	177400	NP_000046	1e-41	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG4703-PA	608801	NP_000150	1e-41	GCDH		Glutaricaciduria, type I, 231670 (3)
CG31721-PA	300552	NP_000372	1e-41	BBBG1;FXY;MID1;OGS1;OSX	FINGER ON X AND Y, MOUSE, HOMOLOG OF; FXY;MIDIN;MIDLINE 1 RING FINGER GENE	Opitz G syndrome, type I, 300000 (3)
CG6320-PB	601949	NP_000717	1e-41	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG6320-PB	601949	NP_001005746	1e-41	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG17309-PA	191315	NP_001007793	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PB	191315	NP_001007793	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PC	191315	NP_001007793	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PD	191315	NP_001007793	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PE	191315	NP_001007793	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PA	191315	NP_001012331	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PB	191315	NP_001012331	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PC	191315	NP_001012331	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PD	191315	NP_001012331	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PE	191315	NP_001012331	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7526-PA	601548	NP_001034437	1e-41	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG7526-PA	601548	NP_001034438	1e-41	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG11678-PA	102560	NP_001605	1e-41	ACTG1;DFNA20;DFNA26	ACTIN, CYTOPLASMIC, 2;ACTIN, GAMMA; ACTG;CYTOSKELETAL GAMMA-ACTIN	Deafness, autosomal dominant 20/26, 604717 (3)
CG12370-PB	114131	NP_001733	1e-41	CALCR;CRT	CTR; CTR1	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
CG7959-PA	121360	NP_001746	1e-41	CBFB	POLYOMAVIRUS ENHANCER-BINDING PROTEIN 2-BETA; PEBP2B	Myeloid leukemia, acute, M4Eo subtype (3)
CG17309-PA	191315	NP_002520	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PB	191315	NP_002520	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PC	191315	NP_002520	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PD	191315	NP_002520	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG17309-PE	191315	NP_002520	1e-41	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG6297-PA	180381	NP_002920	1e-41	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG6297-PB	180381	NP_002920	1e-41	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG7345-PA	184429	NP_003097	1e-41	MCOPS3;SOX2	SRY-RELATED HMG-BOX GENE 2	Microphthalmia, syndromic 3, 206900 (3);Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)
CG7526-PA	601548	NP_004096	1e-41	EFEMP1;FBNL;DHRD	FIBRILLIN-LIKE; FBNL;FIBULIN 3; FBLN3	Doyne honeycomb degeneration of retina, 126600 (3)
CG31547-PA	604878	NP_005126	1e-41	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG31547-PB	604878	NP_005126	1e-41	ACCPN;KCC3;KCC3A;KCC3B;SLC12A6	POTASSIUM-CHLORIDE COTRANSPORTER 3; KCC3;SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)
CG7223-PA	190090	NP_005408	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7223-PB	190090	NP_005408	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7223-PC	190090	NP_005408	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG8665-PA	603178	NP_005580	1e-41	ALDH6A1;MMSDH	ALDEHYDE DEHYDROGENASE 6 FAMILY, MEMBER A1; ALDH6A1	Methylmalonate semialdehyde dehydrogenase deficiency (3)
CG40129-PA	605437	NP_006246	1e-41	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG10975-PA	600716	NP_036543	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG10975-PB	600716	NP_036543	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG1817-PB	600716	NP_036543	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG1817-PC	600716	NP_036543	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG3649-PA	604322	NP_036566	1e-41	SLC17A5;SIASD;SLD	5; SLC17A5;SIALIN	Salla disease, 604369 (3);Sialic acid storage disorder, infantile, 269920 (3)
CG32105-PB	600577	NP_055379	1e-41	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG10975-PA	600716	NP_057051	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG10975-PB	600716	NP_057051	1e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG31045-PB	606808	NP_059129	1e-41	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG31045-PE	606808	NP_059129	1e-41	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG10833-PA	124010	NP_059488	1e-41		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG18085-PA	136350	NP_075599	1e-41	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG31954-PA	605511	NP_076927	1e-41	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG31721-PA	300552	NP_150632	1e-41	BBBG1;FXY;MID1;OGS1;OSX	FINGER ON X AND Y, MOUSE, HOMOLOG OF; FXY;MIDIN;MIDLINE 1 RING FINGER GENE	Opitz G syndrome, type I, 300000 (3)
CG11354-PA	602146	NP_203129	1e-41	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG17941-PA	605516	NP_443068	1e-41	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG3352-PA	605516	NP_443068	1e-41	CDH23;USH1D	OTOCADHERIN	Deafness, autosomal recessive 12, 601386 (3);Usher syndrome, type 1D, 601067 (3)
CG4187-PA	606655	NP_570718	1e-41	GREAT;LGR8	GPR106;GREAT	Cryptorchidism, bilateral, 219050 (3)
CG31190-PA	188840	NP_596869	1e-41	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG7499-PA	111700	NP_619524	1e-41	RHCE	BLOOD GROUP--RHESUS SYSTEM Cc/Ee POLYPEPTIDE;RHC;RHE	Rh-null disease, amorph type (3);[Blood group, Rhesus] (3)
CG7223-PA	190090	NP_938033	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7223-PB	190090	NP_938033	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG7223-PC	190090	NP_938033	1e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG11876-PA	248611	NP_000047	2e-41	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG11876-PD	248611	NP_000047	2e-41	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG32134-PA	300300	NP_000052	2e-41	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG7586-PA	120700	NP_000055	2e-41	C3		C3 deficiency (3)
CG8594-PA	300008	NP_000075	2e-41	CLCK2;CLCN5;DENTS;NPHL2	CHLORIDE CHANNEL, VOLTAGE-GATED, K2; CLCK2;CLC5	Dent disease, 300009 (3);Hypophosphatemia, type III (3);Nephrolithiasis, type I, 310468 (3);Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis (3)
CG8874-PA	176943	NP_000132	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PB	176943	NP_000132	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PC	176943	NP_000132	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PD	176943	NP_000132	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG18247-PA	134934	NP_000133	2e-41	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8137-PA	142360	NP_000176	2e-41	HCF2;HC2;SERPIND1	LEUSERPIN 2; LS2;SERPIND1	Thrombophilia due to heparin cofactor II deficiency (3)
CG10704-PA	607108	NP_000271	2e-41	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG31175-PA	182870	NP_000338	2e-41	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG31175-PC	182870	NP_000338	2e-41	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG3131-PA	300481	NP_000388	2e-41	CGD;CYBB	CYTOCHROME b(558), BETA SUBUNIT;GP91-1;NADPH OXIDASE 2; NOX2;p91-PHOX	Chronic granulomatous disease, X-linked, 306400 (3)
CG3595-PA	160781	NP_000423	2e-41	CMH10;MYL2	MLC2;MYOSIN, LIGHT CHAIN, REGULATORY VENTRICULAR;REGULATORY LIGHT CHAIN OF MYOSIN;RLC OF MYOSIN	Cardiomyopathy, familial hypertrophic, 10, 608758 (3);Cardiomyopathy, hypertrophic, mid-left ventricular chamber type, 608758 (3)
CG8733-PA	122720	NP_000753	2e-41	CYP2A;CYP2A3;CYP2A6;P450C2A	COUMARIN 7-HYDROXYLASE;CYP2A3, FORMERLY;CYTOCHROME P450, PHENOBARBITAL-INDUCIBLE; P450PB	Coumarin resistance, 122700 (3);{Lung cancer, resistance to}, 211980 (3);{Nicotine addiction, protection from} (3)
CG3540-PA	605325	NP_000768	2e-41	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG11715-PB	601310	NP_000769	2e-41		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG18377-PC	606530	NP_000775	2e-41	CTX;CYP27;CYP27A1	CYP27;STEROL 27-HYDROXYLASE	Cerebrotendinous xanthomatosis, 213700 (3)
CG7446-PA	137192	NP_000805	2e-41	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG17309-PA	600456	NP_001018074	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PB	600456	NP_001018074	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PC	600456	NP_001018074	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PD	600456	NP_001018074	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PE	600456	NP_001018074	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG31175-PA	182870	NP_001020029	2e-41	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG31175-PC	182870	NP_001020029	2e-41	SPTB	SPECTRIN, BETA-I	Anemia, neonatal hemolytic, fatal and near-fatal (3);Elliptocytosis-3 (3);Spherocytosis-1 (3)
CG31045-PC	160745	NP_001035202	2e-41	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG31045-PC	160745	NP_001035203	2e-41	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG11678-PA	102630	NP_001092	2e-41		BETA-ACTIN	
CG10776-PA	603248	NP_001194	2e-41	ALK6;BMPR1B	ACTIVIN RECEPTOR-LIKE KINASE 6; ALK6	Brachydactyly, type A2, 112600 (3)
CG4382-PA	114840	NP_001798	2e-41	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG7525-PA	134935	NP_002002	2e-41	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG3978-PA	305371	NP_002040	2e-41	ERYF1;GATA1;GF1;NFE1	ERYTHROID TRANSCRIPTION FACTOR 1; ERYF1;GLOBIN TRANSCRIPTION FACTOR 1; GF1;TRANSCRIPTION FACTOR GATA1	Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Leukemia, megakaryoblastic, of Down syndrome, 190685 (3);Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3);Macrothrombocytopenia, 300367 (3)
CG3978-PB	305371	NP_002040	2e-41	ERYF1;GATA1;GF1;NFE1	ERYTHROID TRANSCRIPTION FACTOR 1; ERYF1;GLOBIN TRANSCRIPTION FACTOR 1; GF1;TRANSCRIPTION FACTOR GATA1	Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Leukemia, megakaryoblastic, of Down syndrome, 190685 (3);Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3);Macrothrombocytopenia, 300367 (3)
CG31045-PC	160745	NP_002465	2e-41	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG8299-PA	276000	NP_002760	2e-41	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG6604-PA	601397	NP_003172	2e-41	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG2125-PA	300265	NP_003404	2e-41	HTX;HTX1;ZIC3	HTX1;ZIC FAMILY MEMBER 3	Heterotaxy, X-linked visceral, 306955 (3)
CG12306-PA	603072	NP_003591	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_003591	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG14709-PA	603201	NP_003733	2e-41	ABCB11;BSEP;PFIC2;SPGP	BILE SALT EXPORT PUMP; BSEP;SISTER OF P-GLYCOPROTEIN; SPGP	Cholestasis, progressive familial intrahepatic 2, 601847 (3)
CG7838-PA	602452	NP_004327	2e-41	BUB1	BUB1;BUB1, S. CEREVISIAE, HOMOLOG OF;MITOTIC CHECKPOINT GENE BUB1	Colorectal cancer with chromosomal instability (3)
CG8049-PA	602337	NP_004551	2e-41	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8049-PB	602337	NP_004551	2e-41	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8049-PC	602337	NP_004551	2e-41	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8049-PD	602337	NP_004551	2e-41	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG10244-PA	131550	NP_005219	2e-41	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG9001-PA	606480	NP_005848	2e-41	FACE1;MADB;STE24;ZMPSTE24	FACE1;STE24, S. CEREVISIAE, HOMOLOG OF	Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);Restrictive dermopathy, lethal, 275210 (3)
CG17309-PA	600456	NP_006171	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PB	600456	NP_006171	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PC	600456	NP_006171	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PD	600456	NP_006171	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG17309-PE	600456	NP_006171	2e-41	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG32134-PA	604705	NP_006334	2e-41	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG9610-PB	167415	NP_039246	2e-41	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4386-PA	264900	NP_062505	2e-41	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG17419-PB	106410	NP_066187	2e-41	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG17419-PC	106410	NP_066187	2e-41	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG32717-PB	300189	NP_066943	2e-41	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG18340-PA	113730	NP_068605	2e-41	UCP1	BROWN ADIPOSE TISSUE UNCOUPLING PROTEIN;THERMOGENIN;UCP	{Obesity, susceptibility to}, 601665 (3)
CG7446-PA	137192	NP_068712	2e-41	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG31045-PC	160745	NP_074035	2e-41	AAT4;FAA4;MYH11	MYOSIN, SMOOTH MUSCLE, HEAVY CHAIN 11; SMHC;SMOOTH MUSCLE MYOSIN HEAVY CHAIN; SMMHC	Aortic aneurysm, familial thoracic 4, 132900 (3)
CG7525-PA	134935	NP_075252	2e-41	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG18247-PA	134934	NP_075254	2e-41	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG8874-PA	176943	NP_075259	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PB	176943	NP_075259	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PC	176943	NP_075259	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8874-PD	176943	NP_075259	2e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4032-PA	136350	NP_075599	2e-41	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG5870-PA	608441	NP_149062	2e-41	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG13320-PA	607696	NP_775748	2e-41	SANS;USH1G	SCAFFOLD PROTEIN CONTAINING ANKYRIN REPEATS AND SAM DOMAIN; SANS	Usher syndrome, type 1G, 606943 (3)
CG13320-PB	607696	NP_775748	2e-41	SANS;USH1G	SCAFFOLD PROTEIN CONTAINING ANKYRIN REPEATS AND SAM DOMAIN; SANS	Usher syndrome, type 1G, 606943 (3)
CG11020-PA	608774	NP_848605	2e-41	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG4719-PA	608774	NP_848605	2e-41	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG10701-PD	607379	NP_861971	2e-41	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG11876-PA	248611	NP_898871	2e-41	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG11876-PD	248611	NP_898871	2e-41	BCKDHB;E1B	E1B	Maple syrup urine disease, type Ib, 248600 (3)
CG12192-PA	605995	NP_904325	2e-41	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG12306-PA	603072	NP_940835	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_940835	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12306-PA	603072	NP_940836	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_940836	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12306-PA	603072	NP_940837	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_940837	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12306-PA	603072	NP_940838	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_940838	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12306-PA	603072	NP_940839	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG15072-PA	603072	NP_940839	2e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7525-PA	134935	NP_998812	2e-41	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG4386-PA	264900	NP_000119	3e-41	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG10079-PA	176943	NP_000132	3e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10079-PB	176943	NP_000132	3e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3969-PB	164860	NP_000236	3e-41	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8358-PA	300550	NP_000435	3e-41	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG4120-PA	118485	NP_000772	3e-41	CYP11A;P450SCC	CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME;CYP11A;CYTOCHROME P450 SIDE-CHAIN CLEAVAGE ENZYME;CYTOCHROME P450C11A1;CYTOCHROME P450SCC	Adrenal insufficiency, congenital with or without 46, XY sex reversal (3);Lipoid congenital adrenal hyperplasia, 201710 (3)
CG2105-PA	229000	NP_000883	3e-41	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG10579-PA	300203	NP_001032420	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PB	300203	NP_001032420	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PC	300203	NP_001032420	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PD	300203	NP_001032420	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PE	300203	NP_001032420	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4721-PA	600423	NP_001388	3e-41	ECE1	ECE;HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION,	Hirschsprung disease, cardiac defects, and autonomic dysfunction (3);{Hypertension, essential, susceptibility to}, 145500 (3)
CG15072-PA	164731	NP_001617	3e-41	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10579-PA	300203	NP_003150	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PB	300203	NP_003150	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PC	300203	NP_003150	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PD	300203	NP_003150	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG10579-PE	300203	NP_003150	3e-41	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4379-PA	603072	NP_003591	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_003591	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_003591	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_003591	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7223-PA	600997	NP_004433	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7223-PB	600997	NP_004433	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7223-PC	600997	NP_004433	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG4032-PA	147796	NP_004963	3e-41	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG32134-PA	131550	NP_005219	3e-41	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG7223-PA	131550	NP_005219	3e-41	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG7223-PB	131550	NP_005219	3e-41	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG7223-PC	131550	NP_005219	3e-41	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10079-PA	190090	NP_005408	3e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10079-PB	190090	NP_005408	3e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG2692-PA	167416	NP_006185	3e-41	PAX9	PAIRED DOMAIN GENE 9	Hypodontia, 106600 (3);Oligodontia, 604625 (3)
CG10079-PA	604705	NP_006334	3e-41	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10079-PB	604705	NP_006334	3e-41	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG9610-PB	167415	NP_039245	3e-41	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG12192-PA	605995	NP_055889	3e-41	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG6899-PA	600716	NP_057051	3e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG6899-PB	600716	NP_057051	3e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG7223-PA	600997	NP_059145	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7223-PB	600997	NP_059145	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG7223-PC	600997	NP_059145	3e-41	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG6730-PA	124010	NP_059488	3e-41		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG6018-PA	300336	NP_061850	3e-41	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG18247-PA	176943	NP_075259	3e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4316-PA	605511	NP_115777	3e-41	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4316-PA	605511	NP_115780	3e-41	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG10079-PA	190090	NP_938033	3e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG10079-PB	190090	NP_938033	3e-41	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4379-PA	603072	NP_940835	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_940835	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_940835	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_940835	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PA	603072	NP_940836	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_940836	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_940836	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_940836	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PA	603072	NP_940837	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_940837	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_940837	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_940837	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PA	603072	NP_940838	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_940838	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_940838	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_940838	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PA	603072	NP_940839	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4379-PB	603072	NP_940839	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PA	603072	NP_940839	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6117-PB	603072	NP_940839	3e-41	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7535-PB	137164	NP_944493	3e-41	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG3499-PB	602783	NP_955399	3e-41	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG4581-PA	607809	NP_000010	4e-41	ACAT1	ACAT;ACETOACETYL-CoA THIOLASE, MITOCHONDRIAL;MITOCHONDRIAL ACETOACETYL-CoA THIOLASE; MAT;T2	Alpha-methylacetoacetic aciduria, 203750 (3)
CG18741-PA	109690	NP_000015	4e-41	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG18741-PB	109690	NP_000015	4e-41	ADRB2	ADRB2R;BETA-2-ADRENOCEPTOR; BAR; B2AR;BETA-ADRENERGIC RECEPTOR; ADRBR	Beta-2-adrenoreceptor agonist, reduced response to (3);{Asthma, nocturnal, susceptibility to}, 600807 (3);{Obesity, susceptibility to}, 601665 (3)
CG18402-PA	300300	NP_000052	4e-41	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG18247-PA	176943	NP_000132	4e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG4007-PA	164860	NP_000236	4e-41	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG3099-PB	601623	NP_000453	4e-41	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG7223-PA	164870	NP_001005862	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7223-PB	164870	NP_001005862	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7223-PC	164870	NP_001005862	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG12029-PA	602053	NP_001008490	4e-41	BCD1;COPEB;KLF6;ZF9	B CELL-DERIVED 1; BCD1;CORE PROMOTER ELEMENT-BINDING PROTEIN; COPEB;PROTOONCOGENE BCD1;TRANSCRIPTION FACTOR ZF9; ZF9	Gastric cancer, somatic, 137215 (3);Prostate cancer, somatic, 176807 (3)
CG17419-PB	106410	NP_001139	4e-41	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG17419-PC	106410	NP_001139	4e-41	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG12029-PA	602053	NP_001291	4e-41	BCD1;COPEB;KLF6;ZF9	B CELL-DERIVED 1; BCD1;CORE PROMOTER ELEMENT-BINDING PROTEIN; COPEB;PROTOONCOGENE BCD1;TRANSCRIPTION FACTOR ZF9; ZF9	Gastric cancer, somatic, 137215 (3);Prostate cancer, somatic, 176807 (3)
CG3068-PA	164731	NP_001617	4e-41	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG8250-PA	136352	NP_002011	4e-41	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG12072-PA	176960	NP_002728	4e-41	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG8637-PA	176980	NP_002730	4e-41	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6453-PA	177060	NP_002734	4e-41	G19P1;PCLD;PRKCSH	G19P1;GLUCOSIDASE II, BETA SUBUNIT	Polycystic liver disease, 174050 (3)
CG10129-PA	606635	NP_002763	4e-41	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG5166-PA	601517	NP_002964	4e-41	ATX2;ATXN2;SCA2		Spinocerebellar ataxia-2, 183090 (3)
CG5166-PC	601517	NP_002964	4e-41	ATX2;ATXN2;SCA2		Spinocerebellar ataxia-2, 183090 (3)
CG18402-PA	136351	NP_004110	4e-41	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG7223-PA	164870	NP_004439	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7223-PB	164870	NP_004439	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7223-PC	164870	NP_004439	4e-41	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG1830-PA	300075	NP_004577	4e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1830-PB	300075	NP_004577	4e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1830-PC	300075	NP_004577	4e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG32697-PA	600716	NP_036543	4e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PB	600716	NP_036543	4e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PC	600716	NP_036543	4e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PD	600716	NP_036543	4e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG7675-PA	605131	NP_057457	4e-41	FOR;WWOX	FRAGILE SITE FRA16D OXIDOREDUCTASE; FOR;WOX1	Esophageal squamous cell carcinoma, 133239 (3)
CG3327-PB	605460	NP_071882	4e-41	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG8887-PA	606681	NP_071900	4e-41	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG10079-PA	176943	NP_075259	4e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG10079-PB	176943	NP_075259	4e-41	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3099-PB	601623	NP_570853	4e-41	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG3099-PB	601623	NP_570854	4e-41	UBE3A;ANCR	HUMAN PAPILLOMAVIRUS E6-ASSOCIATED PROTEIN; E6AP	Angelman syndrome, 105830 (3)
CG8887-PA	606681	NP_758859	4e-41	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG8250-PA	136352	NP_891555	4e-41	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG1470-PA	600179	NP_000171	5e-41	CORD6;GUC2D;GUCY2D;LCA1	GUANYLATE CYCLASE 2D, RETINAL;GUC2D;RETGC;RETGC1	Cone-rod dystrophy 6, 601777(3);Leber congenital amaurosis I, 204000 (3)
CG6805-PA	300535	NP_000267	5e-41	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG8246-PA	607108	NP_000271	5e-41	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG15010-PA	601545	NP_000421	5e-41	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG15010-PB	601545	NP_000421	5e-41	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG15010-PC	601545	NP_000421	5e-41	LIS1;PAFAH1B1	LISSENCEPHALY-1 GENE; LIS1;PAFAH1B1	Lissencephaly-1, 607432 (3);Subcortical laminar heterotopia (3)
CG16916-PA	602136	NP_000457	5e-41	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG5289-PA	602136	NP_000457	5e-41	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG10663-PA	229000	NP_000883	5e-41	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG6805-PA	300535	NP_001578	5e-41	LOCR;NPHL2;OCRL;OCRL1	OCRL1	Dent syndrome, 300009 (3);Lowe syndrome, 309000 (3)
CG4132-PA	604694	NP_009133	5e-41	AKAP10	DUAL-SPECIFIC A KINASE-ANCHORING PROTEIN 2; DAKAP2	{Longevity, reduced}, 152430 (3)
CG32697-PA	600716	NP_057051	5e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PB	600716	NP_057051	5e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PC	600716	NP_057051	5e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32697-PD	600716	NP_057051	5e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG12073-PA	126450	NP_057658	5e-41	DRD2	D2R	Dystonia, myoclonic, 159900 (3)
CG9664-PC	605460	NP_071882	5e-41	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG4316-PA	605511	NP_076927	5e-41	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG10023-PA	300300	NP_000052	6e-41	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG10023-PB	300300	NP_000052	6e-41	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG10023-PC	300300	NP_000052	6e-41	AGMX1;AT;BTK;IMD1;XLA	AGAMMAGLOBULINEMIA TYROSINE KINASE; ATK;B-CELL PROGENITOR KINASE; BPK	Agammaglobulinemia, type 1, X-linked (3);XLA and isolated growth hormone deficiency, 307200 (3)
CG9610-PB	167409	NP_000269	6e-41	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG4163-PA	122720	NP_000753	6e-41	CYP2A;CYP2A3;CYP2A6;P450C2A	COUMARIN 7-HYDROXYLASE;CYP2A3, FORMERLY;CYTOCHROME P450, PHENOBARBITAL-INDUCIBLE; P450PB	Coumarin resistance, 122700 (3);{Lung cancer, resistance to}, 211980 (3);{Nicotine addiction, protection from} (3)
CG6320-PB	601949	NP_001005747	6e-41	CACNB4;EA5;EJM		Epilepsy, generalized idiopathic, 600669 (3);Epilepsy, juvenile myoclonic, 606904 (3);Episodic ataxia, type 5 (3)
CG5899-PA	603615	NP_003570	6e-41	HR54;HRAD54;RAD54L	HR54;HRAD54	Breast cancer, invasive intraductal (3);Colon adenocarcinoma (3);Lymphoma, non-Hodgkin (3)
CG9610-PB	167409	NP_003978	6e-41	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG9610-PB	167409	NP_003979	6e-41	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG9610-PB	167409	NP_003980	6e-41	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG9610-PB	167409	NP_003981	6e-41	PAX2		Optic nerve coloboma with renal disease, 120330 (3);Renal hypoplasia, isolated (3)
CG31349-PA	604090	NP_004738	6e-41	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG31349-PB	604090	NP_004738	6e-41	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG31349-PC	604090	NP_004738	6e-41	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG31349-PE	604090	NP_004738	6e-41	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG31349-PF	604090	NP_004738	6e-41	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG1763-PA	602821	NP_004975	6e-41	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG14622-PA	602121	NP_005210	6e-41	DFNA1;DIAPH1;LFHL1	DIA1	Deafness, autosomal dominant 1, 124900 (3)
CG14622-PB	602121	NP_005210	6e-41	DFNA1;DIAPH1;LFHL1	DIA1	Deafness, autosomal dominant 1, 124900 (3)
CG14622-PC	602121	NP_005210	6e-41	DFNA1;DIAPH1;LFHL1	DIA1	Deafness, autosomal dominant 1, 124900 (3)
CG11397-PA	606062	NP_005436	6e-41	BAM;CDLS3;CSPG6;HCAP;SMC3	BAMACAN; BAM;HUMAN CHROMOSOME-ASSOCIATED POLYPEPTIDE; HCAP;STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	Cornelia de Lange syndrome 3, 610759 (3)
CG2712-PA	314995	NP_009061	6e-41	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1795-PA	601982	NP_058212	6e-41	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG31954-PA	606797	NP_068813	6e-41	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG2712-PA	314995	NP_700359	6e-41	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG14723-PA	137164	NP_944493	6e-41	GABRG2;GEFSP3;CAE2;ECA2	GABA-A RECEPTOR, GAMMA-2 POLYPEPTIDE	Epilepsy, childhood absence, 607681 (3);Epilepsy, generalized, with febrile seizures plus, 604233 (3);Myoclonic epilepsy, severe, of infancy, 607208 (3)
CG18402-PA	600221	NP_000450	7e-41	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG9456-PA	107300	NP_000479	7e-41	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG7285-PA	600018	NP_001008503	7e-41	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG9047-PA	609758	NP_001035304	7e-41	TCBA1		Developmental delay and recurrent infections (3)
CG9047-PB	609758	NP_001035304	7e-41	TCBA1		Developmental delay and recurrent infections (3)
CG9047-PC	609758	NP_001035304	7e-41	TCBA1		Developmental delay and recurrent infections (3)
CG32743-PA	601215	NP_001175	7e-41	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG8529-PA	300377	NP_004008	7e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004008	7e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004008	7e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG1495-PA	300075	NP_004577	7e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1495-PB	300075	NP_004577	7e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1495-PC	300075	NP_004577	7e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1495-PE	300075	NP_004577	7e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG1495-PG	300075	NP_004577	7e-41	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10443-PA	600716	NP_036543	7e-41	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG17821-PA	605512	NP_073563	7e-41	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31175-PA	601239	NP_116760	7e-41	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PB	601239	NP_116760	7e-41	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PC	601239	NP_116760	7e-41	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG12008-PA	608441	NP_892006	7e-41	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG8795-PA	601898	NP_940799	7e-41	GHSR		Short stature, 604271 (3)
CG8795-PB	601898	NP_940799	7e-41	GHSR		Short stature, 604271 (3)
CG17323-PA	191740	NP_000454	8e-41	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG7589-PA	138492	NP_000815	8e-41	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG8529-PA	300377	NP_004009	8e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004009	8e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004009	8e-41	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG5395-PA	601023	NP_009057	8e-41	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG10079-PA	164761	NP_065681	8e-41	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10079-PB	164761	NP_065681	8e-41	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG7432-PA	606797	NP_068813	8e-41	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG7563-PA	605286	NP_075573	8e-41	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG7563-PB	605286	NP_075573	8e-41	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG7873-PA	136350	NP_075599	8e-41	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7873-PB	136350	NP_075599	8e-41	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4386-PA	306900	NP_000124	9e-41	F9;HEMB	CHRISTMAS DISEASE;FACTOR IX DEFICIENCY;PLASMA THROMBOPLASTIN COMPONENT; PTC	Hemophilia B (3);Warfarin sensitivity (3)
CG7285-PA	600018	NP_000905	9e-41	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG7285-PA	600018	NP_001008504	9e-41	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG11678-PA	102610	NP_001091	9e-41	ACTA1;ASMA;CFTD1;NEM1;NEM3	ASMA	Myopathy, actin, congenital, with cores (3);Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3);Myopathy, congenital, with fiber-type disporportion 1, 255310 (3);Myopathy, nemaline, 3, 161800 (3)
CG10339-PA	114840	NP_001798	9e-41	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG10443-PA	176885	NP_002818	9e-41	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG10975-PA	176876	NP_002825	9e-41	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG10975-PB	176876	NP_002825	9e-41	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG17060-PA	603868	NP_004571	9e-41	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG1795-PA	601982	NP_058437	9e-41	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG2105-PA	264900	NP_062505	9e-41	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG10079-PA	164761	NP_066124	9e-41	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG10079-PB	164761	NP_066124	9e-41	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG9652-PA	126451	NP_387512	9e-41	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG4898-PA	191030	NP_705935	9e-41	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG17060-PA	603868	NP_899057	9e-41	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG17060-PA	603868	NP_899058	9e-41	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG17060-PA	603868	NP_899059	9e-41	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG3841-PA	177400	NP_000046	1e-40	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG9858-PA	177400	NP_000046	1e-40	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG6906-PA	259730	NP_000058	1e-40	CA2	CARBONIC ANHYDRASE II DEFICIENCY;GUIBAUD-VAINSEL SYNDROME;MARBLE BRAIN DISEASE	Renal tubular acidosis-osteopetrosis syndrome (3)
CG2105-PA	264900	NP_000119	1e-40	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG15388-PA	601920	NP_000205	1e-40	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG33087-PC	601920	NP_000205	1e-40	AGS;AHD;JAG1	JAGL1	Alagille syndrome, 118450 (3);Deafness, congenital heart defects, and posterior embryotoxon (3);Tetralogy of Fallot, 187500 (3)
CG14528-PA	300550	NP_000435	1e-40	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG10370-PA	602136	NP_000457	1e-40	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG3841-PA	100740	NP_000656	1e-40	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG6989-PA	109630	NP_000675	1e-40	ADRB1;ADRB1R;RHR	ADRB1R;B1AR	[Resting heart rate], 607276 (3);{congestive heart failure, susceptibility to} (3)
CG1594-PA	147370	NP_000866	1e-40	IGF1R		Intrauterine and postnatal growth retardation (3)
CG12350-PA	229000	NP_000883	1e-40	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG8874-PA	164870	NP_001005862	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PB	164870	NP_001005862	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PC	164870	NP_001005862	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PD	164870	NP_001005862	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG7285-PA	600018	NP_001008505	1e-40	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG4843-PA	191010	NP_001018007	1e-40	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_001018007	1e-40	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG9138-PA	602997	NP_001072	1e-40	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG11335-PA	153455	NP_002308	1e-40	LOX		Cutis laxa, recessive, type I, 219100 (1)
CG40129-PA	176980	NP_002730	1e-40	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG9774-PA	176980	NP_002730	1e-40	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG18211-PA	601564	NP_002761	1e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG10663-PA	606635	NP_002763	1e-40	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG4316-PA	606635	NP_002763	1e-40	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG6899-PA	600079	NP_002826	1e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG6899-PB	600079	NP_002826	1e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG14885-PA	108961	NP_003986	1e-40	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG8222-PA	136351	NP_004110	1e-40	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG8222-PB	136351	NP_004110	1e-40	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG8222-PC	136351	NP_004110	1e-40	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG8874-PA	164870	NP_004439	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PB	164870	NP_004439	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PC	164870	NP_004439	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG8874-PD	164870	NP_004439	1e-40	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG32134-PA	602337	NP_004551	1e-40	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG3086-PB	300075	NP_004577	1e-40	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG3086-PC	300075	NP_004577	1e-40	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG3086-PD	300075	NP_004577	1e-40	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG4889-PA	601570	NP_004616	1e-40	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG4889-PB	601570	NP_004616	1e-40	WNT7A		Fuhrmann syndrome, 228930 (3);Ulna and fibula, absence of, with sever limb deficiency, 276820 (3)
CG32134-PA	190090	NP_005408	1e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG2849-PB	600098	NP_036382	1e-40	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG3841-PA	100740	NP_056646	1e-40	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG7525-PA	136350	NP_056934	1e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG1795-PA	601982	NP_058438	1e-40	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG7693-PA	606808	NP_059129	1e-40	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG7693-PB	606808	NP_059129	1e-40	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG6081-PA	124010	NP_059488	1e-40		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG1763-PA	608283	NP_060111	1e-40	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG31689-PA	605460	NP_071882	1e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG31689-PB	605460	NP_071882	1e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG31689-PC	605460	NP_071882	1e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG31689-PD	605460	NP_071882	1e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG7525-PA	136350	NP_075593	1e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7525-PA	136350	NP_075594	1e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4145-PA	120210	NP_511040	1e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG4145-PB	120210	NP_511040	1e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG4145-PC	120210	NP_511040	1e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG7981-PB	188840	NP_596869	1e-40	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG32955-PE	605995	NP_904325	1e-40	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG9293-PB	601566	NP_937862	1e-40	ING1	p33ING1	Squamous cell carcinoma, head and neck, 275355 (3)
CG32134-PA	190090	NP_938033	1e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG1271-PD	300474	NP_976325	1e-40	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG5485-PA	604943	NP_996768	1e-40	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG17419-PB	182900	NP_000028	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PC	182900	NP_000028	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG7892-PA	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7892-PB	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7892-PC	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7892-PE	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7892-PF	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG7892-PG	123829	NP_000066	2e-40	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG2098-PB	177000	NP_000131	2e-40	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG1271-PD	300474	NP_000158	2e-40	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG8222-PA	164920	NP_000213	2e-40	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG8222-PB	164920	NP_000213	2e-40	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG8222-PC	164920	NP_000213	2e-40	KIT;PBT	KIT ONCOGENE;MAST CELL GROWTH FACTOR RECEPTOR;STEM CELL FACTOR RECEPTOR; SCFR	Gastrointestinal stromal tumor, somatic, 606764 (3);Germ cell tumors, 273300 (3);Leukemia, acute myeloid, 601626 (3);Mast cell leukemia (3);Mastocytosis with associated hematologic disorder (3);Piebaldism (3)
CG13758-PA	168468	NP_000307	2e-40	PTHR;PTHR1	PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED PROTEIN RECEPTOR;PTH RECEPTOR; PTHR;PTH/PTHRP RECEPTOR	Enchondromatosis, Ollier type, 166000 (3);Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)
CG16784-PA	261640	NP_000308	2e-40	PTS	PTPS	Phenylketonuria due to PTS deficiency (3)
CG16784-PB	261640	NP_000308	2e-40	PTS	PTPS	Phenylketonuria due to PTS deficiency (3)
CG16784-PC	261640	NP_000308	2e-40	PTS	PTPS	Phenylketonuria due to PTS deficiency (3)
CG7402-PA	253000	NP_000503	2e-40	GALNS;MPS4A	GALACTOSAMINE-6-SULFATASE DEFICIENCY; GALNS DEFICIENCY;MORQUIO SYNDROME A;MPS IVA; MPS4A	Mucopolysaccharidosis IVA (3)
CG16761-PA	605325	NP_000768	2e-40	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG6927-PA	138492	NP_000815	2e-40	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG2872-PC	600018	NP_000905	2e-40	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG7524-PB	191315	NP_001007793	2e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG2872-PC	600018	NP_001008503	2e-40	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG2872-PC	600018	NP_001008504	2e-40	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG2872-PC	600018	NP_001008505	2e-40	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG7524-PB	191315	NP_001012331	2e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG2098-PB	177000	NP_001012533	2e-40	FCE;FECH	ERYTHROHEPATIC PROTOPORPHYRIA; EPP;FERROCHELATASE DEFICIENCY;HEME SYNTHETASE DEFICIENCY	Protoporphyria, erythropoietic (3);Protoporphyria, erythropoietic, recessive, with liver failure (3)
CG14992-PA	600456	NP_001018074	2e-40	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG6800-PA	300203	NP_001032420	2e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG3047-PA	609761	NP_001034230	2e-40	KIAA1662;TRIOBP	KIAA1662;TRIO- AND FILAMENTOUS-ACTIN-BINDING PROTEIN;TRIO-ASSOCIATED REPEAT ON ACTIN; TARA	Deafness, autosomal recessive 28, 609823 (3)
CG9455-PA	107280	NP_001076	2e-40	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG31175-PA	601239	NP_001382	2e-40	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PB	601239	NP_001382	2e-40	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG31175-PC	601239	NP_001382	2e-40	D18S892E;DRP3;DTNA;LVNC1	D18S892E;DYSTROBREVIN;DYSTROPHIN-RELATED PROTEIN 3; DRP3	Left ventricular noncompaction with congenital heart defects, 606617 (3);Left ventricular noncompaction, familial isolated, 1, 604169 (3)
CG1108-PA	114840	NP_001798	2e-40	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG4757-PA	114840	NP_001798	2e-40	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG4145-PA	120210	NP_001842	2e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG4145-PB	120210	NP_001842	2e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG4145-PC	120210	NP_001842	2e-40	COL9A1;MED	ALPHA-1(IX) COLLAGEN CHAIN;CARTILAGE-SPECIFIC SHORT COLLAGEN;COLLAGEN, CARTILAGE-SPECIFIC SHORT	Epiphyseal dysplasia, multiple, COL9A1-related (3)
CG10079-PA	134935	NP_002002	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10079-PB	134935	NP_002002	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG6944-PA	137780	NP_002046	2e-40	GFAP		Alexander disease, 203450 (3)
CG1389-PA	191306	NP_002244	2e-40	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG4007-PA	191306	NP_002244	2e-40	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG7524-PB	191315	NP_002520	2e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG12351-PA	601564	NP_002761	2e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG30025-PA	601564	NP_002761	2e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG30028-PA	601564	NP_002761	2e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG30031-PA	601564	NP_002761	2e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG9372-PA	606635	NP_002763	2e-40	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG2331-PB	602783	NP_003110	2e-40	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG6800-PA	300203	NP_003150	2e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG6634-PA	601397	NP_003172	2e-40	T;TFT	TRANSCRIPTION FACTOR T; TFT	{Neural tube defects, susceptibility to}, 182940 (3)
CG8529-PA	300377	NP_004013	2e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004013	2e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004013	2e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG7223-PA	602337	NP_004551	2e-40	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7223-PB	602337	NP_004551	2e-40	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7223-PC	602337	NP_004551	2e-40	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG3947-PA	603360	NP_004804	2e-40	PEX16	PEROXIN 16	Zellweger syndrome, complementation group 9 (3)
CG7100-PA	125645	NP_004940	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PB	125645	NP_004940	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PC	125645	NP_004940	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PH	125645	NP_004940	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG11678-PA	102540	NP_005150	2e-40	ACTC;CMD1R	ACTIN, ALPHA;SMOOTH MUSCLE ACTIN	Cardiomyopathy, dilated, 1R (3);Cardiomyopathy, familial hypertrophic, 192600 (3)
CG17800-PA	142461	NP_005520	2e-40	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG17800-PB	142461	NP_005520	2e-40	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG6412-PA	604723	NP_005717	2e-40	COXPD3;TSFM	EFTsMT;MITOCHONDRIAL TRANSLATION ELONGATION FACTOR Ts	Combined oxidative phosphorylation deficiency 3, 610505 (3)
CG14992-PA	600456	NP_006171	2e-40	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG30132-PB	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG30132-PC	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG30132-PD	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG30132-PE	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG30132-PF	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG30132-PG	605437	NP_006246	2e-40	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG1208-PA	138140	NP_006507	2e-40	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG10959-PA	314995	NP_009061	2e-40	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG2849-PA	600098	NP_036382	2e-40	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG2849-PC	600098	NP_036382	2e-40	RRAS2;TC21	ONCOGENE RRAS2;TERATOCARCINOMA ONCOGENE TC21; TC21	Ovarian carcinoma (3)
CG1072-PA	600577	NP_055379	2e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG1072-PB	600577	NP_055379	2e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG32955-PE	605995	NP_055889	2e-40	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG18247-PA	136350	NP_056934	2e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG1795-PA	601982	NP_058213	2e-40	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG1795-PA	601982	NP_058214	2e-40	OGG1	8-@HYDROXYGUANINE DNA GLYCOSYLASE	Renal cell carcinoma, clear cell, somatic, 144700 (3)
CG17419-PB	182900	NP_065208	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PC	182900	NP_065208	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PB	182900	NP_065209	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PC	182900	NP_065209	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PB	182900	NP_065210	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG17419-PC	182900	NP_065210	2e-40	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG30387-PA	106410	NP_066187	2e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG30387-PB	106410	NP_066187	2e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG30387-PC	106410	NP_066187	2e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG10079-PA	134935	NP_075252	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10079-PB	134935	NP_075252	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG18247-PA	136350	NP_075593	2e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG18247-PA	136350	NP_075594	2e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4926-PA	136350	NP_075599	2e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7100-PA	125645	NP_077740	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PB	125645	NP_077740	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PC	125645	NP_077740	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PH	125645	NP_077740	2e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG4613-PA	605511	NP_115777	2e-40	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4613-PA	605511	NP_115780	2e-40	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG12008-PA	608441	NP_149062	2e-40	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG10959-PA	314995	NP_700359	2e-40	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG1072-PA	600577	NP_835258	2e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG1072-PB	600577	NP_835258	2e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG33106-PA	608774	NP_848605	2e-40	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG33106-PB	608774	NP_848605	2e-40	ANKK1		Dopamine receptor D2, reduced brain density of (3)
CG8127-PB	190120	NP_955366	2e-40	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG8127-PC	190120	NP_955366	2e-40	ERBA1;THRA;THRA1	ERBA-ALPHA;ERBA-RELATED 7; EAR7;ONCOGENE ERBA; ERBA;THYROID HORMONE RECEPTOR, CENTRAL NERVOUS SYSTEM FORM; THRA1;V-ERB-A AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ERBA1	Pituitary adenoma, nonfunctioning (3)
CG31175-PA	601282	NP_958782	2e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958782	2e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG1271-PA	300474	NP_976325	2e-40	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG10079-PA	134935	NP_998812	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG10079-PB	134935	NP_998812	2e-40	FGFR4	TYROSINE KINASE RELATED TO FIBROBLAST GROWTH FACTOR RECEPTOR; TKF	{Cancer progression/metastasis} (3)
CG32743-PA	601215	XP_001131387	2e-40	ATR;FRP1;SCKL	FRAP-RELATED PROTEIN 1; FRP1	Seckel syndrome 1, 210600 (3)
CG32754-PA	609019	NP_000051	3e-40	BTD		Biotinidase deficiency, 253260 (3)
CG10663-PA	264900	NP_000119	3e-40	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG6246-PA	173110	NP_000297	3e-40	POU1F1;PIT1	GROWTH HORMONE FACTOR 1; GHF1;PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1	Pituitary hormone deficiency, combined (3)
CG11012-PA	191740	NP_000454	3e-40	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG1318-PC	606869	NP_000511	3e-40	HEXA;TSD	BETA-HEXOSAMINIDASE A	GM2-gangliosidosis, several forms, 272800 (3);Tay-Sachs disease, 272800 (3);[Hex A pseudodeficiency], 272800 (3)
CG4898-PA	191010	NP_001018007	3e-40	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG8733-PA	124030	NP_001020332	3e-40	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG11502-PA	600281	NP_001025174	3e-40	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG11502-PA	600281	NP_001025175	3e-40	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG6484-PA	138190	NP_001033	3e-40	SLC2A4;GLUT4	4; SLC2A4;GLUCOSE TRANSPORTER 4; GLUT4;GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE	{Diabetes mellitus, noninsulin-dependent} (3)
CG3051-PA	164731	NP_001617	3e-40	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG3051-PB	164731	NP_001617	3e-40	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG1128-PA	114840	NP_001798	3e-40	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG10521-PA	150325	NP_002283	3e-40	LAMB2;LAMS	LAMININ S; LAMS	Nephrosis, congenital, with or without ocular abnormalities, 609049 (3);Pierson syndrome, 609049 (3)
CG18735-PA	276000	NP_002760	3e-40	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG10975-PA	600079	NP_002826	3e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG10975-PB	600079	NP_002826	3e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG16727-PA	603377	NP_003051	3e-40	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG18418-PA	602044	NP_003347	3e-40	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG8529-PA	300377	NP_004006	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004006	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004006	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004007	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004007	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004007	3e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG5423-PA	120470	NP_005206	3e-40	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG3668-PA	601094	NP_036318	3e-40	ASMD;FKHL12;FOXE3	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 12; FKHL12;FORKHEAD-RELATED ACTIVATOR 8; FREAC8	Anterior segment mesenchymal dysgenesis, 107250 (3);Aphakia, congenital primary, 610256 (3)
CG6899-PA	600716	NP_036543	3e-40	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG6899-PB	600716	NP_036543	3e-40	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG10663-PA	264900	NP_062505	3e-40	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4613-PA	605511	NP_076927	3e-40	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG6919-PA	126451	NP_387512	3e-40	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG11502-PA	600281	NP_787110	3e-40	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG2849-PA	190020	NP_789765	3e-40	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG2849-PB	190020	NP_789765	3e-40	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG2849-PC	190020	NP_789765	3e-40	HRAS	HARVEY MURINE SARCOMA VIRUS ONCOGENE; RASH1;HRAS1;TRANSFORMATION GENE: ONCOGENE HAMSV	Costello syndrome, 218040 (3);{Bladder cancer, somatic}, 109800 (3);{Thyroid carcinoma, follicular, somatic}, 188470 (3)
CG7912-PA	604943	NP_996766	3e-40	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG14396-PA	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PB	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PC	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PD	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PE	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PA	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PB	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PC	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PD	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PE	176947	NP_997402	3e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG10175-PB	177400	NP_000046	4e-40	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG1271-PA	300474	NP_000158	4e-40	GK	ATP:GLYCEROL PHOSPHOTRANSFERASE	Glycerol kinase deficiency, 307030 (3)
CG5372-PA	607759	NP_000410	4e-40	CD41B;GP2B;ITGA2B	CD41B;GP2B;PLATELET FIBRINOGEN RECEPTOR, ALPHA SUBUNIT;PLATELET GLYCOPROTEIN IIb; GPIIb	Glanzmann thrombasthenia, type A, 273800 (3);Thrombocytopenia, neonatal alloimmune (1)
CG1082-PA	100740	NP_000656	4e-40	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG7241-PA	601130	NP_000762	4e-40	CYP2C9		Tolbutamide poor metabolizer (3);Warfarin sensitivity, 122700 (3)
CG8733-PA	601130	NP_000762	4e-40	CYP2C9		Tolbutamide poor metabolizer (3);Warfarin sensitivity, 122700 (3)
CG4163-PA	124040	NP_000764	4e-40		CYP2E1;ETHANOL-INDUCIBLE P450;P450C2E	
CG14992-PA	191315	NP_001007793	4e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG14992-PA	191315	NP_001012331	4e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG30387-PA	106410	NP_001139	4e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG30387-PB	106410	NP_001139	4e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG30387-PC	106410	NP_001139	4e-40	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG8250-PA	191306	NP_002244	4e-40	KDR	FLK1, MOUSE, HOMOLOG OF; FLK1;TYROSINE KINASE GROWTH FACTOR RECEPTOR;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGFR2;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGFR	Hemangioma, capillary infantile, somatic, 602089 (3)
CG14992-PA	191315	NP_002520	4e-40	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG32260-PA	606635	NP_002763	4e-40	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG32697-PA	600079	NP_002826	4e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG32697-PB	600079	NP_002826	4e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG32697-PC	600079	NP_002826	4e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG32697-PD	600079	NP_002826	4e-40	PTPG1;PTPN12	PROTEIN-TYROSINE PHOSPHATASE G1; PTPG1;PTP-PEST	Colon cancer (3)
CG18340-PA	601693	NP_003346	4e-40	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG5284-PA	600570	NP_004357	4e-40	CLCN2;ECA3;EGI3;EGMA	CLC2	Epilepsy with grand mal seizures on awakening, 607628 (3);Epilepsy, childhood absence, 607682 (3);Epilepsy, juvenile absence, 607631 (3);Epilepsy, juvenile myoclonic, 606904 (3)
CG18247-PA	602337	NP_004551	4e-40	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7100-PD	125645	NP_004940	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PE	125645	NP_004940	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PF	125645	NP_004940	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PG	125645	NP_004940	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG4926-PA	147796	NP_004963	4e-40	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG1066-PA	176264	NP_004968	4e-40	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG1066-PB	176264	NP_004968	4e-40	KCNC3;SCA13	KCNC3	Spinocerebellar ataxia-13, 605259 (3)
CG1634-PA	120470	NP_005206	4e-40	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG1634-PB	120470	NP_005206	4e-40	DCC	COLORECTAL CANCER-RELATED CHROMOSOME SEQUENCE 18; CRC18;CRCR1	Colorectal cancer (3)
CG3536-PA	605206	NP_005468	4e-40	HCN4	4; HCN4	Sinus bradycardia syndrome, 163800 (3)
CG1082-PA	100740	NP_056646	4e-40	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG12192-PA	608283	NP_060111	4e-40	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG2969-PA	605460	NP_071882	4e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG2969-PB	605460	NP_071882	4e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG7100-PD	125645	NP_077740	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PE	125645	NP_077740	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PF	125645	NP_077740	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG7100-PG	125645	NP_077740	4e-40	ARVD11;DSC2;DSC3	DESMOCOLLIN 3, FORMERLY; DSC3, FORMERLY;DESMOSOMAL GLYCOPROTEIN II/III; DG2/3; DG2	Arrhythmogenic right ventricular dysplasia, familial, 11, 610476 (3)
CG5424-PB	606351	NP_113663	4e-40	ESPN	DEAFNESS, NEUROSENSORY, WITHOUT VESTIBULAR INVOLVEMENT, AUTOSOMAL	Deafness, autosomal recessive 36, 609006 (3);Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)
CG5424-PD	606351	NP_113663	4e-40	ESPN	DEAFNESS, NEUROSENSORY, WITHOUT VESTIBULAR INVOLVEMENT, AUTOSOMAL	Deafness, autosomal recessive 36, 609006 (3);Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)
CG7912-PA	604943	NP_945350	4e-40	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG5966-PA	151670	NP_000227	5e-40	LIPC	HEPATIC TRIGLYCERIDE LIPASE; HTGL; HL;LIPH	Hepatic lipase deficiency (3)
CG12172-PA	107400	NP_000286	5e-40	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG9475-PB	602136	NP_000457	5e-40	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG7241-PA	124020	NP_000760	5e-40	CYP2C;CYP2C19	CYP2C;MEPHENYTOIN 4-PRIME-HYDROXYLASE;P450C2C	Mephenytoin poor metabolizer (3);Opremazole poor metabolizer (3);Proguanil poor metabolizer (3)
CG11192-PA	229000	NP_000883	5e-40	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG12172-PA	107400	NP_001002235	5e-40	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG12172-PA	107400	NP_001002236	5e-40	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG1362-PA	300203	NP_001032420	5e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG31670-PA	300573	NP_001034980	5e-40	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG10522-PA	176960	NP_002728	5e-40	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG5169-PA	176872	NP_002746	5e-40		MAPK/ERK KINASE 1; MEK1;MKK1; MAPKK1;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1; PRKMK1	
CG10370-PA	602783	NP_003110	5e-40	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG7257-PA	602783	NP_003110	5e-40	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG9475-PA	602783	NP_003110	5e-40	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG1362-PA	300203	NP_003150	5e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4376-PA	300377	NP_003997	5e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004005	5e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004005	5e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004005	5e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8287-PA	603868	NP_004571	5e-40	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG18402-PA	190090	NP_005408	5e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3326-PA	601023	NP_009057	5e-40	IBMPFD;VCP	CDC48, YEAST, HOMOLOG OF;p97	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia, 167320 (3)
CG6509-PA	300189	NP_066943	5e-40	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG6509-PB	300189	NP_066943	5e-40	DLG3;MRX90;NEDLG;SAP102	NEUROENDOCRINE DLG; NEDLG;SYNAPSE-ASSOCIATED PROTEIN 102; SAP102	Mental retardation, X-linked-90 (3)
CG7524-PB	136350	NP_075599	5e-40	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG11228-PA	601263	NP_109587	5e-40		MAPK/ERK KINASE 2; MEK2;MKK2; MAPKK2;PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2; PRKMK2	
CG8287-PA	603868	NP_899057	5e-40	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG8287-PA	603868	NP_899058	5e-40	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG8287-PA	603868	NP_899059	5e-40	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG18402-PA	190090	NP_938033	5e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG31175-PA	601282	NP_958785	5e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958785	5e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG5022-PA	130500	NP_976218	5e-40	EPB41;EL1	PROTEIN 4.1, RED BLOOD CELL TYPE; 4.1R	Elliptocytosis-1 (3)
CG8594-PA	118425	NP_000074	6e-40	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG4995-PA	212138	NP_000378	6e-40	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG4995-PB	212138	NP_000378	6e-40	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG4995-PC	212138	NP_000378	6e-40	CAC;CACT;SLC25A20	20; SLC25A20;CARNITINE-ACYLCARNITINE CARRIER; CAC;CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT	Carnitine-acylcarnitine translocase deficiency (3)
CG7241-PA	601129	NP_000761	6e-40	CYP2C8		Rhabdomyolysis, cerivastatin-induced (3)
CG11340-PA	138492	NP_000815	6e-40	GLRB		Hyperekplexia, autosomal recessive, 149400 (3)
CG4128-PA	100690	NP_001034612	6e-40	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG4128-PC	100690	NP_001034612	6e-40	ACHRD;CHRNA1;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, ALPHA SUBUNIT; ACHRA;CHRNA	Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG8301-PA	300573	NP_001034980	6e-40	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG14396-PA	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PB	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PC	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PD	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14396-PE	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PA	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PB	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PC	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PD	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG17309-PE	176947	NP_001070	6e-40	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG18681-PA	601564	NP_002761	6e-40	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG1817-PB	176876	NP_002825	6e-40	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG1817-PC	176876	NP_002825	6e-40	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG8529-PA	300377	NP_004004	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004004	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004004	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004012	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004012	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004012	6e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG9774-PA	300075	NP_004577	6e-40	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG7260-PA	601621	NP_057653	6e-40	TBX3		Ulnar-mammary syndrome, 181450 (3)
CG6383-PA	602768	NP_058637	6e-40	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG1495-PA	606566	NP_149109	6e-40	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1495-PB	606566	NP_149109	6e-40	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1495-PC	606566	NP_149109	6e-40	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1495-PE	606566	NP_149109	6e-40	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1495-PG	606566	NP_149109	6e-40	MLCK;MYLK2	MLCK, SKELETAL/CARDIAC;MYOSIN LIGHT POLYPEPTIDE KINASE, SKELETAL/CARDIAC	Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
CG1447-PA	601542	NP_700476	6e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG1447-PB	601542	NP_700476	6e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG31175-PA	601282	NP_958783	6e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958783	6e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG6383-PA	602768	NP_982353	6e-40	DLL3;SCDO1	DELTA, DROSOPHILA, HOMOLOG OF	Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
CG3902-PA	608801	NP_000150	7e-40	GCDH		Glutaricaciduria, type I, 231670 (3)
CG18085-PA	136352	NP_002011	7e-40	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG10119-PA	137780	NP_002046	7e-40	GFAP		Alexander disease, 203450 (3)
CG8571-PA	602783	NP_003110	7e-40	CAR;CMAR;PGN;SPG7	CELL ADHESION REGULATOR; CAR;CELL MATRIX ADHESION REGULATOR; CMAR;PGN;SPASTIC PARAPLEGIA 7 GENE	Spastic paraplegia-7, 607259 (3)
CG17216-PA	603072	NP_003591	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6634-PA	604614	NP_005140	7e-40	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG3219-PA	608283	NP_060111	7e-40	CFEOM1;FEOM1;KIAA1708;KIF21A	KIAA1708	Fibrosis of extraocular muscles, congenital, 1, 135700 (3)
CG14992-PA	164761	NP_065681	7e-40	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG14992-PA	164761	NP_066124	7e-40	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8213-PA	606797	NP_068813	7e-40	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG3622-PB	604134	NP_620594	7e-40	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG3622-PB	604134	NP_620596	7e-40	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG18085-PA	136352	NP_891555	7e-40	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG17216-PA	603072	NP_940835	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17216-PA	603072	NP_940836	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17216-PA	603072	NP_940837	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17216-PA	603072	NP_940838	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17216-PA	603072	NP_940839	7e-40	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1447-PA	601542	NP_000316	8e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG1447-PB	601542	NP_000316	8e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG31175-PA	601282	NP_000436	8e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_000436	8e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG10270-PA	300573	NP_001034980	8e-40	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG7524-PB	131550	NP_005219	8e-40	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG4389-PA	601609	NP_005318	8e-40	HADHSC;HHF4;SCHAD	HAD;HADHSC, FORMERLY;HADSC, FORMERLY;SCHAD, FORMERLY	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)
CG4389-PB	601609	NP_005318	8e-40	HADHSC;HHF4;SCHAD	HAD;HADHSC, FORMERLY;HADSC, FORMERLY;SCHAD, FORMERLY	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)
CG4389-PC	601609	NP_005318	8e-40	HADHSC;HHF4;SCHAD	HAD;HADHSC, FORMERLY;HADSC, FORMERLY;SCHAD, FORMERLY	3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)
CG4328-PA	600577	NP_055379	8e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG18735-PA	605511	NP_115777	8e-40	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG18735-PA	605511	NP_115780	8e-40	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG1447-PA	601542	NP_700475	8e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG1447-PB	601542	NP_700475	8e-40	IDG2;IGDS2;PITX2;RGS;RIEG1	ALL1-RESPONSIVE GENE 1; ARP1;PITUITARY HOMEOBOX 2; PTX2;RIEG;RIEG BICOID-RELATED HOMEOBOX TRANSCRIPTION FACTOR 1; RIEG1;SOLURSHIN	Iridogoniodysgenesis syndrome-2, 137600 (3);Rieger syndrome, 180500 (3);Ring dermoid of cornea, 180550 (3)
CG4328-PA	600577	NP_835258	8e-40	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG14228-PA	607379	NP_861971	8e-40	NF2	MERLIN;SCHWANNOMIN; SCH	Meningioma, NF2-related, somatic, 607174 (3);Neurofibromatosis, type 2, 101000 (3);Schwannomatosis, 162091 (3)
CG7831-PA	605995	NP_904325	8e-40	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG9913-PA	605995	NP_904325	8e-40	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG8784-PA	601898	NP_940799	8e-40	GHSR		Short stature, 604271 (3)
CG31175-PA	601282	NP_958781	8e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958781	8e-40	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG4376-PA	300377	NP_000100	9e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG4772-PA	191740	NP_000454	9e-40	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG15002-PB	229000	NP_000883	9e-40	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG18076-PA	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PB	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PC	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PE	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PG	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PH	125647	NP_001008844	9e-40	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG5179-PA	300203	NP_001032420	9e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG31795-PA	176885	NP_002818	9e-40	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG31795-PB	176885	NP_002818	9e-40	PTP1B;PTPN1	PROTEIN PHOSPHOTYROSYLPHOSPHATASE 1B; PTP1B;PROTEIN-TYROSINE PHOSPHATASE, PLACENTAL	[Abdominal body fat distribution, modifier of], 609830 (3);{Insulin resistance, susceptibility to} (3)
CG5179-PA	300203	NP_003150	9e-40	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG31146-PD	188450	NP_003226	9e-40	AITD3;TG		Goiter, adolescent multinodular (1);Goiter, nonendemic, simple (3);Hypothyroidism, hereditary congenital (3);{Autoimmune thyroid disease, susceptibility to 3}, 608175 (3)
CG4376-PB	300377	NP_003997	9e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG4376-PA	300377	NP_004000	9e-40	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG3969-PA	190090	NP_005408	9e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3969-PB	190090	NP_005408	9e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3969-PA	600456	NP_006171	9e-40	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG3969-PB	600456	NP_006171	9e-40	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG9663-PA	605460	NP_071882	9e-40	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG7241-PA	608713	NP_078790	9e-40	CYP2R1		Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
CG3736-PA	300032	NP_612115	9e-40	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG3969-PA	190090	NP_938033	9e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3969-PB	190090	NP_938033	9e-40	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG2151-PA	238331	NP_000099	1e-39	DLD;LAD;PHE3	BRANCHED CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX, E3 COMPONENT;DIAPHORASE;DIHYDROLIPOYL DEHYDROGENASE;GLYCINE CLEAVAGE SYSTEM L PROTEIN; GCSL;LIPOAMIDE DEHYDROGENASE; LAD;LIPOAMIDE REDUCTASE;LIPOYL DEHYDROGENASE;PYRUVATE DEHYDROGENASE COMPONENT E3; PHE3; E3	Leigh syndrome, 256000 (3);Maple syrup urine disease, type III, 248600 (3)
CG2151-PB	238331	NP_000099	1e-39	DLD;LAD;PHE3	BRANCHED CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX, E3 COMPONENT;DIAPHORASE;DIHYDROLIPOYL DEHYDROGENASE;GLYCINE CLEAVAGE SYSTEM L PROTEIN; GCSL;LIPOAMIDE DEHYDROGENASE; LAD;LIPOAMIDE REDUCTASE;LIPOYL DEHYDROGENASE;PYRUVATE DEHYDROGENASE COMPONENT E3; PHE3; E3	Leigh syndrome, 256000 (3);Maple syrup urine disease, type III, 248600 (3)
CG2151-PC	238331	NP_000099	1e-39	DLD;LAD;PHE3	BRANCHED CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX, E3 COMPONENT;DIAPHORASE;DIHYDROLIPOYL DEHYDROGENASE;GLYCINE CLEAVAGE SYSTEM L PROTEIN; GCSL;LIPOAMIDE DEHYDROGENASE; LAD;LIPOAMIDE REDUCTASE;LIPOYL DEHYDROGENASE;PYRUVATE DEHYDROGENASE COMPONENT E3; PHE3; E3	Leigh syndrome, 256000 (3);Maple syrup urine disease, type III, 248600 (3)
CG4376-PB	300377	NP_000100	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG3355-PA	264900	NP_000119	1e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG12262-PA	608801	NP_000150	1e-39	GCDH		Glutaricaciduria, type I, 231670 (3)
CG12370-PA	138033	NP_000151	1e-39	GCGR		{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG17227-PA	126391	NP_000225	1e-39	LIG1	DNA LIGASE I	DNA ligase I deficiency (3)
CG2331-PB	601498	NP_000278	1e-39	PAF2;PEX6;PXAAA1	PEROXIN 6;PEROXISOMAL ASSEMBLY FACTOR 2; PAF2;PEROXISOMAL-TYPE ATPase 1; PXAAA1	Peroxisomal biogenesis disorder, complementation group 4 (3);Peroxisomal biogenesis disorder, complementation group 6 (3)
CG31190-PA	308840	NP_000416	1e-39	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG3736-PA	300032	NP_000480	1e-39	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG17148-PA	100740	NP_000656	1e-39	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8733-PA	124020	NP_000760	1e-39	CYP2C;CYP2C19	CYP2C;MEPHENYTOIN 4-PRIME-HYDROXYLASE;P450C2C	Mephenytoin poor metabolizer (3);Opremazole poor metabolizer (3);Proguanil poor metabolizer (3)
CG8733-PA	601129	NP_000761	1e-39	CYP2C8		Rhabdomyolysis, cerivastatin-induced (3)
CG1438-PA	605325	NP_000768	1e-39	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG13702-PA	600018	NP_000905	1e-39	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG10244-PA	164870	NP_001005862	1e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG13702-PA	600018	NP_001008503	1e-39	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG13702-PA	600018	NP_001008504	1e-39	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG13702-PA	600018	NP_001008505	1e-39	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG5072-PA	300203	NP_001032420	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5072-PB	300203	NP_001032420	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5072-PC	300203	NP_001032420	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG6383-PA	602997	NP_001072	1e-39	CUBN;IFCR;MGA1	INTRINSIC FACTOR-COBALAMIN RECEPTOR; IFCR	Megaloblastic anemia-1, Finnish type, 261100 (3)
CG3992-PB	305371	NP_002040	1e-39	ERYF1;GATA1;GF1;NFE1	ERYTHROID TRANSCRIPTION FACTOR 1; ERYF1;GLOBIN TRANSCRIPTION FACTOR 1; GF1;TRANSCRIPTION FACTOR GATA1	Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Leukemia, megakaryoblastic, of Down syndrome, 190685 (3);Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3);Macrothrombocytopenia, 300367 (3)
CG3992-PC	305371	NP_002040	1e-39	ERYF1;GATA1;GF1;NFE1	ERYTHROID TRANSCRIPTION FACTOR 1; ERYF1;GLOBIN TRANSCRIPTION FACTOR 1; GF1;TRANSCRIPTION FACTOR GATA1	Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Leukemia, megakaryoblastic, of Down syndrome, 190685 (3);Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3);Macrothrombocytopenia, 300367 (3)
CG8095-PA	600536	NP_002197	1e-39	ITGA7		Myopathy, congenital (3)
CG10699-PA	602575	NP_002307	1e-39	LMX1B;NPS1	LMX1.2	Nail-patella syndrome with open-angle glaucoma, 137750 (3);Nail-patella syndrome, 161200 (3)
CG10699-PB	602575	NP_002307	1e-39	LMX1B;NPS1	LMX1.2	Nail-patella syndrome with open-angle glaucoma, 137750 (3);Nail-patella syndrome, 161200 (3)
CG6899-PA	176876	NP_002825	1e-39	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG6117-PA	180381	NP_002920	1e-39	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG6117-PB	180381	NP_002920	1e-39	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG5072-PA	300203	NP_003150	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5072-PB	300203	NP_003150	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG5072-PC	300203	NP_003150	1e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG3850-PA	300265	NP_003404	1e-39	HTX;HTX1;ZIC3	HTX1;ZIC FAMILY MEMBER 3	Heterotaxy, X-linked visceral, 306955 (3)
CG9610-PB	167415	NP_003457	1e-39	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG4376-PB	300377	NP_004000	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004002	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004002	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004002	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004003	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004003	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004003	1e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG18076-PA	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PB	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PC	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PE	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PG	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG18076-PH	125647	NP_004406	1e-39	DSP;KPPS2;PPKS2		Arrhythmogenic right ventricular dysplasia 8, 607450 (3);Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3);Epidermolysis bullosa, lethal acantholytic, 609638 (3);Keratosis palmoplantaris striata II (3);Skin fragility-woolly hair syndrome, 607655 (3)
CG10244-PA	164870	NP_004439	1e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17800-PC	142461	NP_005520	1e-39	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG17800-PD	142461	NP_005520	1e-39	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG31794-PA	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG31794-PB	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG31794-PC	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG31794-PD	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG31794-PE	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG31794-PF	605906	NP_009009	1e-39	CYPHER;KIAA01613;LDB3;ZASP	CYPHER, MOUSE, HOMOLOG OF; CYPHER;KIAA0613;Z-BAND ALTERNATIVELY SPLICED PDZ MOTIF-CONTAINING PROTEIN; ZASP	Cardiomyopathy, dilated (3);Cardiomyopathy, dilated, with left ventricular noncompaction (3);Myopathy, myofibrillar, ZASP-related, 609452 (3)
CG3998-PA	314995	NP_009061	1e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG5776-PA	604277	NP_055761	1e-39	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG7831-PA	605995	NP_055889	1e-39	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG9913-PA	605995	NP_055889	1e-39	CMT2A;CMT2A1;KIF1B		Charcot-Marie-Tooth disease, type 2A1, 118210 (3)
CG17148-PA	100740	NP_056646	1e-39	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG3355-PA	264900	NP_062505	1e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG8224-PA	600956	NP_065434	1e-39	AMHR;AMHR2	ANTI-MULLERIAN HORMONE RECEPTOR; AMHR	Persistent Mullerian duct syndrome, type II, 261550 (3)
CG8224-PB	600956	NP_065434	1e-39	AMHR;AMHR2	ANTI-MULLERIAN HORMONE RECEPTOR; AMHR	Persistent Mullerian duct syndrome, type II, 261550 (3)
CG12428-PA	118490	NP_065574	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PB	118490	NP_065574	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PC	118490	NP_065574	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PD	118490	NP_065574	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PE	118490	NP_065574	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG3277-PA	164761	NP_065681	1e-39	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3277-PB	164761	NP_065681	1e-39	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3277-PA	164761	NP_066124	1e-39	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3277-PB	164761	NP_066124	1e-39	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG12428-PA	118490	NP_066264	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PB	118490	NP_066264	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PC	118490	NP_066264	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PD	118490	NP_066264	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PE	118490	NP_066264	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PA	118490	NP_066265	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PB	118490	NP_066265	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PC	118490	NP_066265	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PD	118490	NP_066265	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PE	118490	NP_066265	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PA	118490	NP_066266	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PB	118490	NP_066266	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PC	118490	NP_066266	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PD	118490	NP_066266	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG12428-PE	118490	NP_066266	1e-39	CHAT;CMS1A2		Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)
CG31190-PA	308840	NP_076493	1e-39	CAML1;HSAS1;L1CAM	MIC5;NEURAL CELL ADHESION MOLECULE L1; CAML1	Corpus callosum, partial agenesis of, 304100 (3);CRASH syndrome, 303350 (3);Hydrocephalus due to aqueductal stenosis, 307000 (3);Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3);Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3);MASA syndrome, 303350 (3)
CG18735-PA	605511	NP_076927	1e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4145-PA	120070	NP_112733	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PB	120070	NP_112733	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PC	120070	NP_112733	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PA	120070	NP_112734	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PB	120070	NP_112734	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG4145-PC	120070	NP_112734	1e-39	COL4A3	COLLAGEN OF BASEMENT MEMBRANE, ALPHA-3 CHAIN	Alport syndrome, autosomal recessive, 203780 (3);Hematuria, benign familial, 141200 (3)
CG18630-PA	608548	NP_114141	1e-39	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG4386-PA	605511	NP_115777	1e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4386-PA	605511	NP_115780	1e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG3736-PA	300032	NP_612114	1e-39	ATRX;MRXHF1;MRXS3;SFM1;SHS;XH2;XNP	HELICASE 2, X-LINKED; XH2;X-LINKED NUCLEAR PROTEIN GENE; XNP	Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3);Alpha-thalassemia/mental retardation syndrome, 301040 (3);Chudley-Lowry syndrome, 309490 (3);Juberg-Marsidi syndrome, 309590 (3);Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);Smith-Fineman-Myers syndrome, 309580 (3);Sutherland-Haan syndrome-like, 300465 (3)
CG32743-PA	607585	NP_612149	1e-39	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG3622-PA	604134	NP_620594	1e-39	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG3622-PA	604134	NP_620596	1e-39	ADAMTS13;TTP;VWFCP	MOTIF, 13; ADAMTS13;VON WILLEBRAND FACTOR-CLEAVING PROTEASE; VWFCP	Thrombotic thrombocytopenic purpura, familial, 274150 (3)
CG13610-PA	607096	NP_700357	1e-39	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG3998-PA	314995	NP_700359	1e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG14808-PA	601411	NP_758447	1e-39	CMD1L;LGMD2F;SGCD;SGD		Cardiomyopathy, dilated, 1L, 606685 (3);Muscular dystrophy, limb-girdle, type 2F, 601287 (3)
CG5776-PA	604277	NP_955468	1e-39	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG31175-PA	601282	NP_958780	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958780	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PA	601282	NP_958784	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958784	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PA	601282	NP_958786	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG31175-PC	601282	NP_958786	1e-39	EBS1;PLEC1;PLTN	PCN; PLTN	Epidermolysis bullosa simplex, Ogna type, 131950 (3);Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)
CG32743-PA	607585	NP_000042	2e-39	AT1;ATA;ATM		Ataxia-telangiectasia, 208900 (3);Lymphoma, B-cell non-Hodgkin, somatic (3);Lymphoma, mantle cell (3);T-cell prolymphocytic leukemia, sporadic (3);{Breast cancer, susceptibility to}, 114480 (3)
CG1082-PA	177400	NP_000046	2e-39	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG4128-PA	100725	NP_000071	2e-39	CHRNE;CMS1D;CMS1E;CMS2A;FCCMS;SCCMS	ACETYLCHOLINE RECEPTOR, MUSCLE, EPSILON SUBUNIT; ACHRE	Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 608931 (3);Myasthenic syndrome, fast-channel congenital, 608930 (3);Myasthenic syndrome, slow-channel congenital, 601462 (3)
CG7241-PA	124030	NP_000097	2e-39	CYP2D;CYP2D@;P450C2D	CPD6;DEBRISOQUINE 4-HYDROXYLASE;P450DB1	Codeine sensitivity (3);Debrisoquine sensitivity (3);{?Parkinsonism, susceptibility to} (1)
CG8529-PA	300377	NP_000100	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_000100	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_000100	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG10369-PA	600359	NP_000211	2e-39	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG1594-PA	164860	NP_000236	2e-39	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG12287-PA	173110	NP_000297	2e-39	POU1F1;PIT1	GROWTH HORMONE FACTOR 1; GHF1;PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1	Pituitary hormone deficiency, combined (3)
CG12287-PB	173110	NP_000297	2e-39	POU1F1;PIT1	GROWTH HORMONE FACTOR 1; GHF1;PITUITARY-SPECIFIC TRANSCRIPTION FACTOR 1; PIT1	Pituitary hormone deficiency, combined (3)
CG11502-PA	600281	NP_000448	2e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG1341-PA	602136	NP_000457	2e-39	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG1644-PA	605325	NP_000768	2e-39	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG17528-PA	604373	NP_001005735	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PB	604373	NP_001005735	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PC	604373	NP_001005735	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PD	604373	NP_001005735	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17309-PA	164870	NP_001005862	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PB	164870	NP_001005862	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PC	164870	NP_001005862	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PD	164870	NP_001005862	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PE	164870	NP_001005862	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG9895-PA	602053	NP_001008490	2e-39	BCD1;COPEB;KLF6;ZF9	B CELL-DERIVED 1; BCD1;CORE PROMOTER ELEMENT-BINDING PROTEIN; COPEB;PROTOONCOGENE BCD1;TRANSCRIPTION FACTOR ZF9; ZF9	Gastric cancer, somatic, 137215 (3);Prostate cancer, somatic, 176807 (3)
CG3969-PA	600456	NP_001018074	2e-39	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG3969-PB	600456	NP_001018074	2e-39	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG8967-PA	600456	NP_001018074	2e-39	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG18476-PA	300573	NP_001034980	2e-39	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG2712-PA	300573	NP_001034980	2e-39	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG9895-PA	602053	NP_001291	2e-39	BCD1;COPEB;KLF6;ZF9	B CELL-DERIVED 1; BCD1;CORE PROMOTER ELEMENT-BINDING PROTEIN; COPEB;PROTOONCOGENE BCD1;TRANSCRIPTION FACTOR ZF9; ZF9	Gastric cancer, somatic, 137215 (3);Prostate cancer, somatic, 176807 (3)
CG8095-PB	600536	NP_002197	2e-39	ITGA7		Myopathy, congenital (3)
CG32755-PA	276000	NP_002760	2e-39	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG4379-PA	180381	NP_002920	2e-39	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG4379-PB	180381	NP_002920	2e-39	GRK1;RHOK;RK	G PROTEIN-DEPENDENT RECEPTOR KINASE 1; GRK1;RK	Oguchi disease-2, 258100 (3)
CG7333-PA	604190	NP_003050	2e-39	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG10033-PA	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_003591	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG14886-PA	108961	NP_003986	2e-39	AMDM;ANPRB;NPR2	ATRIAL NATRIURETIC PEPTIDE RECEPTOR, TYPE B; ANPRB;ATRIONATRIURETIC PEPTIDE RECEPTOR, TYPE B	Acromesomelic dysplasia, Maroteaux type, 602875 (3)
CG8529-PA	300377	NP_003997	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_003997	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_003997	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_003998	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_003998	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_003998	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004000	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004000	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004000	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PA	300377	NP_004001	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PB	300377	NP_004001	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG8529-PC	300377	NP_004001	2e-39	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG3701-PA	108730	NP_004311	2e-39	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG10776-PA	601299	NP_004320	2e-39	ACVRLK3;ALK3;BMPR1A	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 3; ACVRLK3;ACTIVIN RECEPTOR-LIKE KINASE 3; ALK3	Cowden-like syndrome, 158350 (3);Juvenile polyposis syndrome, infantile form, 174900 (3);Polyposis syndrome, hereditary mixed, 2, 610069 (3);Polyposis, juvenile intestinal, 174900 (3)
CG2049-PB	605377	NP_004400	2e-39	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG2049-PC	605377	NP_004400	2e-39	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG2049-PE	605377	NP_004400	2e-39	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG2049-PF	605377	NP_004400	2e-39	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG14992-PA	600997	NP_004433	2e-39	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG17309-PA	164870	NP_004439	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PB	164870	NP_004439	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PC	164870	NP_004439	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PD	164870	NP_004439	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG17309-PE	164870	NP_004439	2e-39	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG3969-PA	602337	NP_004551	2e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG3969-PB	602337	NP_004551	2e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17998-PA	300075	NP_004577	2e-39	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG10079-PA	147796	NP_004963	2e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG10079-PB	147796	NP_004963	2e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG31045-PA	600970	NP_004990	2e-39	DFNA22;DFNB37;MYO6		Deafness, autosomal dominant 22, 606346 (3);Deafness, autosomal recessive 37, 607821 (3);Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)
CG7123-PA	150292	NP_005553	2e-39	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7123-PB	150292	NP_005553	2e-39	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG8967-PA	600456	NP_006171	2e-39	NTRK2;TRKB	TYROSINE KINASE RECEPTOR B; TRKB	Obesity, hyperphagia, and developmental delay (3)
CG1389-PA	604705	NP_006334	2e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8049-PA	604705	NP_006334	2e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8049-PB	604705	NP_006334	2e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8049-PC	604705	NP_006334	2e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8049-PD	604705	NP_006334	2e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG10960-PA	138140	NP_006507	2e-39	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG10960-PB	138140	NP_006507	2e-39	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG10960-PC	138140	NP_006507	2e-39	SLC2A1;GLUT1	1; SLC2A1;ERYTHROCYTE/HEPATOMA GLUCOSE TRANSPORTER;GLUCOSE TRANSPORTER 1; GLUT; GLUT1	Glucose transport defect, blood-brain barrier, 606777 (3)
CG15552-PA	602229	NP_008872	2e-39	SOX10;WS4	DOMINANT MEGACOLON, MOUSE, HOMOLOG OF; DOM;SRY-RELATED HMG-BOX GENE 10	PCWH, 609136 (3);Waardenburg-Shah syndrome, 277580 (3);Yemenite deaf-blind hypopigmentation syndrome, 601706 (3)
CG17528-PA	604373	NP_009125	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PB	604373	NP_009125	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PC	604373	NP_009125	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG17528-PD	604373	NP_009125	2e-39	CDS1;CHEK2;CHK2;LFS2;RAD53	CDS1, S. POMBE, HOMOLOG OF;CHK2;RAD53, S. CEREVISIAE, HOMOLOG OF; RAD53	Li-Fraumeni syndrome, 609265 (3);Osteosarcoma, somatic, 259500 (3);Prostate cancer, familial, 176807 (3);{Breast and colorectal cancer, susceptibility to} (3);{Breast cancer, susceptibility to}, 114480 (3)
CG7499-PA	111680	NP_057208	2e-39	RHD	BLOOD GROUP--RHESUS SYSTEM D POLYPEPTIDE	[Rh-negative blood type] (3)
CG14992-PA	600997	NP_059145	2e-39	CAPB;DRT;EPHB2;EPHT3;ERK;PCBC	DEVELOPMENTALLY REGULATED EPH-RELATED TYROSINE KINASE; DRT;ELK-RELATED TYROSINE KINASE; ERK;EPH TYROSINE KINASE 3; EPHT3;HEK5	Prostate cancer, progression and metastasis of, 603688 (3)
CG14073-PA	300485	NP_060215	2e-39	ANOP2;BCOR;KIAA1575;MAA2;MCOPS2	KIAA1575	Microphthalmia, syndromic 2, 300166 (3)
CG14073-PB	300485	NP_060215	2e-39	ANOP2;BCOR;KIAA1575;MAA2;MCOPS2	KIAA1575	Microphthalmia, syndromic 2, 300166 (3)
CG7123-PA	150292	NP_061486	2e-39	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG7123-PB	150292	NP_061486	2e-39	LAMB2T;LAMC2;LAMNB2	KALININ;LAM5, GAMMA-2 SUBUNIT;LAMB2, TRUNCATED; LAMB2T;LAMININ 5, GAMMA-2 SUBUNIT;LAMININ B2 POLYPEPTIDE, TRUNCATED;LAMININ, NICEIN, BETA-2; LAMNB2	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG4914-PA	606797	NP_068813	2e-39	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG4386-PA	605511	NP_076927	2e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG33141-PA	608548	NP_114141	2e-39	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG1072-PA	602146	NP_203129	2e-39	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG1072-PB	602146	NP_203129	2e-39	LHX4	LHX4	Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)
CG18255-PA	188840	NP_596870	2e-39	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG18255-PC	188840	NP_596870	2e-39	CMD1G;HMERF;LGMD2J;MPRM;TMD;TTN	CONNECTIN	Cardiomyopathy, dilated, 1G, 604145 (3);Cardiomyopathy, familial hypertrophic, 9 (3);Muscular dystrophy, limb-girdle, type 2J, 608807 (3);Myopathy, proximal, with early respiratory muscle involvement, 603689 (3);Tibial muscular dystrophy, tardive, 600334 (3)
CG9317-PA	607096	NP_653186	2e-39	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG9317-PB	607096	NP_653186	2e-39	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG10369-PA	600359	NP_722448	2e-39	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG10369-PA	600359	NP_722449	2e-39	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG10369-PA	600359	NP_722450	2e-39	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG10369-PA	600359	NP_722451	2e-39	KCNJ1;ROMK1	KIR1.1;RENAL OUTER-MEDULLARY POTASSIUM CHANNEL; ROMK; ROMK1	Bartter syndrome, type 2, 241200 (3)
CG3701-PA	108730	NP_775293	2e-39	ATP2A1;SERCA1	SARCOPLASMIC RETICULUM Ca(2+)-ATPase 1; SERCA1	Brody myopathy, 601003 (3)
CG11502-PA	600281	NP_849180	2e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG11502-PA	600281	NP_849181	2e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG10033-PA	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_940835	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PA	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_940836	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PA	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_940837	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PA	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_940838	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PA	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PB	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PC	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PD	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10033-PE	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10539-PA	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17596-PA	603072	NP_940839	2e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG5284-PA	118425	NP_000074	3e-39	CLCN1	CHLORIDE CHANNEL, MUSCLE; CLC1	Myotonia congenita, dominant, 160800 (3);Myotonia congenita, recessive, 255700 (3);Myotonia levior, recessive (3)
CG4998-PA	264900	NP_000119	3e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG10521-PA	150310	NP_000219	3e-39	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG8222-PA	164860	NP_000236	3e-39	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8222-PB	164860	NP_000236	3e-39	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG8222-PC	164860	NP_000236	3e-39	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG10521-PA	150310	NP_001017402	3e-39	LAMB3	LAM5, BETA-3 SUBUNIT;LAMININ 5, BETA-3 SUBUNIT;LAMININ B3	Epidermolysis bullosa, generalized atrophic benign, 226650 (3);Epidermolysis bullosa, Herlitz junctional type, 226700 (3)
CG1847-PA	604392	NP_001028227	3e-39	AIPL1;LCA4		Cone-rod dystrophy (3);Leber congenital amaurosis, 604393 (3);Retinitis pigmentosa, juvenile (3)
CG1847-PB	604392	NP_001028227	3e-39	AIPL1;LCA4		Cone-rod dystrophy (3);Leber congenital amaurosis, 604393 (3);Retinitis pigmentosa, juvenile (3)
CG2621-PA	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PB	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PC	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PD	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PE	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PF	300203	NP_001032420	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG30132-PC	164731	NP_001617	3e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG30132-PD	164731	NP_001617	3e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG30132-PE	164731	NP_001617	3e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG30132-PG	164731	NP_001617	3e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10037-PA	602460	NP_002691	3e-39	BRN3C;POU4F3	BRN3.1, MOUSE, HOMOLOG OF;POU-DOMAIN TRANSCRIPTION FACTOR BRN3C; BRN3C	Deafness, autosomal dominant 15, 602459 (3)
CG2621-PA	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PB	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PC	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PD	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PE	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG2621-PF	300203	NP_003150	3e-39	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG30293-PA	600031	NP_003456	3e-39	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG18076-PC	604638	NP_004915	3e-39	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG18076-PH	604638	NP_004915	3e-39	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG9610-PB	167415	NP_039247	3e-39	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG9610-PB	167415	NP_054698	3e-39	PAX8	PAIRED DOMAIN GENE 8	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)
CG1031-PA	300336	NP_061850	3e-39	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG4998-PA	264900	NP_062505	3e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG7432-PA	605511	NP_115777	3e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG7432-PA	605511	NP_115780	3e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG4898-PA	191030	NP_689476	3e-39	TPM3;NEM1	ALPHA-TROPOMYOSIN 3;ALPHA-TROPOMYOSIN, SLOW SKELETAL	Nemaline myopathy 1, autosomal dominant, 161800 (3)
CG16801-PA	600281	NP_849181	3e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG7912-PA	604943	NP_996767	3e-39	PRES;DFNB61;SLC26A5	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	Deafness, autosomal recessive 61 (3)
CG6802-PA	608614	NP_997235	3e-39	BCD;CYP4V2	CYP4V2	Bietti crystalline corneoretinal dystrophy, 210370 (3)
CG10339-PA	177400	NP_000046	4e-39	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG6018-PA	177400	NP_000046	4e-39	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG7432-PA	264900	NP_000119	4e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG3051-PA	172471	NP_000285	4e-39	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG3051-PB	172471	NP_000285	4e-39	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG16801-PA	600281	NP_000448	4e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG7955-PA	170261	NP_000535	4e-39	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG7955-PB	170261	NP_000535	4e-39	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG7955-PC	170261	NP_000535	4e-39	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG17453-PA	605325	NP_000768	4e-39	CYP3A5;P450PCN3	P450PCN3	{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)
CG6713-PA	602568	NP_002445	4e-39	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG12350-PA	601564	NP_002761	4e-39	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG14857-PA	603377	NP_003051	4e-39	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG7333-PA	603377	NP_003051	4e-39	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG1780-PA	600031	NP_003456	4e-39	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG1780-PB	600031	NP_003456	4e-39	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG12069-PA	603072	NP_003591	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4007-PA	136351	NP_004110	4e-39	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG7140-PA	138090	NP_004276	4e-39	H6PD;GDH;G6PDH	G6PD, H FORM; G6PDH;GDH/6PGL ENDOPLASMIC BIFUNCTIONAL PROTEIN;GLUCOSE 1-DEHYDROGENASE;GLUCOSE DEHYDROGENASE; GDH;GLUCOSE-6-PHOSPHATE DEHYDROGENASE, SALIVARY;HEXOSE-6-PHOSPHATE DEHYDROGENASE PRECURSOR	Cortisone reductase deficiency, 604931 (3)
CG4402-PA	601969	NP_004397	4e-39	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG31175-PA	604638	NP_004915	4e-39	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG31175-PC	604638	NP_004915	4e-39	ACTN4;FSGS1;FSGS	ACTININ-4	Glomerulosclerosis, focal segmental, 1, 603278 (3)
CG10244-PA	147796	NP_004963	4e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG6604-PA	604614	NP_005140	4e-39	TBS19	T-BOX FACTOR, PITUITARY; TPIT	Adrenocorticotropic hormone deficiency, 201400 (3)
CG18402-PA	164770	NP_005202	4e-39	CSF1R;FMS	FRIEND MURINE LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF,;ONCOGENE FMS; FMS;V-FMS MCDONOUGH FELINE SARCOMA VIRAL ONCOGENE HOMOLOG, FORMERLY	Myeloid malignancy, predisposition to (3)
CG1454-PA	314995	NP_009061	4e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG10793-PA	604277	NP_055761	4e-39	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG14992-PA	136350	NP_056934	4e-39	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG7432-PA	264900	NP_062505	4e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG2969-PA	605459	NP_071881	4e-39	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG2969-PB	605459	NP_071881	4e-39	ABCG5	STEROLIN 1	Sitosterolemia, 210250 (3)
CG14992-PA	136350	NP_075593	4e-39	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG14992-PA	136350	NP_075594	4e-39	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG6713-PA	602568	NP_076915	4e-39	MTRR	MSR	Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)
CG1454-PA	314995	NP_700359	4e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG16801-PA	600281	NP_849180	4e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG12069-PA	603072	NP_940835	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12069-PA	603072	NP_940836	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12069-PA	603072	NP_940837	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12069-PA	603072	NP_940838	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG12069-PA	603072	NP_940839	4e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10793-PA	604277	NP_955468	4e-39	SPG4;SPAST	SPASTIN; SPAST	Spastic paraplegia-4, 182601 (3)
CG4402-PA	601969	XP_001133592	4e-39	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG32751-PA	609019	NP_000051	5e-39	BTD		Biotinidase deficiency, 253260 (3)
CG3829-PA	173510	NP_000063	5e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG3969-PA	147670	NP_000199	5e-39	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG3969-PB	147670	NP_000199	5e-39	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG6687-PA	107300	NP_000479	5e-39	AT3	SERPINC1;THROMBOPHILIA, HEREDITARY, DUE TO DEFICIENCY OF AT-III	Antithrombin III deficiency (3)
CG3829-PA	173510	NP_001001547	5e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG3829-PA	173510	NP_001001548	5e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG16801-PA	600281	NP_001025175	5e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG9456-PA	107280	NP_001076	5e-39	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG30132-PB	164731	NP_001617	5e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG30132-PF	164731	NP_001617	5e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG18444-PA	276000	NP_002760	5e-39	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG17751-PA	603377	NP_003051	5e-39	CDSP;OCTN2;SCD;SLC22A5	OCTN2	Carnitine deficiency, systemic primary, 212140 (3)
CG14396-PA	602337	NP_004551	5e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG14396-PB	602337	NP_004551	5e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG14396-PC	602337	NP_004551	5e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG14396-PD	602337	NP_004551	5e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG14396-PE	602337	NP_004551	5e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG7524-PB	147796	NP_004963	5e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG7245-PA	142461	NP_005520	5e-39	HSPG2;PLC;SJA;SJS;SJS1	PERLECAN; PLC	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3);Schwartz-Jampel syndrome, type 1, 255800 (3)
CG10269-PA	314995	NP_009061	5e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4402-PA	601969	NP_015568	5e-39	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG14217-PD	606808	NP_059129	5e-39	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG14217-PE	606808	NP_059129	5e-39	MYO3A;DFNB30		Deafness, autosomal recessive 30, 607101 (3)
CG4402-PA	601969	NP_060049	5e-39	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG3355-PA	606797	NP_068813	5e-39	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG7432-PA	605511	NP_076927	5e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG10269-PA	314995	NP_700359	5e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8222-PA	600221	NP_000450	6e-39	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8222-PB	600221	NP_000450	6e-39	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG8222-PC	600221	NP_000450	6e-39	TEK;TIE2;VMCM	PROTEIN RECEPTOR TYROSINE KINASE, EPITHELIAL-SPECIFIC, TIE-2; TIE2	Venous malformations, multiple cutaneous and mucosal, 600195 (3)
CG4386-PA	176930	NP_000497	6e-39	F2	FACTOR II;PROTHROMBIN;THROMBIN	Dysprothrombinemia (3);Hyperprothrombinemia (3);Hypoprothrombinemia (3)
CG17970-PA	601310	NP_000769	6e-39		CYP4AII;OMEGA-HYDROXYLASE, FATTY ACID	
CG8916-PA	137140	NP_000798	6e-39	GABRA2	GABA-A RECEPTOR, ALPHA-2 POLYPEPTIDE	{Alcoholism, susceptibility to}, 103780 (3)
CG9372-PA	229000	NP_000883	6e-39	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG7075-PB	608893	NP_001003841	6e-39	HND;SLC6A19	SLC6A19;SYSTEM B(0) NEUTRAL AMINO ACID TRANSPORTER 1	Hartnup disorder, 234500 (3)
CG16801-PA	600281	NP_001025174	6e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG12172-PA	107280	NP_001076	6e-39	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG10704-PA	607108	NP_001595	6e-39	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG12203-PA	602694	NP_002486	6e-39	AQDQ;NDUFS4	AQDQ;COMPLEX I, MITOCHONDRIAL RESPIRATORY CHAIN, 18-KD SUBUNIT;NADH-COENZYME Q REDUCTASE, 18-KD	Leigh syndrome, 256000 (3);Mitochondrial complex I deficiency, 252010 (3)
CG3051-PA	176960	NP_002728	6e-39	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG3051-PB	176960	NP_002728	6e-39	PKCA;PRKCA	PKCA	Pituitary tumor, invasive (3)
CG11824-PA	606635	NP_002763	6e-39	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG1725-PA	604090	NP_004738	6e-39	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG1725-PD	604090	NP_004738	6e-39	DLG5;KIAA0583;PDLG	PLACENTA AND PROSTATE DLG; PDLG	{Crohn disease, susceptibility to}, 266600 (3)
CG7223-PA	147796	NP_004963	6e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG7223-PB	147796	NP_004963	6e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG7223-PC	147796	NP_004963	6e-39	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG3068-PA	605437	NP_006246	6e-39	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG17348-PA	604705	NP_006334	6e-39	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG4860-PA	608801	NP_039663	6e-39	GCDH		Glutaricaciduria, type I, 231670 (3)
CG32465-PB	300336	NP_061850	6e-39	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG1112-PA	300427	NP_065793	6e-39	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG14992-PA	134934	NP_075254	6e-39	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG31795-PA	151460	NP_563578	6e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG31795-PB	151460	NP_563578	6e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG16801-PA	600281	NP_787110	6e-39	HNF4A;MODY1;TCF14	HEPATOCYTE NUCLEAR FACTOR 4; HNF4;HNF4-ALPHA;TRANSCRIPTION FACTOR 14, HEPATIC NUCLEAR FACTOR; TCF14	MODY, type I, 125850 (3);{Diabetes mellitus, noninsulin-dependent}, 125853 (3)
CG1112-PA	300427	NP_851849	6e-39	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG6917-PA	177400	NP_000046	7e-39	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG40006-PC	173510	NP_000063	7e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG14992-PA	134934	NP_000133	7e-39	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG11600-PA	278000	NP_000226	7e-39	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG7589-PA	137192	NP_000805	7e-39	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG40006-PC	173510	NP_001001547	7e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG40006-PC	173510	NP_001001548	7e-39	CD36	COLLAGEN RECEPTOR, PLATELET;FATTY ACID TRANSLOCASE; FAT;GLYCOPROTEIN IIIb;GP3B;GP IIIb;LEUKOCYTE DIFFERENTIATION ANTIGEN CD36;PLATELET GLYCOPROTEIN IV; GP4;THROMBOSPONDIN RECEPTOR	Platelet glycoprotein IV deficiency, 608404 (3);[Macrothrombocytopenia] (1);{Malaria, cerebral, reduced risk of}, 248310 (3);{Malaria, cerebral, susceptibility to}, 248310 (3)
CG10023-PA	191315	NP_001007793	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PB	191315	NP_001007793	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PC	191315	NP_001007793	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PA	191315	NP_001012331	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PB	191315	NP_001012331	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PC	191315	NP_001012331	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG7672-PA	300573	NP_001034980	7e-39	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG10023-PA	191315	NP_002520	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PB	191315	NP_002520	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10023-PC	191315	NP_002520	7e-39	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG31795-PA	151460	NP_002829	7e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG31795-PB	151460	NP_002829	7e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG9064-PA	602044	NP_003347	7e-39	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG8485-PA	603072	NP_003591	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_003591	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_003591	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_003591	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG6518-PA	605377	NP_004400	7e-39	DMPK;DM;DMK	DM KINASE; DMK;DM PROTEIN KINASE;MYOTONIN-PROTEIN KINASE	Myotonic dystrophy, 160900 (3)
CG10522-PA	300075	NP_004577	7e-39	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG3219-PA	602821	NP_004975	7e-39	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG4007-PA	131550	NP_005219	7e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG31632-PA	314995	NP_009061	7e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG3156-PA	601439	NP_064693	7e-39	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG7589-PA	137192	NP_068712	7e-39	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG33008-PA	605511	NP_115777	7e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG33008-PC	605511	NP_115777	7e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG33008-PA	605511	NP_115780	7e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG33008-PC	605511	NP_115780	7e-39	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG31795-PA	151460	NP_563579	7e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG31795-PB	151460	NP_563579	7e-39	CD45;LCA;PTPRC	B220;CD45;CD45R;LEUKOCYTE-COMMON ANTIGEN; LCA;Ly5, HOMOLOG OF;T200 GLYCOPROTEIN	Severe combined immunodeficiency due to PTPRC deficiency (3);{Hepatitic C virus, susceptibility to}, 609532 (3);{Multiple sclerosis, susceptibility to}, 126200 (3)
CG7892-PA	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PB	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PC	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PE	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PF	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG7892-PG	602897	NP_620447	7e-39	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG31632-PA	314995	NP_700359	7e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8485-PA	603072	NP_940835	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_940835	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_940835	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_940835	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PA	603072	NP_940836	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_940836	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_940836	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_940836	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PA	603072	NP_940837	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_940837	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_940837	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_940837	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PA	603072	NP_940838	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_940838	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_940838	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_940838	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PA	603072	NP_940839	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PB	603072	NP_940839	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PC	603072	NP_940839	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG8485-PD	603072	NP_940839	7e-39	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10913-PA	107400	NP_000286	8e-39	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG33087-PC	600276	NP_000426	8e-39	CADASIL;CASIL;NOTCH3		Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)
CG7806-PA	170261	NP_000535	8e-39	ABCB3;PSF2;RING11;TAP2	2;2; TAP2;ABC TRANSPORTER, MHC, 2;ANTIGEN PEPTIDE TRANSPORTER 2; APT2;ATP-BINDING CASSETTE TRANSPORTER, MAJOR HISTOCOMPATIBILITY COMPLEX,;ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 3; ABCB3;PEPTIDE SUPPLY FACTOR 2; PSF2;PEPTIDE TRANSPORTER PSF2;RING11;TRANSPORTER, ABC, MHC, 2;WEGENER-LIKE GRANULOMATOSIS	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);Wegener-like granulomatosis (3)
CG10913-PA	107400	NP_001002235	8e-39	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG10913-PA	107400	NP_001002236	8e-39	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG7838-PA	602860	NP_001202	8e-39	BUB1B;BUBR1	BETA; BUB1B;BUB1, S. CEREVISIAE, HOMOLOG OF, BETA;BUBR1;MITOTIC CHECKPOINT GENE BUB1B	Colorectal cancer, 114500 (3)
CG14030-PA	602452	NP_004327	8e-39	BUB1	BUB1;BUB1, S. CEREVISIAE, HOMOLOG OF;MITOTIC CHECKPOINT GENE BUB1	Colorectal cancer with chromosomal instability (3)
CG1403-PB	604061	NP_006631	8e-39	MSF;MSF1;NAPB;SEPT9	KIAA0991;MLL SEPTIN-LIKE FUSION GENE; MSF;MSF1;PEANUT-LIKE 4; PNUTL4;SEPTIN 9; SEPT9;SINT1	Amyotrophy, hereditary neuralgic, 162100 (3);Leukemia, acute myeloid, therapy-related (1);Ovarian carcinoma (1)
CG18735-PA	264900	NP_062505	8e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG5853-PA	605460	NP_071882	8e-39	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG8107-PA	605286	NP_075573	8e-39	CAPN10		{Diabetes mellitus, noninsulin-dependent}, 601283 (3)
CG4898-PB	190990	NP_998839	8e-39	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PD	190990	NP_998839	8e-39	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PG	190990	NP_998839	8e-39	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG4898-PJ	190990	NP_998839	8e-39	AMCD1;DA1;TMSB;TPM2	TROPOMYOSIN, SKELETAL MUSCLE BETA; TMSB	Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);Nemaline myopathy, 161800 (3)
CG18735-PA	264900	NP_000119	9e-39	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG31810-PA	605573	NP_000188	9e-39	EDH17B3;HSD17B3	17-@BETA-HSD III;ESTRADIOL 17-BETA-DEHYDROGENASE; EDH17B3;TESTICULAR 17-@BETA-HYDROXYSTEROID DEHYDROGENASE III	Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
CG4290-PA	164731	NP_001617	9e-39	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG17309-PA	602337	NP_004551	9e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17309-PB	602337	NP_004551	9e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17309-PC	602337	NP_004551	9e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17309-PD	602337	NP_004551	9e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17309-PE	602337	NP_004551	9e-39	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17309-PA	131550	NP_005219	9e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG17309-PB	131550	NP_005219	9e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG17309-PC	131550	NP_005219	9e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG17309-PD	131550	NP_005219	9e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG17309-PE	131550	NP_005219	9e-39	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG8319-PA	314995	NP_009061	9e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8319-PA	314995	NP_700359	9e-39	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG4821-PA	264900	NP_000119	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4821-PB	264900	NP_000119	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4821-PD	264900	NP_000119	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG8170-PA	264900	NP_000119	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG5724-PA	191740	NP_000454	1e-38	GNT1;UGT1;UGT1A1	GNT1;PHENOL/BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE;UDP-GLYCOSYLTRANSFERASE 1;URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE, BILIRUBIN/PHENOL;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1;URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1; UGT1	Crigler-Najjar syndrome, type I, 218800 (3);Crigler-Najjar syndrome, type II, 606785 (3);Hyperbilirubinemia, familial transcient neonatal, 237900 (3);[Gilbert syndrome], 143500 (3)
CG9023-PA	107777	NP_000477	1e-38	AQP2	AQUAPORIN-CD	Diabetes insipidus, nephrogenic, 125800 (3)
CG9023-PB	107777	NP_000477	1e-38	AQP2	AQUAPORIN-CD	Diabetes insipidus, nephrogenic, 125800 (3)
CG8916-PA	137160	NP_000797	1e-38	GABRA1;EJM	GABA-A RECEPTOR, ALPHA-1 POLYPEPTIDE	Epilepsy, juvenile myoclonic, 606904 (3)
CG10001-PA	600018	NP_000905	1e-38	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG8874-PA	191315	NP_001007793	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PB	191315	NP_001007793	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PC	191315	NP_001007793	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PD	191315	NP_001007793	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG10001-PA	600018	NP_001008503	1e-38	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG10001-PA	600018	NP_001008504	1e-38	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG10001-PA	600018	NP_001008505	1e-38	OPRM1	MU OPIOID RECEPTOR; MOR;OPRM	[Response to morphine-6-glucuronide] (3);{Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3)
CG8874-PA	191315	NP_001012331	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PB	191315	NP_001012331	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PC	191315	NP_001012331	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PD	191315	NP_001012331	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG18076-PC	102574	NP_001095	1e-38	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG18076-PH	102574	NP_001095	1e-38	ACTN3		[Alpha-actinin-3 deficiency] (3);[Elite sprint athletic performance] (3)
CG17216-PA	164731	NP_001617	1e-38	AKT2	ONCOGENE AKT2;PKB-BETA;PROTEIN KINASE B-BETA	Diabetes mellitus, type II, 125853 (3)
CG10913-PA	122500	NP_001747	1e-38	CBG	SERPINA6	[Transcortin deficiency] (1)
CG1089-PA	114840	NP_001798	1e-38	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG1389-PA	136352	NP_002011	1e-38	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG8874-PA	191315	NP_002520	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PB	191315	NP_002520	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PC	191315	NP_002520	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG8874-PD	191315	NP_002520	1e-38	MTC;NTRK1;TRKA	TYROSINE KINASE RECEPTOR A; TRKA;TYROSINE KINASE RECEPTOR; TRK	Insensitivity to pain, congenital, with anhidrosis, 256800 (3);Medullary thyroid carcinoma, familial, 155240 (3)
CG12066-PA	176980	NP_002730	1e-38	PKCC;PKCG;PRKCG;SCA14	PKCC; PKCG	Spinocerebellar ataxia 14, 605361 (3)
CG6899-PB	176876	NP_002825	1e-38	NS1;PTP2C;PTPN11;SHP2	PROTEIN-TYROSINE PHOSPHATASE 2C; PTP2C;TYROSINE PHOSPHATASE SHP2; SHP2	Leopard syndrome, 151100 (3);Leukemia, juvenile myelomonocytic, 607785 (3);Noonan syndrome 1, 163950 (3)
CG17751-PA	604190	NP_003050	1e-38	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG1907-PA	602044	NP_003347	1e-38	UCP3		{Obesity, severe, and type II diabetes}, 601665 (3)
CG9108-PA	604067	NP_003826	1e-38	RGS9;PERRS		Bradyopsia, 608415 (3)
CG8874-PA	602337	NP_004551	1e-38	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8874-PB	602337	NP_004551	1e-38	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8874-PC	602337	NP_004551	1e-38	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG8874-PD	602337	NP_004551	1e-38	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG17342-PA	300075	NP_004577	1e-38	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG17342-PB	300075	NP_004577	1e-38	MRX19;RPS6KA3;RSK2	RIBOSOMAL S6 KINASE 2; RSK2	Coffin-Lowry syndrome, 303600 (3);Mental retardation, X-linked nonspecific, type 19 (3)
CG31670-PA	600871	NP_005254	1e-38	GFI1;ZNF163	ZNF163	Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3);Neutropenia, severe congenital, 202700 (3)
CG40064-PA	604741	NP_005980	1e-38		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG1322-PA	605802	NP_055610	1e-38	SIP1;SMADIP1;ZFHX1B	SMAD-INTERACTING PROTEIN 1; SMADIP1; SIP1	Mowat-Wilson syndrome, 235730 (3)
CG1322-PB	605802	NP_055610	1e-38	SIP1;SMADIP1;ZFHX1B	SMAD-INTERACTING PROTEIN 1; SMADIP1; SIP1	Mowat-Wilson syndrome, 235730 (3)
CG7180-PA	600716	NP_057051	1e-38	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG32648-PA	604961	NP_058649	1e-38	PDE11A;PDE11A1;PDE11A2;PDE11A3;PPNAD2	PDE11A1	Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)
CG3841-PA	300336	NP_061850	1e-38	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG9858-PA	300336	NP_061850	1e-38	ASPGX1;AUTSX1;NLGN3		{Asperger syndrome, susceptibility to, X-linked-1}, 300494 (3);{Autism, susceptibility to, X-linked-1}, 300425 (3)
CG6124-PA	600985	NP_061978	1e-38	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG4821-PA	264900	NP_062505	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4821-PB	264900	NP_062505	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4821-PD	264900	NP_062505	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG8170-PA	264900	NP_062505	1e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG9287-PA	300427	NP_065793	1e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG9564-PA	606797	NP_068813	1e-38	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG33008-PA	605511	NP_076927	1e-38	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG33008-PC	605511	NP_076927	1e-38	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG1322-PA	189909	NP_110378	1e-38	PPCD3;TCF8	DELTA-EF1;NIL2A;T-LYMPHOCYTE-SPECIFIC INTERLEUKIN 2 INHIBITOR;ZEB1	Corneal dystrophy, posterior polymorphous, 3, 609141 (3)
CG1322-PB	189909	NP_110378	1e-38	PPCD3;TCF8	DELTA-EF1;NIL2A;T-LYMPHOCYTE-SPECIFIC INTERLEUKIN 2 INHIBITOR;ZEB1	Corneal dystrophy, posterior polymorphous, 3, 609141 (3)
CG9115-PA	607697	NP_112224	1e-38	CMT4B2;MTMR13;SBF2	KIAA1766;MYOTUBULARIN-RELATED 13; MTMR13	Charcot-Marie-Tooth disease, type 4B2, 604563 (3)
CG1084-PA	608548	NP_114141	1e-38	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG5966-PA	607365	NP_640341	1e-38	LIPH	LPD LIPASE-RELATED PROTEIN; LPDLR;MEMBRANE-ASSOCIATED PHOSPHATIDIC ACID-SELECTIVE PHOSPHOLIPASE A1;;MPAPLA1;PHOSPHOLIPASE A1, PHOSPHATIDIC ACID-SELECTIVE, MEMBRANE-ASSOCIATED	Hypotrichosis, total, Mari type, 604379 (3)
CG7442-PA	607096	NP_653186	1e-38	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG9287-PA	300427	NP_851849	1e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG1389-PA	136352	NP_891555	1e-38	FLT4;PCL;VEGFR3	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3; VEGFR3	Hemangioma, capillary infantile, somatic, 602089 (3);Lymphedema, hereditary I, 153100 (3)
CG17148-PA	177400	NP_000046	2e-38	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG7236-PA	123829	NP_000066	2e-38	CDK4;CMM3	CELL DIVISION KINASE 4;PSK-J3	Melanoma, 609048 (3)
CG4914-PA	306900	NP_000124	2e-38	F9;HEMB	CHRISTMAS DISEASE;FACTOR IX DEFICIENCY;PLASMA THROMBOPLASTIN COMPONENT; PTC	Hemophilia B (3);Warfarin sensitivity (3)
CG11340-PA	138491	NP_000162	2e-38	GLRA1;STHE		Hyperekplexia and spastic paraparesis (3);Startle disease, autosomal recessive (3);Startle disease/hyperekplexia, autosomal dominant, 149400 (3)
CG16827-PA	147556	NP_000201	2e-38	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG3635-PA	278000	NP_000226	2e-38	LIPA	ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, TYPE 2;ACID CHOLESTERYL ESTER HYDROLASE DEFICIENCY, WOLMAN TYPE;CHOLESTEROL ESTER HYDROLASE DEFICIENCY;CHOLESTEROL ESTER STORAGE DISEASE; CESD;CHOLESTERYL ESTER STORAGE DISEASE;LAL DEFICIENCY;LIPA DEFICIENCY;LYSOSOMAL ACID LIPASE DEFICIENCY	Cholesteryl ester storage disease (3);Wolman disease (3)
CG30035-PA	138160	NP_000331	2e-38	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG30035-PB	138160	NP_000331	2e-38	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG8234-PA	138160	NP_000331	2e-38	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG8234-PB	138160	NP_000331	2e-38	GLUT2;SLC2A2	2; SLC2A2;GLUCOSE TRANSPORTER 2; GLUT2;GLUCOSE TRANSPORTER, LIVER/ISLET	Fanconi-Bickel syndrome, 227810 (3);{Diabetes mellitus, noninsulin-dependent} (3)
CG4721-PA	300550	NP_000435	2e-38	HPDR1;HYP;PHEX	PEX	Hypophosphatemia, X-linked, 307800 (3)
CG1257-PA	100740	NP_000656	2e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG5030-PA	100740	NP_000656	2e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8299-PA	229000	NP_000883	2e-38	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG4926-PA	164870	NP_001005862	2e-38	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG18211-PA	276000	NP_002760	2e-38	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG3355-PA	601564	NP_002761	2e-38	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG4316-PA	601564	NP_002761	2e-38	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG8170-PA	606635	NP_002763	2e-38	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG32139-PA	184429	NP_003097	2e-38	MCOPS3;SOX2	SRY-RELATED HMG-BOX GENE 2	Microphthalmia, syndromic 3, 206900 (3);Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)
CG1954-PA	603072	NP_003591	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4926-PA	164870	NP_004439	2e-38	ERBB2;HER2;NEU;NGL	NEU;ONCOGENE ERBB2;ONCOGENE NGL, NEUROBLASTOMA- OR GLIOBLASTOMA-DERIVED; NGL;TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2; TKR1	Adenocarcinoma of lung, somatic, 211980 (3);Gastric cancer, somatic, 137215 (3);Glioblastoma, somatic, 137800 (3);Ovarian cancer, somatic, (3)
CG14992-PA	147796	NP_004963	2e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG32134-PA	147796	NP_004963	2e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG32101-PA	604741	NP_005980	2e-38		5-@BETA-REDUCTASE;DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE;STEROID 5-BETA-REDUCTASE; SRD5B1	
CG7524-PB	173490	NP_006197	2e-38	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG6715-PA	605437	NP_006246	2e-38	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG11628-PA	605371	NP_006411	2e-38	ARFGEF2;BIG2	BREFELDIN A-INHIBITED GUANINE NUCLEOTIDE EXCHANGE PROTEIN 2; BIG2	Periventricular heterotopia with microcephaly, 608097 (3)
CG4703-PA	608801	NP_039663	2e-38	GCDH		Glutaricaciduria, type I, 231670 (3)
CG11354-PA	600577	NP_055379	2e-38	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG15782-PA	605020	NP_055403	2e-38	KTCN;PPCD;PPD;RINX;VSX1	CRANIOFACIAL ANOMALIES, EMPTY SELLA TURCICA, CORNEAL ENDOTHELIAL CHANGES,;RETINAL INNER NUCLEAR LAYER HOMEOBOX; RINX	Corneal dystrophy, hereditary polymorphous posterior, 122000 (3);Craniofacial anomalies, empty sella turcica, corneal endothelial changes, and abnormal retinal and auditory bipolar cells (3);Keratoconus, 148300 (3)
CG1257-PA	100740	NP_056646	2e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG5030-PA	100740	NP_056646	2e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG10755-PA	124010	NP_059488	2e-38		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG9081-PA	124010	NP_059488	2e-38		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG9138-PA	600985	NP_061978	2e-38	TNX;TNXB;TNXB1;TNXB2;TNXBS	HEXABRACHION-LIKE; HXBL;TENASCIN X; TNX	Ehlers-Danlos due to tenascin X deficiency, 606408 (3);Ehlers-Danlos syndrome, hypermobility type, 130020 (3)
CG3969-PA	164761	NP_065681	2e-38	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3969-PB	164761	NP_065681	2e-38	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG8424-PA	300427	NP_065793	2e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3969-PA	164761	NP_066124	2e-38	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG3969-PB	164761	NP_066124	2e-38	MEN2A;RET	RET PROTOONCOGENE	Central hypoventilation syndrome, congenital, 209880 (3);Hirschsprung disease, 142623 (3);Medullary thyroid carcinoma, 155240 (3);Multiple endocrine neoplasia IIA, 171400 (3);Multiple endocrine neoplasia IIB, 162300 (3);Pheochromocytoma, 171300 (3)
CG5751-PA	106410	NP_066187	2e-38	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG30171-PB	608630	NP_071765	2e-38	HGPPS;RBIG1;RIG1;ROBO3	RB-INHIBITING GENE 1; RBIG1; RIG1	Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
CG4822-PA	605460	NP_071882	2e-38	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG4822-PB	605460	NP_071882	2e-38	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG4822-PC	605460	NP_071882	2e-38	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG4822-PD	605460	NP_071882	2e-38	ABCG8	STEROLIN 2	Sitosterolemia, 210250 (3)
CG1299-PA	605511	NP_076927	2e-38	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG1299-PA	605511	NP_115777	2e-38	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG1299-PA	605511	NP_115780	2e-38	DFNB10;DFNB8;ECHOS1;TMPRSS3		Deafness, autosomal recessive 10, congenital, 605316 (3);Deafness, autosomal recessive 8, childhood onset, 601072 (3)
CG6600-PA	607096	NP_653186	2e-38	OAT4L;SLC22A12;URAT1	ORGANIC ANION TRANSPORTER 4-LIKE; OAT4L;URATE TRANSPORTER 1; URAT1	Hypouricemia, renal, 220150 (3)
CG11354-PA	600577	NP_835258	2e-38	LHX3	LIM3	Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)
CG8424-PA	300427	NP_851849	2e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG5022-PA	300628	NP_919253	2e-38	FRMD7		Nystagmus 1, congenital, X-linked, 310700 (3)
CG1954-PA	603072	NP_940835	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1954-PA	603072	NP_940836	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1954-PA	603072	NP_940837	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1954-PA	603072	NP_940838	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG1954-PA	603072	NP_940839	2e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG10776-PA	601284	NP_000011	3e-38	ACVRL1;ACVRLK1;ALK1;HHT2	ACTIVIN A RECEPTOR, TYPE II-LIKE KINASE 1; ACVRLK1;ACTIVIN RECEPTOR-LIKE KINASE 1; ALK1	Hereditary hemorrhagic telangiectasia-2, 600376 (3)
CG18247-PA	600173	NP_000206	3e-38	JAK3;JAKL	JANUS KINASE, LEUKOCYTE; JAKL;LJAK	SCID, autosomal recessive, T-negative/B-positive type (3)
CG1495-PD	172471	NP_000285	3e-38	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG1495-PH	172471	NP_000285	3e-38	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG13744-PA	173350	NP_000292	3e-38	PLG		Conjunctivitis, ligneous, 217090 (3);Plasminogen deficiency, types I and II (1);Plasminogen Tochigi disease (3);Thrombophilia, dysplasminogenemic (1)
CG4821-PA	173350	NP_000292	3e-38	PLG		Conjunctivitis, ligneous, 217090 (3);Plasminogen deficiency, types I and II (1);Plasminogen Tochigi disease (3);Thrombophilia, dysplasminogenemic (1)
CG4821-PB	173350	NP_000292	3e-38	PLG		Conjunctivitis, ligneous, 217090 (3);Plasminogen deficiency, types I and II (1);Plasminogen Tochigi disease (3);Thrombophilia, dysplasminogenemic (1)
CG4821-PD	173350	NP_000292	3e-38	PLG		Conjunctivitis, ligneous, 217090 (3);Plasminogen deficiency, types I and II (1);Plasminogen Tochigi disease (3);Thrombophilia, dysplasminogenemic (1)
CG9027-PA	147450	NP_000445	3e-38	ALS1;SOD1	INDOPHENOLOXIDASE A; IPOA;SOD, SOLUBLE;SUPEROXIDE DISMUTASE, COPPER-ZINC;SUPEROXIDE DISMUTASE, CYSTOLIC;SUPEROXIDE DISMUTASE, SOLUBLE	Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)
CG9027-PB	147450	NP_000445	3e-38	ALS1;SOD1	INDOPHENOLOXIDASE A; IPOA;SOD, SOLUBLE;SUPEROXIDE DISMUTASE, COPPER-ZINC;SUPEROXIDE DISMUTASE, CYSTOLIC;SUPEROXIDE DISMUTASE, SOLUBLE	Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)
CG7529-PA	100740	NP_000656	3e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG8127-PA	170998	NP_001001928	3e-38	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PA	170998	NP_001001929	3e-38	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8127-PA	170998	NP_001001930	3e-38	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG4843-PA	191010	NP_001018020	3e-38	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG4843-PB	191010	NP_001018020	3e-38	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG7461-PA	609576	NP_001599	3e-38	ACADL;LCAD		Acyl-CoA dehydrogenase, long chain, deficiency of, 201460 (3)
CG4914-PA	606635	NP_002763	3e-38	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG14857-PA	604190	NP_003050	3e-38	OCTN1;SLC22A4	OCTN1	{Rheumatoid arthritis, susceptibility to}, 180300 (3)
CG3044-PA	600031	NP_003456	3e-38	CHIT	CHITINASE; CHIT;CHITOTRIOSIDASE;METHYLUMBELLIFERYL-TETRA-N-ACETYLCHITOTETRAOSIDE HYDROLASE	[Chitotriosidase deficiency] (3)
CG8127-PA	170998	NP_005027	3e-38	PPAR;PPARA	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR	{Hyperapobetalipoproteinemia, susceptibility to} (3)
CG8874-PA	604705	NP_006334	3e-38	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8874-PB	604705	NP_006334	3e-38	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8874-PC	604705	NP_006334	3e-38	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG8874-PD	604705	NP_006334	3e-38	MERTK		Retinitis pigmentosa, MERTK-related, 268000 (3)
CG7529-PA	100740	NP_056646	3e-38	ACHE;YT	ACETYLCHOLINE ACETYLHYDROLASE	[Blood group, Yt system], 112100 (3)
CG16801-PA	604485	NP_057430	3e-38	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG1131-PA	300427	NP_065793	3e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG1716-PA	606681	NP_071900	3e-38	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG6660-PA	605512	NP_073563	3e-38	ADMD;ELOVL4;STGD2;STGD3		Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3);Stargardt disease 3, 600110 (3)
CG31721-PA	300552	NP_150633	3e-38	BBBG1;FXY;MID1;OGS1;OSX	FINGER ON X AND Y, MOUSE, HOMOLOG OF; FXY;MIDIN;MIDLINE 1 RING FINGER GENE	Opitz G syndrome, type I, 300000 (3)
CG1716-PA	606681	NP_758859	3e-38	ARA267;NSD1;STO	ANDROGEN RECEPTOR-ASSOCIATED COREGULATOR 267; ARA267;DOMAIN PROTEIN 1; NSD1;SET DOMAIN PROTEIN 1	Beckwith-Wiedemann syndrome, 130650 (3);Leukemia, acute myeloid, 601626 (1);Sotos syndrome, 117550 (3);Weaver syndrome, 277590 (3)
CG1131-PA	300427	NP_851849	3e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG18085-PA	176947	NP_997402	3e-38	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG8137-PA	107400	NP_000286	4e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG12172-PA	314200	NP_000345	4e-38	TBG	T4-BINDING GLOBULIN;TBG, SERUM	Thyroxine-binding globulin deficiency (3)
CG7446-PA	137163	NP_000806	4e-38		GABA-A RECEPTOR, DELTA POLYPEPTIDE	
CG8137-PA	107400	NP_001002235	4e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG8137-PA	107400	NP_001002236	4e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG12559-PB	300203	NP_001032420	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG12559-PC	300203	NP_001032420	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG12559-PD	300203	NP_001032420	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG8246-PA	607108	NP_001595	4e-38	AN2;MGDA;PAX6		Cataract, congenital, with late-onset corneal dystrophy (3);Ectopia pupillae, 129750 (3);Eye anomalies, multiplex (3);Foveal hypoplasia, isolated, 136520 (3);Keratitis, 148190 (3);Peters anomaly, 603807 (3)
CG3456-PA	600682	NP_003042	4e-38	MCT1;SLC16A1	1; SLC16A1;MONOCARBOXYLATE TRANSPORTER 1; MCT1	Erythrocyte lactate transporter defect, 245340 (3)
CG12559-PB	300203	NP_003150	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG12559-PC	300203	NP_003150	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG12559-PD	300203	NP_003150	4e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG9913-PA	602821	NP_004975	4e-38	KIF5A;NKHC;SPG10	KINESIN, HEAVY CHAIN, NEURON-SPECIFIC; NKHC	Spastic paraplegia 10, 604187 (3)
CG3051-PA	605437	NP_006246	4e-38	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG3051-PB	605437	NP_006246	4e-38	PKCL;PRKCH;PRKCL	PKCL; PRKCL	{Cerebral infarction, susceptibility to}, 601367 (3)
CG7180-PA	600716	NP_036543	4e-38	LYP;PEP;PTPN22;PTPN8	FORMERLY;LYMPHOID PHOSPHATASE; LYP;PEST-DOMAIN PHOSPHATASE; PEP;PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY; PTPN8,	{Diabetes mellitus, insulin-dependent, susceptibility to}, 222100 (3);{Rheumatoid arthritis, susceptibility to}, 180300 (3);{Systemic lupus erythematosus, susceptibility to}, 152700 (3)
CG3902-PA	608801	NP_039663	4e-38	GCDH		Glutaricaciduria, type I, 231670 (3)
CG16801-PB	604485	NP_057430	4e-38	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG4881-PA	607343	NP_065169	4e-38	SALL4;HSAL4	HSAL4	Duane-radial ray syndrome, 607323 (3)
CG4881-PB	607343	NP_065169	4e-38	SALL4;HSAL4	HSAL4	Duane-radial ray syndrome, 607323 (3)
CG1082-PA	300427	NP_065793	4e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG7529-PA	300427	NP_065793	4e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG14992-PA	176943	NP_075259	4e-38	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG3936-PA	608548	NP_114141	4e-38	FBLN6;FIBL6;HMCN1	FIBL6;FIBULIN 6; FBLN6	Macular degeneration, age-related, 1, 603075 (3)
CG8585-PA	152427	NP_742054	4e-38	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG1082-PA	300427	NP_851849	4e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG7529-PA	300427	NP_851849	4e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4821-PA	601969	XP_001133592	4e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PB	601969	XP_001133592	4e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PD	601969	XP_001133592	4e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG14992-PA	176943	NP_000132	5e-38	BEK;CFD1;FGFR2;JWS	FGF RECEPTOR;PROTEIN TYROSINE KINASE, RECEPTOR-LIKE, 14; TK14	Apert syndrome, 101200 (3);Beare-Stevenson cutis gyrata syndrome, 123790 (3);Crouzon syndrome, 123500 (3);Jackson-Weiss syndrome, 123150 (3);Pfeiffer syndrome, 101600 (3);Saethre-Chotzen syndrome, 101400 (3)
CG8585-PA	152427	NP_000229	5e-38	HERG;KCNH2;LQT2;SQT1	ERG1;ETHER-A-GO-GO-RELATED GENE, HUMAN;HUMAN ETHER-A-GO-GO-RELATED GENE; HERG	Long QT syndrome-2 (3);Short QT syndrome-1, 609620 (3);{Long QT syndrome, acquired, susceptibility to} (3)
CG30281-PA	134820	NP_000499	5e-38	FGA	FIBRINOGEN--ALPHA POLYPEPTIDE CHAIN	Afibrinogenemia, congenital, 202400 (3);Amyloidosis, hereditary renal, 105200 (3);Dysfibrinogenemia, alpha type, causing bleeding diathesis (3);Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)
CG15077-PA	118485	NP_000772	5e-38	CYP11A;P450SCC	CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME;CYP11A;CYTOCHROME P450 SIDE-CHAIN CLEAVAGE ENZYME;CYTOCHROME P450C11A1;CYTOCHROME P450SCC	Adrenal insufficiency, congenital with or without 46, XY sex reversal (3);Lipoid congenital adrenal hyperplasia, 201710 (3)
CG32703-PA	300203	NP_001032420	5e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG9460-PA	107280	NP_001076	5e-38	AACT;ACT;SERPINA3	ANTICHYMOTRYPSIN, ALPHA-1; ACT;SERPINA3	Alpha-1-antichymotrypsin deficiency (3);Cerebrovascular disease, occlusive (3)
CG5751-PA	106410	NP_001139	5e-38	ANK2;LQT4	ANKYRIN, BRAIN;ANKYRIN, NEURONAL;ANKYRIN, NONERYTHROID;ANKYRIN-B	Long QT syndrome-4, 600919 (3)
CG11895-PA	114021	NP_001784	5e-38	CDH3;CDHP;HJMD;PCAD	CADHERIN, PLACENTAL;CALCIUM-DEPENDENT ADHESION PROTEIN, PLACENTAL;CDHP;P-CADHERIN; PCAD	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)
CG12350-PA	276000	NP_002760	5e-38	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG12386-PA	601564	NP_002761	5e-38	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG5197-PA	601564	NP_002761	5e-38	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG32703-PA	300203	NP_003150	5e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG17528-PA	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_003591	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG7524-PB	136351	NP_004110	5e-38	FLT3	FLK2;STEM CELL TYROSINE KINASE 1; STK1	Leukemia, acute lymphoblastic (3);Leukemia, acute myeloid, 601626 (3);Leukemia, acute myeloid, reduced survival in (3)
CG8049-PA	147796	NP_004963	5e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG8049-PB	147796	NP_004963	5e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG8049-PC	147796	NP_004963	5e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG8049-PD	147796	NP_004963	5e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG8874-PA	173490	NP_006197	5e-38	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8874-PB	173490	NP_006197	5e-38	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8874-PC	173490	NP_006197	5e-38	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG8874-PD	173490	NP_006197	5e-38	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG18559-PA	124010	NP_059488	5e-38		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG5137-PA	124010	NP_059488	5e-38		CYP3; CYP3A;CYTOCHROME P450PCN1;GLUCOCORTICOID-INDUCIBLE P450; P450C3;NIFEDIPINE OXIDASE;P450, FAMILY III;P450-III, STEROID-INDUCIBLE	
CG9372-PA	606797	NP_068813	5e-38	MTSP1;ST14	MATRIPTASE;MEMBRANE-TYPE SERINE PROTEASE 1; MTSP1	Ichthyosis with hypotrichosis, 610765 (3)
CG17528-PA	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_940835	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PA	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_940836	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PA	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_940837	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PA	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_940838	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PA	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PB	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PC	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG17528-PD	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PA	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG3051-PB	603072	NP_940839	5e-38	ARK1;AURKA;AURORA2;BTAK;STK15	AURORA-RELATED KINASE 1; ARK1;AURORA2;BTAK;SERINE/THREONINE PROTEIN KINASE 15; STK15;STK6, MOUSE, HOMOLOG OF	{Colon cancer, susceptibility to}, 114500 (3)
CG4225-PA	603234	XP_001125860	5e-38	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG6989-PA	126453	NP_000789	6e-38	DRD1B;DRD1L2;DRD5	DOPAMINE RECEPTOR D1B; DRD1B	Dystonia, primary cervical (3);{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3);{Blepharospasm, primary benign}, 606798 (3)
CG3941-PA	300573	NP_001034980	6e-38	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG3941-PB	300573	NP_001034980	6e-38	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG18085-PA	176947	NP_001070	6e-38	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG31045-PC	160741	NP_002463	6e-38	MYH8	MYHC-PERI;MYHC-PN;MYOSIN, HEAVY CHAIN, PERINATAL	Carney complex variant, 608837 (3);Trismus-pseudocamptodactyly syndrome, 158300 (3)
CG8213-PA	606635	NP_002763	6e-38	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG9064-PA	601693	NP_003346	6e-38	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG4926-PA	131550	NP_005219	6e-38	EGFR	ERBB1;ONCOGENE ERBB;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3);Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3);{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)
CG10002-PA	602402	NP_005242	6e-38	FKHL14;FOXC2;MFH1	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 14; FKHL14;LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS,;MESENCHYME FORKHEAD 1; MFH1	Lymphedema and ptosis, 153000 (3);Lymphedema, hereditary II, 153200 (3);Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus (3);Lymphedema-distichiasis syndrome, 153400 (3);Yellow nail syndrome, 153300 (3)
CG3156-PA	601439	NP_005682	6e-38	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG3156-PA	601439	NP_064694	6e-38	ABCC9;CMD1O;SUR2	SULFONYLUREA RECEPTOR 2; SUR2	Cardiomyopathy, dilated, 1O, 608569 (3)
CG6464-PA	607343	NP_065169	6e-38	SALL4;HSAL4	HSAL4	Duane-radial ray syndrome, 607323 (3)
CG1128-PB	300427	NP_065793	6e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG7221-PA	608830	NP_689656	6e-38	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG1128-PB	300427	NP_851849	6e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG4722-PA	107776	NP_932766	6e-38	AQP1;CHIP28;CO	AQP-CHIP;AQUAPORIN-CHIP;CHANNEL-LIKE INTEGRAL MEMBRANE PROTEIN, 28-KD; CHIP28	[Aquaporin-1 deficiency] (3);[Blood group, Colton], 110450 (3)
CG32134-PA	176947	NP_997402	6e-38	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG14992-PA	147670	NP_000199	7e-38	HHF5;INSR		Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3);Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3);Leprechaunism, 246200 (3);Rabson-Mendenhall syndrome, 262190 (3)
CG4225-PA	603234	NP_001162	7e-38	ABC34;ABCC6;ARA;MLP1;PXE	ANTHRACYCLINE RESISTANCE-ASSOCIATED PROTEIN; ARA;MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 6; MRP6	Pseudoxanthoma elasticum, autosomal dominant, 177850 (3);Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)
CG32465-PB	114840	NP_001798	7e-38	BSSL;CEL;CELL;MODY8	BILE SALT-DEPENDENT LIPASE; BSDL;BILE SALT-STIMULATED LIPASE; BSSL;CARBOXYL-ESTER HYDROLASE;CHOLESTEROL ESTERASE;LYSOPHOSPHOLIPASE	Maturity-onset diabetes of the young, type VIII, 609812 (3)
CG1907-PA	601693	NP_003346	7e-38	UCP2		{Obesity, susceptibility to}, 601665 (3)
CG4879-PA	603780	NP_004251	7e-38	RECQ4;RECQL4;RTS	DNA HELICASE, RECQ-LIKE, TYPE 4; RECQ4	Baller-Gerold syndrome, 218600 (3);RAPADILINO syndrome, 266280 (3);Rothmund-Thomson syndrome, 268400 (3)
CG4879-PB	603780	NP_004251	7e-38	RECQ4;RECQL4;RTS	DNA HELICASE, RECQ-LIKE, TYPE 4; RECQ4	Baller-Gerold syndrome, 218600 (3);RAPADILINO syndrome, 266280 (3);Rothmund-Thomson syndrome, 268400 (3)
CG4821-PA	601969	NP_004397	7e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PB	601969	NP_004397	7e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PD	601969	NP_004397	7e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG18247-PA	147796	NP_004963	7e-38	JAK2		Leukemia, acute myelogenous, 601626 (3);Myelofibrosis, idiopathic, 254450 (3);Polycythemia vera, 263300 (3);Thrombocythemia, essential, 187950 (3);{Budd-Chiari syndrome}, 600880 (3)
CG12201-PA	603859	NP_055066	7e-38	CTLN2;SLC25A13	CITRIN	Citrullinemia, adult-onset type II, 603471 (3);Citrullinemia, type II, neonatal-onset, 605814 (3)
CG10877-PA	604489	NP_055139	7e-38	AMACR		Alpha-methylacyl-CoA racemase deficiency (3)
CG3277-PA	134934	NP_075254	7e-38	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG3277-PB	134934	NP_075254	7e-38	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG9770-PA	607521	NP_852608	7e-38	HPS5;RU2;KIAA1017	ALPHA-INTEGRIN-BINDING PROTEIN 63;KIAA1017;RUBY-EYE 2, MOUSE, HOMOLOG OF; RU2	Hermansky-pudlak syndrome 5, 203300 (3)
CG9547-PA	606885	NP_000008	8e-38	ACADS;SCAD	ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAIN;SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD	Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
CG1031-PA	177400	NP_000046	8e-38	BCHE;CHE1	ACYLCHOLINE ACYLHYDROLASE;BUTYRYLCHOLINESTERASE DEFICIENCY, FLUORIDE-RESISTANT, JAPANESE TYPE,;PSEUDOCHOLINESTERASE E1; CHE1	Apnea, postanesthetic (3)
CG3277-PA	134934	NP_000133	8e-38	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG3277-PB	134934	NP_000133	8e-38	ACH;FGFR3		Achondroplasia, 100800 (3);Bladder cancer, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 109800 (3);Crouzon syndrome with acanthosis nigricans (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Thanatophoric dysplasia, types I and II, 187600 (3)
CG4600-PA	143450	NP_000174	8e-38	HADHB	BETA SUBUNIT; HADHB;ECHB;MITOCHONDRIAL TRIFUNCTIONAL PROTEIN, BETA SUBUNIT;TRIFUNCTIONAL PROTEIN, BETA SUBUNIT	Trifunctional protein deficiency, type II (3)
CG9453-PB	107400	NP_000286	8e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG18741-PA	109630	NP_000675	8e-38	ADRB1;ADRB1R;RHR	ADRB1R;B1AR	[Resting heart rate], 607276 (3);{congestive heart failure, susceptibility to} (3)
CG18741-PB	109630	NP_000675	8e-38	ADRB1;ADRB1R;RHR	ADRB1R;B1AR	[Resting heart rate], 607276 (3);{congestive heart failure, susceptibility to} (3)
CG6919-PA	126451	NP_000787	8e-38	DRD3;ETM1;FET1		{Essential tremor, susceptibility to}, 190300 (3);{Schizophrenia, susceptibility to}, 181500 (3)
CG9453-PB	107400	NP_001002235	8e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG9453-PB	107400	NP_001002236	8e-38	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG31003-PA	300203	NP_001032420	8e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG33173-PA	601615	NP_001080	8e-38	ABC3;ABCA3	ABC TRANSPORTER 3;ATP-BINDING CASSETTE 3; ABC3;ATP-BINDING CASSETTE TRANSPORTER 3;CED7, C. ELEGANS, HOMOLOG OF	Surfactant deficiency, neonatal, 267450 (3)
CG7100-PD	114021	NP_001784	8e-38	CDH3;CDHP;HJMD;PCAD	CADHERIN, PLACENTAL;CALCIUM-DEPENDENT ADHESION PROTEIN, PLACENTAL;CDHP;P-CADHERIN; PCAD	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)
CG7100-PE	114021	NP_001784	8e-38	CDH3;CDHP;HJMD;PCAD	CADHERIN, PLACENTAL;CALCIUM-DEPENDENT ADHESION PROTEIN, PLACENTAL;CDHP;P-CADHERIN; PCAD	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)
CG7100-PF	114021	NP_001784	8e-38	CDH3;CDHP;HJMD;PCAD	CADHERIN, PLACENTAL;CALCIUM-DEPENDENT ADHESION PROTEIN, PLACENTAL;CDHP;P-CADHERIN; PCAD	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)
CG7100-PG	114021	NP_001784	8e-38	CDH3;CDHP;HJMD;PCAD	CADHERIN, PLACENTAL;CALCIUM-DEPENDENT ADHESION PROTEIN, PLACENTAL;CDHP;P-CADHERIN; PCAD	Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)
CG1299-PA	606635	NP_002763	8e-38	PRSS7;ENTK	ENTEROKINASE; ENTK;PROENTEROKINASE	Enterokinase deficiency, 226200 (3)
CG31003-PA	300203	NP_003150	8e-38	CDKL5;ISSX;STK9	SERINE/THREONINE PROTEIN KINASE 9; STK9	Infantile spasm syndrome, X-linked, 308350 (3);Rett syndrome, atypical, 312750 (3)
CG4376-PC	300377	NP_003997	8e-38	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG3320-PA	603868	NP_004571	8e-38	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG1031-PA	300427	NP_065793	8e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG33171-PC	120328	NP_569712	8e-38	COL18A1;KNO		Knobloch syndrome, 267750 (3)
CG11200-PA	608830	NP_689656	8e-38	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG11200-PB	608830	NP_689656	8e-38	LCA3;RDH12	RETINOL DEHYDROGENASE, ALL-TRANS AND 9-CIS	Leber congenital amaurosis, type III, 604232 (3)
CG1031-PA	300427	NP_851849	8e-38	ASPGX2;AUTSX2;KIAA1260;NLGN4	KIAA1260	Mental retardation, X-linked, 300495 (3);{Asperger syndrome, susceptibility to, X-linked-2}, 300497 (3);{Autism, susceptibility to, X-linked-2}, 300495 (3)
CG3320-PA	603868	NP_899057	8e-38	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG3320-PA	603868	NP_899058	8e-38	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG3320-PA	603868	NP_899059	8e-38	GS2;RAB27A;RAM	RAB27;RAS-RELATED GENE FROM MEGAKARYOCYTE; RAM	Griscelli syndrome, type 2, 607624 (3)
CG12289-PA	229800	NP_000212	9e-38	KHK	HEPATIC FRUCTOKINASE DEFICIENCY;KETOHEXOKINASE DEFICIENCY	[Fructosuria] (3)
CG4821-PA	176860	NP_000303	9e-38	PROC	PC DEFICIENCY;PROC DEFICIENCY;THROMBOPHILIA, HEREDITARY;THROMBOPHILIA, HEREDITARY, DUE TO PC DEFICIENCY	Purpura fulminans, neonatal (1);Thrombophilia due to protein C deficiency (3)
CG4821-PB	176860	NP_000303	9e-38	PROC	PC DEFICIENCY;PROC DEFICIENCY;THROMBOPHILIA, HEREDITARY;THROMBOPHILIA, HEREDITARY, DUE TO PC DEFICIENCY	Purpura fulminans, neonatal (1);Thrombophilia due to protein C deficiency (3)
CG4821-PD	176860	NP_000303	9e-38	PROC	PC DEFICIENCY;PROC DEFICIENCY;THROMBOPHILIA, HEREDITARY;THROMBOPHILIA, HEREDITARY, DUE TO PC DEFICIENCY	Purpura fulminans, neonatal (1);Thrombophilia due to protein C deficiency (3)
CG32540-PA	118444	NP_000721	9e-38			
CG30025-PA	276000	NP_002760	9e-38	PRSS1;TRY1	TRYPSIN 1;TRYPSINOGEN 1; TRY1;TRYPSINOGEN, CATIONIC	Pancreatitis, hereditary, 167800 (3);Trypsinogen deficiency (1)
CG4007-PA	190090	NP_005408	9e-38	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG4821-PA	601969	NP_015568	9e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PB	601969	NP_015568	9e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PD	601969	NP_015568	9e-38	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4613-PA	264900	NP_062505	9e-38	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4007-PA	190090	NP_938033	9e-38	ASV;SRC;SRC1	AVIAN SARCOMA VIRUS; ASV;ONCOGENE SRC;PROTOONCOGENE SRC;SRC ONCOGENE	Colon cancer, advanced (3)
CG3104-PA	182900	NP_000028	1e-37	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG3104-PB	182900	NP_000028	1e-37	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG4376-PC	300377	NP_000100	1e-37	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG4613-PA	264900	NP_000119	1e-37	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG9372-PA	264900	NP_000119	1e-37	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG4316-PA	306900	NP_000124	1e-37	F9;HEMB	CHRISTMAS DISEASE;FACTOR IX DEFICIENCY;PLASMA THROMBOPLASTIN COMPONENT; PTC	Hemophilia B (3);Warfarin sensitivity (3)
CG5372-PA	147556	NP_000201	1e-37	ITGA6		Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)
CG1389-PA	164860	NP_000236	1e-37	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG18247-PA	164860	NP_000236	1e-37	MET	HEPATOCYTE GROWTH FACTOR RECEPTOR; HGFR;ONCOGENE MET;RENAL CELL CARCINOMA, PAPILLARY, 2 GENE; RCCP2	Hepatocellular carcinoma, childhood type, 114550 (3);Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)
CG30132-PB	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG30132-PC	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG30132-PD	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG30132-PE	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG30132-PF	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG30132-PG	172471	NP_000285	1e-37	PHKG2		Glycogenosis, hepatic, autosomal (3)
CG9460-PA	107400	NP_000286	1e-37	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG1520-PC	300392	NP_000368	1e-37	IMD2;THC;WAS	WAS PROTEIN; WASP	Neutropenia, severe congenital, X-linked, 300299 (3);Thrombocytopenia, X-linked, 313900 (3);Thrombocytopenia, X-linked, intermittent, 313900 (3);Wiskott-Aldrich syndrome, 301000 (3)
CG3499-PB	602136	NP_000457	1e-37	PEX1;ZWS1	PEROXIN 1	Adrenoleukodystrophy, neonatal, 202370 (3);Refsum disease, infantile, 266510 (3);Zellweger syndrome-1, 214100 (3)
CG4120-PA	610613	NP_000488	1e-37	CYP11B1;P450C11;FHI	P450C11;STEROID 11-BETA-HYDROXYLASE	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3);Aldosteronism, glucocorticoid-remediable, 103900 (3)
CG31661-PA	179820	NP_000528	1e-37	REN		Renal tubular dysgenesis, 267430 (3);[Hyperproreninemia] (3)
CG12344-PA	137192	NP_000805	1e-37	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG6927-PA	137192	NP_000805	1e-37	GABRB3	GABA-A RECEPTOR, BETA-3 POLYPEPTIDE	Insomnia (3) (?)
CG10129-PA	229000	NP_000883	1e-37	KLK3;KLKB1	FLETCHER FACTOR DEFICIENCY; PKK DEFICIENCY;KLK3, FORMERLY	Fletcher factor deficiency (1);Prekallikrein deficiency (3)
CG9460-PA	107400	NP_001002235	1e-37	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG9460-PA	107400	NP_001002236	1e-37	PI;AAT;SERPINA1	ALPHA-1-ANTITRYPSIN; AAT;ANTI-ELASTASE;ANTITRYPSIN;PI1;SERPINA1	Emphysema (3);Emphysema-cirrhosis (3);Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3);{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)
CG4898-PA	191010	NP_001018020	1e-37	CMH3;TPM1	TROPOMYOSIN, SKELETAL MUSCLE ALPHA; TMSA	Cardiomyopathy, familial hypertrophic, 3, 115196 (3)
CG7204-PA	300573	NP_001034980	1e-37	ZNF674;MRX92		Mental retardation, X-linked-92 (3)
CG32134-PA	176947	NP_001070	1e-37	SRK;STD;ZAP70	PROTEIN TYROSINE KINASE ZAP70;SYK-RELATED TYROSINE KINASE; SRK;ZETA-ASSOCIATED PROTEIN, 70-KD	Selective T-cell defect (3)
CG12172-PA	122500	NP_001747	1e-37	CBG	SERPINA6	[Transcortin deficiency] (1)
CG9547-PA	607036	NP_002216	1e-37	IVD		Isovaleric acidemia, 243500 (3)
CG12908-PA	603506	NP_002326	1e-37	BMND1;EVR4;LR3;LRP5;LRP7;OPPG;OPTA1;VBCH2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 7; LRP7;LR3	Exudative vitreoretinopathy 4, 601813 (3);Hyperostosis, endosteal, 144750 (3);Osteopetrosis, AD type I, 607634 (3);Osteoporosis-pseudoglioma syndrome, 259770 (3);Osteosclerosis, 144750 (3);van Buchem disease, type 2, 607636 (3);[Bone mineral density variability 1], 601884 (3);{Osteoporosis}, 166710 (3)
CG5363-PA	602897	NP_002744	1e-37	JNK3;MAPK10;PRKM10	C-JUN KINASE 3; JNK3;PROTEIN KINASE, MITOGEN-ACTIVATED, 10; PRKM10	Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
CG17571-PA	601564	NP_002761	1e-37	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG32755-PA	601564	NP_002761	1e-37	PRSS2;TRY2	TRYPSIN 2;TRYPSINOGEN 2; TRY2;TRYPSINOGEN, ANIONIC	{Pancreatitis, chronic, protection against} (3)
CG4376-PC	300377	NP_004000	1e-37	BMD;CMD3B;DMD		Becker muscular dystrophy, 300376 (3);Cardiomyopathy, dilated, 3B, 302045 (3);Duchenne muscular dystrophy, 310200 (3)
CG10023-PA	602337	NP_004551	1e-37	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG10023-PB	602337	NP_004551	1e-37	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG10023-PC	602337	NP_004551	1e-37	BDB;BDB1;NTRKR2;ROR2	NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 2; NTRKR2	Brachydactyly, type B1, 113000 (3);Robinow syndrome, autosomal recessive, 268310 (3)
CG31293-PA	601806	NP_005906	1e-37	MCM6		Hypolactasia, adult type, 223100 (3);{Tall stature, susceptibility to} (3)
CG8250-PA	173490	NP_006197	1e-37	PDGFRA	PDGFR2	Gastrointestinal stromal tumor, somatic, 606764 (3);Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)
CG3850-PA	603073	NP_009060	1e-37	HPE5;ZIC2	ZIC FAMILY MEMBER 2	Holoprosencephaly-5, 609637 (3)
CG10274-PA	314995	NP_009061	1e-37	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG8643-PA	314995	NP_009061	1e-37	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG9233-PA	314995	NP_009061	1e-37	MRX89;ZNF41		Mental retardation, X-linked-89 (3)
CG18076-PA	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PB	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PC	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PE	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PG	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG18076-PH	608441	NP_056108	1e-37	KIAA0796;KIAA1262;KIAA1756;SCAR8;SYNE1	KIAA0796;KIAA1262;KIAA1756;NESPRIN 1;NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 1	Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)
CG3277-PA	136350	NP_056934	1e-37	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG3277-PB	136350	NP_056934	1e-37	FGFR1;FLT2;KAL2	FMS-LIKE GENE; FLG;FMS-LIKE TYROSINE KINASE 2; FLT2	Jackson-Weiss syndrome, 123150 (3);Kallmann syndrome 2, 147950 (3);Pfeiffer syndrome, 101600 (3)
CG4380-PA	604485	NP_057430	1e-37	ESCS;NR2E3;PNR	PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR; PNR	Enhanced S-cone syndrome, 268100 (3);Retinitis pigmentosa, late onset, 268000 (3)
CG4821-PA	601969	NP_060049	1e-37	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PB	601969	NP_060049	1e-37	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG4821-PD	601969	NP_060049	1e-37	DMBT1	GLYCOPROTEIN 340;GP340;SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D-BINDING PROTEIN	Glioblastoma multiforme, somatic, 137800 (3);Medulloblastoma, 155255 (2)
CG9372-PA	264900	NP_062505	1e-37	F11	F11 DEFICIENCY;FACTOR XI DEFICIENCY;PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;ROSENTHAL SYNDROME	Factor XI deficiency, autosomal dominant (3);Factor XI deficiency, autosomal recessive (3)
CG3104-PA	182900	NP_065208	1e-37	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)
CG3104-PB	182900	NP_065208	1e-37	ANK1;SPH2	SPHEROCYTOSIS, SEVERE ATYPICAL, DUE TO SUSPECTED ANKYRIN DEFECT	Spherocytosis-2 (3)